data_2kdv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kdv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 mt . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.43 -66.16 0.59 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.096 0.872 . . . . 0.0 110.188 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -164.16 -53.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.918 0.487 . . . . 0.0 110.093 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.04 16.66 17.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 123.625 1.678 . . . . 0.0 110.746 -164.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.71 2.16 65.29 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 120.206 -1.558 . . . . 0.0 112.704 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -97.12 159.24 15.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.272 1.536 . . . . 0.0 109.035 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.16 142.03 28.66 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -80.93 144.59 15.21 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.934 1.756 . . . . 0.0 110.648 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.25 154.98 41.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.55 158.26 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.961 0.904 . . . . 0.0 109.126 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.16 162.1 26.81 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.27 144.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -172.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -128.17 136.46 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 mm -116.19 137.46 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 167.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 101' ' ' LEU . 2.1 p -124.12 162.31 23.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.543 1.639 . . . . 0.0 112.69 161.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -106.14 172.65 6.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.047 -2.342 . . . . 0.0 108.834 172.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.0 5.48 6.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -94.1 0.29 55.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.716 0.806 . . . . 0.0 110.975 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.45 21.81 76.73 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.551 0.614 . . . . 0.0 112.196 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -95.15 147.25 23.65 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.8 145.98 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ttm -67.02 145.48 55.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.592 -1.185 . . . . 0.0 107.897 169.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.807 ' HE1' ' HB3' ' A' ' 33' ' ' TRP . 1.8 t90 -144.23 141.14 29.68 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.438 ' N ' ' CD1' ' A' ' 24' ' ' TRP . . . -133.28 167.28 20.68 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 123.52 1.629 . . . . 0.0 115.331 173.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -125.27 124.24 41.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 120.97 -1.081 . . . . 0.0 108.669 -175.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -75.01 148.76 39.6 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.167 -169.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -54.77 132.89 46.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.292 1.62 . . . . 0.0 109.953 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -7.57 5.15 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.446 -1.196 . . . . 0.0 114.395 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -88.17 177.7 6.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -132.95 13.76 4.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.472 0.654 . . . . 0.0 109.853 165.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.89 154.49 21.51 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.807 ' HB3' ' HE1' ' A' ' 24' ' ' TRP 0.286 91.7 m95 -120.72 154.29 35.81 Favored 'General case' 0 N--CA 1.399 -2.977 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.715 -165.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.11 167.76 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.139 1.775 . . . . 0.0 110.952 -170.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -81.48 146.08 56.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.02 160.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -56.23 135.19 68.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.227 2.618 . . . . 0.0 110.666 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -159.53 171.09 20.3 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.236 0.926 . . . . 0.0 111.356 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.04 171.36 44.39 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.972 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.12 147.28 24.55 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.656 -0.908 . . . . 0.0 111.179 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 84.1 mt -74.25 123.12 28.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 165.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.32 155.71 91.16 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.9 124.74 15.54 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 N-CA-C 109.451 -1.019 . . . . 0.0 109.451 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.01 -9.81 76.77 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.803 -0.998 . . . . 0.0 114.322 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.35 151.71 44.93 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 119.683 1.742 . . . . 0.0 111.045 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.11 161.28 18.96 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 161.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.86 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 122.062 -0.398 . . . . 0.0 111.213 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.98 -35.06 74.14 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.971 -0.456 . . . . 0.0 111.016 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -70.08 -43.77 70.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.863 -1.148 . . . . 0.0 109.687 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.99 78.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 123.975 0.797 . . . . 0.0 109.557 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.483 ' SD ' HD13 ' A' ' 102' ' ' LEU . 13.3 tmm? -62.54 -48.86 77.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 35.0 m-85 -68.08 -38.3 82.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.87 0.759 . . . . 0.0 111.338 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.4 ttm-85 -60.07 -55.59 32.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.23 -28.52 64.24 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 tp -54.66 -48.33 72.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 120.442 -1.411 . . . . 0.0 109.699 169.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -60.28 -45.17 94.26 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 117.318 -1.325 . . . . 0.0 109.213 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.97 -31.9 73.36 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.586 1.539 . . . . 0.0 111.652 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -91.67 -49.23 6.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.282 0.947 . . . . 0.0 110.06 -171.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.92 -10.83 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 124.498 1.119 . . . . 0.0 112.27 -168.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.92 1.09 37.71 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 123.824 0.726 . . . . 0.0 113.918 -173.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD2' HD23 ' A' ' 104' ' ' LEU . 58.0 tp -83.23 150.33 26.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.075 1.35 . . . . 0.0 108.682 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.48 168.45 15.63 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.095 0.95 . . . . 0.0 108.731 -175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.487 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 28.4 mtt180 -48.7 -31.87 7.53 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 28.9 mmmt -61.78 -31.14 71.32 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.703 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -114.53 23.52 12.67 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 126.728 2.517 . . . . 0.0 108.23 -168.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.26 162.69 33.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 O-C-N 120.439 -1.413 . . . . 0.0 111.127 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.04 138.09 38.47 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 117.845 -1.074 . . . . 0.0 108.206 165.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.31 119.66 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.0 mt -98.67 -32.47 11.39 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.649 0.593 . . . . 0.0 110.872 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.5 165.56 35.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.5 p -157.3 157.52 34.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.726 1.21 . . . . 0.0 108.738 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -70.64 136.33 49.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.267 1.032 . . . . 0.0 110.633 -174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -81.98 -37.99 25.81 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.468 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -104.34 153.45 21.03 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.004 1.322 . . . . 0.0 108.139 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -84.24 134.91 34.52 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.026 -1.047 . . . . 0.0 108.425 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -89.31 98.71 11.92 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -97.92 147.64 24.26 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.88 153.63 39.36 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.717 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.13 143.49 27.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.488 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.13 150.94 83.56 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 123.863 0.727 . . . . 0.0 109.267 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.05 149.19 71.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.692 2.261 . . . . 0.0 109.225 160.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -67.9 -18.29 64.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -167.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -59.17 -30.56 68.28 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.953 -0.546 . . . . 0.0 112.003 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.38 -19.11 21.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.222 0.609 . . . . 0.0 111.09 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.5 136.55 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.15 75.44 1.37 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.079 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -56.3 -23.11 34.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -73.61 -28.18 61.68 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.078 0.551 . . . . 0.0 111.911 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.3 t -104.82 164.65 11.63 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.441 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -133.05 136.93 28.41 Favored Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.87 149.79 83.89 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 -16.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.97 136.53 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.104 0.961 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.4 p -88.05 132.29 34.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -12.54 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.118 0.567 . . . . 0.0 112.004 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.15 -177.69 41.15 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -153.58 158.1 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -105.48 134.91 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -117.58 130.92 56.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.898 1.279 . . . . 0.0 110.129 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -110.65 136.87 49.08 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -117.83 156.96 27.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -142.25 128.1 19.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.193 1.397 . . . . 0.0 107.748 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 16' ' ' CYS . 1.2 tp -95.6 127.34 41.55 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.483 HD13 ' SD ' ' A' ' 50' ' ' MET . 5.9 mt -115.84 152.57 33.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -100.69 134.85 43.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 159.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.443 HD23 ' CD2' ' A' ' 60' ' ' LEU . 1.6 mt -62.64 135.16 57.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 125.51 1.756 . . . . 0.0 109.298 169.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.5 t -88.72 -51.49 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -171.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -82.81 -17.3 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.8 0.727 . . . . 0.0 111.739 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.33 175.22 35.91 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.404 ' HB2' ' HE1' ' A' ' 126' ' ' TRP . 0.0 OUTLIER -51.89 -21.27 2.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.707 2.403 . . . . 0.0 114.301 -165.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.02 -31.24 40.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.334 1.454 . . . . 0.0 112.456 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.54 19.42 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.847 0.832 . . . . 0.0 112.503 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.17 135.74 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.51 -1.369 . . . . 0.0 108.385 171.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -134.35 109.11 8.58 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 125.724 1.609 . . . . 0.0 107.855 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.02 9.3 20.04 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.99 -1.069 . . . . 0.0 112.651 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 77.04 1.69 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 124.061 1.886 . . . . 0.0 107.777 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -73.75 -60.72 2.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.072 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -72.6 168.58 18.34 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.017 168.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.0 m -58.5 -39.2 79.4 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.954 -0.466 . . . . 0.0 110.446 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 132.6 62.67 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.38 133.59 50.14 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.587 1.524 . . . . 0.0 109.626 164.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -75.25 -26.76 59.11 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.903 0.858 . . . . 0.0 110.792 173.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -118.86 144.97 46.05 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 120.805 -1.185 . . . . 0.0 108.424 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.16 -31.05 22.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.007 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.76 158.95 27.93 Favored Glycine 0 C--N 1.335 0.524 0 O-C-N 120.689 -1.257 . . . . 0.0 111.012 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.73 155.15 42.18 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -150.89 165.59 33.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 108.304 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.404 ' HE1' ' HB2' ' A' ' 108' ' ' ASP . 67.3 m95 -112.78 137.93 50.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.45 152.97 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.94 1.296 . . . . 0.0 109.201 -168.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -59.97 147.47 38.79 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 117.178 -1.391 . . . . 0.0 109.536 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.12 66.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -93.06 -22.93 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.023 -1.048 . . . . 0.0 112.404 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.6 -37.79 55.01 Favored Pre-proline 0 CA--C 1.514 -0.415 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.009 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.637 ' CB ' ' CE3' ' A' ' 24' ' ' TRP . 10.9 Cg_endo -67.54 -37.18 17.6 Favored 'Trans proline' 0 N--CA 1.413 -3.254 0 N-CA-C 117.242 1.978 . . . . 0.0 117.242 -173.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.92 -25.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 112.73 -2.032 . . . . 0.0 109.115 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.02 -32.23 73.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.128 -1.607 . . . . 0.0 113.676 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 -24.82 33.19 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 124.075 0.859 . . . . 0.0 111.5 -168.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.53 167.08 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 122.008 0.908 . . . . 0.0 111.041 -171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.18 172.55 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 120.892 -1.13 . . . . 0.0 109.987 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 m -51.03 -50.0 59.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -79.34 -30.88 42.92 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.224 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -70.6 -38.44 74.01 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.004 -1.06 . . . . 0.0 110.374 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.41 -45.18 62.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.105 0.962 . . . . 0.0 111.866 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.35 -47.52 85.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.043 1.464 . . . . 0.0 108.463 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.38 -51.53 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.199 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -63.67 -37.77 88.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.068 0.849 . . . . 0.0 110.834 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -68.02 -38.81 83.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.432 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -58.82 -49.27 78.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.614 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.36 -39.14 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.623 1.169 . . . . 0.0 110.244 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -74.17 -55.47 6.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -36.45 74.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.624 0.647 . . . . 0.0 111.574 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 151' ' ' PHE . 4.6 tp10 -61.51 -30.82 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.791 0.836 . . . . 0.0 110.7 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 150' ' ' GLU . 0.8 OUTLIER -113.49 -13.41 12.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 0.0 109.798 -172.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.69 71.92 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.684 1.593 . . . . 0.0 110.848 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 m -66.24 -33.58 76.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.577 0.751 . . . . 0.0 111.029 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.8 t -68.86 -43.02 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.515 HG21 ' HG ' ' A' ' 16' ' ' CYS . 27.4 t -59.37 -42.24 86.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.587 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmt -55.96 -52.92 62.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.079 1.309 . . . . 0.0 109.384 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -68.63 -29.12 67.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.063 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.1 tp -69.09 -23.09 63.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.659 1.584 . . . . 0.0 111.596 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.92 -24.85 40.8 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 117.662 -3.149 . . . . 0.0 111.212 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 CA--C 1.498 -1.038 0 CA-C-N 120.234 1.379 . . . . 0.0 114.156 -167.434 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -72.18 -72.87 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.704 0.684 . . . . 0.0 112.079 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -162.25 -49.96 0.04 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.284 1.034 . . . . 0.0 111.669 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -91.46 15.28 12.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.945 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.8 0.81 77.87 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.726 1.155 . . . . 0.0 113.787 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -95.39 162.62 13.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.349 1.074 . . . . 0.0 108.227 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.4 146.16 24.11 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.049 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.27 131.07 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.603 2.202 . . . . 0.0 111.526 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -128.51 157.97 39.69 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.381 1.472 . . . . 0.0 109.228 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.97 164.17 34.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.53 163.53 30.77 Favored Glycine 0 C--N 1.33 0.226 0 O-C-N 121.402 -0.811 . . . . 0.0 112.627 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.07 140.33 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 124.777 1.231 . . . . 0.0 108.582 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.22 137.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.5 mm -111.44 145.22 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.623 1.101 . . . . 0.0 108.054 169.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 p -120.72 150.32 41.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.632 0.773 . . . . 0.0 111.045 169.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -108.29 168.76 9.08 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.747 1.219 . . . . 0.0 108.191 170.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.28 3.82 6.7 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 119.915 -1.741 . . . . 0.0 113.606 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -88.51 -4.78 58.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.353 1.061 . . . . 0.0 110.892 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.26 13.55 83.17 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.896 -0.947 . . . . 0.0 112.296 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -81.9 147.85 29.08 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.175 1.487 . . . . 0.0 107.668 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 m -103.04 149.71 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.777 1.231 . . . . 0.0 108.815 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.67 142.45 30.76 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.147 0.979 . . . . 0.0 109.026 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -146.08 146.77 31.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.319 1.448 . . . . 0.0 108.617 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.43 166.66 29.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.026 1.285 . . . . 0.0 111.82 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -126.8 135.17 50.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.371 1.069 . . . . 0.0 108.828 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -64.96 154.79 36.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 109.7 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.91 128.62 38.0 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.89 0.23 90.1 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.415 -1.214 . . . . 0.0 113.962 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -112.23 150.25 31.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.474 1.637 . . . . 0.0 111.224 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -96.4 -16.2 21.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.154 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 p -83.98 134.68 34.64 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.277 1.431 . . . . 0.0 109.779 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -92.28 153.58 19.15 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.66 0.784 . . . . 0.0 110.729 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -150.39 156.89 42.35 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.967 1.707 . . . . 0.0 109.361 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.89 139.16 69.53 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.65 129.27 13.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.086 2.524 . . . . 0.0 111.455 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -155.43 158.26 38.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 112.598 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.47 -169.74 20.86 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.821 1.677 . . . . 0.0 110.327 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.55 145.99 18.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.43 1.491 . . . . 0.0 110.636 -172.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.26 135.51 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -81.22 156.19 71.72 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.63 121.29 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.07 -2.48 85.47 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.32 -1.267 . . . . 0.0 114.411 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.56 156.05 39.85 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 120.598 2.199 . . . . 0.0 110.286 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -93.08 152.81 19.06 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 168.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.69 80.63 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.302 -0.874 . . . . 0.0 111.837 -172.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.46 -36.43 78.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.61 0.764 . . . . 0.0 110.092 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -68.52 -41.64 79.67 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.04 89.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -60.06 -50.89 71.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.755 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 58.0 m-85 -67.06 -37.35 83.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.39 0.995 . . . . 0.0 112.068 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -63.43 -50.3 70.31 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.579 1.536 . . . . 0.0 109.172 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -71.59 -32.71 68.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -170.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 tp -53.77 -49.64 67.79 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.634 1.174 . . . . 0.0 110.147 169.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.29 -35.76 81.21 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.423 0.556 . . . . 0.0 110.651 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -70.12 -35.2 73.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.919 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.96 -38.38 5.35 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.553 1.07 . . . . 0.0 113.627 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 t -92.62 -31.74 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.196 0.999 . . . . 0.0 108.604 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 0.81 88.35 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.928 1.252 . . . . 0.0 112.743 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.8 tp -87.54 153.44 21.4 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.443 1.897 . . . . 0.0 109.615 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -128.74 166.08 19.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.713 1.205 . . . . 0.0 110.529 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 38.8 mtp180 -45.48 -41.43 9.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.228 1.811 . . . . 0.0 113.106 -172.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.94 -24.95 65.23 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.245 0.618 . . . . 0.0 111.902 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -102.74 9.71 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.528 0.731 . . . . 0.0 111.186 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.5 165.84 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.8 1.64 . . . . 0.0 112.08 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 136.3 31.13 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 168.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.5 mt -78.91 115.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.87 -31.19 13.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.372 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.21 163.92 39.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.28 1.032 . . . . 0.0 108.454 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 p -162.03 154.91 20.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 124.488 1.115 . . . . 0.0 108.835 170.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 p -69.44 132.18 45.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.92 0.866 . . . . 0.0 110.812 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -79.11 -27.44 42.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.248 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.45 151.4 38.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.201 2.2 . . . . 0.0 108.556 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -79.59 134.81 36.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 mt -94.94 129.14 42.1 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -133.16 148.41 52.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.88 1.218 . . . . 0.0 108.512 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.04 146.18 29.93 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.433 0.458 . . . . 0.0 109.774 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.81 146.23 24.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.99 145.75 91.99 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 111.111 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.92 146.99 60.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 N-CA-C 104.982 -2.738 . . . . 0.0 104.982 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -68.89 -12.61 61.76 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.075 -1.641 . . . . 0.0 113.994 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.43 -31.73 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.026 0.83 . . . . 0.0 112.81 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.0 mt -91.79 -20.3 21.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.682 0.793 . . . . 0.0 112.03 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.1 135.81 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -103.16 91.28 4.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.302 1.041 . . . . 0.0 110.071 171.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.65 -23.65 64.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.962 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.73 -33.87 71.29 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.789 0.435 . . . . 0.0 111.801 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -100.01 158.34 15.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.948 0.899 . . . . 0.0 109.576 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -130.63 134.69 26.33 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.434 1.494 . . . . 0.0 109.905 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.45 148.98 91.37 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 O-C-N 122.755 0.871 . . . . 0.0 109.928 -10.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.7 p -78.05 133.81 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.496 0.718 . . . . 0.0 109.37 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.03 128.75 33.65 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.13 -12.09 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 119.03 -0.51 . . . . 0.0 112.022 169.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.25 -178.49 42.49 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -147.3 153.29 39.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.31 1.444 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -108.03 140.2 41.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -127.29 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.362 1.465 . . . . 0.0 108.694 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -133.5 117.97 17.78 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -103.1 158.25 16.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -134.0 125.59 28.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.329 1.451 . . . . 0.0 107.406 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.7 122.08 32.47 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mt -119.42 160.09 22.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -109.42 135.59 50.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 167.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 132.91 54.53 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.64 -53.88 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.5 m -78.44 -30.95 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 112.156 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.49 162.26 11.26 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.82 -18.44 43.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.418 1.487 . . . . 0.0 113.668 -173.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.71 48.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.442 0.697 . . . . 0.0 112.484 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 11.82 3.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.6 mt -91.43 134.94 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.43 -43.06 1.62 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.177 0.591 . . . . 0.0 112.354 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 mtp 66.73 13.38 9.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.664 2.386 . . . . 0.0 114.357 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.66 33.02 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 123.413 1.577 . . . . 0.0 112.423 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -51.47 69.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.396 1.478 . . . . 0.0 109.161 169.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 m -73.85 157.23 36.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.721 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -63.53 -36.85 85.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.073 0.463 . . . . 0.0 109.958 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 131.51 45.3 Favored Pre-proline 0 N--CA 1.443 -0.815 0 C-N-CA 125.259 1.424 . . . . 0.0 109.299 169.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.83 147.34 94.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.59 -11.66 39.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -133.33 152.04 51.9 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.519 1.128 . . . . 0.0 109.868 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.11 -2.36 13.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.441 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.86 146.09 12.87 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -150.8 138.96 20.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.269 1.428 . . . . 0.0 107.565 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.99 173.79 13.9 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.342 1.457 . . . . 0.0 109.085 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -119.79 142.21 48.79 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.92 164.05 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.495 . . . . 0.0 110.437 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -69.67 153.05 43.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 169.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -31.65 72.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -169.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -85.99 -27.56 24.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.316 1.416 . . . . 0.0 112.864 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -54.84 -49.88 89.26 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.563 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.27 -29.78 73.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.153 1.805 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.69 -31.9 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.224 -0.923 . . . . 0.0 110.136 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -66.6 -27.16 67.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.209 -0.932 . . . . 0.0 111.569 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -82.11 -23.94 35.41 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.09 159.81 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.313 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.78 179.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.074 1.749 . . . . 0.0 110.769 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.4 m -55.17 -53.44 55.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.405 1.882 . . . . 0.0 113.293 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.62 -41.86 78.92 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.561 . . . . 0.0 110.318 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.63 -43.44 63.23 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.109 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -59.55 -34.36 72.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.486 1.494 . . . . 0.0 111.8 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 -45.53 88.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.309 0.959 . . . . 0.0 111.314 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.27 -47.5 92.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -69.14 -34.95 75.82 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.234 1.014 . . . . 0.0 110.054 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -66.68 -39.24 88.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.655 1.116 . . . . 0.0 109.927 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.34 -46.6 89.36 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.764 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.6 t -56.88 -41.74 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 110.752 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -70.69 -53.83 14.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.02 -33.88 76.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.066 1.303 . . . . 0.0 111.915 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -53.45 -40.52 65.29 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.854 1.262 . . . . 0.0 111.214 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -110.04 -12.53 14.52 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.006 0.922 . . . . 0.0 112.259 -170.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.44 75.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.811 1.644 . . . . 0.0 110.488 -170.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -69.07 -32.76 72.45 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.444 0.698 . . . . 0.0 109.923 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.5 t -68.24 -45.24 83.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.99 -34.82 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.544 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 mmt -61.66 -57.57 11.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.833 1.197 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -70.1 -26.05 63.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.782 1.233 . . . . 0.0 111.004 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.33 -35.39 71.82 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 128.714 2.806 . . . . 0.0 111.67 170.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -71.2 -39.54 71.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.883 0.765 . . . . 0.0 110.67 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.533 0.295 0 C-N-CA 123.482 0.713 . . . . 0.0 112.061 -169.635 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.53 -68.85 0.36 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.208 0.603 . . . . 0.0 111.281 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -163.9 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.096 0.958 . . . . 0.0 112.22 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.97 17.15 14.43 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.698 1.199 . . . . 0.0 112.858 -169.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.04 7.42 65.88 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.276 0.941 . . . . 0.0 113.787 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.26 157.95 16.03 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.19 149.3 72.27 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.4 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.56 138.92 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.208 1.938 . . . . 0.0 111.242 -173.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -140.8 151.97 44.81 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.367 1.067 . . . . 0.0 110.339 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.89 153.63 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.717 0.807 . . . . 0.0 109.66 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.88 157.39 24.75 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.85 141.99 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.426 1.09 . . . . 0.0 108.568 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.07 137.73 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -115.95 132.3 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.7 m -122.93 144.31 49.32 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -96.63 173.57 7.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.848 1.259 . . . . 0.0 108.666 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.76 9.96 5.58 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.833 -1.167 . . . . 0.0 113.59 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -99.09 0.22 43.17 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.693 0.797 . . . . 0.0 111.175 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.44 20.03 78.96 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.169 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -92.56 142.82 26.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.799 1.299 . . . . 0.0 107.786 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.39 143.12 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.013 1.725 . . . . 0.0 107.295 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -81.31 147.32 29.94 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.726 0.694 . . . . 0.0 109.465 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.0 t90 -151.86 140.48 20.75 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -171.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.46 149.76 51.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.771 1.169 . . . . 0.0 112.565 -169.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -98.44 120.23 38.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.252 1.821 . . . . 0.0 106.699 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -82.91 143.93 30.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.724 1.602 . . . . 0.0 109.616 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.45 132.79 54.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.426 0.69 . . . . 0.0 109.82 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.85 -9.71 16.41 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.925 1.25 . . . . 0.0 114.507 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -90.88 -39.79 12.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.556 1.678 . . . . 0.0 111.368 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.1 m80 57.5 31.66 20.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.162 0.985 . . . . 0.0 110.974 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -129.17 152.36 48.84 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.729 1.612 . . . . 0.0 108.337 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -104.09 146.62 28.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.267 0.627 . . . . 0.0 110.933 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -156.92 163.2 39.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.801 1.241 . . . . 0.0 110.808 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.16 144.5 44.19 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.014 -0.994 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.4 131.87 45.62 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.423 2.749 . . . . 0.0 112.475 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -158.2 167.81 28.78 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.643 0.656 . . . . 0.0 112.484 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.67 167.2 40.32 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.27 0.462 . . . . 0.0 112.207 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.72 146.47 32.61 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.82 127.28 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -78.41 152.57 78.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.12 120.13 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.7 1.6 . . . . 0.0 110.176 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.74 67.99 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.233 -1.315 . . . . 0.0 113.991 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.45 148.58 48.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 120.232 2.016 . . . . 0.0 110.231 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -84.27 153.76 23.37 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -38.67 76.91 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.778 -0.576 . . . . 0.0 111.909 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.91 -34.13 74.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.733 0.813 . . . . 0.0 110.248 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -73.12 -36.12 66.67 Favored 'General case' 0 C--N 1.337 0.045 0 O-C-N 120.89 -1.131 . . . . 0.0 109.908 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.92 90.84 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.8 ttp -58.82 -49.23 78.47 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.999 0.818 . . . . 0.0 109.036 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 49.8 m-85 -66.12 -46.24 78.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.679 1.127 . . . . 0.0 111.584 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -67.6 -45.31 75.84 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.277 0.944 . . . . 0.0 110.17 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -69.49 -34.54 74.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -57.0 -44.86 83.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.848 1.204 . . . . 0.0 110.323 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -61.27 -41.01 96.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.552 0.614 . . . . 0.0 110.212 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.92 -21.53 65.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.312 0.645 . . . . 0.0 112.232 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.39 -60.85 1.63 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.609 1.164 . . . . 0.0 109.629 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 m -112.44 0.69 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.501 1.52 . . . . 0.0 111.972 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.31 48.4 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.376 -1.452 . . . . 0.0 113.897 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -82.41 144.79 30.25 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.416 1.486 . . . . 0.0 110.2 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -123.98 165.5 17.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.34 1.056 . . . . 0.0 109.633 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 50.4 mtt85 -47.73 -35.55 9.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 112.495 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.27 -22.34 66.84 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.403 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.62 22.59 12.62 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.1 164.99 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.758 -1.214 . . . . 0.0 111.869 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 140.72 33.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 116.982 -1.485 . . . . 0.0 107.962 169.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.44 116.28 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.5 -36.01 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.229 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.98 32.54 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.016 0.926 . . . . 0.0 110.456 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -151.66 149.08 28.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.079 1.752 . . . . 0.0 109.42 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -70.81 139.88 51.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.748 1.158 . . . . 0.0 109.786 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -93.2 -29.22 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.332 1.053 . . . . 0.0 109.862 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -110.48 149.61 30.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.471 2.308 . . . . 0.0 107.864 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -82.76 143.03 31.14 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -87.78 91.19 8.66 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 139.35 52.31 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -137.25 153.6 50.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.579 0.752 . . . . 0.0 110.209 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -131.34 138.04 49.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.51 1.924 . . . . 0.0 108.151 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.99 146.9 69.01 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.828 0.851 . . . . 0.0 110.694 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.1 145.94 68.78 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 N-CA-C 104.601 -2.884 . . . . 0.0 104.601 166.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.38 -13.27 62.17 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.031 -1.668 . . . . 0.0 113.835 -169.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -58.81 -30.64 67.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.953 0.797 . . . . 0.0 113.071 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.45 -20.29 21.15 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 112.134 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.24 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -102.83 89.57 3.51 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.959 0.904 . . . . 0.0 109.76 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -67.19 -24.84 65.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.716 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.34 -33.84 71.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.798 0.439 . . . . 0.0 111.747 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -99.36 159.33 15.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.042 0.937 . . . . 0.0 109.398 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -130.79 134.44 26.0 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 125.152 1.381 . . . . 0.0 109.466 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.47 148.23 89.67 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.719 0.852 . . . . 0.0 110.428 -10.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -77.76 139.08 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.675 0.79 . . . . 0.0 109.613 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.1 p -90.43 120.58 31.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.87 0.868 . . . . 0.0 108.89 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -13.09 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 118.848 0.749 . . . . 0.0 112.751 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 -171.47 34.19 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -157.9 167.71 29.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.762 1.225 . . . . 0.0 109.552 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -115.58 127.6 55.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -114.34 129.0 56.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -111.74 139.13 47.47 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -123.19 153.34 40.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.97 128.48 24.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.59 122.5 37.25 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.08 156.83 24.46 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -106.73 129.7 54.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 167.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.76 139.69 58.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.1 1.36 . . . . 0.0 108.52 171.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.99 -44.99 14.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.043 0.383 . . . . 0.0 110.698 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.9 m -87.05 -16.06 36.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.571 0.748 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.56 -167.79 24.82 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.445 ' HB2' ' HE1' ' A' ' 126' ' ' TRP . 1.1 p-10 -60.92 -17.66 52.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.485 1.514 . . . . 0.0 114.698 -171.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.24 47.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.116 0.966 . . . . 0.0 111.774 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.49 50.96 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.829 1.252 . . . . 0.0 110.527 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.9 mt -129.93 129.82 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -113.22 161.56 17.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.391 2.276 . . . . 0.0 106.66 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mmt -126.48 -9.2 6.29 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.029 1.332 . . . . 0.0 111.872 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.35 84.13 2.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 123.718 1.723 . . . . 0.0 107.38 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 -61.12 2.11 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.348 2.659 . . . . 0.0 107.59 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 m -73.22 173.98 8.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.726 1.611 . . . . 0.0 109.009 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m -59.94 -36.81 77.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.496 -0.752 . . . . 0.0 109.807 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 137.05 57.33 Favored Pre-proline 0 N--CA 1.444 -0.772 0 C-N-CA 125.928 1.691 . . . . 0.0 109.133 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.02 133.54 47.87 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 107.212 -1.88 . . . . 0.0 107.212 168.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -85.07 -35.73 21.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -110.98 145.86 37.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.79 -29.24 25.58 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.806 0.842 . . . . 0.0 110.41 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.25 169.49 41.03 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.47 159.99 44.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.772 0.786 . . . . 0.0 109.655 169.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -143.95 169.35 17.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.827 1.251 . . . . 0.0 108.888 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.445 ' HE1' ' HB2' ' A' ' 108' ' ' ASP . 75.4 m95 -111.99 139.43 47.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.58 152.85 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.002 1.321 . . . . 0.0 110.648 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -62.94 143.78 57.39 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -32.31 44.73 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -169.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.99 -18.22 31.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.553 1.07 . . . . 0.0 112.947 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.38 -46.22 70.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.422 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.35 -29.39 85.73 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.774 2.026 . . . . 0.0 112.017 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.4 t -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.899 1.279 . . . . 0.0 109.924 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.263 -0.898 . . . . 0.0 111.443 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -94.31 -21.62 18.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.58 154.01 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 119.031 0.832 . . . . 0.0 110.491 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.58 178.42 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.052 1.341 . . . . 0.0 110.478 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.9 m -55.73 -47.15 77.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.868 1.667 . . . . 0.0 113.236 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -71.73 -45.73 60.83 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.987 -0.446 . . . . 0.0 110.451 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.57 -39.95 73.59 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.679 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -59.71 -31.44 69.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.745 1.157 . . . . 0.0 112.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.19 -43.21 95.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.495 1.043 . . . . 0.0 111.05 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.4 t -62.71 -50.3 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.76 -38.41 90.99 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.919 0.782 . . . . 0.0 109.644 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -65.98 -41.15 91.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.696 1.134 . . . . 0.0 110.243 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -59.6 -49.38 78.0 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.037 0.835 . . . . 0.0 109.615 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.29 -37.59 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.736 1.214 . . . . 0.0 110.977 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.3 mmt -74.28 -54.83 6.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -59.85 -34.14 72.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.42 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.71 -42.11 83.12 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 110.763 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.77 -10.24 19.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.668 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.34 67.48 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.354 1.462 . . . . 0.0 110.559 -171.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 m -68.13 -32.72 73.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.386 0.675 . . . . 0.0 110.548 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.64 -42.81 62.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.4 t -57.29 -38.99 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 117.434 -1.27 . . . . 0.0 110.175 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -62.06 -51.68 66.97 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.472 1.487 . . . . 0.0 111.092 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.4 m -77.23 -24.03 51.27 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.812 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 tp -55.8 -48.66 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.138 1.775 . . . . 0.0 109.359 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -60.27 -33.99 73.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.535 0.734 . . . . 0.0 111.601 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 CA--C 1.531 0.249 0 C-N-CA 124.819 1.248 . . . . 0.0 111.731 -174.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.679 0.752 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.31 -66.7 0.53 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.43 -51.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.05 17.28 14.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.476 1.11 . . . . 0.0 113.385 -169.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.56 62.71 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.12 0.866 . . . . 0.0 113.658 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -103.84 159.44 15.64 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.682 1.241 . . . . 0.0 107.731 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 149.86 64.38 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.25 -1.357 . . . . 0.0 107.834 170.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -91.41 141.52 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.899 1.732 . . . . 0.0 109.425 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -130.1 160.18 34.53 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.253 -0.904 . . . . 0.0 110.455 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.23 167.37 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -159.0 151.9 22.89 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -128.88 142.88 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.444 1.098 . . . . 0.0 108.586 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.77 136.37 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mm -120.37 132.9 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 m -124.2 150.84 44.77 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.492 0.587 . . . . 0.0 111.37 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -109.17 173.41 6.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.409 1.484 . . . . 0.0 108.816 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -74.94 0.17 16.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.11 -1.619 . . . . 0.0 113.002 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -88.68 -3.47 58.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 111.419 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.63 18.63 77.36 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 118.835 0.743 . . . . 0.0 111.48 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -86.13 139.73 30.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 m -108.79 143.82 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 125.514 1.526 . . . . 0.0 107.53 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -79.65 143.07 34.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -146.22 144.18 29.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.03 157.17 46.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.044 0.838 . . . . 0.0 111.557 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -111.53 119.07 37.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -72.48 151.31 42.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.297 1.408 . . . . 0.0 110.261 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.35 148.24 47.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.795 0.838 . . . . 0.0 109.633 -175.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 3.36 50.12 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.7 -1.056 . . . . 0.0 113.569 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.81 159.93 40.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.161 1.481 . . . . 0.0 110.577 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -94.11 -22.15 18.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 m -73.52 154.47 39.86 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.145 0.978 . . . . 0.0 111.63 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -106.45 152.57 23.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.222 1.009 . . . . 0.0 109.978 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -148.73 156.8 42.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.943 1.297 . . . . 0.0 110.778 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -80.62 140.64 51.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.35 137.7 82.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.768 1.645 . . . . 0.0 111.118 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -157.18 171.01 21.2 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.214 0.915 . . . . 0.0 112.198 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.05 -168.79 34.01 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -109.17 150.89 17.2 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.411 1.482 . . . . 0.0 109.943 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.29 119.57 34.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -77.1 159.03 79.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.61 127.9 28.12 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.664 1.576 . . . . 0.0 110.246 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.18 -5.47 79.98 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.395 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.55 148.11 37.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.158 1.979 . . . . 0.0 109.471 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.8 m -90.07 157.91 17.57 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.33 77.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.079 0.854 . . . . 0.0 111.583 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.26 -37.68 78.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.734 0.814 . . . . 0.0 110.216 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -66.49 -41.45 88.91 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.1 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.62 85.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -56.32 -50.86 70.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.612 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.451 1.023 . . . . 0.0 110.566 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -64.76 -47.0 79.79 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.453 1.024 . . . . 0.0 109.965 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.81 -31.99 67.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.6 -49.33 73.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.3 -40.92 95.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.008 0.822 . . . . 0.0 110.824 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.6 -26.66 68.5 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.728 -0.607 . . . . 0.0 112.222 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.15 -57.67 2.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.438 1.095 . . . . 0.0 110.451 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.72 0.64 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 112.383 -169.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.48 4.78 32.99 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.758 1.163 . . . . 0.0 113.702 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -84.1 146.58 27.82 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.303 1.841 . . . . 0.0 109.436 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 m -125.03 166.23 16.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.991 0.917 . . . . 0.0 109.76 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -52.93 -32.64 46.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.701 1.6 . . . . 0.0 112.476 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.37 -26.86 68.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.375 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -111.91 22.2 15.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.845 0.831 . . . . 0.0 112.209 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.18 165.06 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.707 -1.245 . . . . 0.0 111.7 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 140.86 40.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 mt -76.4 119.22 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -93.69 -35.34 12.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.81 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.578 0.751 . . . . 0.0 110.621 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 p -160.88 153.32 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.744 1.618 . . . . 0.0 109.897 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.08 139.06 54.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.783 0.801 . . . . 0.0 110.742 -170.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -94.62 -33.67 12.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -110.72 144.02 40.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.969 2.107 . . . . 0.0 107.327 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -85.51 141.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.39 72.03 7.04 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -71.6 154.29 41.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.36 151.08 50.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.503 1.121 . . . . 0.0 108.879 -169.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -130.48 132.18 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.696 1.598 . . . . 0.0 107.581 174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -80.9 141.77 51.46 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 124.378 1.071 . . . . 0.0 111.995 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.84 149.95 67.07 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 N-CA-C 104.762 -2.822 . . . . 0.0 104.762 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -68.99 -13.56 62.52 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.84 -1.788 . . . . 0.0 114.056 -169.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -62.37 -31.02 71.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.113 0.869 . . . . 0.0 112.558 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -93.73 -18.18 22.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.236 1.014 . . . . 0.0 112.009 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.71 135.02 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -98.1 90.5 4.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.794 0.838 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -71.52 -20.95 61.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.906 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.23 -30.12 57.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.885 0.474 . . . . 0.0 112.196 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.27 160.14 14.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.354 1.061 . . . . 0.0 109.234 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -130.96 133.66 25.03 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 125.783 1.633 . . . . 0.0 108.319 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.32 156.79 94.14 Favored 'Cis proline' 0 CA--C 1.539 0.757 0 O-C-N 122.805 0.897 . . . . 0.0 111.179 -10.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.0 t -74.16 140.33 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.941 0.897 . . . . 0.0 109.741 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 p -93.24 122.61 35.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.119 0.967 . . . . 0.0 108.97 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.15 -12.09 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 119.297 0.953 . . . . 0.0 113.213 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.51 -173.62 43.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -156.31 157.24 35.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.343 1.057 . . . . 0.0 110.173 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -102.72 128.21 49.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -124.58 129.15 50.03 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.531 1.06 . . . . 0.0 111.509 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -88.42 157.37 18.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.626 1.17 . . . . 0.0 108.558 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.47 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 82.5 m95 -133.8 147.26 51.23 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 168.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -131.19 134.69 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.938 1.295 . . . . 0.0 107.924 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.5 tp -96.63 118.45 33.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.79 140.26 49.06 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -89.11 133.3 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 168.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.26 139.71 58.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.397 1.079 . . . . 0.0 109.069 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.41 -48.74 13.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 118.238 0.472 . . . . 0.0 110.041 -171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.7 m -86.21 -18.44 32.14 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.883 0.473 . . . . 0.0 111.11 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.73 -169.0 22.92 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -55.73 -23.47 29.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.264 1.826 . . . . 0.0 113.345 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.39 51.3 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -89.85 14.52 11.81 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.78 138.51 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -124.07 131.6 53.57 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.57 1.948 . . . . 0.0 107.637 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.3 mmt -98.56 -7.65 27.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 112.497 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.69 75.29 0.98 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.436 1.895 . . . . 0.0 108.027 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -75.56 -65.61 0.88 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.978 2.111 . . . . 0.0 108.963 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.1 m -80.29 177.73 8.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.594 1.557 . . . . 0.0 109.483 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 m -56.57 -35.1 67.79 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.979 0.512 . . . . 0.0 110.361 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 128.94 49.37 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 107.87 169.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.92 122.95 10.37 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 169.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.74 -18.49 62.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -116.76 140.18 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.649 0.78 . . . . 0.0 110.374 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.69 -26.98 40.79 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 110.732 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.44 169.29 41.5 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 123.894 0.759 . . . . 0.0 111.315 -174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 160.63 43.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.768 0.827 . . . . 0.0 109.168 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -152.11 165.73 33.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.976 0.91 . . . . 0.0 108.954 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -110.65 133.86 52.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.24 152.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.838 1.255 . . . . 0.0 111.17 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.4 m -60.47 144.08 52.0 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.94 0.791 . . . . 0.0 109.628 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.15 -34.49 60.54 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -87.0 -7.93 57.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.974 -1.079 . . . . 0.0 113.486 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -75.52 -49.39 3.77 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.918 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.31 -21.6 72.23 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 123.044 2.123 . . . . 0.0 113.282 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.8 -35.92 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -68.97 -25.56 64.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.333 -0.855 . . . . 0.0 111.621 -169.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -83.36 -24.75 31.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.55 165.43 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 118.968 0.803 . . . . 0.0 111.07 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.36 175.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 110.166 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -57.42 -44.15 84.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.503 1.521 . . . . 0.0 113.875 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -70.3 -41.93 72.7 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.474 -0.766 . . . . 0.0 110.827 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -74.93 -35.0 62.18 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.233 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -49.33 -46.02 46.26 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.122 0.969 . . . . 0.0 110.462 170.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.28 -43.04 96.05 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.568 0.622 . . . . 0.0 111.089 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.86 -50.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -66.07 -34.75 78.77 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.055 0.942 . . . . 0.0 110.607 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -67.57 -41.31 84.36 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.808 1.186 . . . . 0.0 109.962 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.93 -43.54 98.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.299 0.954 . . . . 0.0 110.873 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.74 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.466 1.106 . . . . 0.0 111.542 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.1 mmt -84.33 -59.83 2.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.71 -34.45 67.47 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.362 1.065 . . . . 0.0 112.178 -173.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -57.61 -38.47 75.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.807 0.843 . . . . 0.0 110.727 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -109.78 -10.62 14.77 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 112.817 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.4 -38.99 72.27 Favored 'General case' 0 C--O 1.228 -0.031 0 C-N-CA 125.658 1.583 . . . . 0.0 110.545 -172.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -68.2 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.64 0.776 . . . . 0.0 110.443 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.7 -45.83 72.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.38 -46.32 92.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 117.627 -1.178 . . . . 0.0 110.236 -175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -43.48 85.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 121.435 1.925 . . . . 0.0 110.317 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.4 t -70.84 -32.13 69.07 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.218 -0.301 . . . . 0.0 111.124 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.0 tp -62.44 -43.28 99.19 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 126.198 1.799 . . . . 0.0 109.568 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -65.38 -43.75 89.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.667 0.387 . . . . 0.0 110.924 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 123.508 0.723 . . . . 0.0 111.806 -169.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 121.414 0.626 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.93 -68.49 0.38 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.63 0.772 . . . . 0.0 110.192 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -164.14 -49.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.964 0.906 . . . . 0.0 113.23 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.2 17.13 14.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.688 1.195 . . . . 0.0 113.233 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.11 10.66 60.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.902 0.763 . . . . 0.0 113.38 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -101.09 155.04 18.22 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.53 31.42 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 117.534 -1.222 . . . . 0.0 109.354 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.76 137.68 16.24 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.469 1.446 . . . . 0.0 110.455 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -142.62 157.18 44.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.122 0.969 . . . . 0.0 109.291 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.25 161.2 35.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 121.267 -0.896 . . . . 0.0 109.669 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.9 163.0 28.35 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -121.65 143.31 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 124.522 1.129 . . . . 0.0 108.393 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.82 136.8 59.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -116.95 133.71 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -125.64 154.02 42.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.843 0.747 . . . . 0.0 111.576 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -104.23 175.16 5.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.002 1.321 . . . . 0.0 108.777 172.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 4.83 8.85 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.237 -1.54 . . . . 0.0 113.267 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -90.94 -2.54 57.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.435 1.094 . . . . 0.0 111.416 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.56 0.618 . . . . 0.0 111.848 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -89.0 144.06 26.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.0 m -115.2 150.02 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.498 1.519 . . . . 0.0 109.161 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 42.8 ttm -65.27 139.75 58.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.708 0.803 . . . . 0.0 108.964 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -142.88 136.92 29.15 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.01 154.57 51.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.712 1.142 . . . . 0.0 111.575 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -114.92 123.23 48.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -76.99 147.85 36.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 121.74 2.064 . . . . 0.0 110.681 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.63 129.67 43.07 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.83 0.08 87.56 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.86 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -110.96 164.42 12.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.216 1.508 . . . . 0.0 110.397 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -101.38 -24.57 14.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.228 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -80.36 159.16 25.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.783 1.233 . . . . 0.0 111.796 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -112.3 155.77 23.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.239 1.015 . . . . 0.0 111.674 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -160.58 164.26 32.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.0 1.72 . . . . 0.0 110.936 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -86.48 149.12 48.38 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.72 130.84 38.89 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.758 2.306 . . . . 0.0 111.951 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.67 161.5 34.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 112.218 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.71 171.58 44.52 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.222 0.439 . . . . 0.0 113.534 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.56 152.75 36.0 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.843 1.211 . . . . 0.0 111.755 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.84 130.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -77.22 157.99 80.17 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.29 123.55 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.98 -6.36 83.6 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.709 -1.051 . . . . 0.0 114.593 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.39 156.15 39.82 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 120.115 1.958 . . . . 0.0 109.439 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.0 p -91.94 166.95 12.45 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.0 81.34 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.782 -0.574 . . . . 0.0 110.815 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.22 -36.5 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.247 0.619 . . . . 0.0 110.582 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.01 -37.25 72.64 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.998 -1.064 . . . . 0.0 110.365 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.42 80.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.402 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.3 tmm? -65.62 -51.44 59.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.14 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -66.82 -31.62 72.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.41 1.459 . . . . 0.0 111.839 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -61.07 -52.03 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.411 1.005 . . . . 0.0 108.925 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -71.47 -27.26 63.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.562 0.619 . . . . 0.0 109.962 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.73 -43.88 90.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.928 -1.107 . . . . 0.0 109.388 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.45 -49.07 52.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.977 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.47 -28.94 68.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.656 1.117 . . . . 0.0 112.608 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -96.16 -52.51 3.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.162 0.985 . . . . 0.0 110.657 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.05 -29.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.543 1.137 . . . . 0.0 110.899 -168.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.3 84.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.447 1.023 . . . . 0.0 112.377 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 tp -78.66 154.15 30.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.172 1.789 . . . . 0.0 109.162 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -132.1 163.98 27.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 109.941 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -39.02 -41.78 0.81 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.9 2.48 . . . . 0.0 112.887 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -63.49 -29.23 70.53 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.77 0.828 . . . . 0.0 112.064 -170.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.5 23.36 13.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.575 0.702 . . . . 0.0 112.185 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.57 165.32 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 O-C-N 120.729 -1.232 . . . . 0.0 112.362 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.57 130.34 27.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.854 168.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mt -69.13 117.26 11.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.1 mt -95.92 -32.84 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.502 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.81 162.78 40.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.671 0.788 . . . . 0.0 109.267 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -159.19 155.05 26.42 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.888 1.275 . . . . 0.0 109.735 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 p -69.27 138.77 54.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.587 0.708 . . . . 0.0 110.525 -169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -86.9 -28.41 22.82 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.56 1.144 . . . . 0.0 109.801 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -119.97 149.67 41.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.394 2.278 . . . . 0.0 108.069 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -78.3 135.77 37.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.61 0.641 . . . . 0.0 109.489 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.3 mt -90.14 89.32 7.62 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -90.01 146.61 24.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -148.59 145.75 27.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 169.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 139.3 30.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.71 150.46 39.68 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.787 0.835 . . . . 0.0 109.302 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.24 158.14 52.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.219 3.28 . . . . 0.0 110.944 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -67.17 -19.37 65.57 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.82 -1.175 . . . . 0.0 112.941 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.84 -30.45 70.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.017 0.826 . . . . 0.0 112.888 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.2 mt -93.45 -14.19 27.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.182 0.993 . . . . 0.0 112.264 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.4 t -67.04 133.66 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -94.6 90.75 6.26 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.769 0.795 . . . . 0.0 109.628 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -71.43 -21.9 61.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.497 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.16 -13.26 59.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.743 0.817 . . . . 0.0 112.781 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -121.29 159.86 25.13 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.264 1.025 . . . . 0.0 109.986 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -127.74 131.54 23.87 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 125.522 1.529 . . . . 0.0 109.938 -173.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.19 149.45 93.15 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 O-C-N 122.741 0.864 . . . . 0.0 110.689 -10.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.01 141.46 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.067 0.947 . . . . 0.0 109.969 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.3 p -94.91 137.17 34.32 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.658 0.783 . . . . 0.0 110.762 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.61 -14.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 169.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.39 179.9 35.6 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.54 157.51 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.456 1.502 . . . . 0.0 108.589 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.92 128.66 56.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 170.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -113.3 131.57 55.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.935 0.789 . . . . 0.0 109.652 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -110.74 125.49 53.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -108.23 154.41 21.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.402 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 84.5 m-85 -135.53 127.12 28.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.43 120.19 31.34 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.8 131.41 56.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -86.79 134.55 33.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.49 141.81 58.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 109.014 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.28 -51.8 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.57 0.623 . . . . 0.0 109.826 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 m -83.76 -19.82 34.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.111 0.564 . . . . 0.0 111.742 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.44 -169.12 23.36 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -18.38 47.52 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.584 1.554 . . . . 0.0 114.157 -169.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 -31.73 48.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.041 . . . . 0.0 112.902 172.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.92 17.62 10.35 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.3 mt -94.9 134.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -120.34 -52.73 2.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.327 0.651 . . . . 0.0 112.252 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 70.56 7.77 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.887 2.475 . . . . 0.0 114.884 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -153.79 78.46 1.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 123.988 1.851 . . . . 0.0 109.616 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -59.73 2.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.12 -2.309 . . . . 0.0 107.997 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -67.97 165.11 18.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.19 1.396 . . . . 0.0 109.498 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -62.77 -33.31 74.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.973 0.509 . . . . 0.0 110.12 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.5 129.94 51.2 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 124.91 1.284 . . . . 0.0 110.2 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -65.58 143.84 76.63 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.083 1.855 . . . . 0.0 108.338 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -83.18 -17.53 42.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.021 -0.424 . . . . 0.0 111.308 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.48 140.69 49.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.136 0.88 . . . . 0.0 110.85 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.31 -29.74 57.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.159 1.384 . . . . 0.0 110.303 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.72 164.6 38.2 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.57 158.15 43.91 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.61 167.99 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -107.38 136.97 46.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 154.85 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.813 1.245 . . . . 0.0 110.126 -171.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -61.4 144.44 54.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.215 0.916 . . . . 0.0 109.403 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -27.39 57.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -88.61 -16.45 32.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.047 1.294 . . . . 0.0 112.985 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.85 -50.41 85.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.428 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.2 -25.85 42.77 Favored 'Trans proline' 0 C--N 1.35 0.638 0 CA-C-N 121.985 1.745 . . . . 0.0 112.65 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.24 -42.3 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.586 -0.696 . . . . 0.0 109.237 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -69.86 -7.8 43.19 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.605 -1.309 . . . . 0.0 114.227 -178.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.08 -28.21 39.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.147 0.885 . . . . 0.0 111.721 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.1 160.26 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.14 163.66 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.074 0.95 . . . . 0.0 108.88 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.1 m -54.21 -45.67 72.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -70.24 -34.52 72.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.993 1.27 . . . . 0.0 111.238 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -75.36 -44.6 44.18 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.896 -0.503 . . . . 0.0 109.936 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -48.04 -40.77 23.94 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.982 1.313 . . . . 0.0 112.752 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.47 -37.67 83.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.111 0.869 . . . . 0.0 111.963 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.09 -53.12 47.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -65.11 -32.52 74.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 112.225 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -65.76 -43.9 87.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.449 1.477 . . . . 0.0 110.606 170.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -44.72 93.4 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.541 1.064 . . . . 0.0 110.383 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.5 t -56.97 -31.96 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.593 1.157 . . . . 0.0 111.472 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.6 mmt -82.35 -59.62 2.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -31.96 69.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.463 0.705 . . . . 0.0 112.598 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.31 -39.58 76.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 112.18 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.89 -13.75 14.08 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.948 0.899 . . . . 0.0 111.416 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.54 -39.59 64.82 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 126.064 1.746 . . . . 0.0 110.631 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 m -66.52 -31.89 72.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.627 0.771 . . . . 0.0 110.903 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.86 -46.15 74.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.78 -40.46 79.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.434 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -55.31 -51.45 66.67 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 120.576 1.534 . . . . 0.0 109.85 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.0 -27.08 60.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.91 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.4 tp -62.5 -40.71 97.6 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.711 1.204 . . . . 0.0 109.937 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -60.41 -44.38 95.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.148 0.579 . . . . 0.0 110.173 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 124.516 1.126 . . . . 0.0 113.24 -170.185 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -68.28 -66.49 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.337 0.655 . . . . 0.0 110.945 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -164.0 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.952 0.901 . . . . 0.0 112.918 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -95.76 17.2 15.56 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.446 1.098 . . . . 0.0 113.006 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.45 5.66 65.0 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.946 0.784 . . . . 0.0 113.656 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.85 154.81 17.38 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.55 148.46 67.54 Favored Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.935 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.86 141.06 14.89 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.319 2.012 . . . . 0.0 110.26 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -145.06 158.68 43.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.272 1.029 . . . . 0.0 109.733 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.95 159.64 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 O-C-N 121.201 -0.937 . . . . 0.0 109.718 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -139.85 156.71 25.0 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.53 141.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.999 1.32 . . . . 0.0 108.261 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.24 139.1 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 mm -116.74 142.79 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 117.243 -1.36 . . . . 0.0 107.568 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.8 p -119.82 154.5 34.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 111.493 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -111.57 171.01 7.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 108.972 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.01 0.52 11.13 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.038 -1.664 . . . . 0.0 114.049 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -88.35 -1.07 57.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.906 0.883 . . . . 0.0 111.053 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.55 17.18 76.2 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.583 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -86.26 145.73 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.72 149.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 109.244 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 ttm -63.84 139.85 58.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.718 0.807 . . . . 0.0 109.329 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -146.23 140.87 26.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.685 1.594 . . . . 0.0 106.804 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.15 146.1 40.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.437 1.472 . . . . 0.0 112.478 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -103.04 114.85 29.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.51 1.924 . . . . 0.0 105.845 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -76.1 147.96 38.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 120.448 1.476 . . . . 0.0 110.036 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -57.33 127.45 32.06 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.66 0.784 . . . . 0.0 110.123 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.04 -4.47 31.39 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.14 1.353 . . . . 0.0 114.841 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -87.66 -35.5 17.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.786 1.793 . . . . 0.0 111.851 -173.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.8 m80 54.99 31.04 15.24 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 112.104 -170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.1 m -138.36 154.59 48.94 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.528 1.931 . . . . 0.0 107.859 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -105.12 157.3 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -163.62 168.68 19.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.074 1.749 . . . . 0.0 109.706 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -87.49 149.45 46.62 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.15 131.17 35.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.461 2.107 . . . . 0.0 111.033 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -158.02 165.79 34.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.334 0.653 . . . . 0.0 111.47 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.88 168.0 40.42 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.951 -0.468 . . . . 0.0 113.09 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.46 152.62 51.96 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.2 mt -75.41 125.19 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 169.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.38 147.79 97.09 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.99 126.07 18.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.336 1.357 . . . . 0.0 109.521 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.75 89.15 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.962 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.09 165.05 25.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.032 1.916 . . . . 0.0 110.57 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -103.03 154.09 19.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.073 -1.876 . . . . 0.0 105.995 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.61 87.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.748 1.158 . . . . 0.0 111.589 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.41 -35.51 79.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.75 0.82 . . . . 0.0 109.882 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.47 -38.76 77.86 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.586 -0.696 . . . . 0.0 109.666 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.3 80.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.676 0.671 . . . . 0.0 109.673 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -60.84 -50.41 73.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -66.63 -38.48 87.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.604 1.093 . . . . 0.0 112.097 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -56.18 -50.45 71.15 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.898 0.879 . . . . 0.0 109.479 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.61 -30.6 59.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.215 -0.422 . . . . 0.0 110.239 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 tp -56.71 -45.35 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.518 1.054 . . . . 0.0 109.819 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.2 -31.69 66.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.2 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.96 -29.92 58.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.284 1.402 . . . . 0.0 112.811 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -99.42 -55.08 2.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.527 1.531 . . . . 0.0 110.809 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 -24.07 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 126.431 1.893 . . . . 0.0 111.131 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.73 -1.49 45.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.042 1.306 . . . . 0.0 113.515 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.72 155.34 35.73 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.048 1.739 . . . . 0.0 109.064 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -131.95 165.66 23.43 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.754 0.822 . . . . 0.0 110.092 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -50.91 -35.21 31.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.857 1.663 . . . . 0.0 112.974 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -64.7 -25.18 67.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.818 -173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -114.58 22.6 13.46 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.55 166.07 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.751 1.62 . . . . 0.0 111.972 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 141.72 33.49 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.7 mt -79.51 115.6 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.8 mt -88.84 -37.49 15.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.381 1.072 . . . . 0.0 110.643 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.21 165.25 36.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.999 0.92 . . . . 0.0 109.031 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 p -161.85 154.92 20.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.261 1.024 . . . . 0.0 110.231 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -70.64 136.3 49.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.641 0.734 . . . . 0.0 110.692 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -81.96 -28.37 32.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.304 1.442 . . . . 0.0 109.782 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -119.37 148.98 42.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.595 2.358 . . . . 0.0 108.233 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -81.81 137.89 35.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.44 104.81 16.77 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -102.06 147.11 26.99 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.66 147.79 30.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 169.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.29 141.93 28.02 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.45 147.98 85.42 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 123.861 0.864 . . . . 0.0 110.272 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.09 149.73 82.32 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 105.197 -2.655 . . . . 0.0 105.197 167.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -69.24 -12.29 61.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.834 -1.791 . . . . 0.0 114.24 -169.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -63.41 -32.53 74.0 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.034 0.833 . . . . 0.0 112.299 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.07 -19.99 20.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.071 0.948 . . . . 0.0 111.382 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.06 135.19 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -103.5 94.54 5.53 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 108.944 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -72.62 -23.0 60.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.763 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.88 -35.48 57.4 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -91.53 157.91 16.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.884 0.874 . . . . 0.0 108.946 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.93 135.54 27.64 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.513 1.525 . . . . 0.0 108.063 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.1 156.22 93.81 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 122.854 0.923 . . . . 0.0 111.002 -10.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.1 t -72.58 137.8 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.993 0.917 . . . . 0.0 109.543 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.7 p -89.95 117.25 28.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.68 -16.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.158 0.89 . . . . 0.0 113.025 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.49 -176.34 37.54 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -156.93 157.13 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.789 1.236 . . . . 0.0 109.016 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -106.93 130.63 54.57 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -113.07 135.48 53.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.783 0.833 . . . . 0.0 109.896 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -113.04 129.2 56.58 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.4 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.9 m95 -110.14 155.11 22.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.211 0.605 . . . . 0.0 109.538 -171.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.57 127.68 25.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.54 124.49 35.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 169.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.93 160.33 22.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -111.27 131.73 54.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 134.66 57.16 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 108.026 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.5 t -89.18 -53.57 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.467 1.03 . . . . 0.0 110.009 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.7 m -77.05 -21.64 54.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.222 0.609 . . . . 0.0 111.653 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.49 171.83 22.12 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -16.08 19.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.973 1.709 . . . . 0.0 113.983 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.07 19.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.139 0.976 . . . . 0.0 112.53 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -88.48 13.29 12.25 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.87 142.78 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -137.63 106.73 6.01 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 108.581 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.9 mmt -81.58 1.47 33.61 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -120.12 72.72 0.95 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 123.983 1.849 . . . . 0.0 107.459 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 p -65.07 -66.66 0.51 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 111.58 -2.554 . . . . 0.0 106.215 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 m -76.37 169.46 18.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 167.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.9 m -59.61 -40.75 88.56 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.41 132.58 83.74 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 125.304 1.442 . . . . 0.0 108.836 169.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.86 133.63 48.87 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.761 1.641 . . . . 0.0 108.002 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.44 -25.62 50.77 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.08 -0.388 . . . . 0.0 110.286 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.55 140.73 52.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.747 0.819 . . . . 0.0 109.769 175.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.25 -28.38 53.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.86 0.864 . . . . 0.0 110.323 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.63 161.21 32.08 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 155.21 41.01 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.84 168.9 19.68 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.416 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -109.68 134.85 51.5 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.33 153.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.813 1.245 . . . . 0.0 111.259 -169.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.9 m -61.01 143.37 55.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -24.55 62.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -87.05 -20.81 26.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.367 1.44 . . . . 0.0 113.273 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -60.95 -46.7 96.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 117.277 -1.344 . . . . 0.0 113.497 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.48 -30.43 86.64 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 122.524 1.937 . . . . 0.0 111.821 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.04 -29.94 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.141 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -69.59 -23.71 63.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.98 -1.075 . . . . 0.0 111.768 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -85.13 -11.17 55.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.47 167.11 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -74.72 174.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.652 1.181 . . . . 0.0 109.669 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.93 -54.99 38.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.738 . . . . 0.0 113.179 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -69.37 -40.28 77.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.22 0.918 . . . . 0.0 110.902 -171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.62 -55.21 18.81 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -60.73 -34.27 74.15 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.771 -174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.77 -40.53 95.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.957 1.253 . . . . 0.0 111.828 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.88 -52.53 59.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.63 -37.53 84.3 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.754 0.706 . . . . 0.0 110.726 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -56.9 -50.06 73.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.857 1.663 . . . . 0.0 109.959 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.8 -47.92 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.427 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -56.93 -42.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.932 1.242 . . . . 0.0 110.847 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.8 mmt -69.0 -51.38 39.88 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -33.55 76.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.408 1.004 . . . . 0.0 111.701 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.85 -43.72 90.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 119.193 0.906 . . . . 0.0 110.411 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -97.69 -12.74 22.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.6 -42.65 67.89 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.769 1.628 . . . . 0.0 110.627 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 m -70.87 -29.63 65.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.744 0.818 . . . . 0.0 111.047 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.92 -43.86 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.93 -44.11 86.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.537 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.25 66.13 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 121.536 1.971 . . . . 0.0 110.649 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -58.33 -30.97 67.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.96 1.704 . . . . 0.0 111.885 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.07 -23.9 51.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.505 1.522 . . . . 0.0 112.547 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -84.02 -44.12 14.46 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.866 0.841 . . . . 0.0 108.916 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.452 -0.368 0 C-N-CA 126.575 1.95 . . . . 0.0 109.85 -175.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.89 -67.17 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -164.09 -49.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 11.49 15.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.156 0.982 . . . . 0.0 112.721 -169.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.6 -5.8 83.51 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.464 1.031 . . . . 0.0 113.295 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -93.65 158.2 15.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.376 1.088 . . . . 0.0 108.751 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -139.14 137.03 18.63 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.016 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.02 136.04 4.07 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.403 2.068 . . . . 0.0 110.665 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -140.73 156.89 46.09 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.949 0.899 . . . . 0.0 109.709 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.76 153.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 123.778 0.831 . . . . 0.0 109.349 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -127.7 161.67 21.68 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.86 143.59 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.2 t -129.78 135.67 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.1 mm -115.16 133.74 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.4 m -116.79 144.07 44.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -101.4 173.14 6.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.191 0.997 . . . . 0.0 108.315 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -77.25 3.74 12.21 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.564 -1.335 . . . . 0.0 113.036 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -93.76 -4.42 50.36 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.515 1.126 . . . . 0.0 111.302 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.98 33.7 54.38 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -112.58 154.98 25.15 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.628 1.214 . . . . 0.0 108.51 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -115.63 152.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.883 2.073 . . . . 0.0 107.925 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 ptp -75.42 151.4 38.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.219 0.463 . . . . 0.0 110.49 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -146.45 132.95 19.72 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 149.1 46.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.137 1.335 . . . . 0.0 110.508 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -106.52 130.15 54.35 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.584 0.753 . . . . 0.0 109.934 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -76.33 146.39 38.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.705 1.139 . . . . 0.0 108.583 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -56.95 131.62 50.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.253 1.021 . . . . 0.0 110.111 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.99 -9.12 9.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.696 1.141 . . . . 0.0 114.692 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -93.47 -39.41 10.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.435 1.618 . . . . 0.0 110.843 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.0 m80 65.06 -23.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.266 2.226 . . . . 0.0 114.63 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -70.27 153.59 42.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.262 1.425 . . . . 0.0 109.759 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -102.88 153.22 20.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 111.718 -169.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.62 168.43 27.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.617 1.567 . . . . 0.0 110.49 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -86.64 152.71 54.8 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.55 133.48 37.21 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.092 1.861 . . . . 0.0 110.803 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.41 169.34 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.914 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.95 171.24 44.29 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.844 -0.535 . . . . 0.0 113.069 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.09 150.53 25.0 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.502 1.048 . . . . 0.0 111.496 -173.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.76 125.79 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.78 154.82 91.12 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.52 122.92 12.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 CA-C-N 120.804 1.323 . . . . 0.0 109.585 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.9 -3.96 85.78 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.521 -1.155 . . . . 0.0 114.749 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.78 156.95 38.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 120.135 1.968 . . . . 0.0 110.547 170.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -95.36 158.34 15.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.59 77.81 Favored 'General case' 0 C--O 1.224 -0.243 0 O-C-N 121.721 -0.612 . . . . 0.0 111.434 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.92 -37.59 79.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.55 0.74 . . . . 0.0 109.997 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -73.61 -35.62 65.38 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.46 92.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -60.87 -50.46 73.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.156 -0.926 . . . . 0.0 108.556 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 47.5 m-85 -66.01 -36.98 84.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.649 1.113 . . . . 0.0 112.41 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.1 ttm-85 -68.33 -50.44 53.3 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.826 1.193 . . . . 0.0 109.445 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.92 -27.75 61.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 tp -52.98 -48.02 67.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.456 0.702 . . . . 0.0 109.351 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.38 -42.5 99.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.779 0.718 . . . . 0.0 109.913 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.35 -28.27 69.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.366 0.985 . . . . 0.0 112.231 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.97 -57.91 2.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.579 0.751 . . . . 0.0 109.86 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.06 1.31 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.452 1.501 . . . . 0.0 112.216 -169.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.62 9.59 55.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.661 1.119 . . . . 0.0 113.39 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.74 150.15 20.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.056 2.142 . . . . 0.0 109.031 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 m -129.78 164.73 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.679 0.792 . . . . 0.0 109.903 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 53.0 mtt85 -45.29 -37.41 4.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.535 1.934 . . . . 0.0 113.12 -173.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.45 -30.35 71.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.873 -172.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.59 21.75 15.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.675 1.125 . . . . 0.0 112.505 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -131.38 165.11 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.246 1.418 . . . . 0.0 110.439 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -143.18 139.88 30.52 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 mt -79.59 121.64 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.12 -36.66 10.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.218 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.23 166.88 31.28 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.601 0.76 . . . . 0.0 109.295 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 p -162.47 155.47 19.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.394 1.077 . . . . 0.0 110.712 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 p -71.66 140.35 49.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.947 -170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.68 -49.64 12.79 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 144.37 26.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.817 1.647 . . . . 0.0 110.457 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -79.36 126.12 30.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.63 126.93 33.78 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -121.88 148.94 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -141.44 145.3 35.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -94.03 143.97 25.89 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.76 142.94 97.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 110.225 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.33 147.18 77.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 104.432 -2.949 . . . . 0.0 104.432 166.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.252 86.6 mttt -68.82 -12.81 61.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.03 -1.669 . . . . 0.0 114.546 -168.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -30.27 70.21 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.47 -15.47 25.53 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.815 0.846 . . . . 0.0 112.435 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.72 133.54 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -100.47 91.79 4.85 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.378 1.071 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -69.92 -22.73 63.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.98 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.7 -25.96 54.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.414 0.686 . . . . 0.0 112.391 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -106.81 155.89 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.944 0.897 . . . . 0.0 109.152 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.46 135.14 27.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.543 1.137 . . . . 0.0 110.246 -169.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.76 150.32 94.03 Favored 'Cis proline' 0 N--CA 1.456 -0.691 0 N-CA-C 109.528 -0.989 . . . . 0.0 109.528 -10.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.3 p -71.2 133.89 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.493 0.717 . . . . 0.0 109.48 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 t -74.4 130.18 39.16 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.25 -13.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.203 169.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.84 47.95 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 120.1 1.318 . . . . 0.0 111.226 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.97 157.8 44.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.021 1.728 . . . . 0.0 109.96 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.36 137.22 44.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.73 130.34 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.553 1.141 . . . . 0.0 109.277 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -112.63 134.01 54.38 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.414 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 66.3 m95 -115.0 157.62 23.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.594 0.634 . . . . 0.0 109.839 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.88 125.33 23.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 108.28 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.29 121.93 31.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 168.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mt -118.68 152.24 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.56 135.29 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 167.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 131.73 50.5 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.56 -50.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 119.44 1.018 . . . . 0.0 109.724 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.9 m -79.29 -25.12 42.48 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.322 0.649 . . . . 0.0 111.696 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.3 169.89 16.02 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -20.19 15.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.51 1.924 . . . . 0.0 113.073 -170.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.95 -26.24 47.14 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.13 10.43 8.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.31 140.63 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -130.35 118.77 21.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.028 1.731 . . . . 0.0 106.899 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.6 mtp -90.17 -3.06 58.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.549 0.613 . . . . 0.0 112.625 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -119.19 71.84 0.88 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.512 2.101 . . . . 0.0 107.026 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 p -65.22 -63.6 1.06 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.879 -2.873 . . . . 0.0 106.435 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 m -78.23 172.73 13.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.365 1.466 . . . . 0.0 107.343 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.5 m -60.33 -41.38 93.42 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.38 135.19 86.6 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 125.433 1.493 . . . . 0.0 108.777 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.13 140.52 89.79 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.654 1.57 . . . . 0.0 109.444 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.26 -46.55 20.0 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.5 141.76 39.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.882 0.873 . . . . 0.0 109.71 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -87.67 -15.02 38.36 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.253 1.021 . . . . 0.0 111.257 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.93 150.22 17.9 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 121.584 -0.698 . . . . 0.0 111.878 -169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 51.2 p-90 -127.38 153.99 45.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.402 1.481 . . . . 0.0 108.484 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.36 141.84 24.33 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 168.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -102.55 123.65 46.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.0 161.57 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.062 1.345 . . . . 0.0 112.517 -168.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m -66.72 149.56 50.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.672 -0.642 . . . . 0.0 109.91 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -30.56 59.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.013 1.325 . . . . 0.0 112.584 -173.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -95.81 -2.47 47.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -76.34 -49.5 3.03 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.369 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.74 -32.52 93.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.495 1.927 . . . . 0.0 112.346 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -66.59 -21.87 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.275 -0.89 . . . . 0.0 112.301 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -69.08 -29.62 67.77 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -86.51 -26.83 24.37 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.47 163.12 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -69.72 173.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.971 1.308 . . . . 0.0 109.797 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.8 m -55.9 -54.24 47.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.749 1.62 . . . . 0.0 113.313 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -70.59 -39.94 73.56 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.854 -172.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.53 -49.03 67.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.15 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -63.69 -33.11 74.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.639 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.0 -47.32 77.91 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 119.098 0.863 . . . . 0.0 110.219 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.11 -49.58 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -61.76 -39.86 93.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.029 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.87 -38.74 76.49 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.896 1.68 . . . . 0.0 110.747 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.89 -45.58 94.01 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.852 0.751 . . . . 0.0 110.225 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.81 -40.02 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 110.565 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mmt -67.21 -49.35 64.88 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.279 1.5 tmtt? -59.86 -31.1 69.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.612 1.096 . . . . 0.0 111.879 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -60.78 -36.75 79.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.269 0.628 . . . . 0.0 110.697 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.83 -15.8 13.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.082 0.953 . . . . 0.0 113.187 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.43 -42.45 70.54 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.428 1.491 . . . . 0.0 110.883 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 m -68.04 -31.78 71.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.855 0.862 . . . . 0.0 110.687 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.28 -44.24 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.9 -40.95 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.831 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.6 mmt -55.77 -47.17 77.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.173 0.897 . . . . 0.0 110.537 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -80.27 -26.68 38.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.921 1.288 . . . . 0.0 111.041 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.4 -41.37 93.73 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.753 1.221 . . . . 0.0 110.142 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -57.29 -36.72 71.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.901 0.481 . . . . 0.0 110.931 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 112.562 -176.092 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.76 -68.62 0.36 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.989 0.516 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -164.47 -49.76 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.768 0.827 . . . . 0.0 113.229 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.0 16.35 11.32 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 113.11 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.59 -2.13 82.34 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.391 0.996 . . . . 0.0 113.14 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.54 155.59 17.23 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.083 0.942 . . . . 0.0 108.507 169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -146.31 126.85 7.1 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 117.442 -1.266 . . . . 0.0 107.973 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -76.07 138.36 20.46 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.611 1.541 . . . . 0.0 111.581 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -139.71 154.67 47.52 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.266 1.026 . . . . 0.0 108.849 -171.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.88 162.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.606 -0.683 . . . . 0.0 109.61 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.5 163.37 28.2 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.14 142.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.07 136.49 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -116.42 136.06 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -124.83 145.56 49.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.816 0.735 . . . . 0.0 110.172 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -95.03 174.09 7.25 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -79.32 16.73 0.94 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.037 -1.664 . . . . 0.0 112.282 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -108.37 -1.3 20.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.422 1.489 . . . . 0.0 111.275 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.14 14.99 80.11 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.287 -172.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -86.8 130.42 34.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.07 152.95 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.951 1.3 . . . . 0.0 108.837 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.0 tpp -62.28 137.69 58.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.24 0.616 . . . . 0.0 109.473 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -140.91 129.7 22.99 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.41 44.46 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 122.957 0.503 . . . . 0.0 111.259 -169.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -124.43 125.66 44.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -88.15 165.05 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.862 0.465 . . . . 0.0 110.891 -169.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -49.51 124.43 9.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.227 1.011 . . . . 0.0 111.694 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.59 8.07 62.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.513 1.054 . . . . 0.0 113.412 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -100.05 153.18 19.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.778 1.289 . . . . 0.0 109.417 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -111.5 19.95 17.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 m -128.34 143.23 50.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.857 1.263 . . . . 0.0 108.29 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -98.2 151.45 20.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.379 0.672 . . . . 0.0 110.227 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -155.56 160.61 40.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.434 1.094 . . . . 0.0 111.051 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.75 148.21 75.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.43 127.39 17.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.828 2.352 . . . . 0.0 112.678 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -142.54 161.53 37.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.555 1.07 . . . . 0.0 112.51 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.99 177.11 48.28 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.199 0.428 . . . . 0.0 113.344 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.15 146.02 17.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 125.346 1.45 . . . . 0.0 110.182 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -79.82 124.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -70.33 155.26 93.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -57.7 125.28 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.95 -7.25 81.09 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.331 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.51 158.71 34.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 120.112 1.956 . . . . 0.0 110.396 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 p -102.16 159.57 15.27 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.35 85.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.625 -0.672 . . . . 0.0 111.627 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.16 -34.64 73.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.733 0.813 . . . . 0.0 110.114 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -72.82 -36.78 67.58 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.698 -1.251 . . . . 0.0 110.227 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.98 93.08 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 ttp -59.81 -49.11 79.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.274 -0.869 . . . . 0.0 108.819 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 46.1 m-85 -64.47 -44.35 91.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.664 1.12 . . . . 0.0 111.975 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -65.9 -49.83 66.64 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.849 1.204 . . . . 0.0 109.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.65 -24.49 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.2 -47.49 83.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -57.14 -39.98 76.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.555 0.616 . . . . 0.0 109.458 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -0.96 14.48 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -115.98 -39.4 3.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.273 1.429 . . . . 0.0 111.933 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.46 2.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.735 1.214 . . . . 0.0 112.666 -171.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.87 6.81 19.59 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-N 119.523 1.056 . . . . 0.0 113.269 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.35 148.65 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.356 1.862 . . . . 0.0 109.238 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 p -126.59 170.11 12.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.665 1.186 . . . . 0.0 109.486 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.407 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 43.9 mtt85 -50.93 -31.93 19.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.906 1.683 . . . . 0.0 112.166 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -66.69 -24.82 66.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.244 0.618 . . . . 0.0 112.349 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.93 24.28 10.93 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.01 164.06 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 120.778 -1.201 . . . . 0.0 111.464 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -141.9 140.51 32.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 mt -82.61 119.52 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.0 mt -94.6 -36.64 11.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.429 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.17 164.4 32.91 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.498 0.719 . . . . 0.0 109.773 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 p -160.08 153.85 22.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.904 1.281 . . . . 0.0 110.974 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 p -70.02 140.26 52.84 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.574 0.702 . . . . 0.0 111.199 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -83.29 -28.3 29.21 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.083 1.353 . . . . 0.0 110.053 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -125.5 148.14 48.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.369 2.267 . . . . 0.0 109.094 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -81.83 136.1 35.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.52 62.04 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.823 0.849 . . . . 0.0 109.442 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -71.21 150.33 45.41 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.4 -0.812 . . . . 0.0 109.914 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.17 148.34 31.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.93 136.77 32.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 169.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.283 0.4 OUTLIER -90.83 149.71 40.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.629 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.59 157.71 44.28 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 124.093 3.195 . . . . 0.0 111.049 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -65.44 -19.9 66.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -171.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -31.01 69.39 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.3 mt -94.22 -22.51 18.37 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.675 1.19 . . . . 0.0 111.489 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.44 133.44 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -99.99 88.42 3.75 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.782 0.801 . . . . 0.0 109.479 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -68.76 -22.04 64.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.768 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.54 -8.99 59.16 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.817 0.847 . . . . 0.0 113.046 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -129.77 162.77 27.69 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 110.274 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.18 134.84 26.36 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.404 1.482 . . . . 0.0 109.231 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.61 147.28 88.97 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 O-C-N 122.666 0.824 . . . . 0.0 110.381 -10.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.72 140.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.003 0.921 . . . . 0.0 109.725 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.2 p -94.61 128.33 41.17 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.374 1.07 . . . . 0.0 109.904 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -14.59 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.92 175.5 47.04 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.07 144.74 26.88 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 108.336 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -90.05 135.45 33.64 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -118.42 132.3 56.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.185 0.902 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -115.74 135.26 54.21 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.52 154.3 31.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.1 125.59 22.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.506 1.123 . . . . 0.0 108.146 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 tp -90.4 124.93 35.36 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.35 149.09 41.07 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -100.67 129.24 46.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.02 134.04 56.11 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.6 t -82.24 -43.27 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.587 -169.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.0 m -97.52 -19.3 18.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.933 0.893 . . . . 0.0 111.704 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.1 -170.11 17.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.416 1.008 . . . . 0.0 111.064 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.68 -22.51 23.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.218 1.807 . . . . 0.0 112.824 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.51 -31.14 63.81 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.957 0.903 . . . . 0.0 113.434 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.96 14.33 14.14 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.98 140.36 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -120.74 115.71 23.83 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.05 6.7 47.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.049 0.539 . . . . 0.0 111.581 -171.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -149.02 66.61 1.04 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.454 1.902 . . . . 0.0 106.663 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -57.03 -60.47 3.55 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 127.218 2.207 . . . . 0.0 111.175 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.4 m -101.19 174.5 5.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.27 1.828 . . . . 0.0 109.93 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -54.67 -37.93 66.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.02 116.16 64.67 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 167.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -61.82 129.99 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 170.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.62 32.5 0.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . 0.26 8.8 t80 -153.18 162.26 41.51 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 120.683 -1.261 . . . . 0.0 112.184 -166.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.75 17.48 0.89 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 171.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.24 149.33 5.13 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 115.443 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.78 153.34 51.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.652 1.181 . . . . 0.0 111.675 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -156.32 152.67 27.93 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.601 1.16 . . . . 0.0 108.742 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -107.72 123.77 49.03 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.64 151.04 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.111 0.964 . . . . 0.0 110.668 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m -55.12 140.03 39.71 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.594 0.758 . . . . 0.0 110.291 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -32.45 18.53 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -85.38 -23.54 27.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.322 1.419 . . . . 0.0 112.971 -176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.72 -46.71 88.5 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.072 -1.442 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.86 -25.79 78.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 123.028 2.117 . . . . 0.0 113.139 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.29 -32.18 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.931 0.893 . . . . 0.0 108.915 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -61.85 -32.58 72.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.368 -0.832 . . . . 0.0 110.949 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -77.99 -27.32 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.33 167.69 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 118.896 0.771 . . . . 0.0 110.879 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.701 1.2 . . . . 0.0 110.226 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.7 m -53.2 -47.0 69.25 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.662 1.585 . . . . 0.0 114.838 -170.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -74.92 -36.7 62.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.051 0.841 . . . . 0.0 111.256 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -74.24 -42.82 59.09 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.503 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -42.88 -44.6 4.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.993 0.917 . . . . 0.0 111.935 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.35 -43.26 98.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.219 0.918 . . . . 0.0 111.097 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.75 -50.63 76.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.23 -32.37 74.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.301 0.64 . . . . 0.0 110.929 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -69.57 -41.78 75.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.836 1.198 . . . . 0.0 110.407 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.06 -41.23 96.22 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.581 1.082 . . . . 0.0 110.576 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.3 t -57.85 -24.97 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 111.591 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.5 mmt -90.51 -58.36 2.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -56.53 -37.12 70.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.637 1.175 . . . . 0.0 112.485 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.1 -36.29 72.68 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 119.062 0.846 . . . . 0.0 111.078 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -106.91 -11.95 15.59 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.183 0.993 . . . . 0.0 112.673 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.68 69.8 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.223 1.409 . . . . 0.0 110.655 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.2 m -67.85 -31.86 71.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.551 0.74 . . . . 0.0 110.654 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.97 -45.23 74.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.43 -41.02 80.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 117.312 -1.327 . . . . 0.0 110.592 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.19 -49.9 72.74 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 120.993 1.724 . . . . 0.0 109.964 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 m -73.55 -26.55 60.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.26 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.5 tp -63.79 -44.07 94.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.296 1.438 . . . . 0.0 109.539 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -61.16 -43.06 99.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.233 0.232 0 C-N-CA 122.937 0.495 . . . . 0.0 112.173 -171.637 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 mt . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.26 150.12 47.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.472 1.129 . . . . 0.0 108.803 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.98 -24.86 56.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.188 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.15 0.19 19.81 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.87 61.78 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.912 1.244 . . . . 0.0 113.386 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -118.2 161.25 20.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -144.18 132.45 10.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.35 136.06 8.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.371 1.381 . . . . 0.0 108.821 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -139.19 152.56 47.47 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.118 -0.989 . . . . 0.0 108.989 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.26 154.09 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.255 1.022 . . . . 0.0 108.892 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.51 157.5 25.14 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.32 143.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.5 138.69 51.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 170.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 mm -116.89 141.21 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.74 157.2 30.18 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.321 1.049 . . . . 0.0 111.364 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -117.89 168.09 10.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.938 1.295 . . . . 0.0 107.987 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -73.66 -0.71 16.28 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.377 -1.452 . . . . 0.0 113.032 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -85.35 -8.84 58.25 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 111.365 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.95 34.83 41.1 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -106.07 154.34 20.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 169.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.84 150.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.34 1.056 . . . . 0.0 109.736 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.6 ttm -66.67 143.26 57.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.203 1.001 . . . . 0.0 108.397 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -150.5 141.85 23.32 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 147.63 31.37 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.463 1.483 . . . . 0.0 110.379 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.09 136.37 47.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.165 0.986 . . . . 0.0 109.089 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm-85 -73.53 160.68 31.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 111.487 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -49.58 123.94 8.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.174 0.99 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.73 6.79 73.1 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.816 1.198 . . . . 0.0 114.145 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -106.42 160.27 15.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.338 1.569 . . . . 0.0 110.616 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -119.91 17.34 12.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.803 1.241 . . . . 0.0 111.598 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 m -128.1 138.71 52.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.048 1.339 . . . . 0.0 108.149 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -94.46 151.21 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.519 0.727 . . . . 0.0 110.549 -170.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -143.57 155.58 44.34 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.165 1.386 . . . . 0.0 110.139 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -82.54 138.9 44.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 167.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.05 135.58 64.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.708 2.272 . . . . 0.0 112.568 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.87 166.2 32.42 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.962 0.801 . . . . 0.0 112.199 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.0 168.01 40.95 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.507 0.575 . . . . 0.0 111.683 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.88 149.01 40.68 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.9 mt -73.57 120.49 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -73.59 157.79 87.2 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.59 122.98 12.7 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.331 1.354 . . . . 0.0 111.539 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.23 2.0 88.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.538 -1.146 . . . . 0.0 114.745 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.85 152.74 43.39 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.158 1.979 . . . . 0.0 111.066 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.0 p -84.76 167.49 16.05 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 167.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -36.32 79.2 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.088 -1.008 . . . . 0.0 111.316 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -40.51 61.13 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.484 0.713 . . . . 0.0 109.802 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -65.65 -40.89 92.94 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.26 75.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.856 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -58.15 -48.23 80.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 57.1 m-85 -66.81 -45.64 77.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.1 0.864 . . . . 0.0 111.642 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -53.57 -51.71 62.09 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.919 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -77.72 -32.34 52.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.9 tp -56.48 -45.65 80.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.25 0.932 . . . . 0.0 109.98 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.84 -40.26 92.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.282 0.492 . . . . 0.0 110.082 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.813 0.733 . . . . 0.0 112.366 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.55 -53.55 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.165 0.986 . . . . 0.0 110.414 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -123.27 3.6 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.488 1.515 . . . . 0.0 112.038 -169.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.43 3.27 24.9 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.005 1.275 . . . . 0.0 113.955 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.81 145.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.7 m -124.3 162.21 24.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.062 . . . . 0.0 109.664 -171.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 46.4 mtp180 -42.73 -40.63 2.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.621 1.968 . . . . 0.0 112.892 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -69.08 -21.15 64.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.376 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.76 19.92 16.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.745 0.784 . . . . 0.0 112.522 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.23 164.19 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.403 1.481 . . . . 0.0 111.337 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 138.93 35.92 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.072 169.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 mt -77.03 116.1 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 mt -93.71 -33.17 13.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.395 174.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.28 164.45 38.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.866 0.866 . . . . 0.0 109.397 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 p -162.21 154.4 19.17 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 110.787 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 p -70.6 136.86 49.53 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.831 -0.543 . . . . 0.0 110.8 -170.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -79.3 -29.79 42.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.633 0.773 . . . . 0.0 110.553 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.344 2.258 . . . . 0.0 108.361 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.3 m95 -77.78 133.64 38.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.998 0.817 . . . . 0.0 109.165 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.03 116.58 27.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -127.05 149.52 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.51 142.55 31.18 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.9 139.77 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.71 139.37 86.05 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.065 0.946 . . . . 0.0 110.418 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.55 148.83 73.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 N-CA-C 104.636 -2.871 . . . . 0.0 104.636 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -68.84 -13.23 62.28 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 119.847 -1.783 . . . . 0.0 114.236 -168.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -62.54 -30.73 71.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.955 0.798 . . . . 0.0 112.634 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.4 mt -94.07 -18.24 22.02 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.161 0.985 . . . . 0.0 112.212 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.48 132.65 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.12 88.39 4.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.729 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -69.98 -17.76 63.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.262 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.83 -27.28 55.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -103.18 163.08 12.46 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.973 . . . . 0.0 110.811 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.38 127.67 22.5 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 125.254 1.422 . . . . 0.0 110.72 -171.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.14 145.24 83.44 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 N-CA-C 109.308 -1.074 . . . . 0.0 109.308 -10.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.28 136.35 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.5 p -96.92 144.22 27.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.594 0.358 . . . . 0.0 110.585 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.84 -7.3 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.45 177.22 41.44 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -150.08 147.25 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.854 1.662 . . . . 0.0 109.016 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -96.23 131.24 42.92 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.17 128.6 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.504 1.047 . . . . 0.0 109.189 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 2.2 ttmm -109.05 121.15 44.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -102.47 151.27 22.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -133.43 131.51 40.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 108.015 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.34 124.8 37.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.51 149.7 42.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -97.57 133.06 42.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 168.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 136.19 57.84 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.235 1.414 . . . . 0.0 107.552 171.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.31 -59.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.563 1.074 . . . . 0.0 110.226 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 m -74.74 -20.03 59.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.423 0.689 . . . . 0.0 111.672 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.21 172.35 25.14 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -58.42 -16.5 15.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.059 1.744 . . . . 0.0 114.112 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.73 -30.89 15.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.194 0.997 . . . . 0.0 113.088 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -85.53 18.98 2.53 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.18 142.05 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.185 1.394 . . . . 0.0 108.614 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -130.94 130.93 44.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.652 1.981 . . . . 0.0 107.895 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mmt -93.95 -14.4 26.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.52 0.728 . . . . 0.0 112.728 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -112.73 74.32 0.86 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 124.38 2.038 . . . . 0.0 107.94 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.0 p -71.49 -63.12 1.18 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 110.891 -2.868 . . . . 0.0 107.117 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.2 m -78.91 175.47 10.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.599 1.56 . . . . 0.0 108.721 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -59.71 -35.24 74.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.541 -0.724 . . . . 0.0 110.486 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.27 137.36 37.04 Favored Pre-proline 0 N--CA 1.446 -0.657 0 C-N-CA 125.945 1.698 . . . . 0.0 108.844 169.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.38 121.32 9.26 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.31 2.007 . . . . 0.0 107.55 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -73.74 -26.05 60.48 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.067 -0.395 . . . . 0.0 111.583 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -107.54 141.29 39.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.22 -27.66 38.74 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.259 0.624 . . . . 0.0 110.313 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.55 150.81 22.88 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.78 140.44 29.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -148.04 168.98 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.586 1.154 . . . . 0.0 109.222 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -117.4 142.56 46.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 149.84 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.702 1.201 . . . . 0.0 109.101 -169.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -51.99 141.81 17.18 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -43.78 -55.51 4.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.78 -7.83 53.53 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.822 1.192 . . . . 0.0 113.596 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.58 -52.44 66.99 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-O 116.825 -1.559 . . . . 0.0 113.68 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.97 -8.73 14.57 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.616 2.877 . . . . 0.0 116.392 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.16 -29.52 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 120.967 -1.083 . . . . 0.0 108.869 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.43 -25.38 63.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.75 -1.219 . . . . 0.0 112.281 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.47 -22.05 21.57 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.92 175.3 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 119.321 0.964 . . . . 0.0 110.612 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 m -83.82 171.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.5 m -56.61 -48.79 76.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.821 2.048 . . . . 0.0 114.327 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -72.07 -35.99 69.42 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.115 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.08 -39.08 72.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.75 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -50.01 -42.81 50.01 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.87 0.868 . . . . 0.0 111.454 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.41 -45.85 91.24 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.465 0.575 . . . . 0.0 110.359 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.1 -50.22 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -62.79 -37.99 88.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.9 0.773 . . . . 0.0 109.974 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -69.24 -36.28 77.02 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.45 -44.66 95.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.077 1.308 . . . . 0.0 110.307 172.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.14 -39.03 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 119.939 1.245 . . . . 0.0 110.451 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.8 mmt -72.45 -59.48 2.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.958 1.303 . . . . 0.0 107.637 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -34.07 72.48 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.588 -1.32 . . . . 0.0 112.313 -172.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -57.93 -41.05 81.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -111.52 -11.95 14.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 112.039 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.2 -42.7 63.73 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 126.786 2.034 . . . . 0.0 110.467 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -68.95 -30.66 69.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.994 0.918 . . . . 0.0 110.916 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.83 -46.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.11 -41.25 88.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.293 -171.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.0 mmt -55.51 -44.41 76.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.348 1.431 . . . . 0.0 110.752 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -81.12 -26.04 36.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.324 1.049 . . . . 0.0 111.502 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.59 -43.78 95.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.043 1.337 . . . . 0.0 109.686 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.63 -40.09 93.63 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.752 0.421 . . . . 0.0 110.718 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 C--O 1.234 0.243 0 C-N-CA 123.217 0.607 . . . . 0.0 112.238 -169.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.44 -63.95 1.12 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.429 0.692 . . . . 0.0 112.627 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.21 -53.84 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.62 17.25 16.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.435 1.094 . . . . 0.0 113.06 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.19 61.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.894 0.759 . . . . 0.0 113.702 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.8 154.4 18.67 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.085 0.943 . . . . 0.0 108.816 171.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 149.88 63.1 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.361 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -90.58 141.78 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.687 1.592 . . . . 0.0 111.757 -174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -135.8 154.32 51.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.143 0.977 . . . . 0.0 109.711 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.82 140.53 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.81 155.62 16.09 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 124.783 1.182 . . . . 0.0 110.211 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.05 142.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.93 135.62 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 mm -108.56 132.76 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.2 m -124.26 145.57 49.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -105.74 173.31 6.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.644 1.177 . . . . 0.0 109.321 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.59 5.75 4.51 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.562 -1.336 . . . . 0.0 113.657 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -96.27 -2.17 46.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 111.482 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.61 22.11 79.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.392 -0.671 . . . . 0.0 111.843 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -93.91 145.39 24.66 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.23 149.85 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.717 1.607 . . . . 0.0 108.934 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.4 ttm -68.37 142.78 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.88 0.872 . . . . 0.0 109.366 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -141.48 123.32 15.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.08 159.35 41.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.134 1.334 . . . . 0.0 112.575 -168.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HG3' ' H ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -157.93 169.52 24.4 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.08 1.309 . . . . 0.0 114.073 177.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' H ' ' HG3' ' A' ' 26' ' ' ARG . 8.2 tpt180 -59.84 154.39 18.57 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 128.035 2.534 . . . . 0.0 112.855 -169.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -61.15 134.39 56.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.614 1.166 . . . . 0.0 108.242 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.61 1.78 78.26 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.361 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -106.15 160.73 15.1 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.564 1.682 . . . . 0.0 110.654 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -128.91 11.99 6.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.671 1.189 . . . . 0.0 111.453 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -85.68 169.15 13.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.902 0.881 . . . . 0.0 109.082 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -133.2 132.12 41.16 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.03 173.94 13.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.391 1.477 . . . . 0.0 108.037 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -75.46 152.93 85.72 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.098 -0.954 . . . . 0.0 108.601 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 133.36 57.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.865 2.377 . . . . 0.0 111.536 170.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.15 171.2 18.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.66 1.118 . . . . 0.0 112.204 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.48 170.36 41.16 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.992 -0.442 . . . . 0.0 112.755 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 144.01 33.59 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 mt -73.99 119.33 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.67 144.1 85.6 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.14 126.17 18.06 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.804 1.67 . . . . 0.0 110.293 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.43 52.79 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.662 1.125 . . . . 0.0 113.283 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 152.1 37.17 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.675 1.737 . . . . 0.0 109.83 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.2 p -80.21 169.4 17.83 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.3 87.75 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 121.68 -0.637 . . . . 0.0 111.379 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.66 -37.77 70.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 110.387 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -68.09 -39.49 82.88 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.603 -1.31 . . . . 0.0 110.08 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.56 -30.66 67.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.676 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.403 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 11.9 tmm? -57.08 -50.73 71.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.425 1.011 . . . . 0.0 108.674 173.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.409 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 52.3 m-85 -66.38 -44.96 81.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.322 0.51 . . . . 0.0 111.119 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -57.35 -50.23 73.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.901 0.88 . . . . 0.0 110.023 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -77.12 -31.08 55.51 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -172.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.9 tp -58.11 -43.26 87.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.369 0.986 . . . . 0.0 110.241 172.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -62.38 -41.47 98.66 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.325 0.511 . . . . 0.0 110.087 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.66 -24.84 65.48 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.804 0.729 . . . . 0.0 112.429 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.04 -61.09 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.802 0.841 . . . . 0.0 108.788 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.88 -4.95 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.436 1.094 . . . . 0.0 113.561 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.799 1.181 . . . . 0.0 114.103 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.08 150.28 30.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.83 1.652 . . . . 0.0 109.099 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 m -127.76 164.34 22.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.332 1.053 . . . . 0.0 109.801 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 60.9 mtt180 -48.28 -36.16 13.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.103 1.761 . . . . 0.0 112.519 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -63.38 -23.45 67.42 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.623 0.769 . . . . 0.0 112.19 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.89 24.58 11.13 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.939 0.4 . . . . 0.0 111.63 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.87 165.09 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.413 1.085 . . . . 0.0 111.957 172.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 134.16 30.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.7 mt -76.65 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -95.88 -32.89 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.19 164.43 38.55 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 p -163.18 154.44 17.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.502 1.121 . . . . 0.0 110.798 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -72.81 140.06 47.41 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 109.969 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -92.22 -27.87 17.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -111.29 150.92 28.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.451 2.3 . . . . 0.0 107.482 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 57.1 m95 -82.3 136.94 34.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.438 0.563 . . . . 0.0 109.518 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.4 71.47 6.05 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -71.77 147.36 47.36 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -146.33 144.01 29.5 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.845 0.458 . . . . 0.0 110.0 170.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.84 146.67 24.04 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.074 0.95 . . . . 0.0 108.504 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.05 145.85 91.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 110.682 169.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.79 145.9 64.42 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 N-CA-C 104.499 -2.924 . . . . 0.0 104.499 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -68.34 -13.13 62.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.909 -1.744 . . . . 0.0 114.151 -169.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -58.7 -31.31 68.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.8 mt -92.55 -19.52 21.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 111.998 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.31 136.09 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -101.58 90.49 4.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.942 0.897 . . . . 0.0 109.473 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -68.42 -24.17 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.807 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.93 -34.42 73.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.617 0.367 . . . . 0.0 111.831 -171.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.93 159.21 15.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.786 0.834 . . . . 0.0 109.678 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -130.88 134.95 26.59 Favored Pre-proline 0 C--O 1.234 0.268 0 C-N-CA 125.325 1.45 . . . . 0.0 109.615 -171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.46 148.03 90.5 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 O-C-N 122.696 0.84 . . . . 0.0 110.07 -10.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -79.24 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.484 0.713 . . . . 0.0 109.532 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.89 127.69 35.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -14.57 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 118.932 0.787 . . . . 0.0 112.861 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.7 -177.11 38.88 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.77 153.82 30.45 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.794 1.238 . . . . 0.0 108.84 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -98.61 132.55 43.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -123.62 122.81 39.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 119.266 0.939 . . . . 0.0 109.566 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 7.6 ttmm -98.72 153.55 18.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -132.32 151.74 51.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.403 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 75.8 m-85 -137.69 127.88 26.09 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 108.893 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.59 122.62 32.91 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.88 136.99 53.75 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.47 132.29 35.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 tp -73.76 132.64 42.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.064 2.146 . . . . 0.0 107.539 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -77.63 -53.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.538 1.135 . . . . 0.0 111.837 -168.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.7 m -87.24 -15.55 37.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 111.563 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.37 -169.92 21.95 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.707 1.146 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -59.1 -17.39 25.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.627 1.571 . . . . 0.0 114.008 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.81 57.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.268 1.027 . . . . 0.0 112.955 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -95.66 18.29 13.22 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.52 113.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -92.74 -56.12 3.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.799 0.272 . . . . 0.0 110.978 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.2 mtp 69.81 3.16 4.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.704 2.401 . . . . 0.0 115.016 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.05 78.76 1.5 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 123.793 1.759 . . . . 0.0 109.825 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -75.93 -59.92 2.55 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.51 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 m -66.15 167.7 9.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.295 1.838 . . . . 0.0 109.53 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -62.44 -38.0 88.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.88 -0.512 . . . . 0.0 109.739 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.62 139.95 51.22 Favored Pre-proline 0 N--CA 1.442 -0.871 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 169.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.62 135.68 69.04 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.628 1.552 . . . . 0.0 108.112 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -81.62 -29.83 33.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.74 153.67 43.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.122 1.769 . . . . 0.0 107.83 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.67 -25.14 1.91 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.353 1.061 . . . . 0.0 110.58 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.83 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -150.76 133.09 15.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.153 0.981 . . . . 0.0 108.402 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -152.48 164.57 37.3 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.125 1.37 . . . . 0.0 108.471 169.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -114.49 141.27 47.93 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 152.79 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 110.292 -170.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m -60.97 142.54 56.44 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 109.043 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -27.58 48.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 32.5 m95 -88.2 -18.57 28.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.03 1.286 . . . . 0.0 113.19 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.91 -50.41 70.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.132 -1.413 . . . . 0.0 113.294 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.7 -28.95 76.95 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.159 1.906 . . . . 0.0 112.629 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.91 -34.88 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.329 1.052 . . . . 0.0 108.788 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -68.94 -19.7 64.19 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.787 -1.196 . . . . 0.0 112.323 -175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -79.87 -32.7 40.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.854 1.206 . . . . 0.0 112.614 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.5 156.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 118.995 0.816 . . . . 0.0 111.482 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -68.65 162.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 m -53.22 -46.63 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.862 2.065 . . . . 0.0 115.236 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -69.33 -32.17 71.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.431 1.014 . . . . 0.0 111.153 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -77.54 -39.6 45.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.6 ttp-105 -50.05 -39.0 40.64 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.788 1.235 . . . . 0.0 112.387 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.24 -43.58 94.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.47 0.577 . . . . 0.0 111.378 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.91 -50.94 78.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -66.61 -34.49 77.99 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.701 -0.624 . . . . 0.0 110.897 -168.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -67.45 -40.61 85.42 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.65 1.114 . . . . 0.0 110.248 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.43 -43.74 98.33 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.725 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.91 -43.22 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 120.29 1.404 . . . . 0.0 109.912 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.5 mmt -74.04 -48.86 27.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -33.81 76.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.998 0.817 . . . . 0.0 112.159 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.74 -45.54 89.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.686 1.195 . . . . 0.0 109.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.19 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.097 1.359 . . . . 0.0 110.792 -174.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -69.34 -31.57 70.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.786 0.834 . . . . 0.0 110.598 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.47 -48.5 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.45 -41.77 82.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.172 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.63 -47.48 73.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.365 1.439 . . . . 0.0 110.71 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m -77.28 -26.85 52.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.173 1.389 . . . . 0.0 110.781 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.53 -42.25 96.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.018 1.727 . . . . 0.0 108.778 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -59.07 -24.64 63.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.344 0.657 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 124.781 1.232 . . . . 0.0 113.116 -171.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -67.37 -69.42 0.31 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.005 0.522 . . . . 0.0 111.661 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -164.74 -48.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.762 0.825 . . . . 0.0 112.84 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.51 13.29 14.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.293 1.037 . . . . 0.0 113.06 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.22 81.82 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.291 0.948 . . . . 0.0 113.163 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.58 157.24 17.61 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.975 0.91 . . . . 0.0 108.749 169.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -148.93 139.77 13.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.594 -172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -87.47 139.7 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 CA-C-N 121.63 1.618 . . . . 0.0 111.987 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.27 165.87 24.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.101 1.36 . . . . 0.0 109.127 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.74 172.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.08 159.75 28.7 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.39 141.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.25 139.26 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mm -119.47 142.83 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.0 p -121.84 154.28 37.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.186 0.903 . . . . 0.0 111.4 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -112.51 168.47 9.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.865 1.266 . . . . 0.0 108.336 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.39 4.46 5.86 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.133 -1.604 . . . . 0.0 113.196 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -90.78 -4.81 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.185 0.994 . . . . 0.0 111.45 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.3 21.06 70.99 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.841 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -95.67 151.34 19.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.674 1.237 . . . . 0.0 107.963 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.21 153.93 20.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.493 1.517 . . . . 0.0 109.495 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.3 tpp -60.55 137.6 58.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.317 1.047 . . . . 0.0 108.802 169.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -147.73 135.15 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 156.01 47.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.226 1.375 . . . . 0.0 112.554 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -109.44 109.32 20.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.149 1.779 . . . . 0.0 107.166 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -66.74 148.72 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.676 1.126 . . . . 0.0 108.06 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -46.25 118.81 2.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.419 1.087 . . . . 0.0 111.311 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.96 4.25 40.56 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.302 -1.277 . . . . 0.0 115.871 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -82.95 -30.42 28.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.235 2.017 . . . . 0.0 112.579 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 m80 53.78 34.22 18.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.323 1.049 . . . . 0.0 111.957 -172.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.3 p -131.22 170.74 14.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.919 2.088 . . . . 0.0 107.49 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -120.19 145.37 47.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.349 0.522 . . . . 0.0 110.505 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 165.61 36.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.071 1.349 . . . . 0.0 110.17 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -79.93 153.07 75.0 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.859 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.34 139.5 59.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.076 2.517 . . . . 0.0 110.324 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -138.59 168.38 19.91 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.383 1.073 . . . . 0.0 112.51 -168.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.89 163.05 30.33 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 119.98 -0.344 . . . . 0.0 112.385 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.49 135.15 12.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 174.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.28 122.49 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -69.86 155.85 92.76 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.27 122.93 12.65 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.991 1.127 . . . . 0.0 109.461 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -3.72 86.75 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.338 -1.256 . . . . 0.0 114.594 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.98 158.92 34.53 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.279 2.04 . . . . 0.0 110.753 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m -98.97 155.83 17.22 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.07 86.48 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.132 -0.98 . . . . 0.0 111.389 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.907 0.883 . . . . 0.0 110.287 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -68.76 -39.24 80.37 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.667 -0.646 . . . . 0.0 110.084 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.29 94.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -60.15 -50.88 71.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.903 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -66.29 -37.24 84.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.893 1.224 . . . . 0.0 112.521 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -63.77 -49.8 71.54 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.069 1.304 . . . . 0.0 109.133 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -76.78 -25.67 53.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.04 -40.73 73.92 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.725 -1.235 . . . . 0.0 110.111 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -70.85 -37.82 73.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.52 0.6 . . . . 0.0 110.537 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.39 -34.2 72.29 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.2 -0.937 . . . . 0.0 111.808 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.78 -52.86 4.54 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.415 1.086 . . . . 0.0 110.114 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.27 -30.1 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.359 1.464 . . . . 0.0 110.233 -168.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 0.77 89.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.944 0.783 . . . . 0.0 112.38 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.2 tp -83.78 155.33 23.08 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.694 1.998 . . . . 0.0 109.334 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 p -133.81 169.13 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.296 1.038 . . . . 0.0 109.751 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -52.48 -33.02 42.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.919 1.688 . . . . 0.0 112.306 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -63.26 -28.02 69.74 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.293 0.637 . . . . 0.0 111.897 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.9 23.27 12.72 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 112.159 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 165.86 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 120.782 -1.199 . . . . 0.0 112.016 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 136.67 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.4 mt -76.12 115.71 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -89.18 -36.44 15.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.607 173.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.79 166.45 33.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.117 0.567 . . . . 0.0 109.778 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 p -161.24 155.6 22.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.981 1.312 . . . . 0.0 110.103 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -68.71 137.28 53.98 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.703 -0.623 . . . . 0.0 111.116 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -81.51 -28.64 33.93 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.214 1.406 . . . . 0.0 109.894 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -120.91 150.38 41.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.613 2.365 . . . . 0.0 108.177 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -81.48 133.38 35.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.4 mt -91.15 136.85 32.8 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -129.63 156.98 43.35 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.933 0.893 . . . . 0.0 111.431 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -143.36 125.92 15.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.17 137.43 36.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.07 142.87 93.6 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.702 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.01 146.49 71.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 104.923 -2.76 . . . . 0.0 104.923 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.61 -11.18 60.63 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.008 -1.682 . . . . 0.0 113.889 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -60.63 -31.42 70.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.973 0.806 . . . . 0.0 112.613 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.3 mt -92.04 -22.23 20.06 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 111.504 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.89 136.88 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -106.52 92.79 4.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.037 0.935 . . . . 0.0 110.063 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -68.4 -24.29 64.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.015 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.3 -25.57 58.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.386 0.674 . . . . 0.0 112.578 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -110.55 156.71 20.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.113 0.965 . . . . 0.0 109.338 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -127.87 137.64 31.21 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 109.975 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.25 149.72 93.66 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.874 0.934 . . . . 0.0 110.177 -10.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 p -78.22 134.33 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 110.142 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.4 p -74.25 126.17 30.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.935 0.894 . . . . 0.0 109.4 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.85 -13.67 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 171.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.35 175.65 46.41 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -151.52 145.25 25.04 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.33 1.452 . . . . 0.0 108.961 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.03 133.83 34.2 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -129.48 123.96 32.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.89 0.768 . . . . 0.0 109.987 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -103.68 127.38 51.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.123 0.969 . . . . 0.0 108.407 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -105.75 153.93 21.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -132.97 128.78 37.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.483 1.113 . . . . 0.0 108.264 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.01 124.54 37.06 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 mt -119.2 149.4 41.8 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -99.71 126.75 45.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.45 138.65 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.318 1.047 . . . . 0.0 108.794 170.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.8 t -90.72 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.414 0.552 . . . . 0.0 110.556 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.0 m -85.59 -18.71 32.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.218 0.607 . . . . 0.0 111.02 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.52 21.4 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.89 -21.14 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.607 1.963 . . . . 0.0 113.345 -172.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.29 -30.01 59.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.579 0.752 . . . . 0.0 113.028 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -93.58 15.65 15.63 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.9 mt -91.74 135.61 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -122.23 -51.84 1.97 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.331 0.652 . . . . 0.0 112.165 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 mtp 65.64 16.82 10.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.416 2.287 . . . . 0.0 113.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.58 29.84 1.93 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.276 1.512 . . . . 0.0 112.142 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -51.41 70.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.659 1.583 . . . . 0.0 108.345 169.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.5 m -68.96 156.45 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.576 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -65.89 -33.48 75.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.015 0.526 . . . . 0.0 110.456 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.56 134.83 33.36 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 124.997 1.319 . . . . 0.0 107.973 169.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.38 122.28 11.4 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.474 2.116 . . . . 0.0 107.315 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.39 -33.4 72.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -117.77 138.81 51.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.19 -19.6 46.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.6 161.79 32.02 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.65 159.07 43.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -151.88 164.87 36.18 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.147 0.979 . . . . 0.0 109.165 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -114.87 127.38 55.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.03 152.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.481 1.112 . . . . 0.0 110.0 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -59.63 147.63 36.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.476 0.58 . . . . 0.0 109.471 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.95 54.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.465 1.106 . . . . 0.0 113.778 -169.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -88.87 -22.66 23.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.332 -0.855 . . . . 0.0 113.09 -172.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -58.24 -49.06 95.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.248 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.85 -29.3 76.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.169 1.81 . . . . 0.0 111.819 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.86 -30.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.26 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -68.3 -27.73 66.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.166 -0.959 . . . . 0.0 111.31 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -83.6 -24.52 31.44 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -168.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.38 160.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.686 0.755 . . . . 0.0 112.713 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.7 175.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.254 1.421 . . . . 0.0 109.856 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.86 -55.93 26.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.944 1.697 . . . . 0.0 113.002 -173.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -70.17 -32.32 70.21 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 -171.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -74.17 -48.05 31.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.974 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -63.48 -30.93 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.706 1.139 . . . . 0.0 112.204 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.7 -35.31 74.25 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.842 174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.81 -49.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.494 1.118 . . . . 0.0 109.949 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -62.39 -31.99 72.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.755 1.162 . . . . 0.0 111.106 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.6 -43.44 98.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.487 1.04 . . . . 0.0 111.384 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -61.13 -45.69 93.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.366 0.985 . . . . 0.0 110.239 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.68 -26.11 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.063 0.945 . . . . 0.0 111.58 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.1 mmt -90.81 -56.29 3.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.998 0.919 . . . . 0.0 108.885 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -57.3 -33.65 67.9 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.462 1.028 . . . . 0.0 112.551 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -63.45 -32.81 74.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.947 0.499 . . . . 0.0 110.574 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -111.58 -14.83 13.61 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.284 1.033 . . . . 0.0 112.889 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.41 -39.97 67.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.594 1.558 . . . . 0.0 110.794 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 m -67.1 -31.6 72.18 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.971 0.908 . . . . 0.0 110.785 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -46.21 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.13 -39.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 117.851 -1.071 . . . . 0.0 109.714 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.6 mmt -55.34 -48.92 73.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.773 1.17 . . . . 0.0 110.437 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.8 m -79.6 -26.05 41.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.779 1.232 . . . . 0.0 110.957 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.3 tp -63.05 -41.39 99.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.612 1.165 . . . . 0.0 109.936 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -58.46 -44.16 89.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 110.154 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.235 0.293 0 C-N-CA 123.713 0.805 . . . . 0.0 111.685 -171.087 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -69.33 0.26 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -164.74 -48.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.166 0.986 . . . . 0.0 112.7 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.13 16.67 10.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.594 1.158 . . . . 0.0 113.137 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.7 63.58 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.312 0.958 . . . . 0.0 113.854 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -93.29 153.78 18.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.499 1.15 . . . . 0.0 108.053 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.16 126.58 17.61 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.595 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -72.33 141.13 34.87 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.108 1.872 . . . . 0.0 111.496 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -140.25 156.44 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.802 0.841 . . . . 0.0 109.079 -173.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.74 150.36 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -128.92 157.53 21.61 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -125.16 142.83 40.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 109.056 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.43 137.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mm -120.01 132.39 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.1 m -119.91 140.6 50.63 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.682 0.674 . . . . 0.0 109.965 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -94.8 174.04 7.3 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.02 -2.37 30.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 120.281 -1.512 . . . . 0.0 112.678 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.61 -2.91 58.65 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.971 1.308 . . . . 0.0 111.582 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.87 19.48 76.93 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.819 0.736 . . . . 0.0 111.711 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -88.55 142.51 27.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 171.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 m -108.48 142.43 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.37 1.468 . . . . 0.0 108.935 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.0 tpp -60.85 134.65 57.3 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.957 1.303 . . . . 0.0 108.822 170.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -143.3 120.39 11.43 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 151.05 29.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.811 1.187 . . . . 0.0 109.836 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -145.48 162.29 37.71 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.176 1.39 . . . . 0.0 114.102 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.65 149.47 35.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.724 2.009 . . . . 0.0 113.872 -168.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -52.46 124.86 14.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.527 1.931 . . . . 0.0 109.489 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.67 8.31 76.49 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.205 -1.331 . . . . 0.0 114.524 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -109.18 157.41 18.81 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.589 1.695 . . . . 0.0 110.573 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -134.39 15.0 3.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 112.258 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.5 m -107.18 127.78 53.82 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -92.05 139.56 30.52 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -156.62 158.54 37.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.193 2.197 . . . . 0.0 107.731 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -73.35 151.84 89.92 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.445 169.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.42 141.17 97.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.969 2.446 . . . . 0.0 112.259 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.85 176.09 11.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.886 -0.509 . . . . 0.0 112.046 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.86 168.61 40.98 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.333 0.492 . . . . 0.0 112.553 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.51 146.39 27.31 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -77.73 127.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -69.47 152.68 96.29 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.48 124.04 14.93 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 108.958 -1.209 . . . . 0.0 108.958 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.41 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.679 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.96 159.26 34.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.072 1.936 . . . . 0.0 110.229 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 p -102.12 156.57 17.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.33 85.91 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.408 -0.808 . . . . 0.0 111.901 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.19 -35.56 76.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.572 0.749 . . . . 0.0 109.588 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -71.86 -37.04 70.28 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.61 91.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -61.61 -50.88 70.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -66.19 -40.97 90.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.228 0.922 . . . . 0.0 110.825 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.5 ttm-85 -66.37 -48.38 70.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.672 1.124 . . . . 0.0 109.688 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.84 -29.35 63.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.56 -47.64 79.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.864 0.756 . . . . 0.0 109.165 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.97 -39.21 91.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.934 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.42 -40.32 93.21 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.979 . . . . 0.0 112.061 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.13 -51.38 9.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 110.357 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 m -123.8 8.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.188 1.395 . . . . 0.0 113.538 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.27 8.41 62.1 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.791 0.723 . . . . 0.0 113.599 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 tp -98.6 141.14 31.81 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.417 1.887 . . . . 0.0 109.945 -171.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 p -115.43 165.53 12.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 109.926 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -48.69 -34.18 11.46 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.109 1.764 . . . . 0.0 112.053 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -29.61 70.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.759 -171.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.35 25.86 10.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.793 1.179 . . . . 0.0 111.628 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.52 165.0 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 O-C-N 120.818 -1.176 . . . . 0.0 111.501 172.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -139.32 144.29 38.22 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.1 mt -82.52 120.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -95.23 -35.98 11.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.615 174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.02 161.33 38.07 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.348 -171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -162.35 154.43 18.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.177 1.391 . . . . 0.0 109.669 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 p -71.09 139.55 50.38 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.852 -0.53 . . . . 0.0 110.261 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -57.06 4.14 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -89.28 151.62 22.01 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.389 1.476 . . . . 0.0 109.188 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -83.21 135.71 34.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.011 0.369 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.81 96.51 10.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -98.19 150.72 21.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.052 0.941 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -147.27 144.69 29.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 168.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.6 143.89 26.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mt -68.23 138.82 92.09 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 169.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.81 148.13 86.14 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 N-CA-C 105.264 -2.629 . . . . 0.0 105.264 167.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -69.14 -11.9 61.2 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.033 -1.667 . . . . 0.0 113.838 -168.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.9 -32.19 73.63 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.944 0.793 . . . . 0.0 112.522 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -92.8 -22.06 19.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.006 0.922 . . . . 0.0 111.567 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.46 136.2 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -103.14 88.68 3.2 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.005 0.907 . . . . 0.0 110.456 174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -68.52 -22.6 64.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.666 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.06 -9.1 58.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.749 0.819 . . . . 0.0 112.876 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.7 t -128.17 160.86 30.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.095 0.958 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -128.43 135.32 27.38 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 125.346 1.458 . . . . 0.0 109.563 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.54 148.36 91.38 Favored 'Cis proline' 0 CA--C 1.538 0.693 0 O-C-N 122.665 0.824 . . . . 0.0 110.534 -10.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 p -77.62 134.98 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.659 0.784 . . . . 0.0 109.75 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.0 p -80.2 127.32 32.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.91 0.884 . . . . 0.0 109.07 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.03 -17.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.02 0.827 . . . . 0.0 113.174 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.51 168.22 37.35 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 119.772 1.169 . . . . 0.0 110.197 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -152.62 150.9 29.99 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.657 1.183 . . . . 0.0 107.889 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 127.04 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -113.78 135.14 54.28 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.825 0.85 . . . . 0.0 110.209 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -113.27 125.08 53.91 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.433 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 89.1 m95 -104.45 149.92 25.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -173.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -133.37 131.66 40.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.835 0.854 . . . . 0.0 108.832 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.8 tp -96.32 119.72 35.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 168.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.09 144.95 40.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -96.9 129.65 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 135.02 57.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.2 t -85.91 -44.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.049 0.386 . . . . 0.0 110.608 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.1 m -90.19 -19.57 24.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.388 0.675 . . . . 0.0 111.198 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.76 -170.42 19.06 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 124.528 1.061 . . . . 0.0 110.558 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -20.84 38.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.624 1.57 . . . . 0.0 113.568 -172.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.46 47.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -93.24 14.63 17.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -173.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.08 140.98 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -133.86 122.03 22.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.346 1.058 . . . . 0.0 108.445 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mmt -89.28 -3.18 58.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.07 0.948 . . . . 0.0 112.252 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -136.63 83.09 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.321 2.01 . . . . 0.0 108.835 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 p -74.5 -60.67 2.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 128.158 2.583 . . . . 0.0 107.872 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.9 m -72.36 174.05 7.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.097 1.759 . . . . 0.0 109.27 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.1 m -61.46 -37.0 82.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 140.43 45.32 Favored Pre-proline 0 N--CA 1.44 -0.945 0 C-N-CA 125.842 1.657 . . . . 0.0 108.577 169.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.93 140.31 94.71 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.926 1.751 . . . . 0.0 108.558 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -76.36 -38.37 55.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -119.4 152.28 37.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.678 1.591 . . . . 0.0 109.542 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -126.52 -25.4 3.44 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.917 1.287 . . . . 0.0 110.149 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.36 130.96 10.49 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -157.9 130.51 7.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.891 1.345 . . . . 0.0 108.608 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -152.08 161.18 43.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.811 1.244 . . . . 0.0 109.084 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -111.52 134.45 53.1 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.05 153.24 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.485 -169.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 m -59.95 140.34 56.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.013 0.824 . . . . 0.0 109.212 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.93 -36.3 48.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -169.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -80.94 -21.81 40.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.008 1.276 . . . . 0.0 112.912 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -66.92 -45.59 53.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.88 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.7 -14.3 41.42 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.697 1.999 . . . . 0.0 113.759 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.1 t -67.57 -33.71 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -63.17 -34.96 78.76 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.812 -1.18 . . . . 0.0 111.689 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -82.76 -19.86 37.03 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -168.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 m -79.95 165.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 118.972 0.806 . . . . 0.0 110.32 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.73 176.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.911 1.285 . . . . 0.0 109.768 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.1 m -52.93 -50.38 64.13 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.683 1.593 . . . . 0.0 114.179 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -72.49 -26.93 61.97 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.972 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -84.29 -43.01 15.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.203 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -44.86 -45.25 10.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.992 0.917 . . . . 0.0 111.061 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.46 -35.66 76.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.877 0.871 . . . . 0.0 111.592 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 36.4 t -76.72 -49.94 22.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 124.792 1.237 . . . . 0.0 110.408 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.91 -35.35 78.12 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.716 0.807 . . . . 0.0 111.537 -168.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.02 -39.89 95.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.974 172.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -62.25 -47.01 86.27 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.633 1.106 . . . . 0.0 110.633 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 81.3 t -55.19 -33.1 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.425 1.011 . . . . 0.0 110.971 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.5 mmt -80.74 -56.89 3.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.896 0.878 . . . . 0.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -35.73 72.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.483 1.038 . . . . 0.0 111.852 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.06 -40.68 81.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.528 1.131 . . . . 0.0 111.614 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -111.04 -14.43 13.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.822 0.701 . . . . 0.0 110.961 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.88 62.48 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.701 1.601 . . . . 0.0 111.031 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.5 m -67.28 -31.62 72.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.339 0.656 . . . . 0.0 110.907 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.23 -45.04 72.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.44 -39.82 76.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.21 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.68 -52.51 62.14 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 120.887 1.676 . . . . 0.0 109.717 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.5 m -72.37 -27.13 62.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.223 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.95 -45.61 91.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.212 1.405 . . . . 0.0 109.701 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.35 -43.82 98.22 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.327 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.233 0.205 0 C-N-CA 123.768 0.827 . . . . 0.0 111.868 -169.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.64 -61.99 2.19 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.497 0.719 . . . . 0.0 111.964 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -162.85 -53.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.01 18.22 16.52 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.651 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.65 9.33 61.44 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.642 0.639 . . . . 0.0 113.513 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -103.85 151.91 22.54 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.507 1.123 . . . . 0.0 108.607 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.57 148.85 63.05 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.369 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -90.36 141.12 3.34 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.746 2.297 . . . . 0.0 111.214 -175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.36 153.04 46.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.117 -0.989 . . . . 0.0 110.097 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.28 143.01 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.283 1.433 . . . . 0.0 108.798 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.19 162.66 24.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 123.922 0.772 . . . . 0.0 111.982 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 143.44 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.295 1.438 . . . . 0.0 108.155 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.81 134.7 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 168.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.37 136.83 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.7 p -124.7 162.76 23.49 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.881 0.764 . . . . 0.0 112.457 169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.5 p30 -110.56 172.93 6.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.557 1.543 . . . . 0.0 108.306 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.34 8.71 3.14 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.451 -1.406 . . . . 0.0 113.233 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -99.54 -1.92 37.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.512 1.525 . . . . 0.0 111.58 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.12 15.97 80.83 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 118.691 0.678 . . . . 0.0 112.022 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -83.96 151.42 25.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.45 150.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.058 1.743 . . . . 0.0 108.501 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -73.23 143.31 47.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -147.4 144.29 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.91 146.8 34.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.389 1.904 . . . . 0.0 112.872 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -88.98 117.88 28.3 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -71.99 151.25 43.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.849 1.204 . . . . 0.0 109.003 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -58.03 129.24 41.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.11 6.24 82.47 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.512 -1.16 . . . . 0.0 114.003 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -113.86 164.25 14.0 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.168 1.484 . . . . 0.0 110.046 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.94 -13.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.829 0.852 . . . . 0.0 111.952 172.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 p -84.38 154.12 23.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.372 1.469 . . . . 0.0 110.281 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -107.45 143.7 35.42 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -142.2 161.21 38.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.169 1.388 . . . . 0.0 110.151 -169.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -90.43 143.11 28.86 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.45 131.93 33.75 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.246 2.63 . . . . 0.0 112.088 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.31 164.8 36.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.05 167.64 40.17 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.324 0.488 . . . . 0.0 113.026 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.14 147.06 43.82 Favored Glycine 0 N--CA 1.444 -0.788 0 O-C-N 121.497 -1.002 . . . . 0.0 110.604 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.7 mt -74.61 129.36 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.45 148.31 95.33 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.94 123.88 14.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.96 1.774 . . . . 0.0 110.24 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.45 1.7 90.2 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.425 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.53 159.3 32.39 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.515 2.158 . . . . 0.0 111.016 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 m -85.06 148.65 26.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.29 -40.14 81.17 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.555 -0.716 . . . . 0.0 111.602 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.86 -35.44 76.92 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.812 0.845 . . . . 0.0 110.248 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -73.55 -39.49 64.69 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.253 -0.904 . . . . 0.0 110.145 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.25 70.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.98 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -59.2 -48.47 81.51 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.169 1.349 . . . . 0.0 108.503 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.5 -36.23 83.51 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.35 1.432 . . . . 0.0 111.854 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -59.18 -49.64 77.08 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.328 0.967 . . . . 0.0 110.066 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -77.14 -26.66 53.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 122.125 -0.359 . . . . 0.0 110.362 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.67 -45.26 85.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.139 -0.976 . . . . 0.0 109.093 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.95 -45.6 81.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.689 0.677 . . . . 0.0 110.958 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.53 -37.34 86.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.538 1.063 . . . . 0.0 112.447 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -94.36 -47.98 6.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.517 1.127 . . . . 0.0 110.955 -170.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.61 -33.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.83 1.252 . . . . 0.0 109.883 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.2 89.94 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.562 1.077 . . . . 0.0 112.226 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.7 tp -87.35 155.08 20.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.619 1.968 . . . . 0.0 109.634 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.8 m -133.52 167.35 20.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.126 0.97 . . . . 0.0 109.533 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -47.78 -33.46 7.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.869 2.067 . . . . 0.0 113.112 -173.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -65.6 -29.89 70.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.284 -171.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -112.46 24.77 12.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.543 1.065 . . . . 0.0 111.541 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.35 165.54 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.599 -1.313 . . . . 0.0 112.817 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.38 136.53 36.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.13 122.44 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt -93.83 -35.79 12.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.162 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.0 35.91 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.266 1.026 . . . . 0.0 109.904 -173.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.8 p -152.49 153.91 34.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.122 1.769 . . . . 0.0 108.829 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.2 135.48 55.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.799 -169.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -84.17 -32.35 24.65 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.943 1.297 . . . . 0.0 107.868 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.77 148.19 49.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.796 2.038 . . . . 0.0 109.865 172.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -74.69 139.58 43.6 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.68 84.66 5.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -82.01 144.25 31.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -147.6 144.57 28.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.09 145.47 24.37 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.84 145.38 91.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 124.845 1.258 . . . . 0.0 110.925 170.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.16 147.34 72.75 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 104.076 -3.086 . . . . 0.0 104.076 166.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.31 -13.83 62.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 119.927 -1.733 . . . . 0.0 114.509 -168.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -60.2 -29.71 68.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -95.67 -13.28 24.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.11 0.964 . . . . 0.0 112.819 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.77 133.28 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -96.42 91.52 5.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.285 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.14 -21.6 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.968 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.33 -29.09 57.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 t -99.57 163.88 12.31 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.577 1.151 . . . . 0.0 109.766 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -128.24 130.51 23.56 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.427 1.491 . . . . 0.0 107.022 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.44 159.98 95.31 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 O-C-N 123.043 1.023 . . . . 0.0 110.462 -9.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.14 132.21 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.2 p -87.04 126.78 34.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.14 -13.52 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.382 0.537 . . . . 0.0 112.312 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.48 37.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.24 156.69 32.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.65 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -106.7 126.55 52.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -119.47 128.67 54.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.692 0.678 . . . . 0.0 110.167 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.09 153.21 17.91 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -134.1 154.81 50.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.237 0.615 . . . . 0.0 109.434 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -135.74 129.62 32.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.5 tp -91.14 123.32 34.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 mp -115.71 155.16 28.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.635 1.174 . . . . 0.0 107.853 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -106.15 131.25 53.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.63 140.21 56.85 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.027 0.931 . . . . 0.0 108.957 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.6 t -88.15 -44.33 15.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -171.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -90.99 -29.44 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.046 0.538 . . . . 0.0 112.106 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.29 178.82 15.51 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.915 0.769 . . . . 0.0 111.28 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.86 -20.86 54.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.691 1.597 . . . . 0.0 114.035 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.8 66.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.276 0.631 . . . . 0.0 111.554 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.58 48.08 1.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.161 1.785 . . . . 0.0 111.506 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.7 mt -128.5 133.09 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -114.48 -51.54 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.696 0.798 . . . . 0.0 111.972 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.4 mtp 67.98 13.32 9.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.017 2.127 . . . . 0.0 114.735 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -151.87 71.03 0.96 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 124.166 1.936 . . . . 0.0 110.394 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -59.11 2.87 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 111.974 -2.375 . . . . 0.0 107.901 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.6 m -63.47 161.96 13.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.392 1.477 . . . . 0.0 109.756 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -58.56 -38.57 78.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 130.41 52.7 Favored Pre-proline 0 N--CA 1.442 -0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 110.3 170.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.51 143.62 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -83.25 -18.29 39.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.894 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.21 141.19 51.8 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.712 0.805 . . . . 0.0 110.321 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.19 -31.89 33.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.021 1.328 . . . . 0.0 110.669 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.87 29.0 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -125.26 151.28 46.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.161 . . . . 0.0 108.825 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.9 166.08 27.04 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -126.51 133.77 51.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.24 157.79 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.937 1.295 . . . . 0.0 110.956 -168.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 m -65.98 144.38 56.8 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -28.29 63.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -88.01 -20.22 26.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.562 1.528 . . . . 0.0 112.924 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.3 -47.92 92.79 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.699 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.54 -27.06 81.48 Favored 'Trans proline' 0 C--N 1.352 0.76 0 CA-C-N 122.828 2.046 . . . . 0.0 112.957 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.89 -27.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.089 1.356 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -65.99 -27.9 68.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.356 -0.84 . . . . 0.0 111.334 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -86.71 -24.36 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.49 156.56 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.805 0.73 . . . . 0.0 112.528 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.2 179.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 110.184 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.8 m -54.54 -52.12 63.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.662 1.585 . . . . 0.0 114.06 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -74.34 -38.73 63.17 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.81 -44.83 69.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.52 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -62.97 -31.81 73.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.349 0.977 . . . . 0.0 111.74 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.57 -42.9 99.84 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.707 0.685 . . . . 0.0 110.924 172.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.73 -51.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.32 -37.61 86.27 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.26 0.937 . . . . 0.0 110.152 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.643 1.111 . . . . 0.0 110.486 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -60.66 -43.39 97.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.877 1.217 . . . . 0.0 110.49 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.42 -24.46 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 119.788 1.176 . . . . 0.0 111.831 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.3 -57.3 2.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -56.14 -34.02 65.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.996 1.318 . . . . 0.0 112.606 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -65.0 -30.04 71.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.04 0.837 . . . . 0.0 111.412 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.39 -11.43 14.13 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.409 1.083 . . . . 0.0 112.684 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.35 69.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.111 1.364 . . . . 0.0 110.905 -171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -62.49 -37.96 88.02 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.262 1.425 . . . . 0.0 111.635 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.84 -42.87 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.21 -40.54 65.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-O 117.169 -1.396 . . . . 0.0 109.765 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.4 -54.11 49.49 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.764 1.62 . . . . 0.0 110.04 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 m -64.86 -32.21 73.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.531 1.133 . . . . 0.0 110.94 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.19 -31.01 70.25 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.326 1.85 . . . . 0.0 111.142 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -72.79 -44.58 61.35 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.961 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 123.377 0.671 . . . . 0.0 112.461 -170.177 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 121.79 0.805 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -62.68 1.63 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.918 0.887 . . . . 0.0 112.125 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -163.04 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.34 0.186 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -100.84 20.65 14.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.641 1.177 . . . . 0.0 113.302 -169.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.49 18.38 49.04 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.494 0.568 . . . . 0.0 113.419 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -107.48 156.1 19.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.08 25.64 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.566 -1.207 . . . . 0.0 108.677 171.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -82.58 136.49 8.57 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.83 1.687 . . . . 0.0 110.454 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -133.86 160.73 36.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.403 1.481 . . . . 0.0 109.075 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.31 154.79 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 123.518 0.727 . . . . 0.0 109.946 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.24 156.64 23.1 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -116.43 141.98 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 125.499 1.519 . . . . 0.0 107.748 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.1 134.9 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.55 135.11 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.0 p -128.55 159.33 35.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.22 0.918 . . . . 0.0 112.289 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -110.17 177.3 4.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 108.78 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -75.87 0.36 18.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.405 -1.434 . . . . 0.0 112.995 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -88.21 -3.6 58.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.386 1.074 . . . . 0.0 111.013 172.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.67 76.59 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -90.31 143.27 26.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 m -108.45 145.89 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.513 1.525 . . . . 0.0 107.805 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -87.29 139.43 30.56 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -148.02 146.37 28.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.699 1.599 . . . . 0.0 107.051 -170.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.66 154.79 44.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.226 1.375 . . . . 0.0 113.577 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -98.54 118.23 34.77 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.193 1.797 . . . . 0.0 106.857 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -77.57 141.83 39.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 121.886 2.13 . . . . 0.0 108.471 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -55.13 127.1 27.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.368 1.067 . . . . 0.0 109.477 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -6.39 20.28 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.612 -1.104 . . . . 0.0 115.089 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -91.29 -32.13 15.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.787 1.794 . . . . 0.0 111.656 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.1 m80 64.55 -21.84 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.347 2.259 . . . . 0.0 114.611 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -75.9 160.76 29.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.298 1.439 . . . . 0.0 110.643 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.03 149.96 28.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.743 0.817 . . . . 0.0 110.939 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.89 155.38 42.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.362 1.865 . . . . 0.0 111.122 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -84.12 131.84 49.79 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -51.63 128.08 24.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.328 2.685 . . . . 0.0 112.3 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.36 164.54 36.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.751 1.16 . . . . 0.0 112.906 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.16 -178.97 42.75 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 123.458 0.551 . . . . 0.0 112.793 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.89 151.25 23.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.252 0.929 . . . . 0.0 111.913 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.91 126.9 38.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -74.08 156.39 87.78 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.69 122.19 10.66 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 109.038 -1.178 . . . . 0.0 109.038 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 0.0 87.98 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.643 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.14 154.35 41.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.361 2.081 . . . . 0.0 109.837 169.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.07 153.61 17.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.07 84.02 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.324 -0.86 . . . . 0.0 111.719 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.81 -31.95 70.13 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.288 0.635 . . . . 0.0 110.367 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -70.93 -39.6 72.57 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.271 -0.893 . . . . 0.0 109.792 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.31 83.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -63.3 -50.72 68.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.792 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 55.8 m-85 -66.72 -33.06 74.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.926 1.239 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -60.86 -50.28 74.05 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.07 1.305 . . . . 0.0 109.187 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.27 -27.58 62.58 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.384 0.538 . . . . 0.0 110.33 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.69 -43.43 90.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 109.454 170.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -69.55 -48.76 59.26 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.474 0.579 . . . . 0.0 110.834 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.85 -30.7 69.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.988 1.267 . . . . 0.0 112.609 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -93.29 -51.48 4.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.153 0.981 . . . . 0.0 110.532 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.61 -31.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.267 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.17 -1.85 78.73 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.464 1.03 . . . . 0.0 112.275 -171.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.76 155.74 32.93 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.645 1.978 . . . . 0.0 108.854 174.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.5 p -133.09 170.3 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.988 0.915 . . . . 0.0 110.466 -172.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 37.3 mtp180 -46.13 -37.15 6.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.819 2.047 . . . . 0.0 112.52 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -68.77 -26.04 65.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.385 0.674 . . . . 0.0 112.525 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.36 23.59 12.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.522 0.677 . . . . 0.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.5 165.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 O-C-N 120.734 -1.229 . . . . 0.0 112.729 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.83 132.94 29.61 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -73.69 116.21 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.6 mt -89.63 -36.88 15.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.426 174.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.41 164.7 36.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.864 0.865 . . . . 0.0 109.749 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 p -162.63 153.41 17.11 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.795 1.238 . . . . 0.0 110.265 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.6 p -71.89 138.76 48.41 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.635 -0.666 . . . . 0.0 109.579 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -77.86 -51.41 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -70.26 171.12 10.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 110.962 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE3' ' HB2' ' A' ' 98' ' ' LYS . 84.2 m95 -112.38 123.72 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 168.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -79.2 142.32 36.38 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.62 152.35 43.9 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.289 1.036 . . . . 0.0 108.955 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -140.3 139.78 35.55 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.974 1.31 . . . . 0.0 108.115 169.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -77.27 139.04 39.74 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.68 139.17 95.76 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.766 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -68.2 145.36 66.19 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 104.431 -2.95 . . . . 0.0 104.431 167.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -67.96 -12.94 61.72 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.05 -1.657 . . . . 0.0 114.16 -168.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.11 -31.01 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.809 0.732 . . . . 0.0 112.806 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.5 -20.01 21.4 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.776 0.83 . . . . 0.0 112.085 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.16 135.28 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -101.37 89.89 3.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 109.807 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.8 -22.31 63.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.918 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -74.86 -19.22 60.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.573 0.749 . . . . 0.0 112.728 -171.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -117.37 161.0 20.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.487 1.115 . . . . 0.0 109.957 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -128.24 135.45 27.55 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 125.178 1.391 . . . . 0.0 109.59 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.48 148.56 92.16 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 O-C-N 122.731 0.858 . . . . 0.0 110.384 -10.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.76 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 109.532 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.5 p -89.91 138.58 31.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.0 109.566 170.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.44 -13.07 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 170.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.29 -174.05 31.72 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.09 -178.23 6.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.593 1.157 . . . . 0.0 109.02 -172.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -127.33 137.26 52.76 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 104.322 -2.474 . . . . 0.0 104.322 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -122.59 122.7 39.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 120.82 1.646 . . . . 0.0 107.951 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.404 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 10.2 ttmm -111.78 129.1 56.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -114.27 152.21 31.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -134.78 121.73 21.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.9 tp -88.67 119.64 29.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.56 144.46 43.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -97.47 132.7 42.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 141.93 58.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 108.923 171.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.91 -48.79 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.568 0.622 . . . . 0.0 109.827 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.5 m -89.33 -19.58 25.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.408 0.683 . . . . 0.0 111.786 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.59 20.67 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.42 -22.35 31.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.093 1.757 . . . . 0.0 113.105 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.08 59.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 113.438 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -92.62 16.55 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.73 139.73 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.694 1.198 . . . . 0.0 108.088 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -120.6 -50.98 2.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.593 0.757 . . . . 0.0 112.304 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.2 mtp 70.44 9.25 6.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.84 2.456 . . . . 0.0 115.122 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.71 76.96 1.03 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 124.016 1.865 . . . . 0.0 110.184 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.85 -59.58 2.67 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.05 -2.341 . . . . 0.0 107.695 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -66.37 162.73 19.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.157 1.383 . . . . 0.0 109.452 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 m -63.01 -33.73 76.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.087 0.555 . . . . 0.0 110.367 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 128.95 52.89 Favored Pre-proline 0 N--CA 1.447 -0.587 0 C-N-CA 124.911 1.284 . . . . 0.0 110.193 170.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.88 137.23 48.3 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.357 2.038 . . . . 0.0 108.097 168.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.83 -16.0 59.56 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.876 -0.515 . . . . 0.0 111.566 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -119.91 138.43 53.43 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.63 -26.73 45.3 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.924 1.29 . . . . 0.0 111.255 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.84 162.37 34.55 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 153.74 45.93 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.306 1.043 . . . . 0.0 108.193 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -152.42 159.63 43.37 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -109.38 131.99 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.72 170.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.062 1.745 . . . . 0.0 109.739 -169.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.8 p -65.41 166.82 9.57 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -18.65 64.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.858 172.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -98.81 -31.62 11.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 113.225 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.21 -43.98 96.21 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.84 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.36 -24.84 76.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 122.508 1.931 . . . . 0.0 113.264 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.7 t -67.55 -41.4 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -57.68 -35.53 70.72 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.528 -0.732 . . . . 0.0 111.963 -171.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -79.13 -26.4 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.46 171.66 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 118.499 0.591 . . . . 0.0 112.127 -172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 175.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.9 m -54.7 -49.99 69.39 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.031 1.733 . . . . 0.0 114.208 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -72.35 -32.34 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.178 -0.952 . . . . 0.0 111.459 -174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.1 -39.96 32.38 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.221 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -47.25 -46.2 24.32 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.899 0.88 . . . . 0.0 110.733 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.12 -45.76 92.02 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.245 0.341 . . . . 0.0 110.287 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.5 -46.86 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.772 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -62.01 -47.68 83.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.45 -42.18 96.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.349 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.64 -49.69 76.5 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.436 1.017 . . . . 0.0 110.5 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.9 t -56.68 -42.58 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.217 1.007 . . . . 0.0 109.39 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.7 mmt -67.43 -51.81 47.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.268 1.027 . . . . 0.0 108.273 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -37.03 69.91 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.804 0.842 . . . . 0.0 110.729 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.18 -35.33 73.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 118.797 0.726 . . . . 0.0 111.526 -174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.62 -13.49 15.29 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.641 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.21 -39.13 63.49 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.401 1.48 . . . . 0.0 110.949 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -66.86 -32.07 73.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.289 0.636 . . . . 0.0 110.722 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.2 -44.95 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.4 -40.54 78.64 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 CA-C-O 117.365 -1.303 . . . . 0.0 110.097 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -56.07 -51.93 66.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 120.82 1.645 . . . . 0.0 109.969 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -71.25 -28.7 64.36 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.93 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.37 -41.11 98.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.084 1.354 . . . . 0.0 110.184 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.8 -43.98 97.38 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.233 0.216 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.702 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.264 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.519 0.676 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.85 -68.19 0.45 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.456 0.702 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -163.06 -51.68 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.969 0.908 . . . . 0.0 112.421 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.04 17.04 14.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 112.82 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.54 7.09 65.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.36 0.981 . . . . 0.0 113.741 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -96.19 155.66 16.67 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.49 152.65 71.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.649 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -88.11 134.87 3.14 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.276 1.984 . . . . 0.0 111.135 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -131.79 163.92 27.17 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.022 1.329 . . . . 0.0 109.484 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.04 167.77 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.263 175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 163.08 33.3 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.82 144.94 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.1 137.91 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.81 133.19 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.7 m -124.45 145.59 49.42 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.814 0.696 . . . . 0.0 110.571 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -97.74 170.58 8.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.849 1.259 . . . . 0.0 108.626 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.61 8.56 3.46 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.039 -1.663 . . . . 0.0 113.151 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.63 -3.68 54.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.386 1.075 . . . . 0.0 111.164 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.35 18.69 79.89 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 118.861 0.755 . . . . 0.0 112.071 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -90.23 141.42 28.72 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.31 147.74 12.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.081 1.753 . . . . 0.0 108.452 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.6 ttm -65.86 138.58 57.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.583 0.753 . . . . 0.0 109.337 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -142.82 140.36 31.28 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.78 1.632 . . . . 0.0 106.833 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.17 161.68 36.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.66 1.118 . . . . 0.0 112.187 -171.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -118.97 118.88 32.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.555 1.942 . . . . 0.0 106.978 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -67.21 150.68 48.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.605 1.093 . . . . 0.0 108.873 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.41 142.35 58.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.35 6.57 75.88 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.318 -1.268 . . . . 0.0 114.038 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -134.03 157.21 46.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.543 1.671 . . . . 0.0 109.612 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -98.42 -14.12 20.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.864 0.466 . . . . 0.0 112.227 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -78.57 152.24 31.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.397 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -110.6 158.17 18.87 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.461 1.104 . . . . 0.0 111.155 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -159.74 159.31 32.67 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.728 1.211 . . . . 0.0 110.396 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.73 157.49 71.92 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.84 134.65 60.02 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -131.26 169.59 15.76 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.059 1.344 . . . . 0.0 112.282 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.08 169.61 38.29 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.571 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.7 137.24 13.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.3 mt -75.14 126.24 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -84.65 150.41 56.43 Favored Pre-proline 0 C--O 1.235 0.324 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.26 122.18 10.28 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.775 1.65 . . . . 0.0 109.832 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.79 -20.64 43.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.845 1.212 . . . . 0.0 113.469 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.08 152.92 42.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.722 1.761 . . . . 0.0 109.941 170.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.2 p -83.43 169.8 15.16 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.1 80.55 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 122.001 -0.437 . . . . 0.0 110.461 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.74 -38.79 64.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.592 0.757 . . . . 0.0 110.586 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -67.82 -41.32 83.24 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.251 -0.906 . . . . 0.0 110.03 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -36.41 81.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.956 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.57 -53.72 52.93 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.147 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -67.68 -42.19 82.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.302 0.955 . . . . 0.0 111.706 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -45.44 94.79 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.971 0.509 . . . . 0.0 109.942 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.76 -31.13 35.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.094 -0.479 . . . . 0.0 110.227 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.9 tp -53.27 -43.27 67.29 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.709 0.686 . . . . 0.0 110.091 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -57.14 -38.21 73.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.464 0.574 . . . . 0.0 111.231 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -70.29 -20.89 63.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.097 0.862 . . . . 0.0 111.734 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -94.73 -48.88 5.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.357 1.063 . . . . 0.0 110.936 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 60' ' ' LEU . 3.5 p -120.17 -3.3 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.759 1.224 . . . . 0.0 112.413 -169.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.83 1.02 9.85 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 121.24 -0.913 . . . . 0.0 112.957 -170.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.446 ' H ' HG13 ' A' ' 58' ' ' VAL . 14.6 tp -79.08 144.07 34.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.277 1.031 . . . . 0.0 110.002 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 p -122.5 164.43 18.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.647 1.179 . . . . 0.0 109.498 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -40.71 -38.87 0.97 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.168 1.787 . . . . 0.0 112.616 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -67.34 -20.33 65.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.269 -169.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.72 21.03 10.91 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.527 0.603 . . . . 0.0 112.528 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.61 160.36 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.925 -1.109 . . . . 0.0 110.73 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -138.12 137.37 37.64 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.13 120.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.76 -36.77 11.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.721 172.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.56 164.3 34.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.127 0.971 . . . . 0.0 109.523 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.0 p -160.42 151.47 19.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.267 1.427 . . . . 0.0 109.897 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -69.09 131.47 45.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.729 0.776 . . . . 0.0 109.645 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -79.81 -48.16 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -75.53 179.94 4.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.44 2.296 . . . . 0.0 108.247 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.536 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 73.2 m95 -114.49 142.91 45.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 168.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.37 85.43 6.57 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -81.44 144.01 31.69 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.43 147.93 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.41 144.67 25.36 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.8 mt -73.05 144.88 85.52 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 124.998 1.319 . . . . 0.0 111.302 171.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.32 149.26 69.46 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 105.174 -2.664 . . . . 0.0 105.174 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -68.73 -13.46 62.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.944 -1.723 . . . . 0.0 113.956 -169.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -61.76 -30.78 71.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.094 0.861 . . . . 0.0 112.789 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.64 -18.16 21.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.906 0.883 . . . . 0.0 112.123 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.61 134.9 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -98.9 89.83 4.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.71 0.804 . . . . 0.0 109.687 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.5 -21.2 62.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.082 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.81 -30.55 56.46 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 t -97.64 162.15 13.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.576 1.15 . . . . 0.0 109.523 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -130.67 132.43 23.94 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.529 1.532 . . . . 0.0 108.319 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.25 157.33 93.54 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 O-C-N 122.72 0.853 . . . . 0.0 111.307 -10.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.4 t -74.45 138.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.889 0.876 . . . . 0.0 109.455 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 p -89.13 122.64 32.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.899 0.88 . . . . 0.0 108.726 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -14.56 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.184 0.902 . . . . 0.0 113.296 172.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.57 38.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -158.19 158.92 35.48 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.052 0.941 . . . . 0.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -101.5 124.82 47.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 169.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.22 123.9 50.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.903 1.229 . . . . 0.0 109.548 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -86.73 149.33 24.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -127.99 153.89 46.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.057 0.844 . . . . 0.0 109.467 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -134.36 134.29 41.58 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.833 1.253 . . . . 0.0 108.451 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.9 tp -98.08 120.86 39.22 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mt -116.97 146.83 42.77 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -97.42 135.69 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 168.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.55 132.38 49.72 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.0 t -81.29 -46.0 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 122.74 0.416 . . . . 0.0 110.256 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 t -83.12 -37.31 23.94 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.0 -169.04 12.82 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -170.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 -15.88 38.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.61 1.564 . . . . 0.0 114.307 -172.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.03 63.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 0.0 113.031 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -95.12 26.18 3.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.19 0.996 . . . . 0.0 113.357 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 89.7 mt -99.58 139.98 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.808 1.243 . . . . 0.0 108.765 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -138.98 117.2 11.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.779 1.232 . . . . 0.0 109.757 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 mmt -89.78 -4.29 57.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.424 0.69 . . . . 0.0 112.58 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -119.8 75.5 1.08 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 124.207 1.956 . . . . 0.0 107.145 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 p -65.48 -65.07 0.72 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 111.204 -2.725 . . . . 0.0 106.777 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -78.48 173.63 12.17 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -58.1 -42.15 85.05 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.166 -0.959 . . . . 0.0 109.168 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 134.91 82.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 108.512 169.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -62.16 135.36 54.15 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 107.537 -1.755 . . . . 0.0 107.537 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -85.17 -34.21 22.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -109.88 135.82 50.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -75.03 -35.08 61.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.671 0.788 . . . . 0.0 110.475 173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.48 29.84 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.84 158.77 44.41 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.566 0.746 . . . . 0.0 109.057 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -145.9 167.57 22.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.916 1.286 . . . . 0.0 108.828 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -109.9 129.7 55.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.46 153.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.815 1.246 . . . . 0.0 110.714 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 m -57.85 143.04 43.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.036 0.835 . . . . 0.0 109.835 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -32.87 61.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -83.84 -21.23 32.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.158 1.344 . . . . 0.0 112.692 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -60.11 -50.79 84.5 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.118 -1.42 . . . . 0.0 113.407 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.84 -27.7 85.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 122.681 1.993 . . . . 0.0 113.291 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.69 -31.59 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.848 0.859 . . . . 0.0 109.013 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -66.22 -24.42 66.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.163 -0.961 . . . . 0.0 111.679 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.94 -27.91 28.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.14 168.58 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 118.744 0.702 . . . . 0.0 112.397 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -83.16 175.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.379 1.471 . . . . 0.0 110.487 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 m -52.44 -51.4 59.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.825 1.65 . . . . 0.0 114.586 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -74.05 -36.77 64.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.458 1.026 . . . . 0.0 110.716 -175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.05 -36.61 66.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.51 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -51.28 -45.14 62.03 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.106 0.866 . . . . 0.0 110.493 171.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.63 -42.98 95.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.503 0.592 . . . . 0.0 110.926 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.15 -52.62 56.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.55 -32.56 74.21 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.211 -0.93 . . . . 0.0 111.24 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -67.27 -42.83 83.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.237 1.38 . . . . 0.0 110.327 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.41 -42.65 96.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.76 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.2 -25.95 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.49 1.041 . . . . 0.0 111.427 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -88.42 -58.66 2.48 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -33.41 70.47 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.716 1.207 . . . . 0.0 112.501 -172.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.72 -40.12 78.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.391 0.996 . . . . 0.0 110.565 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -106.42 -9.86 16.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.272 1.029 . . . . 0.0 112.952 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.33 73.12 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 125.187 1.395 . . . . 0.0 110.594 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -67.13 -31.98 72.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.677 0.791 . . . . 0.0 110.653 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.75 -43.63 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.31 -41.36 81.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.083 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -46.53 87.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 120.478 1.49 . . . . 0.0 110.53 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 t -66.46 -28.45 68.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 110.689 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.7 tp -69.59 -31.34 69.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.299 -1.501 . . . . 0.0 109.875 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -75.76 -25.74 56.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.026 169.895 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.53 -68.37 0.34 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.0 -49.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -87.02 11.32 13.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.104 0.962 . . . . 0.0 112.735 -169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.63 -8.4 79.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.698 1.142 . . . . 0.0 113.069 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -90.4 159.13 16.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.263 1.032 . . . . 0.0 108.498 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -137.65 142.33 36.42 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.248 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -89.34 135.91 2.71 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.879 1.719 . . . . 0.0 111.035 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.3 159.75 41.25 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.158 -0.964 . . . . 0.0 110.387 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.56 159.8 34.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 119.538 1.063 . . . . 0.0 110.418 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.88 160.21 24.21 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.05 143.66 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.182 1.393 . . . . 0.0 107.762 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.01 136.93 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm -121.09 133.03 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.0 p -124.97 156.65 37.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.506 0.594 . . . . 0.0 111.623 170.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -104.51 172.73 6.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.438 1.495 . . . . 0.0 108.18 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -73.79 2.6 8.01 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.269 -1.519 . . . . 0.0 113.119 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -88.01 -4.84 58.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.069 0.947 . . . . 0.0 111.277 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.57 19.87 79.75 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.943 0.792 . . . . 0.0 111.601 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.87 147.01 25.3 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.09 148.72 17.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.171 1.789 . . . . 0.0 107.058 174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.6 ptm -76.12 148.5 37.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.392 0.542 . . . . 0.0 109.863 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -148.22 140.1 23.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -174.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.32 148.17 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.426 1.466 . . . . 0.0 113.087 -169.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -101.06 115.29 30.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.661 1.984 . . . . 0.0 106.559 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -68.75 151.6 46.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.663 1.119 . . . . 0.0 109.226 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.32 132.52 54.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.46 85.03 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.746 1.165 . . . . 0.0 113.726 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -115.3 162.32 17.27 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.33 1.565 . . . . 0.0 110.296 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.62 -13.68 16.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.479 0.711 . . . . 0.0 111.662 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -86.34 150.35 24.39 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.726 1.61 . . . . 0.0 110.968 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -103.61 151.64 22.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.141 0.977 . . . . 0.0 110.061 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -155.18 166.87 32.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.139 1.376 . . . . 0.0 110.211 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -85.38 155.15 59.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.95 127.2 19.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.321 2.014 . . . . 0.0 110.473 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -157.55 163.55 38.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.69 44.26 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.792 -0.567 . . . . 0.0 113.454 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.75 152.6 41.06 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 124.733 1.159 . . . . 0.0 112.075 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.2 mt -84.03 122.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.22 159.38 85.58 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.0 123.87 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 121.199 1.266 . . . . 0.0 109.414 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.17 -6.07 80.79 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 118.772 -1.015 . . . . 0.0 114.646 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.37 156.55 39.36 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.043 1.922 . . . . 0.0 109.227 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -93.26 167.29 11.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.67 83.37 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.62 -0.675 . . . . 0.0 110.987 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -36.46 69.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.299 0.64 . . . . 0.0 110.503 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.76 -36.21 70.33 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.893 -1.129 . . . . 0.0 110.629 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.21 86.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -63.4 -51.74 64.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.104 -0.951 . . . . 0.0 108.672 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -66.76 -31.74 72.59 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 112.133 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -63.69 -52.95 58.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.528 1.058 . . . . 0.0 109.071 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -71.23 -25.07 62.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -172.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.73 -42.51 88.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 171.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -71.91 -50.14 31.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.121 0.873 . . . . 0.0 110.753 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.28 -21.92 66.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.905 1.229 . . . . 0.0 112.806 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.39 -53.5 2.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.791 1.236 . . . . 0.0 111.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.2 -21.92 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 112.396 -168.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 -3.19 33.66 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.204 1.383 . . . . 0.0 112.887 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.77 157.95 34.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.712 2.005 . . . . 0.0 109.768 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 p -137.11 168.15 20.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 110.185 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -53.14 -34.09 55.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.099 1.76 . . . . 0.0 112.292 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.781 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.95 24.39 12.72 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.844 1.202 . . . . 0.0 111.419 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.74 166.06 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.912 -1.118 . . . . 0.0 112.266 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 133.73 27.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.599 169.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.57 113.01 10.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.16 -34.0 18.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.489 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.44 39.12 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 109.759 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 p -158.66 154.33 26.26 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.112 1.365 . . . . 0.0 110.04 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -69.04 139.72 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.508 0.671 . . . . 0.0 111.472 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -86.11 -28.48 23.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.804 1.642 . . . . 0.0 109.838 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -121.77 148.64 44.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.022 2.129 . . . . 0.0 108.536 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -80.68 133.39 35.7 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.24 64.79 7.06 Favored 'General case' 0 N--CA 1.46 0.072 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -71.52 146.17 48.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -142.94 145.53 33.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.285 0.634 . . . . 0.0 110.256 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.26 147.04 23.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.87 148.06 98.92 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.823 0.849 . . . . 0.0 109.782 169.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -66.92 143.86 68.11 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 N-CA-C 104.311 -2.996 . . . . 0.0 104.311 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -67.99 -13.07 61.89 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.051 -1.656 . . . . 0.0 114.135 -168.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -57.15 -30.56 64.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 170.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.8 mt -91.79 -20.49 21.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.382 0.673 . . . . 0.0 112.034 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.17 135.23 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -103.34 89.97 3.56 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.188 0.995 . . . . 0.0 108.486 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -65.28 -9.31 23.1 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.17 27.93 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.443 1.097 . . . . 0.0 110.472 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.6 p -77.16 157.72 30.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.113 0.959 . . . . 0.0 112.873 -169.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -130.56 110.16 16.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.697 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.37 142.26 64.97 Favored 'Cis proline' 0 CA--C 1.537 0.66 0 N-CA-C 108.09 -1.542 . . . . 0.0 108.09 -11.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 p -64.47 133.96 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 O-C-N 121.659 -0.65 . . . . 0.0 110.79 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.3 t -72.57 124.73 25.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.97 -14.9 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.24 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.42 -179.56 48.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 119.689 1.131 . . . . 0.0 110.342 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.77 152.98 45.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.308 . . . . 0.0 110.037 173.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.55 135.51 34.75 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -128.42 129.34 46.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.09 0.859 . . . . 0.0 110.485 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -111.92 142.02 44.84 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -124.2 155.28 38.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.417 0.553 . . . . 0.0 109.703 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -137.73 125.64 22.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.9 tp -92.33 122.77 35.11 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 168.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mt -117.87 148.28 42.27 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -97.34 132.37 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.76 138.31 58.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.881 1.272 . . . . 0.0 108.922 171.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -88.38 -49.45 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.241 0.616 . . . . 0.0 110.09 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.2 m -87.08 -19.38 28.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.77 -169.39 20.13 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -20.42 44.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.649 1.58 . . . . 0.0 113.792 -171.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -30.58 43.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.508 1.123 . . . . 0.0 112.839 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.87 13.0 23.97 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 66.9 mt -85.17 137.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -136.7 105.2 5.77 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.1 mmt -82.67 1.7 37.17 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.67 73.97 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 123.942 1.83 . . . . 0.0 107.961 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -70.05 -64.13 0.95 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.589 -2.096 . . . . 0.0 105.558 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.0 m -72.44 167.24 20.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.459 1.503 . . . . 0.0 107.647 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 m -61.46 -41.16 96.79 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.286 -0.884 . . . . 0.0 109.171 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.49 132.76 89.27 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.67 1.588 . . . . 0.0 109.387 170.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.94 143.3 99.32 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.763 1.642 . . . . 0.0 109.537 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -86.74 -21.1 26.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.76 0.424 . . . . 0.0 110.673 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -128.37 144.07 51.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.067 0.947 . . . . 0.0 109.136 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.74 -30.52 59.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.152 0.981 . . . . 0.0 110.522 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.86 155.54 26.44 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 150.39 37.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -146.58 170.28 17.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 109.13 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -116.2 137.23 52.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.05 154.17 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 109.954 -169.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.8 m -60.32 144.06 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.947 0.794 . . . . 0.0 109.504 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -25.42 63.83 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -88.66 -10.9 46.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.403 1.456 . . . . 0.0 113.38 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -72.79 -47.35 8.9 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.608 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.84 -24.53 68.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.903 2.073 . . . . 0.0 112.921 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.2 -30.77 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.268 1.027 . . . . 0.0 109.273 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.06 -24.4 63.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.042 -1.036 . . . . 0.0 111.514 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -81.18 -30.12 34.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.068 0.849 . . . . 0.0 112.87 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.12 168.43 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.554 0.615 . . . . 0.0 112.638 -169.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -85.13 175.33 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.206 1.402 . . . . 0.0 110.417 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -52.65 -50.68 62.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.617 1.567 . . . . 0.0 114.64 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -74.16 -34.74 63.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.142 0.883 . . . . 0.0 110.984 -175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.4 -37.92 60.2 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.705 -0.622 . . . . 0.0 110.353 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -50.18 -44.11 52.73 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.538 171.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -65.45 -41.52 93.34 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.626 0.648 . . . . 0.0 111.064 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.9 -53.0 46.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -65.11 -31.93 73.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.385 0.993 . . . . 0.0 112.229 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -66.21 -44.6 83.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.255 1.389 . . . . 0.0 110.276 171.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -59.54 -43.76 93.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.378 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.8 t -56.95 -27.95 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.571 1.148 . . . . 0.0 111.779 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -87.75 -58.18 2.67 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -58.18 -36.07 72.52 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.082 0.953 . . . . 0.0 112.276 -173.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.81 -36.82 75.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 119.086 0.857 . . . . 0.0 110.723 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -105.27 -12.76 15.93 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.055 0.942 . . . . 0.0 112.337 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.96 68.7 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.416 1.487 . . . . 0.0 110.78 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 m -68.19 -30.65 69.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.759 0.823 . . . . 0.0 111.058 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.9 t -69.68 -43.03 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.72 -43.88 88.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.545 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -45.19 84.37 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 121.991 2.178 . . . . 0.0 111.666 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -81.2 -8.71 59.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 125.146 1.378 . . . . 0.0 111.924 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.84 -42.5 19.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 120.417 -1.427 . . . . 0.0 108.851 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.45 -41.8 90.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 125.195 1.398 . . . . 0.0 114.226 170.048 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.48 -77.46 0.07 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.682 0.793 . . . . 0.0 110.903 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -164.47 -44.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -91.79 16.89 9.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.712 1.205 . . . . 0.0 113.072 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 17.29 60.28 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.11 0.862 . . . . 0.0 112.929 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -111.93 155.31 23.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.8 128.08 22.92 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.44 141.27 46.07 Favored 'Trans proline' 0 C--N 1.345 0.391 0 CA-C-N 121.328 1.51 . . . . 0.0 110.053 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -138.43 148.24 44.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.78 0.832 . . . . 0.0 109.214 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.52 149.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.206 1.402 . . . . 0.0 108.081 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.85 161.6 28.08 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 122.043 -0.411 . . . . 0.0 112.246 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.21 143.2 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 122.991 0.517 . . . . 0.0 109.933 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -122.44 131.59 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 mm -108.39 130.96 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.2 m -111.98 146.82 37.18 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 124.362 1.039 . . . . 0.0 109.289 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -98.78 176.65 5.54 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 14.38 3.71 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.905 -1.122 . . . . 0.0 113.028 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -106.35 -3.85 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.587 1.555 . . . . 0.0 111.307 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.47 83.22 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.756 -170.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -80.56 149.8 29.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.075 1.438 . . . . 0.0 107.477 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.03 153.49 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.969 2.107 . . . . 0.0 108.424 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.7 ptm -68.18 153.7 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.845 0.458 . . . . 0.0 110.713 171.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -154.74 132.34 11.33 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.03 150.54 41.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.39 1.45 . . . . 0.0 111.468 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -102.4 115.57 30.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -70.1 149.07 47.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.844 1.656 . . . . 0.0 109.644 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.67 140.91 57.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.16 85.96 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.219 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -123.34 169.08 11.69 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.025 1.413 . . . . 0.0 109.812 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -125.69 27.61 6.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.11 1.364 . . . . 0.0 108.93 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -125.35 143.3 51.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.042 1.337 . . . . 0.0 108.458 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -99.48 149.48 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.812 0.845 . . . . 0.0 110.491 -174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -159.77 168.65 25.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.918 1.287 . . . . 0.0 110.214 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.83 152.54 66.24 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -46.99 129.57 15.07 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.582 2.855 . . . . 0.0 111.443 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -161.35 155.88 23.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.163 0.985 . . . . 0.0 110.176 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.55 168.21 40.84 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.265 0.935 . . . . 0.0 111.664 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.03 147.4 39.57 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -74.78 113.36 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.68 144.59 96.27 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.39 127.18 24.49 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.681 1.587 . . . . 0.0 110.883 -169.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.34 -8.83 77.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 114.15 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.64 152.84 39.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.829 1.814 . . . . 0.0 111.273 171.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.0 p -86.62 166.81 15.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 167.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.78 77.07 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 120.723 -1.236 . . . . 0.0 111.588 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.92 -38.3 61.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.362 0.665 . . . . 0.0 110.534 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -66.55 -40.27 88.97 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.55 -33.26 72.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.904 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -56.75 -50.42 72.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -66.67 -44.67 81.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.915 0.78 . . . . 0.0 111.84 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -54.92 -52.02 64.25 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.474 1.034 . . . . 0.0 111.04 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.96 -36.14 64.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.5 tp -53.42 -51.14 63.57 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.409 0.684 . . . . 0.0 110.129 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.78 -43.23 99.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -63.42 -23.51 67.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.728 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.81 -35.9 4.03 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 120.495 1.498 . . . . 0.0 113.385 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.02 5.04 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 119.373 0.988 . . . . 0.0 111.959 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.55 -4.3 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.781 -1.2 . . . . 0.0 114.869 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.1 144.26 34.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.887 1.675 . . . . 0.0 109.987 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -122.58 163.0 20.79 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.296 1.038 . . . . 0.0 109.813 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -42.02 -40.59 2.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.876 2.07 . . . . 0.0 112.527 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -67.84 -20.86 65.2 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.37 -0.824 . . . . 0.0 113.131 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.56 20.69 15.78 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.366 0.53 . . . . 0.0 111.516 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -137.68 161.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 O-C-N 120.533 -1.354 . . . . 0.0 112.896 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.55 138.81 46.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.09 121.09 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.3 mt -94.77 -36.1 11.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.563 0.745 . . . . 0.0 109.77 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.06 164.8 27.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.64 1.176 . . . . 0.0 109.546 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 p -155.54 154.93 32.51 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.593 1.557 . . . . 0.0 108.896 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.25 136.73 57.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.02 0.914 . . . . 0.0 111.106 -169.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtt-85 -80.16 -30.49 38.87 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.061 1.745 . . . . 0.0 108.419 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 146.6 52.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.202 2.201 . . . . 0.0 109.565 176.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.406 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 86.6 m95 -73.89 143.43 45.79 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.94 86.37 6.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -68.85 142.59 54.79 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -137.13 142.31 42.26 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.089 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -131.99 141.48 49.29 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.538 2.335 . . . . 0.0 106.451 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER -104.87 148.42 36.08 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.1 153.87 62.53 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.447 2.765 . . . . 0.0 109.148 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -59.55 -31.09 69.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 170.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.4 mt -90.77 -15.35 30.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.694 0.798 . . . . 0.0 112.042 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.57 133.37 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -94.51 93.66 7.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.544 0.738 . . . . 0.0 109.195 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -71.09 -23.73 62.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.126 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.81 -26.45 57.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.227 0.611 . . . . 0.0 112.485 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -104.6 156.16 18.21 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.726 0.81 . . . . 0.0 109.249 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.23 137.54 31.09 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 124.94 1.296 . . . . 0.0 109.974 -169.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.23 144.13 80.03 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.807 0.898 . . . . 0.0 110.309 -10.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 141.76 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.014 0.926 . . . . 0.0 110.351 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 p -100.25 140.93 33.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.397 1.079 . . . . 0.0 110.794 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.05 -14.34 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.341 0.656 . . . . 0.0 112.505 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.01 -175.18 36.19 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -164.39 164.93 21.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.317 1.447 . . . . 0.0 110.124 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.41 117.63 34.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 120.341 1.428 . . . . 0.0 108.528 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 74' ' ' TRP . 1.2 tttm -94.53 152.86 18.22 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -136.59 150.54 48.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.299 0.5 . . . . 0.0 109.806 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -136.57 127.53 27.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.65 117.85 30.11 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.29 157.68 19.87 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -110.61 142.43 42.47 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 144.54 38.06 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.669 1.188 . . . . 0.0 109.682 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.35 -44.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.2 m -91.03 -30.12 16.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.385 0.674 . . . . 0.0 111.464 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.58 -178.41 16.41 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.778 1.18 . . . . 0.0 110.478 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -52.46 -25.45 10.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.389 1.876 . . . . 0.0 113.143 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.7 -31.08 62.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 113.916 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.84 16.03 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -170.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.71 134.94 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 107.371 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -123.6 122.58 38.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 125.98 1.712 . . . . 0.0 107.311 174.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.7 mmt -84.32 -17.96 37.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.045 0.538 . . . . 0.0 112.201 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.55 71.81 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.144 1.778 . . . . 0.0 107.293 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.7 p -75.52 -64.86 0.98 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.487 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -85.62 -178.18 6.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 108.648 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 m -56.7 -35.77 68.89 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.733 -0.604 . . . . 0.0 109.925 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.96 130.46 46.42 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.936 1.694 . . . . 0.0 107.722 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.39 135.56 37.02 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 N-CA-C 107.499 -1.77 . . . . 0.0 107.499 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.73 -21.64 63.45 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -121.98 142.23 50.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.942 0.897 . . . . 0.0 109.634 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.24 -23.24 38.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 111.072 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.51 156.95 27.54 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.41 151.44 41.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 109.159 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -153.93 169.91 22.31 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.616 1.166 . . . . 0.0 109.015 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.47 137.29 54.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.57 158.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.406 1.482 . . . . 0.0 111.057 -168.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -64.32 145.27 56.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.277 169.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -30.87 49.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -86.72 -21.23 26.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.354 1.433 . . . . 0.0 112.568 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -63.48 -43.46 78.78 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 116.594 -1.669 . . . . 0.0 114.149 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.22 -30.54 91.46 Favored 'Trans proline' 0 C--N 1.353 0.784 0 CA-C-N 123.364 2.237 . . . . 0.0 112.833 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.17 -27.37 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.097 0.959 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -71.39 -24.35 62.05 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.117 -0.99 . . . . 0.0 111.595 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.66 -33.06 41.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.314 0.961 . . . . 0.0 112.533 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 m -83.76 166.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -85.1 174.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.569 1.548 . . . . 0.0 109.126 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.3 m -54.04 -44.79 71.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.442 1.497 . . . . 0.0 114.418 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -64.1 -41.95 97.08 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.111 0.868 . . . . 0.0 111.463 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.78 -35.65 38.26 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.282 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -52.0 -45.92 64.7 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.232 0.924 . . . . 0.0 110.527 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.96 -44.31 89.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.323 0.511 . . . . 0.0 110.864 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.15 -52.29 49.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -69.25 -30.57 68.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.157 -169.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -66.49 -42.35 87.55 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.507 1.503 . . . . 0.0 110.213 169.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -58.78 -46.24 87.97 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 119.231 0.923 . . . . 0.0 110.606 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.17 -24.61 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.657 1.183 . . . . 0.0 112.041 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.8 mmt -86.54 -58.11 2.74 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -60.0 -32.97 71.36 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.305 1.042 . . . . 0.0 112.082 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.08 -34.82 72.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.228 0.922 . . . . 0.0 111.366 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -112.15 -9.05 13.97 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.466 1.106 . . . . 0.0 113.343 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.47 72.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.977 1.262 . . . . 0.0 110.958 -169.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.0 m -67.8 -32.35 72.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.281 0.632 . . . . 0.0 110.763 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.8 t -69.26 -44.43 80.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.33 -42.34 73.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.432 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.2 mmt -56.95 -54.44 46.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.235 1.38 . . . . 0.0 110.065 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.6 m -70.32 -26.59 63.83 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.835 1.254 . . . . 0.0 110.787 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -36.7 84.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.598 1.959 . . . . 0.0 109.541 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -70.54 -20.73 62.78 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.837 1.199 . . . . 0.0 112.668 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 N--CA 1.466 0.354 0 C-N-CA 125.85 1.66 . . . . 0.0 111.306 -177.172 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.55 -45.98 81.29 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 112.978 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -147.71 -118.81 0.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.175 0.99 . . . . 0.0 108.784 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.14 -15.63 56.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.675 1.59 . . . . 0.0 111.396 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.16 178.82 47.51 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 126.133 1.825 . . . . 0.0 109.567 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.4 153.15 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.617 2.767 . . . . 0.0 113.743 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.69 137.56 15.34 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 120.506 -1.371 . . . . 0.0 107.974 174.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -74.09 140.88 28.77 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.323 2.015 . . . . 0.0 109.42 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -141.27 154.09 45.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.765 0.826 . . . . 0.0 109.143 -170.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.29 136.32 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.524 1.53 . . . . 0.0 107.475 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.41 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -122.03 158.09 16.75 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 172.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -124.12 144.33 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 125.619 1.568 . . . . 0.0 107.556 -171.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.65 137.12 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm -120.94 134.17 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.2 p -124.83 158.24 33.91 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.1 0.864 . . . . 0.0 112.267 170.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -108.24 170.6 7.91 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.462 1.505 . . . . 0.0 108.658 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -0.56 15.88 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.095 -1.628 . . . . 0.0 113.648 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -81.61 -6.51 59.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.679 0.672 . . . . 0.0 110.544 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.68 78.66 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.028 -0.874 . . . . 0.0 111.489 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -89.15 150.36 22.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.73 148.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.487 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.9 tpp -63.53 128.4 35.66 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.706 1.202 . . . . 0.0 108.175 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CZ2' ' HB2' ' A' ' 33' ' ' TRP . 10.0 t90 -146.73 140.45 25.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.45 146.55 33.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.669 1.122 . . . . 0.0 113.653 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -85.53 121.32 28.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.329 1.852 . . . . 0.0 106.704 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -79.66 149.62 31.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.63 1.559 . . . . 0.0 109.349 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.42 117.09 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.061 1.745 . . . . 0.0 110.925 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.62 -1.07 31.39 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.738 1.161 . . . . 0.0 115.499 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -83.39 -31.25 26.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.747 1.774 . . . . 0.0 111.987 -172.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.8 m80 54.66 31.2 14.75 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.518 1.127 . . . . 0.0 112.008 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.2 m -138.43 154.03 48.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.548 1.939 . . . . 0.0 107.518 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.409 ' HB2' ' CZ2' ' A' ' 24' ' ' TRP . 77.4 m95 -108.55 151.76 25.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.109 0.564 . . . . 0.0 111.176 -169.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -148.17 159.71 43.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.921 1.688 . . . . 0.0 110.833 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.3 141.39 29.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.77 130.19 32.13 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 0.0 111.586 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -159.5 162.26 35.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.243 0.929 . . . . 0.0 112.764 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.19 176.98 47.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.421 1.01 . . . . 0.0 111.926 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.85 150.16 32.25 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 121.166 -1.196 . . . . 0.0 111.859 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.1 mt -79.94 129.37 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 168.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -71.95 152.86 93.0 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -57.53 123.58 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 120.962 1.108 . . . . 0.0 109.334 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.91 -5.58 84.43 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.384 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.05 155.47 37.19 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.237 2.018 . . . . 0.0 109.681 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -97.19 154.93 17.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.43 88.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.464 -0.773 . . . . 0.0 112.32 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.96 -34.35 75.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.951 0.501 . . . . 0.0 109.96 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -68.03 -42.96 79.79 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.08 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.15 81.5 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 119.272 -0.395 . . . . 0.0 110.15 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -57.41 -49.02 77.56 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.49 -35.18 79.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -62.95 -46.21 88.84 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.817 1.644 . . . . 0.0 109.686 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -69.15 -25.55 64.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.708 -0.62 . . . . 0.0 110.728 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.22 -43.12 95.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.746 -1.221 . . . . 0.0 109.774 172.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.19 -37.11 86.3 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.754 -0.591 . . . . 0.0 110.389 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.33 -35.56 66.05 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.425 -0.797 . . . . 0.0 112.629 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.3 -57.14 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.335 0.654 . . . . 0.0 110.294 -169.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.01 -15.78 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.713 0.805 . . . . 0.0 110.15 -172.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.71 19.29 79.17 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.716 -0.615 . . . . 0.0 111.737 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.7 tp -108.48 150.86 26.85 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.683 1.993 . . . . 0.0 108.266 -172.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m -127.58 168.22 15.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.607 0.763 . . . . 0.0 109.819 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -49.51 -33.95 15.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.664 1.585 . . . . 0.0 112.606 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -65.33 -23.36 66.98 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.037 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.98 24.66 10.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.488 0.661 . . . . 0.0 112.708 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -134.15 165.24 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.336 1.054 . . . . 0.0 111.34 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -141.06 141.37 34.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -80.51 120.59 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.49 -35.52 11.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.816 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.01 161.97 39.56 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.338 0.59 . . . . 0.0 110.16 -172.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 p -158.16 155.2 28.66 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.651 1.58 . . . . 0.0 109.526 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 143.64 56.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.69 0.757 . . . . 0.0 111.595 -170.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -80.47 -29.34 37.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.199 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -136.74 152.23 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.594 2.358 . . . . 0.0 109.065 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -76.06 136.93 39.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.75 102.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -106.94 146.19 31.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -147.67 146.36 29.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -91.26 144.68 25.36 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -71.46 149.22 93.63 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 123.943 0.897 . . . . 0.0 110.55 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.52 144.91 74.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 N-CA-C 105.082 -2.699 . . . . 0.0 105.082 167.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.52 -12.1 60.78 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.242 -1.536 . . . . 0.0 113.831 -169.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -58.14 -31.62 67.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -90.0 -23.08 21.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 111.817 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.05 137.96 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 109.45 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -107.82 90.99 3.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.14 0.976 . . . . 0.0 109.934 169.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -68.55 -24.6 64.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.825 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.58 -24.74 60.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.69 0.796 . . . . 0.0 112.433 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -111.3 156.79 20.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.228 1.011 . . . . 0.0 109.293 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -129.9 140.16 37.82 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.101 1.36 . . . . 0.0 109.239 -169.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.74 150.8 96.06 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 O-C-N 122.826 0.908 . . . . 0.0 110.865 -10.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.7 136.8 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.922 0.889 . . . . 0.0 111.656 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.2 t -81.85 108.37 15.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.6 -14.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.727 0.811 . . . . 0.0 112.584 170.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.37 -174.52 47.03 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.99 157.9 36.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 109.11 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.3 125.61 54.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 169.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -117.26 129.54 55.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.013 0.824 . . . . 0.0 111.405 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -88.04 154.04 20.79 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 167.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.41 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 84.5 m95 -132.54 143.6 49.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -130.41 132.5 45.77 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.572 1.149 . . . . 0.0 107.926 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.1 tp -97.06 126.03 41.93 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.85 146.64 43.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -95.72 133.34 39.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 167.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.97 130.78 47.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.225 1.41 . . . . 0.0 108.542 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.9 t -86.31 -38.6 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.587 0.631 . . . . 0.0 110.803 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.5 m -95.41 -21.15 18.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.865 0.757 . . . . 0.0 112.302 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.65 -176.43 24.07 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -19.24 28.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.686 1.594 . . . . 0.0 114.506 -169.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.33 -31.46 33.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.378 1.071 . . . . 0.0 112.912 171.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -92.85 16.07 13.32 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.86 141.17 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -126.23 -49.38 1.56 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.529 0.732 . . . . 0.0 111.676 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 68.64 9.87 7.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.3 2.24 . . . . 0.0 115.2 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.26 69.66 0.83 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 124.325 2.012 . . . . 0.0 111.227 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -56.37 5.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.347 169.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 m -63.99 160.92 16.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.044 1.337 . . . . 0.0 109.063 168.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -63.57 -33.17 75.01 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.99 -0.444 . . . . 0.0 110.721 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.53 131.38 38.28 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.356 1.463 . . . . 0.0 110.27 170.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.67 132.67 31.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.212 1.941 . . . . 0.0 107.883 168.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -73.4 -23.65 60.19 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.862 -0.524 . . . . 0.0 111.074 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -116.12 139.29 50.46 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.543 0.737 . . . . 0.0 110.085 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.74 -21.09 34.85 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.072 0.949 . . . . 0.0 110.709 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -165.93 158.57 31.53 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.39 155.53 47.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.167 0.983 . . . . 0.0 108.497 169.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -144.79 149.03 34.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -96.9 98.11 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.52 168.92 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 110.296 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -64.31 168.13 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 109.507 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -30.68 70.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.196 -0.94 . . . . 0.0 111.563 175.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -92.01 -32.7 15.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.127 1.331 . . . . 0.0 113.607 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -54.39 -45.25 99.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 116.825 -1.559 . . . . 0.0 114.326 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.74 -19.96 68.01 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 123.273 2.205 . . . . 0.0 113.646 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.83 -33.68 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.11 -37.11 85.92 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.268 -0.895 . . . . 0.0 111.11 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -78.75 -27.0 44.65 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.78 166.23 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 118.804 0.729 . . . . 0.0 111.229 -173.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.65 174.23 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.855 1.262 . . . . 0.0 109.857 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.2 m -54.59 -49.42 70.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.493 1.517 . . . . 0.0 113.429 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -60.1 -39.09 84.96 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.317 0.647 . . . . 0.0 111.146 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -85.6 -40.14 16.57 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.974 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -46.85 -46.33 20.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.861 0.864 . . . . 0.0 111.097 170.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.83 -35.49 78.4 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.484 0.713 . . . . 0.0 111.367 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.14 -50.8 17.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.015 . . . . 0.0 110.169 171.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -61.78 -32.69 72.99 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.302 0.955 . . . . 0.0 111.586 -169.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -63.71 -42.99 97.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.259 0.936 . . . . 0.0 111.27 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -61.88 -44.7 96.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.83 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -55.73 -30.84 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.484 1.038 . . . . 0.0 111.222 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.4 mmt -86.25 -54.81 4.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.362 1.065 . . . . 0.0 108.717 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -36.49 73.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.076 0.853 . . . . 0.0 111.635 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.73 -40.13 78.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.143 0.977 . . . . 0.0 111.077 -173.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.24 -14.15 13.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 111.025 -172.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.31 57.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 111.139 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 m -66.34 -31.48 72.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.312 0.645 . . . . 0.0 111.067 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.32 -45.91 67.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -58.47 -41.12 80.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 116.949 -1.5 . . . . 0.0 110.217 -173.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.3 mmt -54.48 -49.42 70.15 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 121.137 1.79 . . . . 0.0 110.318 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 m -76.64 -26.48 54.94 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.355 1.062 . . . . 0.0 111.144 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 18.6 tp -62.68 -44.22 96.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.111 1.365 . . . . 0.0 109.411 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -60.12 -39.9 87.83 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.845 0.458 . . . . 0.0 110.827 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.233 0.195 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.109 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.406 0.622 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -63.76 -67.08 0.46 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -169.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -162.68 -52.64 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.82 14.83 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 112.776 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.85 1.08 77.31 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.788 1.185 . . . . 0.0 114.001 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.51 165.28 11.18 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.917 0.865 . . . . 0.0 109.223 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -148.47 145.74 20.98 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.163 1.385 . . . . 0.0 107.456 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -85.71 133.39 4.37 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.476 1.451 . . . . 0.0 109.935 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.7 150.01 52.29 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 109.253 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.3 m -129.13 154.97 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.071 0.948 . . . . 0.0 108.83 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.13 158.29 25.23 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.49 143.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.565 1.146 . . . . 0.0 108.06 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.14 136.73 58.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mm -117.45 135.96 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -123.56 153.76 40.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.987 0.812 . . . . 0.0 112.117 171.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -103.72 175.12 5.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.425 1.49 . . . . 0.0 109.156 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -78.27 8.07 5.51 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.466 -1.396 . . . . 0.0 113.241 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -96.52 -5.76 38.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.439 1.096 . . . . 0.0 111.447 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.79 66.9 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.867 0.758 . . . . 0.0 111.885 -172.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -98.11 150.35 21.53 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -114.39 146.47 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 106.938 174.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 ptm -78.95 147.69 32.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.851 0.75 . . . . 0.0 109.672 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -148.55 146.59 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.63 148.2 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.977 1.262 . . . . 0.0 111.701 -170.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -99.5 127.79 45.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.81 0.732 . . . . 0.0 109.203 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -78.18 145.69 35.45 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.699 0.681 . . . . 0.0 109.867 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.13 136.1 57.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.066 0.946 . . . . 0.0 109.508 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.86 10.26 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.885 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -100.88 -45.21 5.51 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.328 1.564 . . . . 0.0 110.083 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 53.92 29.56 10.15 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.844 1.258 . . . . 0.0 111.826 -174.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -120.28 148.48 43.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.895 2.078 . . . . 0.0 106.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -92.82 148.61 21.89 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -152.24 162.89 40.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.538 1.935 . . . . 0.0 110.141 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.54 141.23 23.17 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.39 135.92 44.79 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.036 2.491 . . . . 0.0 111.671 -174.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -158.22 166.96 31.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.445 -171.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.29 172.57 42.31 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.165 0.412 . . . . 0.0 112.127 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.77 143.62 16.83 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.4 mt -76.81 122.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 168.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.99 148.29 78.46 Favored Pre-proline 0 N--CA 1.464 0.253 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.21 124.12 14.55 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.162 1.241 . . . . 0.0 109.055 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.38 -15.79 58.53 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.636 1.112 . . . . 0.0 113.803 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -73.67 148.16 43.02 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.644 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 p -85.96 168.95 13.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 168.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.59 87.88 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.262 -0.899 . . . . 0.0 110.943 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.97 -39.01 63.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.239 0.616 . . . . 0.0 110.611 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.81 -41.82 86.92 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.638 -0.664 . . . . 0.0 109.59 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.85 79.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.411 0.55 . . . . 0.0 109.629 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -62.02 -51.72 66.89 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.06 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.75 -35.35 79.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.916 1.235 . . . . 0.0 111.571 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.35 94.86 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.851 0.86 . . . . 0.0 110.388 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.89 -24.56 26.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.276 0.489 . . . . 0.0 110.933 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.1 tp -55.23 -39.59 69.88 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.152 -0.967 . . . . 0.0 109.471 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -63.12 -49.15 75.56 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.004 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.63 -32.74 73.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 0.0 112.715 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.8 -46.29 10.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.763 0.711 . . . . 0.0 111.135 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.75 -31.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.562 1.145 . . . . 0.0 110.975 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.67 87.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.817 1.199 . . . . 0.0 111.778 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.79 155.47 19.88 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.456 1.902 . . . . 0.0 110.039 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 p -131.76 164.48 25.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.765 1.226 . . . . 0.0 109.724 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -41.39 -40.56 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.315 2.246 . . . . 0.0 112.698 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.91 -28.18 69.36 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.42 0.688 . . . . 0.0 112.659 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -111.67 22.6 14.82 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.458 0.647 . . . . 0.0 112.08 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.22 165.38 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 O-C-N 120.769 -1.207 . . . . 0.0 112.544 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 137.48 39.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 168.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.7 mt -74.53 119.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 171.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.76 -33.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.889 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.05 163.15 39.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.404 1.082 . . . . 0.0 108.745 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -162.24 153.24 17.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.587 1.155 . . . . 0.0 109.573 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 p -70.7 136.09 48.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.346 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -52.51 21.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -72.33 170.4 14.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.582 1.553 . . . . 0.0 111.652 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.435 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 87.0 m95 -108.44 125.58 51.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 167.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.97 106.04 8.4 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -73.62 140.3 46.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.74 143.32 50.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -131.66 141.7 49.66 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 126.283 1.833 . . . . 0.0 106.081 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pp -110.29 150.2 41.22 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.527 1.131 . . . . 0.0 109.613 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -73.12 158.18 49.57 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.427 3.418 . . . . 0.0 109.947 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -68.41 -18.41 64.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.41 -29.07 68.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.0 mt -94.55 -7.89 39.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.123 0.969 . . . . 0.0 112.416 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.03 132.02 33.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.74 97.01 10.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -75.6 -19.52 59.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.861 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.29 -27.94 56.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -101.12 158.17 16.22 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.125 0.97 . . . . 0.0 109.836 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -132.66 132.02 22.43 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 125.967 1.707 . . . . 0.0 109.724 -170.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.5 150.72 89.94 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 O-C-N 122.879 0.936 . . . . 0.0 110.858 -10.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.24 141.55 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.899 1.28 . . . . 0.0 111.269 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.0 p -81.24 123.18 28.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.62 -16.11 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.843 0.747 . . . . 0.0 111.449 169.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.2 -174.16 40.07 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -160.96 162.84 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.223 1.809 . . . . 0.0 110.536 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -98.6 129.58 45.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -111.72 143.32 42.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.045 1.293 . . . . 0.0 110.237 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 6.2 ttmm -131.88 118.92 20.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -104.43 153.89 20.55 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.65 125.31 30.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 tp -91.16 121.41 32.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 168.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.67 157.09 23.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 167.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 141.23 56.62 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.956 1.303 . . . . 0.0 109.43 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.94 -47.51 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.114 0.566 . . . . 0.0 110.094 -171.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.8 m -86.1 -16.0 39.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.138 0.575 . . . . 0.0 111.55 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.25 -169.61 22.84 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -17.01 53.55 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 125.264 1.426 . . . . 0.0 114.311 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.68 57.05 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.917 0.887 . . . . 0.0 111.76 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -91.71 51.76 1.91 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 110.958 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.16 129.61 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.76 -53.72 2.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.375 0.67 . . . . 0.0 111.406 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 67.57 12.01 8.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.948 2.099 . . . . 0.0 114.628 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -150.31 73.89 1.17 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 124.016 1.865 . . . . 0.0 109.713 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -71.93 -60.08 2.41 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.269 -2.241 . . . . 0.0 107.843 171.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -66.71 166.44 13.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 109.917 169.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -57.43 -38.01 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.895 . . . . 0.0 110.829 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 130.52 54.77 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.865 1.266 . . . . 0.0 110.454 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.99 142.0 73.02 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.926 1.751 . . . . 0.0 108.453 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -81.34 -24.94 36.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.552 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.08 140.04 53.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.303 0.956 . . . . 0.0 109.998 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.0 -17.97 24.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.691 1.196 . . . . 0.0 111.371 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.85 151.82 23.19 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.57 148.85 31.57 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.816 0.847 . . . . 0.0 108.778 171.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -148.52 172.65 14.16 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.905 1.282 . . . . 0.0 109.204 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -112.97 139.77 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.59 152.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 109.853 -169.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m -59.94 147.9 37.09 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.819 0.736 . . . . 0.0 109.419 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -38.16 37.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -88.53 -25.1 22.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -170.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -57.87 -47.82 98.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.055 -1.45 . . . . 0.0 113.693 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -63.84 -21.3 69.24 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.865 2.059 . . . . 0.0 113.171 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.62 -36.38 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -62.85 -35.57 80.38 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.285 -0.885 . . . . 0.0 111.099 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.89 -21.4 34.27 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -81.73 167.87 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.389 0.995 . . . . 0.0 110.251 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.2 176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.719 1.208 . . . . 0.0 110.638 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 m -53.12 -48.5 67.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.021 1.729 . . . . 0.0 114.494 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -74.5 -31.34 62.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.257 -0.902 . . . . 0.0 111.394 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -80.77 -40.16 25.61 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.253 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -44.33 -46.2 9.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 0.0 111.633 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.96 -42.45 94.6 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.302 0.501 . . . . 0.0 111.352 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -67.5 -44.84 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 121.638 -0.664 . . . . 0.0 109.361 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.45 -41.76 98.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -66.34 -43.9 84.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.159 0.891 . . . . 0.0 110.333 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.31 -47.73 84.6 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.071 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.1 -39.45 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.733 1.213 . . . . 0.0 110.431 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.2 mmt -69.49 -54.45 14.19 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -57.24 -34.66 68.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.878 0.871 . . . . 0.0 111.774 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -45.55 79.29 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.281 1.033 . . . . 0.0 110.185 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -104.63 -9.52 18.19 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.485 0.714 . . . . 0.0 112.381 -173.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.13 -43.81 70.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.133 1.773 . . . . 0.0 110.548 -173.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.7 m -66.7 -31.99 73.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.463 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.63 -47.14 81.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 118.055 -0.974 . . . . 0.0 108.384 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.6 t -58.42 -45.35 89.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 109.48 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.9 mtt -61.62 -33.82 74.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.624 0.647 . . . . 0.0 111.216 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -82.79 -31.36 28.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.575 1.15 . . . . 0.0 110.824 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.1 tp -58.33 -40.25 81.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.154 1.782 . . . . 0.0 110.155 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.93 -29.75 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.194 0.598 . . . . 0.0 111.985 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 125.825 1.65 . . . . 0.0 111.74 -177.826 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.23 -64.83 0.81 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.4 -50.69 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.31 16.79 14.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 113.084 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 10.47 67.94 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.888 0.756 . . . . 0.0 113.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -105.0 155.6 18.81 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 108.714 170.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.96 147.76 67.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.446 169.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.55 142.23 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 110.528 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -143.57 155.44 44.3 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.252 1.421 . . . . 0.0 109.498 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.17 153.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.072 0.549 . . . . 0.0 110.372 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.74 160.37 19.36 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.84 146.55 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.76 135.9 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.9 mm -112.03 134.75 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.0 m -124.12 145.38 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.842 0.714 . . . . 0.0 110.008 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -104.22 173.53 6.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.116 1.366 . . . . 0.0 108.51 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.31 9.86 5.27 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.5 -1.375 . . . . 0.0 112.632 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -98.41 -3.51 36.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.099 1.36 . . . . 0.0 111.444 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.2 21.54 70.19 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 118.777 0.717 . . . . 0.0 111.916 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.98 150.7 21.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.647 1.223 . . . . 0.0 107.842 172.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.87 151.04 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 108.296 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.3 mtp -70.56 147.57 49.14 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.277 0.49 . . . . 0.0 110.026 169.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -151.2 141.16 22.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.62 145.74 47.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.28 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -97.13 107.95 20.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.961 2.105 . . . . 0.0 107.143 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -74.7 139.32 43.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.556 1.525 . . . . 0.0 109.939 -169.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.68 135.99 57.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.36 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.55 -24.56 3.64 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.546 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -82.49 -44.68 15.68 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.56 1.68 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m80 59.47 28.45 17.83 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.23 0.956 . . . . 0.0 109.734 -168.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -122.93 155.27 37.08 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 108.025 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -101.88 146.53 27.7 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -169.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -149.43 164.06 36.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.512 1.525 . . . . 0.0 110.334 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -87.52 143.95 34.82 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 130.49 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 110.59 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -159.07 168.17 27.37 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.113 0.87 . . . . 0.0 112.244 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.44 163.52 37.24 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.653 0.644 . . . . 0.0 111.661 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.6 150.85 45.52 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -77.55 113.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -70.93 156.03 92.58 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.58 123.9 12.83 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 CA-C-N 120.719 1.293 . . . . 0.0 109.674 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.09 -5.35 78.56 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.212 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -74.34 154.19 38.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.075 1.937 . . . . 0.0 110.524 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.4 p -94.56 168.37 10.9 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.46 90.02 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.024 -1.048 . . . . 0.0 111.342 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.06 -38.62 72.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.146 0.578 . . . . 0.0 110.26 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -67.69 -39.18 84.45 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.8 92.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -60.52 -52.52 64.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.42 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.6 m-85 -66.46 -44.44 82.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.973 0.806 . . . . 0.0 111.465 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -44.78 80.04 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 121.816 -0.552 . . . . 0.0 110.337 -173.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -71.54 -37.14 71.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 tp -53.76 -43.83 69.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.094 0.861 . . . . 0.0 110.588 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.27 -39.14 81.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.232 0.469 . . . . 0.0 110.834 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.11 -18.71 60.19 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.3 -0.875 . . . . 0.0 112.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -90.03 -50.38 6.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.666 0.787 . . . . 0.0 110.563 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.86 3.33 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 0.0 111.837 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.58 -1.52 14.26 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.469 -1.395 . . . . 0.0 113.529 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -80.72 144.42 32.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.186 1.794 . . . . 0.0 109.741 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -125.04 166.3 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 109.445 -174.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 56.7 mtt180 -48.96 -35.28 14.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.361 1.464 . . . . 0.0 112.43 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.35 -24.28 67.21 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.82 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.29 22.84 12.57 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.491 0.662 . . . . 0.0 112.113 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.19 164.24 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.675 1.19 . . . . 0.0 112.212 170.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.35 134.52 29.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.576 -1.202 . . . . 0.0 108.114 168.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mt -71.27 113.64 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.7 mt -91.54 -33.99 14.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.848 173.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.93 165.42 36.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.406 0.682 . . . . 0.0 109.344 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 p -159.09 157.53 31.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.61 1.164 . . . . 0.0 110.422 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -75.04 134.72 41.34 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.562 -0.711 . . . . 0.0 109.169 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.11 -48.17 25.09 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -79.41 165.17 23.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.022 1.329 . . . . 0.0 110.461 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -102.79 128.65 49.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -80.3 92.34 5.75 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -81.41 145.31 30.86 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.74 151.16 49.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -128.43 133.13 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.758 1.623 . . . . 0.0 106.898 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -90.64 147.9 37.35 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.36 0.664 . . . . 0.0 112.715 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.2 150.53 71.72 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 105.046 -2.713 . . . . 0.0 105.046 166.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -69.35 -13.45 62.38 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 119.805 -1.809 . . . . 0.0 114.147 -169.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.16 -31.38 71.86 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.821 0.737 . . . . 0.0 112.76 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.08 -18.69 21.55 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.107 0.963 . . . . 0.0 112.009 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.91 134.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.53 83.96 3.89 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.151 0.976 . . . . 0.0 110.223 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -67.29 -19.92 65.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.066 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.49 -20.99 53.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -107.07 160.88 15.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.948 0.899 . . . . 0.0 109.965 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -130.43 127.07 22.35 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 125.442 1.497 . . . . 0.0 109.19 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.39 159.53 91.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 O-C-N 122.717 0.851 . . . . 0.0 111.246 -10.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 80.5 t -75.01 140.04 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 123.906 0.882 . . . . 0.0 110.045 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 p -91.89 121.45 33.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.697 1.199 . . . . 0.0 108.925 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.29 -13.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.803 0.728 . . . . 0.0 112.716 171.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.91 46.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -157.01 161.48 39.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.675 1.19 . . . . 0.0 109.566 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -112.43 132.69 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -123.29 122.15 37.62 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.429 0.692 . . . . 0.0 109.524 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -105.97 140.35 39.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.67 156.16 38.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.676 0.671 . . . . 0.0 109.364 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -139.8 127.01 21.17 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.161 0.984 . . . . 0.0 108.516 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.82 116.3 26.99 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.6 mp -112.11 137.46 50.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.866 0.867 . . . . 0.0 108.917 172.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.99 134.88 33.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.477 1.49 . . . . 0.0 107.213 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.97 133.43 51.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.64 1.576 . . . . 0.0 107.269 170.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.34 -55.24 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.834 1.197 . . . . 0.0 110.634 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.1 m -75.78 -19.46 58.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.59 0.756 . . . . 0.0 111.227 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.44 27.26 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -57.75 -18.18 19.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 0.0 114.367 -169.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.03 10.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.268 1.027 . . . . 0.0 112.619 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -87.15 14.97 6.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.1 mt -91.33 137.9 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -129.27 128.46 43.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.337 1.855 . . . . 0.0 106.874 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.1 mmt -97.91 -11.04 23.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.579 0.627 . . . . 0.0 111.526 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.91 63.32 0.71 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.979 2.112 . . . . 0.0 106.587 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -68.65 -60.05 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 127.185 2.194 . . . . 0.0 109.361 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -90.67 174.87 7.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.457 1.903 . . . . 0.0 110.021 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 m -60.17 -25.72 65.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.192 0.997 . . . . 0.0 112.004 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.94 136.82 23.37 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 168.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 155.2 68.4 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.575 2.183 . . . . 0.0 111.8 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.39 -35.25 27.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.745 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.67 137.8 54.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.574 0.75 . . . . 0.0 109.437 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.3 -26.71 56.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.837 0.855 . . . . 0.0 110.787 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.89 166.84 38.33 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.39 160.01 44.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 169.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -145.65 167.05 24.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.79 133.93 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 151.29 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.853 1.261 . . . . 0.0 110.083 -169.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -60.73 146.6 45.28 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -33.53 30.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.022 1.329 . . . . 0.0 113.698 -169.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -91.72 -14.75 29.46 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -65.17 -47.81 71.05 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.335 -1.317 . . . . 0.0 112.858 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.55 -28.88 83.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 CA-C-N 122.547 1.945 . . . . 0.0 112.35 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.15 -25.82 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.191 1.396 . . . . 0.0 109.819 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -65.87 -31.42 72.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.424 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -100.01 -22.16 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.75 151.89 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 118.793 0.724 . . . . 0.0 110.065 171.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.36 176.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.688 1.195 . . . . 0.0 109.706 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -55.38 -44.3 75.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.393 1.477 . . . . 0.0 112.911 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -70.65 -41.75 71.73 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 111.088 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.42 -41.06 28.49 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.83 -0.544 . . . . 0.0 110.731 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -61.63 -29.41 70.04 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.853 0.751 . . . . 0.0 112.383 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.17 -45.75 87.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.497 0.589 . . . . 0.0 110.688 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.25 -47.14 91.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.525 -0.734 . . . . 0.0 109.099 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -61.62 -45.52 93.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -66.08 -40.65 90.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.971 -1.081 . . . . 0.0 110.933 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.63 -48.02 83.65 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.474 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.01 -39.9 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.279 1.032 . . . . 0.0 110.039 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.6 mmt -67.12 -52.83 36.98 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.996 0.919 . . . . 0.0 108.647 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.462 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -29.54 69.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.37 0.987 . . . . 0.0 112.006 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -111.37 -14.47 13.76 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.09 0.956 . . . . 0.0 113.468 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.28 69.33 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.371 1.468 . . . . 0.0 110.641 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 m -68.53 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.864 0.866 . . . . 0.0 110.687 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.62 -43.67 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.68 -39.91 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.458 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.0 mmt -57.44 -50.38 73.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.643 1.11 . . . . 0.0 109.852 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 m -73.31 -28.04 61.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.173 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.01 -42.58 99.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.666 1.186 . . . . 0.0 110.152 172.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.44 -42.52 98.88 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -170.143 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.61 -69.09 0.31 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.246 0.618 . . . . 0.0 112.623 -169.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.34 -52.4 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.663 0.785 . . . . 0.0 112.953 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.62 17.0 10.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.699 1.199 . . . . 0.0 112.459 -169.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.54 85.72 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.744 1.164 . . . . 0.0 113.24 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -88.21 157.88 18.67 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.263 1.025 . . . . 0.0 109.367 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -150.31 127.29 5.4 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 116.996 -1.478 . . . . 0.0 107.292 -169.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -80.32 132.58 9.25 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.505 1.47 . . . . 0.0 109.424 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.36 155.61 49.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.909 0.884 . . . . 0.0 108.656 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.42 137.77 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.16 154.41 16.82 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.45 141.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 125.397 1.479 . . . . 0.0 107.962 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.88 142.7 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mm -117.09 142.25 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 117.293 -1.337 . . . . 0.0 107.663 169.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.6 p -125.78 160.11 30.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.651 1.114 . . . . 0.0 112.708 170.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -121.61 172.18 8.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.613 1.565 . . . . 0.0 109.145 176.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.99 7.7 4.6 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.439 -1.413 . . . . 0.0 112.977 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -94.08 -5.13 48.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.434 1.093 . . . . 0.0 111.715 174.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 31.72 60.75 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -108.57 154.6 21.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.22 150.3 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 174.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -84.52 143.59 29.25 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -144.65 140.47 28.68 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -175.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.78 158.46 42.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.581 1.537 . . . . 0.0 111.531 -170.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.68 145.83 51.05 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.875 1.67 . . . . 0.0 108.45 -171.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -112.11 163.39 14.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.341 0.973 . . . . 0.0 109.664 174.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -72.88 153.67 40.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.328 1.051 . . . . 0.0 109.013 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.96 -52.63 3.3 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.138 1.351 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.17 -45.73 66.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.43 0.615 . . . . 0.0 110.079 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.1 m170 56.18 -0.37 0.05 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.292 2.237 . . . . 0.0 115.377 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -77.82 163.23 26.27 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.565 1.946 . . . . 0.0 108.348 169.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -112.68 146.7 38.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -174.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.34 158.51 44.14 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.958 1.303 . . . . 0.0 110.686 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.62 134.22 65.87 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 169.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -54.34 139.76 73.42 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.214 2.609 . . . . 0.0 112.578 -178.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -161.95 169.17 21.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.161 0.891 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.86 169.48 42.54 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.156 0.407 . . . . 0.0 112.368 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.79 147.51 36.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -73.89 114.94 14.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 169.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -68.22 145.72 97.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.19 125.14 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.518 1.479 . . . . 0.0 112.076 -169.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.2 85.93 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.55 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.15 147.55 48.27 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.133 1.967 . . . . 0.0 110.595 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -85.24 156.48 20.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 167.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.64 75.63 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.014 -1.054 . . . . 0.0 112.119 -169.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.71 -36.67 70.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 110.094 -178.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -70.28 -37.65 74.88 Favored 'General case' 0 C--O 1.23 0.061 0 O-C-N 121.172 -0.955 . . . . 0.0 109.995 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.57 77.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.566 175.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -58.09 -48.65 79.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.4 m-85 -66.32 -46.91 75.24 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.913 0.779 . . . . 0.0 111.766 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -52.52 -52.51 54.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.133 0.973 . . . . 0.0 110.901 177.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.87 -37.35 59.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -170.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -54.61 -45.41 73.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 110.595 173.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.76 -39.62 89.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.159 0.436 . . . . 0.0 110.28 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.36 -24.64 60.37 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.08 -46.01 12.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.313 0.96 . . . . 0.0 111.459 -175.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.52 4.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 112.32 -169.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.93 -2.97 14.5 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 120.431 -1.418 . . . . 0.0 113.513 -178.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.0 tp -78.89 140.88 38.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.677 1.591 . . . . 0.0 109.771 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 p -120.96 163.67 17.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.877 1.271 . . . . 0.0 109.902 -171.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 67.0 mtt85 -46.58 -37.58 8.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.054 1.742 . . . . 0.0 112.23 -177.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -30.19 71.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.885 -173.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.33 21.42 16.71 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.679 1.127 . . . . 0.0 112.011 -173.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.01 165.6 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.53 1.532 . . . . 0.0 111.829 171.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.65 140.31 33.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.279 169.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.52 116.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 177.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.58 -33.57 12.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.405 174.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.82 164.04 39.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.799 0.84 . . . . 0.0 108.919 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -163.68 154.4 15.92 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.1 0.96 . . . . 0.0 109.879 170.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -70.07 139.28 52.57 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -175.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -56.98 4.87 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -72.84 -178.16 2.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.514 1.925 . . . . 0.0 111.062 174.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.414 ' CD2' ' HE2' ' A' ' 96' ' ' LYS . 55.8 m95 -118.75 146.85 44.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.12 102.16 13.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 137.37 40.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -135.82 143.26 45.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -87.74 139.13 30.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 pp -91.02 148.82 38.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 169.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.92 155.14 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.45 2.767 . . . . 0.0 110.497 -175.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -65.75 -20.24 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.046 -1.034 . . . . 0.0 112.8 -170.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.62 -32.81 67.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.688 0.676 . . . . 0.0 112.739 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.05 -20.08 22.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.042 0.937 . . . . 0.0 111.436 -177.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.17 134.79 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -109.26 96.21 6.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.126 0.97 . . . . 0.0 109.398 171.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -70.99 -27.15 63.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.237 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.16 -10.32 59.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.309 1.043 . . . . 0.0 112.534 -170.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -129.73 158.9 38.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.928 0.891 . . . . 0.0 108.974 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -127.29 141.5 41.0 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.177 1.391 . . . . 0.0 108.993 -171.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.76 147.55 89.84 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 O-C-N 122.875 0.934 . . . . 0.0 111.35 -10.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -83.72 141.27 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.405 1.082 . . . . 0.0 108.908 175.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -103.96 139.6 38.88 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.461 0.704 . . . . 0.0 109.533 169.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 -17.42 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 122.937 0.495 . . . . 0.0 111.347 169.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.91 161.97 28.12 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.98 143.41 33.19 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.586 1.154 . . . . 0.0 108.599 -177.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' A' ' 74' ' ' TRP . 85.2 tttt -94.72 120.77 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -119.15 131.0 55.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.065 1.302 . . . . 0.0 112.893 -172.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 3.7 ttmm -99.4 152.79 19.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -128.54 148.6 50.77 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -133.58 129.73 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.871 1.269 . . . . 0.0 108.491 -177.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.07 125.64 39.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.13 157.02 31.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -105.84 132.99 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 137.83 58.32 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -89.5 -55.33 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.611 1.096 . . . . 0.0 109.97 -172.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -76.87 -21.62 54.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.458 0.703 . . . . 0.0 111.432 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.18 169.32 20.56 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -13.91 26.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.573 1.549 . . . . 0.0 114.433 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.63 39.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.286 1.034 . . . . 0.0 112.712 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.59 22.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.39 137.21 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.193 1.397 . . . . 0.0 108.155 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -124.03 129.01 50.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.332 1.853 . . . . 0.0 107.888 170.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.8 mmt -93.68 -8.04 42.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.369 0.668 . . . . 0.0 112.697 -176.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -127.22 81.08 1.99 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 124.084 1.897 . . . . 0.0 108.83 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 p -79.57 -64.14 1.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.209 2.603 . . . . 0.0 107.58 178.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -72.85 174.22 8.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.578 1.551 . . . . 0.0 109.711 169.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -60.53 -36.82 79.32 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.85 -0.531 . . . . 0.0 109.974 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.12 136.28 57.54 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.48 1.512 . . . . 0.0 107.991 169.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 117.55 4.34 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 122.44 2.093 . . . . 0.0 107.622 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -72.99 -18.87 61.31 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.763 -0.586 . . . . 0.0 110.297 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.03 155.88 49.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.919 1.288 . . . . 0.0 107.974 168.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.3 -14.77 14.1 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.975 2.11 . . . . 0.0 110.808 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.02 154.55 25.56 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.68 149.88 51.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.43 164.96 33.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -121.88 132.44 54.57 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.28 162.48 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.166 1.386 . . . . 0.0 111.984 -168.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.7 m -69.07 157.56 36.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 109.567 169.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.95 78.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 112.651 -171.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -91.31 -27.9 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.241 -0.912 . . . . 0.0 112.969 -169.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -51.34 -46.92 89.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.99 -25.4 59.29 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.14 1.8 . . . . 0.0 113.152 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.62 -41.3 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.318 0.0 OUTLIER -74.16 -5.53 42.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.273 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -95.01 -15.93 23.13 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.338 -0.839 . . . . 0.0 113.129 -174.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 m -104.16 172.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.624 1.102 . . . . 0.0 111.771 -175.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.5 m -73.27 166.61 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.905 0.882 . . . . 0.0 109.584 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -52.67 -50.54 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.048 1.739 . . . . 0.0 114.188 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -69.69 -33.12 72.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.656 -0.652 . . . . 0.0 110.888 -175.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -76.81 -37.26 56.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.375 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -51.4 -47.03 63.07 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.008 0.822 . . . . 0.0 109.915 173.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.55 -42.97 99.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.868 0.304 . . . . 0.0 110.791 -176.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.69 -50.79 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -58.61 -41.98 87.1 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.607 0.763 . . . . 0.0 109.027 -176.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.98 -52.93 63.66 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.679 0.792 . . . . 0.0 110.345 176.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -54.9 -49.55 70.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.68 -43.77 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.087 0.858 . . . . 0.0 110.491 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.8 mmt -69.8 -52.44 25.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -173.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -30.59 71.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.218 0.917 . . . . 0.0 112.234 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -45.31 85.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.793 0.724 . . . . 0.0 110.616 177.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -106.11 -11.41 16.11 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.01 66.83 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.169 1.788 . . . . 0.0 110.652 -174.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -67.11 -31.64 72.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.591 0.756 . . . . 0.0 110.465 -174.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.91 -45.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.3 -44.38 92.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.054 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -47.49 82.91 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 120.453 1.479 . . . . 0.0 110.056 -177.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.7 t -68.61 -31.23 70.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.712 0.405 . . . . 0.0 111.077 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.29 -38.63 91.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.124 1.369 . . . . 0.0 110.464 176.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -67.19 -44.15 80.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.803 0.274 . . . . 0.0 110.332 173.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.237 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.89 144.52 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 164.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.43 -66.16 0.59 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.096 0.872 . . . . 0.0 110.188 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -164.16 -53.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.918 0.487 . . . . 0.0 110.093 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.04 16.66 17.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 123.625 1.678 . . . . 0.0 110.746 -164.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.71 2.16 65.29 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 120.206 -1.558 . . . . 0.0 112.704 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -97.12 159.24 15.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.272 1.536 . . . . 0.0 109.035 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.16 142.03 28.66 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -80.93 144.59 15.21 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.934 1.756 . . . . 0.0 110.648 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.25 154.98 41.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.55 158.26 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.961 0.904 . . . . 0.0 109.126 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.16 162.1 26.81 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.27 144.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -172.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -128.17 136.46 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 mm -116.19 137.46 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 167.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 101' ' ' LEU . 2.1 p -124.12 162.31 23.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.543 1.639 . . . . 0.0 112.69 161.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -106.14 172.65 6.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.047 -2.342 . . . . 0.0 108.834 172.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.0 5.48 6.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -94.1 0.29 55.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.716 0.806 . . . . 0.0 110.975 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.45 21.81 76.73 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.551 0.614 . . . . 0.0 112.196 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -95.15 147.25 23.65 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.8 145.98 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ttm -67.02 145.48 55.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.592 -1.185 . . . . 0.0 107.897 169.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.807 ' HE1' ' HB3' ' A' ' 33' ' ' TRP . 1.8 t90 -144.23 141.14 29.68 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.438 ' N ' ' CD1' ' A' ' 24' ' ' TRP . . . -133.28 167.28 20.68 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 123.52 1.629 . . . . 0.0 115.331 173.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -125.27 124.24 41.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 120.97 -1.081 . . . . 0.0 108.669 -175.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -75.01 148.76 39.6 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.167 -169.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -54.77 132.89 46.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.292 1.62 . . . . 0.0 109.953 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -7.57 5.15 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.446 -1.196 . . . . 0.0 114.395 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -88.17 177.7 6.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -132.95 13.76 4.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.472 0.654 . . . . 0.0 109.853 165.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.89 154.49 21.51 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.807 ' HB3' ' HE1' ' A' ' 24' ' ' TRP 0.286 91.7 m95 -120.72 154.29 35.81 Favored 'General case' 0 N--CA 1.399 -2.977 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.715 -165.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.11 167.76 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.139 1.775 . . . . 0.0 110.952 -170.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -81.48 146.08 56.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.02 160.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -56.23 135.19 68.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.227 2.618 . . . . 0.0 110.666 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -159.53 171.09 20.3 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.236 0.926 . . . . 0.0 111.356 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.04 171.36 44.39 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.972 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.12 147.28 24.55 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.656 -0.908 . . . . 0.0 111.179 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 84.1 mt -74.25 123.12 28.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 165.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.32 155.71 91.16 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.9 124.74 15.54 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 N-CA-C 109.451 -1.019 . . . . 0.0 109.451 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.01 -9.81 76.77 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.803 -0.998 . . . . 0.0 114.322 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.35 151.71 44.93 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 119.683 1.742 . . . . 0.0 111.045 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.11 161.28 18.96 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 161.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.86 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 122.062 -0.398 . . . . 0.0 111.213 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.98 -35.06 74.14 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.971 -0.456 . . . . 0.0 111.016 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -70.08 -43.77 70.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.863 -1.148 . . . . 0.0 109.687 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.99 78.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 123.975 0.797 . . . . 0.0 109.557 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.483 ' SD ' HD13 ' A' ' 102' ' ' LEU . 13.3 tmm? -62.54 -48.86 77.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.487 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 35.0 m-85 -68.08 -38.3 82.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.87 0.759 . . . . 0.0 111.338 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.4 ttm-85 -60.07 -55.59 32.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.23 -28.52 64.24 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 tp -54.66 -48.33 72.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 120.442 -1.411 . . . . 0.0 109.699 169.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -60.28 -45.17 94.26 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 117.318 -1.325 . . . . 0.0 109.213 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.97 -31.9 73.36 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.586 1.539 . . . . 0.0 111.652 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -91.67 -49.23 6.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.282 0.947 . . . . 0.0 110.06 -171.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.92 -10.83 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 124.498 1.119 . . . . 0.0 112.27 -168.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.92 1.09 37.71 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 123.824 0.726 . . . . 0.0 113.918 -173.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD2' HD23 ' A' ' 104' ' ' LEU . 58.0 tp -83.23 150.33 26.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.075 1.35 . . . . 0.0 108.682 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.48 168.45 15.63 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.095 0.95 . . . . 0.0 108.731 -175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.487 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 28.4 mtt180 -48.7 -31.87 7.53 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 28.9 mmmt -61.78 -31.14 71.32 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.703 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -114.53 23.52 12.67 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 126.728 2.517 . . . . 0.0 108.23 -168.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.26 162.69 33.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 O-C-N 120.439 -1.413 . . . . 0.0 111.127 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.04 138.09 38.47 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 117.845 -1.074 . . . . 0.0 108.206 165.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.31 119.66 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.0 mt -98.67 -32.47 11.39 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.649 0.593 . . . . 0.0 110.872 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.5 165.56 35.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.5 p -157.3 157.52 34.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.726 1.21 . . . . 0.0 108.738 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -70.64 136.33 49.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.267 1.032 . . . . 0.0 110.633 -174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -81.98 -37.99 25.81 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.468 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -104.34 153.45 21.03 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.004 1.322 . . . . 0.0 108.139 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -84.24 134.91 34.52 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.026 -1.047 . . . . 0.0 108.425 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -89.31 98.71 11.92 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -97.92 147.64 24.26 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.88 153.63 39.36 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.717 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.13 143.49 27.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.488 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.13 150.94 83.56 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 123.863 0.727 . . . . 0.0 109.267 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.05 149.19 71.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.692 2.261 . . . . 0.0 109.225 160.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -67.9 -18.29 64.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -167.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -59.17 -30.56 68.28 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.953 -0.546 . . . . 0.0 112.003 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.38 -19.11 21.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.222 0.609 . . . . 0.0 111.09 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.5 136.55 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.15 75.44 1.37 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.079 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -56.3 -23.11 34.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -73.61 -28.18 61.68 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.078 0.551 . . . . 0.0 111.911 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.3 t -104.82 164.65 11.63 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.441 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -133.05 136.93 28.41 Favored Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.87 149.79 83.89 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 -16.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.97 136.53 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.104 0.961 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.4 p -88.05 132.29 34.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -12.54 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.118 0.567 . . . . 0.0 112.004 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.15 -177.69 41.15 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -153.58 158.1 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -105.48 134.91 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -117.58 130.92 56.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.898 1.279 . . . . 0.0 110.129 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -110.65 136.87 49.08 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -117.83 156.96 27.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -142.25 128.1 19.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.193 1.397 . . . . 0.0 107.748 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 16' ' ' CYS . 1.2 tp -95.6 127.34 41.55 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.483 HD13 ' SD ' ' A' ' 50' ' ' MET . 5.9 mt -115.84 152.57 33.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -100.69 134.85 43.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 159.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.443 HD23 ' CD2' ' A' ' 60' ' ' LEU . 1.6 mt -62.64 135.16 57.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 125.51 1.756 . . . . 0.0 109.298 169.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.5 t -88.72 -51.49 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -171.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -82.81 -17.3 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.8 0.727 . . . . 0.0 111.739 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.33 175.22 35.91 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.404 ' HB2' ' HE1' ' A' ' 126' ' ' TRP . 0.0 OUTLIER -51.89 -21.27 2.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.707 2.403 . . . . 0.0 114.301 -165.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.02 -31.24 40.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.334 1.454 . . . . 0.0 112.456 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.54 19.42 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.847 0.832 . . . . 0.0 112.503 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.17 135.74 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.51 -1.369 . . . . 0.0 108.385 171.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -134.35 109.11 8.58 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 125.724 1.609 . . . . 0.0 107.855 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.02 9.3 20.04 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.99 -1.069 . . . . 0.0 112.651 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 77.04 1.69 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 124.061 1.886 . . . . 0.0 107.777 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -73.75 -60.72 2.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.072 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -72.6 168.58 18.34 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.017 168.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.0 m -58.5 -39.2 79.4 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.954 -0.466 . . . . 0.0 110.446 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 132.6 62.67 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.38 133.59 50.14 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.587 1.524 . . . . 0.0 109.626 164.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -75.25 -26.76 59.11 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.903 0.858 . . . . 0.0 110.792 173.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -118.86 144.97 46.05 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 120.805 -1.185 . . . . 0.0 108.424 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.16 -31.05 22.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.007 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.76 158.95 27.93 Favored Glycine 0 C--N 1.335 0.524 0 O-C-N 120.689 -1.257 . . . . 0.0 111.012 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.73 155.15 42.18 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -150.89 165.59 33.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 108.304 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.404 ' HE1' ' HB2' ' A' ' 108' ' ' ASP . 67.3 m95 -112.78 137.93 50.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.45 152.97 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.94 1.296 . . . . 0.0 109.201 -168.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -59.97 147.47 38.79 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 117.178 -1.391 . . . . 0.0 109.536 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.12 66.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -93.06 -22.93 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.023 -1.048 . . . . 0.0 112.404 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.6 -37.79 55.01 Favored Pre-proline 0 CA--C 1.514 -0.415 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.009 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.637 ' CB ' ' CE3' ' A' ' 24' ' ' TRP . 10.9 Cg_endo -67.54 -37.18 17.6 Favored 'Trans proline' 0 N--CA 1.413 -3.254 0 N-CA-C 117.242 1.978 . . . . 0.0 117.242 -173.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.92 -25.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 112.73 -2.032 . . . . 0.0 109.115 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.02 -32.23 73.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.128 -1.607 . . . . 0.0 113.676 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 -24.82 33.19 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 124.075 0.859 . . . . 0.0 111.5 -168.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.53 167.08 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 122.008 0.908 . . . . 0.0 111.041 -171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.18 172.55 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 120.892 -1.13 . . . . 0.0 109.987 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 m -51.03 -50.0 59.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -79.34 -30.88 42.92 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.224 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -70.6 -38.44 74.01 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.004 -1.06 . . . . 0.0 110.374 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.41 -45.18 62.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.105 0.962 . . . . 0.0 111.866 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.35 -47.52 85.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.043 1.464 . . . . 0.0 108.463 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.38 -51.53 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.199 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -63.67 -37.77 88.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.068 0.849 . . . . 0.0 110.834 -169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -68.02 -38.81 83.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.432 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -58.82 -49.27 78.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.614 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.36 -39.14 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.623 1.169 . . . . 0.0 110.244 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -74.17 -55.47 6.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -36.45 74.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.624 0.647 . . . . 0.0 111.574 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 151' ' ' PHE . 4.6 tp10 -61.51 -30.82 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.791 0.836 . . . . 0.0 110.7 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 150' ' ' GLU . 0.8 OUTLIER -113.49 -13.41 12.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 0.0 109.798 -172.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.69 71.92 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.684 1.593 . . . . 0.0 110.848 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 m -66.24 -33.58 76.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.577 0.751 . . . . 0.0 111.029 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.8 t -68.86 -43.02 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.515 HG21 ' HG ' ' A' ' 16' ' ' CYS . 27.4 t -59.37 -42.24 86.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.587 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmt -55.96 -52.92 62.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.079 1.309 . . . . 0.0 109.384 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -68.63 -29.12 67.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.063 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.479 ' O ' ' CD ' ' A' ' 163' ' ' PRO . 14.1 tp -69.09 -23.09 63.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.659 1.584 . . . . 0.0 111.596 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.92 -24.85 40.8 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 117.662 -3.149 . . . . 0.0 111.212 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -97.97 -31.97 11.9 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 120.234 1.379 . . . . 0.0 114.156 -167.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.47 ' O ' ' HE2' ' A' ' 164' ' ' LYS . 7.8 m-80 -62.89 -18.41 62.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.154 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.423 ' O ' ' HE2' ' A' ' 164' ' ' LYS . 1.5 p 26.03 62.09 0.51 Allowed Pre-proline 0 CA--C 1.436 -3.42 2 C-N-CA 134.367 5.067 . . . . 0.0 97.748 -142.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.479 ' CD ' ' O ' ' A' ' 158' ' ' LEU . 13.8 Cg_endo -57.06 120.12 7.84 Favored 'Trans proline' 1 N--CA 1.385 -4.899 1 N-CA-C 100.11 -4.612 . . . . 0.0 100.11 -178.328 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 161' ' ' ASN 0.345 71.2 mmtt . . . . . 1 N--CA 1.378 -4.034 1 CA-C-N 100.314 -7.676 . . . . 0.0 103.665 -155.155 . . . . . . . . 4 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt -134.88 143.91 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -72.18 -72.87 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.704 0.684 . . . . 0.0 112.079 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -162.25 -49.96 0.04 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.284 1.034 . . . . 0.0 111.669 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -91.46 15.28 12.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.945 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.8 0.81 77.87 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.726 1.155 . . . . 0.0 113.787 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -95.39 162.62 13.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.349 1.074 . . . . 0.0 108.227 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.4 146.16 24.11 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.049 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.27 131.07 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.603 2.202 . . . . 0.0 111.526 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -128.51 157.97 39.69 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.381 1.472 . . . . 0.0 109.228 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.97 164.17 34.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.53 163.53 30.77 Favored Glycine 0 C--N 1.33 0.226 0 O-C-N 121.402 -0.811 . . . . 0.0 112.627 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.07 140.33 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 124.777 1.231 . . . . 0.0 108.582 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.22 137.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.5 mm -111.44 145.22 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.623 1.101 . . . . 0.0 108.054 169.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 p -120.72 150.32 41.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.632 0.773 . . . . 0.0 111.045 169.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -108.29 168.76 9.08 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.747 1.219 . . . . 0.0 108.191 170.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.28 3.82 6.7 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 119.915 -1.741 . . . . 0.0 113.606 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -88.51 -4.78 58.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.353 1.061 . . . . 0.0 110.892 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.26 13.55 83.17 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.896 -0.947 . . . . 0.0 112.296 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -81.9 147.85 29.08 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.175 1.487 . . . . 0.0 107.668 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 m -103.04 149.71 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.777 1.231 . . . . 0.0 108.815 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.67 142.45 30.76 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.147 0.979 . . . . 0.0 109.026 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -146.08 146.77 31.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.319 1.448 . . . . 0.0 108.617 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.43 166.66 29.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.026 1.285 . . . . 0.0 111.82 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -126.8 135.17 50.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.371 1.069 . . . . 0.0 108.828 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -64.96 154.79 36.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 109.7 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.91 128.62 38.0 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.89 0.23 90.1 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.415 -1.214 . . . . 0.0 113.962 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -112.23 150.25 31.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.474 1.637 . . . . 0.0 111.224 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -96.4 -16.2 21.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.154 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 p -83.98 134.68 34.64 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.277 1.431 . . . . 0.0 109.779 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -92.28 153.58 19.15 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.66 0.784 . . . . 0.0 110.729 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -150.39 156.89 42.35 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.967 1.707 . . . . 0.0 109.361 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.89 139.16 69.53 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.65 129.27 13.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.086 2.524 . . . . 0.0 111.455 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -155.43 158.26 38.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 112.598 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.47 -169.74 20.86 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.821 1.677 . . . . 0.0 110.327 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.55 145.99 18.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.43 1.491 . . . . 0.0 110.636 -172.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.26 135.51 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -81.22 156.19 71.72 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.63 121.29 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.07 -2.48 85.47 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.32 -1.267 . . . . 0.0 114.411 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.56 156.05 39.85 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 120.598 2.199 . . . . 0.0 110.286 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -93.08 152.81 19.06 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 168.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.69 80.63 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.302 -0.874 . . . . 0.0 111.837 -172.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.46 -36.43 78.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.61 0.764 . . . . 0.0 110.092 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -68.52 -41.64 79.67 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.04 89.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -60.06 -50.89 71.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.755 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 58.0 m-85 -67.06 -37.35 83.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.39 0.995 . . . . 0.0 112.068 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -63.43 -50.3 70.31 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.579 1.536 . . . . 0.0 109.172 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -71.59 -32.71 68.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -170.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 tp -53.77 -49.64 67.79 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.634 1.174 . . . . 0.0 110.147 169.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.29 -35.76 81.21 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.423 0.556 . . . . 0.0 110.651 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -70.12 -35.2 73.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.919 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.96 -38.38 5.35 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.553 1.07 . . . . 0.0 113.627 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 t -92.62 -31.74 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.196 0.999 . . . . 0.0 108.604 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 0.81 88.35 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.928 1.252 . . . . 0.0 112.743 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.8 tp -87.54 153.44 21.4 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.443 1.897 . . . . 0.0 109.615 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -128.74 166.08 19.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.713 1.205 . . . . 0.0 110.529 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 38.8 mtp180 -45.48 -41.43 9.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.228 1.811 . . . . 0.0 113.106 -172.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.94 -24.95 65.23 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.245 0.618 . . . . 0.0 111.902 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -102.74 9.71 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.528 0.731 . . . . 0.0 111.186 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.5 165.84 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.8 1.64 . . . . 0.0 112.08 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 136.3 31.13 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 168.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.5 mt -78.91 115.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.87 -31.19 13.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.372 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.21 163.92 39.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.28 1.032 . . . . 0.0 108.454 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 p -162.03 154.91 20.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 124.488 1.115 . . . . 0.0 108.835 170.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 p -69.44 132.18 45.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.92 0.866 . . . . 0.0 110.812 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -79.11 -27.44 42.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.248 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.45 151.4 38.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.201 2.2 . . . . 0.0 108.556 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -79.59 134.81 36.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 mt -94.94 129.14 42.1 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -133.16 148.41 52.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.88 1.218 . . . . 0.0 108.512 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.04 146.18 29.93 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.433 0.458 . . . . 0.0 109.774 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.81 146.23 24.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.99 145.75 91.99 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 111.111 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.92 146.99 60.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 N-CA-C 104.982 -2.738 . . . . 0.0 104.982 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -68.89 -12.61 61.76 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.075 -1.641 . . . . 0.0 113.994 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.43 -31.73 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.026 0.83 . . . . 0.0 112.81 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.0 mt -91.79 -20.3 21.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.682 0.793 . . . . 0.0 112.03 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.1 135.81 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -103.16 91.28 4.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.302 1.041 . . . . 0.0 110.071 171.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.65 -23.65 64.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.962 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.73 -33.87 71.29 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.789 0.435 . . . . 0.0 111.801 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -100.01 158.34 15.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.948 0.899 . . . . 0.0 109.576 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -130.63 134.69 26.33 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.434 1.494 . . . . 0.0 109.905 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.45 148.98 91.37 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 O-C-N 122.755 0.871 . . . . 0.0 109.928 -10.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.7 p -78.05 133.81 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.496 0.718 . . . . 0.0 109.37 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.03 128.75 33.65 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.13 -12.09 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 119.03 -0.51 . . . . 0.0 112.022 169.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.25 -178.49 42.49 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -147.3 153.29 39.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.31 1.444 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -108.03 140.2 41.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -127.29 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.362 1.465 . . . . 0.0 108.694 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -133.5 117.97 17.78 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -103.1 158.25 16.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -134.0 125.59 28.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.329 1.451 . . . . 0.0 107.406 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.7 122.08 32.47 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mt -119.42 160.09 22.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -109.42 135.59 50.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 167.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 132.91 54.53 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.64 -53.88 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.5 m -78.44 -30.95 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 112.156 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.49 162.26 11.26 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.82 -18.44 43.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.418 1.487 . . . . 0.0 113.668 -173.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.71 48.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.442 0.697 . . . . 0.0 112.484 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 11.82 3.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.6 mt -91.43 134.94 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.43 -43.06 1.62 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.177 0.591 . . . . 0.0 112.354 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 mtp 66.73 13.38 9.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.664 2.386 . . . . 0.0 114.357 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.66 33.02 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 123.413 1.577 . . . . 0.0 112.423 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -51.47 69.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.396 1.478 . . . . 0.0 109.161 169.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 m -73.85 157.23 36.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.721 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -63.53 -36.85 85.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.073 0.463 . . . . 0.0 109.958 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 131.51 45.3 Favored Pre-proline 0 N--CA 1.443 -0.815 0 C-N-CA 125.259 1.424 . . . . 0.0 109.299 169.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.83 147.34 94.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.59 -11.66 39.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -133.33 152.04 51.9 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.519 1.128 . . . . 0.0 109.868 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.11 -2.36 13.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.441 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.86 146.09 12.87 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -150.8 138.96 20.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.269 1.428 . . . . 0.0 107.565 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.99 173.79 13.9 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.342 1.457 . . . . 0.0 109.085 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -119.79 142.21 48.79 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.92 164.05 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.495 . . . . 0.0 110.437 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -69.67 153.05 43.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 169.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -31.65 72.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -169.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -85.99 -27.56 24.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.316 1.416 . . . . 0.0 112.864 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -54.84 -49.88 89.26 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.563 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.27 -29.78 73.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.153 1.805 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.69 -31.9 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.224 -0.923 . . . . 0.0 110.136 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -66.6 -27.16 67.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.209 -0.932 . . . . 0.0 111.569 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -82.11 -23.94 35.41 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.09 159.81 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.313 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.78 179.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.074 1.749 . . . . 0.0 110.769 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.4 m -55.17 -53.44 55.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.405 1.882 . . . . 0.0 113.293 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.62 -41.86 78.92 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.561 . . . . 0.0 110.318 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.63 -43.44 63.23 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.109 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -59.55 -34.36 72.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.486 1.494 . . . . 0.0 111.8 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 -45.53 88.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.309 0.959 . . . . 0.0 111.314 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.27 -47.5 92.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -69.14 -34.95 75.82 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.234 1.014 . . . . 0.0 110.054 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -66.68 -39.24 88.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.655 1.116 . . . . 0.0 109.927 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.34 -46.6 89.36 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.764 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.6 t -56.88 -41.74 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 110.752 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -70.69 -53.83 14.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.02 -33.88 76.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.066 1.303 . . . . 0.0 111.915 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -53.45 -40.52 65.29 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.854 1.262 . . . . 0.0 111.214 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -110.04 -12.53 14.52 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.006 0.922 . . . . 0.0 112.259 -170.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.44 75.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.811 1.644 . . . . 0.0 110.488 -170.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -69.07 -32.76 72.45 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.444 0.698 . . . . 0.0 109.923 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.5 t -68.24 -45.24 83.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.99 -34.82 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.544 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 mmt -61.66 -57.57 11.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.833 1.197 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -70.1 -26.05 63.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.782 1.233 . . . . 0.0 111.004 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.33 -35.39 71.82 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 128.714 2.806 . . . . 0.0 111.67 170.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -71.2 -39.54 71.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.883 0.765 . . . . 0.0 110.67 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.27 -28.77 38.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.482 0.713 . . . . 0.0 112.061 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -114.31 -10.96 12.63 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.274 0.63 . . . . 0.0 112.29 -171.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.1 p 48.63 26.65 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.888 2.075 . . . . 0.0 114.327 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . 0.366 0.1 OUTLIER 12.95 49.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 1 C-N-CA 129.588 6.859 . . . . 0.0 118.815 -167.983 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.427 2.291 . . . . 0.0 111.441 174.688 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptm . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.16 143.19 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.53 -68.85 0.36 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.208 0.603 . . . . 0.0 111.281 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -163.9 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.096 0.958 . . . . 0.0 112.22 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.97 17.15 14.43 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.698 1.199 . . . . 0.0 112.858 -169.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.04 7.42 65.88 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.276 0.941 . . . . 0.0 113.787 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.26 157.95 16.03 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.19 149.3 72.27 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.4 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.56 138.92 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.208 1.938 . . . . 0.0 111.242 -173.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -140.8 151.97 44.81 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.367 1.067 . . . . 0.0 110.339 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.89 153.63 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.717 0.807 . . . . 0.0 109.66 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.88 157.39 24.75 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.85 141.99 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.426 1.09 . . . . 0.0 108.568 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.07 137.73 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -115.95 132.3 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.7 m -122.93 144.31 49.32 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -96.63 173.57 7.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.848 1.259 . . . . 0.0 108.666 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.76 9.96 5.58 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.833 -1.167 . . . . 0.0 113.59 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -99.09 0.22 43.17 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.693 0.797 . . . . 0.0 111.175 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.44 20.03 78.96 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.169 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -92.56 142.82 26.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.799 1.299 . . . . 0.0 107.786 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.39 143.12 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.013 1.725 . . . . 0.0 107.295 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -81.31 147.32 29.94 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.726 0.694 . . . . 0.0 109.465 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.0 t90 -151.86 140.48 20.75 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -171.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.46 149.76 51.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.771 1.169 . . . . 0.0 112.565 -169.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -98.44 120.23 38.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.252 1.821 . . . . 0.0 106.699 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -82.91 143.93 30.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.724 1.602 . . . . 0.0 109.616 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.45 132.79 54.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.426 0.69 . . . . 0.0 109.82 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.85 -9.71 16.41 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.925 1.25 . . . . 0.0 114.507 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -90.88 -39.79 12.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.556 1.678 . . . . 0.0 111.368 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.1 m80 57.5 31.66 20.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.162 0.985 . . . . 0.0 110.974 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -129.17 152.36 48.84 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.729 1.612 . . . . 0.0 108.337 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -104.09 146.62 28.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.267 0.627 . . . . 0.0 110.933 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -156.92 163.2 39.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.801 1.241 . . . . 0.0 110.808 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.16 144.5 44.19 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.014 -0.994 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.4 131.87 45.62 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.423 2.749 . . . . 0.0 112.475 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -158.2 167.81 28.78 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.643 0.656 . . . . 0.0 112.484 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.67 167.2 40.32 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.27 0.462 . . . . 0.0 112.207 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.72 146.47 32.61 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.82 127.28 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -78.41 152.57 78.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.12 120.13 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.7 1.6 . . . . 0.0 110.176 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.74 67.99 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.233 -1.315 . . . . 0.0 113.991 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.45 148.58 48.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 120.232 2.016 . . . . 0.0 110.231 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -84.27 153.76 23.37 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -38.67 76.91 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.778 -0.576 . . . . 0.0 111.909 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.91 -34.13 74.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.733 0.813 . . . . 0.0 110.248 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -73.12 -36.12 66.67 Favored 'General case' 0 C--N 1.337 0.045 0 O-C-N 120.89 -1.131 . . . . 0.0 109.908 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.92 90.84 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.8 ttp -58.82 -49.23 78.47 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.999 0.818 . . . . 0.0 109.036 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 49.8 m-85 -66.12 -46.24 78.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.679 1.127 . . . . 0.0 111.584 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -67.6 -45.31 75.84 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.277 0.944 . . . . 0.0 110.17 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -69.49 -34.54 74.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -57.0 -44.86 83.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.848 1.204 . . . . 0.0 110.323 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -61.27 -41.01 96.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.552 0.614 . . . . 0.0 110.212 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.92 -21.53 65.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.312 0.645 . . . . 0.0 112.232 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.39 -60.85 1.63 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.609 1.164 . . . . 0.0 109.629 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 m -112.44 0.69 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.501 1.52 . . . . 0.0 111.972 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.31 48.4 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.376 -1.452 . . . . 0.0 113.897 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -82.41 144.79 30.25 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.416 1.486 . . . . 0.0 110.2 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -123.98 165.5 17.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.34 1.056 . . . . 0.0 109.633 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 50.4 mtt85 -47.73 -35.55 9.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 112.495 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.27 -22.34 66.84 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.403 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.62 22.59 12.62 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.1 164.99 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.758 -1.214 . . . . 0.0 111.869 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 140.72 33.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 116.982 -1.485 . . . . 0.0 107.962 169.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.44 116.28 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.5 -36.01 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.229 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.98 32.54 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.016 0.926 . . . . 0.0 110.456 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -151.66 149.08 28.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.079 1.752 . . . . 0.0 109.42 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -70.81 139.88 51.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.748 1.158 . . . . 0.0 109.786 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -93.2 -29.22 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.332 1.053 . . . . 0.0 109.862 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -110.48 149.61 30.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.471 2.308 . . . . 0.0 107.864 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -82.76 143.03 31.14 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -87.78 91.19 8.66 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 139.35 52.31 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -137.25 153.6 50.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.579 0.752 . . . . 0.0 110.209 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -131.34 138.04 49.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.51 1.924 . . . . 0.0 108.151 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.99 146.9 69.01 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.828 0.851 . . . . 0.0 110.694 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.1 145.94 68.78 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 N-CA-C 104.601 -2.884 . . . . 0.0 104.601 166.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.38 -13.27 62.17 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.031 -1.668 . . . . 0.0 113.835 -169.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -58.81 -30.64 67.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.953 0.797 . . . . 0.0 113.071 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.45 -20.29 21.15 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 112.134 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.24 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -102.83 89.57 3.51 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.959 0.904 . . . . 0.0 109.76 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -67.19 -24.84 65.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.716 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.34 -33.84 71.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.798 0.439 . . . . 0.0 111.747 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -99.36 159.33 15.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.042 0.937 . . . . 0.0 109.398 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -130.79 134.44 26.0 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 125.152 1.381 . . . . 0.0 109.466 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.47 148.23 89.67 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.719 0.852 . . . . 0.0 110.428 -10.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -77.76 139.08 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.675 0.79 . . . . 0.0 109.613 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.1 p -90.43 120.58 31.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.87 0.868 . . . . 0.0 108.89 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -13.09 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 118.848 0.749 . . . . 0.0 112.751 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 -171.47 34.19 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -157.9 167.71 29.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.762 1.225 . . . . 0.0 109.552 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -115.58 127.6 55.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -114.34 129.0 56.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -111.74 139.13 47.47 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -123.19 153.34 40.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.97 128.48 24.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.59 122.5 37.25 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.08 156.83 24.46 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -106.73 129.7 54.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 167.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.76 139.69 58.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.1 1.36 . . . . 0.0 108.52 171.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.99 -44.99 14.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.043 0.383 . . . . 0.0 110.698 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.9 m -87.05 -16.06 36.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.571 0.748 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.56 -167.79 24.82 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.445 ' HB2' ' HE1' ' A' ' 126' ' ' TRP . 1.1 p-10 -60.92 -17.66 52.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.485 1.514 . . . . 0.0 114.698 -171.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.24 47.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.116 0.966 . . . . 0.0 111.774 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.49 50.96 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.829 1.252 . . . . 0.0 110.527 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.9 mt -129.93 129.82 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -113.22 161.56 17.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.391 2.276 . . . . 0.0 106.66 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mmt -126.48 -9.2 6.29 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.029 1.332 . . . . 0.0 111.872 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.35 84.13 2.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 123.718 1.723 . . . . 0.0 107.38 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 -61.12 2.11 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.348 2.659 . . . . 0.0 107.59 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 m -73.22 173.98 8.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.726 1.611 . . . . 0.0 109.009 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m -59.94 -36.81 77.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.496 -0.752 . . . . 0.0 109.807 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 137.05 57.33 Favored Pre-proline 0 N--CA 1.444 -0.772 0 C-N-CA 125.928 1.691 . . . . 0.0 109.133 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.02 133.54 47.87 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 107.212 -1.88 . . . . 0.0 107.212 168.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -85.07 -35.73 21.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -110.98 145.86 37.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.79 -29.24 25.58 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.806 0.842 . . . . 0.0 110.41 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.25 169.49 41.03 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.47 159.99 44.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.772 0.786 . . . . 0.0 109.655 169.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -143.95 169.35 17.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.827 1.251 . . . . 0.0 108.888 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.445 ' HE1' ' HB2' ' A' ' 108' ' ' ASP . 75.4 m95 -111.99 139.43 47.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.58 152.85 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.002 1.321 . . . . 0.0 110.648 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -62.94 143.78 57.39 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -32.31 44.73 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -169.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.99 -18.22 31.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.553 1.07 . . . . 0.0 112.947 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.38 -46.22 70.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.422 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.35 -29.39 85.73 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.774 2.026 . . . . 0.0 112.017 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.4 t -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.899 1.279 . . . . 0.0 109.924 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.263 -0.898 . . . . 0.0 111.443 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -94.31 -21.62 18.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.58 154.01 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 119.031 0.832 . . . . 0.0 110.491 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.58 178.42 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.052 1.341 . . . . 0.0 110.478 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.9 m -55.73 -47.15 77.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.868 1.667 . . . . 0.0 113.236 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -71.73 -45.73 60.83 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.987 -0.446 . . . . 0.0 110.451 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.57 -39.95 73.59 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.679 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -59.71 -31.44 69.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.745 1.157 . . . . 0.0 112.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.19 -43.21 95.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.495 1.043 . . . . 0.0 111.05 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.4 t -62.71 -50.3 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.76 -38.41 90.99 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.919 0.782 . . . . 0.0 109.644 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -65.98 -41.15 91.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.696 1.134 . . . . 0.0 110.243 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -59.6 -49.38 78.0 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.037 0.835 . . . . 0.0 109.615 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.29 -37.59 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.736 1.214 . . . . 0.0 110.977 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.3 mmt -74.28 -54.83 6.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -59.85 -34.14 72.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.42 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.71 -42.11 83.12 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 110.763 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.77 -10.24 19.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.668 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.34 67.48 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.354 1.462 . . . . 0.0 110.559 -171.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 m -68.13 -32.72 73.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.386 0.675 . . . . 0.0 110.548 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.64 -42.81 62.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.4 t -57.29 -38.99 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 117.434 -1.27 . . . . 0.0 110.175 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -62.06 -51.68 66.97 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.472 1.487 . . . . 0.0 111.092 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.4 m -77.23 -24.03 51.27 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.812 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 tp -55.8 -48.66 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.138 1.775 . . . . 0.0 109.359 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -60.27 -33.99 73.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.535 0.734 . . . . 0.0 111.601 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -85.42 -17.87 35.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.819 1.248 . . . . 0.0 111.731 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -96.71 -46.0 6.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.283 1.033 . . . . 0.0 109.101 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.256 46.8 p -88.83 -162.08 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -106.52 -179.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.697 2.931 . . . . 0.0 111.65 -176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.558 179.406 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.315 4.9 ppp? . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.767 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 64.81 129.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.71 2.404 . . . . 0.0 109.833 -169.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.31 -66.7 0.53 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.43 -51.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.05 17.28 14.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.476 1.11 . . . . 0.0 113.385 -169.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.56 62.71 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.12 0.866 . . . . 0.0 113.658 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -103.84 159.44 15.64 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.682 1.241 . . . . 0.0 107.731 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 149.86 64.38 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.25 -1.357 . . . . 0.0 107.834 170.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -91.41 141.52 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.899 1.732 . . . . 0.0 109.425 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -130.1 160.18 34.53 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.253 -0.904 . . . . 0.0 110.455 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.23 167.37 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -159.0 151.9 22.89 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -128.88 142.88 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.444 1.098 . . . . 0.0 108.586 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.77 136.37 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mm -120.37 132.9 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 m -124.2 150.84 44.77 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.492 0.587 . . . . 0.0 111.37 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -109.17 173.41 6.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.409 1.484 . . . . 0.0 108.816 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -74.94 0.17 16.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.11 -1.619 . . . . 0.0 113.002 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -88.68 -3.47 58.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 111.419 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.63 18.63 77.36 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 118.835 0.743 . . . . 0.0 111.48 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -86.13 139.73 30.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 m -108.79 143.82 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 125.514 1.526 . . . . 0.0 107.53 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -79.65 143.07 34.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -146.22 144.18 29.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.03 157.17 46.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.044 0.838 . . . . 0.0 111.557 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -111.53 119.07 37.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -72.48 151.31 42.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.297 1.408 . . . . 0.0 110.261 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.35 148.24 47.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.795 0.838 . . . . 0.0 109.633 -175.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 3.36 50.12 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.7 -1.056 . . . . 0.0 113.569 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.81 159.93 40.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.161 1.481 . . . . 0.0 110.577 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -94.11 -22.15 18.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 m -73.52 154.47 39.86 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.145 0.978 . . . . 0.0 111.63 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -106.45 152.57 23.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.222 1.009 . . . . 0.0 109.978 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -148.73 156.8 42.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.943 1.297 . . . . 0.0 110.778 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -80.62 140.64 51.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.35 137.7 82.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.768 1.645 . . . . 0.0 111.118 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -157.18 171.01 21.2 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.214 0.915 . . . . 0.0 112.198 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.05 -168.79 34.01 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -109.17 150.89 17.2 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.411 1.482 . . . . 0.0 109.943 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.29 119.57 34.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -77.1 159.03 79.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.61 127.9 28.12 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.664 1.576 . . . . 0.0 110.246 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.18 -5.47 79.98 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.395 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.55 148.11 37.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.158 1.979 . . . . 0.0 109.471 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.8 m -90.07 157.91 17.57 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.33 77.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.079 0.854 . . . . 0.0 111.583 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.26 -37.68 78.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.734 0.814 . . . . 0.0 110.216 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -66.49 -41.45 88.91 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.1 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.62 85.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -56.32 -50.86 70.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.612 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.451 1.023 . . . . 0.0 110.566 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -64.76 -47.0 79.79 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.453 1.024 . . . . 0.0 109.965 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.81 -31.99 67.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.6 -49.33 73.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.3 -40.92 95.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.008 0.822 . . . . 0.0 110.824 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.6 -26.66 68.5 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.728 -0.607 . . . . 0.0 112.222 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.15 -57.67 2.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.438 1.095 . . . . 0.0 110.451 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.72 0.64 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 112.383 -169.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.48 4.78 32.99 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.758 1.163 . . . . 0.0 113.702 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -84.1 146.58 27.82 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.303 1.841 . . . . 0.0 109.436 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 m -125.03 166.23 16.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.991 0.917 . . . . 0.0 109.76 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -52.93 -32.64 46.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.701 1.6 . . . . 0.0 112.476 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.37 -26.86 68.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.375 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -111.91 22.2 15.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.845 0.831 . . . . 0.0 112.209 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.18 165.06 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.707 -1.245 . . . . 0.0 111.7 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 140.86 40.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 mt -76.4 119.22 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -93.69 -35.34 12.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.81 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.578 0.751 . . . . 0.0 110.621 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 p -160.88 153.32 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.744 1.618 . . . . 0.0 109.897 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.08 139.06 54.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.783 0.801 . . . . 0.0 110.742 -170.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -94.62 -33.67 12.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -110.72 144.02 40.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.969 2.107 . . . . 0.0 107.327 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -85.51 141.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.39 72.03 7.04 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -71.6 154.29 41.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.36 151.08 50.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.503 1.121 . . . . 0.0 108.879 -169.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -130.48 132.18 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.696 1.598 . . . . 0.0 107.581 174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -80.9 141.77 51.46 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 124.378 1.071 . . . . 0.0 111.995 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.84 149.95 67.07 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 N-CA-C 104.762 -2.822 . . . . 0.0 104.762 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -68.99 -13.56 62.52 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.84 -1.788 . . . . 0.0 114.056 -169.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -62.37 -31.02 71.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.113 0.869 . . . . 0.0 112.558 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -93.73 -18.18 22.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.236 1.014 . . . . 0.0 112.009 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.71 135.02 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -98.1 90.5 4.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.794 0.838 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -71.52 -20.95 61.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.906 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.23 -30.12 57.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.885 0.474 . . . . 0.0 112.196 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.27 160.14 14.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.354 1.061 . . . . 0.0 109.234 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -130.96 133.66 25.03 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 125.783 1.633 . . . . 0.0 108.319 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.32 156.79 94.14 Favored 'Cis proline' 0 CA--C 1.539 0.757 0 O-C-N 122.805 0.897 . . . . 0.0 111.179 -10.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.0 t -74.16 140.33 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.941 0.897 . . . . 0.0 109.741 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 p -93.24 122.61 35.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.119 0.967 . . . . 0.0 108.97 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.15 -12.09 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 119.297 0.953 . . . . 0.0 113.213 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.51 -173.62 43.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -156.31 157.24 35.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.343 1.057 . . . . 0.0 110.173 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -102.72 128.21 49.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -124.58 129.15 50.03 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.531 1.06 . . . . 0.0 111.509 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -88.42 157.37 18.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.626 1.17 . . . . 0.0 108.558 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.47 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 82.5 m95 -133.8 147.26 51.23 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 168.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -131.19 134.69 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.938 1.295 . . . . 0.0 107.924 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.5 tp -96.63 118.45 33.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.79 140.26 49.06 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -89.11 133.3 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 168.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.26 139.71 58.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.397 1.079 . . . . 0.0 109.069 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.41 -48.74 13.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 118.238 0.472 . . . . 0.0 110.041 -171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.7 m -86.21 -18.44 32.14 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.883 0.473 . . . . 0.0 111.11 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.73 -169.0 22.92 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -55.73 -23.47 29.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.264 1.826 . . . . 0.0 113.345 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.39 51.3 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -89.85 14.52 11.81 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.78 138.51 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -124.07 131.6 53.57 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.57 1.948 . . . . 0.0 107.637 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.3 mmt -98.56 -7.65 27.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 112.497 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.69 75.29 0.98 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.436 1.895 . . . . 0.0 108.027 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -75.56 -65.61 0.88 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.978 2.111 . . . . 0.0 108.963 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.1 m -80.29 177.73 8.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.594 1.557 . . . . 0.0 109.483 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 m -56.57 -35.1 67.79 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.979 0.512 . . . . 0.0 110.361 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 128.94 49.37 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 107.87 169.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.92 122.95 10.37 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 169.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.74 -18.49 62.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -116.76 140.18 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.649 0.78 . . . . 0.0 110.374 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.69 -26.98 40.79 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 110.732 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.44 169.29 41.5 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 123.894 0.759 . . . . 0.0 111.315 -174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 160.63 43.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.768 0.827 . . . . 0.0 109.168 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -152.11 165.73 33.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.976 0.91 . . . . 0.0 108.954 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -110.65 133.86 52.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.24 152.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.838 1.255 . . . . 0.0 111.17 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.4 m -60.47 144.08 52.0 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.94 0.791 . . . . 0.0 109.628 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.15 -34.49 60.54 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -87.0 -7.93 57.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.974 -1.079 . . . . 0.0 113.486 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -75.52 -49.39 3.77 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.918 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.31 -21.6 72.23 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 123.044 2.123 . . . . 0.0 113.282 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.8 -35.92 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -68.97 -25.56 64.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.333 -0.855 . . . . 0.0 111.621 -169.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -83.36 -24.75 31.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.55 165.43 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 118.968 0.803 . . . . 0.0 111.07 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.36 175.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 110.166 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -57.42 -44.15 84.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.503 1.521 . . . . 0.0 113.875 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -70.3 -41.93 72.7 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.474 -0.766 . . . . 0.0 110.827 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -74.93 -35.0 62.18 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.233 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -49.33 -46.02 46.26 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.122 0.969 . . . . 0.0 110.462 170.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.28 -43.04 96.05 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.568 0.622 . . . . 0.0 111.089 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.86 -50.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -66.07 -34.75 78.77 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.055 0.942 . . . . 0.0 110.607 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -67.57 -41.31 84.36 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.808 1.186 . . . . 0.0 109.962 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.93 -43.54 98.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.299 0.954 . . . . 0.0 110.873 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.74 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.466 1.106 . . . . 0.0 111.542 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.1 mmt -84.33 -59.83 2.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.71 -34.45 67.47 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.362 1.065 . . . . 0.0 112.178 -173.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -57.61 -38.47 75.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.807 0.843 . . . . 0.0 110.727 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -109.78 -10.62 14.77 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 112.817 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.4 -38.99 72.27 Favored 'General case' 0 C--O 1.228 -0.031 0 C-N-CA 125.658 1.583 . . . . 0.0 110.545 -172.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -68.2 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.64 0.776 . . . . 0.0 110.443 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.7 -45.83 72.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.38 -46.32 92.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 117.627 -1.178 . . . . 0.0 110.236 -175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -43.48 85.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 121.435 1.925 . . . . 0.0 110.317 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.4 t -70.84 -32.13 69.07 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.218 -0.301 . . . . 0.0 111.124 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.0 tp -62.44 -43.28 99.19 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 126.198 1.799 . . . . 0.0 109.568 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -65.38 -43.75 89.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.667 0.387 . . . . 0.0 110.924 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.77 -35.75 70.16 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.508 0.723 . . . . 0.0 111.806 -169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -89.77 -29.87 18.38 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.101 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.321 14.1 t 40.76 60.92 7.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -169.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.48 177.09 5.74 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.377 2.718 . . . . 0.0 112.329 -168.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.138 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ttp . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 67.5 135.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 126.975 2.11 . . . . 0.0 109.697 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.93 -68.49 0.38 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.63 0.772 . . . . 0.0 110.192 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -164.14 -49.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.964 0.906 . . . . 0.0 113.23 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.2 17.13 14.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.688 1.195 . . . . 0.0 113.233 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.11 10.66 60.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.902 0.763 . . . . 0.0 113.38 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -101.09 155.04 18.22 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.53 31.42 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 117.534 -1.222 . . . . 0.0 109.354 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.76 137.68 16.24 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.469 1.446 . . . . 0.0 110.455 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -142.62 157.18 44.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.122 0.969 . . . . 0.0 109.291 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.25 161.2 35.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 121.267 -0.896 . . . . 0.0 109.669 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.9 163.0 28.35 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -121.65 143.31 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 124.522 1.129 . . . . 0.0 108.393 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.82 136.8 59.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -116.95 133.71 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -125.64 154.02 42.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.843 0.747 . . . . 0.0 111.576 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -104.23 175.16 5.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.002 1.321 . . . . 0.0 108.777 172.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 4.83 8.85 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.237 -1.54 . . . . 0.0 113.267 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -90.94 -2.54 57.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.435 1.094 . . . . 0.0 111.416 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.56 0.618 . . . . 0.0 111.848 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -89.0 144.06 26.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.0 m -115.2 150.02 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.498 1.519 . . . . 0.0 109.161 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 42.8 ttm -65.27 139.75 58.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.708 0.803 . . . . 0.0 108.964 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -142.88 136.92 29.15 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.01 154.57 51.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.712 1.142 . . . . 0.0 111.575 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -114.92 123.23 48.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -76.99 147.85 36.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 121.74 2.064 . . . . 0.0 110.681 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.63 129.67 43.07 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.83 0.08 87.56 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.86 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -110.96 164.42 12.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.216 1.508 . . . . 0.0 110.397 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -101.38 -24.57 14.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.228 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -80.36 159.16 25.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.783 1.233 . . . . 0.0 111.796 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -112.3 155.77 23.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.239 1.015 . . . . 0.0 111.674 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -160.58 164.26 32.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.0 1.72 . . . . 0.0 110.936 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -86.48 149.12 48.38 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.72 130.84 38.89 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.758 2.306 . . . . 0.0 111.951 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.67 161.5 34.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 112.218 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.71 171.58 44.52 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.222 0.439 . . . . 0.0 113.534 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.56 152.75 36.0 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.843 1.211 . . . . 0.0 111.755 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.84 130.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -77.22 157.99 80.17 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.29 123.55 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.98 -6.36 83.6 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.709 -1.051 . . . . 0.0 114.593 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.39 156.15 39.82 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 120.115 1.958 . . . . 0.0 109.439 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.0 p -91.94 166.95 12.45 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.0 81.34 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.782 -0.574 . . . . 0.0 110.815 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.22 -36.5 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.247 0.619 . . . . 0.0 110.582 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.01 -37.25 72.64 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.998 -1.064 . . . . 0.0 110.365 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.42 80.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.402 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.3 tmm? -65.62 -51.44 59.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.14 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -66.82 -31.62 72.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.41 1.459 . . . . 0.0 111.839 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -61.07 -52.03 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.411 1.005 . . . . 0.0 108.925 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -71.47 -27.26 63.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.562 0.619 . . . . 0.0 109.962 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.73 -43.88 90.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.928 -1.107 . . . . 0.0 109.388 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.45 -49.07 52.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.977 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.47 -28.94 68.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.656 1.117 . . . . 0.0 112.608 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -96.16 -52.51 3.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.162 0.985 . . . . 0.0 110.657 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.05 -29.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.543 1.137 . . . . 0.0 110.899 -168.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.3 84.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.447 1.023 . . . . 0.0 112.377 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 tp -78.66 154.15 30.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.172 1.789 . . . . 0.0 109.162 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -132.1 163.98 27.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 109.941 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -39.02 -41.78 0.81 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.9 2.48 . . . . 0.0 112.887 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -63.49 -29.23 70.53 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.77 0.828 . . . . 0.0 112.064 -170.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.5 23.36 13.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.575 0.702 . . . . 0.0 112.185 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.57 165.32 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 O-C-N 120.729 -1.232 . . . . 0.0 112.362 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.57 130.34 27.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.854 168.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mt -69.13 117.26 11.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.1 mt -95.92 -32.84 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.502 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.81 162.78 40.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.671 0.788 . . . . 0.0 109.267 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -159.19 155.05 26.42 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.888 1.275 . . . . 0.0 109.735 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 p -69.27 138.77 54.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.587 0.708 . . . . 0.0 110.525 -169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -86.9 -28.41 22.82 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.56 1.144 . . . . 0.0 109.801 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -119.97 149.67 41.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.394 2.278 . . . . 0.0 108.069 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -78.3 135.77 37.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.61 0.641 . . . . 0.0 109.489 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.3 mt -90.14 89.32 7.62 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -90.01 146.61 24.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -148.59 145.75 27.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 169.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 139.3 30.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.71 150.46 39.68 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.787 0.835 . . . . 0.0 109.302 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.24 158.14 52.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.219 3.28 . . . . 0.0 110.944 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -67.17 -19.37 65.57 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.82 -1.175 . . . . 0.0 112.941 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.84 -30.45 70.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.017 0.826 . . . . 0.0 112.888 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.2 mt -93.45 -14.19 27.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.182 0.993 . . . . 0.0 112.264 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.4 t -67.04 133.66 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -94.6 90.75 6.26 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.769 0.795 . . . . 0.0 109.628 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -71.43 -21.9 61.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.497 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.16 -13.26 59.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.743 0.817 . . . . 0.0 112.781 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -121.29 159.86 25.13 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.264 1.025 . . . . 0.0 109.986 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -127.74 131.54 23.87 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 125.522 1.529 . . . . 0.0 109.938 -173.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.19 149.45 93.15 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 O-C-N 122.741 0.864 . . . . 0.0 110.689 -10.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.01 141.46 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.067 0.947 . . . . 0.0 109.969 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.3 p -94.91 137.17 34.32 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.658 0.783 . . . . 0.0 110.762 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.61 -14.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 169.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.39 179.9 35.6 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.54 157.51 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.456 1.502 . . . . 0.0 108.589 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.92 128.66 56.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 170.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -113.3 131.57 55.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.935 0.789 . . . . 0.0 109.652 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -110.74 125.49 53.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -108.23 154.41 21.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.402 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 84.5 m-85 -135.53 127.12 28.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.43 120.19 31.34 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.8 131.41 56.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -86.79 134.55 33.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.49 141.81 58.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 109.014 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.28 -51.8 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.57 0.623 . . . . 0.0 109.826 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 m -83.76 -19.82 34.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.111 0.564 . . . . 0.0 111.742 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.44 -169.12 23.36 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -18.38 47.52 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.584 1.554 . . . . 0.0 114.157 -169.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 -31.73 48.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.041 . . . . 0.0 112.902 172.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.92 17.62 10.35 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.3 mt -94.9 134.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -120.34 -52.73 2.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.327 0.651 . . . . 0.0 112.252 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 70.56 7.77 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.887 2.475 . . . . 0.0 114.884 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -153.79 78.46 1.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 123.988 1.851 . . . . 0.0 109.616 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -59.73 2.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.12 -2.309 . . . . 0.0 107.997 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -67.97 165.11 18.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.19 1.396 . . . . 0.0 109.498 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -62.77 -33.31 74.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.973 0.509 . . . . 0.0 110.12 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.5 129.94 51.2 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 124.91 1.284 . . . . 0.0 110.2 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -65.58 143.84 76.63 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.083 1.855 . . . . 0.0 108.338 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -83.18 -17.53 42.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.021 -0.424 . . . . 0.0 111.308 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.48 140.69 49.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.136 0.88 . . . . 0.0 110.85 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.31 -29.74 57.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.159 1.384 . . . . 0.0 110.303 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.72 164.6 38.2 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.57 158.15 43.91 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.61 167.99 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -107.38 136.97 46.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 154.85 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.813 1.245 . . . . 0.0 110.126 -171.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -61.4 144.44 54.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.215 0.916 . . . . 0.0 109.403 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -27.39 57.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -88.61 -16.45 32.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.047 1.294 . . . . 0.0 112.985 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.85 -50.41 85.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.428 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.2 -25.85 42.77 Favored 'Trans proline' 0 C--N 1.35 0.638 0 CA-C-N 121.985 1.745 . . . . 0.0 112.65 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.24 -42.3 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.586 -0.696 . . . . 0.0 109.237 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -69.86 -7.8 43.19 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.605 -1.309 . . . . 0.0 114.227 -178.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.08 -28.21 39.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.147 0.885 . . . . 0.0 111.721 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.1 160.26 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.14 163.66 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.074 0.95 . . . . 0.0 108.88 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.1 m -54.21 -45.67 72.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -70.24 -34.52 72.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.993 1.27 . . . . 0.0 111.238 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -75.36 -44.6 44.18 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.896 -0.503 . . . . 0.0 109.936 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -48.04 -40.77 23.94 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.982 1.313 . . . . 0.0 112.752 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.47 -37.67 83.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.111 0.869 . . . . 0.0 111.963 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.09 -53.12 47.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -65.11 -32.52 74.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 112.225 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -65.76 -43.9 87.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.449 1.477 . . . . 0.0 110.606 170.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -44.72 93.4 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.541 1.064 . . . . 0.0 110.383 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.5 t -56.97 -31.96 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.593 1.157 . . . . 0.0 111.472 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.6 mmt -82.35 -59.62 2.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -31.96 69.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.463 0.705 . . . . 0.0 112.598 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.31 -39.58 76.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 112.18 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.89 -13.75 14.08 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.948 0.899 . . . . 0.0 111.416 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.54 -39.59 64.82 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 126.064 1.746 . . . . 0.0 110.631 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 m -66.52 -31.89 72.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.627 0.771 . . . . 0.0 110.903 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.86 -46.15 74.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.78 -40.46 79.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.434 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -55.31 -51.45 66.67 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 120.576 1.534 . . . . 0.0 109.85 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.0 -27.08 60.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.91 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 27.4 tp -62.5 -40.71 97.6 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.711 1.204 . . . . 0.0 109.937 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -60.41 -44.38 95.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.148 0.579 . . . . 0.0 110.173 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.23 -24.8 61.44 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.516 1.126 . . . . 0.0 113.24 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -85.87 -13.89 46.57 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.229 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.257 30.4 p 42.79 62.52 8.3 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 126.67 1.988 . . . . 0.0 109.536 -175.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.41 -178.49 1.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.016 1.811 . . . . 0.0 114.282 -168.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.958 0.903 . . . . 0.0 108.566 174.778 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptm . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.29 145.53 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 169.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -68.28 -66.49 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.337 0.655 . . . . 0.0 110.945 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -164.0 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.952 0.901 . . . . 0.0 112.918 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -95.76 17.2 15.56 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.446 1.098 . . . . 0.0 113.006 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.45 5.66 65.0 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.946 0.784 . . . . 0.0 113.656 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.85 154.81 17.38 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.55 148.46 67.54 Favored Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.935 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.86 141.06 14.89 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.319 2.012 . . . . 0.0 110.26 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -145.06 158.68 43.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.272 1.029 . . . . 0.0 109.733 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.95 159.64 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 O-C-N 121.201 -0.937 . . . . 0.0 109.718 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -139.85 156.71 25.0 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.53 141.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.999 1.32 . . . . 0.0 108.261 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.24 139.1 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 mm -116.74 142.79 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 117.243 -1.36 . . . . 0.0 107.568 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.8 p -119.82 154.5 34.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 111.493 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -111.57 171.01 7.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 108.972 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.01 0.52 11.13 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.038 -1.664 . . . . 0.0 114.049 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -88.35 -1.07 57.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.906 0.883 . . . . 0.0 111.053 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.55 17.18 76.2 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.583 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -86.26 145.73 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.72 149.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 109.244 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 ttm -63.84 139.85 58.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.718 0.807 . . . . 0.0 109.329 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -146.23 140.87 26.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.685 1.594 . . . . 0.0 106.804 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.15 146.1 40.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.437 1.472 . . . . 0.0 112.478 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -103.04 114.85 29.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.51 1.924 . . . . 0.0 105.845 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -76.1 147.96 38.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 120.448 1.476 . . . . 0.0 110.036 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -57.33 127.45 32.06 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.66 0.784 . . . . 0.0 110.123 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.04 -4.47 31.39 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.14 1.353 . . . . 0.0 114.841 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -87.66 -35.5 17.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.786 1.793 . . . . 0.0 111.851 -173.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.8 m80 54.99 31.04 15.24 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 112.104 -170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.1 m -138.36 154.59 48.94 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.528 1.931 . . . . 0.0 107.859 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -105.12 157.3 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -163.62 168.68 19.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.074 1.749 . . . . 0.0 109.706 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -87.49 149.45 46.62 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.15 131.17 35.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.461 2.107 . . . . 0.0 111.033 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -158.02 165.79 34.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.334 0.653 . . . . 0.0 111.47 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.88 168.0 40.42 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.951 -0.468 . . . . 0.0 113.09 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.46 152.62 51.96 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.2 mt -75.41 125.19 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 169.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.38 147.79 97.09 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.99 126.07 18.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.336 1.357 . . . . 0.0 109.521 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.75 89.15 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.962 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.09 165.05 25.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.032 1.916 . . . . 0.0 110.57 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -103.03 154.09 19.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.073 -1.876 . . . . 0.0 105.995 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.61 87.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.748 1.158 . . . . 0.0 111.589 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.41 -35.51 79.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.75 0.82 . . . . 0.0 109.882 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.47 -38.76 77.86 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.586 -0.696 . . . . 0.0 109.666 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.3 80.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.676 0.671 . . . . 0.0 109.673 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -60.84 -50.41 73.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -66.63 -38.48 87.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.604 1.093 . . . . 0.0 112.097 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -56.18 -50.45 71.15 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.898 0.879 . . . . 0.0 109.479 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.61 -30.6 59.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.215 -0.422 . . . . 0.0 110.239 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 tp -56.71 -45.35 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.518 1.054 . . . . 0.0 109.819 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.2 -31.69 66.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.2 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.96 -29.92 58.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.284 1.402 . . . . 0.0 112.811 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -99.42 -55.08 2.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.527 1.531 . . . . 0.0 110.809 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 -24.07 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 126.431 1.893 . . . . 0.0 111.131 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.73 -1.49 45.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.042 1.306 . . . . 0.0 113.515 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.72 155.34 35.73 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.048 1.739 . . . . 0.0 109.064 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -131.95 165.66 23.43 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.754 0.822 . . . . 0.0 110.092 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -50.91 -35.21 31.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.857 1.663 . . . . 0.0 112.974 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -64.7 -25.18 67.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.818 -173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -114.58 22.6 13.46 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.55 166.07 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.751 1.62 . . . . 0.0 111.972 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 141.72 33.49 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.7 mt -79.51 115.6 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.8 mt -88.84 -37.49 15.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.381 1.072 . . . . 0.0 110.643 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.21 165.25 36.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.999 0.92 . . . . 0.0 109.031 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 p -161.85 154.92 20.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.261 1.024 . . . . 0.0 110.231 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -70.64 136.3 49.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.641 0.734 . . . . 0.0 110.692 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -81.96 -28.37 32.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.304 1.442 . . . . 0.0 109.782 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -119.37 148.98 42.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.595 2.358 . . . . 0.0 108.233 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -81.81 137.89 35.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.44 104.81 16.77 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -102.06 147.11 26.99 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.66 147.79 30.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 169.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.29 141.93 28.02 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.45 147.98 85.42 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 123.861 0.864 . . . . 0.0 110.272 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.09 149.73 82.32 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 105.197 -2.655 . . . . 0.0 105.197 167.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -69.24 -12.29 61.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.834 -1.791 . . . . 0.0 114.24 -169.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -63.41 -32.53 74.0 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.034 0.833 . . . . 0.0 112.299 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.07 -19.99 20.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.071 0.948 . . . . 0.0 111.382 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.06 135.19 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -103.5 94.54 5.53 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 108.944 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -72.62 -23.0 60.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.763 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.88 -35.48 57.4 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -91.53 157.91 16.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.884 0.874 . . . . 0.0 108.946 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.93 135.54 27.64 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.513 1.525 . . . . 0.0 108.063 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.1 156.22 93.81 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 122.854 0.923 . . . . 0.0 111.002 -10.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.1 t -72.58 137.8 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.993 0.917 . . . . 0.0 109.543 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.7 p -89.95 117.25 28.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.68 -16.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.158 0.89 . . . . 0.0 113.025 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.49 -176.34 37.54 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -156.93 157.13 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.789 1.236 . . . . 0.0 109.016 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -106.93 130.63 54.57 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -113.07 135.48 53.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.783 0.833 . . . . 0.0 109.896 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -113.04 129.2 56.58 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.4 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.9 m95 -110.14 155.11 22.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.211 0.605 . . . . 0.0 109.538 -171.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.57 127.68 25.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.54 124.49 35.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 169.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.93 160.33 22.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -111.27 131.73 54.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 134.66 57.16 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 108.026 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.5 t -89.18 -53.57 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.467 1.03 . . . . 0.0 110.009 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.7 m -77.05 -21.64 54.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.222 0.609 . . . . 0.0 111.653 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.49 171.83 22.12 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -16.08 19.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.973 1.709 . . . . 0.0 113.983 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.07 19.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.139 0.976 . . . . 0.0 112.53 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -88.48 13.29 12.25 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.87 142.78 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -137.63 106.73 6.01 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 108.581 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.9 mmt -81.58 1.47 33.61 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -120.12 72.72 0.95 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 123.983 1.849 . . . . 0.0 107.459 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 p -65.07 -66.66 0.51 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 111.58 -2.554 . . . . 0.0 106.215 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 m -76.37 169.46 18.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 167.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.9 m -59.61 -40.75 88.56 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.41 132.58 83.74 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 125.304 1.442 . . . . 0.0 108.836 169.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.86 133.63 48.87 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.761 1.641 . . . . 0.0 108.002 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.44 -25.62 50.77 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.08 -0.388 . . . . 0.0 110.286 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.55 140.73 52.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.747 0.819 . . . . 0.0 109.769 175.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.25 -28.38 53.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.86 0.864 . . . . 0.0 110.323 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.63 161.21 32.08 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 155.21 41.01 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.84 168.9 19.68 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.416 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -109.68 134.85 51.5 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.33 153.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.813 1.245 . . . . 0.0 111.259 -169.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.9 m -61.01 143.37 55.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -24.55 62.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -87.05 -20.81 26.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.367 1.44 . . . . 0.0 113.273 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -60.95 -46.7 96.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 117.277 -1.344 . . . . 0.0 113.497 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.48 -30.43 86.64 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 122.524 1.937 . . . . 0.0 111.821 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.04 -29.94 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.141 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -69.59 -23.71 63.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.98 -1.075 . . . . 0.0 111.768 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -85.13 -11.17 55.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.47 167.11 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -74.72 174.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.652 1.181 . . . . 0.0 109.669 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.93 -54.99 38.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.738 . . . . 0.0 113.179 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -69.37 -40.28 77.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.22 0.918 . . . . 0.0 110.902 -171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -65.62 -55.21 18.81 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -60.73 -34.27 74.15 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.771 -174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.77 -40.53 95.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.957 1.253 . . . . 0.0 111.828 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.88 -52.53 59.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.63 -37.53 84.3 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.754 0.706 . . . . 0.0 110.726 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -56.9 -50.06 73.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.857 1.663 . . . . 0.0 109.959 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.8 -47.92 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.427 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -56.93 -42.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.932 1.242 . . . . 0.0 110.847 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.8 mmt -69.0 -51.38 39.88 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -33.55 76.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.408 1.004 . . . . 0.0 111.701 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.85 -43.72 90.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 119.193 0.906 . . . . 0.0 110.411 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -97.69 -12.74 22.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.6 -42.65 67.89 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.769 1.628 . . . . 0.0 110.627 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 m -70.87 -29.63 65.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.744 0.818 . . . . 0.0 111.047 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.92 -43.86 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.93 -44.11 86.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.537 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.25 66.13 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 121.536 1.971 . . . . 0.0 110.649 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -58.33 -30.97 67.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.96 1.704 . . . . 0.0 111.885 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.07 -23.9 51.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.505 1.522 . . . . 0.0 112.547 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -84.02 -44.12 14.46 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.866 0.841 . . . . 0.0 108.916 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.52 -45.46 87.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.575 1.95 . . . . 0.0 109.85 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . 0.366 0.5 OUTLIER 51.75 39.68 25.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.739 2.016 . . . . 0.0 112.666 -169.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -143.9 59.31 6.97 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 111.953 -2.385 . . . . 0.0 106.59 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -61.24 164.96 13.61 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 120.819 1.013 . . . . 0.0 110.043 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.543 -169.131 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.97 130.3 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 168.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.89 -67.17 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -164.09 -49.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 11.49 15.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.156 0.982 . . . . 0.0 112.721 -169.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.6 -5.8 83.51 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.464 1.031 . . . . 0.0 113.295 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -93.65 158.2 15.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.376 1.088 . . . . 0.0 108.751 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -139.14 137.03 18.63 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.016 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.02 136.04 4.07 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.403 2.068 . . . . 0.0 110.665 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -140.73 156.89 46.09 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.949 0.899 . . . . 0.0 109.709 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.76 153.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 123.778 0.831 . . . . 0.0 109.349 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -127.7 161.67 21.68 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.86 143.59 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.2 t -129.78 135.67 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.1 mm -115.16 133.74 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.4 m -116.79 144.07 44.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -101.4 173.14 6.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.191 0.997 . . . . 0.0 108.315 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -77.25 3.74 12.21 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.564 -1.335 . . . . 0.0 113.036 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -93.76 -4.42 50.36 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.515 1.126 . . . . 0.0 111.302 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.98 33.7 54.38 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -112.58 154.98 25.15 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.628 1.214 . . . . 0.0 108.51 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -115.63 152.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.883 2.073 . . . . 0.0 107.925 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 ptp -75.42 151.4 38.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.219 0.463 . . . . 0.0 110.49 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -146.45 132.95 19.72 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 149.1 46.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.137 1.335 . . . . 0.0 110.508 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -106.52 130.15 54.35 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.584 0.753 . . . . 0.0 109.934 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -76.33 146.39 38.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.705 1.139 . . . . 0.0 108.583 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -56.95 131.62 50.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.253 1.021 . . . . 0.0 110.111 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.99 -9.12 9.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.696 1.141 . . . . 0.0 114.692 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -93.47 -39.41 10.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.435 1.618 . . . . 0.0 110.843 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.0 m80 65.06 -23.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.266 2.226 . . . . 0.0 114.63 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -70.27 153.59 42.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.262 1.425 . . . . 0.0 109.759 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -102.88 153.22 20.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 111.718 -169.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.62 168.43 27.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.617 1.567 . . . . 0.0 110.49 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -86.64 152.71 54.8 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.55 133.48 37.21 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.092 1.861 . . . . 0.0 110.803 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.41 169.34 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.914 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.95 171.24 44.29 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.844 -0.535 . . . . 0.0 113.069 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.09 150.53 25.0 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.502 1.048 . . . . 0.0 111.496 -173.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.76 125.79 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.78 154.82 91.12 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.52 122.92 12.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 CA-C-N 120.804 1.323 . . . . 0.0 109.585 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.9 -3.96 85.78 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.521 -1.155 . . . . 0.0 114.749 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.78 156.95 38.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 120.135 1.968 . . . . 0.0 110.547 170.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -95.36 158.34 15.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.59 77.81 Favored 'General case' 0 C--O 1.224 -0.243 0 O-C-N 121.721 -0.612 . . . . 0.0 111.434 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.92 -37.59 79.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.55 0.74 . . . . 0.0 109.997 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -73.61 -35.62 65.38 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.46 92.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -60.87 -50.46 73.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.156 -0.926 . . . . 0.0 108.556 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 47.5 m-85 -66.01 -36.98 84.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.649 1.113 . . . . 0.0 112.41 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.1 ttm-85 -68.33 -50.44 53.3 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.826 1.193 . . . . 0.0 109.445 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.92 -27.75 61.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 tp -52.98 -48.02 67.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.456 0.702 . . . . 0.0 109.351 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.38 -42.5 99.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.779 0.718 . . . . 0.0 109.913 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.35 -28.27 69.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.366 0.985 . . . . 0.0 112.231 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.97 -57.91 2.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.579 0.751 . . . . 0.0 109.86 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.06 1.31 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.452 1.501 . . . . 0.0 112.216 -169.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.62 9.59 55.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.661 1.119 . . . . 0.0 113.39 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.74 150.15 20.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.056 2.142 . . . . 0.0 109.031 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 m -129.78 164.73 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.679 0.792 . . . . 0.0 109.903 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 53.0 mtt85 -45.29 -37.41 4.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.535 1.934 . . . . 0.0 113.12 -173.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.45 -30.35 71.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.873 -172.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.59 21.75 15.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.675 1.125 . . . . 0.0 112.505 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -131.38 165.11 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.246 1.418 . . . . 0.0 110.439 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -143.18 139.88 30.52 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 mt -79.59 121.64 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.12 -36.66 10.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.218 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.23 166.88 31.28 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.601 0.76 . . . . 0.0 109.295 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 p -162.47 155.47 19.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.394 1.077 . . . . 0.0 110.712 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 p -71.66 140.35 49.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.947 -170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.68 -49.64 12.79 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 144.37 26.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.817 1.647 . . . . 0.0 110.457 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -79.36 126.12 30.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.63 126.93 33.78 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -121.88 148.94 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -141.44 145.3 35.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -94.03 143.97 25.89 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.76 142.94 97.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 110.225 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.33 147.18 77.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 104.432 -2.949 . . . . 0.0 104.432 166.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . 0.252 86.6 mttt -68.82 -12.81 61.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.03 -1.669 . . . . 0.0 114.546 -168.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -30.27 70.21 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.47 -15.47 25.53 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.815 0.846 . . . . 0.0 112.435 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.72 133.54 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -100.47 91.79 4.85 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.378 1.071 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -69.92 -22.73 63.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.98 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.7 -25.96 54.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.414 0.686 . . . . 0.0 112.391 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -106.81 155.89 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.944 0.897 . . . . 0.0 109.152 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.46 135.14 27.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.543 1.137 . . . . 0.0 110.246 -169.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.76 150.32 94.03 Favored 'Cis proline' 0 N--CA 1.456 -0.691 0 N-CA-C 109.528 -0.989 . . . . 0.0 109.528 -10.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.3 p -71.2 133.89 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.493 0.717 . . . . 0.0 109.48 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 t -74.4 130.18 39.16 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.25 -13.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.203 169.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.84 47.95 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 120.1 1.318 . . . . 0.0 111.226 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.97 157.8 44.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.021 1.728 . . . . 0.0 109.96 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.36 137.22 44.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.73 130.34 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.553 1.141 . . . . 0.0 109.277 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -112.63 134.01 54.38 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.414 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 66.3 m95 -115.0 157.62 23.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.594 0.634 . . . . 0.0 109.839 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.88 125.33 23.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 108.28 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.29 121.93 31.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 168.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mt -118.68 152.24 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.56 135.29 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 167.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 131.73 50.5 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.56 -50.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 119.44 1.018 . . . . 0.0 109.724 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.9 m -79.29 -25.12 42.48 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.322 0.649 . . . . 0.0 111.696 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.3 169.89 16.02 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -20.19 15.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.51 1.924 . . . . 0.0 113.073 -170.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.95 -26.24 47.14 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.13 10.43 8.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.31 140.63 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -130.35 118.77 21.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.028 1.731 . . . . 0.0 106.899 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.6 mtp -90.17 -3.06 58.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.549 0.613 . . . . 0.0 112.625 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -119.19 71.84 0.88 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.512 2.101 . . . . 0.0 107.026 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 p -65.22 -63.6 1.06 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.879 -2.873 . . . . 0.0 106.435 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 m -78.23 172.73 13.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.365 1.466 . . . . 0.0 107.343 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.5 m -60.33 -41.38 93.42 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.38 135.19 86.6 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 125.433 1.493 . . . . 0.0 108.777 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.13 140.52 89.79 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.654 1.57 . . . . 0.0 109.444 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.26 -46.55 20.0 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.5 141.76 39.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.882 0.873 . . . . 0.0 109.71 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -87.67 -15.02 38.36 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.253 1.021 . . . . 0.0 111.257 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.93 150.22 17.9 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 121.584 -0.698 . . . . 0.0 111.878 -169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 51.2 p-90 -127.38 153.99 45.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.402 1.481 . . . . 0.0 108.484 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.36 141.84 24.33 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 168.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -102.55 123.65 46.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.0 161.57 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.062 1.345 . . . . 0.0 112.517 -168.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m -66.72 149.56 50.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.672 -0.642 . . . . 0.0 109.91 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -30.56 59.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.013 1.325 . . . . 0.0 112.584 -173.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -95.81 -2.47 47.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -76.34 -49.5 3.03 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.369 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.74 -32.52 93.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.495 1.927 . . . . 0.0 112.346 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -66.59 -21.87 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.275 -0.89 . . . . 0.0 112.301 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -69.08 -29.62 67.77 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -86.51 -26.83 24.37 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.47 163.12 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -69.72 173.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.971 1.308 . . . . 0.0 109.797 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.8 m -55.9 -54.24 47.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.749 1.62 . . . . 0.0 113.313 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -70.59 -39.94 73.56 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.854 -172.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.53 -49.03 67.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.15 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -63.69 -33.11 74.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.639 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.0 -47.32 77.91 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 119.098 0.863 . . . . 0.0 110.219 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.11 -49.58 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -61.76 -39.86 93.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.029 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.87 -38.74 76.49 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.896 1.68 . . . . 0.0 110.747 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.89 -45.58 94.01 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.852 0.751 . . . . 0.0 110.225 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.81 -40.02 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 110.565 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mmt -67.21 -49.35 64.88 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.279 1.5 tmtt? -59.86 -31.1 69.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.612 1.096 . . . . 0.0 111.879 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -60.78 -36.75 79.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.269 0.628 . . . . 0.0 110.697 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.83 -15.8 13.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.082 0.953 . . . . 0.0 113.187 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.43 -42.45 70.54 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.428 1.491 . . . . 0.0 110.883 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 m -68.04 -31.78 71.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.855 0.862 . . . . 0.0 110.687 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.28 -44.24 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.9 -40.95 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.831 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.6 mmt -55.77 -47.17 77.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.173 0.897 . . . . 0.0 110.537 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -80.27 -26.68 38.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.921 1.288 . . . . 0.0 111.041 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.4 -41.37 93.73 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.753 1.221 . . . . 0.0 110.142 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -57.29 -36.72 71.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.901 0.481 . . . . 0.0 110.931 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.67 -14.16 49.33 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 112.562 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -100.06 -27.97 13.29 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.456 0.702 . . . . 0.0 112.299 -169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.9 t -142.22 50.1 1.54 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.969 0.508 . . . . 0.0 110.697 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -72.21 -174.03 1.28 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.859 2.373 . . . . 0.0 110.439 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? . . . . . 0 C--O 1.255 1.353 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.398 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.36 144.62 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.76 -68.62 0.36 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.989 0.516 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -164.47 -49.76 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.768 0.827 . . . . 0.0 113.229 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.0 16.35 11.32 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 113.11 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.59 -2.13 82.34 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.391 0.996 . . . . 0.0 113.14 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.54 155.59 17.23 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.083 0.942 . . . . 0.0 108.507 169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -146.31 126.85 7.1 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 117.442 -1.266 . . . . 0.0 107.973 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -76.07 138.36 20.46 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.611 1.541 . . . . 0.0 111.581 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -139.71 154.67 47.52 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.266 1.026 . . . . 0.0 108.849 -171.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.88 162.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.606 -0.683 . . . . 0.0 109.61 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.5 163.37 28.2 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.14 142.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.07 136.49 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -116.42 136.06 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -124.83 145.56 49.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.816 0.735 . . . . 0.0 110.172 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -95.03 174.09 7.25 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -79.32 16.73 0.94 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.037 -1.664 . . . . 0.0 112.282 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -108.37 -1.3 20.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.422 1.489 . . . . 0.0 111.275 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.14 14.99 80.11 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.287 -172.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -86.8 130.42 34.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.07 152.95 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.951 1.3 . . . . 0.0 108.837 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.0 tpp -62.28 137.69 58.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.24 0.616 . . . . 0.0 109.473 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -140.91 129.7 22.99 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.41 44.46 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 122.957 0.503 . . . . 0.0 111.259 -169.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -124.43 125.66 44.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -88.15 165.05 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.862 0.465 . . . . 0.0 110.891 -169.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -49.51 124.43 9.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.227 1.011 . . . . 0.0 111.694 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.59 8.07 62.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.513 1.054 . . . . 0.0 113.412 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -100.05 153.18 19.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.778 1.289 . . . . 0.0 109.417 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -111.5 19.95 17.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 m -128.34 143.23 50.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.857 1.263 . . . . 0.0 108.29 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -98.2 151.45 20.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.379 0.672 . . . . 0.0 110.227 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -155.56 160.61 40.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.434 1.094 . . . . 0.0 111.051 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.75 148.21 75.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.43 127.39 17.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.828 2.352 . . . . 0.0 112.678 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -142.54 161.53 37.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.555 1.07 . . . . 0.0 112.51 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.99 177.11 48.28 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.199 0.428 . . . . 0.0 113.344 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.15 146.02 17.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 125.346 1.45 . . . . 0.0 110.182 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -79.82 124.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -70.33 155.26 93.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -57.7 125.28 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.95 -7.25 81.09 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.331 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.51 158.71 34.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 120.112 1.956 . . . . 0.0 110.396 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 p -102.16 159.57 15.27 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.35 85.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.625 -0.672 . . . . 0.0 111.627 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.16 -34.64 73.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.733 0.813 . . . . 0.0 110.114 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -72.82 -36.78 67.58 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.698 -1.251 . . . . 0.0 110.227 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.98 93.08 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 ttp -59.81 -49.11 79.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.274 -0.869 . . . . 0.0 108.819 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 46.1 m-85 -64.47 -44.35 91.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.664 1.12 . . . . 0.0 111.975 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -65.9 -49.83 66.64 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.849 1.204 . . . . 0.0 109.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.65 -24.49 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.2 -47.49 83.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -57.14 -39.98 76.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.555 0.616 . . . . 0.0 109.458 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -0.96 14.48 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -115.98 -39.4 3.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.273 1.429 . . . . 0.0 111.933 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.46 2.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.735 1.214 . . . . 0.0 112.666 -171.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.87 6.81 19.59 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-N 119.523 1.056 . . . . 0.0 113.269 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.35 148.65 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.356 1.862 . . . . 0.0 109.238 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 p -126.59 170.11 12.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.665 1.186 . . . . 0.0 109.486 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.407 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 43.9 mtt85 -50.93 -31.93 19.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.906 1.683 . . . . 0.0 112.166 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -66.69 -24.82 66.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.244 0.618 . . . . 0.0 112.349 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.93 24.28 10.93 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.01 164.06 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 120.778 -1.201 . . . . 0.0 111.464 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -141.9 140.51 32.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 mt -82.61 119.52 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.0 mt -94.6 -36.64 11.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.429 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.17 164.4 32.91 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.498 0.719 . . . . 0.0 109.773 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 p -160.08 153.85 22.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.904 1.281 . . . . 0.0 110.974 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 p -70.02 140.26 52.84 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.574 0.702 . . . . 0.0 111.199 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -83.29 -28.3 29.21 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.083 1.353 . . . . 0.0 110.053 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -125.5 148.14 48.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.369 2.267 . . . . 0.0 109.094 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -81.83 136.1 35.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.52 62.04 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.823 0.849 . . . . 0.0 109.442 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -71.21 150.33 45.41 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.4 -0.812 . . . . 0.0 109.914 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.17 148.34 31.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.93 136.77 32.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 169.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.283 0.4 OUTLIER -90.83 149.71 40.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.629 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.59 157.71 44.28 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 124.093 3.195 . . . . 0.0 111.049 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -65.44 -19.9 66.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -171.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -31.01 69.39 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.3 mt -94.22 -22.51 18.37 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.675 1.19 . . . . 0.0 111.489 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.44 133.44 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -99.99 88.42 3.75 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.782 0.801 . . . . 0.0 109.479 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -68.76 -22.04 64.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.768 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.54 -8.99 59.16 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.817 0.847 . . . . 0.0 113.046 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -129.77 162.77 27.69 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 110.274 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.18 134.84 26.36 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.404 1.482 . . . . 0.0 109.231 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.61 147.28 88.97 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 O-C-N 122.666 0.824 . . . . 0.0 110.381 -10.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.72 140.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.003 0.921 . . . . 0.0 109.725 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.2 p -94.61 128.33 41.17 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.374 1.07 . . . . 0.0 109.904 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -14.59 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.92 175.5 47.04 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.07 144.74 26.88 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 108.336 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -90.05 135.45 33.64 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -118.42 132.3 56.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.185 0.902 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -115.74 135.26 54.21 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.52 154.3 31.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.1 125.59 22.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.506 1.123 . . . . 0.0 108.146 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 tp -90.4 124.93 35.36 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.35 149.09 41.07 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -100.67 129.24 46.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.02 134.04 56.11 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.6 t -82.24 -43.27 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.587 -169.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.0 m -97.52 -19.3 18.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.933 0.893 . . . . 0.0 111.704 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.1 -170.11 17.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.416 1.008 . . . . 0.0 111.064 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.68 -22.51 23.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.218 1.807 . . . . 0.0 112.824 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.51 -31.14 63.81 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.957 0.903 . . . . 0.0 113.434 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.96 14.33 14.14 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.98 140.36 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -120.74 115.71 23.83 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.05 6.7 47.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.049 0.539 . . . . 0.0 111.581 -171.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -149.02 66.61 1.04 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.454 1.902 . . . . 0.0 106.663 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -57.03 -60.47 3.55 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 127.218 2.207 . . . . 0.0 111.175 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.4 m -101.19 174.5 5.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.27 1.828 . . . . 0.0 109.93 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -54.67 -37.93 66.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.02 116.16 64.67 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 167.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -61.82 129.99 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 170.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.62 32.5 0.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . 0.26 8.8 t80 -153.18 162.26 41.51 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 120.683 -1.261 . . . . 0.0 112.184 -166.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.75 17.48 0.89 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 171.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.24 149.33 5.13 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 115.443 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.78 153.34 51.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.652 1.181 . . . . 0.0 111.675 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -156.32 152.67 27.93 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.601 1.16 . . . . 0.0 108.742 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -107.72 123.77 49.03 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.64 151.04 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.111 0.964 . . . . 0.0 110.668 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m -55.12 140.03 39.71 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.594 0.758 . . . . 0.0 110.291 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -32.45 18.53 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -85.38 -23.54 27.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.322 1.419 . . . . 0.0 112.971 -176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.72 -46.71 88.5 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.072 -1.442 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.86 -25.79 78.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 123.028 2.117 . . . . 0.0 113.139 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.29 -32.18 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.931 0.893 . . . . 0.0 108.915 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -61.85 -32.58 72.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.368 -0.832 . . . . 0.0 110.949 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -77.99 -27.32 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.33 167.69 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 118.896 0.771 . . . . 0.0 110.879 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.701 1.2 . . . . 0.0 110.226 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.7 m -53.2 -47.0 69.25 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.662 1.585 . . . . 0.0 114.838 -170.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -74.92 -36.7 62.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.051 0.841 . . . . 0.0 111.256 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -74.24 -42.82 59.09 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.503 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -42.88 -44.6 4.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.993 0.917 . . . . 0.0 111.935 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.35 -43.26 98.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.219 0.918 . . . . 0.0 111.097 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.75 -50.63 76.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.23 -32.37 74.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.301 0.64 . . . . 0.0 110.929 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -69.57 -41.78 75.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.836 1.198 . . . . 0.0 110.407 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.06 -41.23 96.22 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.581 1.082 . . . . 0.0 110.576 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.3 t -57.85 -24.97 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 111.591 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.5 mmt -90.51 -58.36 2.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -56.53 -37.12 70.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.637 1.175 . . . . 0.0 112.485 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.1 -36.29 72.68 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 119.062 0.846 . . . . 0.0 111.078 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -106.91 -11.95 15.59 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.183 0.993 . . . . 0.0 112.673 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.68 69.8 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.223 1.409 . . . . 0.0 110.655 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.2 m -67.85 -31.86 71.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.551 0.74 . . . . 0.0 110.654 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.97 -45.23 74.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.43 -41.02 80.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 117.312 -1.327 . . . . 0.0 110.592 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.19 -49.9 72.74 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 120.993 1.724 . . . . 0.0 109.964 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 m -73.55 -26.55 60.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.26 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.5 tp -63.79 -44.07 94.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.296 1.438 . . . . 0.0 109.539 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -61.16 -43.06 99.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.34 -34.84 70.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.937 0.495 . . . . 0.0 112.173 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -92.26 -29.48 16.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.922 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.283 9.8 t 39.6 64.68 4.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.018 1.727 . . . . 0.0 108.069 -169.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.07 164.18 17.68 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.128 1.885 . . . . 0.0 113.682 -168.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp . . . . . 0 C--O 1.251 1.174 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.982 -171.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.23 128.27 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 168.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.26 150.12 47.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.472 1.129 . . . . 0.0 108.803 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.98 -24.86 56.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.188 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.15 0.19 19.81 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.87 61.78 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.912 1.244 . . . . 0.0 113.386 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -118.2 161.25 20.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -144.18 132.45 10.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.35 136.06 8.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.371 1.381 . . . . 0.0 108.821 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -139.19 152.56 47.47 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.118 -0.989 . . . . 0.0 108.989 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.26 154.09 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.255 1.022 . . . . 0.0 108.892 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.51 157.5 25.14 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.32 143.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.5 138.69 51.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 170.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 mm -116.89 141.21 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.74 157.2 30.18 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.321 1.049 . . . . 0.0 111.364 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -117.89 168.09 10.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.938 1.295 . . . . 0.0 107.987 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -73.66 -0.71 16.28 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.377 -1.452 . . . . 0.0 113.032 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -85.35 -8.84 58.25 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 111.365 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.95 34.83 41.1 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -106.07 154.34 20.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 169.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.84 150.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.34 1.056 . . . . 0.0 109.736 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.6 ttm -66.67 143.26 57.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.203 1.001 . . . . 0.0 108.397 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -150.5 141.85 23.32 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 147.63 31.37 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.463 1.483 . . . . 0.0 110.379 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.09 136.37 47.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.165 0.986 . . . . 0.0 109.089 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm-85 -73.53 160.68 31.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 111.487 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -49.58 123.94 8.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.174 0.99 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.73 6.79 73.1 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.816 1.198 . . . . 0.0 114.145 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -106.42 160.27 15.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.338 1.569 . . . . 0.0 110.616 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -119.91 17.34 12.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.803 1.241 . . . . 0.0 111.598 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 m -128.1 138.71 52.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.048 1.339 . . . . 0.0 108.149 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -94.46 151.21 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.519 0.727 . . . . 0.0 110.549 -170.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -143.57 155.58 44.34 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.165 1.386 . . . . 0.0 110.139 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -82.54 138.9 44.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 167.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.05 135.58 64.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.708 2.272 . . . . 0.0 112.568 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.87 166.2 32.42 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.962 0.801 . . . . 0.0 112.199 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.0 168.01 40.95 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.507 0.575 . . . . 0.0 111.683 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.88 149.01 40.68 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.9 mt -73.57 120.49 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -73.59 157.79 87.2 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.59 122.98 12.7 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.331 1.354 . . . . 0.0 111.539 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.23 2.0 88.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.538 -1.146 . . . . 0.0 114.745 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.85 152.74 43.39 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.158 1.979 . . . . 0.0 111.066 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.0 p -84.76 167.49 16.05 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 167.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -36.32 79.2 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.088 -1.008 . . . . 0.0 111.316 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -40.51 61.13 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.484 0.713 . . . . 0.0 109.802 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -65.65 -40.89 92.94 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.26 75.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.856 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -58.15 -48.23 80.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 57.1 m-85 -66.81 -45.64 77.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.1 0.864 . . . . 0.0 111.642 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -53.57 -51.71 62.09 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.919 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -77.72 -32.34 52.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.9 tp -56.48 -45.65 80.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.25 0.932 . . . . 0.0 109.98 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.84 -40.26 92.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.282 0.492 . . . . 0.0 110.082 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.813 0.733 . . . . 0.0 112.366 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.55 -53.55 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.165 0.986 . . . . 0.0 110.414 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -123.27 3.6 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.488 1.515 . . . . 0.0 112.038 -169.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.43 3.27 24.9 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.005 1.275 . . . . 0.0 113.955 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.81 145.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.7 m -124.3 162.21 24.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.062 . . . . 0.0 109.664 -171.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 46.4 mtp180 -42.73 -40.63 2.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.621 1.968 . . . . 0.0 112.892 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -69.08 -21.15 64.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.376 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.76 19.92 16.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.745 0.784 . . . . 0.0 112.522 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.23 164.19 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.403 1.481 . . . . 0.0 111.337 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 138.93 35.92 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.072 169.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 mt -77.03 116.1 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 mt -93.71 -33.17 13.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.395 174.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.28 164.45 38.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.866 0.866 . . . . 0.0 109.397 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 p -162.21 154.4 19.17 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 110.787 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 p -70.6 136.86 49.53 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.831 -0.543 . . . . 0.0 110.8 -170.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -79.3 -29.79 42.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.633 0.773 . . . . 0.0 110.553 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.344 2.258 . . . . 0.0 108.361 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.3 m95 -77.78 133.64 38.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.998 0.817 . . . . 0.0 109.165 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.03 116.58 27.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -127.05 149.52 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.51 142.55 31.18 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.9 139.77 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.71 139.37 86.05 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.065 0.946 . . . . 0.0 110.418 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.55 148.83 73.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 N-CA-C 104.636 -2.871 . . . . 0.0 104.636 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -68.84 -13.23 62.28 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 119.847 -1.783 . . . . 0.0 114.236 -168.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -62.54 -30.73 71.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.955 0.798 . . . . 0.0 112.634 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.4 mt -94.07 -18.24 22.02 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.161 0.985 . . . . 0.0 112.212 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.48 132.65 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.12 88.39 4.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.729 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -69.98 -17.76 63.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.262 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.83 -27.28 55.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -103.18 163.08 12.46 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.973 . . . . 0.0 110.811 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.38 127.67 22.5 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 125.254 1.422 . . . . 0.0 110.72 -171.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.14 145.24 83.44 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 N-CA-C 109.308 -1.074 . . . . 0.0 109.308 -10.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.28 136.35 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.5 p -96.92 144.22 27.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.594 0.358 . . . . 0.0 110.585 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.84 -7.3 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.45 177.22 41.44 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -150.08 147.25 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.854 1.662 . . . . 0.0 109.016 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -96.23 131.24 42.92 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.17 128.6 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.504 1.047 . . . . 0.0 109.189 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 2.2 ttmm -109.05 121.15 44.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -102.47 151.27 22.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -133.43 131.51 40.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 108.015 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.34 124.8 37.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 169.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.51 149.7 42.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -97.57 133.06 42.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 168.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 136.19 57.84 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.235 1.414 . . . . 0.0 107.552 171.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.31 -59.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.563 1.074 . . . . 0.0 110.226 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 m -74.74 -20.03 59.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.423 0.689 . . . . 0.0 111.672 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.21 172.35 25.14 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -58.42 -16.5 15.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.059 1.744 . . . . 0.0 114.112 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.73 -30.89 15.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.194 0.997 . . . . 0.0 113.088 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -85.53 18.98 2.53 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.18 142.05 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.185 1.394 . . . . 0.0 108.614 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -130.94 130.93 44.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.652 1.981 . . . . 0.0 107.895 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mmt -93.95 -14.4 26.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.52 0.728 . . . . 0.0 112.728 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -112.73 74.32 0.86 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 124.38 2.038 . . . . 0.0 107.94 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.0 p -71.49 -63.12 1.18 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 110.891 -2.868 . . . . 0.0 107.117 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.2 m -78.91 175.47 10.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.599 1.56 . . . . 0.0 108.721 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -59.71 -35.24 74.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.541 -0.724 . . . . 0.0 110.486 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.27 137.36 37.04 Favored Pre-proline 0 N--CA 1.446 -0.657 0 C-N-CA 125.945 1.698 . . . . 0.0 108.844 169.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.38 121.32 9.26 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.31 2.007 . . . . 0.0 107.55 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -73.74 -26.05 60.48 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.067 -0.395 . . . . 0.0 111.583 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -107.54 141.29 39.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.22 -27.66 38.74 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.259 0.624 . . . . 0.0 110.313 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.55 150.81 22.88 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.78 140.44 29.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -148.04 168.98 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.586 1.154 . . . . 0.0 109.222 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -117.4 142.56 46.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 149.84 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.702 1.201 . . . . 0.0 109.101 -169.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -51.99 141.81 17.18 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -43.78 -55.51 4.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.78 -7.83 53.53 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.822 1.192 . . . . 0.0 113.596 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.58 -52.44 66.99 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-O 116.825 -1.559 . . . . 0.0 113.68 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.97 -8.73 14.57 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.616 2.877 . . . . 0.0 116.392 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.16 -29.52 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 120.967 -1.083 . . . . 0.0 108.869 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.43 -25.38 63.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.75 -1.219 . . . . 0.0 112.281 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.47 -22.05 21.57 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.92 175.3 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 119.321 0.964 . . . . 0.0 110.612 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 m -83.82 171.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.5 m -56.61 -48.79 76.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.821 2.048 . . . . 0.0 114.327 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -72.07 -35.99 69.42 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.115 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.08 -39.08 72.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.75 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -50.01 -42.81 50.01 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.87 0.868 . . . . 0.0 111.454 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.41 -45.85 91.24 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.465 0.575 . . . . 0.0 110.359 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.1 -50.22 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -62.79 -37.99 88.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.9 0.773 . . . . 0.0 109.974 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -69.24 -36.28 77.02 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.45 -44.66 95.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.077 1.308 . . . . 0.0 110.307 172.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.14 -39.03 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 119.939 1.245 . . . . 0.0 110.451 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.8 mmt -72.45 -59.48 2.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.958 1.303 . . . . 0.0 107.637 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -34.07 72.48 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.588 -1.32 . . . . 0.0 112.313 -172.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -57.93 -41.05 81.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -111.52 -11.95 14.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 112.039 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.2 -42.7 63.73 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 126.786 2.034 . . . . 0.0 110.467 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -68.95 -30.66 69.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.994 0.918 . . . . 0.0 110.916 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.83 -46.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.11 -41.25 88.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.293 -171.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.0 mmt -55.51 -44.41 76.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.348 1.431 . . . . 0.0 110.752 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -81.12 -26.04 36.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.324 1.049 . . . . 0.0 111.502 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.59 -43.78 95.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.043 1.337 . . . . 0.0 109.686 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.63 -40.09 93.63 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.752 0.421 . . . . 0.0 110.718 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.62 -32.08 53.27 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.217 0.607 . . . . 0.0 112.238 -169.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -100.45 -20.24 15.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.838 -169.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.1 p 40.8 62.86 6.1 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 126.946 2.098 . . . . 0.0 109.556 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.37 167.1 15.48 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 121.422 1.415 . . . . 0.0 114.113 -167.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt . . . . . 0 C--O 1.255 1.364 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.769 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tmm? . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.43 131.35 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 169.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.44 -63.95 1.12 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.429 0.692 . . . . 0.0 112.627 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.21 -53.84 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.62 17.25 16.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.435 1.094 . . . . 0.0 113.06 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.19 61.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.894 0.759 . . . . 0.0 113.702 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.8 154.4 18.67 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.085 0.943 . . . . 0.0 108.816 171.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 149.88 63.1 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.361 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -90.58 141.78 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.687 1.592 . . . . 0.0 111.757 -174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -135.8 154.32 51.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.143 0.977 . . . . 0.0 109.711 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.82 140.53 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.81 155.62 16.09 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 124.783 1.182 . . . . 0.0 110.211 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.05 142.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.93 135.62 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 mm -108.56 132.76 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.2 m -124.26 145.57 49.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -105.74 173.31 6.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.644 1.177 . . . . 0.0 109.321 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.59 5.75 4.51 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.562 -1.336 . . . . 0.0 113.657 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -96.27 -2.17 46.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 111.482 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.61 22.11 79.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.392 -0.671 . . . . 0.0 111.843 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -93.91 145.39 24.66 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.23 149.85 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.717 1.607 . . . . 0.0 108.934 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.4 ttm -68.37 142.78 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.88 0.872 . . . . 0.0 109.366 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -141.48 123.32 15.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.08 159.35 41.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.134 1.334 . . . . 0.0 112.575 -168.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HG3' ' H ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -157.93 169.52 24.4 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.08 1.309 . . . . 0.0 114.073 177.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' H ' ' HG3' ' A' ' 26' ' ' ARG . 8.2 tpt180 -59.84 154.39 18.57 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 128.035 2.534 . . . . 0.0 112.855 -169.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -61.15 134.39 56.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.614 1.166 . . . . 0.0 108.242 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.61 1.78 78.26 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.361 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -106.15 160.73 15.1 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.564 1.682 . . . . 0.0 110.654 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -128.91 11.99 6.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.671 1.189 . . . . 0.0 111.453 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -85.68 169.15 13.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.902 0.881 . . . . 0.0 109.082 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -133.2 132.12 41.16 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.03 173.94 13.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.391 1.477 . . . . 0.0 108.037 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -75.46 152.93 85.72 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.098 -0.954 . . . . 0.0 108.601 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 133.36 57.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.865 2.377 . . . . 0.0 111.536 170.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.15 171.2 18.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.66 1.118 . . . . 0.0 112.204 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.48 170.36 41.16 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.992 -0.442 . . . . 0.0 112.755 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 144.01 33.59 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 mt -73.99 119.33 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.67 144.1 85.6 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.14 126.17 18.06 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.804 1.67 . . . . 0.0 110.293 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.43 52.79 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.662 1.125 . . . . 0.0 113.283 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 152.1 37.17 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.675 1.737 . . . . 0.0 109.83 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.2 p -80.21 169.4 17.83 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.3 87.75 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 121.68 -0.637 . . . . 0.0 111.379 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.66 -37.77 70.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 110.387 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -68.09 -39.49 82.88 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.603 -1.31 . . . . 0.0 110.08 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.56 -30.66 67.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.676 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.403 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 11.9 tmm? -57.08 -50.73 71.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.425 1.011 . . . . 0.0 108.674 173.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.409 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 52.3 m-85 -66.38 -44.96 81.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.322 0.51 . . . . 0.0 111.119 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -57.35 -50.23 73.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.901 0.88 . . . . 0.0 110.023 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -77.12 -31.08 55.51 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -172.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.9 tp -58.11 -43.26 87.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.369 0.986 . . . . 0.0 110.241 172.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -62.38 -41.47 98.66 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.325 0.511 . . . . 0.0 110.087 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.66 -24.84 65.48 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.804 0.729 . . . . 0.0 112.429 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.04 -61.09 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.802 0.841 . . . . 0.0 108.788 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.88 -4.95 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.436 1.094 . . . . 0.0 113.561 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.799 1.181 . . . . 0.0 114.103 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.08 150.28 30.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.83 1.652 . . . . 0.0 109.099 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 m -127.76 164.34 22.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.332 1.053 . . . . 0.0 109.801 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 60.9 mtt180 -48.28 -36.16 13.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.103 1.761 . . . . 0.0 112.519 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -63.38 -23.45 67.42 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.623 0.769 . . . . 0.0 112.19 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.89 24.58 11.13 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.939 0.4 . . . . 0.0 111.63 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.87 165.09 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.413 1.085 . . . . 0.0 111.957 172.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 134.16 30.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.7 mt -76.65 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -95.88 -32.89 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.19 164.43 38.55 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 p -163.18 154.44 17.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.502 1.121 . . . . 0.0 110.798 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -72.81 140.06 47.41 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 109.969 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -92.22 -27.87 17.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -111.29 150.92 28.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.451 2.3 . . . . 0.0 107.482 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 57.1 m95 -82.3 136.94 34.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.438 0.563 . . . . 0.0 109.518 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.4 71.47 6.05 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -71.77 147.36 47.36 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -146.33 144.01 29.5 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.845 0.458 . . . . 0.0 110.0 170.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.84 146.67 24.04 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.074 0.95 . . . . 0.0 108.504 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.05 145.85 91.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 110.682 169.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.79 145.9 64.42 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 N-CA-C 104.499 -2.924 . . . . 0.0 104.499 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -68.34 -13.13 62.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.909 -1.744 . . . . 0.0 114.151 -169.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -58.7 -31.31 68.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.8 mt -92.55 -19.52 21.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 111.998 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.31 136.09 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -101.58 90.49 4.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.942 0.897 . . . . 0.0 109.473 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -68.42 -24.17 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.807 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.93 -34.42 73.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.617 0.367 . . . . 0.0 111.831 -171.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.93 159.21 15.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.786 0.834 . . . . 0.0 109.678 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -130.88 134.95 26.59 Favored Pre-proline 0 C--O 1.234 0.268 0 C-N-CA 125.325 1.45 . . . . 0.0 109.615 -171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.46 148.03 90.5 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 O-C-N 122.696 0.84 . . . . 0.0 110.07 -10.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -79.24 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.484 0.713 . . . . 0.0 109.532 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.89 127.69 35.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -14.57 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 118.932 0.787 . . . . 0.0 112.861 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.7 -177.11 38.88 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.77 153.82 30.45 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.794 1.238 . . . . 0.0 108.84 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -98.61 132.55 43.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -123.62 122.81 39.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 119.266 0.939 . . . . 0.0 109.566 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 7.6 ttmm -98.72 153.55 18.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -132.32 151.74 51.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.403 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 75.8 m-85 -137.69 127.88 26.09 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 108.893 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.59 122.62 32.91 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.88 136.99 53.75 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.47 132.29 35.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 tp -73.76 132.64 42.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.064 2.146 . . . . 0.0 107.539 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -77.63 -53.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.538 1.135 . . . . 0.0 111.837 -168.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.7 m -87.24 -15.55 37.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 111.563 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.37 -169.92 21.95 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.707 1.146 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -59.1 -17.39 25.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.627 1.571 . . . . 0.0 114.008 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.81 57.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.268 1.027 . . . . 0.0 112.955 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -95.66 18.29 13.22 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.52 113.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -92.74 -56.12 3.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.799 0.272 . . . . 0.0 110.978 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.2 mtp 69.81 3.16 4.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.704 2.401 . . . . 0.0 115.016 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.05 78.76 1.5 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 123.793 1.759 . . . . 0.0 109.825 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -75.93 -59.92 2.55 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.51 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 m -66.15 167.7 9.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.295 1.838 . . . . 0.0 109.53 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -62.44 -38.0 88.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.88 -0.512 . . . . 0.0 109.739 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.62 139.95 51.22 Favored Pre-proline 0 N--CA 1.442 -0.871 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 169.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.62 135.68 69.04 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.628 1.552 . . . . 0.0 108.112 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -81.62 -29.83 33.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.74 153.67 43.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.122 1.769 . . . . 0.0 107.83 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.67 -25.14 1.91 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.353 1.061 . . . . 0.0 110.58 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.83 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -150.76 133.09 15.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.153 0.981 . . . . 0.0 108.402 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -152.48 164.57 37.3 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.125 1.37 . . . . 0.0 108.471 169.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -114.49 141.27 47.93 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 152.79 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 110.292 -170.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m -60.97 142.54 56.44 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 109.043 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -27.58 48.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 32.5 m95 -88.2 -18.57 28.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.03 1.286 . . . . 0.0 113.19 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.91 -50.41 70.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.132 -1.413 . . . . 0.0 113.294 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.7 -28.95 76.95 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.159 1.906 . . . . 0.0 112.629 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.91 -34.88 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.329 1.052 . . . . 0.0 108.788 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -68.94 -19.7 64.19 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.787 -1.196 . . . . 0.0 112.323 -175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -79.87 -32.7 40.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.854 1.206 . . . . 0.0 112.614 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.5 156.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 118.995 0.816 . . . . 0.0 111.482 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -68.65 162.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 m -53.22 -46.63 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.862 2.065 . . . . 0.0 115.236 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -69.33 -32.17 71.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.431 1.014 . . . . 0.0 111.153 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -77.54 -39.6 45.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.6 ttp-105 -50.05 -39.0 40.64 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.788 1.235 . . . . 0.0 112.387 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.24 -43.58 94.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.47 0.577 . . . . 0.0 111.378 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.91 -50.94 78.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -66.61 -34.49 77.99 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.701 -0.624 . . . . 0.0 110.897 -168.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -67.45 -40.61 85.42 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.65 1.114 . . . . 0.0 110.248 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.43 -43.74 98.33 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.725 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.91 -43.22 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 120.29 1.404 . . . . 0.0 109.912 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.5 mmt -74.04 -48.86 27.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -33.81 76.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.998 0.817 . . . . 0.0 112.159 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.74 -45.54 89.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.686 1.195 . . . . 0.0 109.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.19 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.097 1.359 . . . . 0.0 110.792 -174.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -69.34 -31.57 70.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.786 0.834 . . . . 0.0 110.598 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.47 -48.5 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.45 -41.77 82.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.172 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.63 -47.48 73.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.365 1.439 . . . . 0.0 110.71 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m -77.28 -26.85 52.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.173 1.389 . . . . 0.0 110.781 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.53 -42.25 96.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.018 1.727 . . . . 0.0 108.778 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -59.07 -24.64 63.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.344 0.657 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.93 -18.54 13.89 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.781 1.232 . . . . 0.0 113.116 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -116.62 -20.83 9.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.795 -169.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 p 41.86 62.76 7.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.201 1.8 . . . . 0.0 110.307 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 157.82 36.79 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.974 1.782 . . . . 0.0 113.798 -168.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt . . . . . 0 C--O 1.253 1.26 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.541 -169.536 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.75 142.12 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 168.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -67.37 -69.42 0.31 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.005 0.522 . . . . 0.0 111.661 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -164.74 -48.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.762 0.825 . . . . 0.0 112.84 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.51 13.29 14.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.293 1.037 . . . . 0.0 113.06 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.22 81.82 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.291 0.948 . . . . 0.0 113.163 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.58 157.24 17.61 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.975 0.91 . . . . 0.0 108.749 169.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -148.93 139.77 13.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.594 -172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -87.47 139.7 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 CA-C-N 121.63 1.618 . . . . 0.0 111.987 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.27 165.87 24.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.101 1.36 . . . . 0.0 109.127 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.74 172.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.08 159.75 28.7 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.39 141.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.25 139.26 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mm -119.47 142.83 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.0 p -121.84 154.28 37.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.186 0.903 . . . . 0.0 111.4 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -112.51 168.47 9.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.865 1.266 . . . . 0.0 108.336 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.39 4.46 5.86 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.133 -1.604 . . . . 0.0 113.196 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -90.78 -4.81 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.185 0.994 . . . . 0.0 111.45 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.3 21.06 70.99 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.841 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -95.67 151.34 19.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.674 1.237 . . . . 0.0 107.963 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.21 153.93 20.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.493 1.517 . . . . 0.0 109.495 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.3 tpp -60.55 137.6 58.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.317 1.047 . . . . 0.0 108.802 169.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -147.73 135.15 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 156.01 47.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.226 1.375 . . . . 0.0 112.554 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -109.44 109.32 20.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.149 1.779 . . . . 0.0 107.166 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -66.74 148.72 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.676 1.126 . . . . 0.0 108.06 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -46.25 118.81 2.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.419 1.087 . . . . 0.0 111.311 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.96 4.25 40.56 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.302 -1.277 . . . . 0.0 115.871 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -82.95 -30.42 28.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.235 2.017 . . . . 0.0 112.579 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 m80 53.78 34.22 18.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.323 1.049 . . . . 0.0 111.957 -172.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.3 p -131.22 170.74 14.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.919 2.088 . . . . 0.0 107.49 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -120.19 145.37 47.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.349 0.522 . . . . 0.0 110.505 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 165.61 36.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.071 1.349 . . . . 0.0 110.17 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -79.93 153.07 75.0 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.859 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.34 139.5 59.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.076 2.517 . . . . 0.0 110.324 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -138.59 168.38 19.91 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.383 1.073 . . . . 0.0 112.51 -168.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.89 163.05 30.33 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 119.98 -0.344 . . . . 0.0 112.385 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.49 135.15 12.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 174.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.28 122.49 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -69.86 155.85 92.76 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.27 122.93 12.65 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.991 1.127 . . . . 0.0 109.461 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -3.72 86.75 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.338 -1.256 . . . . 0.0 114.594 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.98 158.92 34.53 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.279 2.04 . . . . 0.0 110.753 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m -98.97 155.83 17.22 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.07 86.48 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.132 -0.98 . . . . 0.0 111.389 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.907 0.883 . . . . 0.0 110.287 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -68.76 -39.24 80.37 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.667 -0.646 . . . . 0.0 110.084 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.29 94.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -60.15 -50.88 71.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.903 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -66.29 -37.24 84.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.893 1.224 . . . . 0.0 112.521 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -63.77 -49.8 71.54 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.069 1.304 . . . . 0.0 109.133 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -76.78 -25.67 53.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.04 -40.73 73.92 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.725 -1.235 . . . . 0.0 110.111 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -70.85 -37.82 73.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.52 0.6 . . . . 0.0 110.537 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.39 -34.2 72.29 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.2 -0.937 . . . . 0.0 111.808 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.78 -52.86 4.54 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.415 1.086 . . . . 0.0 110.114 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.27 -30.1 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.359 1.464 . . . . 0.0 110.233 -168.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 0.77 89.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.944 0.783 . . . . 0.0 112.38 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.2 tp -83.78 155.33 23.08 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.694 1.998 . . . . 0.0 109.334 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 p -133.81 169.13 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.296 1.038 . . . . 0.0 109.751 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -52.48 -33.02 42.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.919 1.688 . . . . 0.0 112.306 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -63.26 -28.02 69.74 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.293 0.637 . . . . 0.0 111.897 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.9 23.27 12.72 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 112.159 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 165.86 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 120.782 -1.199 . . . . 0.0 112.016 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 136.67 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.4 mt -76.12 115.71 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -89.18 -36.44 15.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.607 173.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.79 166.45 33.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.117 0.567 . . . . 0.0 109.778 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 p -161.24 155.6 22.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.981 1.312 . . . . 0.0 110.103 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -68.71 137.28 53.98 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.703 -0.623 . . . . 0.0 111.116 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -81.51 -28.64 33.93 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.214 1.406 . . . . 0.0 109.894 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -120.91 150.38 41.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.613 2.365 . . . . 0.0 108.177 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -81.48 133.38 35.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.4 mt -91.15 136.85 32.8 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -129.63 156.98 43.35 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.933 0.893 . . . . 0.0 111.431 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -143.36 125.92 15.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.17 137.43 36.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.07 142.87 93.6 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.702 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.01 146.49 71.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 104.923 -2.76 . . . . 0.0 104.923 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.61 -11.18 60.63 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.008 -1.682 . . . . 0.0 113.889 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -60.63 -31.42 70.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.973 0.806 . . . . 0.0 112.613 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.3 mt -92.04 -22.23 20.06 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 111.504 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.89 136.88 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -106.52 92.79 4.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.037 0.935 . . . . 0.0 110.063 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -68.4 -24.29 64.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.015 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.3 -25.57 58.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.386 0.674 . . . . 0.0 112.578 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -110.55 156.71 20.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.113 0.965 . . . . 0.0 109.338 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -127.87 137.64 31.21 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 109.975 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.25 149.72 93.66 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.874 0.934 . . . . 0.0 110.177 -10.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 p -78.22 134.33 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 110.142 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.4 p -74.25 126.17 30.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.935 0.894 . . . . 0.0 109.4 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.85 -13.67 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 171.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.35 175.65 46.41 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -151.52 145.25 25.04 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.33 1.452 . . . . 0.0 108.961 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.03 133.83 34.2 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -129.48 123.96 32.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.89 0.768 . . . . 0.0 109.987 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -103.68 127.38 51.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.123 0.969 . . . . 0.0 108.407 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -105.75 153.93 21.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -132.97 128.78 37.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.483 1.113 . . . . 0.0 108.264 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.01 124.54 37.06 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 mt -119.2 149.4 41.8 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -99.71 126.75 45.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.45 138.65 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.318 1.047 . . . . 0.0 108.794 170.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.8 t -90.72 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.414 0.552 . . . . 0.0 110.556 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.0 m -85.59 -18.71 32.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.218 0.607 . . . . 0.0 111.02 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.52 21.4 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.89 -21.14 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.607 1.963 . . . . 0.0 113.345 -172.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.29 -30.01 59.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.579 0.752 . . . . 0.0 113.028 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -93.58 15.65 15.63 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.9 mt -91.74 135.61 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -122.23 -51.84 1.97 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.331 0.652 . . . . 0.0 112.165 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 mtp 65.64 16.82 10.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.416 2.287 . . . . 0.0 113.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.58 29.84 1.93 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.276 1.512 . . . . 0.0 112.142 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -51.41 70.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.659 1.583 . . . . 0.0 108.345 169.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.5 m -68.96 156.45 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.576 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -65.89 -33.48 75.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.015 0.526 . . . . 0.0 110.456 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.56 134.83 33.36 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 124.997 1.319 . . . . 0.0 107.973 169.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.38 122.28 11.4 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.474 2.116 . . . . 0.0 107.315 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.39 -33.4 72.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -117.77 138.81 51.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.19 -19.6 46.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.6 161.79 32.02 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.65 159.07 43.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -151.88 164.87 36.18 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.147 0.979 . . . . 0.0 109.165 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -114.87 127.38 55.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.03 152.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.481 1.112 . . . . 0.0 110.0 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -59.63 147.63 36.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.476 0.58 . . . . 0.0 109.471 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.95 54.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.465 1.106 . . . . 0.0 113.778 -169.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -88.87 -22.66 23.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.332 -0.855 . . . . 0.0 113.09 -172.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -58.24 -49.06 95.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.248 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.85 -29.3 76.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.169 1.81 . . . . 0.0 111.819 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.86 -30.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.26 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -68.3 -27.73 66.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.166 -0.959 . . . . 0.0 111.31 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -83.6 -24.52 31.44 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -168.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.38 160.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.686 0.755 . . . . 0.0 112.713 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.7 175.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.254 1.421 . . . . 0.0 109.856 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.86 -55.93 26.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.944 1.697 . . . . 0.0 113.002 -173.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -70.17 -32.32 70.21 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 -171.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -74.17 -48.05 31.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.974 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -63.48 -30.93 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.706 1.139 . . . . 0.0 112.204 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.7 -35.31 74.25 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.842 174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.81 -49.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.494 1.118 . . . . 0.0 109.949 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -62.39 -31.99 72.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.755 1.162 . . . . 0.0 111.106 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.6 -43.44 98.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.487 1.04 . . . . 0.0 111.384 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -61.13 -45.69 93.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.366 0.985 . . . . 0.0 110.239 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.68 -26.11 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.063 0.945 . . . . 0.0 111.58 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.1 mmt -90.81 -56.29 3.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.998 0.919 . . . . 0.0 108.885 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -57.3 -33.65 67.9 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.462 1.028 . . . . 0.0 112.551 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -63.45 -32.81 74.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.947 0.499 . . . . 0.0 110.574 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -111.58 -14.83 13.61 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.284 1.033 . . . . 0.0 112.889 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.41 -39.97 67.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.594 1.558 . . . . 0.0 110.794 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 m -67.1 -31.6 72.18 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.971 0.908 . . . . 0.0 110.785 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -46.21 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.13 -39.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 117.851 -1.071 . . . . 0.0 109.714 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.6 mmt -55.34 -48.92 73.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.773 1.17 . . . . 0.0 110.437 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.8 m -79.6 -26.05 41.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.779 1.232 . . . . 0.0 110.957 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.3 tp -63.05 -41.39 99.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.612 1.165 . . . . 0.0 109.936 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -58.46 -44.16 89.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 110.154 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.18 -31.39 64.19 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.713 0.805 . . . . 0.0 111.685 -171.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -89.12 -32.68 17.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.129 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.284 12.4 t 39.35 62.59 5.02 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -75.45 59.7 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.685 2.923 . . . . 0.0 115.568 -166.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.807 2.043 . . . . 0.0 112.118 169.591 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 119.66 -0.209 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 143.71 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -69.33 0.26 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -164.74 -48.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.166 0.986 . . . . 0.0 112.7 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.13 16.67 10.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.594 1.158 . . . . 0.0 113.137 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.7 63.58 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.312 0.958 . . . . 0.0 113.854 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -93.29 153.78 18.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.499 1.15 . . . . 0.0 108.053 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.16 126.58 17.61 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.595 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -72.33 141.13 34.87 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.108 1.872 . . . . 0.0 111.496 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -140.25 156.44 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.802 0.841 . . . . 0.0 109.079 -173.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.74 150.36 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -128.92 157.53 21.61 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -125.16 142.83 40.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 109.056 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.43 137.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mm -120.01 132.39 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.1 m -119.91 140.6 50.63 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.682 0.674 . . . . 0.0 109.965 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -94.8 174.04 7.3 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.02 -2.37 30.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 120.281 -1.512 . . . . 0.0 112.678 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.61 -2.91 58.65 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.971 1.308 . . . . 0.0 111.582 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.87 19.48 76.93 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.819 0.736 . . . . 0.0 111.711 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -88.55 142.51 27.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 171.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 m -108.48 142.43 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.37 1.468 . . . . 0.0 108.935 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.0 tpp -60.85 134.65 57.3 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.957 1.303 . . . . 0.0 108.822 170.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -143.3 120.39 11.43 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 151.05 29.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.811 1.187 . . . . 0.0 109.836 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -145.48 162.29 37.71 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.176 1.39 . . . . 0.0 114.102 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.65 149.47 35.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.724 2.009 . . . . 0.0 113.872 -168.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -52.46 124.86 14.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.527 1.931 . . . . 0.0 109.489 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.67 8.31 76.49 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.205 -1.331 . . . . 0.0 114.524 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -109.18 157.41 18.81 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.589 1.695 . . . . 0.0 110.573 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -134.39 15.0 3.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 112.258 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.5 m -107.18 127.78 53.82 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -92.05 139.56 30.52 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -156.62 158.54 37.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.193 2.197 . . . . 0.0 107.731 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -73.35 151.84 89.92 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.445 169.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.42 141.17 97.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.969 2.446 . . . . 0.0 112.259 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.85 176.09 11.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.886 -0.509 . . . . 0.0 112.046 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.86 168.61 40.98 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.333 0.492 . . . . 0.0 112.553 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.51 146.39 27.31 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -77.73 127.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -69.47 152.68 96.29 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.48 124.04 14.93 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 108.958 -1.209 . . . . 0.0 108.958 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.41 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.679 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.96 159.26 34.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.072 1.936 . . . . 0.0 110.229 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 p -102.12 156.57 17.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.33 85.91 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.408 -0.808 . . . . 0.0 111.901 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.19 -35.56 76.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.572 0.749 . . . . 0.0 109.588 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -71.86 -37.04 70.28 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.61 91.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -61.61 -50.88 70.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -66.19 -40.97 90.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.228 0.922 . . . . 0.0 110.825 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.5 ttm-85 -66.37 -48.38 70.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.672 1.124 . . . . 0.0 109.688 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.84 -29.35 63.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.56 -47.64 79.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.864 0.756 . . . . 0.0 109.165 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.97 -39.21 91.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.934 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.42 -40.32 93.21 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.979 . . . . 0.0 112.061 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.13 -51.38 9.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 110.357 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 m -123.8 8.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.188 1.395 . . . . 0.0 113.538 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.27 8.41 62.1 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.791 0.723 . . . . 0.0 113.599 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 tp -98.6 141.14 31.81 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.417 1.887 . . . . 0.0 109.945 -171.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 p -115.43 165.53 12.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 109.926 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -48.69 -34.18 11.46 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.109 1.764 . . . . 0.0 112.053 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -29.61 70.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.759 -171.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.35 25.86 10.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.793 1.179 . . . . 0.0 111.628 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.52 165.0 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 O-C-N 120.818 -1.176 . . . . 0.0 111.501 172.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -139.32 144.29 38.22 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.1 mt -82.52 120.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -95.23 -35.98 11.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.615 174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.02 161.33 38.07 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.348 -171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -162.35 154.43 18.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.177 1.391 . . . . 0.0 109.669 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 p -71.09 139.55 50.38 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.852 -0.53 . . . . 0.0 110.261 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -57.06 4.14 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -89.28 151.62 22.01 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.389 1.476 . . . . 0.0 109.188 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -83.21 135.71 34.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.011 0.369 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.81 96.51 10.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -98.19 150.72 21.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.052 0.941 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -147.27 144.69 29.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 168.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.6 143.89 26.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mt -68.23 138.82 92.09 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 169.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.81 148.13 86.14 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 N-CA-C 105.264 -2.629 . . . . 0.0 105.264 167.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -69.14 -11.9 61.2 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.033 -1.667 . . . . 0.0 113.838 -168.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.9 -32.19 73.63 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.944 0.793 . . . . 0.0 112.522 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -92.8 -22.06 19.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.006 0.922 . . . . 0.0 111.567 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.46 136.2 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -103.14 88.68 3.2 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.005 0.907 . . . . 0.0 110.456 174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -68.52 -22.6 64.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.666 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.06 -9.1 58.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.749 0.819 . . . . 0.0 112.876 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.7 t -128.17 160.86 30.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.095 0.958 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -128.43 135.32 27.38 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 125.346 1.458 . . . . 0.0 109.563 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.54 148.36 91.38 Favored 'Cis proline' 0 CA--C 1.538 0.693 0 O-C-N 122.665 0.824 . . . . 0.0 110.534 -10.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 p -77.62 134.98 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.659 0.784 . . . . 0.0 109.75 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.0 p -80.2 127.32 32.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.91 0.884 . . . . 0.0 109.07 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.03 -17.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.02 0.827 . . . . 0.0 113.174 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.51 168.22 37.35 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 119.772 1.169 . . . . 0.0 110.197 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -152.62 150.9 29.99 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.657 1.183 . . . . 0.0 107.889 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 127.04 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -113.78 135.14 54.28 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.825 0.85 . . . . 0.0 110.209 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -113.27 125.08 53.91 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.433 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 89.1 m95 -104.45 149.92 25.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -173.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -133.37 131.66 40.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.835 0.854 . . . . 0.0 108.832 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.8 tp -96.32 119.72 35.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 168.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.09 144.95 40.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -96.9 129.65 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 135.02 57.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.2 t -85.91 -44.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.049 0.386 . . . . 0.0 110.608 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.1 m -90.19 -19.57 24.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.388 0.675 . . . . 0.0 111.198 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.76 -170.42 19.06 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 124.528 1.061 . . . . 0.0 110.558 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -20.84 38.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.624 1.57 . . . . 0.0 113.568 -172.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.46 47.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -93.24 14.63 17.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -173.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.08 140.98 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -133.86 122.03 22.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.346 1.058 . . . . 0.0 108.445 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mmt -89.28 -3.18 58.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.07 0.948 . . . . 0.0 112.252 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -136.63 83.09 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.321 2.01 . . . . 0.0 108.835 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 p -74.5 -60.67 2.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 128.158 2.583 . . . . 0.0 107.872 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.9 m -72.36 174.05 7.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.097 1.759 . . . . 0.0 109.27 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.1 m -61.46 -37.0 82.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 140.43 45.32 Favored Pre-proline 0 N--CA 1.44 -0.945 0 C-N-CA 125.842 1.657 . . . . 0.0 108.577 169.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.93 140.31 94.71 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.926 1.751 . . . . 0.0 108.558 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -76.36 -38.37 55.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -119.4 152.28 37.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.678 1.591 . . . . 0.0 109.542 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -126.52 -25.4 3.44 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.917 1.287 . . . . 0.0 110.149 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.36 130.96 10.49 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -157.9 130.51 7.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.891 1.345 . . . . 0.0 108.608 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -152.08 161.18 43.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.811 1.244 . . . . 0.0 109.084 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -111.52 134.45 53.1 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.05 153.24 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.485 -169.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 m -59.95 140.34 56.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.013 0.824 . . . . 0.0 109.212 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.93 -36.3 48.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -169.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -80.94 -21.81 40.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.008 1.276 . . . . 0.0 112.912 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -66.92 -45.59 53.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.88 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.7 -14.3 41.42 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.697 1.999 . . . . 0.0 113.759 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.1 t -67.57 -33.71 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -63.17 -34.96 78.76 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.812 -1.18 . . . . 0.0 111.689 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -82.76 -19.86 37.03 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -168.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 m -79.95 165.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 118.972 0.806 . . . . 0.0 110.32 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.73 176.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.911 1.285 . . . . 0.0 109.768 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.1 m -52.93 -50.38 64.13 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.683 1.593 . . . . 0.0 114.179 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -72.49 -26.93 61.97 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.972 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -84.29 -43.01 15.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.203 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -44.86 -45.25 10.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.992 0.917 . . . . 0.0 111.061 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.46 -35.66 76.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.877 0.871 . . . . 0.0 111.592 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 36.4 t -76.72 -49.94 22.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 124.792 1.237 . . . . 0.0 110.408 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.91 -35.35 78.12 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.716 0.807 . . . . 0.0 111.537 -168.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.02 -39.89 95.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.974 172.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -62.25 -47.01 86.27 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.633 1.106 . . . . 0.0 110.633 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 81.3 t -55.19 -33.1 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.425 1.011 . . . . 0.0 110.971 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.5 mmt -80.74 -56.89 3.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.896 0.878 . . . . 0.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -35.73 72.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.483 1.038 . . . . 0.0 111.852 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.06 -40.68 81.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.528 1.131 . . . . 0.0 111.614 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -111.04 -14.43 13.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.822 0.701 . . . . 0.0 110.961 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.88 62.48 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.701 1.601 . . . . 0.0 111.031 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.5 m -67.28 -31.62 72.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.339 0.656 . . . . 0.0 110.907 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.23 -45.04 72.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.44 -39.82 76.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.21 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.68 -52.51 62.14 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 120.887 1.676 . . . . 0.0 109.717 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.5 m -72.37 -27.13 62.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.223 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.95 -45.61 91.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.212 1.405 . . . . 0.0 109.701 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.35 -43.82 98.22 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.327 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.99 -34.6 71.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.768 0.827 . . . . 0.0 111.868 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -88.51 -27.2 21.61 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.579 -0.725 . . . . 0.0 109.095 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.298 9.7 t 40.1 59.72 7.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.782 . . . . 0.0 107.572 -169.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.25 162.4 41.95 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.797 1.665 . . . . 0.0 111.271 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.928 0.891 . . . . 0.0 108.717 -169.28 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 tmm? . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt -126.46 131.99 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.64 -61.99 2.19 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.497 0.719 . . . . 0.0 111.964 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -162.85 -53.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.01 18.22 16.52 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.651 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.65 9.33 61.44 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.642 0.639 . . . . 0.0 113.513 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -103.85 151.91 22.54 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.507 1.123 . . . . 0.0 108.607 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.57 148.85 63.05 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.369 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -90.36 141.12 3.34 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.746 2.297 . . . . 0.0 111.214 -175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.36 153.04 46.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.117 -0.989 . . . . 0.0 110.097 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.28 143.01 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.283 1.433 . . . . 0.0 108.798 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.19 162.66 24.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 123.922 0.772 . . . . 0.0 111.982 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 143.44 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.295 1.438 . . . . 0.0 108.155 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.81 134.7 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 168.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.37 136.83 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.7 p -124.7 162.76 23.49 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.881 0.764 . . . . 0.0 112.457 169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.5 p30 -110.56 172.93 6.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.557 1.543 . . . . 0.0 108.306 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.34 8.71 3.14 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.451 -1.406 . . . . 0.0 113.233 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -99.54 -1.92 37.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.512 1.525 . . . . 0.0 111.58 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.12 15.97 80.83 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 118.691 0.678 . . . . 0.0 112.022 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -83.96 151.42 25.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.45 150.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.058 1.743 . . . . 0.0 108.501 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -73.23 143.31 47.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -147.4 144.29 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.91 146.8 34.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.389 1.904 . . . . 0.0 112.872 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -88.98 117.88 28.3 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -71.99 151.25 43.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.849 1.204 . . . . 0.0 109.003 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -58.03 129.24 41.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.11 6.24 82.47 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.512 -1.16 . . . . 0.0 114.003 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -113.86 164.25 14.0 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.168 1.484 . . . . 0.0 110.046 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.94 -13.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.829 0.852 . . . . 0.0 111.952 172.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 p -84.38 154.12 23.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.372 1.469 . . . . 0.0 110.281 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -107.45 143.7 35.42 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -142.2 161.21 38.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.169 1.388 . . . . 0.0 110.151 -169.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -90.43 143.11 28.86 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.45 131.93 33.75 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.246 2.63 . . . . 0.0 112.088 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.31 164.8 36.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.05 167.64 40.17 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.324 0.488 . . . . 0.0 113.026 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.14 147.06 43.82 Favored Glycine 0 N--CA 1.444 -0.788 0 O-C-N 121.497 -1.002 . . . . 0.0 110.604 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.7 mt -74.61 129.36 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.45 148.31 95.33 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.94 123.88 14.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.96 1.774 . . . . 0.0 110.24 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.45 1.7 90.2 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.425 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.53 159.3 32.39 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.515 2.158 . . . . 0.0 111.016 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 m -85.06 148.65 26.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.29 -40.14 81.17 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.555 -0.716 . . . . 0.0 111.602 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.86 -35.44 76.92 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.812 0.845 . . . . 0.0 110.248 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -73.55 -39.49 64.69 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.253 -0.904 . . . . 0.0 110.145 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.25 70.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.98 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -59.2 -48.47 81.51 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.169 1.349 . . . . 0.0 108.503 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.5 -36.23 83.51 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.35 1.432 . . . . 0.0 111.854 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -59.18 -49.64 77.08 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.328 0.967 . . . . 0.0 110.066 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -77.14 -26.66 53.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 122.125 -0.359 . . . . 0.0 110.362 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.67 -45.26 85.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.139 -0.976 . . . . 0.0 109.093 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.95 -45.6 81.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.689 0.677 . . . . 0.0 110.958 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.53 -37.34 86.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.538 1.063 . . . . 0.0 112.447 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -94.36 -47.98 6.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.517 1.127 . . . . 0.0 110.955 -170.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.61 -33.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.83 1.252 . . . . 0.0 109.883 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.2 89.94 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.562 1.077 . . . . 0.0 112.226 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.7 tp -87.35 155.08 20.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.619 1.968 . . . . 0.0 109.634 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.8 m -133.52 167.35 20.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.126 0.97 . . . . 0.0 109.533 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -47.78 -33.46 7.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.869 2.067 . . . . 0.0 113.112 -173.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -65.6 -29.89 70.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.284 -171.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -112.46 24.77 12.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.543 1.065 . . . . 0.0 111.541 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.35 165.54 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.599 -1.313 . . . . 0.0 112.817 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.38 136.53 36.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.13 122.44 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt -93.83 -35.79 12.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.162 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.0 35.91 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.266 1.026 . . . . 0.0 109.904 -173.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.8 p -152.49 153.91 34.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.122 1.769 . . . . 0.0 108.829 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.2 135.48 55.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.799 -169.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -84.17 -32.35 24.65 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.943 1.297 . . . . 0.0 107.868 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.77 148.19 49.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.796 2.038 . . . . 0.0 109.865 172.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -74.69 139.58 43.6 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.68 84.66 5.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -82.01 144.25 31.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -147.6 144.57 28.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.09 145.47 24.37 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.84 145.38 91.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 124.845 1.258 . . . . 0.0 110.925 170.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.16 147.34 72.75 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 104.076 -3.086 . . . . 0.0 104.076 166.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -68.31 -13.83 62.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 119.927 -1.733 . . . . 0.0 114.509 -168.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -60.2 -29.71 68.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -95.67 -13.28 24.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.11 0.964 . . . . 0.0 112.819 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.77 133.28 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -96.42 91.52 5.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.285 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.14 -21.6 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.968 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.33 -29.09 57.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 t -99.57 163.88 12.31 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.577 1.151 . . . . 0.0 109.766 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -128.24 130.51 23.56 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.427 1.491 . . . . 0.0 107.022 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.44 159.98 95.31 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 O-C-N 123.043 1.023 . . . . 0.0 110.462 -9.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.14 132.21 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.2 p -87.04 126.78 34.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.14 -13.52 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.382 0.537 . . . . 0.0 112.312 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.48 37.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.24 156.69 32.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.65 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -106.7 126.55 52.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -119.47 128.67 54.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.692 0.678 . . . . 0.0 110.167 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.09 153.21 17.91 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -134.1 154.81 50.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.237 0.615 . . . . 0.0 109.434 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -135.74 129.62 32.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.5 tp -91.14 123.32 34.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 mp -115.71 155.16 28.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.635 1.174 . . . . 0.0 107.853 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -106.15 131.25 53.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.63 140.21 56.85 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.027 0.931 . . . . 0.0 108.957 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.6 t -88.15 -44.33 15.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -171.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -90.99 -29.44 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.046 0.538 . . . . 0.0 112.106 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.29 178.82 15.51 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.915 0.769 . . . . 0.0 111.28 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.86 -20.86 54.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.691 1.597 . . . . 0.0 114.035 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.8 66.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.276 0.631 . . . . 0.0 111.554 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.58 48.08 1.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.161 1.785 . . . . 0.0 111.506 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.7 mt -128.5 133.09 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -114.48 -51.54 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.696 0.798 . . . . 0.0 111.972 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.4 mtp 67.98 13.32 9.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.017 2.127 . . . . 0.0 114.735 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -151.87 71.03 0.96 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 124.166 1.936 . . . . 0.0 110.394 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -59.11 2.87 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 111.974 -2.375 . . . . 0.0 107.901 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.6 m -63.47 161.96 13.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.392 1.477 . . . . 0.0 109.756 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -58.56 -38.57 78.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 130.41 52.7 Favored Pre-proline 0 N--CA 1.442 -0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 110.3 170.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.51 143.62 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -83.25 -18.29 39.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.894 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.21 141.19 51.8 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.712 0.805 . . . . 0.0 110.321 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.19 -31.89 33.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.021 1.328 . . . . 0.0 110.669 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.87 29.0 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -125.26 151.28 46.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.161 . . . . 0.0 108.825 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.9 166.08 27.04 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -126.51 133.77 51.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.24 157.79 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.937 1.295 . . . . 0.0 110.956 -168.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 m -65.98 144.38 56.8 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -28.29 63.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -88.01 -20.22 26.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.562 1.528 . . . . 0.0 112.924 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.3 -47.92 92.79 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.699 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.54 -27.06 81.48 Favored 'Trans proline' 0 C--N 1.352 0.76 0 CA-C-N 122.828 2.046 . . . . 0.0 112.957 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.89 -27.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.089 1.356 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -65.99 -27.9 68.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.356 -0.84 . . . . 0.0 111.334 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -86.71 -24.36 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.49 156.56 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.805 0.73 . . . . 0.0 112.528 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.2 179.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 110.184 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.8 m -54.54 -52.12 63.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.662 1.585 . . . . 0.0 114.06 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -74.34 -38.73 63.17 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.81 -44.83 69.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.52 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -62.97 -31.81 73.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.349 0.977 . . . . 0.0 111.74 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.57 -42.9 99.84 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.707 0.685 . . . . 0.0 110.924 172.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.73 -51.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.32 -37.61 86.27 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.26 0.937 . . . . 0.0 110.152 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.643 1.111 . . . . 0.0 110.486 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -60.66 -43.39 97.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.877 1.217 . . . . 0.0 110.49 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.42 -24.46 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 119.788 1.176 . . . . 0.0 111.831 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.3 -57.3 2.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -56.14 -34.02 65.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.996 1.318 . . . . 0.0 112.606 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -65.0 -30.04 71.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.04 0.837 . . . . 0.0 111.412 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.39 -11.43 14.13 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.409 1.083 . . . . 0.0 112.684 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.35 69.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.111 1.364 . . . . 0.0 110.905 -171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -62.49 -37.96 88.02 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.262 1.425 . . . . 0.0 111.635 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.84 -42.87 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.21 -40.54 65.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-O 117.169 -1.396 . . . . 0.0 109.765 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.4 -54.11 49.49 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.764 1.62 . . . . 0.0 110.04 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 m -64.86 -32.21 73.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.531 1.133 . . . . 0.0 110.94 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -68.19 -31.01 70.25 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.326 1.85 . . . . 0.0 111.142 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -72.79 -44.58 61.35 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.961 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.28 -24.62 66.53 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.377 0.671 . . . . 0.0 112.461 -170.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -76.51 -36.27 57.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.338 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.6 t -160.34 79.55 2.45 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.856 0.753 . . . . 0.0 109.71 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.48 22.93 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.676 2.917 . . . . 0.0 113.928 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? . . . . . 0 C--O 1.252 1.227 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.162 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 tmm? . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 62.53 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 126.995 2.118 . . . . 0.0 110.757 -170.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -62.68 1.63 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.918 0.887 . . . . 0.0 112.125 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -163.04 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.34 0.186 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -100.84 20.65 14.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.641 1.177 . . . . 0.0 113.302 -169.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.49 18.38 49.04 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.494 0.568 . . . . 0.0 113.419 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -107.48 156.1 19.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.08 25.64 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.566 -1.207 . . . . 0.0 108.677 171.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -82.58 136.49 8.57 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.83 1.687 . . . . 0.0 110.454 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -133.86 160.73 36.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.403 1.481 . . . . 0.0 109.075 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.31 154.79 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 123.518 0.727 . . . . 0.0 109.946 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.24 156.64 23.1 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -116.43 141.98 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 125.499 1.519 . . . . 0.0 107.748 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.1 134.9 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.55 135.11 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.0 p -128.55 159.33 35.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.22 0.918 . . . . 0.0 112.289 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -110.17 177.3 4.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 108.78 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -75.87 0.36 18.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.405 -1.434 . . . . 0.0 112.995 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -88.21 -3.6 58.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.386 1.074 . . . . 0.0 111.013 172.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.67 76.59 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -90.31 143.27 26.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 m -108.45 145.89 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.513 1.525 . . . . 0.0 107.805 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -87.29 139.43 30.56 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -148.02 146.37 28.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.699 1.599 . . . . 0.0 107.051 -170.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.66 154.79 44.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.226 1.375 . . . . 0.0 113.577 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -98.54 118.23 34.77 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.193 1.797 . . . . 0.0 106.857 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -77.57 141.83 39.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 121.886 2.13 . . . . 0.0 108.471 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -55.13 127.1 27.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.368 1.067 . . . . 0.0 109.477 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -6.39 20.28 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.612 -1.104 . . . . 0.0 115.089 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -91.29 -32.13 15.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.787 1.794 . . . . 0.0 111.656 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.1 m80 64.55 -21.84 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.347 2.259 . . . . 0.0 114.611 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -75.9 160.76 29.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.298 1.439 . . . . 0.0 110.643 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.03 149.96 28.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.743 0.817 . . . . 0.0 110.939 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.89 155.38 42.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.362 1.865 . . . . 0.0 111.122 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -84.12 131.84 49.79 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -51.63 128.08 24.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.328 2.685 . . . . 0.0 112.3 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.36 164.54 36.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.751 1.16 . . . . 0.0 112.906 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.16 -178.97 42.75 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 123.458 0.551 . . . . 0.0 112.793 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.89 151.25 23.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.252 0.929 . . . . 0.0 111.913 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.91 126.9 38.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -74.08 156.39 87.78 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.69 122.19 10.66 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 109.038 -1.178 . . . . 0.0 109.038 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 0.0 87.98 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.643 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.14 154.35 41.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.361 2.081 . . . . 0.0 109.837 169.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.07 153.61 17.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.07 84.02 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.324 -0.86 . . . . 0.0 111.719 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.81 -31.95 70.13 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.288 0.635 . . . . 0.0 110.367 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -70.93 -39.6 72.57 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.271 -0.893 . . . . 0.0 109.792 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.31 83.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -63.3 -50.72 68.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.792 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 55.8 m-85 -66.72 -33.06 74.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.926 1.239 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -60.86 -50.28 74.05 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.07 1.305 . . . . 0.0 109.187 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.27 -27.58 62.58 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.384 0.538 . . . . 0.0 110.33 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.69 -43.43 90.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 109.454 170.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -69.55 -48.76 59.26 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.474 0.579 . . . . 0.0 110.834 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.85 -30.7 69.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.988 1.267 . . . . 0.0 112.609 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -93.29 -51.48 4.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.153 0.981 . . . . 0.0 110.532 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.61 -31.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.267 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.17 -1.85 78.73 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.464 1.03 . . . . 0.0 112.275 -171.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.76 155.74 32.93 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.645 1.978 . . . . 0.0 108.854 174.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.5 p -133.09 170.3 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.988 0.915 . . . . 0.0 110.466 -172.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 37.3 mtp180 -46.13 -37.15 6.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.819 2.047 . . . . 0.0 112.52 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -68.77 -26.04 65.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.385 0.674 . . . . 0.0 112.525 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.36 23.59 12.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.522 0.677 . . . . 0.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.5 165.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 O-C-N 120.734 -1.229 . . . . 0.0 112.729 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.83 132.94 29.61 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -73.69 116.21 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.6 mt -89.63 -36.88 15.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.426 174.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.41 164.7 36.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.864 0.865 . . . . 0.0 109.749 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 p -162.63 153.41 17.11 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.795 1.238 . . . . 0.0 110.265 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.6 p -71.89 138.76 48.41 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.635 -0.666 . . . . 0.0 109.579 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -77.86 -51.41 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -70.26 171.12 10.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 110.962 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE3' ' HB2' ' A' ' 98' ' ' LYS . 84.2 m95 -112.38 123.72 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 168.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -79.2 142.32 36.38 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.62 152.35 43.9 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.289 1.036 . . . . 0.0 108.955 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -140.3 139.78 35.55 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.974 1.31 . . . . 0.0 108.115 169.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -77.27 139.04 39.74 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.68 139.17 95.76 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.766 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -68.2 145.36 66.19 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 104.431 -2.95 . . . . 0.0 104.431 167.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -67.96 -12.94 61.72 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.05 -1.657 . . . . 0.0 114.16 -168.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.11 -31.01 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.809 0.732 . . . . 0.0 112.806 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.5 -20.01 21.4 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.776 0.83 . . . . 0.0 112.085 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.16 135.28 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -101.37 89.89 3.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 109.807 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.8 -22.31 63.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.918 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -74.86 -19.22 60.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.573 0.749 . . . . 0.0 112.728 -171.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -117.37 161.0 20.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.487 1.115 . . . . 0.0 109.957 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -128.24 135.45 27.55 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 125.178 1.391 . . . . 0.0 109.59 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.48 148.56 92.16 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 O-C-N 122.731 0.858 . . . . 0.0 110.384 -10.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.76 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 109.532 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.5 p -89.91 138.58 31.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.0 109.566 170.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.44 -13.07 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 170.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.29 -174.05 31.72 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.09 -178.23 6.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.593 1.157 . . . . 0.0 109.02 -172.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -127.33 137.26 52.76 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 104.322 -2.474 . . . . 0.0 104.322 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -122.59 122.7 39.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 120.82 1.646 . . . . 0.0 107.951 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.404 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 10.2 ttmm -111.78 129.1 56.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -114.27 152.21 31.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -134.78 121.73 21.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.9 tp -88.67 119.64 29.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.56 144.46 43.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -97.47 132.7 42.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 141.93 58.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 108.923 171.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.91 -48.79 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.568 0.622 . . . . 0.0 109.827 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.5 m -89.33 -19.58 25.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.408 0.683 . . . . 0.0 111.786 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.59 20.67 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.42 -22.35 31.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.093 1.757 . . . . 0.0 113.105 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.08 59.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 113.438 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -92.62 16.55 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.73 139.73 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.694 1.198 . . . . 0.0 108.088 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -120.6 -50.98 2.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.593 0.757 . . . . 0.0 112.304 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.2 mtp 70.44 9.25 6.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.84 2.456 . . . . 0.0 115.122 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.71 76.96 1.03 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 124.016 1.865 . . . . 0.0 110.184 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.85 -59.58 2.67 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.05 -2.341 . . . . 0.0 107.695 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -66.37 162.73 19.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.157 1.383 . . . . 0.0 109.452 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 m -63.01 -33.73 76.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.087 0.555 . . . . 0.0 110.367 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 128.95 52.89 Favored Pre-proline 0 N--CA 1.447 -0.587 0 C-N-CA 124.911 1.284 . . . . 0.0 110.193 170.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.88 137.23 48.3 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.357 2.038 . . . . 0.0 108.097 168.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.83 -16.0 59.56 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.876 -0.515 . . . . 0.0 111.566 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -119.91 138.43 53.43 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.63 -26.73 45.3 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.924 1.29 . . . . 0.0 111.255 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.84 162.37 34.55 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 153.74 45.93 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.306 1.043 . . . . 0.0 108.193 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -152.42 159.63 43.37 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -109.38 131.99 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.72 170.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.062 1.745 . . . . 0.0 109.739 -169.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.8 p -65.41 166.82 9.57 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -18.65 64.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.858 172.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -98.81 -31.62 11.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 113.225 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.21 -43.98 96.21 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.84 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.36 -24.84 76.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 122.508 1.931 . . . . 0.0 113.264 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.7 t -67.55 -41.4 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -57.68 -35.53 70.72 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.528 -0.732 . . . . 0.0 111.963 -171.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -79.13 -26.4 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.46 171.66 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 118.499 0.591 . . . . 0.0 112.127 -172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 175.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.9 m -54.7 -49.99 69.39 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.031 1.733 . . . . 0.0 114.208 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -72.35 -32.34 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.178 -0.952 . . . . 0.0 111.459 -174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.1 -39.96 32.38 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.221 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -47.25 -46.2 24.32 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.899 0.88 . . . . 0.0 110.733 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.12 -45.76 92.02 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.245 0.341 . . . . 0.0 110.287 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.5 -46.86 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.772 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -62.01 -47.68 83.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.45 -42.18 96.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.349 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.64 -49.69 76.5 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.436 1.017 . . . . 0.0 110.5 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.9 t -56.68 -42.58 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.217 1.007 . . . . 0.0 109.39 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.7 mmt -67.43 -51.81 47.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.268 1.027 . . . . 0.0 108.273 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -37.03 69.91 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.804 0.842 . . . . 0.0 110.729 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.18 -35.33 73.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 118.797 0.726 . . . . 0.0 111.526 -174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.62 -13.49 15.29 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.641 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.21 -39.13 63.49 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.401 1.48 . . . . 0.0 110.949 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -66.86 -32.07 73.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.289 0.636 . . . . 0.0 110.722 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.2 -44.95 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.4 -40.54 78.64 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 CA-C-O 117.365 -1.303 . . . . 0.0 110.097 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -56.07 -51.93 66.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 120.82 1.645 . . . . 0.0 109.969 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -71.25 -28.7 64.36 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.93 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.37 -41.11 98.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.084 1.354 . . . . 0.0 110.184 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.8 -43.98 97.38 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.66 -30.02 66.51 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -86.69 -15.69 38.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.595 -170.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.255 33.7 p 41.83 63.81 6.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 126.802 2.041 . . . . 0.0 109.441 -174.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.98 -178.93 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 121.507 1.472 . . . . 0.0 114.171 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt . . . . . 0 C--O 1.252 1.197 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HG3' ' H ' ' A' ' 2' ' ' ILE 0.276 13.7 ptm . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.419 ' H ' ' HG3' ' A' ' 1' ' ' MET 0.264 0.9 OUTLIER 66.76 134.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.886 2.075 . . . . 0.0 109.41 -168.761 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.85 -68.19 0.45 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.456 0.702 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -163.06 -51.68 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.969 0.908 . . . . 0.0 112.421 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.04 17.04 14.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 112.82 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.54 7.09 65.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.36 0.981 . . . . 0.0 113.741 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -96.19 155.66 16.67 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.49 152.65 71.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.649 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -88.11 134.87 3.14 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.276 1.984 . . . . 0.0 111.135 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -131.79 163.92 27.17 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.022 1.329 . . . . 0.0 109.484 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.04 167.77 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.263 175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 163.08 33.3 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.82 144.94 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.1 137.91 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.81 133.19 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.7 m -124.45 145.59 49.42 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.814 0.696 . . . . 0.0 110.571 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -97.74 170.58 8.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.849 1.259 . . . . 0.0 108.626 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.61 8.56 3.46 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.039 -1.663 . . . . 0.0 113.151 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.63 -3.68 54.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.386 1.075 . . . . 0.0 111.164 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.35 18.69 79.89 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 118.861 0.755 . . . . 0.0 112.071 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -90.23 141.42 28.72 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.31 147.74 12.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.081 1.753 . . . . 0.0 108.452 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.6 ttm -65.86 138.58 57.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.583 0.753 . . . . 0.0 109.337 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -142.82 140.36 31.28 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.78 1.632 . . . . 0.0 106.833 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.17 161.68 36.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.66 1.118 . . . . 0.0 112.187 -171.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -118.97 118.88 32.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.555 1.942 . . . . 0.0 106.978 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -67.21 150.68 48.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.605 1.093 . . . . 0.0 108.873 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.41 142.35 58.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.35 6.57 75.88 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.318 -1.268 . . . . 0.0 114.038 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -134.03 157.21 46.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.543 1.671 . . . . 0.0 109.612 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -98.42 -14.12 20.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.864 0.466 . . . . 0.0 112.227 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -78.57 152.24 31.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.397 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -110.6 158.17 18.87 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.461 1.104 . . . . 0.0 111.155 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -159.74 159.31 32.67 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.728 1.211 . . . . 0.0 110.396 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.73 157.49 71.92 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.84 134.65 60.02 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -131.26 169.59 15.76 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.059 1.344 . . . . 0.0 112.282 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.08 169.61 38.29 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.571 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.7 137.24 13.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.3 mt -75.14 126.24 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -84.65 150.41 56.43 Favored Pre-proline 0 C--O 1.235 0.324 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.26 122.18 10.28 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.775 1.65 . . . . 0.0 109.832 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.79 -20.64 43.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.845 1.212 . . . . 0.0 113.469 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.08 152.92 42.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.722 1.761 . . . . 0.0 109.941 170.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.2 p -83.43 169.8 15.16 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.1 80.55 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 122.001 -0.437 . . . . 0.0 110.461 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.74 -38.79 64.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.592 0.757 . . . . 0.0 110.586 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -67.82 -41.32 83.24 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.251 -0.906 . . . . 0.0 110.03 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -36.41 81.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.956 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.57 -53.72 52.93 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.147 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -67.68 -42.19 82.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.302 0.955 . . . . 0.0 111.706 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -45.44 94.79 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.971 0.509 . . . . 0.0 109.942 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.76 -31.13 35.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.094 -0.479 . . . . 0.0 110.227 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.9 tp -53.27 -43.27 67.29 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.709 0.686 . . . . 0.0 110.091 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -57.14 -38.21 73.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.464 0.574 . . . . 0.0 111.231 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -70.29 -20.89 63.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.097 0.862 . . . . 0.0 111.734 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -94.73 -48.88 5.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.357 1.063 . . . . 0.0 110.936 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 60' ' ' LEU . 3.5 p -120.17 -3.3 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.759 1.224 . . . . 0.0 112.413 -169.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.83 1.02 9.85 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 121.24 -0.913 . . . . 0.0 112.957 -170.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.446 ' H ' HG13 ' A' ' 58' ' ' VAL . 14.6 tp -79.08 144.07 34.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.277 1.031 . . . . 0.0 110.002 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 p -122.5 164.43 18.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.647 1.179 . . . . 0.0 109.498 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -40.71 -38.87 0.97 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.168 1.787 . . . . 0.0 112.616 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -67.34 -20.33 65.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.269 -169.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.72 21.03 10.91 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.527 0.603 . . . . 0.0 112.528 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.61 160.36 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.925 -1.109 . . . . 0.0 110.73 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -138.12 137.37 37.64 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.13 120.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.76 -36.77 11.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.721 172.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.56 164.3 34.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.127 0.971 . . . . 0.0 109.523 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.0 p -160.42 151.47 19.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.267 1.427 . . . . 0.0 109.897 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -69.09 131.47 45.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.729 0.776 . . . . 0.0 109.645 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -79.81 -48.16 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -75.53 179.94 4.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.44 2.296 . . . . 0.0 108.247 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.536 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 73.2 m95 -114.49 142.91 45.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 168.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.37 85.43 6.57 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -81.44 144.01 31.69 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.43 147.93 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.41 144.67 25.36 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.8 mt -73.05 144.88 85.52 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 124.998 1.319 . . . . 0.0 111.302 171.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.32 149.26 69.46 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 105.174 -2.664 . . . . 0.0 105.174 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -68.73 -13.46 62.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.944 -1.723 . . . . 0.0 113.956 -169.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -61.76 -30.78 71.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.094 0.861 . . . . 0.0 112.789 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.64 -18.16 21.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.906 0.883 . . . . 0.0 112.123 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.61 134.9 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -98.9 89.83 4.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.71 0.804 . . . . 0.0 109.687 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.5 -21.2 62.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.082 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.81 -30.55 56.46 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 t -97.64 162.15 13.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.576 1.15 . . . . 0.0 109.523 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -130.67 132.43 23.94 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.529 1.532 . . . . 0.0 108.319 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.25 157.33 93.54 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 O-C-N 122.72 0.853 . . . . 0.0 111.307 -10.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.4 t -74.45 138.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.889 0.876 . . . . 0.0 109.455 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 p -89.13 122.64 32.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.899 0.88 . . . . 0.0 108.726 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -14.56 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.184 0.902 . . . . 0.0 113.296 172.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.57 38.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -158.19 158.92 35.48 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.052 0.941 . . . . 0.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -101.5 124.82 47.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 169.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.22 123.9 50.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.903 1.229 . . . . 0.0 109.548 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -86.73 149.33 24.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -127.99 153.89 46.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.057 0.844 . . . . 0.0 109.467 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -134.36 134.29 41.58 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.833 1.253 . . . . 0.0 108.451 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.9 tp -98.08 120.86 39.22 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mt -116.97 146.83 42.77 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -97.42 135.69 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 168.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.55 132.38 49.72 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.0 t -81.29 -46.0 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 122.74 0.416 . . . . 0.0 110.256 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 t -83.12 -37.31 23.94 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.0 -169.04 12.82 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -170.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 -15.88 38.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.61 1.564 . . . . 0.0 114.307 -172.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.03 63.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 0.0 113.031 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -95.12 26.18 3.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.19 0.996 . . . . 0.0 113.357 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 89.7 mt -99.58 139.98 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.808 1.243 . . . . 0.0 108.765 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -138.98 117.2 11.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.779 1.232 . . . . 0.0 109.757 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 mmt -89.78 -4.29 57.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.424 0.69 . . . . 0.0 112.58 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -119.8 75.5 1.08 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 124.207 1.956 . . . . 0.0 107.145 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 p -65.48 -65.07 0.72 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 111.204 -2.725 . . . . 0.0 106.777 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -78.48 173.63 12.17 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -58.1 -42.15 85.05 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.166 -0.959 . . . . 0.0 109.168 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 134.91 82.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 108.512 169.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -62.16 135.36 54.15 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 107.537 -1.755 . . . . 0.0 107.537 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -85.17 -34.21 22.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -109.88 135.82 50.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -75.03 -35.08 61.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.671 0.788 . . . . 0.0 110.475 173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.48 29.84 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.84 158.77 44.41 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.566 0.746 . . . . 0.0 109.057 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -145.9 167.57 22.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.916 1.286 . . . . 0.0 108.828 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -109.9 129.7 55.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.46 153.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.815 1.246 . . . . 0.0 110.714 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 m -57.85 143.04 43.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.036 0.835 . . . . 0.0 109.835 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -32.87 61.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -83.84 -21.23 32.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.158 1.344 . . . . 0.0 112.692 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -60.11 -50.79 84.5 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.118 -1.42 . . . . 0.0 113.407 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.84 -27.7 85.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 122.681 1.993 . . . . 0.0 113.291 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.69 -31.59 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.848 0.859 . . . . 0.0 109.013 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -66.22 -24.42 66.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.163 -0.961 . . . . 0.0 111.679 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.94 -27.91 28.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.14 168.58 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 118.744 0.702 . . . . 0.0 112.397 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -83.16 175.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.379 1.471 . . . . 0.0 110.487 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 m -52.44 -51.4 59.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.825 1.65 . . . . 0.0 114.586 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -74.05 -36.77 64.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.458 1.026 . . . . 0.0 110.716 -175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.05 -36.61 66.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.51 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -51.28 -45.14 62.03 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.106 0.866 . . . . 0.0 110.493 171.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.63 -42.98 95.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.503 0.592 . . . . 0.0 110.926 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.15 -52.62 56.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.55 -32.56 74.21 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.211 -0.93 . . . . 0.0 111.24 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -67.27 -42.83 83.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.237 1.38 . . . . 0.0 110.327 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.41 -42.65 96.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.76 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.2 -25.95 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.49 1.041 . . . . 0.0 111.427 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -88.42 -58.66 2.48 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -33.41 70.47 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.716 1.207 . . . . 0.0 112.501 -172.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.72 -40.12 78.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.391 0.996 . . . . 0.0 110.565 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -106.42 -9.86 16.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.272 1.029 . . . . 0.0 112.952 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.33 73.12 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 125.187 1.395 . . . . 0.0 110.594 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -67.13 -31.98 72.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.677 0.791 . . . . 0.0 110.653 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.75 -43.63 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.31 -41.36 81.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.083 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -46.53 87.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 120.478 1.49 . . . . 0.0 110.53 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 t -66.46 -28.45 68.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 110.689 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.7 tp -69.59 -31.34 69.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.299 -1.501 . . . . 0.0 109.875 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -75.76 -25.74 56.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.67 -9.3 56.78 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.026 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.62 20.98 4.24 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.977 0.894 . . . . 0.0 108.915 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.385 24.6 p 73.71 140.61 0.08 OUTLIER Pre-proline 0 N--CA 1.436 -1.149 1 C-N-CA 133.386 4.674 . . . . 0.0 114.434 170.521 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.34 33.46 0.51 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.444 2.096 . . . . 0.0 113.061 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.254 1.329 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.154 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tmm? . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt -132.16 130.88 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.53 -68.37 0.34 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.0 -49.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -87.02 11.32 13.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.104 0.962 . . . . 0.0 112.735 -169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.63 -8.4 79.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.698 1.142 . . . . 0.0 113.069 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -90.4 159.13 16.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.263 1.032 . . . . 0.0 108.498 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -137.65 142.33 36.42 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.248 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -89.34 135.91 2.71 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.879 1.719 . . . . 0.0 111.035 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.3 159.75 41.25 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.158 -0.964 . . . . 0.0 110.387 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.56 159.8 34.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 119.538 1.063 . . . . 0.0 110.418 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.88 160.21 24.21 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.05 143.66 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.182 1.393 . . . . 0.0 107.762 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.01 136.93 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm -121.09 133.03 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.0 p -124.97 156.65 37.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.506 0.594 . . . . 0.0 111.623 170.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -104.51 172.73 6.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.438 1.495 . . . . 0.0 108.18 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -73.79 2.6 8.01 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.269 -1.519 . . . . 0.0 113.119 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -88.01 -4.84 58.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.069 0.947 . . . . 0.0 111.277 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.57 19.87 79.75 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.943 0.792 . . . . 0.0 111.601 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.87 147.01 25.3 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.09 148.72 17.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.171 1.789 . . . . 0.0 107.058 174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.6 ptm -76.12 148.5 37.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.392 0.542 . . . . 0.0 109.863 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -148.22 140.1 23.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -174.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.32 148.17 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.426 1.466 . . . . 0.0 113.087 -169.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -101.06 115.29 30.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.661 1.984 . . . . 0.0 106.559 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -68.75 151.6 46.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.663 1.119 . . . . 0.0 109.226 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.32 132.52 54.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.46 85.03 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.746 1.165 . . . . 0.0 113.726 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -115.3 162.32 17.27 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.33 1.565 . . . . 0.0 110.296 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.62 -13.68 16.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.479 0.711 . . . . 0.0 111.662 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -86.34 150.35 24.39 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.726 1.61 . . . . 0.0 110.968 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -103.61 151.64 22.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.141 0.977 . . . . 0.0 110.061 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -155.18 166.87 32.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.139 1.376 . . . . 0.0 110.211 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -85.38 155.15 59.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.95 127.2 19.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.321 2.014 . . . . 0.0 110.473 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -157.55 163.55 38.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.69 44.26 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.792 -0.567 . . . . 0.0 113.454 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.75 152.6 41.06 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 124.733 1.159 . . . . 0.0 112.075 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.2 mt -84.03 122.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.22 159.38 85.58 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.0 123.87 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 121.199 1.266 . . . . 0.0 109.414 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.17 -6.07 80.79 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 118.772 -1.015 . . . . 0.0 114.646 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.37 156.55 39.36 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.043 1.922 . . . . 0.0 109.227 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -93.26 167.29 11.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.67 83.37 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.62 -0.675 . . . . 0.0 110.987 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -36.46 69.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.299 0.64 . . . . 0.0 110.503 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.76 -36.21 70.33 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.893 -1.129 . . . . 0.0 110.629 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.21 86.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -63.4 -51.74 64.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.104 -0.951 . . . . 0.0 108.672 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -66.76 -31.74 72.59 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 112.133 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -63.69 -52.95 58.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.528 1.058 . . . . 0.0 109.071 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -71.23 -25.07 62.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -172.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.73 -42.51 88.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 171.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -71.91 -50.14 31.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.121 0.873 . . . . 0.0 110.753 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.28 -21.92 66.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.905 1.229 . . . . 0.0 112.806 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.39 -53.5 2.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.791 1.236 . . . . 0.0 111.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.2 -21.92 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 112.396 -168.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 -3.19 33.66 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.204 1.383 . . . . 0.0 112.887 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.77 157.95 34.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.712 2.005 . . . . 0.0 109.768 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 p -137.11 168.15 20.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 110.185 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -53.14 -34.09 55.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.099 1.76 . . . . 0.0 112.292 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.781 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.95 24.39 12.72 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.844 1.202 . . . . 0.0 111.419 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.74 166.06 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.912 -1.118 . . . . 0.0 112.266 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 133.73 27.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.599 169.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.57 113.01 10.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.16 -34.0 18.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.489 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.44 39.12 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 109.759 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 p -158.66 154.33 26.26 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.112 1.365 . . . . 0.0 110.04 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -69.04 139.72 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.508 0.671 . . . . 0.0 111.472 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -86.11 -28.48 23.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.804 1.642 . . . . 0.0 109.838 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -121.77 148.64 44.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.022 2.129 . . . . 0.0 108.536 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -80.68 133.39 35.7 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.24 64.79 7.06 Favored 'General case' 0 N--CA 1.46 0.072 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -71.52 146.17 48.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -142.94 145.53 33.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.285 0.634 . . . . 0.0 110.256 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.26 147.04 23.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.87 148.06 98.92 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.823 0.849 . . . . 0.0 109.782 169.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -66.92 143.86 68.11 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 N-CA-C 104.311 -2.996 . . . . 0.0 104.311 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -67.99 -13.07 61.89 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.051 -1.656 . . . . 0.0 114.135 -168.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -57.15 -30.56 64.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 170.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.8 mt -91.79 -20.49 21.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.382 0.673 . . . . 0.0 112.034 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.17 135.23 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -103.34 89.97 3.56 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.188 0.995 . . . . 0.0 108.486 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -65.28 -9.31 23.1 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.17 27.93 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.443 1.097 . . . . 0.0 110.472 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.6 p -77.16 157.72 30.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.113 0.959 . . . . 0.0 112.873 -169.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -130.56 110.16 16.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.697 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.37 142.26 64.97 Favored 'Cis proline' 0 CA--C 1.537 0.66 0 N-CA-C 108.09 -1.542 . . . . 0.0 108.09 -11.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 p -64.47 133.96 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 O-C-N 121.659 -0.65 . . . . 0.0 110.79 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.3 t -72.57 124.73 25.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.97 -14.9 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.24 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.42 -179.56 48.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 119.689 1.131 . . . . 0.0 110.342 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.77 152.98 45.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.308 . . . . 0.0 110.037 173.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.55 135.51 34.75 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -128.42 129.34 46.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.09 0.859 . . . . 0.0 110.485 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -111.92 142.02 44.84 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -124.2 155.28 38.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.417 0.553 . . . . 0.0 109.703 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -137.73 125.64 22.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.9 tp -92.33 122.77 35.11 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 168.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mt -117.87 148.28 42.27 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -97.34 132.37 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.76 138.31 58.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.881 1.272 . . . . 0.0 108.922 171.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -88.38 -49.45 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.241 0.616 . . . . 0.0 110.09 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.2 m -87.08 -19.38 28.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.77 -169.39 20.13 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -20.42 44.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.649 1.58 . . . . 0.0 113.792 -171.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -30.58 43.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.508 1.123 . . . . 0.0 112.839 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.87 13.0 23.97 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 66.9 mt -85.17 137.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -136.7 105.2 5.77 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.1 mmt -82.67 1.7 37.17 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.67 73.97 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 123.942 1.83 . . . . 0.0 107.961 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -70.05 -64.13 0.95 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.589 -2.096 . . . . 0.0 105.558 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.0 m -72.44 167.24 20.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.459 1.503 . . . . 0.0 107.647 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 m -61.46 -41.16 96.79 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.286 -0.884 . . . . 0.0 109.171 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.49 132.76 89.27 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.67 1.588 . . . . 0.0 109.387 170.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.94 143.3 99.32 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.763 1.642 . . . . 0.0 109.537 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -86.74 -21.1 26.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.76 0.424 . . . . 0.0 110.673 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -128.37 144.07 51.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.067 0.947 . . . . 0.0 109.136 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.74 -30.52 59.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.152 0.981 . . . . 0.0 110.522 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.86 155.54 26.44 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 150.39 37.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -146.58 170.28 17.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 109.13 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -116.2 137.23 52.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.05 154.17 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 109.954 -169.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.8 m -60.32 144.06 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.947 0.794 . . . . 0.0 109.504 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -25.42 63.83 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -88.66 -10.9 46.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.403 1.456 . . . . 0.0 113.38 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -72.79 -47.35 8.9 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.608 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.84 -24.53 68.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.903 2.073 . . . . 0.0 112.921 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.2 -30.77 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.268 1.027 . . . . 0.0 109.273 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.06 -24.4 63.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.042 -1.036 . . . . 0.0 111.514 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -81.18 -30.12 34.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.068 0.849 . . . . 0.0 112.87 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.12 168.43 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.554 0.615 . . . . 0.0 112.638 -169.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -85.13 175.33 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.206 1.402 . . . . 0.0 110.417 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -52.65 -50.68 62.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.617 1.567 . . . . 0.0 114.64 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -74.16 -34.74 63.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.142 0.883 . . . . 0.0 110.984 -175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.4 -37.92 60.2 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.705 -0.622 . . . . 0.0 110.353 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -50.18 -44.11 52.73 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.538 171.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -65.45 -41.52 93.34 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.626 0.648 . . . . 0.0 111.064 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.9 -53.0 46.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -65.11 -31.93 73.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.385 0.993 . . . . 0.0 112.229 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -66.21 -44.6 83.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.255 1.389 . . . . 0.0 110.276 171.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -59.54 -43.76 93.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.378 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.8 t -56.95 -27.95 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.571 1.148 . . . . 0.0 111.779 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -87.75 -58.18 2.67 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -58.18 -36.07 72.52 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.082 0.953 . . . . 0.0 112.276 -173.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.81 -36.82 75.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 119.086 0.857 . . . . 0.0 110.723 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -105.27 -12.76 15.93 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.055 0.942 . . . . 0.0 112.337 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.96 68.7 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.416 1.487 . . . . 0.0 110.78 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 m -68.19 -30.65 69.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.759 0.823 . . . . 0.0 111.058 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.9 t -69.68 -43.03 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.72 -43.88 88.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.545 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -45.19 84.37 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 121.991 2.178 . . . . 0.0 111.666 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -81.2 -8.71 59.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 125.146 1.378 . . . . 0.0 111.924 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.84 -42.5 19.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 120.417 -1.427 . . . . 0.0 108.851 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.45 -41.8 90.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.628 ' C ' HD21 ' A' ' 161' ' ' ASN . 38.4 mt-10 -89.56 40.99 1.02 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.195 1.398 . . . . 0.0 114.226 170.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.628 HD21 ' C ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER 39.21 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 136.257 5.823 . . . . 0.0 120.679 165.458 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.3 t -136.04 77.28 49.93 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.85 158.44 51.06 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.167 1.911 . . . . 0.0 110.296 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.253 1.248 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.531 -169.682 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 119.007 -0.52 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.03 143.95 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.48 -77.46 0.07 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.682 0.793 . . . . 0.0 110.903 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -164.47 -44.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -91.79 16.89 9.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.712 1.205 . . . . 0.0 113.072 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 17.29 60.28 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.11 0.862 . . . . 0.0 112.929 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -111.93 155.31 23.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.8 128.08 22.92 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.44 141.27 46.07 Favored 'Trans proline' 0 C--N 1.345 0.391 0 CA-C-N 121.328 1.51 . . . . 0.0 110.053 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -138.43 148.24 44.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.78 0.832 . . . . 0.0 109.214 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.52 149.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.206 1.402 . . . . 0.0 108.081 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.85 161.6 28.08 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 122.043 -0.411 . . . . 0.0 112.246 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.21 143.2 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 122.991 0.517 . . . . 0.0 109.933 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -122.44 131.59 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 mm -108.39 130.96 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.2 m -111.98 146.82 37.18 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 124.362 1.039 . . . . 0.0 109.289 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -98.78 176.65 5.54 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 14.38 3.71 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.905 -1.122 . . . . 0.0 113.028 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -106.35 -3.85 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.587 1.555 . . . . 0.0 111.307 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.47 83.22 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.756 -170.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -80.56 149.8 29.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.075 1.438 . . . . 0.0 107.477 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.03 153.49 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.969 2.107 . . . . 0.0 108.424 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.7 ptm -68.18 153.7 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.845 0.458 . . . . 0.0 110.713 171.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -154.74 132.34 11.33 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.03 150.54 41.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.39 1.45 . . . . 0.0 111.468 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -102.4 115.57 30.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -70.1 149.07 47.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.844 1.656 . . . . 0.0 109.644 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.67 140.91 57.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.16 85.96 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.219 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -123.34 169.08 11.69 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.025 1.413 . . . . 0.0 109.812 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -125.69 27.61 6.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.11 1.364 . . . . 0.0 108.93 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -125.35 143.3 51.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.042 1.337 . . . . 0.0 108.458 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -99.48 149.48 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.812 0.845 . . . . 0.0 110.491 -174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -159.77 168.65 25.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.918 1.287 . . . . 0.0 110.214 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.83 152.54 66.24 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -46.99 129.57 15.07 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.582 2.855 . . . . 0.0 111.443 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -161.35 155.88 23.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.163 0.985 . . . . 0.0 110.176 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.55 168.21 40.84 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.265 0.935 . . . . 0.0 111.664 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.03 147.4 39.57 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -74.78 113.36 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.68 144.59 96.27 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.39 127.18 24.49 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.681 1.587 . . . . 0.0 110.883 -169.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.34 -8.83 77.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 114.15 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.64 152.84 39.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.829 1.814 . . . . 0.0 111.273 171.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.0 p -86.62 166.81 15.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 167.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.78 77.07 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 120.723 -1.236 . . . . 0.0 111.588 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.92 -38.3 61.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.362 0.665 . . . . 0.0 110.534 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -66.55 -40.27 88.97 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.55 -33.26 72.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.904 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -56.75 -50.42 72.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -66.67 -44.67 81.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.915 0.78 . . . . 0.0 111.84 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -54.92 -52.02 64.25 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.474 1.034 . . . . 0.0 111.04 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.96 -36.14 64.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.5 tp -53.42 -51.14 63.57 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.409 0.684 . . . . 0.0 110.129 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.78 -43.23 99.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -63.42 -23.51 67.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.728 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.81 -35.9 4.03 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 120.495 1.498 . . . . 0.0 113.385 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.02 5.04 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 119.373 0.988 . . . . 0.0 111.959 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.55 -4.3 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.781 -1.2 . . . . 0.0 114.869 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.1 144.26 34.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.887 1.675 . . . . 0.0 109.987 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -122.58 163.0 20.79 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.296 1.038 . . . . 0.0 109.813 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -42.02 -40.59 2.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.876 2.07 . . . . 0.0 112.527 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -67.84 -20.86 65.2 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.37 -0.824 . . . . 0.0 113.131 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.56 20.69 15.78 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.366 0.53 . . . . 0.0 111.516 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -137.68 161.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 O-C-N 120.533 -1.354 . . . . 0.0 112.896 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.55 138.81 46.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.09 121.09 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.3 mt -94.77 -36.1 11.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.563 0.745 . . . . 0.0 109.77 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.06 164.8 27.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.64 1.176 . . . . 0.0 109.546 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 p -155.54 154.93 32.51 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.593 1.557 . . . . 0.0 108.896 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.25 136.73 57.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.02 0.914 . . . . 0.0 111.106 -169.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtt-85 -80.16 -30.49 38.87 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.061 1.745 . . . . 0.0 108.419 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 146.6 52.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.202 2.201 . . . . 0.0 109.565 176.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.406 ' CE2' ' HE2' ' A' ' 98' ' ' LYS . 86.6 m95 -73.89 143.43 45.79 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.94 86.37 6.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -68.85 142.59 54.79 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -137.13 142.31 42.26 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.089 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -131.99 141.48 49.29 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.538 2.335 . . . . 0.0 106.451 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER -104.87 148.42 36.08 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.1 153.87 62.53 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.447 2.765 . . . . 0.0 109.148 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -59.55 -31.09 69.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 170.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.4 mt -90.77 -15.35 30.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.694 0.798 . . . . 0.0 112.042 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.57 133.37 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -94.51 93.66 7.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.544 0.738 . . . . 0.0 109.195 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -71.09 -23.73 62.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.126 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.81 -26.45 57.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.227 0.611 . . . . 0.0 112.485 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -104.6 156.16 18.21 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.726 0.81 . . . . 0.0 109.249 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.23 137.54 31.09 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 124.94 1.296 . . . . 0.0 109.974 -169.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.23 144.13 80.03 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.807 0.898 . . . . 0.0 110.309 -10.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 141.76 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.014 0.926 . . . . 0.0 110.351 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 p -100.25 140.93 33.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.397 1.079 . . . . 0.0 110.794 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.05 -14.34 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.341 0.656 . . . . 0.0 112.505 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.01 -175.18 36.19 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -164.39 164.93 21.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.317 1.447 . . . . 0.0 110.124 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.41 117.63 34.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 120.341 1.428 . . . . 0.0 108.528 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 74' ' ' TRP . 1.2 tttm -94.53 152.86 18.22 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -136.59 150.54 48.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.299 0.5 . . . . 0.0 109.806 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -136.57 127.53 27.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.65 117.85 30.11 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.29 157.68 19.87 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -110.61 142.43 42.47 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 144.54 38.06 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.669 1.188 . . . . 0.0 109.682 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.35 -44.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.2 m -91.03 -30.12 16.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.385 0.674 . . . . 0.0 111.464 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.58 -178.41 16.41 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.778 1.18 . . . . 0.0 110.478 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -52.46 -25.45 10.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.389 1.876 . . . . 0.0 113.143 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.7 -31.08 62.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 113.916 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.84 16.03 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -170.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.71 134.94 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 107.371 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -123.6 122.58 38.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 125.98 1.712 . . . . 0.0 107.311 174.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.7 mmt -84.32 -17.96 37.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.045 0.538 . . . . 0.0 112.201 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.55 71.81 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.144 1.778 . . . . 0.0 107.293 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.7 p -75.52 -64.86 0.98 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.487 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -85.62 -178.18 6.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 108.648 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 m -56.7 -35.77 68.89 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.733 -0.604 . . . . 0.0 109.925 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.96 130.46 46.42 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.936 1.694 . . . . 0.0 107.722 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.39 135.56 37.02 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 N-CA-C 107.499 -1.77 . . . . 0.0 107.499 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.73 -21.64 63.45 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -121.98 142.23 50.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.942 0.897 . . . . 0.0 109.634 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.24 -23.24 38.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 111.072 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.51 156.95 27.54 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.41 151.44 41.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 109.159 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -153.93 169.91 22.31 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.616 1.166 . . . . 0.0 109.015 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.47 137.29 54.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.57 158.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.406 1.482 . . . . 0.0 111.057 -168.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -64.32 145.27 56.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.277 169.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -30.87 49.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -86.72 -21.23 26.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.354 1.433 . . . . 0.0 112.568 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -63.48 -43.46 78.78 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 116.594 -1.669 . . . . 0.0 114.149 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.22 -30.54 91.46 Favored 'Trans proline' 0 C--N 1.353 0.784 0 CA-C-N 123.364 2.237 . . . . 0.0 112.833 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.17 -27.37 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.097 0.959 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -71.39 -24.35 62.05 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.117 -0.99 . . . . 0.0 111.595 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.66 -33.06 41.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.314 0.961 . . . . 0.0 112.533 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 m -83.76 166.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -85.1 174.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.569 1.548 . . . . 0.0 109.126 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.3 m -54.04 -44.79 71.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.442 1.497 . . . . 0.0 114.418 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -64.1 -41.95 97.08 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.111 0.868 . . . . 0.0 111.463 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.78 -35.65 38.26 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.282 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -52.0 -45.92 64.7 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.232 0.924 . . . . 0.0 110.527 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.96 -44.31 89.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.323 0.511 . . . . 0.0 110.864 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.15 -52.29 49.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -69.25 -30.57 68.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.157 -169.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -66.49 -42.35 87.55 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.507 1.503 . . . . 0.0 110.213 169.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -58.78 -46.24 87.97 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 119.231 0.923 . . . . 0.0 110.606 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.17 -24.61 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.657 1.183 . . . . 0.0 112.041 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.8 mmt -86.54 -58.11 2.74 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -60.0 -32.97 71.36 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.305 1.042 . . . . 0.0 112.082 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.08 -34.82 72.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.228 0.922 . . . . 0.0 111.366 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -112.15 -9.05 13.97 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.466 1.106 . . . . 0.0 113.343 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.47 72.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.977 1.262 . . . . 0.0 110.958 -169.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.0 m -67.8 -32.35 72.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.281 0.632 . . . . 0.0 110.763 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.8 t -69.26 -44.43 80.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.33 -42.34 73.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.432 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.2 mmt -56.95 -54.44 46.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.235 1.38 . . . . 0.0 110.065 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.6 m -70.32 -26.59 63.83 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.835 1.254 . . . . 0.0 110.787 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -36.7 84.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.598 1.959 . . . . 0.0 109.541 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -70.54 -20.73 62.78 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.837 1.199 . . . . 0.0 112.668 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.87 0.93 52.69 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.85 1.66 . . . . 0.0 111.306 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -122.6 -47.43 2.09 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.387 1.075 . . . . 0.0 109.253 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.316 30.2 p -85.5 -176.25 0.74 Allowed Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -85.29 -164.59 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.906 3.07 . . . . 0.0 110.759 -169.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? . . . . . 0 C--O 1.25 1.083 0 O-C-N 121.101 -1.0 . . . . 0.0 109.606 170.063 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.12 140.74 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 168.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.55 -45.98 81.29 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 112.978 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -147.71 -118.81 0.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.175 0.99 . . . . 0.0 108.784 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.14 -15.63 56.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.675 1.59 . . . . 0.0 111.396 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.16 178.82 47.51 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 126.133 1.825 . . . . 0.0 109.567 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.4 153.15 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.617 2.767 . . . . 0.0 113.743 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.69 137.56 15.34 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 120.506 -1.371 . . . . 0.0 107.974 174.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -74.09 140.88 28.77 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.323 2.015 . . . . 0.0 109.42 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -141.27 154.09 45.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.765 0.826 . . . . 0.0 109.143 -170.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.29 136.32 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.524 1.53 . . . . 0.0 107.475 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -122.03 158.09 16.75 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 172.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -124.12 144.33 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 125.619 1.568 . . . . 0.0 107.556 -171.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.65 137.12 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm -120.94 134.17 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.2 p -124.83 158.24 33.91 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.1 0.864 . . . . 0.0 112.267 170.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -108.24 170.6 7.91 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.462 1.505 . . . . 0.0 108.658 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -0.56 15.88 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.095 -1.628 . . . . 0.0 113.648 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -81.61 -6.51 59.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.679 0.672 . . . . 0.0 110.544 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.68 78.66 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.028 -0.874 . . . . 0.0 111.489 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -89.15 150.36 22.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.73 148.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.487 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.9 tpp -63.53 128.4 35.66 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.706 1.202 . . . . 0.0 108.175 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CZ2' ' HB2' ' A' ' 33' ' ' TRP . 10.0 t90 -146.73 140.45 25.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.45 146.55 33.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.669 1.122 . . . . 0.0 113.653 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -85.53 121.32 28.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.329 1.852 . . . . 0.0 106.704 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -79.66 149.62 31.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.63 1.559 . . . . 0.0 109.349 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.42 117.09 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.061 1.745 . . . . 0.0 110.925 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.62 -1.07 31.39 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.738 1.161 . . . . 0.0 115.499 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -83.39 -31.25 26.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.747 1.774 . . . . 0.0 111.987 -172.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.8 m80 54.66 31.2 14.75 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.518 1.127 . . . . 0.0 112.008 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.2 m -138.43 154.03 48.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.548 1.939 . . . . 0.0 107.518 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.409 ' HB2' ' CZ2' ' A' ' 24' ' ' TRP . 77.4 m95 -108.55 151.76 25.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.109 0.564 . . . . 0.0 111.176 -169.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -148.17 159.71 43.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.921 1.688 . . . . 0.0 110.833 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.3 141.39 29.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.77 130.19 32.13 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 0.0 111.586 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -159.5 162.26 35.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.243 0.929 . . . . 0.0 112.764 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.19 176.98 47.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.421 1.01 . . . . 0.0 111.926 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.85 150.16 32.25 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 121.166 -1.196 . . . . 0.0 111.859 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.1 mt -79.94 129.37 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 168.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -71.95 152.86 93.0 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -57.53 123.58 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 120.962 1.108 . . . . 0.0 109.334 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.91 -5.58 84.43 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.384 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.05 155.47 37.19 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.237 2.018 . . . . 0.0 109.681 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -97.19 154.93 17.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.43 88.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.464 -0.773 . . . . 0.0 112.32 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.96 -34.35 75.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.951 0.501 . . . . 0.0 109.96 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -68.03 -42.96 79.79 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.08 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.15 81.5 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 119.272 -0.395 . . . . 0.0 110.15 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -57.41 -49.02 77.56 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.49 -35.18 79.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -62.95 -46.21 88.84 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.817 1.644 . . . . 0.0 109.686 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -69.15 -25.55 64.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.708 -0.62 . . . . 0.0 110.728 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.22 -43.12 95.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.746 -1.221 . . . . 0.0 109.774 172.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.19 -37.11 86.3 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.754 -0.591 . . . . 0.0 110.389 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.33 -35.56 66.05 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.425 -0.797 . . . . 0.0 112.629 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.3 -57.14 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.335 0.654 . . . . 0.0 110.294 -169.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.01 -15.78 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.713 0.805 . . . . 0.0 110.15 -172.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.71 19.29 79.17 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.716 -0.615 . . . . 0.0 111.737 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.7 tp -108.48 150.86 26.85 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.683 1.993 . . . . 0.0 108.266 -172.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m -127.58 168.22 15.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.607 0.763 . . . . 0.0 109.819 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -49.51 -33.95 15.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.664 1.585 . . . . 0.0 112.606 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -65.33 -23.36 66.98 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.037 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.98 24.66 10.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.488 0.661 . . . . 0.0 112.708 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -134.15 165.24 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.336 1.054 . . . . 0.0 111.34 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -141.06 141.37 34.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -80.51 120.59 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.49 -35.52 11.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.816 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.01 161.97 39.56 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.338 0.59 . . . . 0.0 110.16 -172.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 p -158.16 155.2 28.66 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.651 1.58 . . . . 0.0 109.526 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 143.64 56.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.69 0.757 . . . . 0.0 111.595 -170.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -80.47 -29.34 37.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.199 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -136.74 152.23 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.594 2.358 . . . . 0.0 109.065 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -76.06 136.93 39.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.75 102.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -106.94 146.19 31.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -147.67 146.36 29.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -91.26 144.68 25.36 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -71.46 149.22 93.63 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 123.943 0.897 . . . . 0.0 110.55 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.52 144.91 74.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 N-CA-C 105.082 -2.699 . . . . 0.0 105.082 167.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -68.52 -12.1 60.78 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.242 -1.536 . . . . 0.0 113.831 -169.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -58.14 -31.62 67.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -90.0 -23.08 21.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 111.817 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.05 137.96 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 109.45 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -107.82 90.99 3.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.14 0.976 . . . . 0.0 109.934 169.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -68.55 -24.6 64.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.825 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.58 -24.74 60.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.69 0.796 . . . . 0.0 112.433 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -111.3 156.79 20.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.228 1.011 . . . . 0.0 109.293 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -129.9 140.16 37.82 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.101 1.36 . . . . 0.0 109.239 -169.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.74 150.8 96.06 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 O-C-N 122.826 0.908 . . . . 0.0 110.865 -10.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.7 136.8 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.922 0.889 . . . . 0.0 111.656 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.2 t -81.85 108.37 15.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.6 -14.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.727 0.811 . . . . 0.0 112.584 170.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.37 -174.52 47.03 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.99 157.9 36.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 109.11 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.3 125.61 54.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 169.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -117.26 129.54 55.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.013 0.824 . . . . 0.0 111.405 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -88.04 154.04 20.79 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 167.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.41 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 84.5 m95 -132.54 143.6 49.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -130.41 132.5 45.77 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.572 1.149 . . . . 0.0 107.926 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.1 tp -97.06 126.03 41.93 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.85 146.64 43.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -95.72 133.34 39.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 167.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.97 130.78 47.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.225 1.41 . . . . 0.0 108.542 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.9 t -86.31 -38.6 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.587 0.631 . . . . 0.0 110.803 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.5 m -95.41 -21.15 18.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.865 0.757 . . . . 0.0 112.302 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.65 -176.43 24.07 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -19.24 28.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.686 1.594 . . . . 0.0 114.506 -169.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.33 -31.46 33.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.378 1.071 . . . . 0.0 112.912 171.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -92.85 16.07 13.32 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.86 141.17 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -126.23 -49.38 1.56 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.529 0.732 . . . . 0.0 111.676 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 68.64 9.87 7.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.3 2.24 . . . . 0.0 115.2 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.26 69.66 0.83 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 124.325 2.012 . . . . 0.0 111.227 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -56.37 5.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.347 169.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 m -63.99 160.92 16.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.044 1.337 . . . . 0.0 109.063 168.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -63.57 -33.17 75.01 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.99 -0.444 . . . . 0.0 110.721 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.53 131.38 38.28 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.356 1.463 . . . . 0.0 110.27 170.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.67 132.67 31.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.212 1.941 . . . . 0.0 107.883 168.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -73.4 -23.65 60.19 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.862 -0.524 . . . . 0.0 111.074 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -116.12 139.29 50.46 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.543 0.737 . . . . 0.0 110.085 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.74 -21.09 34.85 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.072 0.949 . . . . 0.0 110.709 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -165.93 158.57 31.53 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.39 155.53 47.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.167 0.983 . . . . 0.0 108.497 169.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -144.79 149.03 34.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -96.9 98.11 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.52 168.92 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 110.296 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -64.31 168.13 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 109.507 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -30.68 70.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.196 -0.94 . . . . 0.0 111.563 175.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -92.01 -32.7 15.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.127 1.331 . . . . 0.0 113.607 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -54.39 -45.25 99.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 116.825 -1.559 . . . . 0.0 114.326 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.74 -19.96 68.01 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 123.273 2.205 . . . . 0.0 113.646 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.83 -33.68 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.11 -37.11 85.92 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.268 -0.895 . . . . 0.0 111.11 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -78.75 -27.0 44.65 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.78 166.23 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 118.804 0.729 . . . . 0.0 111.229 -173.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.65 174.23 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.855 1.262 . . . . 0.0 109.857 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.2 m -54.59 -49.42 70.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.493 1.517 . . . . 0.0 113.429 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -60.1 -39.09 84.96 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.317 0.647 . . . . 0.0 111.146 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -85.6 -40.14 16.57 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.974 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -46.85 -46.33 20.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.861 0.864 . . . . 0.0 111.097 170.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.83 -35.49 78.4 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.484 0.713 . . . . 0.0 111.367 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.14 -50.8 17.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.015 . . . . 0.0 110.169 171.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -61.78 -32.69 72.99 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.302 0.955 . . . . 0.0 111.586 -169.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -63.71 -42.99 97.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.259 0.936 . . . . 0.0 111.27 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -61.88 -44.7 96.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.83 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -55.73 -30.84 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.484 1.038 . . . . 0.0 111.222 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.4 mmt -86.25 -54.81 4.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.362 1.065 . . . . 0.0 108.717 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -36.49 73.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.076 0.853 . . . . 0.0 111.635 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.73 -40.13 78.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.143 0.977 . . . . 0.0 111.077 -173.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.24 -14.15 13.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 111.025 -172.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.31 57.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 111.139 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 m -66.34 -31.48 72.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.312 0.645 . . . . 0.0 111.067 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.32 -45.91 67.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -58.47 -41.12 80.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 116.949 -1.5 . . . . 0.0 110.217 -173.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.3 mmt -54.48 -49.42 70.15 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 121.137 1.79 . . . . 0.0 110.318 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 m -76.64 -26.48 54.94 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.355 1.062 . . . . 0.0 111.144 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 18.6 tp -62.68 -44.22 96.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.111 1.365 . . . . 0.0 109.411 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -60.12 -39.9 87.83 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.845 0.458 . . . . 0.0 110.827 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.41 -32.67 54.91 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -95.26 -22.86 17.52 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.198 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.259 14.6 p 44.36 60.18 12.48 Favored Pre-proline 0 N--CA 1.445 -0.678 0 C-N-CA 126.431 1.892 . . . . 0.0 110.071 -172.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -62.44 158.38 41.12 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.687 0.924 . . . . 0.0 113.524 -168.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -169.294 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 61.43 122.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.628 2.371 . . . . 0.0 110.611 -169.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -63.76 -67.08 0.46 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -169.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -162.68 -52.64 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.82 14.83 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 112.776 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.85 1.08 77.31 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.788 1.185 . . . . 0.0 114.001 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.51 165.28 11.18 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.917 0.865 . . . . 0.0 109.223 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -148.47 145.74 20.98 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.163 1.385 . . . . 0.0 107.456 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -85.71 133.39 4.37 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.476 1.451 . . . . 0.0 109.935 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.7 150.01 52.29 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 109.253 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.3 m -129.13 154.97 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.071 0.948 . . . . 0.0 108.83 170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.13 158.29 25.23 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.49 143.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.565 1.146 . . . . 0.0 108.06 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.14 136.73 58.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mm -117.45 135.96 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -123.56 153.76 40.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.987 0.812 . . . . 0.0 112.117 171.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -103.72 175.12 5.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.425 1.49 . . . . 0.0 109.156 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -78.27 8.07 5.51 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.466 -1.396 . . . . 0.0 113.241 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -96.52 -5.76 38.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.439 1.096 . . . . 0.0 111.447 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.79 66.9 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.867 0.758 . . . . 0.0 111.885 -172.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -98.11 150.35 21.53 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -114.39 146.47 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 106.938 174.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 ptm -78.95 147.69 32.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.851 0.75 . . . . 0.0 109.672 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -148.55 146.59 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.63 148.2 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.977 1.262 . . . . 0.0 111.701 -170.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -99.5 127.79 45.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.81 0.732 . . . . 0.0 109.203 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -78.18 145.69 35.45 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.699 0.681 . . . . 0.0 109.867 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.13 136.1 57.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.066 0.946 . . . . 0.0 109.508 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.86 10.26 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.885 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -100.88 -45.21 5.51 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.328 1.564 . . . . 0.0 110.083 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 53.92 29.56 10.15 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.844 1.258 . . . . 0.0 111.826 -174.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -120.28 148.48 43.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.895 2.078 . . . . 0.0 106.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -92.82 148.61 21.89 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -152.24 162.89 40.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.538 1.935 . . . . 0.0 110.141 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.54 141.23 23.17 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.39 135.92 44.79 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.036 2.491 . . . . 0.0 111.671 -174.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -158.22 166.96 31.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.445 -171.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.29 172.57 42.31 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.165 0.412 . . . . 0.0 112.127 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.77 143.62 16.83 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.4 mt -76.81 122.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 168.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.99 148.29 78.46 Favored Pre-proline 0 N--CA 1.464 0.253 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.21 124.12 14.55 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.162 1.241 . . . . 0.0 109.055 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.38 -15.79 58.53 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.636 1.112 . . . . 0.0 113.803 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -73.67 148.16 43.02 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.644 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 p -85.96 168.95 13.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 168.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.59 87.88 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.262 -0.899 . . . . 0.0 110.943 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.97 -39.01 63.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.239 0.616 . . . . 0.0 110.611 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.81 -41.82 86.92 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.638 -0.664 . . . . 0.0 109.59 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.85 79.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.411 0.55 . . . . 0.0 109.629 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -62.02 -51.72 66.89 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.06 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.75 -35.35 79.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.916 1.235 . . . . 0.0 111.571 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.35 94.86 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.851 0.86 . . . . 0.0 110.388 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.89 -24.56 26.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.276 0.489 . . . . 0.0 110.933 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.1 tp -55.23 -39.59 69.88 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.152 -0.967 . . . . 0.0 109.471 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -63.12 -49.15 75.56 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.004 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.63 -32.74 73.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 0.0 112.715 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.8 -46.29 10.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.763 0.711 . . . . 0.0 111.135 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.75 -31.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.562 1.145 . . . . 0.0 110.975 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.67 87.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.817 1.199 . . . . 0.0 111.778 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.79 155.47 19.88 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.456 1.902 . . . . 0.0 110.039 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 p -131.76 164.48 25.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.765 1.226 . . . . 0.0 109.724 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -41.39 -40.56 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.315 2.246 . . . . 0.0 112.698 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.91 -28.18 69.36 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.42 0.688 . . . . 0.0 112.659 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -111.67 22.6 14.82 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.458 0.647 . . . . 0.0 112.08 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.22 165.38 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 O-C-N 120.769 -1.207 . . . . 0.0 112.544 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 137.48 39.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 168.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.7 mt -74.53 119.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 171.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.76 -33.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.889 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.05 163.15 39.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.404 1.082 . . . . 0.0 108.745 -175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -162.24 153.24 17.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.587 1.155 . . . . 0.0 109.573 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 p -70.7 136.09 48.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.346 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -52.51 21.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -72.33 170.4 14.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.582 1.553 . . . . 0.0 111.652 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.435 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 87.0 m95 -108.44 125.58 51.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 167.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.97 106.04 8.4 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -73.62 140.3 46.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.74 143.32 50.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -131.66 141.7 49.66 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 126.283 1.833 . . . . 0.0 106.081 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pp -110.29 150.2 41.22 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.527 1.131 . . . . 0.0 109.613 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -73.12 158.18 49.57 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.427 3.418 . . . . 0.0 109.947 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -68.41 -18.41 64.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.41 -29.07 68.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.0 mt -94.55 -7.89 39.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.123 0.969 . . . . 0.0 112.416 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.03 132.02 33.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.74 97.01 10.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -75.6 -19.52 59.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.861 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.29 -27.94 56.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -101.12 158.17 16.22 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.125 0.97 . . . . 0.0 109.836 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -132.66 132.02 22.43 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 125.967 1.707 . . . . 0.0 109.724 -170.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.5 150.72 89.94 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 O-C-N 122.879 0.936 . . . . 0.0 110.858 -10.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.24 141.55 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.899 1.28 . . . . 0.0 111.269 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.0 p -81.24 123.18 28.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.62 -16.11 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.843 0.747 . . . . 0.0 111.449 169.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.2 -174.16 40.07 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -160.96 162.84 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.223 1.809 . . . . 0.0 110.536 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -98.6 129.58 45.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -111.72 143.32 42.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.045 1.293 . . . . 0.0 110.237 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 6.2 ttmm -131.88 118.92 20.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -104.43 153.89 20.55 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.65 125.31 30.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 tp -91.16 121.41 32.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 168.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.67 157.09 23.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 167.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 141.23 56.62 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.956 1.303 . . . . 0.0 109.43 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.94 -47.51 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.114 0.566 . . . . 0.0 110.094 -171.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.8 m -86.1 -16.0 39.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.138 0.575 . . . . 0.0 111.55 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.25 -169.61 22.84 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -17.01 53.55 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 125.264 1.426 . . . . 0.0 114.311 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.68 57.05 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.917 0.887 . . . . 0.0 111.76 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -91.71 51.76 1.91 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 110.958 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.16 129.61 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.76 -53.72 2.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.375 0.67 . . . . 0.0 111.406 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 67.57 12.01 8.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.948 2.099 . . . . 0.0 114.628 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -150.31 73.89 1.17 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 124.016 1.865 . . . . 0.0 109.713 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -71.93 -60.08 2.41 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.269 -2.241 . . . . 0.0 107.843 171.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -66.71 166.44 13.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 109.917 169.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -57.43 -38.01 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.895 . . . . 0.0 110.829 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 130.52 54.77 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.865 1.266 . . . . 0.0 110.454 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.99 142.0 73.02 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.926 1.751 . . . . 0.0 108.453 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -81.34 -24.94 36.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.552 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.08 140.04 53.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.303 0.956 . . . . 0.0 109.998 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.0 -17.97 24.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.691 1.196 . . . . 0.0 111.371 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.85 151.82 23.19 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.57 148.85 31.57 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.816 0.847 . . . . 0.0 108.778 171.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -148.52 172.65 14.16 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.905 1.282 . . . . 0.0 109.204 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -112.97 139.77 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.59 152.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 109.853 -169.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m -59.94 147.9 37.09 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.819 0.736 . . . . 0.0 109.419 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -38.16 37.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -88.53 -25.1 22.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -170.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -57.87 -47.82 98.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.055 -1.45 . . . . 0.0 113.693 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -63.84 -21.3 69.24 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.865 2.059 . . . . 0.0 113.171 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.62 -36.38 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -62.85 -35.57 80.38 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.285 -0.885 . . . . 0.0 111.099 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.89 -21.4 34.27 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -81.73 167.87 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.389 0.995 . . . . 0.0 110.251 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.2 176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.719 1.208 . . . . 0.0 110.638 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 m -53.12 -48.5 67.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.021 1.729 . . . . 0.0 114.494 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -74.5 -31.34 62.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.257 -0.902 . . . . 0.0 111.394 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -80.77 -40.16 25.61 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.253 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -44.33 -46.2 9.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 0.0 111.633 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.96 -42.45 94.6 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.302 0.501 . . . . 0.0 111.352 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -67.5 -44.84 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 121.638 -0.664 . . . . 0.0 109.361 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.45 -41.76 98.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -66.34 -43.9 84.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.159 0.891 . . . . 0.0 110.333 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.31 -47.73 84.6 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.071 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.1 -39.45 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.733 1.213 . . . . 0.0 110.431 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.2 mmt -69.49 -54.45 14.19 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -57.24 -34.66 68.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.878 0.871 . . . . 0.0 111.774 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -45.55 79.29 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.281 1.033 . . . . 0.0 110.185 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -104.63 -9.52 18.19 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.485 0.714 . . . . 0.0 112.381 -173.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.13 -43.81 70.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.133 1.773 . . . . 0.0 110.548 -173.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.7 m -66.7 -31.99 73.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.463 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.63 -47.14 81.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 118.055 -0.974 . . . . 0.0 108.384 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.6 t -58.42 -45.35 89.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 109.48 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.9 mtt -61.62 -33.82 74.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.624 0.647 . . . . 0.0 111.216 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -82.79 -31.36 28.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.575 1.15 . . . . 0.0 110.824 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.1 tp -58.33 -40.25 81.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.154 1.782 . . . . 0.0 110.155 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.93 -29.75 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.194 0.598 . . . . 0.0 111.985 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -93.74 -8.47 40.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.825 1.65 . . . . 0.0 111.74 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -110.63 -22.87 11.4 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.919 1.287 . . . . 0.0 111.397 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.7 p -124.08 38.31 0.38 Allowed Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.3 -178.88 2.36 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.454 2.769 . . . . 0.0 111.25 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.279 1.832 . . . . 0.0 110.026 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tmm? . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.37 128.84 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 169.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.23 -64.83 0.81 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.4 -50.69 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.31 16.79 14.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 113.084 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 10.47 67.94 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.888 0.756 . . . . 0.0 113.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -105.0 155.6 18.81 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 108.714 170.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.96 147.76 67.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.446 169.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.55 142.23 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 110.528 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -143.57 155.44 44.3 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.252 1.421 . . . . 0.0 109.498 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.17 153.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.072 0.549 . . . . 0.0 110.372 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.74 160.37 19.36 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.84 146.55 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.76 135.9 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.9 mm -112.03 134.75 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.0 m -124.12 145.38 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.842 0.714 . . . . 0.0 110.008 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -104.22 173.53 6.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.116 1.366 . . . . 0.0 108.51 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.31 9.86 5.27 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.5 -1.375 . . . . 0.0 112.632 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -98.41 -3.51 36.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.099 1.36 . . . . 0.0 111.444 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.2 21.54 70.19 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 118.777 0.717 . . . . 0.0 111.916 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.98 150.7 21.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.647 1.223 . . . . 0.0 107.842 172.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.87 151.04 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 108.296 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.3 mtp -70.56 147.57 49.14 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.277 0.49 . . . . 0.0 110.026 169.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -151.2 141.16 22.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.62 145.74 47.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.28 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -97.13 107.95 20.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.961 2.105 . . . . 0.0 107.143 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -74.7 139.32 43.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.556 1.525 . . . . 0.0 109.939 -169.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.68 135.99 57.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.36 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.55 -24.56 3.64 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.546 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -82.49 -44.68 15.68 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.56 1.68 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m80 59.47 28.45 17.83 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.23 0.956 . . . . 0.0 109.734 -168.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -122.93 155.27 37.08 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 108.025 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -101.88 146.53 27.7 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -169.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -149.43 164.06 36.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.512 1.525 . . . . 0.0 110.334 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -87.52 143.95 34.82 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 130.49 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 110.59 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -159.07 168.17 27.37 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.113 0.87 . . . . 0.0 112.244 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.44 163.52 37.24 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.653 0.644 . . . . 0.0 111.661 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.6 150.85 45.52 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -77.55 113.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -70.93 156.03 92.58 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.58 123.9 12.83 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 CA-C-N 120.719 1.293 . . . . 0.0 109.674 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.09 -5.35 78.56 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.212 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -74.34 154.19 38.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.075 1.937 . . . . 0.0 110.524 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.4 p -94.56 168.37 10.9 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.46 90.02 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.024 -1.048 . . . . 0.0 111.342 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.06 -38.62 72.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.146 0.578 . . . . 0.0 110.26 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -67.69 -39.18 84.45 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.8 92.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -60.52 -52.52 64.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.42 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.6 m-85 -66.46 -44.44 82.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.973 0.806 . . . . 0.0 111.465 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -44.78 80.04 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 121.816 -0.552 . . . . 0.0 110.337 -173.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -71.54 -37.14 71.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 tp -53.76 -43.83 69.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.094 0.861 . . . . 0.0 110.588 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.27 -39.14 81.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.232 0.469 . . . . 0.0 110.834 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.11 -18.71 60.19 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.3 -0.875 . . . . 0.0 112.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -90.03 -50.38 6.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.666 0.787 . . . . 0.0 110.563 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.86 3.33 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 0.0 111.837 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.58 -1.52 14.26 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.469 -1.395 . . . . 0.0 113.529 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -80.72 144.42 32.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.186 1.794 . . . . 0.0 109.741 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -125.04 166.3 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 109.445 -174.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 56.7 mtt180 -48.96 -35.28 14.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.361 1.464 . . . . 0.0 112.43 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.35 -24.28 67.21 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.82 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.29 22.84 12.57 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.491 0.662 . . . . 0.0 112.113 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.19 164.24 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.675 1.19 . . . . 0.0 112.212 170.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.35 134.52 29.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.576 -1.202 . . . . 0.0 108.114 168.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mt -71.27 113.64 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.7 mt -91.54 -33.99 14.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.848 173.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.93 165.42 36.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.406 0.682 . . . . 0.0 109.344 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 p -159.09 157.53 31.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.61 1.164 . . . . 0.0 110.422 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -75.04 134.72 41.34 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.562 -0.711 . . . . 0.0 109.169 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.11 -48.17 25.09 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -79.41 165.17 23.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.022 1.329 . . . . 0.0 110.461 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -102.79 128.65 49.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -80.3 92.34 5.75 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -81.41 145.31 30.86 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.74 151.16 49.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -128.43 133.13 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.758 1.623 . . . . 0.0 106.898 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -90.64 147.9 37.35 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.36 0.664 . . . . 0.0 112.715 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.2 150.53 71.72 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 105.046 -2.713 . . . . 0.0 105.046 166.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -69.35 -13.45 62.38 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 119.805 -1.809 . . . . 0.0 114.147 -169.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.16 -31.38 71.86 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.821 0.737 . . . . 0.0 112.76 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.08 -18.69 21.55 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.107 0.963 . . . . 0.0 112.009 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.91 134.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.53 83.96 3.89 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.151 0.976 . . . . 0.0 110.223 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -67.29 -19.92 65.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.066 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.49 -20.99 53.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -107.07 160.88 15.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.948 0.899 . . . . 0.0 109.965 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -130.43 127.07 22.35 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 125.442 1.497 . . . . 0.0 109.19 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.39 159.53 91.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 O-C-N 122.717 0.851 . . . . 0.0 111.246 -10.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 80.5 t -75.01 140.04 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 123.906 0.882 . . . . 0.0 110.045 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 p -91.89 121.45 33.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.697 1.199 . . . . 0.0 108.925 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.29 -13.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.803 0.728 . . . . 0.0 112.716 171.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.91 46.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -157.01 161.48 39.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.675 1.19 . . . . 0.0 109.566 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -112.43 132.69 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -123.29 122.15 37.62 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.429 0.692 . . . . 0.0 109.524 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -105.97 140.35 39.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.67 156.16 38.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.676 0.671 . . . . 0.0 109.364 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -139.8 127.01 21.17 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.161 0.984 . . . . 0.0 108.516 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.82 116.3 26.99 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.6 mp -112.11 137.46 50.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.866 0.867 . . . . 0.0 108.917 172.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.99 134.88 33.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.477 1.49 . . . . 0.0 107.213 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.97 133.43 51.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.64 1.576 . . . . 0.0 107.269 170.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.34 -55.24 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.834 1.197 . . . . 0.0 110.634 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.1 m -75.78 -19.46 58.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.59 0.756 . . . . 0.0 111.227 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.44 27.26 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -57.75 -18.18 19.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 0.0 114.367 -169.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.03 10.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.268 1.027 . . . . 0.0 112.619 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -87.15 14.97 6.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.1 mt -91.33 137.9 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -129.27 128.46 43.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.337 1.855 . . . . 0.0 106.874 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.1 mmt -97.91 -11.04 23.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.579 0.627 . . . . 0.0 111.526 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.91 63.32 0.71 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.979 2.112 . . . . 0.0 106.587 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -68.65 -60.05 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 127.185 2.194 . . . . 0.0 109.361 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -90.67 174.87 7.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.457 1.903 . . . . 0.0 110.021 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 m -60.17 -25.72 65.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.192 0.997 . . . . 0.0 112.004 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.94 136.82 23.37 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 168.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 155.2 68.4 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.575 2.183 . . . . 0.0 111.8 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.39 -35.25 27.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.745 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.67 137.8 54.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.574 0.75 . . . . 0.0 109.437 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.3 -26.71 56.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.837 0.855 . . . . 0.0 110.787 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.89 166.84 38.33 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.39 160.01 44.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 169.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -145.65 167.05 24.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.79 133.93 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 151.29 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.853 1.261 . . . . 0.0 110.083 -169.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -60.73 146.6 45.28 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -33.53 30.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.022 1.329 . . . . 0.0 113.698 -169.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -91.72 -14.75 29.46 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -65.17 -47.81 71.05 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.335 -1.317 . . . . 0.0 112.858 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.55 -28.88 83.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 CA-C-N 122.547 1.945 . . . . 0.0 112.35 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.15 -25.82 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.191 1.396 . . . . 0.0 109.819 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -65.87 -31.42 72.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.424 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -100.01 -22.16 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.75 151.89 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 118.793 0.724 . . . . 0.0 110.065 171.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.36 176.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.688 1.195 . . . . 0.0 109.706 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -55.38 -44.3 75.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.393 1.477 . . . . 0.0 112.911 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -70.65 -41.75 71.73 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 111.088 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.42 -41.06 28.49 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.83 -0.544 . . . . 0.0 110.731 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -61.63 -29.41 70.04 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.853 0.751 . . . . 0.0 112.383 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.17 -45.75 87.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.497 0.589 . . . . 0.0 110.688 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.25 -47.14 91.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.525 -0.734 . . . . 0.0 109.099 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -61.62 -45.52 93.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -66.08 -40.65 90.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.971 -1.081 . . . . 0.0 110.933 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.63 -48.02 83.65 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.474 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.01 -39.9 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.279 1.032 . . . . 0.0 110.039 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.6 mmt -67.12 -52.83 36.98 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.996 0.919 . . . . 0.0 108.647 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.462 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -29.54 69.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.37 0.987 . . . . 0.0 112.006 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -111.37 -14.47 13.76 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.09 0.956 . . . . 0.0 113.468 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.28 69.33 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.371 1.468 . . . . 0.0 110.641 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 m -68.53 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.864 0.866 . . . . 0.0 110.687 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.62 -43.67 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.68 -39.91 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.458 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.0 mmt -57.44 -50.38 73.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.643 1.11 . . . . 0.0 109.852 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 m -73.31 -28.04 61.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.173 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.01 -42.58 99.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.666 1.186 . . . . 0.0 110.152 172.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.44 -42.52 98.88 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.08 -28.07 64.07 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -170.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.89 -21.13 23.8 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.336 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.5 p 38.89 56.44 5.5 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.726 2.011 . . . . 0.0 109.306 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.59 167.13 21.73 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.081 1.188 . . . . 0.0 111.971 -167.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.4 mttt . . . . . 0 C--O 1.25 1.096 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -169.92 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mt -138.56 141.72 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.61 -69.09 0.31 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.246 0.618 . . . . 0.0 112.623 -169.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.34 -52.4 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.663 0.785 . . . . 0.0 112.953 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.62 17.0 10.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.699 1.199 . . . . 0.0 112.459 -169.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.54 85.72 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.744 1.164 . . . . 0.0 113.24 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -88.21 157.88 18.67 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.263 1.025 . . . . 0.0 109.367 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -150.31 127.29 5.4 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 116.996 -1.478 . . . . 0.0 107.292 -169.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -80.32 132.58 9.25 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.505 1.47 . . . . 0.0 109.424 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.36 155.61 49.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.909 0.884 . . . . 0.0 108.656 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.42 137.77 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.16 154.41 16.82 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.45 141.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 125.397 1.479 . . . . 0.0 107.962 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.88 142.7 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mm -117.09 142.25 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 117.293 -1.337 . . . . 0.0 107.663 169.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.6 p -125.78 160.11 30.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.651 1.114 . . . . 0.0 112.708 170.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -121.61 172.18 8.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.613 1.565 . . . . 0.0 109.145 176.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.99 7.7 4.6 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.439 -1.413 . . . . 0.0 112.977 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -94.08 -5.13 48.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.434 1.093 . . . . 0.0 111.715 174.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 31.72 60.75 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -108.57 154.6 21.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.22 150.3 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 174.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -84.52 143.59 29.25 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -144.65 140.47 28.68 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -175.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.78 158.46 42.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.581 1.537 . . . . 0.0 111.531 -170.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.68 145.83 51.05 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.875 1.67 . . . . 0.0 108.45 -171.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -112.11 163.39 14.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.341 0.973 . . . . 0.0 109.664 174.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -72.88 153.67 40.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.328 1.051 . . . . 0.0 109.013 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.96 -52.63 3.3 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.138 1.351 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.17 -45.73 66.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.43 0.615 . . . . 0.0 110.079 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.1 m170 56.18 -0.37 0.05 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.292 2.237 . . . . 0.0 115.377 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -77.82 163.23 26.27 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.565 1.946 . . . . 0.0 108.348 169.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -112.68 146.7 38.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -174.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.34 158.51 44.14 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.958 1.303 . . . . 0.0 110.686 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.62 134.22 65.87 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 169.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -54.34 139.76 73.42 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.214 2.609 . . . . 0.0 112.578 -178.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -161.95 169.17 21.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.161 0.891 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.86 169.48 42.54 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.156 0.407 . . . . 0.0 112.368 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.79 147.51 36.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -73.89 114.94 14.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 169.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -68.22 145.72 97.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.19 125.14 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.518 1.479 . . . . 0.0 112.076 -169.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.2 85.93 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.55 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.15 147.55 48.27 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.133 1.967 . . . . 0.0 110.595 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -85.24 156.48 20.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 167.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.64 75.63 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.014 -1.054 . . . . 0.0 112.119 -169.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.71 -36.67 70.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 110.094 -178.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -70.28 -37.65 74.88 Favored 'General case' 0 C--O 1.23 0.061 0 O-C-N 121.172 -0.955 . . . . 0.0 109.995 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.57 77.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.566 175.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -58.09 -48.65 79.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.4 m-85 -66.32 -46.91 75.24 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.913 0.779 . . . . 0.0 111.766 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -52.52 -52.51 54.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.133 0.973 . . . . 0.0 110.901 177.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.87 -37.35 59.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -170.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -54.61 -45.41 73.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 110.595 173.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.76 -39.62 89.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.159 0.436 . . . . 0.0 110.28 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.36 -24.64 60.37 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.08 -46.01 12.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.313 0.96 . . . . 0.0 111.459 -175.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.52 4.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 112.32 -169.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.93 -2.97 14.5 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 120.431 -1.418 . . . . 0.0 113.513 -178.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.0 tp -78.89 140.88 38.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.677 1.591 . . . . 0.0 109.771 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 p -120.96 163.67 17.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.877 1.271 . . . . 0.0 109.902 -171.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 67.0 mtt85 -46.58 -37.58 8.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.054 1.742 . . . . 0.0 112.23 -177.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -30.19 71.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.885 -173.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.33 21.42 16.71 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.679 1.127 . . . . 0.0 112.011 -173.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.01 165.6 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.53 1.532 . . . . 0.0 111.829 171.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.65 140.31 33.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.279 169.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.52 116.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 177.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.58 -33.57 12.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.405 174.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.82 164.04 39.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.799 0.84 . . . . 0.0 108.919 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -163.68 154.4 15.92 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.1 0.96 . . . . 0.0 109.879 170.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 p -70.07 139.28 52.57 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -175.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -56.98 4.87 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -72.84 -178.16 2.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.514 1.925 . . . . 0.0 111.062 174.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.414 ' CD2' ' HE2' ' A' ' 96' ' ' LYS . 55.8 m95 -118.75 146.85 44.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.12 102.16 13.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 137.37 40.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -135.82 143.26 45.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -87.74 139.13 30.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 pp -91.02 148.82 38.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 169.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.92 155.14 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.45 2.767 . . . . 0.0 110.497 -175.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -65.75 -20.24 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.046 -1.034 . . . . 0.0 112.8 -170.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.62 -32.81 67.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.688 0.676 . . . . 0.0 112.739 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.05 -20.08 22.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.042 0.937 . . . . 0.0 111.436 -177.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.17 134.79 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -109.26 96.21 6.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.126 0.97 . . . . 0.0 109.398 171.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -70.99 -27.15 63.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.237 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.16 -10.32 59.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.309 1.043 . . . . 0.0 112.534 -170.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -129.73 158.9 38.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.928 0.891 . . . . 0.0 108.974 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -127.29 141.5 41.0 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.177 1.391 . . . . 0.0 108.993 -171.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.76 147.55 89.84 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 O-C-N 122.875 0.934 . . . . 0.0 111.35 -10.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -83.72 141.27 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.405 1.082 . . . . 0.0 108.908 175.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -103.96 139.6 38.88 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.461 0.704 . . . . 0.0 109.533 169.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 -17.42 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 122.937 0.495 . . . . 0.0 111.347 169.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.91 161.97 28.12 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.98 143.41 33.19 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.586 1.154 . . . . 0.0 108.599 -177.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' A' ' 74' ' ' TRP . 85.2 tttt -94.72 120.77 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -119.15 131.0 55.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.065 1.302 . . . . 0.0 112.893 -172.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 3.7 ttmm -99.4 152.79 19.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -128.54 148.6 50.77 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -133.58 129.73 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.871 1.269 . . . . 0.0 108.491 -177.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.07 125.64 39.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.13 157.02 31.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -105.84 132.99 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 137.83 58.32 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -89.5 -55.33 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.611 1.096 . . . . 0.0 109.97 -172.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -76.87 -21.62 54.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.458 0.703 . . . . 0.0 111.432 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.18 169.32 20.56 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -13.91 26.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.573 1.549 . . . . 0.0 114.433 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.63 39.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.286 1.034 . . . . 0.0 112.712 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.59 22.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.39 137.21 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.193 1.397 . . . . 0.0 108.155 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -124.03 129.01 50.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.332 1.853 . . . . 0.0 107.888 170.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.8 mmt -93.68 -8.04 42.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.369 0.668 . . . . 0.0 112.697 -176.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -127.22 81.08 1.99 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 124.084 1.897 . . . . 0.0 108.83 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 p -79.57 -64.14 1.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.209 2.603 . . . . 0.0 107.58 178.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -72.85 174.22 8.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.578 1.551 . . . . 0.0 109.711 169.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -60.53 -36.82 79.32 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.85 -0.531 . . . . 0.0 109.974 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.12 136.28 57.54 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.48 1.512 . . . . 0.0 107.991 169.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 117.55 4.34 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 122.44 2.093 . . . . 0.0 107.622 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -72.99 -18.87 61.31 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.763 -0.586 . . . . 0.0 110.297 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.03 155.88 49.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.919 1.288 . . . . 0.0 107.974 168.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.3 -14.77 14.1 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.975 2.11 . . . . 0.0 110.808 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.02 154.55 25.56 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.68 149.88 51.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.43 164.96 33.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -121.88 132.44 54.57 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.28 162.48 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.166 1.386 . . . . 0.0 111.984 -168.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.7 m -69.07 157.56 36.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 109.567 169.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.95 78.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 112.651 -171.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -91.31 -27.9 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.241 -0.912 . . . . 0.0 112.969 -169.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -51.34 -46.92 89.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.99 -25.4 59.29 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.14 1.8 . . . . 0.0 113.152 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.62 -41.3 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.318 0.0 OUTLIER -74.16 -5.53 42.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.273 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -95.01 -15.93 23.13 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.338 -0.839 . . . . 0.0 113.129 -174.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 m -104.16 172.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.624 1.102 . . . . 0.0 111.771 -175.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.5 m -73.27 166.61 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.905 0.882 . . . . 0.0 109.584 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -52.67 -50.54 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.048 1.739 . . . . 0.0 114.188 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -69.69 -33.12 72.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.656 -0.652 . . . . 0.0 110.888 -175.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -76.81 -37.26 56.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.375 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -51.4 -47.03 63.07 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.008 0.822 . . . . 0.0 109.915 173.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.55 -42.97 99.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.868 0.304 . . . . 0.0 110.791 -176.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.69 -50.79 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -58.61 -41.98 87.1 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.607 0.763 . . . . 0.0 109.027 -176.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.98 -52.93 63.66 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.679 0.792 . . . . 0.0 110.345 176.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -54.9 -49.55 70.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.68 -43.77 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.087 0.858 . . . . 0.0 110.491 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.8 mmt -69.8 -52.44 25.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -173.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -30.59 71.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.218 0.917 . . . . 0.0 112.234 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -45.31 85.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.793 0.724 . . . . 0.0 110.616 177.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -106.11 -11.41 16.11 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.01 66.83 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.169 1.788 . . . . 0.0 110.652 -174.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -67.11 -31.64 72.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.591 0.756 . . . . 0.0 110.465 -174.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.91 -45.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.3 -44.38 92.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.054 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -47.49 82.91 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 120.453 1.479 . . . . 0.0 110.056 -177.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.7 t -68.61 -31.23 70.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.712 0.405 . . . . 0.0 111.077 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.29 -38.63 91.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.124 1.369 . . . . 0.0 110.464 176.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -67.19 -44.15 80.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.803 0.274 . . . . 0.0 110.332 173.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.29 -28.92 64.47 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -81.02 -18.36 47.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.392 -175.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.258 24.1 p 42.48 55.4 10.12 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 126.192 1.797 . . . . 0.0 108.631 -169.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.36 179.42 5.07 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.689 1.593 . . . . 0.0 112.25 -167.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.745 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 mt . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.43 -66.16 0.59 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.096 0.872 . . . . 0.0 110.188 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -164.16 -53.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.918 0.487 . . . . 0.0 110.093 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.04 16.66 17.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 123.625 1.678 . . . . 0.0 110.746 -164.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.71 2.16 65.29 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 120.206 -1.558 . . . . 0.0 112.704 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -97.12 159.24 15.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.272 1.536 . . . . 0.0 109.035 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -140.16 142.03 28.66 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.518 ' HB2' HD12 ' A' ' 40' ' ' ILE . 10.9 Cg_endo -80.93 144.59 15.21 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.934 1.756 . . . . 0.0 110.648 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.25 154.98 41.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.55 158.26 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.961 0.904 . . . . 0.0 109.126 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -141.16 162.1 26.81 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG21 HD13 ' A' ' 54' ' ' LEU . 2.9 mp -126.27 144.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -172.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -128.17 136.46 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 ' HG ' ' A' ' 104' ' ' LEU . 17.5 mm -116.19 137.46 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 167.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.905 ' SG ' HD11 ' A' ' 101' ' ' LEU . 2.1 p -124.12 162.31 23.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.543 1.639 . . . . 0.0 112.69 161.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -106.14 172.65 6.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.047 -2.342 . . . . 0.0 108.834 172.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.0 5.48 6.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -94.1 0.29 55.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.716 0.806 . . . . 0.0 110.975 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.45 21.81 76.73 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.551 0.614 . . . . 0.0 112.196 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -95.15 147.25 23.65 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.8 145.98 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ttm -67.02 145.48 55.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.592 -1.185 . . . . 0.0 107.897 169.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 1.059 ' NE1' ' HB3' ' A' ' 33' ' ' TRP . 1.8 t90 -144.23 141.14 29.68 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.553 ' N ' ' HD1' ' A' ' 24' ' ' TRP . . . -133.28 167.28 20.68 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 123.52 1.629 . . . . 0.0 115.331 173.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' HB2' ' CE3' ' A' ' 33' ' ' TRP . 37.3 ttp180 -125.27 124.24 41.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 120.97 -1.081 . . . . 0.0 108.669 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -75.01 148.76 39.6 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.167 -169.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -54.77 132.89 46.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.292 1.62 . . . . 0.0 109.953 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -7.57 5.15 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.446 -1.196 . . . . 0.0 114.395 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -88.17 177.7 6.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -132.95 13.76 4.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.472 0.654 . . . . 0.0 109.853 165.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.89 154.49 21.51 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 1.059 ' HB3' ' NE1' ' A' ' 24' ' ' TRP 0.286 91.7 m95 -120.72 154.29 35.81 Favored 'General case' 0 N--CA 1.399 -2.977 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.715 -165.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.11 167.76 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.139 1.775 . . . . 0.0 110.952 -170.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -81.48 146.08 56.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.02 160.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -56.23 135.19 68.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.227 2.618 . . . . 0.0 110.666 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.433 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 14.2 pt20 -159.53 171.09 20.3 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.236 0.926 . . . . 0.0 111.356 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.04 171.36 44.39 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.972 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.12 147.28 24.55 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.656 -0.908 . . . . 0.0 111.179 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 9' ' ' PRO . 84.1 mt -74.25 123.12 28.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 165.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.32 155.71 91.16 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.9 124.74 15.54 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 N-CA-C 109.451 -1.019 . . . . 0.0 109.451 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.01 -9.81 76.77 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.803 -0.998 . . . . 0.0 114.322 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.35 151.71 44.93 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 119.683 1.742 . . . . 0.0 111.045 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.11 161.28 18.96 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 161.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.86 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 122.062 -0.398 . . . . 0.0 111.213 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.98 -35.06 74.14 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.971 -0.456 . . . . 0.0 111.016 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -70.08 -43.77 70.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.863 -1.148 . . . . 0.0 109.687 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.99 78.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 123.975 0.797 . . . . 0.0 109.557 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.479 ' SD ' HD11 ' A' ' 102' ' ' LEU . 13.3 tmm? -62.54 -48.86 77.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 35.0 m-85 -68.08 -38.3 82.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.87 0.759 . . . . 0.0 111.338 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.4 ttm-85 -60.07 -55.59 32.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.23 -28.52 64.24 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 13' ' ' ILE . 16.1 tp -54.66 -48.33 72.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 120.442 -1.411 . . . . 0.0 109.699 169.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.412 ' O ' HG21 ' A' ' 115' ' ' THR . 34.6 t80 -60.28 -45.17 94.26 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 117.318 -1.325 . . . . 0.0 109.213 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.97 -31.9 73.36 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.586 1.539 . . . . 0.0 111.652 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -91.67 -49.23 6.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.282 0.947 . . . . 0.0 110.06 -171.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.555 HG12 HG23 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -110.92 -10.83 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 124.498 1.119 . . . . 0.0 112.27 -168.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.92 1.09 37.71 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 123.824 0.726 . . . . 0.0 113.918 -173.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -83.23 150.33 26.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.075 1.35 . . . . 0.0 108.682 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.48 168.45 15.63 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.095 0.95 . . . . 0.0 108.731 -175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.49 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 28.4 mtt180 -48.7 -31.87 7.53 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 63' ' ' LYS . 28.9 mmmt -61.78 -31.14 71.32 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.703 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -114.53 23.52 12.67 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 126.728 2.517 . . . . 0.0 108.23 -168.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.26 162.69 33.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 O-C-N 120.439 -1.413 . . . . 0.0 111.127 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.04 138.09 38.47 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 117.845 -1.074 . . . . 0.0 108.206 165.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.31 119.66 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' A' ' 101' ' ' LEU . 84.0 mt -98.67 -32.47 11.39 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.649 0.593 . . . . 0.0 110.872 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.5 165.56 35.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.5 p -157.3 157.52 34.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.726 1.21 . . . . 0.0 108.738 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.532 HG22 ' HG2' ' A' ' 150' ' ' GLU . 1.7 p -70.64 136.33 49.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.267 1.032 . . . . 0.0 110.633 -174.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -81.98 -37.99 25.81 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.468 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -104.34 153.45 21.03 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.004 1.322 . . . . 0.0 108.139 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -84.24 134.91 34.52 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.026 -1.047 . . . . 0.0 108.425 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -89.31 98.71 11.92 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -97.92 147.64 24.26 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.88 153.63 39.36 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.717 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.13 143.49 27.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.488 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.13 150.94 83.56 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 123.863 0.727 . . . . 0.0 109.267 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.05 149.19 71.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.692 2.261 . . . . 0.0 109.225 160.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.8 mtpt -67.9 -18.29 64.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -167.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -59.17 -30.56 68.28 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.953 -0.546 . . . . 0.0 112.003 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.38 -19.11 21.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.222 0.609 . . . . 0.0 111.09 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 81' ' ' LYS . 93.3 t -63.5 136.55 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.15 75.44 1.37 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.079 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -56.3 -23.11 34.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -73.61 -28.18 61.68 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.078 0.551 . . . . 0.0 111.911 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.3 t -104.82 164.65 11.63 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.441 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -133.05 136.93 28.41 Favored Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.87 149.79 83.89 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 -16.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.97 136.53 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.104 0.961 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.4 p -88.05 132.29 34.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -12.54 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.118 0.567 . . . . 0.0 112.004 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.15 -177.69 41.15 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -153.58 158.1 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -105.48 134.91 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -117.58 130.92 56.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.898 1.279 . . . . 0.0 110.129 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -110.65 136.87 49.08 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -117.83 156.96 27.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -142.25 128.1 19.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.193 1.397 . . . . 0.0 107.748 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.905 HD11 ' SG ' ' A' ' 16' ' ' CYS . 1.2 tp -95.6 127.34 41.55 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.479 HD11 ' SD ' ' A' ' 50' ' ' MET . 5.9 mt -115.84 152.57 33.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.6 tt0 -100.69 134.85 43.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 159.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.526 ' HG ' HG21 ' A' ' 15' ' ' ILE . 1.6 mt -62.64 135.16 57.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 125.51 1.756 . . . . 0.0 109.298 169.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.5 t -88.72 -51.49 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -171.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -82.81 -17.3 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.8 0.727 . . . . 0.0 111.739 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.33 175.22 35.91 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -21.27 2.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.707 2.403 . . . . 0.0 114.301 -165.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.02 -31.24 40.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.334 1.454 . . . . 0.0 112.456 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.54 19.42 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.847 0.832 . . . . 0.0 112.503 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.555 HG23 HG12 ' A' ' 58' ' ' VAL . 79.0 mt -94.17 135.74 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.51 -1.369 . . . . 0.0 108.385 171.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -134.35 109.11 8.58 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 125.724 1.609 . . . . 0.0 107.855 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.02 9.3 20.04 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.99 -1.069 . . . . 0.0 112.651 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.8 77.04 1.69 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 124.061 1.886 . . . . 0.0 107.777 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 55' ' ' PHE . 2.0 p -73.75 -60.72 2.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.072 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -72.6 168.58 18.34 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.017 168.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.0 m -58.5 -39.2 79.4 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.954 -0.466 . . . . 0.0 110.446 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 132.6 62.67 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.38 133.59 50.14 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.587 1.524 . . . . 0.0 109.626 164.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -75.25 -26.76 59.11 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.903 0.858 . . . . 0.0 110.792 173.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -118.86 144.97 46.05 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 120.805 -1.185 . . . . 0.0 108.424 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.16 -31.05 22.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.007 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.76 158.95 27.93 Favored Glycine 0 C--N 1.335 0.524 0 O-C-N 120.689 -1.257 . . . . 0.0 111.012 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.73 155.15 42.18 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -150.89 165.59 33.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 108.304 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -112.78 137.93 50.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.45 152.97 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.94 1.296 . . . . 0.0 109.201 -168.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -59.97 147.47 38.79 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 117.178 -1.391 . . . . 0.0 109.536 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.12 66.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -93.06 -22.93 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.023 -1.048 . . . . 0.0 112.404 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.441 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 87.5 t80 -53.6 -37.79 55.01 Favored Pre-proline 0 CA--C 1.514 -0.415 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.009 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 1.021 ' HB3' ' HE3' ' A' ' 24' ' ' TRP . 10.9 Cg_endo -67.54 -37.18 17.6 Favored 'Trans proline' 0 N--CA 1.413 -3.254 0 N-CA-C 117.242 1.978 . . . . 0.0 117.242 -173.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.92 -25.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 112.73 -2.032 . . . . 0.0 109.115 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.02 -32.23 73.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.128 -1.607 . . . . 0.0 113.676 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 -24.82 33.19 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 124.075 0.859 . . . . 0.0 111.5 -168.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 144' ' ' TYR . 2.5 m -86.53 167.08 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 122.008 0.908 . . . . 0.0 111.041 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.18 172.55 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 120.892 -1.13 . . . . 0.0 109.987 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 m -51.03 -50.0 59.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -79.34 -30.88 42.92 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.224 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -70.6 -38.44 74.01 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.004 -1.06 . . . . 0.0 110.374 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.41 -45.18 62.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.105 0.962 . . . . 0.0 111.866 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.35 -47.52 85.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.043 1.464 . . . . 0.0 108.463 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.38 -51.53 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.199 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.408 ' CE2' HG11 ' A' ' 136' ' ' VAL . 6.0 m-30 -63.67 -37.77 88.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.068 0.849 . . . . 0.0 110.834 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -68.02 -38.81 83.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.432 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -58.82 -49.27 78.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.614 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.36 -39.14 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.623 1.169 . . . . 0.0 110.244 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -74.17 -55.47 6.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -36.45 74.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.624 0.647 . . . . 0.0 111.574 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 151' ' ' PHE . 4.6 tp10 -61.51 -30.82 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.791 0.836 . . . . 0.0 110.7 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.814 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 0.8 OUTLIER -113.49 -13.41 12.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 0.0 109.798 -172.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.69 71.92 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.684 1.593 . . . . 0.0 110.848 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 m -66.24 -33.58 76.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.577 0.751 . . . . 0.0 111.029 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.8 t -68.86 -43.02 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.454 HG22 ' SG ' ' A' ' 16' ' ' CYS . 27.4 t -59.37 -42.24 86.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.587 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmt -55.96 -52.92 62.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.079 1.309 . . . . 0.0 109.384 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -68.63 -29.12 67.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.063 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.504 HD13 HD13 ' A' ' 68' ' ' LEU . 14.1 tp -69.09 -23.09 63.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.659 1.584 . . . . 0.0 111.596 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.92 -24.85 40.8 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 117.662 -3.149 . . . . 0.0 111.212 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 CA--C 1.498 -1.038 0 CA-C-N 120.234 1.379 . . . . 0.0 114.156 -167.434 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -72.18 -72.87 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.704 0.684 . . . . 0.0 112.079 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -162.25 -49.96 0.04 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.284 1.034 . . . . 0.0 111.669 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -91.46 15.28 12.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.945 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.8 0.81 77.87 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.726 1.155 . . . . 0.0 113.787 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -95.39 162.62 13.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.349 1.074 . . . . 0.0 108.227 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.4 146.16 24.11 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.049 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 40' ' ' ILE . 44.5 Cg_endo -91.27 131.07 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.603 2.202 . . . . 0.0 111.526 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -128.51 157.97 39.69 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.381 1.472 . . . . 0.0 109.228 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.432 HG13 HD11 ' A' ' 40' ' ' ILE . 16.0 m -134.97 164.17 34.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -153.53 163.53 30.77 Favored Glycine 0 C--N 1.33 0.226 0 O-C-N 121.402 -0.811 . . . . 0.0 112.627 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.07 140.33 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 124.777 1.231 . . . . 0.0 108.582 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.22 137.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.5 mm -111.44 145.22 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.623 1.101 . . . . 0.0 108.054 169.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 p -120.72 150.32 41.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.632 0.773 . . . . 0.0 111.045 169.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -108.29 168.76 9.08 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.747 1.219 . . . . 0.0 108.191 170.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.28 3.82 6.7 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 119.915 -1.741 . . . . 0.0 113.606 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -88.51 -4.78 58.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.353 1.061 . . . . 0.0 110.892 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.26 13.55 83.17 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.896 -0.947 . . . . 0.0 112.296 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -81.9 147.85 29.08 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.175 1.487 . . . . 0.0 107.668 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 m -103.04 149.71 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.777 1.231 . . . . 0.0 108.815 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.67 142.45 30.76 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.147 0.979 . . . . 0.0 109.026 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -146.08 146.77 31.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.319 1.448 . . . . 0.0 108.617 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.43 166.66 29.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.026 1.285 . . . . 0.0 111.82 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -126.8 135.17 50.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.371 1.069 . . . . 0.0 108.828 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -64.96 154.79 36.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 109.7 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.91 128.62 38.0 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.89 0.23 90.1 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.415 -1.214 . . . . 0.0 113.962 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -112.23 150.25 31.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.474 1.637 . . . . 0.0 111.224 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -96.4 -16.2 21.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.154 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 p -83.98 134.68 34.64 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.277 1.431 . . . . 0.0 109.779 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -92.28 153.58 19.15 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.66 0.784 . . . . 0.0 110.729 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -150.39 156.89 42.35 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.967 1.707 . . . . 0.0 109.361 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.89 139.16 69.53 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.65 129.27 13.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.086 2.524 . . . . 0.0 111.455 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 29.6 pt20 -155.43 158.26 38.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 112.598 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.47 -169.74 20.86 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.821 1.677 . . . . 0.0 110.327 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.55 145.99 18.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.43 1.491 . . . . 0.0 110.636 -172.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 11' ' ' VAL . 62.1 mt -79.26 135.51 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 169.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -81.22 156.19 71.72 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.63 121.29 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.07 -2.48 85.47 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.32 -1.267 . . . . 0.0 114.411 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.56 156.05 39.85 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 120.598 2.199 . . . . 0.0 110.286 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -93.08 152.81 19.06 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 168.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.69 80.63 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.302 -0.874 . . . . 0.0 111.837 -172.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.46 -36.43 78.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.61 0.764 . . . . 0.0 110.092 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -68.52 -41.64 79.67 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.04 89.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -60.06 -50.89 71.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.755 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 58.0 m-85 -67.06 -37.35 83.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.39 0.995 . . . . 0.0 112.068 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -63.43 -50.3 70.31 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.579 1.536 . . . . 0.0 109.172 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -71.59 -32.71 68.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -170.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 58' ' ' VAL . 8.3 tp -53.77 -49.64 67.79 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.634 1.174 . . . . 0.0 110.147 169.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.29 -35.76 81.21 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.423 0.556 . . . . 0.0 110.651 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -70.12 -35.2 73.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.919 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.96 -38.38 5.35 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.553 1.07 . . . . 0.0 113.627 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.514 HG21 HD12 ' A' ' 54' ' ' LEU . 13.3 t -92.62 -31.74 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.196 0.999 . . . . 0.0 108.604 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 0.81 88.35 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.928 1.252 . . . . 0.0 112.743 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.8 tp -87.54 153.44 21.4 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.443 1.897 . . . . 0.0 109.615 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -128.74 166.08 19.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.713 1.205 . . . . 0.0 110.529 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 38.8 mtp180 -45.48 -41.43 9.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.228 1.811 . . . . 0.0 113.106 -172.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.94 -24.95 65.23 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.245 0.618 . . . . 0.0 111.902 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -102.74 9.71 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.528 0.731 . . . . 0.0 111.186 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.5 165.84 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.8 1.64 . . . . 0.0 112.08 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 136.3 31.13 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 168.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.5 mt -78.91 115.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 103' ' ' GLN . 78.6 mt -95.87 -31.19 13.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.372 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 154' ' ' VAL . . . -154.21 163.92 39.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.28 1.032 . . . . 0.0 108.454 -178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 p -162.03 154.91 20.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 124.488 1.115 . . . . 0.0 108.835 170.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.427 HG22 ' HG3' ' A' ' 150' ' ' GLU . 6.7 p -69.44 132.18 45.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.92 0.866 . . . . 0.0 110.812 -169.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -79.11 -27.44 42.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.248 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.45 151.4 38.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.201 2.2 . . . . 0.0 108.556 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.7 m95 -79.59 134.81 36.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 mt -94.94 129.14 42.1 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -133.16 148.41 52.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.88 1.218 . . . . 0.0 108.512 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.04 146.18 29.93 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.433 0.458 . . . . 0.0 109.774 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.81 146.23 24.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.99 145.75 91.99 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 111.111 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.92 146.99 60.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 N-CA-C 104.982 -2.738 . . . . 0.0 104.982 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.3 mtpt -68.89 -12.61 61.76 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.075 -1.641 . . . . 0.0 113.994 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.43 -31.73 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.026 0.83 . . . . 0.0 112.81 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.0 mt -91.79 -20.3 21.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.682 0.793 . . . . 0.0 112.03 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 81' ' ' LYS . 90.7 t -65.1 135.81 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -103.16 91.28 4.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.302 1.041 . . . . 0.0 110.071 171.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.65 -23.65 64.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.962 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.73 -33.87 71.29 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.789 0.435 . . . . 0.0 111.801 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -100.01 158.34 15.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.948 0.899 . . . . 0.0 109.576 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -130.63 134.69 26.33 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.434 1.494 . . . . 0.0 109.905 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.45 148.98 91.37 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 O-C-N 122.755 0.871 . . . . 0.0 109.928 -10.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.7 p -78.05 133.81 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.496 0.718 . . . . 0.0 109.37 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.03 128.75 33.65 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.13 -12.09 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 119.03 -0.51 . . . . 0.0 112.022 169.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.25 -178.49 42.49 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -147.3 153.29 39.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.31 1.444 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -108.03 140.2 41.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -127.29 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.362 1.465 . . . . 0.0 108.694 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.7 ttmm -133.5 117.97 17.78 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -103.1 158.25 16.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -134.0 125.59 28.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.329 1.451 . . . . 0.0 107.406 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -89.7 122.08 32.47 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mt -119.42 160.09 22.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.569 ' HB2' HD11 ' A' ' 68' ' ' LEU . 4.1 tt0 -109.42 135.59 50.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 132.91 54.53 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.64 -53.88 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.5 m -78.44 -30.95 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 112.156 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.49 162.26 11.26 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.82 -18.44 43.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.418 1.487 . . . . 0.0 113.668 -173.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.71 48.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.442 0.697 . . . . 0.0 112.484 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 11.82 3.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.6 mt -91.43 134.94 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.43 -43.06 1.62 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.177 0.591 . . . . 0.0 112.354 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 mtp 66.73 13.38 9.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.664 2.386 . . . . 0.0 114.357 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.66 33.02 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 123.413 1.577 . . . . 0.0 112.423 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -51.47 69.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.396 1.478 . . . . 0.0 109.161 169.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 m -73.85 157.23 36.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.721 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -63.53 -36.85 85.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.073 0.463 . . . . 0.0 109.958 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 131.51 45.3 Favored Pre-proline 0 N--CA 1.443 -0.815 0 C-N-CA 125.259 1.424 . . . . 0.0 109.299 169.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.83 147.34 94.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.59 -11.66 39.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -133.33 152.04 51.9 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.519 1.128 . . . . 0.0 109.868 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.11 -2.36 13.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.441 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.86 146.09 12.87 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -150.8 138.96 20.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.269 1.428 . . . . 0.0 107.565 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.99 173.79 13.9 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.342 1.457 . . . . 0.0 109.085 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -119.79 142.21 48.79 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.92 164.05 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.495 . . . . 0.0 110.437 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -69.67 153.05 43.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 169.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -31.65 72.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -169.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -85.99 -27.56 24.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.316 1.416 . . . . 0.0 112.864 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -54.84 -49.88 89.26 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.563 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.27 -29.78 73.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.153 1.805 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.69 -31.9 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.224 -0.923 . . . . 0.0 110.136 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -66.6 -27.16 67.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.209 -0.932 . . . . 0.0 111.569 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -82.11 -23.94 35.41 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.09 159.81 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.313 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.78 179.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.074 1.749 . . . . 0.0 110.769 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.4 m -55.17 -53.44 55.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.405 1.882 . . . . 0.0 113.293 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.62 -41.86 78.92 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.561 . . . . 0.0 110.318 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.63 -43.44 63.23 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.109 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -59.55 -34.36 72.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.486 1.494 . . . . 0.0 111.8 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 -45.53 88.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.309 0.959 . . . . 0.0 111.314 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.27 -47.5 92.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -69.14 -34.95 75.82 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.234 1.014 . . . . 0.0 110.054 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -66.68 -39.24 88.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.655 1.116 . . . . 0.0 109.927 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.34 -46.6 89.36 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.764 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.6 t -56.88 -41.74 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 110.752 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -70.69 -53.83 14.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.02 -33.88 76.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.066 1.303 . . . . 0.0 111.915 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HG3' HG22 ' A' ' 71' ' ' THR . 3.2 mm-40 -53.45 -40.52 65.29 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.854 1.262 . . . . 0.0 111.214 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -110.04 -12.53 14.52 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.006 0.922 . . . . 0.0 112.259 -170.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.44 75.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.811 1.644 . . . . 0.0 110.488 -170.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -69.07 -32.76 72.45 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.444 0.698 . . . . 0.0 109.923 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 69' ' ' ALA . 23.5 t -68.24 -45.24 83.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.99 -34.82 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.544 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 mmt -61.66 -57.57 11.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.833 1.197 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -70.1 -26.05 63.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.782 1.233 . . . . 0.0 111.004 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 68' ' ' LEU . 1.2 tm? -58.33 -35.39 71.82 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 128.714 2.806 . . . . 0.0 111.67 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -71.2 -39.54 71.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.883 0.765 . . . . 0.0 110.67 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.533 0.295 0 C-N-CA 123.482 0.713 . . . . 0.0 112.061 -169.635 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.53 -68.85 0.36 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.208 0.603 . . . . 0.0 111.281 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -163.9 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.096 0.958 . . . . 0.0 112.22 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.97 17.15 14.43 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.698 1.199 . . . . 0.0 112.858 -169.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.04 7.42 65.88 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.276 0.941 . . . . 0.0 113.787 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.26 157.95 16.03 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.19 149.3 72.27 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.4 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' A' ' 40' ' ' ILE . 69.3 Cg_endo -84.56 138.92 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.208 1.938 . . . . 0.0 111.242 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -140.8 151.97 44.81 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.367 1.067 . . . . 0.0 110.339 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 40' ' ' ILE . 35.3 m -134.89 153.63 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.717 0.807 . . . . 0.0 109.66 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.88 157.39 24.75 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.85 141.99 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.426 1.09 . . . . 0.0 108.568 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.07 137.73 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -115.95 132.3 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 22' ' ' VAL . 70.7 m -122.93 144.31 49.32 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -96.63 173.57 7.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.848 1.259 . . . . 0.0 108.666 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.76 9.96 5.58 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.833 -1.167 . . . . 0.0 113.59 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -99.09 0.22 43.17 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.693 0.797 . . . . 0.0 111.175 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.44 20.03 78.96 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.169 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -92.56 142.82 26.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.799 1.299 . . . . 0.0 107.786 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -113.39 143.12 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.013 1.725 . . . . 0.0 107.295 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -81.31 147.32 29.94 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.726 0.694 . . . . 0.0 109.465 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.0 t90 -151.86 140.48 20.75 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -171.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.46 149.76 51.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.771 1.169 . . . . 0.0 112.565 -169.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -98.44 120.23 38.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.252 1.821 . . . . 0.0 106.699 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -82.91 143.93 30.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.724 1.602 . . . . 0.0 109.616 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.45 132.79 54.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.426 0.69 . . . . 0.0 109.82 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.85 -9.71 16.41 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.925 1.25 . . . . 0.0 114.507 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -90.88 -39.79 12.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.556 1.678 . . . . 0.0 111.368 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.1 m80 57.5 31.66 20.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.162 0.985 . . . . 0.0 110.974 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -129.17 152.36 48.84 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.729 1.612 . . . . 0.0 108.337 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -104.09 146.62 28.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.267 0.627 . . . . 0.0 110.933 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -156.92 163.2 39.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.801 1.241 . . . . 0.0 110.808 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.16 144.5 44.19 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.014 -0.994 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.4 131.87 45.62 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.423 2.749 . . . . 0.0 112.475 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -158.2 167.81 28.78 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.643 0.656 . . . . 0.0 112.484 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.67 167.2 40.32 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.27 0.462 . . . . 0.0 112.207 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.72 146.47 32.61 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 9' ' ' PRO . 66.2 mt -74.82 127.28 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -78.41 152.57 78.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.12 120.13 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.7 1.6 . . . . 0.0 110.176 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.74 67.99 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.233 -1.315 . . . . 0.0 113.991 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.45 148.58 48.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 120.232 2.016 . . . . 0.0 110.231 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -84.27 153.76 23.37 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -38.67 76.91 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.778 -0.576 . . . . 0.0 111.909 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.91 -34.13 74.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.733 0.813 . . . . 0.0 110.248 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -73.12 -36.12 66.67 Favored 'General case' 0 C--N 1.337 0.045 0 O-C-N 120.89 -1.131 . . . . 0.0 109.908 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.92 90.84 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.8 ttp -58.82 -49.23 78.47 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.999 0.818 . . . . 0.0 109.036 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 49.8 m-85 -66.12 -46.24 78.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.679 1.127 . . . . 0.0 111.584 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -67.6 -45.31 75.84 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.277 0.944 . . . . 0.0 110.17 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -69.49 -34.54 74.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -57.0 -44.86 83.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.848 1.204 . . . . 0.0 110.323 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -61.27 -41.01 96.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.552 0.614 . . . . 0.0 110.212 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.92 -21.53 65.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.312 0.645 . . . . 0.0 112.232 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.39 -60.85 1.63 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.609 1.164 . . . . 0.0 109.629 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 m -112.44 0.69 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.501 1.52 . . . . 0.0 111.972 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.31 48.4 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.376 -1.452 . . . . 0.0 113.897 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -82.41 144.79 30.25 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.416 1.486 . . . . 0.0 110.2 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -123.98 165.5 17.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.34 1.056 . . . . 0.0 109.633 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 50.4 mtt85 -47.73 -35.55 9.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 112.495 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.27 -22.34 66.84 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.403 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.62 22.59 12.62 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.1 164.99 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.758 -1.214 . . . . 0.0 111.869 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 140.72 33.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 116.982 -1.485 . . . . 0.0 107.962 169.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.44 116.28 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 103' ' ' GLN . 97.9 mt -90.5 -36.01 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.229 174.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.98 32.54 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.016 0.926 . . . . 0.0 110.456 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -151.66 149.08 28.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.079 1.752 . . . . 0.0 109.42 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 150' ' ' GLU . 3.3 p -70.81 139.88 51.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.748 1.158 . . . . 0.0 109.786 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -93.2 -29.22 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.332 1.053 . . . . 0.0 109.862 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -110.48 149.61 30.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.471 2.308 . . . . 0.0 107.864 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 65.4 m95 -82.76 143.03 31.14 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -87.78 91.19 8.66 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 139.35 52.31 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -137.25 153.6 50.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.579 0.752 . . . . 0.0 110.209 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -131.34 138.04 49.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.51 1.924 . . . . 0.0 108.151 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.99 146.9 69.01 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.828 0.851 . . . . 0.0 110.694 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.1 145.94 68.78 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 N-CA-C 104.601 -2.884 . . . . 0.0 104.601 166.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.4 mtpt -68.38 -13.27 62.17 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.031 -1.668 . . . . 0.0 113.835 -169.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -58.81 -30.64 67.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.953 0.797 . . . . 0.0 113.071 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.45 -20.29 21.15 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 112.134 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 81' ' ' LYS . 59.6 t -65.24 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -102.83 89.57 3.51 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.959 0.904 . . . . 0.0 109.76 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -67.19 -24.84 65.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.716 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.34 -33.84 71.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.798 0.439 . . . . 0.0 111.747 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -99.36 159.33 15.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.042 0.937 . . . . 0.0 109.398 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -130.79 134.44 26.0 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 125.152 1.381 . . . . 0.0 109.466 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.47 148.23 89.67 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.719 0.852 . . . . 0.0 110.428 -10.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -77.76 139.08 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.675 0.79 . . . . 0.0 109.613 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.1 p -90.43 120.58 31.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.87 0.868 . . . . 0.0 108.89 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -13.09 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 118.848 0.749 . . . . 0.0 112.751 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 -171.47 34.19 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -157.9 167.71 29.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.762 1.225 . . . . 0.0 109.552 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -115.58 127.6 55.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -114.34 129.0 56.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 10.0 ttmm -111.74 139.13 47.47 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -123.19 153.34 40.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.97 128.48 24.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.59 122.5 37.25 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.08 156.83 24.46 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.659 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.1 tt0 -106.73 129.7 54.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 167.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.76 139.69 58.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.1 1.36 . . . . 0.0 108.52 171.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.99 -44.99 14.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.043 0.383 . . . . 0.0 110.698 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.9 m -87.05 -16.06 36.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.571 0.748 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.56 -167.79 24.82 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.451 ' HB2' ' HE1' ' A' ' 126' ' ' TRP . 1.1 p-10 -60.92 -17.66 52.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.485 1.514 . . . . 0.0 114.698 -171.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.24 47.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.116 0.966 . . . . 0.0 111.774 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.49 50.96 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.829 1.252 . . . . 0.0 110.527 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.9 mt -129.93 129.82 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -113.22 161.56 17.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.391 2.276 . . . . 0.0 106.66 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mmt -126.48 -9.2 6.29 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.029 1.332 . . . . 0.0 111.872 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.35 84.13 2.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 123.718 1.723 . . . . 0.0 107.38 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 -61.12 2.11 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.348 2.659 . . . . 0.0 107.59 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 m -73.22 173.98 8.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.726 1.611 . . . . 0.0 109.009 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m -59.94 -36.81 77.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.496 -0.752 . . . . 0.0 109.807 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 137.05 57.33 Favored Pre-proline 0 N--CA 1.444 -0.772 0 C-N-CA 125.928 1.691 . . . . 0.0 109.133 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.02 133.54 47.87 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 107.212 -1.88 . . . . 0.0 107.212 168.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -85.07 -35.73 21.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -110.98 145.86 37.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.79 -29.24 25.58 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.806 0.842 . . . . 0.0 110.41 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.25 169.49 41.03 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.47 159.99 44.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.772 0.786 . . . . 0.0 109.655 169.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -143.95 169.35 17.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.827 1.251 . . . . 0.0 108.888 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.451 ' HE1' ' HB2' ' A' ' 108' ' ' ASP . 75.4 m95 -111.99 139.43 47.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.58 152.85 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.002 1.321 . . . . 0.0 110.648 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -62.94 143.78 57.39 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -32.31 44.73 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -169.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.99 -18.22 31.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.553 1.07 . . . . 0.0 112.947 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.38 -46.22 70.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.422 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.35 -29.39 85.73 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.774 2.026 . . . . 0.0 112.017 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.4 t -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.899 1.279 . . . . 0.0 109.924 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.263 -0.898 . . . . 0.0 111.443 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -94.31 -21.62 18.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.58 154.01 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 119.031 0.832 . . . . 0.0 110.491 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.58 178.42 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.052 1.341 . . . . 0.0 110.478 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.9 m -55.73 -47.15 77.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.868 1.667 . . . . 0.0 113.236 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -71.73 -45.73 60.83 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.987 -0.446 . . . . 0.0 110.451 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.57 -39.95 73.59 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.679 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -59.71 -31.44 69.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.745 1.157 . . . . 0.0 112.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.19 -43.21 95.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.495 1.043 . . . . 0.0 111.05 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.4 t -62.71 -50.3 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.76 -38.41 90.99 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.919 0.782 . . . . 0.0 109.644 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -65.98 -41.15 91.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.696 1.134 . . . . 0.0 110.243 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -59.6 -49.38 78.0 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.037 0.835 . . . . 0.0 109.615 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.29 -37.59 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.736 1.214 . . . . 0.0 110.977 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.3 mmt -74.28 -54.83 6.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -59.85 -34.14 72.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.42 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 71' ' ' THR . 5.5 tp10 -57.71 -42.11 83.12 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 110.763 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.77 -10.24 19.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.668 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.34 67.48 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.354 1.462 . . . . 0.0 110.559 -171.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 m -68.13 -32.72 73.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.386 0.675 . . . . 0.0 110.548 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.64 -42.81 62.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.4 t -57.29 -38.99 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 117.434 -1.27 . . . . 0.0 110.175 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -62.06 -51.68 66.97 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.472 1.487 . . . . 0.0 111.092 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.4 m -77.23 -24.03 51.27 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.812 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 tp -55.8 -48.66 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.138 1.775 . . . . 0.0 109.359 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -60.27 -33.99 73.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.535 0.734 . . . . 0.0 111.601 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 CA--C 1.531 0.249 0 C-N-CA 124.819 1.248 . . . . 0.0 111.731 -174.895 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.679 0.752 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.31 -66.7 0.53 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.43 -51.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.05 17.28 14.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.476 1.11 . . . . 0.0 113.385 -169.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.56 62.71 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.12 0.866 . . . . 0.0 113.658 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -103.84 159.44 15.64 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.682 1.241 . . . . 0.0 107.731 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 149.86 64.38 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.25 -1.357 . . . . 0.0 107.834 170.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -91.41 141.52 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.899 1.732 . . . . 0.0 109.425 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -130.1 160.18 34.53 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.253 -0.904 . . . . 0.0 110.455 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.23 167.37 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -159.0 151.9 22.89 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -128.88 142.88 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.444 1.098 . . . . 0.0 108.586 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.77 136.37 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mm -120.37 132.9 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' A' ' 22' ' ' VAL . 43.3 m -124.2 150.84 44.77 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.492 0.587 . . . . 0.0 111.37 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -109.17 173.41 6.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.409 1.484 . . . . 0.0 108.816 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -74.94 0.17 16.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.11 -1.619 . . . . 0.0 113.002 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -88.68 -3.47 58.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 111.419 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.63 18.63 77.36 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 118.835 0.743 . . . . 0.0 111.48 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -86.13 139.73 30.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.511 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.0 m -108.79 143.82 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 125.514 1.526 . . . . 0.0 107.53 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -79.65 143.07 34.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -146.22 144.18 29.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.03 157.17 46.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.044 0.838 . . . . 0.0 111.557 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -111.53 119.07 37.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -72.48 151.31 42.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.297 1.408 . . . . 0.0 110.261 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.35 148.24 47.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.795 0.838 . . . . 0.0 109.633 -175.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 3.36 50.12 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.7 -1.056 . . . . 0.0 113.569 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.81 159.93 40.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.161 1.481 . . . . 0.0 110.577 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -94.11 -22.15 18.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 m -73.52 154.47 39.86 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.145 0.978 . . . . 0.0 111.63 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -106.45 152.57 23.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.222 1.009 . . . . 0.0 109.978 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -148.73 156.8 42.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.943 1.297 . . . . 0.0 110.778 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -80.62 140.64 51.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.35 137.7 82.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.768 1.645 . . . . 0.0 111.118 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -157.18 171.01 21.2 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.214 0.915 . . . . 0.0 112.198 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.05 -168.79 34.01 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -109.17 150.89 17.2 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.411 1.482 . . . . 0.0 109.943 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.29 119.57 34.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -77.1 159.03 79.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.61 127.9 28.12 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.664 1.576 . . . . 0.0 110.246 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.18 -5.47 79.98 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.395 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.55 148.11 37.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.158 1.979 . . . . 0.0 109.471 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.8 m -90.07 157.91 17.57 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.33 77.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.079 0.854 . . . . 0.0 111.583 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.26 -37.68 78.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.734 0.814 . . . . 0.0 110.216 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -66.49 -41.45 88.91 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.1 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.62 85.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -56.32 -50.86 70.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.612 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.451 1.023 . . . . 0.0 110.566 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -64.76 -47.0 79.79 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.453 1.024 . . . . 0.0 109.965 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.81 -31.99 67.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.6 -49.33 73.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.3 -40.92 95.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.008 0.822 . . . . 0.0 110.824 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.6 -26.66 68.5 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.728 -0.607 . . . . 0.0 112.222 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.15 -57.67 2.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.438 1.095 . . . . 0.0 110.451 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.72 0.64 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 112.383 -169.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.48 4.78 32.99 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.758 1.163 . . . . 0.0 113.702 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -84.1 146.58 27.82 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.303 1.841 . . . . 0.0 109.436 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 m -125.03 166.23 16.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.991 0.917 . . . . 0.0 109.76 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -52.93 -32.64 46.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.701 1.6 . . . . 0.0 112.476 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.37 -26.86 68.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.375 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -111.91 22.2 15.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.845 0.831 . . . . 0.0 112.209 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.18 165.06 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.707 -1.245 . . . . 0.0 111.7 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 140.86 40.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 mt -76.4 119.22 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 103' ' ' GLN . 92.7 mt -93.69 -35.34 12.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.81 170.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.578 0.751 . . . . 0.0 110.621 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 p -160.88 153.32 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.744 1.618 . . . . 0.0 109.897 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.08 139.06 54.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.783 0.801 . . . . 0.0 110.742 -170.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -94.62 -33.67 12.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -110.72 144.02 40.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.969 2.107 . . . . 0.0 107.327 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -85.51 141.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.39 72.03 7.04 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -71.6 154.29 41.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.36 151.08 50.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.503 1.121 . . . . 0.0 108.879 -169.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -130.48 132.18 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.696 1.598 . . . . 0.0 107.581 174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -80.9 141.77 51.46 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 124.378 1.071 . . . . 0.0 111.995 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.84 149.95 67.07 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 N-CA-C 104.762 -2.822 . . . . 0.0 104.762 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.9 mtpt -68.99 -13.56 62.52 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.84 -1.788 . . . . 0.0 114.056 -169.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -62.37 -31.02 71.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.113 0.869 . . . . 0.0 112.558 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -93.73 -18.18 22.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.236 1.014 . . . . 0.0 112.009 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 81' ' ' LYS . 95.6 t -64.71 135.02 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -98.1 90.5 4.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.794 0.838 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -71.52 -20.95 61.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.906 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.23 -30.12 57.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.885 0.474 . . . . 0.0 112.196 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.27 160.14 14.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.354 1.061 . . . . 0.0 109.234 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -130.96 133.66 25.03 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 125.783 1.633 . . . . 0.0 108.319 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.32 156.79 94.14 Favored 'Cis proline' 0 CA--C 1.539 0.757 0 O-C-N 122.805 0.897 . . . . 0.0 111.179 -10.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.0 t -74.16 140.33 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.941 0.897 . . . . 0.0 109.741 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 p -93.24 122.61 35.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.119 0.967 . . . . 0.0 108.97 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.15 -12.09 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 119.297 0.953 . . . . 0.0 113.213 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.51 -173.62 43.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -156.31 157.24 35.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.343 1.057 . . . . 0.0 110.173 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -102.72 128.21 49.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -124.58 129.15 50.03 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.531 1.06 . . . . 0.0 111.509 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -88.42 157.37 18.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.626 1.17 . . . . 0.0 108.558 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.494 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 82.5 m95 -133.8 147.26 51.23 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 168.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -131.19 134.69 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.938 1.295 . . . . 0.0 107.924 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.5 tp -96.63 118.45 33.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.79 140.26 49.06 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.6 tt0 -89.11 133.3 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 168.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.26 139.71 58.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.397 1.079 . . . . 0.0 109.069 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.41 -48.74 13.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 118.238 0.472 . . . . 0.0 110.041 -171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.7 m -86.21 -18.44 32.14 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.883 0.473 . . . . 0.0 111.11 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.73 -169.0 22.92 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -55.73 -23.47 29.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.264 1.826 . . . . 0.0 113.345 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.39 51.3 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -89.85 14.52 11.81 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.78 138.51 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -124.07 131.6 53.57 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.57 1.948 . . . . 0.0 107.637 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.3 mmt -98.56 -7.65 27.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 112.497 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.69 75.29 0.98 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.436 1.895 . . . . 0.0 108.027 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -75.56 -65.61 0.88 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.978 2.111 . . . . 0.0 108.963 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.1 m -80.29 177.73 8.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.594 1.557 . . . . 0.0 109.483 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 m -56.57 -35.1 67.79 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.979 0.512 . . . . 0.0 110.361 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 128.94 49.37 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 107.87 169.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.92 122.95 10.37 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 169.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.74 -18.49 62.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -116.76 140.18 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.649 0.78 . . . . 0.0 110.374 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.69 -26.98 40.79 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 110.732 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.44 169.29 41.5 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 123.894 0.759 . . . . 0.0 111.315 -174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 160.63 43.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.768 0.827 . . . . 0.0 109.168 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -152.11 165.73 33.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.976 0.91 . . . . 0.0 108.954 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -110.65 133.86 52.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.24 152.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.838 1.255 . . . . 0.0 111.17 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.4 m -60.47 144.08 52.0 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.94 0.791 . . . . 0.0 109.628 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.15 -34.49 60.54 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -87.0 -7.93 57.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.974 -1.079 . . . . 0.0 113.486 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -75.52 -49.39 3.77 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.918 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.31 -21.6 72.23 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 123.044 2.123 . . . . 0.0 113.282 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.8 -35.92 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -68.97 -25.56 64.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.333 -0.855 . . . . 0.0 111.621 -169.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -83.36 -24.75 31.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.55 165.43 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 118.968 0.803 . . . . 0.0 111.07 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.36 175.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 110.166 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -57.42 -44.15 84.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.503 1.521 . . . . 0.0 113.875 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -70.3 -41.93 72.7 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.474 -0.766 . . . . 0.0 110.827 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -74.93 -35.0 62.18 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.233 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -49.33 -46.02 46.26 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.122 0.969 . . . . 0.0 110.462 170.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.28 -43.04 96.05 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.568 0.622 . . . . 0.0 111.089 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.86 -50.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -66.07 -34.75 78.77 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.055 0.942 . . . . 0.0 110.607 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -67.57 -41.31 84.36 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.808 1.186 . . . . 0.0 109.962 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.93 -43.54 98.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.299 0.954 . . . . 0.0 110.873 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 99' ' ' TRP . 89.8 t -57.74 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.466 1.106 . . . . 0.0 111.542 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.1 mmt -84.33 -59.83 2.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.71 -34.45 67.47 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.362 1.065 . . . . 0.0 112.178 -173.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -57.61 -38.47 75.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.807 0.843 . . . . 0.0 110.727 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -109.78 -10.62 14.77 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 112.817 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.4 -38.99 72.27 Favored 'General case' 0 C--O 1.228 -0.031 0 C-N-CA 125.658 1.583 . . . . 0.0 110.545 -172.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -68.2 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.64 0.776 . . . . 0.0 110.443 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.7 -45.83 72.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.38 -46.32 92.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 117.627 -1.178 . . . . 0.0 110.236 -175.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -43.48 85.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 121.435 1.925 . . . . 0.0 110.317 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.4 t -70.84 -32.13 69.07 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.218 -0.301 . . . . 0.0 111.124 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.0 tp -62.44 -43.28 99.19 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 126.198 1.799 . . . . 0.0 109.568 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -65.38 -43.75 89.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.667 0.387 . . . . 0.0 110.924 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 123.508 0.723 . . . . 0.0 111.806 -169.919 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 121.414 0.626 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.93 -68.49 0.38 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.63 0.772 . . . . 0.0 110.192 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -164.14 -49.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.964 0.906 . . . . 0.0 113.23 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.2 17.13 14.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.688 1.195 . . . . 0.0 113.233 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.11 10.66 60.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.902 0.763 . . . . 0.0 113.38 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -101.09 155.04 18.22 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.53 31.42 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 117.534 -1.222 . . . . 0.0 109.354 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.76 137.68 16.24 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.469 1.446 . . . . 0.0 110.455 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -142.62 157.18 44.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.122 0.969 . . . . 0.0 109.291 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.25 161.2 35.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 121.267 -0.896 . . . . 0.0 109.669 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.9 163.0 28.35 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -121.65 143.31 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 124.522 1.129 . . . . 0.0 108.393 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.82 136.8 59.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -116.95 133.71 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -125.64 154.02 42.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.843 0.747 . . . . 0.0 111.576 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -104.23 175.16 5.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.002 1.321 . . . . 0.0 108.777 172.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 4.83 8.85 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.237 -1.54 . . . . 0.0 113.267 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -90.94 -2.54 57.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.435 1.094 . . . . 0.0 111.416 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.56 0.618 . . . . 0.0 111.848 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -89.0 144.06 26.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.0 m -115.2 150.02 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.498 1.519 . . . . 0.0 109.161 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 42.8 ttm -65.27 139.75 58.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.708 0.803 . . . . 0.0 108.964 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -142.88 136.92 29.15 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.01 154.57 51.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.712 1.142 . . . . 0.0 111.575 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -114.92 123.23 48.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -76.99 147.85 36.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 121.74 2.064 . . . . 0.0 110.681 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.63 129.67 43.07 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.83 0.08 87.56 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.86 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -110.96 164.42 12.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.216 1.508 . . . . 0.0 110.397 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -101.38 -24.57 14.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.228 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -80.36 159.16 25.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.783 1.233 . . . . 0.0 111.796 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -112.3 155.77 23.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.239 1.015 . . . . 0.0 111.674 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -160.58 164.26 32.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.0 1.72 . . . . 0.0 110.936 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -86.48 149.12 48.38 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.72 130.84 38.89 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.758 2.306 . . . . 0.0 111.951 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.67 161.5 34.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 112.218 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.71 171.58 44.52 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.222 0.439 . . . . 0.0 113.534 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.56 152.75 36.0 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.843 1.211 . . . . 0.0 111.755 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.84 130.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -77.22 157.99 80.17 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.29 123.55 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.98 -6.36 83.6 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.709 -1.051 . . . . 0.0 114.593 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.39 156.15 39.82 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 120.115 1.958 . . . . 0.0 109.439 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.0 p -91.94 166.95 12.45 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.0 81.34 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.782 -0.574 . . . . 0.0 110.815 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.22 -36.5 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.247 0.619 . . . . 0.0 110.582 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.01 -37.25 72.64 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.998 -1.064 . . . . 0.0 110.365 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.42 80.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.418 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.3 tmm? -65.62 -51.44 59.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.14 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -66.82 -31.62 72.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.41 1.459 . . . . 0.0 111.839 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -61.07 -52.03 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.411 1.005 . . . . 0.0 108.925 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -71.47 -27.26 63.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.562 0.619 . . . . 0.0 109.962 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.73 -43.88 90.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.928 -1.107 . . . . 0.0 109.388 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.45 -49.07 52.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.977 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.47 -28.94 68.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.656 1.117 . . . . 0.0 112.608 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -96.16 -52.51 3.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.162 0.985 . . . . 0.0 110.657 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.05 -29.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.543 1.137 . . . . 0.0 110.899 -168.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.3 84.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.447 1.023 . . . . 0.0 112.377 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 tp -78.66 154.15 30.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.172 1.789 . . . . 0.0 109.162 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -132.1 163.98 27.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 109.941 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -39.02 -41.78 0.81 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.9 2.48 . . . . 0.0 112.887 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -63.49 -29.23 70.53 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.77 0.828 . . . . 0.0 112.064 -170.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.5 23.36 13.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.575 0.702 . . . . 0.0 112.185 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.57 165.32 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 O-C-N 120.729 -1.232 . . . . 0.0 112.362 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.57 130.34 27.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.854 168.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mt -69.13 117.26 11.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 103' ' ' GLN . 87.1 mt -95.92 -32.84 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.502 173.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -154.81 162.78 40.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.671 0.788 . . . . 0.0 109.267 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -159.19 155.05 26.42 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.888 1.275 . . . . 0.0 109.735 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.637 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -69.27 138.77 54.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.587 0.708 . . . . 0.0 110.525 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -86.9 -28.41 22.82 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.56 1.144 . . . . 0.0 109.801 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -119.97 149.67 41.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.394 2.278 . . . . 0.0 108.069 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -78.3 135.77 37.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.61 0.641 . . . . 0.0 109.489 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.3 mt -90.14 89.32 7.62 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -90.01 146.61 24.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -148.59 145.75 27.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 169.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 139.3 30.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.71 150.46 39.68 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.787 0.835 . . . . 0.0 109.302 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.8 Cg_endo -72.24 158.14 52.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.219 3.28 . . . . 0.0 110.944 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -67.17 -19.37 65.57 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.82 -1.175 . . . . 0.0 112.941 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.84 -30.45 70.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.017 0.826 . . . . 0.0 112.888 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 80' ' ' PRO . 51.2 mt -93.45 -14.19 27.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.182 0.993 . . . . 0.0 112.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.4 t -67.04 133.66 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -94.6 90.75 6.26 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.769 0.795 . . . . 0.0 109.628 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -71.43 -21.9 61.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.497 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.16 -13.26 59.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.743 0.817 . . . . 0.0 112.781 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -121.29 159.86 25.13 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.264 1.025 . . . . 0.0 109.986 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -127.74 131.54 23.87 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 125.522 1.529 . . . . 0.0 109.938 -173.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.19 149.45 93.15 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 O-C-N 122.741 0.864 . . . . 0.0 110.689 -10.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.01 141.46 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.067 0.947 . . . . 0.0 109.969 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.3 p -94.91 137.17 34.32 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.658 0.783 . . . . 0.0 110.762 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.61 -14.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 169.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.39 179.9 35.6 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.54 157.51 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.456 1.502 . . . . 0.0 108.589 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.92 128.66 56.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 170.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -113.3 131.57 55.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.935 0.789 . . . . 0.0 109.652 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -110.74 125.49 53.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -108.23 154.41 21.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 84.5 m-85 -135.53 127.12 28.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 19.7 tp -90.43 120.19 31.34 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.8 131.41 56.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.9 tt0 -86.79 134.55 33.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.49 141.81 58.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 109.014 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.28 -51.8 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.57 0.623 . . . . 0.0 109.826 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 m -83.76 -19.82 34.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.111 0.564 . . . . 0.0 111.742 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.44 -169.12 23.36 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -18.38 47.52 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.584 1.554 . . . . 0.0 114.157 -169.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 -31.73 48.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.041 . . . . 0.0 112.902 172.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.92 17.62 10.35 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.3 mt -94.9 134.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -120.34 -52.73 2.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.327 0.651 . . . . 0.0 112.252 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 70.56 7.77 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.887 2.475 . . . . 0.0 114.884 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -153.79 78.46 1.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 123.988 1.851 . . . . 0.0 109.616 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -59.73 2.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.12 -2.309 . . . . 0.0 107.997 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -67.97 165.11 18.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.19 1.396 . . . . 0.0 109.498 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -62.77 -33.31 74.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.973 0.509 . . . . 0.0 110.12 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.5 129.94 51.2 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 124.91 1.284 . . . . 0.0 110.2 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -65.58 143.84 76.63 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.083 1.855 . . . . 0.0 108.338 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -83.18 -17.53 42.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.021 -0.424 . . . . 0.0 111.308 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.48 140.69 49.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.136 0.88 . . . . 0.0 110.85 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.31 -29.74 57.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.159 1.384 . . . . 0.0 110.303 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.72 164.6 38.2 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.57 158.15 43.91 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.61 167.99 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -107.38 136.97 46.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 154.85 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.813 1.245 . . . . 0.0 110.126 -171.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -61.4 144.44 54.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.215 0.916 . . . . 0.0 109.403 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -27.39 57.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -88.61 -16.45 32.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.047 1.294 . . . . 0.0 112.985 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.85 -50.41 85.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.428 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.2 -25.85 42.77 Favored 'Trans proline' 0 C--N 1.35 0.638 0 CA-C-N 121.985 1.745 . . . . 0.0 112.65 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.24 -42.3 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.586 -0.696 . . . . 0.0 109.237 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -69.86 -7.8 43.19 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.605 -1.309 . . . . 0.0 114.227 -178.714 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.08 -28.21 39.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.147 0.885 . . . . 0.0 111.721 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.1 160.26 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.14 163.66 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.074 0.95 . . . . 0.0 108.88 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.1 m -54.21 -45.67 72.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -70.24 -34.52 72.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.993 1.27 . . . . 0.0 111.238 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -75.36 -44.6 44.18 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.896 -0.503 . . . . 0.0 109.936 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -48.04 -40.77 23.94 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.982 1.313 . . . . 0.0 112.752 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.47 -37.67 83.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.111 0.869 . . . . 0.0 111.963 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.09 -53.12 47.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -65.11 -32.52 74.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 112.225 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -65.76 -43.9 87.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.449 1.477 . . . . 0.0 110.606 170.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -44.72 93.4 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.541 1.064 . . . . 0.0 110.383 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.5 t -56.97 -31.96 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.593 1.157 . . . . 0.0 111.472 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.6 mmt -82.35 -59.62 2.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -31.96 69.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.463 0.705 . . . . 0.0 112.598 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.637 ' HG3' HG22 ' A' ' 71' ' ' THR . 2.0 mm-40 -57.31 -39.58 76.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 112.18 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.89 -13.75 14.08 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.948 0.899 . . . . 0.0 111.416 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.54 -39.59 64.82 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 126.064 1.746 . . . . 0.0 110.631 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 m -66.52 -31.89 72.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.627 0.771 . . . . 0.0 110.903 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.86 -46.15 74.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.78 -40.46 79.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.434 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -55.31 -51.45 66.67 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 120.576 1.534 . . . . 0.0 109.85 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.0 -27.08 60.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.91 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.415 HD21 ' NE2' ' A' ' 103' ' ' GLN . 27.4 tp -62.5 -40.71 97.6 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.711 1.204 . . . . 0.0 109.937 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -60.41 -44.38 95.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.148 0.579 . . . . 0.0 110.173 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 124.516 1.126 . . . . 0.0 113.24 -170.185 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -68.28 -66.49 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.337 0.655 . . . . 0.0 110.945 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -164.0 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.952 0.901 . . . . 0.0 112.918 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -95.76 17.2 15.56 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.446 1.098 . . . . 0.0 113.006 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.45 5.66 65.0 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.946 0.784 . . . . 0.0 113.656 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.85 154.81 17.38 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.55 148.46 67.54 Favored Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.935 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.523 ' HB2' HD12 ' A' ' 40' ' ' ILE . 90.3 Cg_endo -79.86 141.06 14.89 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.319 2.012 . . . . 0.0 110.26 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -145.06 158.68 43.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.272 1.029 . . . . 0.0 109.733 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.95 159.64 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 O-C-N 121.201 -0.937 . . . . 0.0 109.718 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -139.85 156.71 25.0 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.53 141.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.999 1.32 . . . . 0.0 108.261 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.24 139.1 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 mm -116.74 142.79 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 117.243 -1.36 . . . . 0.0 107.568 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.8 p -119.82 154.5 34.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 111.493 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -111.57 171.01 7.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 108.972 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.01 0.52 11.13 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.038 -1.664 . . . . 0.0 114.049 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -88.35 -1.07 57.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.906 0.883 . . . . 0.0 111.053 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.55 17.18 76.2 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.583 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -86.26 145.73 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.72 149.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 109.244 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 ttm -63.84 139.85 58.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.718 0.807 . . . . 0.0 109.329 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.415 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 22.0 t-105 -146.23 140.87 26.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.685 1.594 . . . . 0.0 106.804 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' A' ' 121' ' ' PHE . . . -139.15 146.1 40.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.437 1.472 . . . . 0.0 112.478 -171.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -103.04 114.85 29.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.51 1.924 . . . . 0.0 105.845 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -76.1 147.96 38.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 120.448 1.476 . . . . 0.0 110.036 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -57.33 127.45 32.06 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.66 0.784 . . . . 0.0 110.123 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.04 -4.47 31.39 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.14 1.353 . . . . 0.0 114.841 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -87.66 -35.5 17.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.786 1.793 . . . . 0.0 111.851 -173.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.8 m80 54.99 31.04 15.24 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 112.104 -170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.1 m -138.36 154.59 48.94 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.528 1.931 . . . . 0.0 107.859 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 75.4 m95 -105.12 157.3 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -163.62 168.68 19.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.074 1.749 . . . . 0.0 109.706 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -87.49 149.45 46.62 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.15 131.17 35.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.461 2.107 . . . . 0.0 111.033 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -158.02 165.79 34.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.334 0.653 . . . . 0.0 111.47 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.88 168.0 40.42 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.951 -0.468 . . . . 0.0 113.09 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.46 152.62 51.96 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 9' ' ' PRO . 68.2 mt -75.41 125.19 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 169.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.38 147.79 97.09 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.99 126.07 18.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.336 1.357 . . . . 0.0 109.521 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.75 89.15 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.962 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.09 165.05 25.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.032 1.916 . . . . 0.0 110.57 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -103.03 154.09 19.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.073 -1.876 . . . . 0.0 105.995 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.61 87.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.748 1.158 . . . . 0.0 111.589 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.41 -35.51 79.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.75 0.82 . . . . 0.0 109.882 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.47 -38.76 77.86 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.586 -0.696 . . . . 0.0 109.666 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.3 80.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.676 0.671 . . . . 0.0 109.673 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -60.84 -50.41 73.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -66.63 -38.48 87.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.604 1.093 . . . . 0.0 112.097 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -56.18 -50.45 71.15 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.898 0.879 . . . . 0.0 109.479 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.61 -30.6 59.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.215 -0.422 . . . . 0.0 110.239 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 tp -56.71 -45.35 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.518 1.054 . . . . 0.0 109.819 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.2 -31.69 66.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.2 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.96 -29.92 58.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.284 1.402 . . . . 0.0 112.811 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -99.42 -55.08 2.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.527 1.531 . . . . 0.0 110.809 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 -24.07 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 126.431 1.893 . . . . 0.0 111.131 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.73 -1.49 45.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.042 1.306 . . . . 0.0 113.515 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.72 155.34 35.73 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.048 1.739 . . . . 0.0 109.064 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -131.95 165.66 23.43 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.754 0.822 . . . . 0.0 110.092 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -50.91 -35.21 31.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.857 1.663 . . . . 0.0 112.974 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -64.7 -25.18 67.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.818 -173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -114.58 22.6 13.46 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.55 166.07 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.751 1.62 . . . . 0.0 111.972 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 141.72 33.49 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.7 mt -79.51 115.6 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 103' ' ' GLN . 94.8 mt -88.84 -37.49 15.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.381 1.072 . . . . 0.0 110.643 175.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.21 165.25 36.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.999 0.92 . . . . 0.0 109.031 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 p -161.85 154.92 20.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.261 1.024 . . . . 0.0 110.231 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -70.64 136.3 49.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.641 0.734 . . . . 0.0 110.692 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -81.96 -28.37 32.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.304 1.442 . . . . 0.0 109.782 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -119.37 148.98 42.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.595 2.358 . . . . 0.0 108.233 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 69.0 m95 -81.81 137.89 35.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.44 104.81 16.77 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -102.06 147.11 26.99 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.66 147.79 30.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 169.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.29 141.93 28.02 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.45 147.98 85.42 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 123.861 0.864 . . . . 0.0 110.272 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.09 149.73 82.32 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 105.197 -2.655 . . . . 0.0 105.197 167.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.1 mtpt -69.24 -12.29 61.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.834 -1.791 . . . . 0.0 114.24 -169.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -63.41 -32.53 74.0 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.034 0.833 . . . . 0.0 112.299 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.07 -19.99 20.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.071 0.948 . . . . 0.0 111.382 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 81' ' ' LYS . 92.1 t -62.06 135.19 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -103.5 94.54 5.53 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 108.944 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -72.62 -23.0 60.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.763 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.88 -35.48 57.4 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -91.53 157.91 16.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.884 0.874 . . . . 0.0 108.946 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.93 135.54 27.64 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.513 1.525 . . . . 0.0 108.063 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.1 156.22 93.81 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 122.854 0.923 . . . . 0.0 111.002 -10.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.1 t -72.58 137.8 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.993 0.917 . . . . 0.0 109.543 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.7 p -89.95 117.25 28.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.68 -16.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.158 0.89 . . . . 0.0 113.025 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.49 -176.34 37.54 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -156.93 157.13 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.789 1.236 . . . . 0.0 109.016 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -106.93 130.63 54.57 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -113.07 135.48 53.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.783 0.833 . . . . 0.0 109.896 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.6 ttmm -113.04 129.2 56.58 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.9 m95 -110.14 155.11 22.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.211 0.605 . . . . 0.0 109.538 -171.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.57 127.68 25.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -91.54 124.49 35.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 169.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.93 160.33 22.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.767 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.2 tt0 -111.27 131.73 54.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 134.66 57.16 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 108.026 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.5 t -89.18 -53.57 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.467 1.03 . . . . 0.0 110.009 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.7 m -77.05 -21.64 54.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.222 0.609 . . . . 0.0 111.653 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.49 171.83 22.12 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -16.08 19.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.973 1.709 . . . . 0.0 113.983 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.07 19.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.139 0.976 . . . . 0.0 112.53 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -88.48 13.29 12.25 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.87 142.78 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -137.63 106.73 6.01 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 108.581 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.9 mmt -81.58 1.47 33.61 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -120.12 72.72 0.95 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 123.983 1.849 . . . . 0.0 107.459 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 p -65.07 -66.66 0.51 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 111.58 -2.554 . . . . 0.0 106.215 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 m -76.37 169.46 18.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 167.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.9 m -59.61 -40.75 88.56 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.41 132.58 83.74 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 125.304 1.442 . . . . 0.0 108.836 169.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.86 133.63 48.87 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.761 1.641 . . . . 0.0 108.002 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.44 -25.62 50.77 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.08 -0.388 . . . . 0.0 110.286 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 96.9 m-85 -122.55 140.73 52.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.747 0.819 . . . . 0.0 109.769 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.25 -28.38 53.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.86 0.864 . . . . 0.0 110.323 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.63 161.21 32.08 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 155.21 41.01 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.84 168.9 19.68 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.416 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -109.68 134.85 51.5 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.33 153.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.813 1.245 . . . . 0.0 111.259 -169.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.9 m -61.01 143.37 55.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -24.55 62.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -87.05 -20.81 26.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.367 1.44 . . . . 0.0 113.273 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -60.95 -46.7 96.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 117.277 -1.344 . . . . 0.0 113.497 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.48 -30.43 86.64 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 122.524 1.937 . . . . 0.0 111.821 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.04 -29.94 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.141 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -69.59 -23.71 63.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.98 -1.075 . . . . 0.0 111.768 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -85.13 -11.17 55.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.4 HG11 ' HE2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -122.47 167.11 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -74.72 174.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.652 1.181 . . . . 0.0 109.669 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.93 -54.99 38.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.738 . . . . 0.0 113.179 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -69.37 -40.28 77.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.22 0.918 . . . . 0.0 110.902 -171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.4 ' HE2' HG11 ' A' ' 136' ' ' VAL . 53.3 mtpt -65.62 -55.21 18.81 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -60.73 -34.27 74.15 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.771 -174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.77 -40.53 95.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.957 1.253 . . . . 0.0 111.828 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.88 -52.53 59.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.63 -37.53 84.3 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.754 0.706 . . . . 0.0 110.726 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -56.9 -50.06 73.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.857 1.663 . . . . 0.0 109.959 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.8 -47.92 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.427 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -56.93 -42.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.932 1.242 . . . . 0.0 110.847 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.8 mmt -69.0 -51.38 39.88 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -33.55 76.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.408 1.004 . . . . 0.0 111.701 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.85 -43.72 90.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 119.193 0.906 . . . . 0.0 110.411 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.565 ' HB3' HD12 ' A' ' 101' ' ' LEU . 14.5 m-30 -97.69 -12.74 22.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.6 -42.65 67.89 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.769 1.628 . . . . 0.0 110.627 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 m -70.87 -29.63 65.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.744 0.818 . . . . 0.0 111.047 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.92 -43.86 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.93 -44.11 86.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.537 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.25 66.13 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 121.536 1.971 . . . . 0.0 110.649 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -58.33 -30.97 67.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.96 1.704 . . . . 0.0 111.885 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -77.07 -23.9 51.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.505 1.522 . . . . 0.0 112.547 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -84.02 -44.12 14.46 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.866 0.841 . . . . 0.0 108.916 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.452 -0.368 0 C-N-CA 126.575 1.95 . . . . 0.0 109.85 -175.919 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.89 -67.17 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -164.09 -49.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 11.49 15.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.156 0.982 . . . . 0.0 112.721 -169.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.6 -5.8 83.51 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.464 1.031 . . . . 0.0 113.295 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -93.65 158.2 15.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.376 1.088 . . . . 0.0 108.751 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -139.14 137.03 18.63 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.016 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.02 136.04 4.07 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.403 2.068 . . . . 0.0 110.665 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -140.73 156.89 46.09 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.949 0.899 . . . . 0.0 109.709 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.76 153.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 123.778 0.831 . . . . 0.0 109.349 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -127.7 161.67 21.68 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.86 143.59 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.2 t -129.78 135.67 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.1 mm -115.16 133.74 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.4 m -116.79 144.07 44.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -101.4 173.14 6.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.191 0.997 . . . . 0.0 108.315 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -77.25 3.74 12.21 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.564 -1.335 . . . . 0.0 113.036 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -93.76 -4.42 50.36 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.515 1.126 . . . . 0.0 111.302 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.98 33.7 54.38 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -112.58 154.98 25.15 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.628 1.214 . . . . 0.0 108.51 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -115.63 152.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.883 2.073 . . . . 0.0 107.925 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 ptp -75.42 151.4 38.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.219 0.463 . . . . 0.0 110.49 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -146.45 132.95 19.72 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 149.1 46.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.137 1.335 . . . . 0.0 110.508 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -106.52 130.15 54.35 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.584 0.753 . . . . 0.0 109.934 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -76.33 146.39 38.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.705 1.139 . . . . 0.0 108.583 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -56.95 131.62 50.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.253 1.021 . . . . 0.0 110.111 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.99 -9.12 9.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.696 1.141 . . . . 0.0 114.692 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -93.47 -39.41 10.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.435 1.618 . . . . 0.0 110.843 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.0 m80 65.06 -23.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.266 2.226 . . . . 0.0 114.63 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -70.27 153.59 42.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.262 1.425 . . . . 0.0 109.759 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -102.88 153.22 20.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 111.718 -169.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.62 168.43 27.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.617 1.567 . . . . 0.0 110.49 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -86.64 152.71 54.8 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.55 133.48 37.21 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.092 1.861 . . . . 0.0 110.803 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.41 169.34 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.914 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.95 171.24 44.29 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.844 -0.535 . . . . 0.0 113.069 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.09 150.53 25.0 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.502 1.048 . . . . 0.0 111.496 -173.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.76 125.79 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.78 154.82 91.12 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.52 122.92 12.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 CA-C-N 120.804 1.323 . . . . 0.0 109.585 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.9 -3.96 85.78 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.521 -1.155 . . . . 0.0 114.749 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.78 156.95 38.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 120.135 1.968 . . . . 0.0 110.547 170.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -95.36 158.34 15.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.59 77.81 Favored 'General case' 0 C--O 1.224 -0.243 0 O-C-N 121.721 -0.612 . . . . 0.0 111.434 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.92 -37.59 79.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.55 0.74 . . . . 0.0 109.997 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -73.61 -35.62 65.38 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.46 92.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -60.87 -50.46 73.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.156 -0.926 . . . . 0.0 108.556 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 47.5 m-85 -66.01 -36.98 84.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.649 1.113 . . . . 0.0 112.41 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.1 ttm-85 -68.33 -50.44 53.3 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.826 1.193 . . . . 0.0 109.445 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.92 -27.75 61.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 tp -52.98 -48.02 67.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.456 0.702 . . . . 0.0 109.351 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.38 -42.5 99.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.779 0.718 . . . . 0.0 109.913 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.35 -28.27 69.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.366 0.985 . . . . 0.0 112.231 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.97 -57.91 2.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.579 0.751 . . . . 0.0 109.86 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.06 1.31 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.452 1.501 . . . . 0.0 112.216 -169.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.62 9.59 55.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.661 1.119 . . . . 0.0 113.39 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.74 150.15 20.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.056 2.142 . . . . 0.0 109.031 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 m -129.78 164.73 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.679 0.792 . . . . 0.0 109.903 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 53.0 mtt85 -45.29 -37.41 4.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.535 1.934 . . . . 0.0 113.12 -173.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.45 -30.35 71.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.873 -172.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.59 21.75 15.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.675 1.125 . . . . 0.0 112.505 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -131.38 165.11 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.246 1.418 . . . . 0.0 110.439 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -143.18 139.88 30.52 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 mt -79.59 121.64 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 103' ' ' GLN . 68.2 mt -96.12 -36.66 10.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.218 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.23 166.88 31.28 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.601 0.76 . . . . 0.0 109.295 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 p -162.47 155.47 19.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.394 1.077 . . . . 0.0 110.712 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.457 HG22 ' HG2' ' A' ' 150' ' ' GLU . 5.0 p -71.66 140.35 49.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.947 -170.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.68 -49.64 12.79 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 144.37 26.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.817 1.647 . . . . 0.0 110.457 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -79.36 126.12 30.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.63 126.93 33.78 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -121.88 148.94 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -141.44 145.3 35.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -94.03 143.97 25.89 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.76 142.94 97.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 110.225 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.33 147.18 77.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 104.432 -2.949 . . . . 0.0 104.432 166.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HA ' HG23 ' A' ' 84' ' ' VAL 0.252 86.6 mttt -68.82 -12.81 61.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.03 -1.669 . . . . 0.0 114.546 -168.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -30.27 70.21 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.47 -15.47 25.53 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.815 0.846 . . . . 0.0 112.435 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 81' ' ' LYS . 94.2 t -64.72 133.54 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -100.47 91.79 4.85 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.378 1.071 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -69.92 -22.73 63.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.98 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.7 -25.96 54.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.414 0.686 . . . . 0.0 112.391 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -106.81 155.89 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.944 0.897 . . . . 0.0 109.152 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.46 135.14 27.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.543 1.137 . . . . 0.0 110.246 -169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.76 150.32 94.03 Favored 'Cis proline' 0 N--CA 1.456 -0.691 0 N-CA-C 109.528 -0.989 . . . . 0.0 109.528 -10.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.3 p -71.2 133.89 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.493 0.717 . . . . 0.0 109.48 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 t -74.4 130.18 39.16 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.25 -13.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.203 169.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.84 47.95 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 120.1 1.318 . . . . 0.0 111.226 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.97 157.8 44.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.021 1.728 . . . . 0.0 109.96 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.36 137.22 44.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.73 130.34 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.553 1.141 . . . . 0.0 109.277 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -112.63 134.01 54.38 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.434 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 66.3 m95 -115.0 157.62 23.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.594 0.634 . . . . 0.0 109.839 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.88 125.33 23.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 108.28 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -88.29 121.93 31.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 168.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mt -118.68 152.24 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.632 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.4 tt0 -100.56 135.29 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 131.73 50.5 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.56 -50.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 119.44 1.018 . . . . 0.0 109.724 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.9 m -79.29 -25.12 42.48 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.322 0.649 . . . . 0.0 111.696 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.3 169.89 16.02 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -20.19 15.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.51 1.924 . . . . 0.0 113.073 -170.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.95 -26.24 47.14 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.13 10.43 8.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.31 140.63 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -130.35 118.77 21.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.028 1.731 . . . . 0.0 106.899 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.6 mtp -90.17 -3.06 58.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.549 0.613 . . . . 0.0 112.625 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -119.19 71.84 0.88 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.512 2.101 . . . . 0.0 107.026 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 p -65.22 -63.6 1.06 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.879 -2.873 . . . . 0.0 106.435 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 m -78.23 172.73 13.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.365 1.466 . . . . 0.0 107.343 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.5 m -60.33 -41.38 93.42 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.38 135.19 86.6 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 125.433 1.493 . . . . 0.0 108.777 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.13 140.52 89.79 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.654 1.57 . . . . 0.0 109.444 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.26 -46.55 20.0 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.5 141.76 39.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.882 0.873 . . . . 0.0 109.71 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -87.67 -15.02 38.36 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.253 1.021 . . . . 0.0 111.257 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.93 150.22 17.9 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 121.584 -0.698 . . . . 0.0 111.878 -169.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 51.2 p-90 -127.38 153.99 45.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.402 1.481 . . . . 0.0 108.484 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.36 141.84 24.33 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 168.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -102.55 123.65 46.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.0 161.57 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.062 1.345 . . . . 0.0 112.517 -168.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m -66.72 149.56 50.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.672 -0.642 . . . . 0.0 109.91 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -30.56 59.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.013 1.325 . . . . 0.0 112.584 -173.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -95.81 -2.47 47.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -76.34 -49.5 3.03 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.369 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.74 -32.52 93.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.495 1.927 . . . . 0.0 112.346 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -66.59 -21.87 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.275 -0.89 . . . . 0.0 112.301 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -69.08 -29.62 67.77 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -86.51 -26.83 24.37 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.47 163.12 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -69.72 173.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.971 1.308 . . . . 0.0 109.797 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.8 m -55.9 -54.24 47.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.749 1.62 . . . . 0.0 113.313 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -70.59 -39.94 73.56 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.854 -172.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.53 -49.03 67.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.15 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -63.69 -33.11 74.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.639 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.0 -47.32 77.91 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 119.098 0.863 . . . . 0.0 110.219 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.11 -49.58 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -61.76 -39.86 93.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.029 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.87 -38.74 76.49 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.896 1.68 . . . . 0.0 110.747 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.89 -45.58 94.01 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.852 0.751 . . . . 0.0 110.225 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.81 -40.02 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 110.565 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mmt -67.21 -49.35 64.88 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.279 1.5 tmtt? -59.86 -31.1 69.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.612 1.096 . . . . 0.0 111.879 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.457 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.1 tp10 -60.78 -36.75 79.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.269 0.628 . . . . 0.0 110.697 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.504 ' HB3' HD12 ' A' ' 101' ' ' LEU . 15.7 m-85 -110.83 -15.8 13.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.082 0.953 . . . . 0.0 113.187 -172.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.43 -42.45 70.54 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.428 1.491 . . . . 0.0 110.883 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 m -68.04 -31.78 71.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.855 0.862 . . . . 0.0 110.687 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.28 -44.24 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.9 -40.95 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.831 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.6 mmt -55.77 -47.17 77.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.173 0.897 . . . . 0.0 110.537 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -80.27 -26.68 38.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.921 1.288 . . . . 0.0 111.041 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.4 -41.37 93.73 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.753 1.221 . . . . 0.0 110.142 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -57.29 -36.72 71.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.901 0.481 . . . . 0.0 110.931 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 112.562 -176.092 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.76 -68.62 0.36 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.989 0.516 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -164.47 -49.76 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.768 0.827 . . . . 0.0 113.229 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.0 16.35 11.32 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 113.11 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.59 -2.13 82.34 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.391 0.996 . . . . 0.0 113.14 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.54 155.59 17.23 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.083 0.942 . . . . 0.0 108.507 169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -146.31 126.85 7.1 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 117.442 -1.266 . . . . 0.0 107.973 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -76.07 138.36 20.46 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.611 1.541 . . . . 0.0 111.581 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -139.71 154.67 47.52 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.266 1.026 . . . . 0.0 108.849 -171.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.88 162.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.606 -0.683 . . . . 0.0 109.61 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.5 163.37 28.2 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.14 142.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.07 136.49 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -116.42 136.06 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -124.83 145.56 49.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.816 0.735 . . . . 0.0 110.172 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -95.03 174.09 7.25 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -79.32 16.73 0.94 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.037 -1.664 . . . . 0.0 112.282 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -108.37 -1.3 20.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.422 1.489 . . . . 0.0 111.275 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.14 14.99 80.11 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.287 -172.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -86.8 130.42 34.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.07 152.95 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.951 1.3 . . . . 0.0 108.837 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.0 tpp -62.28 137.69 58.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.24 0.616 . . . . 0.0 109.473 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -140.91 129.7 22.99 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.41 44.46 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 122.957 0.503 . . . . 0.0 111.259 -169.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -124.43 125.66 44.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -88.15 165.05 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.862 0.465 . . . . 0.0 110.891 -169.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -49.51 124.43 9.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.227 1.011 . . . . 0.0 111.694 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.59 8.07 62.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.513 1.054 . . . . 0.0 113.412 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -100.05 153.18 19.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.778 1.289 . . . . 0.0 109.417 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -111.5 19.95 17.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 m -128.34 143.23 50.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.857 1.263 . . . . 0.0 108.29 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -98.2 151.45 20.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.379 0.672 . . . . 0.0 110.227 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -155.56 160.61 40.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.434 1.094 . . . . 0.0 111.051 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.75 148.21 75.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.43 127.39 17.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.828 2.352 . . . . 0.0 112.678 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -142.54 161.53 37.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.555 1.07 . . . . 0.0 112.51 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.99 177.11 48.28 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.199 0.428 . . . . 0.0 113.344 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.15 146.02 17.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 125.346 1.45 . . . . 0.0 110.182 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -79.82 124.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -70.33 155.26 93.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -57.7 125.28 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.95 -7.25 81.09 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.331 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.51 158.71 34.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 120.112 1.956 . . . . 0.0 110.396 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 p -102.16 159.57 15.27 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.35 85.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.625 -0.672 . . . . 0.0 111.627 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.16 -34.64 73.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.733 0.813 . . . . 0.0 110.114 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -72.82 -36.78 67.58 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.698 -1.251 . . . . 0.0 110.227 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.98 93.08 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 ttp -59.81 -49.11 79.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.274 -0.869 . . . . 0.0 108.819 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 46.1 m-85 -64.47 -44.35 91.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.664 1.12 . . . . 0.0 111.975 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -65.9 -49.83 66.64 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.849 1.204 . . . . 0.0 109.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.65 -24.49 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.2 -47.49 83.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -57.14 -39.98 76.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.555 0.616 . . . . 0.0 109.458 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -0.96 14.48 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -115.98 -39.4 3.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.273 1.429 . . . . 0.0 111.933 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.46 2.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.735 1.214 . . . . 0.0 112.666 -171.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.87 6.81 19.59 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-N 119.523 1.056 . . . . 0.0 113.269 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.35 148.65 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.356 1.862 . . . . 0.0 109.238 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 p -126.59 170.11 12.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.665 1.186 . . . . 0.0 109.486 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 43.9 mtt85 -50.93 -31.93 19.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.906 1.683 . . . . 0.0 112.166 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -66.69 -24.82 66.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.244 0.618 . . . . 0.0 112.349 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.93 24.28 10.93 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.01 164.06 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 120.778 -1.201 . . . . 0.0 111.464 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -141.9 140.51 32.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 mt -82.61 119.52 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 103' ' ' GLN . 90.0 mt -94.6 -36.64 11.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.429 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.17 164.4 32.91 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.498 0.719 . . . . 0.0 109.773 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 p -160.08 153.85 22.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.904 1.281 . . . . 0.0 110.974 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 p -70.02 140.26 52.84 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.574 0.702 . . . . 0.0 111.199 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -83.29 -28.3 29.21 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.083 1.353 . . . . 0.0 110.053 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -125.5 148.14 48.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.369 2.267 . . . . 0.0 109.094 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -81.83 136.1 35.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.52 62.04 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.823 0.849 . . . . 0.0 109.442 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -71.21 150.33 45.41 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.4 -0.812 . . . . 0.0 109.914 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.17 148.34 31.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.93 136.77 32.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 169.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.283 0.4 OUTLIER -90.83 149.71 40.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.629 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.1 Cg_endo -74.59 157.71 44.28 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 124.093 3.195 . . . . 0.0 111.049 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -65.44 -19.9 66.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -171.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -31.01 69.39 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.414 HD12 ' HD2' ' A' ' 80' ' ' PRO . 35.3 mt -94.22 -22.51 18.37 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.675 1.19 . . . . 0.0 111.489 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 86' ' ' TRP . 62.2 t -65.44 133.44 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -99.99 88.42 3.75 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.782 0.801 . . . . 0.0 109.479 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.41 ' CE2' HG11 ' A' ' 84' ' ' VAL . 85.5 m95 -68.76 -22.04 64.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.768 175.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.54 -8.99 59.16 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.817 0.847 . . . . 0.0 113.046 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -129.77 162.77 27.69 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 110.274 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.18 134.84 26.36 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.404 1.482 . . . . 0.0 109.231 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.61 147.28 88.97 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 O-C-N 122.666 0.824 . . . . 0.0 110.381 -10.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.72 140.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.003 0.921 . . . . 0.0 109.725 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.2 p -94.61 128.33 41.17 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.374 1.07 . . . . 0.0 109.904 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -14.59 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.92 175.5 47.04 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.07 144.74 26.88 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 108.336 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -90.05 135.45 33.64 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -118.42 132.3 56.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.185 0.902 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -115.74 135.26 54.21 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.52 154.3 31.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.1 125.59 22.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.506 1.123 . . . . 0.0 108.146 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 tp -90.4 124.93 35.36 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.35 149.09 41.07 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.9 tt0 -100.67 129.24 46.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.02 134.04 56.11 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.6 t -82.24 -43.27 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.587 -169.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.0 m -97.52 -19.3 18.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.933 0.893 . . . . 0.0 111.704 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.1 -170.11 17.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.416 1.008 . . . . 0.0 111.064 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.68 -22.51 23.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.218 1.807 . . . . 0.0 112.824 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.51 -31.14 63.81 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.957 0.903 . . . . 0.0 113.434 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.96 14.33 14.14 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.98 140.36 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -120.74 115.71 23.83 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.05 6.7 47.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.049 0.539 . . . . 0.0 111.581 -171.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -149.02 66.61 1.04 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.454 1.902 . . . . 0.0 106.663 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -57.03 -60.47 3.55 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 127.218 2.207 . . . . 0.0 111.175 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.4 m -101.19 174.5 5.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.27 1.828 . . . . 0.0 109.93 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -54.67 -37.93 66.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.02 116.16 64.67 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 167.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -61.82 129.99 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 170.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.62 32.5 0.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . 0.26 8.8 t80 -153.18 162.26 41.51 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 120.683 -1.261 . . . . 0.0 112.184 -166.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.75 17.48 0.89 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 171.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.24 149.33 5.13 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 115.443 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.78 153.34 51.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.652 1.181 . . . . 0.0 111.675 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -156.32 152.67 27.93 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.601 1.16 . . . . 0.0 108.742 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -107.72 123.77 49.03 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.64 151.04 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.111 0.964 . . . . 0.0 110.668 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m -55.12 140.03 39.71 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.594 0.758 . . . . 0.0 110.291 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -32.45 18.53 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -85.38 -23.54 27.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.322 1.419 . . . . 0.0 112.971 -176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.72 -46.71 88.5 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.072 -1.442 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.86 -25.79 78.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 123.028 2.117 . . . . 0.0 113.139 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.29 -32.18 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.931 0.893 . . . . 0.0 108.915 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -61.85 -32.58 72.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.368 -0.832 . . . . 0.0 110.949 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -77.99 -27.32 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.33 167.69 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 118.896 0.771 . . . . 0.0 110.879 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.701 1.2 . . . . 0.0 110.226 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.7 m -53.2 -47.0 69.25 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.662 1.585 . . . . 0.0 114.838 -170.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -74.92 -36.7 62.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.051 0.841 . . . . 0.0 111.256 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -74.24 -42.82 59.09 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.503 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -42.88 -44.6 4.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.993 0.917 . . . . 0.0 111.935 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.35 -43.26 98.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.219 0.918 . . . . 0.0 111.097 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.75 -50.63 76.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.23 -32.37 74.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.301 0.64 . . . . 0.0 110.929 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -69.57 -41.78 75.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.836 1.198 . . . . 0.0 110.407 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.06 -41.23 96.22 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.581 1.082 . . . . 0.0 110.576 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.3 t -57.85 -24.97 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 111.591 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.5 mmt -90.51 -58.36 2.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -56.53 -37.12 70.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.637 1.175 . . . . 0.0 112.485 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.1 -36.29 72.68 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 119.062 0.846 . . . . 0.0 111.078 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -106.91 -11.95 15.59 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.183 0.993 . . . . 0.0 112.673 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.68 69.8 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.223 1.409 . . . . 0.0 110.655 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.2 m -67.85 -31.86 71.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.551 0.74 . . . . 0.0 110.654 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.97 -45.23 74.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.43 -41.02 80.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 117.312 -1.327 . . . . 0.0 110.592 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.19 -49.9 72.74 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 120.993 1.724 . . . . 0.0 109.964 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 m -73.55 -26.55 60.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.26 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.5 tp -63.79 -44.07 94.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.296 1.438 . . . . 0.0 109.539 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -61.16 -43.06 99.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.233 0.232 0 C-N-CA 122.937 0.495 . . . . 0.0 112.173 -171.637 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 92' ' ' CYS . 1.9 mt . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.26 150.12 47.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.472 1.129 . . . . 0.0 108.803 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.98 -24.86 56.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.188 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.15 0.19 19.81 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.87 61.78 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.912 1.244 . . . . 0.0 113.386 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -118.2 161.25 20.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -144.18 132.45 10.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HB2' HD12 ' A' ' 40' ' ' ILE . 93.9 Cg_endo -82.35 136.06 8.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.371 1.381 . . . . 0.0 108.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -139.19 152.56 47.47 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.118 -0.989 . . . . 0.0 108.989 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.454 HG13 HD11 ' A' ' 40' ' ' ILE . 12.5 m -134.26 154.09 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.255 1.022 . . . . 0.0 108.892 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.51 157.5 25.14 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.32 143.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.5 138.69 51.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 170.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 mm -116.89 141.21 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 101' ' ' LEU . 25.6 p -120.74 157.2 30.18 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.321 1.049 . . . . 0.0 111.364 174.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -117.89 168.09 10.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.938 1.295 . . . . 0.0 107.987 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -73.66 -0.71 16.28 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.377 -1.452 . . . . 0.0 113.032 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -85.35 -8.84 58.25 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 111.365 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.95 34.83 41.1 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -106.07 154.34 20.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 169.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.84 150.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.34 1.056 . . . . 0.0 109.736 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.6 ttm -66.67 143.26 57.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.203 1.001 . . . . 0.0 108.397 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -150.5 141.85 23.32 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 147.63 31.37 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.463 1.483 . . . . 0.0 110.379 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.09 136.37 47.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.165 0.986 . . . . 0.0 109.089 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm-85 -73.53 160.68 31.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 111.487 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -49.58 123.94 8.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.174 0.99 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.73 6.79 73.1 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.816 1.198 . . . . 0.0 114.145 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -106.42 160.27 15.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.338 1.569 . . . . 0.0 110.616 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -119.91 17.34 12.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.803 1.241 . . . . 0.0 111.598 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 m -128.1 138.71 52.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.048 1.339 . . . . 0.0 108.149 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -94.46 151.21 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.519 0.727 . . . . 0.0 110.549 -170.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -143.57 155.58 44.34 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.165 1.386 . . . . 0.0 110.139 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -82.54 138.9 44.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 167.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.05 135.58 64.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.708 2.272 . . . . 0.0 112.568 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.87 166.2 32.42 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.962 0.801 . . . . 0.0 112.199 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.0 168.01 40.95 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.507 0.575 . . . . 0.0 111.683 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.88 149.01 40.68 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 9' ' ' PRO . 59.9 mt -73.57 120.49 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -73.59 157.79 87.2 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.59 122.98 12.7 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.331 1.354 . . . . 0.0 111.539 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.23 2.0 88.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.538 -1.146 . . . . 0.0 114.745 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.85 152.74 43.39 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.158 1.979 . . . . 0.0 111.066 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.0 p -84.76 167.49 16.05 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 167.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -36.32 79.2 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.088 -1.008 . . . . 0.0 111.316 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -40.51 61.13 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.484 0.713 . . . . 0.0 109.802 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -65.65 -40.89 92.94 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.26 75.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.856 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -58.15 -48.23 80.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 57.1 m-85 -66.81 -45.64 77.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.1 0.864 . . . . 0.0 111.642 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -53.57 -51.71 62.09 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.919 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -77.72 -32.34 52.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.9 tp -56.48 -45.65 80.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.25 0.932 . . . . 0.0 109.98 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.84 -40.26 92.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.282 0.492 . . . . 0.0 110.082 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.813 0.733 . . . . 0.0 112.366 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.55 -53.55 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.165 0.986 . . . . 0.0 110.414 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -123.27 3.6 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.488 1.515 . . . . 0.0 112.038 -169.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.43 3.27 24.9 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.005 1.275 . . . . 0.0 113.955 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.81 145.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.7 m -124.3 162.21 24.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.062 . . . . 0.0 109.664 -171.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.433 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 46.4 mtp180 -42.73 -40.63 2.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.621 1.968 . . . . 0.0 112.892 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -69.08 -21.15 64.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.376 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.76 19.92 16.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.745 0.784 . . . . 0.0 112.522 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.23 164.19 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.403 1.481 . . . . 0.0 111.337 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 138.93 35.92 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.072 169.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 mt -77.03 116.1 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 103' ' ' GLN . 58.6 mt -93.71 -33.17 13.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.395 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.28 164.45 38.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.866 0.866 . . . . 0.0 109.397 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 p -162.21 154.4 19.17 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 110.787 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.597 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -70.6 136.86 49.53 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.831 -0.543 . . . . 0.0 110.8 -170.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -79.3 -29.79 42.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.633 0.773 . . . . 0.0 110.553 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.344 2.258 . . . . 0.0 108.361 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.3 m95 -77.78 133.64 38.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.998 0.817 . . . . 0.0 109.165 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.03 116.58 27.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -127.05 149.52 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.51 142.55 31.18 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.9 139.77 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.71 139.37 86.05 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.065 0.946 . . . . 0.0 110.418 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.55 148.83 73.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 N-CA-C 104.636 -2.871 . . . . 0.0 104.636 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.7 mtpt -68.84 -13.23 62.28 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 119.847 -1.783 . . . . 0.0 114.236 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -62.54 -30.73 71.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.955 0.798 . . . . 0.0 112.634 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.4 mt -94.07 -18.24 22.02 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.161 0.985 . . . . 0.0 112.212 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 81' ' ' LYS . 59.9 t -64.48 132.65 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.12 88.39 4.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.729 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -69.98 -17.76 63.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.262 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.83 -27.28 55.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -103.18 163.08 12.46 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.973 . . . . 0.0 110.811 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.38 127.67 22.5 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 125.254 1.422 . . . . 0.0 110.72 -171.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.14 145.24 83.44 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 N-CA-C 109.308 -1.074 . . . . 0.0 109.308 -10.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.28 136.35 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.405 ' HB3' HD13 ' A' ' 2' ' ' ILE . 19.5 p -96.92 144.22 27.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.594 0.358 . . . . 0.0 110.585 170.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.84 -7.3 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.45 177.22 41.44 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -150.08 147.25 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.854 1.662 . . . . 0.0 109.016 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -96.23 131.24 42.92 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.17 128.6 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.504 1.047 . . . . 0.0 109.189 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 2.2 ttmm -109.05 121.15 44.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -102.47 151.27 22.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -133.43 131.51 40.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 108.015 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -93.34 124.8 37.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 169.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.51 149.7 42.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.1 tt0 -97.57 133.06 42.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 136.19 57.84 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.235 1.414 . . . . 0.0 107.552 171.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.31 -59.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.563 1.074 . . . . 0.0 110.226 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 m -74.74 -20.03 59.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.423 0.689 . . . . 0.0 111.672 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.21 172.35 25.14 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -58.42 -16.5 15.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.059 1.744 . . . . 0.0 114.112 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.73 -30.89 15.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.194 0.997 . . . . 0.0 113.088 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -85.53 18.98 2.53 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.18 142.05 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.185 1.394 . . . . 0.0 108.614 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -130.94 130.93 44.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.652 1.981 . . . . 0.0 107.895 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mmt -93.95 -14.4 26.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.52 0.728 . . . . 0.0 112.728 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -112.73 74.32 0.86 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 124.38 2.038 . . . . 0.0 107.94 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.0 p -71.49 -63.12 1.18 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 110.891 -2.868 . . . . 0.0 107.117 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.2 m -78.91 175.47 10.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.599 1.56 . . . . 0.0 108.721 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -59.71 -35.24 74.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.541 -0.724 . . . . 0.0 110.486 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.27 137.36 37.04 Favored Pre-proline 0 N--CA 1.446 -0.657 0 C-N-CA 125.945 1.698 . . . . 0.0 108.844 169.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.38 121.32 9.26 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.31 2.007 . . . . 0.0 107.55 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -73.74 -26.05 60.48 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.067 -0.395 . . . . 0.0 111.583 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -107.54 141.29 39.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.22 -27.66 38.74 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.259 0.624 . . . . 0.0 110.313 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.55 150.81 22.88 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.78 140.44 29.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -148.04 168.98 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.586 1.154 . . . . 0.0 109.222 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -117.4 142.56 46.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 149.84 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.702 1.201 . . . . 0.0 109.101 -169.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -51.99 141.81 17.18 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -43.78 -55.51 4.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.78 -7.83 53.53 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.822 1.192 . . . . 0.0 113.596 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.58 -52.44 66.99 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-O 116.825 -1.559 . . . . 0.0 113.68 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.97 -8.73 14.57 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.616 2.877 . . . . 0.0 116.392 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.16 -29.52 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 120.967 -1.083 . . . . 0.0 108.869 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.43 -25.38 63.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.75 -1.219 . . . . 0.0 112.281 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.47 -22.05 21.57 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.92 175.3 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 119.321 0.964 . . . . 0.0 110.612 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 m -83.82 171.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.5 m -56.61 -48.79 76.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.821 2.048 . . . . 0.0 114.327 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -72.07 -35.99 69.42 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.115 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.08 -39.08 72.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.75 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -50.01 -42.81 50.01 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.87 0.868 . . . . 0.0 111.454 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.41 -45.85 91.24 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.465 0.575 . . . . 0.0 110.359 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.1 -50.22 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -62.79 -37.99 88.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.9 0.773 . . . . 0.0 109.974 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -69.24 -36.28 77.02 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.45 -44.66 95.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.077 1.308 . . . . 0.0 110.307 172.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.14 -39.03 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 119.939 1.245 . . . . 0.0 110.451 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.8 mmt -72.45 -59.48 2.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.958 1.303 . . . . 0.0 107.637 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -34.07 72.48 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.588 -1.32 . . . . 0.0 112.313 -172.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 71' ' ' THR . 2.3 mm-40 -57.93 -41.05 81.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.423 ' HB3' HD12 ' A' ' 101' ' ' LEU . 4.5 m-85 -111.52 -11.95 14.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 112.039 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.2 -42.7 63.73 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 126.786 2.034 . . . . 0.0 110.467 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -68.95 -30.66 69.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.994 0.918 . . . . 0.0 110.916 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.83 -46.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.11 -41.25 88.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.293 -171.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.0 mmt -55.51 -44.41 76.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.348 1.431 . . . . 0.0 110.752 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -81.12 -26.04 36.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.324 1.049 . . . . 0.0 111.502 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.59 -43.78 95.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.043 1.337 . . . . 0.0 109.686 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.63 -40.09 93.63 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.752 0.421 . . . . 0.0 110.718 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 C--O 1.234 0.243 0 C-N-CA 123.217 0.607 . . . . 0.0 112.238 -169.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.44 -63.95 1.12 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.429 0.692 . . . . 0.0 112.627 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.21 -53.84 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.62 17.25 16.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.435 1.094 . . . . 0.0 113.06 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.19 61.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.894 0.759 . . . . 0.0 113.702 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.8 154.4 18.67 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.085 0.943 . . . . 0.0 108.816 171.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -139.01 149.88 63.1 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.361 174.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HB2' HD12 ' A' ' 40' ' ' ILE . 9.4 Cg_exo -90.58 141.78 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.687 1.592 . . . . 0.0 111.757 -174.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -135.8 154.32 51.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.143 0.977 . . . . 0.0 109.711 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 40' ' ' ILE . 6.2 m -133.82 140.53 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -119.81 155.62 16.09 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 124.783 1.182 . . . . 0.0 110.211 176.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.05 142.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.93 135.62 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 104' ' ' LEU . 22.8 mm -108.56 132.76 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.2 m -124.26 145.57 49.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -105.74 173.31 6.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.644 1.177 . . . . 0.0 109.321 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.59 5.75 4.51 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.562 -1.336 . . . . 0.0 113.657 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -96.27 -2.17 46.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 111.482 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.61 22.11 79.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.392 -0.671 . . . . 0.0 111.843 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -93.91 145.39 24.66 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.23 149.85 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.717 1.607 . . . . 0.0 108.934 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.4 ttm -68.37 142.78 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.88 0.872 . . . . 0.0 109.366 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -141.48 123.32 15.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.08 159.35 41.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.134 1.334 . . . . 0.0 112.575 -168.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -157.93 169.52 24.4 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.08 1.309 . . . . 0.0 114.073 177.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.523 ' H ' ' HG3' ' A' ' 26' ' ' ARG . 8.2 tpt180 -59.84 154.39 18.57 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 128.035 2.534 . . . . 0.0 112.855 -169.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -61.15 134.39 56.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.614 1.166 . . . . 0.0 108.242 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.61 1.78 78.26 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.361 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -106.15 160.73 15.1 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.564 1.682 . . . . 0.0 110.654 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -128.91 11.99 6.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.671 1.189 . . . . 0.0 111.453 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -85.68 169.15 13.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.902 0.881 . . . . 0.0 109.082 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -133.2 132.12 41.16 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.03 173.94 13.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.391 1.477 . . . . 0.0 108.037 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -75.46 152.93 85.72 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.098 -0.954 . . . . 0.0 108.601 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 133.36 57.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.865 2.377 . . . . 0.0 111.536 170.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.15 171.2 18.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.66 1.118 . . . . 0.0 112.204 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.48 170.36 41.16 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.992 -0.442 . . . . 0.0 112.755 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 144.01 33.59 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.469 HD11 HG13 ' A' ' 11' ' ' VAL . 31.1 mt -73.99 119.33 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.67 144.1 85.6 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.14 126.17 18.06 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.804 1.67 . . . . 0.0 110.293 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.43 52.79 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.662 1.125 . . . . 0.0 113.283 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 152.1 37.17 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.675 1.737 . . . . 0.0 109.83 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.2 p -80.21 169.4 17.83 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.3 87.75 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 121.68 -0.637 . . . . 0.0 111.379 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.66 -37.77 70.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 110.387 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -68.09 -39.49 82.88 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.603 -1.31 . . . . 0.0 110.08 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.56 -30.66 67.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.676 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.419 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 11.9 tmm? -57.08 -50.73 71.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.425 1.011 . . . . 0.0 108.674 173.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 52.3 m-85 -66.38 -44.96 81.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.322 0.51 . . . . 0.0 111.119 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -57.35 -50.23 73.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.901 0.88 . . . . 0.0 110.023 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -77.12 -31.08 55.51 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -172.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.9 tp -58.11 -43.26 87.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.369 0.986 . . . . 0.0 110.241 172.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -62.38 -41.47 98.66 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.325 0.511 . . . . 0.0 110.087 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.66 -24.84 65.48 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.804 0.729 . . . . 0.0 112.429 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.04 -61.09 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.802 0.841 . . . . 0.0 108.788 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.88 -4.95 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.436 1.094 . . . . 0.0 113.561 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.799 1.181 . . . . 0.0 114.103 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.08 150.28 30.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.83 1.652 . . . . 0.0 109.099 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 m -127.76 164.34 22.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.332 1.053 . . . . 0.0 109.801 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.407 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 60.9 mtt180 -48.28 -36.16 13.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.103 1.761 . . . . 0.0 112.519 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -63.38 -23.45 67.42 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.623 0.769 . . . . 0.0 112.19 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.89 24.58 11.13 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.939 0.4 . . . . 0.0 111.63 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.87 165.09 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.413 1.085 . . . . 0.0 111.957 172.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 134.16 30.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.7 mt -76.65 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -95.88 -32.89 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -154.19 164.43 38.55 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 p -163.18 154.44 17.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.502 1.121 . . . . 0.0 110.798 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -72.81 140.06 47.41 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 109.969 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -92.22 -27.87 17.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -111.29 150.92 28.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.451 2.3 . . . . 0.0 107.482 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 57.1 m95 -82.3 136.94 34.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.438 0.563 . . . . 0.0 109.518 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.4 71.47 6.05 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -71.77 147.36 47.36 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -146.33 144.01 29.5 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.845 0.458 . . . . 0.0 110.0 170.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.84 146.67 24.04 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.074 0.95 . . . . 0.0 108.504 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.05 145.85 91.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 110.682 169.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.79 145.9 64.42 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 N-CA-C 104.499 -2.924 . . . . 0.0 104.499 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.8 mtpt -68.34 -13.13 62.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.909 -1.744 . . . . 0.0 114.151 -169.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -58.7 -31.31 68.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.8 mt -92.55 -19.52 21.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 111.998 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 81' ' ' LYS . 58.2 t -65.31 136.09 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -101.58 90.49 4.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.942 0.897 . . . . 0.0 109.473 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -68.42 -24.17 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.807 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.93 -34.42 73.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.617 0.367 . . . . 0.0 111.831 -171.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.93 159.21 15.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.786 0.834 . . . . 0.0 109.678 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -130.88 134.95 26.59 Favored Pre-proline 0 C--O 1.234 0.268 0 C-N-CA 125.325 1.45 . . . . 0.0 109.615 -171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.46 148.03 90.5 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 O-C-N 122.696 0.84 . . . . 0.0 110.07 -10.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -79.24 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.484 0.713 . . . . 0.0 109.532 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.89 127.69 35.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -14.57 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 118.932 0.787 . . . . 0.0 112.861 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.7 -177.11 38.88 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.77 153.82 30.45 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.794 1.238 . . . . 0.0 108.84 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -98.61 132.55 43.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -123.62 122.81 39.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 119.266 0.939 . . . . 0.0 109.566 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 7.6 ttmm -98.72 153.55 18.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.2 m95 -132.32 151.74 51.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.419 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 75.8 m-85 -137.69 127.88 26.09 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 108.893 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -89.59 122.62 32.91 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.88 136.99 53.75 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.47 132.29 35.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.421 ' HB2' HG21 ' A' ' 15' ' ' ILE . 13.9 tp -73.76 132.64 42.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.064 2.146 . . . . 0.0 107.539 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -77.63 -53.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.538 1.135 . . . . 0.0 111.837 -168.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.7 m -87.24 -15.55 37.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 111.563 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.37 -169.92 21.95 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.707 1.146 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -59.1 -17.39 25.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.627 1.571 . . . . 0.0 114.008 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.81 57.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.268 1.027 . . . . 0.0 112.955 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -95.66 18.29 13.22 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.52 113.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -92.74 -56.12 3.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.799 0.272 . . . . 0.0 110.978 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.2 mtp 69.81 3.16 4.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.704 2.401 . . . . 0.0 115.016 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.05 78.76 1.5 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 123.793 1.759 . . . . 0.0 109.825 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -75.93 -59.92 2.55 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.51 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 m -66.15 167.7 9.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.295 1.838 . . . . 0.0 109.53 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -62.44 -38.0 88.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.88 -0.512 . . . . 0.0 109.739 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.62 139.95 51.22 Favored Pre-proline 0 N--CA 1.442 -0.871 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 169.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.62 135.68 69.04 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.628 1.552 . . . . 0.0 108.112 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -81.62 -29.83 33.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.74 153.67 43.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.122 1.769 . . . . 0.0 107.83 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.67 -25.14 1.91 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.353 1.061 . . . . 0.0 110.58 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.83 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -150.76 133.09 15.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.153 0.981 . . . . 0.0 108.402 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -152.48 164.57 37.3 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.125 1.37 . . . . 0.0 108.471 169.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -114.49 141.27 47.93 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 152.79 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 110.292 -170.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m -60.97 142.54 56.44 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 109.043 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -27.58 48.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 32.5 m95 -88.2 -18.57 28.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.03 1.286 . . . . 0.0 113.19 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.91 -50.41 70.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.132 -1.413 . . . . 0.0 113.294 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.7 -28.95 76.95 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.159 1.906 . . . . 0.0 112.629 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.91 -34.88 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.329 1.052 . . . . 0.0 108.788 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -68.94 -19.7 64.19 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.787 -1.196 . . . . 0.0 112.323 -175.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -79.87 -32.7 40.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.854 1.206 . . . . 0.0 112.614 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.5 156.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 118.995 0.816 . . . . 0.0 111.482 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -68.65 162.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 m -53.22 -46.63 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.862 2.065 . . . . 0.0 115.236 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -69.33 -32.17 71.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.431 1.014 . . . . 0.0 111.153 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -77.54 -39.6 45.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.6 ttp-105 -50.05 -39.0 40.64 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.788 1.235 . . . . 0.0 112.387 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.24 -43.58 94.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.47 0.577 . . . . 0.0 111.378 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.91 -50.94 78.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -66.61 -34.49 77.99 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.701 -0.624 . . . . 0.0 110.897 -168.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -67.45 -40.61 85.42 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.65 1.114 . . . . 0.0 110.248 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.43 -43.74 98.33 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.725 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.91 -43.22 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 120.29 1.404 . . . . 0.0 109.912 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.5 mmt -74.04 -48.86 27.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -33.81 76.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.998 0.817 . . . . 0.0 112.159 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.74 -45.54 89.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.686 1.195 . . . . 0.0 109.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.453 ' HB3' HD12 ' A' ' 101' ' ' LEU . 13.4 m-85 -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.19 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.097 1.359 . . . . 0.0 110.792 -174.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -69.34 -31.57 70.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.786 0.834 . . . . 0.0 110.598 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 69' ' ' ALA . 45.5 t -67.47 -48.5 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.45 -41.77 82.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.172 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.63 -47.48 73.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.365 1.439 . . . . 0.0 110.71 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m -77.28 -26.85 52.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.173 1.389 . . . . 0.0 110.781 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.53 -42.25 96.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.018 1.727 . . . . 0.0 108.778 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -59.07 -24.64 63.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.344 0.657 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 124.781 1.232 . . . . 0.0 113.116 -171.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -67.37 -69.42 0.31 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.005 0.522 . . . . 0.0 111.661 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -164.74 -48.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.762 0.825 . . . . 0.0 112.84 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.51 13.29 14.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.293 1.037 . . . . 0.0 113.06 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.22 81.82 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.291 0.948 . . . . 0.0 113.163 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.58 157.24 17.61 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.975 0.91 . . . . 0.0 108.749 169.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 3.2 ptm180 -148.93 139.77 13.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.594 -172.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 16.6 Cg_exo -87.47 139.7 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 CA-C-N 121.63 1.618 . . . . 0.0 111.987 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.27 165.87 24.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.101 1.36 . . . . 0.0 109.127 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.74 172.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -153.08 159.75 28.7 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.39 141.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.25 139.26 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mm -119.47 142.83 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.0 p -121.84 154.28 37.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.186 0.903 . . . . 0.0 111.4 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -112.51 168.47 9.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.865 1.266 . . . . 0.0 108.336 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.39 4.46 5.86 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.133 -1.604 . . . . 0.0 113.196 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -90.78 -4.81 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.185 0.994 . . . . 0.0 111.45 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.3 21.06 70.99 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.841 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -95.67 151.34 19.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.674 1.237 . . . . 0.0 107.963 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.21 153.93 20.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.493 1.517 . . . . 0.0 109.495 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.3 tpp -60.55 137.6 58.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.317 1.047 . . . . 0.0 108.802 169.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -147.73 135.15 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 156.01 47.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.226 1.375 . . . . 0.0 112.554 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -109.44 109.32 20.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.149 1.779 . . . . 0.0 107.166 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -66.74 148.72 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.676 1.126 . . . . 0.0 108.06 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -46.25 118.81 2.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.419 1.087 . . . . 0.0 111.311 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.96 4.25 40.56 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.302 -1.277 . . . . 0.0 115.871 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -82.95 -30.42 28.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.235 2.017 . . . . 0.0 112.579 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 m80 53.78 34.22 18.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.323 1.049 . . . . 0.0 111.957 -172.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.3 p -131.22 170.74 14.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.919 2.088 . . . . 0.0 107.49 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -120.19 145.37 47.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.349 0.522 . . . . 0.0 110.505 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 165.61 36.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.071 1.349 . . . . 0.0 110.17 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -79.93 153.07 75.0 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.859 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.34 139.5 59.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.076 2.517 . . . . 0.0 110.324 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 53.8 mt-30 -138.59 168.38 19.91 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.383 1.073 . . . . 0.0 112.51 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.89 163.05 30.33 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 119.98 -0.344 . . . . 0.0 112.385 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.49 135.15 12.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 174.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.28 122.49 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -69.86 155.85 92.76 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.27 122.93 12.65 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.991 1.127 . . . . 0.0 109.461 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -3.72 86.75 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.338 -1.256 . . . . 0.0 114.594 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.98 158.92 34.53 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.279 2.04 . . . . 0.0 110.753 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m -98.97 155.83 17.22 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.07 86.48 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.132 -0.98 . . . . 0.0 111.389 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.907 0.883 . . . . 0.0 110.287 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -68.76 -39.24 80.37 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.667 -0.646 . . . . 0.0 110.084 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.29 94.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -60.15 -50.88 71.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.903 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -66.29 -37.24 84.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.893 1.224 . . . . 0.0 112.521 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -63.77 -49.8 71.54 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.069 1.304 . . . . 0.0 109.133 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -76.78 -25.67 53.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.04 -40.73 73.92 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.725 -1.235 . . . . 0.0 110.111 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -70.85 -37.82 73.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.52 0.6 . . . . 0.0 110.537 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.39 -34.2 72.29 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.2 -0.937 . . . . 0.0 111.808 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.78 -52.86 4.54 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.415 1.086 . . . . 0.0 110.114 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.27 -30.1 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.359 1.464 . . . . 0.0 110.233 -168.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 0.77 89.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.944 0.783 . . . . 0.0 112.38 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.2 tp -83.78 155.33 23.08 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.694 1.998 . . . . 0.0 109.334 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 p -133.81 169.13 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.296 1.038 . . . . 0.0 109.751 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -52.48 -33.02 42.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.919 1.688 . . . . 0.0 112.306 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -63.26 -28.02 69.74 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.293 0.637 . . . . 0.0 111.897 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.9 23.27 12.72 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 112.159 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 165.86 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 120.782 -1.199 . . . . 0.0 112.016 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 136.67 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.4 mt -76.12 115.71 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 103' ' ' GLN . 72.7 mt -89.18 -36.44 15.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.607 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.79 166.45 33.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.117 0.567 . . . . 0.0 109.778 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 p -161.24 155.6 22.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.981 1.312 . . . . 0.0 110.103 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -68.71 137.28 53.98 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.703 -0.623 . . . . 0.0 111.116 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -81.51 -28.64 33.93 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.214 1.406 . . . . 0.0 109.894 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -120.91 150.38 41.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.613 2.365 . . . . 0.0 108.177 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -81.48 133.38 35.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.4 mt -91.15 136.85 32.8 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -129.63 156.98 43.35 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.933 0.893 . . . . 0.0 111.431 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -143.36 125.92 15.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.17 137.43 36.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.07 142.87 93.6 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.702 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.01 146.49 71.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 104.923 -2.76 . . . . 0.0 104.923 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.61 -11.18 60.63 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.008 -1.682 . . . . 0.0 113.889 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -60.63 -31.42 70.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.973 0.806 . . . . 0.0 112.613 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.3 mt -92.04 -22.23 20.06 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 111.504 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.89 136.88 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -106.52 92.79 4.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.037 0.935 . . . . 0.0 110.063 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -68.4 -24.29 64.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.015 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.3 -25.57 58.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.386 0.674 . . . . 0.0 112.578 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -110.55 156.71 20.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.113 0.965 . . . . 0.0 109.338 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -127.87 137.64 31.21 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 109.975 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.25 149.72 93.66 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.874 0.934 . . . . 0.0 110.177 -10.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.6 p -78.22 134.33 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 110.142 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.4 p -74.25 126.17 30.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.935 0.894 . . . . 0.0 109.4 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.85 -13.67 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 171.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.35 175.65 46.41 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -151.52 145.25 25.04 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.33 1.452 . . . . 0.0 108.961 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.03 133.83 34.2 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -129.48 123.96 32.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.89 0.768 . . . . 0.0 109.987 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -103.68 127.38 51.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.123 0.969 . . . . 0.0 108.407 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -105.75 153.93 21.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -132.97 128.78 37.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.483 1.113 . . . . 0.0 108.264 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -93.01 124.54 37.06 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.473 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 mt -119.2 149.4 41.8 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.62 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.4 tt0 -99.71 126.75 45.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.45 138.65 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.318 1.047 . . . . 0.0 108.794 170.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.8 t -90.72 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.414 0.552 . . . . 0.0 110.556 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.0 m -85.59 -18.71 32.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.218 0.607 . . . . 0.0 111.02 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.52 21.4 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.89 -21.14 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.607 1.963 . . . . 0.0 113.345 -172.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.29 -30.01 59.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.579 0.752 . . . . 0.0 113.028 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -93.58 15.65 15.63 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.9 mt -91.74 135.61 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -122.23 -51.84 1.97 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.331 0.652 . . . . 0.0 112.165 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 mtp 65.64 16.82 10.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.416 2.287 . . . . 0.0 113.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.58 29.84 1.93 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.276 1.512 . . . . 0.0 112.142 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -51.41 70.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.659 1.583 . . . . 0.0 108.345 169.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.5 m -68.96 156.45 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.576 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -65.89 -33.48 75.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.015 0.526 . . . . 0.0 110.456 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.56 134.83 33.36 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 124.997 1.319 . . . . 0.0 107.973 169.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.38 122.28 11.4 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.474 2.116 . . . . 0.0 107.315 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.39 -33.4 72.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -117.77 138.81 51.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.19 -19.6 46.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.6 161.79 32.02 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.65 159.07 43.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -151.88 164.87 36.18 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.147 0.979 . . . . 0.0 109.165 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -114.87 127.38 55.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.03 152.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.481 1.112 . . . . 0.0 110.0 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -59.63 147.63 36.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.476 0.58 . . . . 0.0 109.471 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.95 54.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.465 1.106 . . . . 0.0 113.778 -169.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -88.87 -22.66 23.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.332 -0.855 . . . . 0.0 113.09 -172.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -58.24 -49.06 95.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.248 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.85 -29.3 76.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.169 1.81 . . . . 0.0 111.819 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.86 -30.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.26 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -68.3 -27.73 66.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.166 -0.959 . . . . 0.0 111.31 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -83.6 -24.52 31.44 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -168.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.38 160.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.686 0.755 . . . . 0.0 112.713 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.7 175.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.254 1.421 . . . . 0.0 109.856 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.86 -55.93 26.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.944 1.697 . . . . 0.0 113.002 -173.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -70.17 -32.32 70.21 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 -171.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -74.17 -48.05 31.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.974 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -63.48 -30.93 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.706 1.139 . . . . 0.0 112.204 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.7 -35.31 74.25 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.842 174.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.81 -49.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.494 1.118 . . . . 0.0 109.949 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -62.39 -31.99 72.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.755 1.162 . . . . 0.0 111.106 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.6 -43.44 98.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.487 1.04 . . . . 0.0 111.384 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -61.13 -45.69 93.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.366 0.985 . . . . 0.0 110.239 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.68 -26.11 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.063 0.945 . . . . 0.0 111.58 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.1 mmt -90.81 -56.29 3.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.998 0.919 . . . . 0.0 108.885 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -57.3 -33.65 67.9 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.462 1.028 . . . . 0.0 112.551 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -63.45 -32.81 74.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.947 0.499 . . . . 0.0 110.574 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.516 ' HB3' HD12 ' A' ' 101' ' ' LEU . 8.0 m-85 -111.58 -14.83 13.61 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.284 1.033 . . . . 0.0 112.889 -174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.41 -39.97 67.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.594 1.558 . . . . 0.0 110.794 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 m -67.1 -31.6 72.18 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.971 0.908 . . . . 0.0 110.785 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -46.21 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.13 -39.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 117.851 -1.071 . . . . 0.0 109.714 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.6 mmt -55.34 -48.92 73.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.773 1.17 . . . . 0.0 110.437 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.8 m -79.6 -26.05 41.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.779 1.232 . . . . 0.0 110.957 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.3 tp -63.05 -41.39 99.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.612 1.165 . . . . 0.0 109.936 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -58.46 -44.16 89.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 110.154 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.235 0.293 0 C-N-CA 123.713 0.805 . . . . 0.0 111.685 -171.087 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -69.33 0.26 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -164.74 -48.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.166 0.986 . . . . 0.0 112.7 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.13 16.67 10.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.594 1.158 . . . . 0.0 113.137 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.7 63.58 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.312 0.958 . . . . 0.0 113.854 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -93.29 153.78 18.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.499 1.15 . . . . 0.0 108.053 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.16 126.58 17.61 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.595 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -72.33 141.13 34.87 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.108 1.872 . . . . 0.0 111.496 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -140.25 156.44 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.802 0.841 . . . . 0.0 109.079 -173.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.74 150.36 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.454 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -128.92 157.53 21.61 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -125.16 142.83 40.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 109.056 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.43 137.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mm -120.01 132.39 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' A' ' 22' ' ' VAL . 78.1 m -119.91 140.6 50.63 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.682 0.674 . . . . 0.0 109.965 173.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -94.8 174.04 7.3 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.02 -2.37 30.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 120.281 -1.512 . . . . 0.0 112.678 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.61 -2.91 58.65 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.971 1.308 . . . . 0.0 111.582 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.87 19.48 76.93 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.819 0.736 . . . . 0.0 111.711 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -88.55 142.51 27.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 171.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.0 m -108.48 142.43 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.37 1.468 . . . . 0.0 108.935 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.0 tpp -60.85 134.65 57.3 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.957 1.303 . . . . 0.0 108.822 170.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -143.3 120.39 11.43 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 151.05 29.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.811 1.187 . . . . 0.0 109.836 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -145.48 162.29 37.71 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.176 1.39 . . . . 0.0 114.102 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.65 149.47 35.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.724 2.009 . . . . 0.0 113.872 -168.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -52.46 124.86 14.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.527 1.931 . . . . 0.0 109.489 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.67 8.31 76.49 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.205 -1.331 . . . . 0.0 114.524 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -109.18 157.41 18.81 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.589 1.695 . . . . 0.0 110.573 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -134.39 15.0 3.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 112.258 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.5 m -107.18 127.78 53.82 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -92.05 139.56 30.52 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -156.62 158.54 37.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.193 2.197 . . . . 0.0 107.731 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -73.35 151.84 89.92 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.445 169.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.42 141.17 97.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.969 2.446 . . . . 0.0 112.259 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.85 176.09 11.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.886 -0.509 . . . . 0.0 112.046 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.86 168.61 40.98 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.333 0.492 . . . . 0.0 112.553 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.51 146.39 27.31 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -77.73 127.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -69.47 152.68 96.29 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.48 124.04 14.93 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 108.958 -1.209 . . . . 0.0 108.958 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.41 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.679 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.96 159.26 34.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.072 1.936 . . . . 0.0 110.229 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 p -102.12 156.57 17.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.33 85.91 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.408 -0.808 . . . . 0.0 111.901 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.19 -35.56 76.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.572 0.749 . . . . 0.0 109.588 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -71.86 -37.04 70.28 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.61 91.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -61.61 -50.88 70.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -66.19 -40.97 90.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.228 0.922 . . . . 0.0 110.825 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.5 ttm-85 -66.37 -48.38 70.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.672 1.124 . . . . 0.0 109.688 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.84 -29.35 63.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.56 -47.64 79.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.864 0.756 . . . . 0.0 109.165 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.97 -39.21 91.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.934 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.42 -40.32 93.21 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.979 . . . . 0.0 112.061 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.13 -51.38 9.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 110.357 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 m -123.8 8.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.188 1.395 . . . . 0.0 113.538 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.27 8.41 62.1 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.791 0.723 . . . . 0.0 113.599 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 tp -98.6 141.14 31.81 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.417 1.887 . . . . 0.0 109.945 -171.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 p -115.43 165.53 12.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 109.926 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -48.69 -34.18 11.46 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.109 1.764 . . . . 0.0 112.053 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -29.61 70.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.759 -171.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.35 25.86 10.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.793 1.179 . . . . 0.0 111.628 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.52 165.0 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 O-C-N 120.818 -1.176 . . . . 0.0 111.501 172.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -139.32 144.29 38.22 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.1 mt -82.52 120.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' A' ' 103' ' ' GLN . 96.1 mt -95.23 -35.98 11.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.615 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -158.02 161.33 38.07 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.348 -171.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -162.35 154.43 18.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.177 1.391 . . . . 0.0 109.669 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.5 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -71.09 139.55 50.38 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.852 -0.53 . . . . 0.0 110.261 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -57.06 4.14 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -89.28 151.62 22.01 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.389 1.476 . . . . 0.0 109.188 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -83.21 135.71 34.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.011 0.369 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.81 96.51 10.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -98.19 150.72 21.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.052 0.941 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -147.27 144.69 29.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 168.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.6 143.89 26.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mt -68.23 138.82 92.09 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 169.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.81 148.13 86.14 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 N-CA-C 105.264 -2.629 . . . . 0.0 105.264 167.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -69.14 -11.9 61.2 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.033 -1.667 . . . . 0.0 113.838 -168.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.9 -32.19 73.63 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.944 0.793 . . . . 0.0 112.522 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -92.8 -22.06 19.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.006 0.922 . . . . 0.0 111.567 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.46 136.2 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -103.14 88.68 3.2 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.005 0.907 . . . . 0.0 110.456 174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -68.52 -22.6 64.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.666 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.06 -9.1 58.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.749 0.819 . . . . 0.0 112.876 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.7 t -128.17 160.86 30.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.095 0.958 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -128.43 135.32 27.38 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 125.346 1.458 . . . . 0.0 109.563 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.54 148.36 91.38 Favored 'Cis proline' 0 CA--C 1.538 0.693 0 O-C-N 122.665 0.824 . . . . 0.0 110.534 -10.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 p -77.62 134.98 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.659 0.784 . . . . 0.0 109.75 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.0 p -80.2 127.32 32.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.91 0.884 . . . . 0.0 109.07 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.03 -17.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.02 0.827 . . . . 0.0 113.174 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.51 168.22 37.35 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 119.772 1.169 . . . . 0.0 110.197 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -152.62 150.9 29.99 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.657 1.183 . . . . 0.0 107.889 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 127.04 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -113.78 135.14 54.28 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.825 0.85 . . . . 0.0 110.209 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -113.27 125.08 53.91 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.454 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 89.1 m95 -104.45 149.92 25.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -173.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -133.37 131.66 40.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.835 0.854 . . . . 0.0 108.832 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 18.8 tp -96.32 119.72 35.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 168.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.09 144.95 40.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.625 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.7 tt0 -96.9 129.65 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 135.02 57.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.2 t -85.91 -44.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.049 0.386 . . . . 0.0 110.608 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.1 m -90.19 -19.57 24.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.388 0.675 . . . . 0.0 111.198 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.76 -170.42 19.06 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 124.528 1.061 . . . . 0.0 110.558 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -20.84 38.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.624 1.57 . . . . 0.0 113.568 -172.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.46 47.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -93.24 14.63 17.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -173.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.08 140.98 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -133.86 122.03 22.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.346 1.058 . . . . 0.0 108.445 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mmt -89.28 -3.18 58.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.07 0.948 . . . . 0.0 112.252 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -136.63 83.09 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.321 2.01 . . . . 0.0 108.835 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 p -74.5 -60.67 2.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 128.158 2.583 . . . . 0.0 107.872 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.9 m -72.36 174.05 7.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.097 1.759 . . . . 0.0 109.27 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.1 m -61.46 -37.0 82.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 140.43 45.32 Favored Pre-proline 0 N--CA 1.44 -0.945 0 C-N-CA 125.842 1.657 . . . . 0.0 108.577 169.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.93 140.31 94.71 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.926 1.751 . . . . 0.0 108.558 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -76.36 -38.37 55.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -119.4 152.28 37.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.678 1.591 . . . . 0.0 109.542 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -126.52 -25.4 3.44 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.917 1.287 . . . . 0.0 110.149 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.36 130.96 10.49 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -157.9 130.51 7.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.891 1.345 . . . . 0.0 108.608 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -152.08 161.18 43.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.811 1.244 . . . . 0.0 109.084 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -111.52 134.45 53.1 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.05 153.24 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.485 -169.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 m -59.95 140.34 56.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.013 0.824 . . . . 0.0 109.212 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.93 -36.3 48.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -169.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -80.94 -21.81 40.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.008 1.276 . . . . 0.0 112.912 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -66.92 -45.59 53.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.88 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.7 -14.3 41.42 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.697 1.999 . . . . 0.0 113.759 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.1 t -67.57 -33.71 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -63.17 -34.96 78.76 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.812 -1.18 . . . . 0.0 111.689 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -82.76 -19.86 37.03 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -168.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 m -79.95 165.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 118.972 0.806 . . . . 0.0 110.32 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.73 176.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.911 1.285 . . . . 0.0 109.768 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.1 m -52.93 -50.38 64.13 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.683 1.593 . . . . 0.0 114.179 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -72.49 -26.93 61.97 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.972 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -84.29 -43.01 15.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.203 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -44.86 -45.25 10.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.992 0.917 . . . . 0.0 111.061 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.46 -35.66 76.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.877 0.871 . . . . 0.0 111.592 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 36.4 t -76.72 -49.94 22.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 124.792 1.237 . . . . 0.0 110.408 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.91 -35.35 78.12 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.716 0.807 . . . . 0.0 111.537 -168.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.02 -39.89 95.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.974 172.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -62.25 -47.01 86.27 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.633 1.106 . . . . 0.0 110.633 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 81.3 t -55.19 -33.1 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.425 1.011 . . . . 0.0 110.971 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.5 mmt -80.74 -56.89 3.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.896 0.878 . . . . 0.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -35.73 72.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.483 1.038 . . . . 0.0 111.852 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 71' ' ' THR . 23.5 mm-40 -58.06 -40.68 81.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.528 1.131 . . . . 0.0 111.614 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -111.04 -14.43 13.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.822 0.701 . . . . 0.0 110.961 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.88 62.48 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.701 1.601 . . . . 0.0 111.031 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.5 m -67.28 -31.62 72.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.339 0.656 . . . . 0.0 110.907 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.23 -45.04 72.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.44 -39.82 76.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.21 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.68 -52.51 62.14 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 120.887 1.676 . . . . 0.0 109.717 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.5 m -72.37 -27.13 62.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.223 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.95 -45.61 91.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.212 1.405 . . . . 0.0 109.701 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.35 -43.82 98.22 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.327 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.233 0.205 0 C-N-CA 123.768 0.827 . . . . 0.0 111.868 -169.935 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.64 -61.99 2.19 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.497 0.719 . . . . 0.0 111.964 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -162.85 -53.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.01 18.22 16.52 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.651 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.65 9.33 61.44 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.642 0.639 . . . . 0.0 113.513 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -103.85 151.91 22.54 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.507 1.123 . . . . 0.0 108.607 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.57 148.85 63.05 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.369 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HB2' HD12 ' A' ' 40' ' ' ILE . 55.4 Cg_endo -90.36 141.12 3.34 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.746 2.297 . . . . 0.0 111.214 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.36 153.04 46.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.117 -0.989 . . . . 0.0 110.097 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.594 HG13 HD11 ' A' ' 40' ' ' ILE . 2.5 m -135.28 143.01 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.283 1.433 . . . . 0.0 108.798 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.19 162.66 24.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 123.922 0.772 . . . . 0.0 111.982 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 143.44 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.295 1.438 . . . . 0.0 108.155 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.81 134.7 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 168.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.37 136.83 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' SG ' HD11 ' A' ' 101' ' ' LEU . 12.7 p -124.7 162.76 23.49 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.881 0.764 . . . . 0.0 112.457 169.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.5 p30 -110.56 172.93 6.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.557 1.543 . . . . 0.0 108.306 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.34 8.71 3.14 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.451 -1.406 . . . . 0.0 113.233 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -99.54 -1.92 37.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.512 1.525 . . . . 0.0 111.58 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.12 15.97 80.83 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 118.691 0.678 . . . . 0.0 112.022 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -83.96 151.42 25.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.45 150.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.058 1.743 . . . . 0.0 108.501 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -73.23 143.31 47.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -147.4 144.29 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.91 146.8 34.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.389 1.904 . . . . 0.0 112.872 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -88.98 117.88 28.3 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -71.99 151.25 43.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.849 1.204 . . . . 0.0 109.003 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -58.03 129.24 41.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.11 6.24 82.47 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.512 -1.16 . . . . 0.0 114.003 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -113.86 164.25 14.0 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.168 1.484 . . . . 0.0 110.046 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.94 -13.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.829 0.852 . . . . 0.0 111.952 172.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 p -84.38 154.12 23.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.372 1.469 . . . . 0.0 110.281 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -107.45 143.7 35.42 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -142.2 161.21 38.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.169 1.388 . . . . 0.0 110.151 -169.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -90.43 143.11 28.86 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.45 131.93 33.75 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.246 2.63 . . . . 0.0 112.088 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.31 164.8 36.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.05 167.64 40.17 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.324 0.488 . . . . 0.0 113.026 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.14 147.06 43.82 Favored Glycine 0 N--CA 1.444 -0.788 0 O-C-N 121.497 -1.002 . . . . 0.0 110.604 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.603 HD12 ' HB2' ' A' ' 9' ' ' PRO . 70.7 mt -74.61 129.36 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.45 148.31 95.33 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.94 123.88 14.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.96 1.774 . . . . 0.0 110.24 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.45 1.7 90.2 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.425 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.53 159.3 32.39 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.515 2.158 . . . . 0.0 111.016 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 m -85.06 148.65 26.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.29 -40.14 81.17 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.555 -0.716 . . . . 0.0 111.602 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.86 -35.44 76.92 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.812 0.845 . . . . 0.0 110.248 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -73.55 -39.49 64.69 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.253 -0.904 . . . . 0.0 110.145 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.25 70.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.98 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -59.2 -48.47 81.51 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.169 1.349 . . . . 0.0 108.503 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.5 -36.23 83.51 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.35 1.432 . . . . 0.0 111.854 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -59.18 -49.64 77.08 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.328 0.967 . . . . 0.0 110.066 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -77.14 -26.66 53.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 122.125 -0.359 . . . . 0.0 110.362 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.67 -45.26 85.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.139 -0.976 . . . . 0.0 109.093 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.95 -45.6 81.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.689 0.677 . . . . 0.0 110.958 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.53 -37.34 86.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.538 1.063 . . . . 0.0 112.447 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -94.36 -47.98 6.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.517 1.127 . . . . 0.0 110.955 -170.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.61 -33.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.83 1.252 . . . . 0.0 109.883 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.2 89.94 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.562 1.077 . . . . 0.0 112.226 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 64' ' ' ASP . 28.7 tp -87.35 155.08 20.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.619 1.968 . . . . 0.0 109.634 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.8 m -133.52 167.35 20.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.126 0.97 . . . . 0.0 109.533 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -47.78 -33.46 7.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.869 2.067 . . . . 0.0 113.112 -173.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -65.6 -29.89 70.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.284 -171.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' HB3' HD11 ' A' ' 60' ' ' LEU . 4.6 t70 -112.46 24.77 12.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.543 1.065 . . . . 0.0 111.541 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.35 165.54 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.599 -1.313 . . . . 0.0 112.817 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.38 136.53 36.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.418 HG12 HD11 ' A' ' 102' ' ' LEU . 60.8 mt -74.13 122.44 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 103' ' ' GLN . 62.8 mt -93.83 -35.79 12.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.162 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.0 35.91 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.266 1.026 . . . . 0.0 109.904 -173.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.8 p -152.49 153.91 34.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.122 1.769 . . . . 0.0 108.829 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 150' ' ' GLU . 0.7 OUTLIER -65.2 135.48 55.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.799 -169.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -84.17 -32.35 24.65 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.943 1.297 . . . . 0.0 107.868 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.77 148.19 49.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.796 2.038 . . . . 0.0 109.865 172.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -74.69 139.58 43.6 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.68 84.66 5.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -82.01 144.25 31.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -147.6 144.57 28.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.09 145.47 24.37 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.84 145.38 91.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 124.845 1.258 . . . . 0.0 110.925 170.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.16 147.34 72.75 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 104.076 -3.086 . . . . 0.0 104.076 166.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 84' ' ' VAL . 91.4 mttt -68.31 -13.83 62.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 119.927 -1.733 . . . . 0.0 114.509 -168.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -60.2 -29.71 68.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -95.67 -13.28 24.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.11 0.964 . . . . 0.0 112.819 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 81' ' ' LYS . 79.7 t -62.77 133.28 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -96.42 91.52 5.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.285 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.14 -21.6 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.968 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.33 -29.09 57.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 t -99.57 163.88 12.31 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.577 1.151 . . . . 0.0 109.766 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -128.24 130.51 23.56 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.427 1.491 . . . . 0.0 107.022 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.44 159.98 95.31 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 O-C-N 123.043 1.023 . . . . 0.0 110.462 -9.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.14 132.21 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.2 p -87.04 126.78 34.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.14 -13.52 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.382 0.537 . . . . 0.0 112.312 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.48 37.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.24 156.69 32.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.65 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -106.7 126.55 52.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -119.47 128.67 54.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.692 0.678 . . . . 0.0 110.167 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.09 153.21 17.91 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CD1' HG22 ' A' ' 147' ' ' VAL . 85.5 m95 -134.1 154.81 50.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.237 0.615 . . . . 0.0 109.434 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -135.74 129.62 32.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.458 HD11 ' SG ' ' A' ' 16' ' ' CYS . 12.5 tp -91.14 123.32 34.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 67' ' ' ILE . 8.7 mp -115.71 155.16 28.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.635 1.174 . . . . 0.0 107.853 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.775 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.4 tt0 -106.15 131.25 53.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 168.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.63 140.21 56.85 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.027 0.931 . . . . 0.0 108.957 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.6 t -88.15 -44.33 15.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -171.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -90.99 -29.44 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.046 0.538 . . . . 0.0 112.106 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.29 178.82 15.51 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.915 0.769 . . . . 0.0 111.28 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.86 -20.86 54.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.691 1.597 . . . . 0.0 114.035 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.8 66.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.276 0.631 . . . . 0.0 111.554 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.58 48.08 1.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.161 1.785 . . . . 0.0 111.506 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.7 mt -128.5 133.09 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -114.48 -51.54 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.696 0.798 . . . . 0.0 111.972 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.4 mtp 67.98 13.32 9.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.017 2.127 . . . . 0.0 114.735 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -151.87 71.03 0.96 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 124.166 1.936 . . . . 0.0 110.394 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -59.11 2.87 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 111.974 -2.375 . . . . 0.0 107.901 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.6 m -63.47 161.96 13.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.392 1.477 . . . . 0.0 109.756 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -58.56 -38.57 78.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 130.41 52.7 Favored Pre-proline 0 N--CA 1.442 -0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 110.3 170.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.51 143.62 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -83.25 -18.29 39.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.894 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.21 141.19 51.8 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.712 0.805 . . . . 0.0 110.321 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.19 -31.89 33.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.021 1.328 . . . . 0.0 110.669 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.87 29.0 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -125.26 151.28 46.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.161 . . . . 0.0 108.825 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.9 166.08 27.04 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -126.51 133.77 51.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.24 157.79 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.937 1.295 . . . . 0.0 110.956 -168.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 m -65.98 144.38 56.8 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -28.29 63.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -88.01 -20.22 26.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.562 1.528 . . . . 0.0 112.924 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.3 -47.92 92.79 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.699 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.54 -27.06 81.48 Favored 'Trans proline' 0 C--N 1.352 0.76 0 CA-C-N 122.828 2.046 . . . . 0.0 112.957 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.89 -27.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.089 1.356 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -65.99 -27.9 68.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.356 -0.84 . . . . 0.0 111.334 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -86.71 -24.36 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.49 156.56 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.805 0.73 . . . . 0.0 112.528 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.2 179.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 110.184 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.8 m -54.54 -52.12 63.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.662 1.585 . . . . 0.0 114.06 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -74.34 -38.73 63.17 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.81 -44.83 69.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.52 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -62.97 -31.81 73.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.349 0.977 . . . . 0.0 111.74 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.57 -42.9 99.84 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.707 0.685 . . . . 0.0 110.924 172.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.73 -51.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.32 -37.61 86.27 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.26 0.937 . . . . 0.0 110.152 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.643 1.111 . . . . 0.0 110.486 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -60.66 -43.39 97.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.877 1.217 . . . . 0.0 110.49 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 99' ' ' TRP . 96.0 t -57.42 -24.46 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 119.788 1.176 . . . . 0.0 111.831 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.3 -57.3 2.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -56.14 -34.02 65.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.996 1.318 . . . . 0.0 112.606 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.7 tp10 -65.0 -30.04 71.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.04 0.837 . . . . 0.0 111.412 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.39 -11.43 14.13 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.409 1.083 . . . . 0.0 112.684 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.35 69.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.111 1.364 . . . . 0.0 110.905 -171.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -62.49 -37.96 88.02 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.262 1.425 . . . . 0.0 111.635 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.84 -42.87 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.21 -40.54 65.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-O 117.169 -1.396 . . . . 0.0 109.765 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.4 -54.11 49.49 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.764 1.62 . . . . 0.0 110.04 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 m -64.86 -32.21 73.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.531 1.133 . . . . 0.0 110.94 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.592 ' HG ' HD13 ' A' ' 68' ' ' LEU . 1.2 tm? -68.19 -31.01 70.25 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.326 1.85 . . . . 0.0 111.142 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -72.79 -44.58 61.35 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.961 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 123.377 0.671 . . . . 0.0 112.461 -170.177 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 121.79 0.805 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -62.68 1.63 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.918 0.887 . . . . 0.0 112.125 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -163.04 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.34 0.186 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -100.84 20.65 14.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.641 1.177 . . . . 0.0 113.302 -169.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.49 18.38 49.04 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.494 0.568 . . . . 0.0 113.419 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -107.48 156.1 19.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.08 25.64 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.566 -1.207 . . . . 0.0 108.677 171.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HB2' HD12 ' A' ' 40' ' ' ILE . 13.2 Cg_exo -82.58 136.49 8.57 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.83 1.687 . . . . 0.0 110.454 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -133.86 160.73 36.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.403 1.481 . . . . 0.0 109.075 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.31 154.79 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 123.518 0.727 . . . . 0.0 109.946 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.24 156.64 23.1 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -116.43 141.98 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 125.499 1.519 . . . . 0.0 107.748 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.1 134.9 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.55 135.11 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 101' ' ' LEU . 13.0 p -128.55 159.33 35.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.22 0.918 . . . . 0.0 112.289 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -110.17 177.3 4.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 108.78 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -75.87 0.36 18.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.405 -1.434 . . . . 0.0 112.995 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -88.21 -3.6 58.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.386 1.074 . . . . 0.0 111.013 172.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.67 76.59 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -90.31 143.27 26.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 m -108.45 145.89 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.513 1.525 . . . . 0.0 107.805 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -87.29 139.43 30.56 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -148.02 146.37 28.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.699 1.599 . . . . 0.0 107.051 -170.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.66 154.79 44.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.226 1.375 . . . . 0.0 113.577 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -98.54 118.23 34.77 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.193 1.797 . . . . 0.0 106.857 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -77.57 141.83 39.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 121.886 2.13 . . . . 0.0 108.471 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -55.13 127.1 27.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.368 1.067 . . . . 0.0 109.477 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -6.39 20.28 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.612 -1.104 . . . . 0.0 115.089 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -91.29 -32.13 15.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.787 1.794 . . . . 0.0 111.656 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.1 m80 64.55 -21.84 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.347 2.259 . . . . 0.0 114.611 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -75.9 160.76 29.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.298 1.439 . . . . 0.0 110.643 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.03 149.96 28.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.743 0.817 . . . . 0.0 110.939 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.89 155.38 42.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.362 1.865 . . . . 0.0 111.122 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -84.12 131.84 49.79 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -51.63 128.08 24.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.328 2.685 . . . . 0.0 112.3 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.36 164.54 36.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.751 1.16 . . . . 0.0 112.906 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.16 -178.97 42.75 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 123.458 0.551 . . . . 0.0 112.793 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.89 151.25 23.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.252 0.929 . . . . 0.0 111.913 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 9' ' ' PRO . 78.5 mt -77.91 126.9 38.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -74.08 156.39 87.78 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.69 122.19 10.66 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 109.038 -1.178 . . . . 0.0 109.038 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 0.0 87.98 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.643 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.14 154.35 41.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.361 2.081 . . . . 0.0 109.837 169.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.07 153.61 17.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.07 84.02 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.324 -0.86 . . . . 0.0 111.719 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.81 -31.95 70.13 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.288 0.635 . . . . 0.0 110.367 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -70.93 -39.6 72.57 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.271 -0.893 . . . . 0.0 109.792 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.31 83.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -63.3 -50.72 68.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.792 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 55.8 m-85 -66.72 -33.06 74.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.926 1.239 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -60.86 -50.28 74.05 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.07 1.305 . . . . 0.0 109.187 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.27 -27.58 62.58 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.384 0.538 . . . . 0.0 110.33 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.69 -43.43 90.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 109.454 170.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -69.55 -48.76 59.26 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.474 0.579 . . . . 0.0 110.834 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.85 -30.7 69.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.988 1.267 . . . . 0.0 112.609 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -93.29 -51.48 4.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.153 0.981 . . . . 0.0 110.532 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.61 -31.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.267 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.17 -1.85 78.73 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.464 1.03 . . . . 0.0 112.275 -171.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.76 155.74 32.93 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.645 1.978 . . . . 0.0 108.854 174.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.5 p -133.09 170.3 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.988 0.915 . . . . 0.0 110.466 -172.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 37.3 mtp180 -46.13 -37.15 6.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.819 2.047 . . . . 0.0 112.52 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -68.77 -26.04 65.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.385 0.674 . . . . 0.0 112.525 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.36 23.59 12.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.522 0.677 . . . . 0.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.5 165.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 O-C-N 120.734 -1.229 . . . . 0.0 112.729 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.83 132.94 29.61 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -73.69 116.21 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 103' ' ' GLN . 95.6 mt -89.63 -36.88 15.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.426 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.41 164.7 36.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.864 0.865 . . . . 0.0 109.749 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 p -162.63 153.41 17.11 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.795 1.238 . . . . 0.0 110.265 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.633 HG22 ' HG2' ' A' ' 150' ' ' GLU . 2.6 p -71.89 138.76 48.41 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.635 -0.666 . . . . 0.0 109.579 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -77.86 -51.41 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -70.26 171.12 10.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 110.962 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 84.2 m95 -112.38 123.72 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 168.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -79.2 142.32 36.38 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.62 152.35 43.9 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.289 1.036 . . . . 0.0 108.955 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -140.3 139.78 35.55 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.974 1.31 . . . . 0.0 108.115 169.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -77.27 139.04 39.74 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.68 139.17 95.76 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.766 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -68.2 145.36 66.19 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 104.431 -2.95 . . . . 0.0 104.431 167.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.506 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.3 mtpt -67.96 -12.94 61.72 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.05 -1.657 . . . . 0.0 114.16 -168.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.11 -31.01 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.809 0.732 . . . . 0.0 112.806 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.5 -20.01 21.4 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.776 0.83 . . . . 0.0 112.085 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 81' ' ' LYS . 61.5 t -65.16 135.28 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -101.37 89.89 3.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 109.807 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.8 -22.31 63.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.918 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -74.86 -19.22 60.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.573 0.749 . . . . 0.0 112.728 -171.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -117.37 161.0 20.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.487 1.115 . . . . 0.0 109.957 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -128.24 135.45 27.55 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 125.178 1.391 . . . . 0.0 109.59 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.48 148.56 92.16 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 O-C-N 122.731 0.858 . . . . 0.0 110.384 -10.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.76 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 109.532 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.5 p -89.91 138.58 31.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.0 109.566 170.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.44 -13.07 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 170.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.29 -174.05 31.72 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.09 -178.23 6.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.593 1.157 . . . . 0.0 109.02 -172.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -127.33 137.26 52.76 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 104.322 -2.474 . . . . 0.0 104.322 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -122.59 122.7 39.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 120.82 1.646 . . . . 0.0 107.951 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 ttmm -111.78 129.1 56.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -114.27 152.21 31.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -134.78 121.73 21.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 16' ' ' CYS . 14.9 tp -88.67 119.64 29.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.56 144.46 43.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.667 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.1 tt0 -97.47 132.7 42.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 168.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 141.93 58.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 108.923 171.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.91 -48.79 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.568 0.622 . . . . 0.0 109.827 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.5 m -89.33 -19.58 25.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.408 0.683 . . . . 0.0 111.786 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.59 20.67 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.42 -22.35 31.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.093 1.757 . . . . 0.0 113.105 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.08 59.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 113.438 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -92.62 16.55 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.73 139.73 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.694 1.198 . . . . 0.0 108.088 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -120.6 -50.98 2.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.593 0.757 . . . . 0.0 112.304 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.2 mtp 70.44 9.25 6.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.84 2.456 . . . . 0.0 115.122 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.71 76.96 1.03 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 124.016 1.865 . . . . 0.0 110.184 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.85 -59.58 2.67 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.05 -2.341 . . . . 0.0 107.695 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -66.37 162.73 19.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.157 1.383 . . . . 0.0 109.452 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 m -63.01 -33.73 76.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.087 0.555 . . . . 0.0 110.367 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 128.95 52.89 Favored Pre-proline 0 N--CA 1.447 -0.587 0 C-N-CA 124.911 1.284 . . . . 0.0 110.193 170.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.88 137.23 48.3 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.357 2.038 . . . . 0.0 108.097 168.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.83 -16.0 59.56 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.876 -0.515 . . . . 0.0 111.566 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -119.91 138.43 53.43 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.63 -26.73 45.3 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.924 1.29 . . . . 0.0 111.255 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.84 162.37 34.55 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 153.74 45.93 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.306 1.043 . . . . 0.0 108.193 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -152.42 159.63 43.37 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -109.38 131.99 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.72 170.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.062 1.745 . . . . 0.0 109.739 -169.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.8 p -65.41 166.82 9.57 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -18.65 64.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.858 172.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -98.81 -31.62 11.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 113.225 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.21 -43.98 96.21 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.84 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.36 -24.84 76.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 122.508 1.931 . . . . 0.0 113.264 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.7 t -67.55 -41.4 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -57.68 -35.53 70.72 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.528 -0.732 . . . . 0.0 111.963 -171.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -79.13 -26.4 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.46 171.66 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 118.499 0.591 . . . . 0.0 112.127 -172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 175.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.9 m -54.7 -49.99 69.39 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.031 1.733 . . . . 0.0 114.208 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -72.35 -32.34 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.178 -0.952 . . . . 0.0 111.459 -174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.1 -39.96 32.38 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.221 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -47.25 -46.2 24.32 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.899 0.88 . . . . 0.0 110.733 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.12 -45.76 92.02 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.245 0.341 . . . . 0.0 110.287 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.5 -46.86 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.772 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -62.01 -47.68 83.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.45 -42.18 96.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.349 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.64 -49.69 76.5 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.436 1.017 . . . . 0.0 110.5 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.9 t -56.68 -42.58 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.217 1.007 . . . . 0.0 109.39 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.7 mmt -67.43 -51.81 47.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.268 1.027 . . . . 0.0 108.273 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -37.03 69.91 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.804 0.842 . . . . 0.0 110.729 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.633 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.1 tp10 -59.18 -35.33 73.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 118.797 0.726 . . . . 0.0 111.526 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.62 -13.49 15.29 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.641 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.21 -39.13 63.49 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.401 1.48 . . . . 0.0 110.949 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -66.86 -32.07 73.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.289 0.636 . . . . 0.0 110.722 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.2 -44.95 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.4 -40.54 78.64 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 CA-C-O 117.365 -1.303 . . . . 0.0 110.097 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -56.07 -51.93 66.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 120.82 1.645 . . . . 0.0 109.969 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -71.25 -28.7 64.36 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.93 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.401 HD21 ' NE2' ' A' ' 103' ' ' GLN . 19.1 tp -63.37 -41.11 98.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.084 1.354 . . . . 0.0 110.184 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.8 -43.98 97.38 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.233 0.216 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.702 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.264 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.519 0.676 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.85 -68.19 0.45 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.456 0.702 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -163.06 -51.68 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.969 0.908 . . . . 0.0 112.421 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.04 17.04 14.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 112.82 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.54 7.09 65.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.36 0.981 . . . . 0.0 113.741 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -96.19 155.66 16.67 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.49 152.65 71.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.649 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -88.11 134.87 3.14 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.276 1.984 . . . . 0.0 111.135 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -131.79 163.92 27.17 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.022 1.329 . . . . 0.0 109.484 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 98' ' ' LYS . 3.2 m -133.04 167.77 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.263 175.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 163.08 33.3 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.82 144.94 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.1 137.91 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.81 133.19 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 22' ' ' VAL . 61.7 m -124.45 145.59 49.42 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.814 0.696 . . . . 0.0 110.571 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -97.74 170.58 8.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.849 1.259 . . . . 0.0 108.626 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.61 8.56 3.46 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.039 -1.663 . . . . 0.0 113.151 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.63 -3.68 54.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.386 1.075 . . . . 0.0 111.164 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.35 18.69 79.89 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 118.861 0.755 . . . . 0.0 112.071 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -90.23 141.42 28.72 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.552 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.3 m -108.31 147.74 12.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.081 1.753 . . . . 0.0 108.452 178.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.6 ttm -65.86 138.58 57.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.583 0.753 . . . . 0.0 109.337 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -142.82 140.36 31.28 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.78 1.632 . . . . 0.0 106.833 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -139.17 161.68 36.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.66 1.118 . . . . 0.0 112.187 -171.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -118.97 118.88 32.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.555 1.942 . . . . 0.0 106.978 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -67.21 150.68 48.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.605 1.093 . . . . 0.0 108.873 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.41 142.35 58.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.35 6.57 75.88 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.318 -1.268 . . . . 0.0 114.038 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -134.03 157.21 46.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.543 1.671 . . . . 0.0 109.612 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -98.42 -14.12 20.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.864 0.466 . . . . 0.0 112.227 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -78.57 152.24 31.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.397 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -110.6 158.17 18.87 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.461 1.104 . . . . 0.0 111.155 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -159.74 159.31 32.67 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.728 1.211 . . . . 0.0 110.396 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.73 157.49 71.92 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.84 134.65 60.02 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -131.26 169.59 15.76 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.059 1.344 . . . . 0.0 112.282 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.08 169.61 38.29 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.571 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.7 137.24 13.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.3 mt -75.14 126.24 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -84.65 150.41 56.43 Favored Pre-proline 0 C--O 1.235 0.324 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.26 122.18 10.28 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.775 1.65 . . . . 0.0 109.832 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.79 -20.64 43.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.845 1.212 . . . . 0.0 113.469 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.08 152.92 42.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.722 1.761 . . . . 0.0 109.941 170.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.2 p -83.43 169.8 15.16 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.1 80.55 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 122.001 -0.437 . . . . 0.0 110.461 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.74 -38.79 64.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.592 0.757 . . . . 0.0 110.586 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -67.82 -41.32 83.24 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.251 -0.906 . . . . 0.0 110.03 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -36.41 81.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.956 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.57 -53.72 52.93 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.147 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -67.68 -42.19 82.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.302 0.955 . . . . 0.0 111.706 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -45.44 94.79 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.971 0.509 . . . . 0.0 109.942 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.76 -31.13 35.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.094 -0.479 . . . . 0.0 110.227 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 58' ' ' VAL . 32.9 tp -53.27 -43.27 67.29 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.709 0.686 . . . . 0.0 110.091 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -57.14 -38.21 73.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.464 0.574 . . . . 0.0 111.231 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -70.29 -20.89 63.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.097 0.862 . . . . 0.0 111.734 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -94.73 -48.88 5.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.357 1.063 . . . . 0.0 110.936 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 60' ' ' LEU . 3.5 p -120.17 -3.3 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.759 1.224 . . . . 0.0 112.413 -169.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.83 1.02 9.85 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 121.24 -0.913 . . . . 0.0 112.957 -170.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 58' ' ' VAL . 14.6 tp -79.08 144.07 34.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.277 1.031 . . . . 0.0 110.002 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 p -122.5 164.43 18.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.647 1.179 . . . . 0.0 109.498 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -40.71 -38.87 0.97 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.168 1.787 . . . . 0.0 112.616 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -67.34 -20.33 65.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.269 -169.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.72 21.03 10.91 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.527 0.603 . . . . 0.0 112.528 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.61 160.36 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.925 -1.109 . . . . 0.0 110.73 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -138.12 137.37 37.64 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.13 120.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.624 HD11 ' HB2' ' A' ' 103' ' ' GLN . 96.4 mt -94.76 -36.77 11.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.721 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.56 164.3 34.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.127 0.971 . . . . 0.0 109.523 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.0 p -160.42 151.47 19.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.267 1.427 . . . . 0.0 109.897 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -69.09 131.47 45.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.729 0.776 . . . . 0.0 109.645 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -79.81 -48.16 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -75.53 179.94 4.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.44 2.296 . . . . 0.0 108.247 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.555 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 73.2 m95 -114.49 142.91 45.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 168.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.37 85.43 6.57 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -81.44 144.01 31.69 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.43 147.93 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.41 144.67 25.36 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.8 mt -73.05 144.88 85.52 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 124.998 1.319 . . . . 0.0 111.302 171.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.32 149.26 69.46 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 105.174 -2.664 . . . . 0.0 105.174 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.1 mtpt -68.73 -13.46 62.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.944 -1.723 . . . . 0.0 113.956 -169.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -61.76 -30.78 71.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.094 0.861 . . . . 0.0 112.789 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.64 -18.16 21.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.906 0.883 . . . . 0.0 112.123 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 81' ' ' LYS . 80.1 t -63.61 134.9 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -98.9 89.83 4.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.71 0.804 . . . . 0.0 109.687 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.5 -21.2 62.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.082 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.81 -30.55 56.46 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 t -97.64 162.15 13.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.576 1.15 . . . . 0.0 109.523 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -130.67 132.43 23.94 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.529 1.532 . . . . 0.0 108.319 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.25 157.33 93.54 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 O-C-N 122.72 0.853 . . . . 0.0 111.307 -10.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.4 t -74.45 138.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.889 0.876 . . . . 0.0 109.455 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 p -89.13 122.64 32.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.899 0.88 . . . . 0.0 108.726 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -14.56 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.184 0.902 . . . . 0.0 113.296 172.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.57 38.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -158.19 158.92 35.48 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.052 0.941 . . . . 0.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -101.5 124.82 47.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 169.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.22 123.9 50.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.903 1.229 . . . . 0.0 109.548 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.555 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -86.73 149.33 24.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -127.99 153.89 46.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.057 0.844 . . . . 0.0 109.467 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -134.36 134.29 41.58 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.833 1.253 . . . . 0.0 108.451 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.9 tp -98.08 120.86 39.22 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mt -116.97 146.83 42.77 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.624 ' HB2' HD11 ' A' ' 68' ' ' LEU . 4.3 tt0 -97.42 135.69 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 168.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.55 132.38 49.72 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.0 t -81.29 -46.0 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 122.74 0.416 . . . . 0.0 110.256 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 t -83.12 -37.31 23.94 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.0 -169.04 12.82 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -170.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 -15.88 38.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.61 1.564 . . . . 0.0 114.307 -172.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.03 63.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 0.0 113.031 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -95.12 26.18 3.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.19 0.996 . . . . 0.0 113.357 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 89.7 mt -99.58 139.98 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.808 1.243 . . . . 0.0 108.765 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -138.98 117.2 11.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.779 1.232 . . . . 0.0 109.757 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 mmt -89.78 -4.29 57.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.424 0.69 . . . . 0.0 112.58 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -119.8 75.5 1.08 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 124.207 1.956 . . . . 0.0 107.145 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 p -65.48 -65.07 0.72 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 111.204 -2.725 . . . . 0.0 106.777 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -78.48 173.63 12.17 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -58.1 -42.15 85.05 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.166 -0.959 . . . . 0.0 109.168 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 134.91 82.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 108.512 169.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -62.16 135.36 54.15 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 107.537 -1.755 . . . . 0.0 107.537 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -85.17 -34.21 22.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -109.88 135.82 50.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -75.03 -35.08 61.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.671 0.788 . . . . 0.0 110.475 173.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.48 29.84 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -148.84 158.77 44.41 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.566 0.746 . . . . 0.0 109.057 169.344 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -145.9 167.57 22.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.916 1.286 . . . . 0.0 108.828 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -109.9 129.7 55.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.46 153.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.815 1.246 . . . . 0.0 110.714 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 m -57.85 143.04 43.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.036 0.835 . . . . 0.0 109.835 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -32.87 61.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -83.84 -21.23 32.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.158 1.344 . . . . 0.0 112.692 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -60.11 -50.79 84.5 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.118 -1.42 . . . . 0.0 113.407 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.84 -27.7 85.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 122.681 1.993 . . . . 0.0 113.291 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.69 -31.59 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.848 0.859 . . . . 0.0 109.013 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -66.22 -24.42 66.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.163 -0.961 . . . . 0.0 111.679 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.94 -27.91 28.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.14 168.58 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 118.744 0.702 . . . . 0.0 112.397 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -83.16 175.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.379 1.471 . . . . 0.0 110.487 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 m -52.44 -51.4 59.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.825 1.65 . . . . 0.0 114.586 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -74.05 -36.77 64.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.458 1.026 . . . . 0.0 110.716 -175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.05 -36.61 66.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.51 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -51.28 -45.14 62.03 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.106 0.866 . . . . 0.0 110.493 171.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.63 -42.98 95.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.503 0.592 . . . . 0.0 110.926 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.15 -52.62 56.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.55 -32.56 74.21 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.211 -0.93 . . . . 0.0 111.24 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -67.27 -42.83 83.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.237 1.38 . . . . 0.0 110.327 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.41 -42.65 96.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.76 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.2 -25.95 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.49 1.041 . . . . 0.0 111.427 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -88.42 -58.66 2.48 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -33.41 70.47 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.716 1.207 . . . . 0.0 112.501 -172.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.72 -40.12 78.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.391 0.996 . . . . 0.0 110.565 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -106.42 -9.86 16.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.272 1.029 . . . . 0.0 112.952 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.33 73.12 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 125.187 1.395 . . . . 0.0 110.594 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -67.13 -31.98 72.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.677 0.791 . . . . 0.0 110.653 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.75 -43.63 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.31 -41.36 81.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.083 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -46.53 87.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 120.478 1.49 . . . . 0.0 110.53 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 t -66.46 -28.45 68.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 110.689 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.7 tp -69.59 -31.34 69.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.299 -1.501 . . . . 0.0 109.875 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -75.76 -25.74 56.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.026 169.895 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.53 -68.37 0.34 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.0 -49.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -87.02 11.32 13.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.104 0.962 . . . . 0.0 112.735 -169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.63 -8.4 79.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.698 1.142 . . . . 0.0 113.069 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -90.4 159.13 16.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.263 1.032 . . . . 0.0 108.498 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -137.65 142.33 36.42 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.248 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HB2' HD12 ' A' ' 40' ' ' ILE . 69.5 Cg_endo -89.34 135.91 2.71 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.879 1.719 . . . . 0.0 111.035 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.3 159.75 41.25 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.158 -0.964 . . . . 0.0 110.387 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.56 159.8 34.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 119.538 1.063 . . . . 0.0 110.418 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.88 160.21 24.21 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.05 143.66 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.182 1.393 . . . . 0.0 107.762 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.01 136.93 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm -121.09 133.03 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 101' ' ' LEU . 13.0 p -124.97 156.65 37.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.506 0.594 . . . . 0.0 111.623 170.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -104.51 172.73 6.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.438 1.495 . . . . 0.0 108.18 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -73.79 2.6 8.01 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.269 -1.519 . . . . 0.0 113.119 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -88.01 -4.84 58.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.069 0.947 . . . . 0.0 111.277 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.57 19.87 79.75 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.943 0.792 . . . . 0.0 111.601 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.87 147.01 25.3 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.09 148.72 17.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.171 1.789 . . . . 0.0 107.058 174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.6 ptm -76.12 148.5 37.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.392 0.542 . . . . 0.0 109.863 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -148.22 140.1 23.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -174.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB1' ' CD2' ' A' ' 121' ' ' PHE . . . -144.32 148.17 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.426 1.466 . . . . 0.0 113.087 -169.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -101.06 115.29 30.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.661 1.984 . . . . 0.0 106.559 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -68.75 151.6 46.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.663 1.119 . . . . 0.0 109.226 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.32 132.52 54.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.46 85.03 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.746 1.165 . . . . 0.0 113.726 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -115.3 162.32 17.27 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.33 1.565 . . . . 0.0 110.296 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.62 -13.68 16.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.479 0.711 . . . . 0.0 111.662 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -86.34 150.35 24.39 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.726 1.61 . . . . 0.0 110.968 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -103.61 151.64 22.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.141 0.977 . . . . 0.0 110.061 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -155.18 166.87 32.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.139 1.376 . . . . 0.0 110.211 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -85.38 155.15 59.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.95 127.2 19.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.321 2.014 . . . . 0.0 110.473 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -157.55 163.55 38.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.69 44.26 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.792 -0.567 . . . . 0.0 113.454 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.75 152.6 41.06 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 124.733 1.159 . . . . 0.0 112.075 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 9' ' ' PRO . 62.2 mt -84.03 122.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 169.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.22 159.38 85.58 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.0 123.87 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 121.199 1.266 . . . . 0.0 109.414 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.17 -6.07 80.79 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 118.772 -1.015 . . . . 0.0 114.646 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.37 156.55 39.36 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.043 1.922 . . . . 0.0 109.227 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -93.26 167.29 11.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.67 83.37 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.62 -0.675 . . . . 0.0 110.987 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -36.46 69.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.299 0.64 . . . . 0.0 110.503 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.76 -36.21 70.33 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.893 -1.129 . . . . 0.0 110.629 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.21 86.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -63.4 -51.74 64.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.104 -0.951 . . . . 0.0 108.672 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -66.76 -31.74 72.59 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 112.133 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -63.69 -52.95 58.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.528 1.058 . . . . 0.0 109.071 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -71.23 -25.07 62.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -172.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.73 -42.51 88.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 171.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -71.91 -50.14 31.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.121 0.873 . . . . 0.0 110.753 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.28 -21.92 66.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.905 1.229 . . . . 0.0 112.806 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.39 -53.5 2.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.791 1.236 . . . . 0.0 111.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.2 -21.92 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 112.396 -168.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 -3.19 33.66 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.204 1.383 . . . . 0.0 112.887 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.77 157.95 34.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.712 2.005 . . . . 0.0 109.768 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 p -137.11 168.15 20.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 110.185 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -53.14 -34.09 55.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.099 1.76 . . . . 0.0 112.292 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.781 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.95 24.39 12.72 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.844 1.202 . . . . 0.0 111.419 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.74 166.06 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.912 -1.118 . . . . 0.0 112.266 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 133.73 27.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.599 169.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.57 113.01 10.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 103' ' ' GLN . 70.8 mt -88.16 -34.0 18.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.489 173.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.44 39.12 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 109.759 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 p -158.66 154.33 26.26 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.112 1.365 . . . . 0.0 110.04 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.416 HG22 ' HG2' ' A' ' 150' ' ' GLU . 2.1 p -69.04 139.72 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.508 0.671 . . . . 0.0 111.472 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -86.11 -28.48 23.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.804 1.642 . . . . 0.0 109.838 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -121.77 148.64 44.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.022 2.129 . . . . 0.0 108.536 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -80.68 133.39 35.7 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.24 64.79 7.06 Favored 'General case' 0 N--CA 1.46 0.072 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -71.52 146.17 48.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -142.94 145.53 33.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.285 0.634 . . . . 0.0 110.256 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.26 147.04 23.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.87 148.06 98.92 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.823 0.849 . . . . 0.0 109.782 169.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -66.92 143.86 68.11 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 N-CA-C 104.311 -2.996 . . . . 0.0 104.311 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.1 mtpt -67.99 -13.07 61.89 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.051 -1.656 . . . . 0.0 114.135 -168.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -57.15 -30.56 64.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 170.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.8 mt -91.79 -20.49 21.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.382 0.673 . . . . 0.0 112.034 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.509 HG23 ' HA ' ' A' ' 81' ' ' LYS . 48.0 t -67.17 135.23 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -103.34 89.97 3.56 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.188 0.995 . . . . 0.0 108.486 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.423 ' CE2' HG11 ' A' ' 84' ' ' VAL . 84.7 m95 -65.28 -9.31 23.1 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.17 27.93 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.443 1.097 . . . . 0.0 110.472 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.6 p -77.16 157.72 30.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.113 0.959 . . . . 0.0 112.873 -169.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -130.56 110.16 16.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.697 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.37 142.26 64.97 Favored 'Cis proline' 0 CA--C 1.537 0.66 0 N-CA-C 108.09 -1.542 . . . . 0.0 108.09 -11.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.4 p -64.47 133.96 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 O-C-N 121.659 -0.65 . . . . 0.0 110.79 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.3 t -72.57 124.73 25.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.97 -14.9 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.24 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.42 -179.56 48.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 119.689 1.131 . . . . 0.0 110.342 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.77 152.98 45.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.308 . . . . 0.0 110.037 173.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.55 135.51 34.75 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -128.42 129.34 46.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.09 0.859 . . . . 0.0 110.485 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -111.92 142.02 44.84 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -124.2 155.28 38.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.417 0.553 . . . . 0.0 109.703 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -137.73 125.64 22.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.42 HD11 ' SG ' ' A' ' 16' ' ' CYS . 10.9 tp -92.33 122.77 35.11 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 168.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mt -117.87 148.28 42.27 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.459 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.0 tt0 -97.34 132.37 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.76 138.31 58.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.881 1.272 . . . . 0.0 108.922 171.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -88.38 -49.45 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.241 0.616 . . . . 0.0 110.09 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.2 m -87.08 -19.38 28.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.77 -169.39 20.13 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -20.42 44.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.649 1.58 . . . . 0.0 113.792 -171.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -30.58 43.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.508 1.123 . . . . 0.0 112.839 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.87 13.0 23.97 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 66.9 mt -85.17 137.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -136.7 105.2 5.77 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.1 mmt -82.67 1.7 37.17 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.67 73.97 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 123.942 1.83 . . . . 0.0 107.961 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -70.05 -64.13 0.95 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.589 -2.096 . . . . 0.0 105.558 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.0 m -72.44 167.24 20.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.459 1.503 . . . . 0.0 107.647 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 m -61.46 -41.16 96.79 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.286 -0.884 . . . . 0.0 109.171 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.49 132.76 89.27 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.67 1.588 . . . . 0.0 109.387 170.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.94 143.3 99.32 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.763 1.642 . . . . 0.0 109.537 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -86.74 -21.1 26.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.76 0.424 . . . . 0.0 110.673 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.436 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 85.2 m-85 -128.37 144.07 51.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.067 0.947 . . . . 0.0 109.136 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.74 -30.52 59.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.152 0.981 . . . . 0.0 110.522 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.86 155.54 26.44 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 150.39 37.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -146.58 170.28 17.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 109.13 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -116.2 137.23 52.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.05 154.17 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 109.954 -169.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.8 m -60.32 144.06 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.947 0.794 . . . . 0.0 109.504 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -25.42 63.83 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -88.66 -10.9 46.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.403 1.456 . . . . 0.0 113.38 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -72.79 -47.35 8.9 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.608 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.84 -24.53 68.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.903 2.073 . . . . 0.0 112.921 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.2 -30.77 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.268 1.027 . . . . 0.0 109.273 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.06 -24.4 63.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.042 -1.036 . . . . 0.0 111.514 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -81.18 -30.12 34.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.068 0.849 . . . . 0.0 112.87 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.12 168.43 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.554 0.615 . . . . 0.0 112.638 -169.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -85.13 175.33 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.206 1.402 . . . . 0.0 110.417 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -52.65 -50.68 62.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.617 1.567 . . . . 0.0 114.64 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -74.16 -34.74 63.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.142 0.883 . . . . 0.0 110.984 -175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.4 -37.92 60.2 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.705 -0.622 . . . . 0.0 110.353 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -50.18 -44.11 52.73 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.538 171.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -65.45 -41.52 93.34 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.626 0.648 . . . . 0.0 111.064 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.9 -53.0 46.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -65.11 -31.93 73.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.385 0.993 . . . . 0.0 112.229 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -66.21 -44.6 83.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.255 1.389 . . . . 0.0 110.276 171.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -59.54 -43.76 93.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.378 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.8 t -56.95 -27.95 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.571 1.148 . . . . 0.0 111.779 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -87.75 -58.18 2.67 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -58.18 -36.07 72.52 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.082 0.953 . . . . 0.0 112.276 -173.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.7 tp10 -58.81 -36.82 75.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 119.086 0.857 . . . . 0.0 110.723 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -105.27 -12.76 15.93 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.055 0.942 . . . . 0.0 112.337 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.96 68.7 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.416 1.487 . . . . 0.0 110.78 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 m -68.19 -30.65 69.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.759 0.823 . . . . 0.0 111.058 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.9 t -69.68 -43.03 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.72 -43.88 88.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.545 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -45.19 84.37 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 121.991 2.178 . . . . 0.0 111.666 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -81.2 -8.71 59.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 125.146 1.378 . . . . 0.0 111.924 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.84 -42.5 19.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 120.417 -1.427 . . . . 0.0 108.851 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.45 -41.8 90.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 125.195 1.398 . . . . 0.0 114.226 170.048 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.48 -77.46 0.07 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.682 0.793 . . . . 0.0 110.903 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -164.47 -44.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -91.79 16.89 9.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.712 1.205 . . . . 0.0 113.072 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 17.29 60.28 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.11 0.862 . . . . 0.0 112.929 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -111.93 155.31 23.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.8 128.08 22.92 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.44 141.27 46.07 Favored 'Trans proline' 0 C--N 1.345 0.391 0 CA-C-N 121.328 1.51 . . . . 0.0 110.053 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -138.43 148.24 44.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.78 0.832 . . . . 0.0 109.214 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 40' ' ' ILE . 4.6 m -134.52 149.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.206 1.402 . . . . 0.0 108.081 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -144.85 161.6 28.08 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 122.043 -0.411 . . . . 0.0 112.246 174.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.21 143.2 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 122.991 0.517 . . . . 0.0 109.933 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -122.44 131.59 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 mm -108.39 130.96 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.597 ' SG ' HG12 ' A' ' 22' ' ' VAL . 64.2 m -111.98 146.82 37.18 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 124.362 1.039 . . . . 0.0 109.289 169.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -98.78 176.65 5.54 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 14.38 3.71 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.905 -1.122 . . . . 0.0 113.028 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -106.35 -3.85 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.587 1.555 . . . . 0.0 111.307 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.47 83.22 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.756 -170.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -80.56 149.8 29.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.075 1.438 . . . . 0.0 107.477 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.597 HG12 ' SG ' ' A' ' 16' ' ' CYS . 6.4 m -128.03 153.49 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.969 2.107 . . . . 0.0 108.424 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.7 ptm -68.18 153.7 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.845 0.458 . . . . 0.0 110.713 171.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -154.74 132.34 11.33 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.03 150.54 41.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.39 1.45 . . . . 0.0 111.468 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -102.4 115.57 30.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -70.1 149.07 47.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.844 1.656 . . . . 0.0 109.644 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.67 140.91 57.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.16 85.96 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.219 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -123.34 169.08 11.69 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.025 1.413 . . . . 0.0 109.812 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -125.69 27.61 6.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.11 1.364 . . . . 0.0 108.93 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -125.35 143.3 51.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.042 1.337 . . . . 0.0 108.458 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -99.48 149.48 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.812 0.845 . . . . 0.0 110.491 -174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -159.77 168.65 25.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.918 1.287 . . . . 0.0 110.214 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.83 152.54 66.24 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -46.99 129.57 15.07 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.582 2.855 . . . . 0.0 111.443 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 7.2 pt20 -161.35 155.88 23.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.163 0.985 . . . . 0.0 110.176 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.55 168.21 40.84 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.265 0.935 . . . . 0.0 111.664 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.03 147.4 39.57 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 11' ' ' VAL . 68.6 mt -74.78 113.36 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 169.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.68 144.59 96.27 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.39 127.18 24.49 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.681 1.587 . . . . 0.0 110.883 -169.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.34 -8.83 77.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 114.15 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.64 152.84 39.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.829 1.814 . . . . 0.0 111.273 171.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.0 p -86.62 166.81 15.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 167.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.78 77.07 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 120.723 -1.236 . . . . 0.0 111.588 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.92 -38.3 61.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.362 0.665 . . . . 0.0 110.534 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -66.55 -40.27 88.97 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.55 -33.26 72.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.904 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.404 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 12.0 tmm? -56.75 -50.42 72.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 60.7 m-85 -66.67 -44.67 81.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.915 0.78 . . . . 0.0 111.84 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -54.92 -52.02 64.25 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.474 1.034 . . . . 0.0 111.04 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.96 -36.14 64.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.5 tp -53.42 -51.14 63.57 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.409 0.684 . . . . 0.0 110.129 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.78 -43.23 99.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -63.42 -23.51 67.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.728 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.81 -35.9 4.03 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 120.495 1.498 . . . . 0.0 113.385 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.561 ' HB ' HG23 ' A' ' 111' ' ' ILE . 27.5 m -117.02 5.04 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 119.373 0.988 . . . . 0.0 111.959 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.55 -4.3 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.781 -1.2 . . . . 0.0 114.869 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.1 144.26 34.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.887 1.675 . . . . 0.0 109.987 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -122.58 163.0 20.79 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.296 1.038 . . . . 0.0 109.813 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 47.3 mtp180 -42.02 -40.59 2.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.876 2.07 . . . . 0.0 112.527 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -67.84 -20.86 65.2 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.37 -0.824 . . . . 0.0 113.131 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.56 20.69 15.78 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.366 0.53 . . . . 0.0 111.516 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -137.68 161.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 O-C-N 120.533 -1.354 . . . . 0.0 112.896 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.55 138.81 46.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.09 121.09 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 103' ' ' GLN . 52.3 mt -94.77 -36.1 11.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.563 0.745 . . . . 0.0 109.77 174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.06 164.8 27.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.64 1.176 . . . . 0.0 109.546 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 p -155.54 154.93 32.51 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.593 1.557 . . . . 0.0 108.896 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 150' ' ' GLU . 0.7 OUTLIER -63.25 136.73 57.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.02 0.914 . . . . 0.0 111.106 -169.613 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtt-85 -80.16 -30.49 38.87 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.061 1.745 . . . . 0.0 108.419 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 146.6 52.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.202 2.201 . . . . 0.0 109.565 176.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -73.89 143.43 45.79 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.94 86.37 6.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -68.85 142.59 54.79 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -137.13 142.31 42.26 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.089 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -131.99 141.48 49.29 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.538 2.335 . . . . 0.0 106.451 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER -104.87 148.42 36.08 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.139 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.464 ' HD2' HD12 ' A' ' 83' ' ' LEU . 74.4 Cg_endo -71.1 153.87 62.53 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.447 2.765 . . . . 0.0 109.148 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.559 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.8 mtmt -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -59.55 -31.09 69.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 170.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' ' 80' ' ' PRO . 53.4 mt -90.77 -15.35 30.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.694 0.798 . . . . 0.0 112.042 -178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 81' ' ' LYS . 95.8 t -67.57 133.37 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -94.51 93.66 7.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.544 0.738 . . . . 0.0 109.195 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -71.09 -23.73 62.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.126 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.81 -26.45 57.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.227 0.611 . . . . 0.0 112.485 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -104.6 156.16 18.21 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.726 0.81 . . . . 0.0 109.249 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.23 137.54 31.09 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 124.94 1.296 . . . . 0.0 109.974 -169.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.23 144.13 80.03 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.807 0.898 . . . . 0.0 110.309 -10.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 141.76 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.014 0.926 . . . . 0.0 110.351 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 p -100.25 140.93 33.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.397 1.079 . . . . 0.0 110.794 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.05 -14.34 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.341 0.656 . . . . 0.0 112.505 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.01 -175.18 36.19 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -164.39 164.93 21.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.317 1.447 . . . . 0.0 110.124 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.41 117.63 34.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 120.341 1.428 . . . . 0.0 108.528 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -94.53 152.86 18.22 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -136.59 150.54 48.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.299 0.5 . . . . 0.0 109.806 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.404 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 48.8 m-85 -136.57 127.53 27.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.65 117.85 30.11 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.29 157.68 19.87 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.743 ' HB2' HD11 ' A' ' 68' ' ' LEU . 8.4 tt0 -110.61 142.43 42.47 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 144.54 38.06 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.669 1.188 . . . . 0.0 109.682 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.35 -44.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.2 m -91.03 -30.12 16.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.385 0.674 . . . . 0.0 111.464 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.58 -178.41 16.41 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.778 1.18 . . . . 0.0 110.478 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -52.46 -25.45 10.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.389 1.876 . . . . 0.0 113.143 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.7 -31.08 62.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 113.916 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.84 16.03 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -170.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.561 HG23 ' HB ' ' A' ' 58' ' ' VAL . 77.9 mt -100.71 134.94 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 107.371 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -123.6 122.58 38.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 125.98 1.712 . . . . 0.0 107.311 174.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.7 mmt -84.32 -17.96 37.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.045 0.538 . . . . 0.0 112.201 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.55 71.81 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.144 1.778 . . . . 0.0 107.293 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.7 p -75.52 -64.86 0.98 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.487 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -85.62 -178.18 6.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 108.648 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 m -56.7 -35.77 68.89 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.733 -0.604 . . . . 0.0 109.925 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.96 130.46 46.42 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.936 1.694 . . . . 0.0 107.722 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.39 135.56 37.02 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 N-CA-C 107.499 -1.77 . . . . 0.0 107.499 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.73 -21.64 63.45 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -121.98 142.23 50.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.942 0.897 . . . . 0.0 109.634 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.24 -23.24 38.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 111.072 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.51 156.95 27.54 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.41 151.44 41.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 109.159 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -153.93 169.91 22.31 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.616 1.166 . . . . 0.0 109.015 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.47 137.29 54.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.57 158.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.406 1.482 . . . . 0.0 111.057 -168.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -64.32 145.27 56.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.277 169.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -30.87 49.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -86.72 -21.23 26.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.354 1.433 . . . . 0.0 112.568 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -63.48 -43.46 78.78 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 116.594 -1.669 . . . . 0.0 114.149 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.22 -30.54 91.46 Favored 'Trans proline' 0 C--N 1.353 0.784 0 CA-C-N 123.364 2.237 . . . . 0.0 112.833 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.17 -27.37 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.097 0.959 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -71.39 -24.35 62.05 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.117 -0.99 . . . . 0.0 111.595 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.66 -33.06 41.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.314 0.961 . . . . 0.0 112.533 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 m -83.76 166.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -85.1 174.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.569 1.548 . . . . 0.0 109.126 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.3 m -54.04 -44.79 71.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.442 1.497 . . . . 0.0 114.418 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -64.1 -41.95 97.08 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.111 0.868 . . . . 0.0 111.463 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.78 -35.65 38.26 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.282 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -52.0 -45.92 64.7 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.232 0.924 . . . . 0.0 110.527 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.96 -44.31 89.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.323 0.511 . . . . 0.0 110.864 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.15 -52.29 49.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -69.25 -30.57 68.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.157 -169.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -66.49 -42.35 87.55 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.507 1.503 . . . . 0.0 110.213 169.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -58.78 -46.24 87.97 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 119.231 0.923 . . . . 0.0 110.606 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.17 -24.61 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.657 1.183 . . . . 0.0 112.041 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.8 mmt -86.54 -58.11 2.74 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -60.0 -32.97 71.36 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.305 1.042 . . . . 0.0 112.082 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.409 ' HG2' HG22 ' A' ' 71' ' ' THR . 2.0 tp10 -59.08 -34.82 72.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.228 0.922 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -112.15 -9.05 13.97 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.466 1.106 . . . . 0.0 113.343 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.47 72.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.977 1.262 . . . . 0.0 110.958 -169.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.0 m -67.8 -32.35 72.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.281 0.632 . . . . 0.0 110.763 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.8 t -69.26 -44.43 80.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.33 -42.34 73.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.432 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.2 mmt -56.95 -54.44 46.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.235 1.38 . . . . 0.0 110.065 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.6 m -70.32 -26.59 63.83 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.835 1.254 . . . . 0.0 110.787 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.62 ' HG ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -65.79 -36.7 84.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.598 1.959 . . . . 0.0 109.541 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -70.54 -20.73 62.78 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.837 1.199 . . . . 0.0 112.668 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 N--CA 1.466 0.354 0 C-N-CA 125.85 1.66 . . . . 0.0 111.306 -177.172 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.55 -45.98 81.29 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 112.978 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -147.71 -118.81 0.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.175 0.99 . . . . 0.0 108.784 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.14 -15.63 56.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.675 1.59 . . . . 0.0 111.396 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.16 178.82 47.51 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 126.133 1.825 . . . . 0.0 109.567 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.4 153.15 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.617 2.767 . . . . 0.0 113.743 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.69 137.56 15.34 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 120.506 -1.371 . . . . 0.0 107.974 174.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -74.09 140.88 28.77 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.323 2.015 . . . . 0.0 109.42 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -141.27 154.09 45.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.765 0.826 . . . . 0.0 109.143 -170.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 98' ' ' LYS . 3.3 m -129.29 136.32 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.524 1.53 . . . . 0.0 107.475 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -122.03 158.09 16.75 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 172.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -124.12 144.33 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 125.619 1.568 . . . . 0.0 107.556 -171.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.65 137.12 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm -120.94 134.17 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 101' ' ' LEU . 19.2 p -124.83 158.24 33.91 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.1 0.864 . . . . 0.0 112.267 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -108.24 170.6 7.91 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.462 1.505 . . . . 0.0 108.658 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -0.56 15.88 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.095 -1.628 . . . . 0.0 113.648 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -81.61 -6.51 59.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.679 0.672 . . . . 0.0 110.544 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.68 78.66 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.028 -0.874 . . . . 0.0 111.489 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -89.15 150.36 22.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.73 148.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.487 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.9 tpp -63.53 128.4 35.66 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.706 1.202 . . . . 0.0 108.175 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 33' ' ' TRP . 10.0 t90 -146.73 140.45 25.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.45 146.55 33.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.669 1.122 . . . . 0.0 113.653 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -85.53 121.32 28.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.329 1.852 . . . . 0.0 106.704 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -79.66 149.62 31.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.63 1.559 . . . . 0.0 109.349 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.42 117.09 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.061 1.745 . . . . 0.0 110.925 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.62 -1.07 31.39 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.738 1.161 . . . . 0.0 115.499 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -83.39 -31.25 26.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.747 1.774 . . . . 0.0 111.987 -172.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.8 m80 54.66 31.2 14.75 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.518 1.127 . . . . 0.0 112.008 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.2 m -138.43 154.03 48.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.548 1.939 . . . . 0.0 107.518 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 24' ' ' TRP . 77.4 m95 -108.55 151.76 25.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.109 0.564 . . . . 0.0 111.176 -169.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -148.17 159.71 43.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.921 1.688 . . . . 0.0 110.833 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.3 141.39 29.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.77 130.19 32.13 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 0.0 111.586 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -159.5 162.26 35.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.243 0.929 . . . . 0.0 112.764 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.19 176.98 47.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.421 1.01 . . . . 0.0 111.926 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.85 150.16 32.25 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 121.166 -1.196 . . . . 0.0 111.859 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 11' ' ' VAL . 46.1 mt -79.94 129.37 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 168.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -71.95 152.86 93.0 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -57.53 123.58 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 120.962 1.108 . . . . 0.0 109.334 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.91 -5.58 84.43 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.384 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.05 155.47 37.19 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.237 2.018 . . . . 0.0 109.681 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -97.19 154.93 17.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.43 88.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.464 -0.773 . . . . 0.0 112.32 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.96 -34.35 75.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.951 0.501 . . . . 0.0 109.96 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -68.03 -42.96 79.79 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.08 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.15 81.5 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 119.272 -0.395 . . . . 0.0 110.15 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -57.41 -49.02 77.56 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.49 -35.18 79.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -62.95 -46.21 88.84 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.817 1.644 . . . . 0.0 109.686 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -69.15 -25.55 64.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.708 -0.62 . . . . 0.0 110.728 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.22 -43.12 95.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.746 -1.221 . . . . 0.0 109.774 172.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.19 -37.11 86.3 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.754 -0.591 . . . . 0.0 110.389 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.33 -35.56 66.05 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.425 -0.797 . . . . 0.0 112.629 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.3 -57.14 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.335 0.654 . . . . 0.0 110.294 -169.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.01 -15.78 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.713 0.805 . . . . 0.0 110.15 -172.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.71 19.29 79.17 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.716 -0.615 . . . . 0.0 111.737 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.7 tp -108.48 150.86 26.85 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.683 1.993 . . . . 0.0 108.266 -172.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m -127.58 168.22 15.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.607 0.763 . . . . 0.0 109.819 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -49.51 -33.95 15.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.664 1.585 . . . . 0.0 112.606 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -65.33 -23.36 66.98 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.037 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.98 24.66 10.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.488 0.661 . . . . 0.0 112.708 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -134.15 165.24 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.336 1.054 . . . . 0.0 111.34 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -141.06 141.37 34.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -80.51 120.59 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 103' ' ' GLN . 79.9 mt -96.49 -35.52 11.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.816 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -157.01 161.97 39.56 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.338 0.59 . . . . 0.0 110.16 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 p -158.16 155.2 28.66 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.651 1.58 . . . . 0.0 109.526 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 150' ' ' GLU . 0.6 OUTLIER -66.7 143.64 56.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.69 0.757 . . . . 0.0 111.595 -170.648 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -80.47 -29.34 37.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.199 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -136.74 152.23 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.594 2.358 . . . . 0.0 109.065 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -76.06 136.93 39.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.75 102.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -106.94 146.19 31.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -147.67 146.36 29.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -91.26 144.68 25.36 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -71.46 149.22 93.63 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 123.943 0.897 . . . . 0.0 110.55 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.52 144.91 74.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 N-CA-C 105.082 -2.699 . . . . 0.0 105.082 167.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.4 mtpt -68.52 -12.1 60.78 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.242 -1.536 . . . . 0.0 113.831 -169.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -58.14 -31.62 67.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -90.0 -23.08 21.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 111.817 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 81' ' ' LYS . 53.1 t -66.05 137.96 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 109.45 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -107.82 90.99 3.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.14 0.976 . . . . 0.0 109.934 169.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -68.55 -24.6 64.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.825 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.58 -24.74 60.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.69 0.796 . . . . 0.0 112.433 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -111.3 156.79 20.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.228 1.011 . . . . 0.0 109.293 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -129.9 140.16 37.82 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.101 1.36 . . . . 0.0 109.239 -169.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.74 150.8 96.06 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 O-C-N 122.826 0.908 . . . . 0.0 110.865 -10.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.7 136.8 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.922 0.889 . . . . 0.0 111.656 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.2 t -81.85 108.37 15.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.6 -14.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.727 0.811 . . . . 0.0 112.584 170.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.37 -174.52 47.03 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.99 157.9 36.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 109.11 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.3 125.61 54.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 169.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -117.26 129.54 55.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.013 0.824 . . . . 0.0 111.405 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HB2' HG12 ' A' ' 11' ' ' VAL . 32.5 mmtt -88.04 154.04 20.79 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 84.5 m95 -132.54 143.6 49.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -130.41 132.5 45.77 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.572 1.149 . . . . 0.0 107.926 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 22.1 tp -97.06 126.03 41.93 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.85 146.64 43.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.6 tt0 -95.72 133.34 39.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 167.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.97 130.78 47.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.225 1.41 . . . . 0.0 108.542 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.9 t -86.31 -38.6 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.587 0.631 . . . . 0.0 110.803 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.5 m -95.41 -21.15 18.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.865 0.757 . . . . 0.0 112.302 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.65 -176.43 24.07 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -19.24 28.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.686 1.594 . . . . 0.0 114.506 -169.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.33 -31.46 33.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.378 1.071 . . . . 0.0 112.912 171.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -92.85 16.07 13.32 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.86 141.17 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -126.23 -49.38 1.56 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.529 0.732 . . . . 0.0 111.676 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 68.64 9.87 7.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.3 2.24 . . . . 0.0 115.2 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.26 69.66 0.83 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 124.325 2.012 . . . . 0.0 111.227 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -56.37 5.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.347 169.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 m -63.99 160.92 16.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.044 1.337 . . . . 0.0 109.063 168.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -63.57 -33.17 75.01 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.99 -0.444 . . . . 0.0 110.721 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.53 131.38 38.28 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.356 1.463 . . . . 0.0 110.27 170.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.67 132.67 31.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.212 1.941 . . . . 0.0 107.883 168.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -73.4 -23.65 60.19 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.862 -0.524 . . . . 0.0 111.074 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -116.12 139.29 50.46 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.543 0.737 . . . . 0.0 110.085 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.74 -21.09 34.85 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.072 0.949 . . . . 0.0 110.709 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -165.93 158.57 31.53 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.39 155.53 47.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.167 0.983 . . . . 0.0 108.497 169.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -144.79 149.03 34.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -96.9 98.11 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.52 168.92 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 110.296 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -64.31 168.13 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 109.507 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -30.68 70.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.196 -0.94 . . . . 0.0 111.563 175.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -92.01 -32.7 15.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.127 1.331 . . . . 0.0 113.607 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -54.39 -45.25 99.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 116.825 -1.559 . . . . 0.0 114.326 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.74 -19.96 68.01 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 123.273 2.205 . . . . 0.0 113.646 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.83 -33.68 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.11 -37.11 85.92 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.268 -0.895 . . . . 0.0 111.11 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -78.75 -27.0 44.65 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.78 166.23 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 118.804 0.729 . . . . 0.0 111.229 -173.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.65 174.23 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.855 1.262 . . . . 0.0 109.857 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.2 m -54.59 -49.42 70.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.493 1.517 . . . . 0.0 113.429 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -60.1 -39.09 84.96 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.317 0.647 . . . . 0.0 111.146 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -85.6 -40.14 16.57 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.974 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -46.85 -46.33 20.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.861 0.864 . . . . 0.0 111.097 170.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.83 -35.49 78.4 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.484 0.713 . . . . 0.0 111.367 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.14 -50.8 17.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.015 . . . . 0.0 110.169 171.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -61.78 -32.69 72.99 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.302 0.955 . . . . 0.0 111.586 -169.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -63.71 -42.99 97.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.259 0.936 . . . . 0.0 111.27 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -61.88 -44.7 96.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.83 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -55.73 -30.84 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.484 1.038 . . . . 0.0 111.222 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.4 mmt -86.25 -54.81 4.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.362 1.065 . . . . 0.0 108.717 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -36.49 73.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.076 0.853 . . . . 0.0 111.635 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 71' ' ' THR . 4.4 mm-40 -57.73 -40.13 78.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.143 0.977 . . . . 0.0 111.077 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.24 -14.15 13.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 111.025 -172.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.31 57.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 111.139 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 m -66.34 -31.48 72.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.312 0.645 . . . . 0.0 111.067 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.32 -45.91 67.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -58.47 -41.12 80.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 116.949 -1.5 . . . . 0.0 110.217 -173.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.3 mmt -54.48 -49.42 70.15 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 121.137 1.79 . . . . 0.0 110.318 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 m -76.64 -26.48 54.94 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.355 1.062 . . . . 0.0 111.144 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 18.6 tp -62.68 -44.22 96.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.111 1.365 . . . . 0.0 109.411 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -60.12 -39.9 87.83 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.845 0.458 . . . . 0.0 110.827 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.233 0.195 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.109 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.406 0.622 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -63.76 -67.08 0.46 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -169.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -162.68 -52.64 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.82 14.83 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 112.776 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.85 1.08 77.31 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.788 1.185 . . . . 0.0 114.001 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.51 165.28 11.18 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.917 0.865 . . . . 0.0 109.223 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -148.47 145.74 20.98 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.163 1.385 . . . . 0.0 107.456 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HB2' HD12 ' A' ' 40' ' ' ILE . 93.1 Cg_endo -85.71 133.39 4.37 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.476 1.451 . . . . 0.0 109.935 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.7 150.01 52.29 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 109.253 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.461 HG13 HD11 ' A' ' 40' ' ' ILE . 18.3 m -129.13 154.97 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.071 0.948 . . . . 0.0 108.83 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.13 158.29 25.23 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.49 143.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.565 1.146 . . . . 0.0 108.06 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.14 136.73 58.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mm -117.45 135.96 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' HD11 ' A' ' 101' ' ' LEU . 15.6 p -123.56 153.76 40.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.987 0.812 . . . . 0.0 112.117 171.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -103.72 175.12 5.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.425 1.49 . . . . 0.0 109.156 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -78.27 8.07 5.51 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.466 -1.396 . . . . 0.0 113.241 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -96.52 -5.76 38.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.439 1.096 . . . . 0.0 111.447 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.79 66.9 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.867 0.758 . . . . 0.0 111.885 -172.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -98.11 150.35 21.53 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -114.39 146.47 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 106.938 174.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 ptm -78.95 147.69 32.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.851 0.75 . . . . 0.0 109.672 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 20.3 t90 -148.55 146.59 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.63 148.2 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.977 1.262 . . . . 0.0 111.701 -170.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -99.5 127.79 45.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.81 0.732 . . . . 0.0 109.203 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -78.18 145.69 35.45 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.699 0.681 . . . . 0.0 109.867 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.13 136.1 57.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.066 0.946 . . . . 0.0 109.508 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.86 10.26 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.885 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -100.88 -45.21 5.51 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.328 1.564 . . . . 0.0 110.083 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 53.92 29.56 10.15 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.844 1.258 . . . . 0.0 111.826 -174.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -120.28 148.48 43.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.895 2.078 . . . . 0.0 106.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 70.3 m95 -92.82 148.61 21.89 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -152.24 162.89 40.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.538 1.935 . . . . 0.0 110.141 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.54 141.23 23.17 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.39 135.92 44.79 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.036 2.491 . . . . 0.0 111.671 -174.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -158.22 166.96 31.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.445 -171.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.29 172.57 42.31 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.165 0.412 . . . . 0.0 112.127 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.77 143.62 16.83 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.461 HD11 HG13 ' A' ' 11' ' ' VAL . 57.4 mt -76.81 122.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 168.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.99 148.29 78.46 Favored Pre-proline 0 N--CA 1.464 0.253 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.21 124.12 14.55 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.162 1.241 . . . . 0.0 109.055 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.38 -15.79 58.53 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.636 1.112 . . . . 0.0 113.803 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -73.67 148.16 43.02 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.644 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 p -85.96 168.95 13.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 168.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.59 87.88 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.262 -0.899 . . . . 0.0 110.943 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.97 -39.01 63.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.239 0.616 . . . . 0.0 110.611 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.81 -41.82 86.92 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.638 -0.664 . . . . 0.0 109.59 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.85 79.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.411 0.55 . . . . 0.0 109.629 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -62.02 -51.72 66.89 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.06 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.75 -35.35 79.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.916 1.235 . . . . 0.0 111.571 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.35 94.86 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.851 0.86 . . . . 0.0 110.388 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.89 -24.56 26.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.276 0.489 . . . . 0.0 110.933 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.44 HD12 HG21 ' A' ' 58' ' ' VAL . 11.1 tp -55.23 -39.59 69.88 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.152 -0.967 . . . . 0.0 109.471 169.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -63.12 -49.15 75.56 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.004 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.63 -32.74 73.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 0.0 112.715 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.8 -46.29 10.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.763 0.711 . . . . 0.0 111.135 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 54' ' ' LEU . 4.6 t -106.75 -31.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.562 1.145 . . . . 0.0 110.975 -168.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.67 87.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.817 1.199 . . . . 0.0 111.778 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 64' ' ' ASP . 22.9 tp -87.79 155.47 19.88 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.456 1.902 . . . . 0.0 110.039 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 p -131.76 164.48 25.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.765 1.226 . . . . 0.0 109.724 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -41.39 -40.56 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.315 2.246 . . . . 0.0 112.698 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.91 -28.18 69.36 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.42 0.688 . . . . 0.0 112.659 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' HD11 ' A' ' 60' ' ' LEU . 3.8 t70 -111.67 22.6 14.82 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.458 0.647 . . . . 0.0 112.08 -176.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.22 165.38 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 O-C-N 120.769 -1.207 . . . . 0.0 112.544 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 137.48 39.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 168.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.7 mt -74.53 119.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 171.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 103' ' ' GLN . 88.1 mt -95.76 -33.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.889 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -157.05 163.15 39.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.404 1.082 . . . . 0.0 108.745 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -162.24 153.24 17.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.587 1.155 . . . . 0.0 109.573 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 150' ' ' GLU . 3.7 p -70.7 136.09 48.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.346 -170.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -52.51 21.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -72.33 170.4 14.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.582 1.553 . . . . 0.0 111.652 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.477 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 87.0 m95 -108.44 125.58 51.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 167.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.97 106.04 8.4 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -73.62 140.3 46.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.74 143.32 50.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -131.66 141.7 49.66 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 126.283 1.833 . . . . 0.0 106.081 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pp -110.29 150.2 41.22 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.527 1.131 . . . . 0.0 109.613 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 83' ' ' LEU . 82.8 Cg_endo -73.12 158.18 49.57 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.427 3.418 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.6 mtmt -68.41 -18.41 64.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.41 -29.07 68.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD12 ' HD2' ' A' ' 80' ' ' PRO . 52.0 mt -94.55 -7.89 39.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.123 0.969 . . . . 0.0 112.416 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 81' ' ' LYS . 74.2 t -70.03 132.02 33.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.74 97.01 10.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -75.6 -19.52 59.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.861 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.29 -27.94 56.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -101.12 158.17 16.22 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.125 0.97 . . . . 0.0 109.836 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -132.66 132.02 22.43 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 125.967 1.707 . . . . 0.0 109.724 -170.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.5 150.72 89.94 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 O-C-N 122.879 0.936 . . . . 0.0 110.858 -10.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.24 141.55 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.899 1.28 . . . . 0.0 111.269 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.0 p -81.24 123.18 28.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.62 -16.11 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.843 0.747 . . . . 0.0 111.449 169.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.2 -174.16 40.07 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -160.96 162.84 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.223 1.809 . . . . 0.0 110.536 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -98.6 129.58 45.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -111.72 143.32 42.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.045 1.293 . . . . 0.0 110.237 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 6.2 ttmm -131.88 118.92 20.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -104.43 153.89 20.55 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.65 125.31 30.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.58 HD11 ' SG ' ' A' ' 16' ' ' CYS . 13.1 tp -91.16 121.41 32.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 168.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.67 157.09 23.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.682 ' HB2' HD11 ' A' ' 68' ' ' LEU . 5.1 tt0 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 167.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 141.23 56.62 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.956 1.303 . . . . 0.0 109.43 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.94 -47.51 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.114 0.566 . . . . 0.0 110.094 -171.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.8 m -86.1 -16.0 39.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.138 0.575 . . . . 0.0 111.55 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.25 -169.61 22.84 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -17.01 53.55 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 125.264 1.426 . . . . 0.0 114.311 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.68 57.05 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.917 0.887 . . . . 0.0 111.76 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -91.71 51.76 1.91 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 110.958 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.16 129.61 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.76 -53.72 2.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.375 0.67 . . . . 0.0 111.406 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 67.57 12.01 8.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.948 2.099 . . . . 0.0 114.628 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -150.31 73.89 1.17 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 124.016 1.865 . . . . 0.0 109.713 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -71.93 -60.08 2.41 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.269 -2.241 . . . . 0.0 107.843 171.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -66.71 166.44 13.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 109.917 169.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -57.43 -38.01 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.895 . . . . 0.0 110.829 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 130.52 54.77 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.865 1.266 . . . . 0.0 110.454 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.99 142.0 73.02 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.926 1.751 . . . . 0.0 108.453 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -81.34 -24.94 36.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.552 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.08 140.04 53.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.303 0.956 . . . . 0.0 109.998 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.0 -17.97 24.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.691 1.196 . . . . 0.0 111.371 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.85 151.82 23.19 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.57 148.85 31.57 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.816 0.847 . . . . 0.0 108.778 171.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -148.52 172.65 14.16 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.905 1.282 . . . . 0.0 109.204 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -112.97 139.77 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.59 152.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 109.853 -169.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m -59.94 147.9 37.09 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.819 0.736 . . . . 0.0 109.419 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -38.16 37.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -88.53 -25.1 22.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -170.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -57.87 -47.82 98.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.055 -1.45 . . . . 0.0 113.693 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -63.84 -21.3 69.24 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.865 2.059 . . . . 0.0 113.171 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.62 -36.38 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -62.85 -35.57 80.38 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.285 -0.885 . . . . 0.0 111.099 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.89 -21.4 34.27 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -81.73 167.87 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.389 0.995 . . . . 0.0 110.251 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.2 176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.719 1.208 . . . . 0.0 110.638 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 m -53.12 -48.5 67.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.021 1.729 . . . . 0.0 114.494 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -74.5 -31.34 62.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.257 -0.902 . . . . 0.0 111.394 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -80.77 -40.16 25.61 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.253 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -44.33 -46.2 9.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 0.0 111.633 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.96 -42.45 94.6 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.302 0.501 . . . . 0.0 111.352 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -67.5 -44.84 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 121.638 -0.664 . . . . 0.0 109.361 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.45 -41.76 98.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -66.34 -43.9 84.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.159 0.891 . . . . 0.0 110.333 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.31 -47.73 84.6 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.071 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.1 -39.45 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.733 1.213 . . . . 0.0 110.431 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.2 mmt -69.49 -54.45 14.19 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -57.24 -34.66 68.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.878 0.871 . . . . 0.0 111.774 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.627 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -56.07 -45.55 79.29 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.281 1.033 . . . . 0.0 110.185 -178.717 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.445 ' CZ ' HG23 ' A' ' 71' ' ' THR . 3.1 m-85 -104.63 -9.52 18.19 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.485 0.714 . . . . 0.0 112.381 -173.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.13 -43.81 70.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.133 1.773 . . . . 0.0 110.548 -173.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.7 m -66.7 -31.99 73.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.463 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.63 -47.14 81.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 118.055 -0.974 . . . . 0.0 108.384 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.6 t -58.42 -45.35 89.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 109.48 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.9 mtt -61.62 -33.82 74.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.624 0.647 . . . . 0.0 111.216 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -82.79 -31.36 28.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.575 1.15 . . . . 0.0 110.824 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.413 HD21 ' NE2' ' A' ' 103' ' ' GLN . 28.1 tp -58.33 -40.25 81.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.154 1.782 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.93 -29.75 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.194 0.598 . . . . 0.0 111.985 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 125.825 1.65 . . . . 0.0 111.74 -177.826 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.23 -64.83 0.81 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.4 -50.69 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.31 16.79 14.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 113.084 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 10.47 67.94 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.888 0.756 . . . . 0.0 113.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -105.0 155.6 18.81 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 108.714 170.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.96 147.76 67.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.446 169.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HB2' HD12 ' A' ' 40' ' ' ILE . 92.5 Cg_endo -85.55 142.23 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 110.528 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -143.57 155.44 44.3 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.252 1.421 . . . . 0.0 109.498 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.17 153.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.072 0.549 . . . . 0.0 110.372 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.74 160.37 19.36 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.84 146.55 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.76 135.9 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.9 mm -112.03 134.75 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.0 m -124.12 145.38 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.842 0.714 . . . . 0.0 110.008 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -104.22 173.53 6.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.116 1.366 . . . . 0.0 108.51 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.31 9.86 5.27 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.5 -1.375 . . . . 0.0 112.632 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -98.41 -3.51 36.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.099 1.36 . . . . 0.0 111.444 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.2 21.54 70.19 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 118.777 0.717 . . . . 0.0 111.916 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.98 150.7 21.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.647 1.223 . . . . 0.0 107.842 172.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.87 151.04 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 108.296 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.3 mtp -70.56 147.57 49.14 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.277 0.49 . . . . 0.0 110.026 169.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 14.4 t90 -151.2 141.16 22.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.62 145.74 47.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.28 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -97.13 107.95 20.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.961 2.105 . . . . 0.0 107.143 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -74.7 139.32 43.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.556 1.525 . . . . 0.0 109.939 -169.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.68 135.99 57.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.36 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.55 -24.56 3.64 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.546 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -82.49 -44.68 15.68 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.56 1.68 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m80 59.47 28.45 17.83 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.23 0.956 . . . . 0.0 109.734 -168.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -122.93 155.27 37.08 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 108.025 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 73.5 m95 -101.88 146.53 27.7 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -169.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -149.43 164.06 36.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.512 1.525 . . . . 0.0 110.334 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -87.52 143.95 34.82 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 130.49 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 110.59 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -159.07 168.17 27.37 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.113 0.87 . . . . 0.0 112.244 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.44 163.52 37.24 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.653 0.644 . . . . 0.0 111.661 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.6 150.85 45.52 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 9' ' ' PRO . 67.7 mt -77.55 113.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -70.93 156.03 92.58 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.58 123.9 12.83 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 CA-C-N 120.719 1.293 . . . . 0.0 109.674 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.09 -5.35 78.56 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.212 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -74.34 154.19 38.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.075 1.937 . . . . 0.0 110.524 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.4 p -94.56 168.37 10.9 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.46 90.02 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.024 -1.048 . . . . 0.0 111.342 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.06 -38.62 72.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.146 0.578 . . . . 0.0 110.26 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -67.69 -39.18 84.45 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.8 92.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 102' ' ' LEU . 12.6 tmm? -60.52 -52.52 64.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.6 m-85 -66.46 -44.44 82.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.973 0.806 . . . . 0.0 111.465 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -44.78 80.04 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 121.816 -0.552 . . . . 0.0 110.337 -173.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -71.54 -37.14 71.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 tp -53.76 -43.83 69.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.094 0.861 . . . . 0.0 110.588 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.27 -39.14 81.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.232 0.469 . . . . 0.0 110.834 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.11 -18.71 60.19 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.3 -0.875 . . . . 0.0 112.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -90.03 -50.38 6.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.666 0.787 . . . . 0.0 110.563 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.86 3.33 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 0.0 111.837 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.58 -1.52 14.26 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.469 -1.395 . . . . 0.0 113.529 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -80.72 144.42 32.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.186 1.794 . . . . 0.0 109.741 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -125.04 166.3 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 109.445 -174.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 56.7 mtt180 -48.96 -35.28 14.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.361 1.464 . . . . 0.0 112.43 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.35 -24.28 67.21 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.82 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.29 22.84 12.57 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.491 0.662 . . . . 0.0 112.113 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.19 164.24 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.675 1.19 . . . . 0.0 112.212 170.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.35 134.52 29.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.576 -1.202 . . . . 0.0 108.114 168.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mt -71.27 113.64 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 103' ' ' GLN . 68.7 mt -91.54 -33.99 14.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.848 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -153.93 165.42 36.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.406 0.682 . . . . 0.0 109.344 -174.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 p -159.09 157.53 31.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.61 1.164 . . . . 0.0 110.422 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -75.04 134.72 41.34 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.562 -0.711 . . . . 0.0 109.169 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.11 -48.17 25.09 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -79.41 165.17 23.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.022 1.329 . . . . 0.0 110.461 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 68.5 m95 -102.79 128.65 49.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -80.3 92.34 5.75 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -81.41 145.31 30.86 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.74 151.16 49.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -128.43 133.13 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.758 1.623 . . . . 0.0 106.898 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -90.64 147.9 37.35 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.36 0.664 . . . . 0.0 112.715 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.2 150.53 71.72 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 105.046 -2.713 . . . . 0.0 105.046 166.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.8 mtpt -69.35 -13.45 62.38 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 119.805 -1.809 . . . . 0.0 114.147 -169.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.16 -31.38 71.86 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.821 0.737 . . . . 0.0 112.76 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.08 -18.69 21.55 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.107 0.963 . . . . 0.0 112.009 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 81' ' ' LYS . 86.5 t -62.91 134.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.53 83.96 3.89 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.151 0.976 . . . . 0.0 110.223 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -67.29 -19.92 65.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.066 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.49 -20.99 53.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -107.07 160.88 15.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.948 0.899 . . . . 0.0 109.965 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -130.43 127.07 22.35 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 125.442 1.497 . . . . 0.0 109.19 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.39 159.53 91.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 O-C-N 122.717 0.851 . . . . 0.0 111.246 -10.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 80.5 t -75.01 140.04 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 123.906 0.882 . . . . 0.0 110.045 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 p -91.89 121.45 33.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.697 1.199 . . . . 0.0 108.925 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.29 -13.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.803 0.728 . . . . 0.0 112.716 171.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.91 46.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -157.01 161.48 39.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.675 1.19 . . . . 0.0 109.566 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -112.43 132.69 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -123.29 122.15 37.62 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.429 0.692 . . . . 0.0 109.524 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.2 ttmm -105.97 140.35 39.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.67 156.16 38.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.676 0.671 . . . . 0.0 109.364 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -139.8 127.01 21.17 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.161 0.984 . . . . 0.0 108.516 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -88.82 116.3 26.99 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.603 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 50' ' ' MET . 9.6 mp -112.11 137.46 50.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.866 0.867 . . . . 0.0 108.917 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.3 tt0 -89.99 134.88 33.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.477 1.49 . . . . 0.0 107.213 168.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.97 133.43 51.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.64 1.576 . . . . 0.0 107.269 170.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.34 -55.24 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.834 1.197 . . . . 0.0 110.634 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.1 m -75.78 -19.46 58.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.59 0.756 . . . . 0.0 111.227 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.44 27.26 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -57.75 -18.18 19.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 0.0 114.367 -169.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.03 10.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.268 1.027 . . . . 0.0 112.619 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -87.15 14.97 6.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.1 mt -91.33 137.9 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -129.27 128.46 43.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.337 1.855 . . . . 0.0 106.874 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.1 mmt -97.91 -11.04 23.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.579 0.627 . . . . 0.0 111.526 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.91 63.32 0.71 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.979 2.112 . . . . 0.0 106.587 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -68.65 -60.05 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 127.185 2.194 . . . . 0.0 109.361 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -90.67 174.87 7.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.457 1.903 . . . . 0.0 110.021 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 m -60.17 -25.72 65.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.192 0.997 . . . . 0.0 112.004 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.94 136.82 23.37 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 168.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 155.2 68.4 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.575 2.183 . . . . 0.0 111.8 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.39 -35.25 27.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.745 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.67 137.8 54.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.574 0.75 . . . . 0.0 109.437 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.3 -26.71 56.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.837 0.855 . . . . 0.0 110.787 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.89 166.84 38.33 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.39 160.01 44.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 169.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -145.65 167.05 24.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.79 133.93 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 151.29 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.853 1.261 . . . . 0.0 110.083 -169.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -60.73 146.6 45.28 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -33.53 30.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.022 1.329 . . . . 0.0 113.698 -169.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -91.72 -14.75 29.46 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -65.17 -47.81 71.05 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.335 -1.317 . . . . 0.0 112.858 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.55 -28.88 83.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 CA-C-N 122.547 1.945 . . . . 0.0 112.35 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.15 -25.82 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.191 1.396 . . . . 0.0 109.819 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -65.87 -31.42 72.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.424 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -100.01 -22.16 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.75 151.89 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 118.793 0.724 . . . . 0.0 110.065 171.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.36 176.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.688 1.195 . . . . 0.0 109.706 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -55.38 -44.3 75.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.393 1.477 . . . . 0.0 112.911 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -70.65 -41.75 71.73 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 111.088 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.42 -41.06 28.49 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.83 -0.544 . . . . 0.0 110.731 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -61.63 -29.41 70.04 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.853 0.751 . . . . 0.0 112.383 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.17 -45.75 87.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.497 0.589 . . . . 0.0 110.688 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.25 -47.14 91.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.525 -0.734 . . . . 0.0 109.099 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -61.62 -45.52 93.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -66.08 -40.65 90.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.971 -1.081 . . . . 0.0 110.933 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.63 -48.02 83.65 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.474 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.01 -39.9 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.279 1.032 . . . . 0.0 110.039 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.6 mmt -67.12 -52.83 36.98 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.996 0.919 . . . . 0.0 108.647 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.462 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -29.54 69.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.37 0.987 . . . . 0.0 112.006 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.422 ' HB3' HD12 ' A' ' 101' ' ' LEU . 14.9 m-85 -111.37 -14.47 13.76 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.09 0.956 . . . . 0.0 113.468 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.28 69.33 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.371 1.468 . . . . 0.0 110.641 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 m -68.53 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.864 0.866 . . . . 0.0 110.687 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 69' ' ' ALA . 41.5 t -68.62 -43.67 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.68 -39.91 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.458 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.0 mmt -57.44 -50.38 73.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.643 1.11 . . . . 0.0 109.852 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 m -73.31 -28.04 61.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.173 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.408 HD21 ' NE2' ' A' ' 103' ' ' GLN . 65.6 tp -62.01 -42.58 99.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.666 1.186 . . . . 0.0 110.152 172.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.44 -42.52 98.88 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -170.143 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.61 -69.09 0.31 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.246 0.618 . . . . 0.0 112.623 -169.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.34 -52.4 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.663 0.785 . . . . 0.0 112.953 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.62 17.0 10.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.699 1.199 . . . . 0.0 112.459 -169.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.54 85.72 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.744 1.164 . . . . 0.0 113.24 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -88.21 157.88 18.67 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.263 1.025 . . . . 0.0 109.367 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -150.31 127.29 5.4 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 116.996 -1.478 . . . . 0.0 107.292 -169.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -80.32 132.58 9.25 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.505 1.47 . . . . 0.0 109.424 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.36 155.61 49.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.909 0.884 . . . . 0.0 108.656 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.42 137.77 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.16 154.41 16.82 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.45 141.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 125.397 1.479 . . . . 0.0 107.962 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.88 142.7 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mm -117.09 142.25 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 117.293 -1.337 . . . . 0.0 107.663 169.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' SG ' HD21 ' A' ' 101' ' ' LEU . 27.6 p -125.78 160.11 30.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.651 1.114 . . . . 0.0 112.708 170.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -121.61 172.18 8.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.613 1.565 . . . . 0.0 109.145 176.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.99 7.7 4.6 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.439 -1.413 . . . . 0.0 112.977 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -94.08 -5.13 48.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.434 1.093 . . . . 0.0 111.715 174.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 31.72 60.75 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -108.57 154.6 21.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.22 150.3 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 174.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -84.52 143.59 29.25 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -144.65 140.47 28.68 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -175.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.78 158.46 42.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.581 1.537 . . . . 0.0 111.531 -170.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.68 145.83 51.05 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.875 1.67 . . . . 0.0 108.45 -171.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -112.11 163.39 14.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.341 0.973 . . . . 0.0 109.664 174.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -72.88 153.67 40.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.328 1.051 . . . . 0.0 109.013 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.96 -52.63 3.3 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.138 1.351 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.17 -45.73 66.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.43 0.615 . . . . 0.0 110.079 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.1 m170 56.18 -0.37 0.05 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.292 2.237 . . . . 0.0 115.377 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -77.82 163.23 26.27 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.565 1.946 . . . . 0.0 108.348 169.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -112.68 146.7 38.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -174.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.34 158.51 44.14 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.958 1.303 . . . . 0.0 110.686 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.62 134.22 65.87 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 169.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -54.34 139.76 73.42 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.214 2.609 . . . . 0.0 112.578 -178.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -161.95 169.17 21.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.161 0.891 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.86 169.48 42.54 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.156 0.407 . . . . 0.0 112.368 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.79 147.51 36.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -73.89 114.94 14.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 169.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -68.22 145.72 97.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.19 125.14 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.518 1.479 . . . . 0.0 112.076 -169.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.2 85.93 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.55 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.15 147.55 48.27 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.133 1.967 . . . . 0.0 110.595 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -85.24 156.48 20.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 167.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.64 75.63 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.014 -1.054 . . . . 0.0 112.119 -169.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.71 -36.67 70.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 110.094 -178.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -70.28 -37.65 74.88 Favored 'General case' 0 C--O 1.23 0.061 0 O-C-N 121.172 -0.955 . . . . 0.0 109.995 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.57 77.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.566 175.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -58.09 -48.65 79.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.4 m-85 -66.32 -46.91 75.24 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.913 0.779 . . . . 0.0 111.766 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -52.52 -52.51 54.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.133 0.973 . . . . 0.0 110.901 177.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.87 -37.35 59.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -170.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -54.61 -45.41 73.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 110.595 173.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.76 -39.62 89.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.159 0.436 . . . . 0.0 110.28 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.36 -24.64 60.37 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.08 -46.01 12.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.313 0.96 . . . . 0.0 111.459 -175.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.52 4.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 112.32 -169.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.93 -2.97 14.5 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 120.431 -1.418 . . . . 0.0 113.513 -178.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.0 tp -78.89 140.88 38.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.677 1.591 . . . . 0.0 109.771 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 p -120.96 163.67 17.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.877 1.271 . . . . 0.0 109.902 -171.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 67.0 mtt85 -46.58 -37.58 8.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.054 1.742 . . . . 0.0 112.23 -177.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -30.19 71.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.885 -173.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.33 21.42 16.71 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.679 1.127 . . . . 0.0 112.011 -173.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.01 165.6 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.53 1.532 . . . . 0.0 111.829 171.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.65 140.31 33.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.279 169.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.52 116.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 177.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 103' ' ' GLN . 78.0 mt -94.58 -33.57 12.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.405 174.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.82 164.04 39.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.799 0.84 . . . . 0.0 108.919 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -163.68 154.4 15.92 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.1 0.96 . . . . 0.0 109.879 170.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 150' ' ' GLU . 2.1 p -70.07 139.28 52.57 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -175.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -56.98 4.87 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -72.84 -178.16 2.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.514 1.925 . . . . 0.0 111.062 174.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 55.8 m95 -118.75 146.85 44.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.162 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.12 102.16 13.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 137.37 40.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -135.82 143.26 45.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -87.74 139.13 30.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 83' ' ' LEU . 1.1 pp -91.02 148.82 38.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 169.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.8 Cg_endo -71.92 155.14 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.45 2.767 . . . . 0.0 110.497 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -65.75 -20.24 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.046 -1.034 . . . . 0.0 112.8 -170.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.62 -32.81 67.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.688 0.676 . . . . 0.0 112.739 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.465 HD12 ' HD2' ' A' ' 80' ' ' PRO . 67.4 mt -91.05 -20.08 22.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.042 0.937 . . . . 0.0 111.436 -177.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.17 134.79 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -109.26 96.21 6.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.126 0.97 . . . . 0.0 109.398 171.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -70.99 -27.15 63.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.237 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.16 -10.32 59.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.309 1.043 . . . . 0.0 112.534 -170.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -129.73 158.9 38.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.928 0.891 . . . . 0.0 108.974 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -127.29 141.5 41.0 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.177 1.391 . . . . 0.0 108.993 -171.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.76 147.55 89.84 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 O-C-N 122.875 0.934 . . . . 0.0 111.35 -10.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -83.72 141.27 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.405 1.082 . . . . 0.0 108.908 175.245 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -103.96 139.6 38.88 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.461 0.704 . . . . 0.0 109.533 169.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 -17.42 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 122.937 0.495 . . . . 0.0 111.347 169.219 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.91 161.97 28.12 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.98 143.41 33.19 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.586 1.154 . . . . 0.0 108.599 -177.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HE2' ' CD2' ' A' ' 74' ' ' TRP . 85.2 tttt -94.72 120.77 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -119.15 131.0 55.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.065 1.302 . . . . 0.0 112.893 -172.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 3.7 ttmm -99.4 152.79 19.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -128.54 148.6 50.77 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -133.58 129.73 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.871 1.269 . . . . 0.0 108.491 -177.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -95.07 125.64 39.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.444 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.13 157.02 31.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.655 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.0 tt0 -105.84 132.99 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 137.83 58.32 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -89.5 -55.33 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.611 1.096 . . . . 0.0 109.97 -172.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -76.87 -21.62 54.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.458 0.703 . . . . 0.0 111.432 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.18 169.32 20.56 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -13.91 26.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.573 1.549 . . . . 0.0 114.433 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.63 39.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.286 1.034 . . . . 0.0 112.712 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.59 22.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.39 137.21 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.193 1.397 . . . . 0.0 108.155 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -124.03 129.01 50.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.332 1.853 . . . . 0.0 107.888 170.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.8 mmt -93.68 -8.04 42.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.369 0.668 . . . . 0.0 112.697 -176.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -127.22 81.08 1.99 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 124.084 1.897 . . . . 0.0 108.83 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 p -79.57 -64.14 1.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.209 2.603 . . . . 0.0 107.58 178.263 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -72.85 174.22 8.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.578 1.551 . . . . 0.0 109.711 169.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -60.53 -36.82 79.32 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.85 -0.531 . . . . 0.0 109.974 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.12 136.28 57.54 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.48 1.512 . . . . 0.0 107.991 169.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 117.55 4.34 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 122.44 2.093 . . . . 0.0 107.622 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -72.99 -18.87 61.31 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.763 -0.586 . . . . 0.0 110.297 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.03 155.88 49.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.919 1.288 . . . . 0.0 107.974 168.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.3 -14.77 14.1 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.975 2.11 . . . . 0.0 110.808 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.02 154.55 25.56 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.68 149.88 51.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.43 164.96 33.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -121.88 132.44 54.57 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.28 162.48 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.166 1.386 . . . . 0.0 111.984 -168.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.7 m -69.07 157.56 36.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 109.567 169.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.95 78.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 112.651 -171.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -91.31 -27.9 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.241 -0.912 . . . . 0.0 112.969 -169.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -51.34 -46.92 89.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.99 -25.4 59.29 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.14 1.8 . . . . 0.0 113.152 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.62 -41.3 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.318 0.0 OUTLIER -74.16 -5.53 42.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.273 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -95.01 -15.93 23.13 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.338 -0.839 . . . . 0.0 113.129 -174.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 m -104.16 172.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.624 1.102 . . . . 0.0 111.771 -175.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.5 m -73.27 166.61 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.905 0.882 . . . . 0.0 109.584 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -52.67 -50.54 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.048 1.739 . . . . 0.0 114.188 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -69.69 -33.12 72.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.656 -0.652 . . . . 0.0 110.888 -175.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -76.81 -37.26 56.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.375 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -51.4 -47.03 63.07 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.008 0.822 . . . . 0.0 109.915 173.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.55 -42.97 99.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.868 0.304 . . . . 0.0 110.791 -176.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.69 -50.79 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -58.61 -41.98 87.1 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.607 0.763 . . . . 0.0 109.027 -176.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.98 -52.93 63.66 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.679 0.792 . . . . 0.0 110.345 176.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -54.9 -49.55 70.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.68 -43.77 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.087 0.858 . . . . 0.0 110.491 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.8 mmt -69.8 -52.44 25.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -173.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -30.59 71.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.218 0.917 . . . . 0.0 112.234 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.547 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -57.52 -45.31 85.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.793 0.724 . . . . 0.0 110.616 177.577 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.49 ' HB3' HD12 ' A' ' 101' ' ' LEU . 7.3 m-85 -106.11 -11.41 16.11 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.01 66.83 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.169 1.788 . . . . 0.0 110.652 -174.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -67.11 -31.64 72.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.591 0.756 . . . . 0.0 110.465 -174.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.91 -45.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.3 -44.38 92.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.054 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -47.49 82.91 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 120.453 1.479 . . . . 0.0 110.056 -177.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.7 t -68.61 -31.23 70.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.712 0.405 . . . . 0.0 111.077 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.435 HD21 ' NE2' ' A' ' 103' ' ' GLN . 21.2 tp -64.29 -38.63 91.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.124 1.369 . . . . 0.0 110.464 176.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -67.19 -44.15 80.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.803 0.274 . . . . 0.0 110.332 173.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.237 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.89 144.52 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 164.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.43 -66.16 0.59 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.096 0.872 . . . . 0.0 110.188 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -164.16 -53.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.918 0.487 . . . . 0.0 110.093 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.04 16.66 17.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 123.625 1.678 . . . . 0.0 110.746 -164.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.71 2.16 65.29 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 120.206 -1.558 . . . . 0.0 112.704 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -97.12 159.24 15.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.272 1.536 . . . . 0.0 109.035 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -140.16 142.03 28.66 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.518 ' HB2' HD12 ' A' ' 40' ' ' ILE . 10.9 Cg_endo -80.93 144.59 15.21 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.934 1.756 . . . . 0.0 110.648 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.25 154.98 41.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.55 158.26 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.961 0.904 . . . . 0.0 109.126 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -141.16 162.1 26.81 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG21 HD13 ' A' ' 54' ' ' LEU . 2.9 mp -126.27 144.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -172.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -128.17 136.46 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 ' HG ' ' A' ' 104' ' ' LEU . 17.5 mm -116.19 137.46 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 167.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.905 ' SG ' HD11 ' A' ' 101' ' ' LEU . 2.1 p -124.12 162.31 23.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.543 1.639 . . . . 0.0 112.69 161.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -106.14 172.65 6.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.047 -2.342 . . . . 0.0 108.834 172.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.0 5.48 6.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -94.1 0.29 55.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.716 0.806 . . . . 0.0 110.975 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.45 21.81 76.73 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.551 0.614 . . . . 0.0 112.196 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -95.15 147.25 23.65 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.8 145.98 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ttm -67.02 145.48 55.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.592 -1.185 . . . . 0.0 107.897 169.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 1.059 ' NE1' ' HB3' ' A' ' 33' ' ' TRP . 1.8 t90 -144.23 141.14 29.68 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' N ' ' HD1' ' A' ' 24' ' ' TRP . . . -133.28 167.28 20.68 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 123.52 1.629 . . . . 0.0 115.331 173.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' HB2' ' CE3' ' A' ' 33' ' ' TRP . 37.3 ttp180 -125.27 124.24 41.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 120.97 -1.081 . . . . 0.0 108.669 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -75.01 148.76 39.6 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.167 -169.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -54.77 132.89 46.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.292 1.62 . . . . 0.0 109.953 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -7.57 5.15 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.446 -1.196 . . . . 0.0 114.395 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -88.17 177.7 6.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -132.95 13.76 4.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.472 0.654 . . . . 0.0 109.853 165.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.89 154.49 21.51 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 1.059 ' HB3' ' NE1' ' A' ' 24' ' ' TRP 0.286 91.7 m95 -120.72 154.29 35.81 Favored 'General case' 0 N--CA 1.399 -2.977 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.715 -165.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.11 167.76 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.139 1.775 . . . . 0.0 110.952 -170.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -81.48 146.08 56.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.02 160.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -56.23 135.19 68.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.227 2.618 . . . . 0.0 110.666 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.433 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 14.2 pt20 -159.53 171.09 20.3 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.236 0.926 . . . . 0.0 111.356 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.04 171.36 44.39 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.972 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.12 147.28 24.55 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.656 -0.908 . . . . 0.0 111.179 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 9' ' ' PRO . 84.1 mt -74.25 123.12 28.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 165.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.32 155.71 91.16 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.9 124.74 15.54 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 N-CA-C 109.451 -1.019 . . . . 0.0 109.451 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.01 -9.81 76.77 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.803 -0.998 . . . . 0.0 114.322 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.35 151.71 44.93 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 119.683 1.742 . . . . 0.0 111.045 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.11 161.28 18.96 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 161.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.86 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 122.062 -0.398 . . . . 0.0 111.213 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.98 -35.06 74.14 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.971 -0.456 . . . . 0.0 111.016 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -70.08 -43.77 70.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.863 -1.148 . . . . 0.0 109.687 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.99 78.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 123.975 0.797 . . . . 0.0 109.557 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.479 ' SD ' HD11 ' A' ' 102' ' ' LEU . 13.3 tmm? -62.54 -48.86 77.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 35.0 m-85 -68.08 -38.3 82.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.87 0.759 . . . . 0.0 111.338 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.4 ttm-85 -60.07 -55.59 32.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.23 -28.52 64.24 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 13' ' ' ILE . 16.1 tp -54.66 -48.33 72.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 120.442 -1.411 . . . . 0.0 109.699 169.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.412 ' O ' HG21 ' A' ' 115' ' ' THR . 34.6 t80 -60.28 -45.17 94.26 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 117.318 -1.325 . . . . 0.0 109.213 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.97 -31.9 73.36 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.586 1.539 . . . . 0.0 111.652 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -91.67 -49.23 6.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.282 0.947 . . . . 0.0 110.06 -171.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.555 HG12 HG23 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -110.92 -10.83 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 124.498 1.119 . . . . 0.0 112.27 -168.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.92 1.09 37.71 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 123.824 0.726 . . . . 0.0 113.918 -173.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -83.23 150.33 26.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.075 1.35 . . . . 0.0 108.682 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.48 168.45 15.63 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.095 0.95 . . . . 0.0 108.731 -175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.49 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 28.4 mtt180 -48.7 -31.87 7.53 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 63' ' ' LYS . 28.9 mmmt -61.78 -31.14 71.32 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.703 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -114.53 23.52 12.67 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 126.728 2.517 . . . . 0.0 108.23 -168.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.26 162.69 33.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 O-C-N 120.439 -1.413 . . . . 0.0 111.127 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.04 138.09 38.47 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 117.845 -1.074 . . . . 0.0 108.206 165.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.31 119.66 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' A' ' 101' ' ' LEU . 84.0 mt -98.67 -32.47 11.39 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.649 0.593 . . . . 0.0 110.872 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.5 165.56 35.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.5 p -157.3 157.52 34.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.726 1.21 . . . . 0.0 108.738 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.532 HG22 ' HG2' ' A' ' 150' ' ' GLU . 1.7 p -70.64 136.33 49.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.267 1.032 . . . . 0.0 110.633 -174.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -81.98 -37.99 25.81 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.468 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -104.34 153.45 21.03 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.004 1.322 . . . . 0.0 108.139 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -84.24 134.91 34.52 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.026 -1.047 . . . . 0.0 108.425 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -89.31 98.71 11.92 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -97.92 147.64 24.26 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.88 153.63 39.36 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.717 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.13 143.49 27.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.488 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.13 150.94 83.56 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 123.863 0.727 . . . . 0.0 109.267 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.05 149.19 71.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.692 2.261 . . . . 0.0 109.225 160.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.8 mtpt -67.9 -18.29 64.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -167.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -59.17 -30.56 68.28 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.953 -0.546 . . . . 0.0 112.003 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.38 -19.11 21.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.222 0.609 . . . . 0.0 111.09 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 81' ' ' LYS . 93.3 t -63.5 136.55 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.15 75.44 1.37 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.079 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -56.3 -23.11 34.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -73.61 -28.18 61.68 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.078 0.551 . . . . 0.0 111.911 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.3 t -104.82 164.65 11.63 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.441 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -133.05 136.93 28.41 Favored Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.87 149.79 83.89 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 -16.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.97 136.53 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.104 0.961 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.4 p -88.05 132.29 34.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -12.54 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.118 0.567 . . . . 0.0 112.004 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.15 -177.69 41.15 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -153.58 158.1 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -105.48 134.91 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -117.58 130.92 56.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.898 1.279 . . . . 0.0 110.129 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -110.65 136.87 49.08 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -117.83 156.96 27.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -142.25 128.1 19.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.193 1.397 . . . . 0.0 107.748 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.905 HD11 ' SG ' ' A' ' 16' ' ' CYS . 1.2 tp -95.6 127.34 41.55 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.479 HD11 ' SD ' ' A' ' 50' ' ' MET . 5.9 mt -115.84 152.57 33.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.6 tt0 -100.69 134.85 43.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 159.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.526 ' HG ' HG21 ' A' ' 15' ' ' ILE . 1.6 mt -62.64 135.16 57.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 125.51 1.756 . . . . 0.0 109.298 169.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.5 t -88.72 -51.49 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -171.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -82.81 -17.3 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.8 0.727 . . . . 0.0 111.739 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.33 175.22 35.91 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -21.27 2.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.707 2.403 . . . . 0.0 114.301 -165.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.02 -31.24 40.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.334 1.454 . . . . 0.0 112.456 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.54 19.42 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.847 0.832 . . . . 0.0 112.503 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.555 HG23 HG12 ' A' ' 58' ' ' VAL . 79.0 mt -94.17 135.74 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.51 -1.369 . . . . 0.0 108.385 171.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -134.35 109.11 8.58 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 125.724 1.609 . . . . 0.0 107.855 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.02 9.3 20.04 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.99 -1.069 . . . . 0.0 112.651 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.8 77.04 1.69 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 124.061 1.886 . . . . 0.0 107.777 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 55' ' ' PHE . 2.0 p -73.75 -60.72 2.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.072 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -72.6 168.58 18.34 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.017 168.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.0 m -58.5 -39.2 79.4 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.954 -0.466 . . . . 0.0 110.446 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 132.6 62.67 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.38 133.59 50.14 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.587 1.524 . . . . 0.0 109.626 164.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -75.25 -26.76 59.11 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.903 0.858 . . . . 0.0 110.792 173.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -118.86 144.97 46.05 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 120.805 -1.185 . . . . 0.0 108.424 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.16 -31.05 22.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.007 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.76 158.95 27.93 Favored Glycine 0 C--N 1.335 0.524 0 O-C-N 120.689 -1.257 . . . . 0.0 111.012 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.73 155.15 42.18 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -150.89 165.59 33.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 108.304 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -112.78 137.93 50.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.45 152.97 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.94 1.296 . . . . 0.0 109.201 -168.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -59.97 147.47 38.79 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 117.178 -1.391 . . . . 0.0 109.536 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.12 66.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -93.06 -22.93 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.023 -1.048 . . . . 0.0 112.404 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.441 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 87.5 t80 -53.6 -37.79 55.01 Favored Pre-proline 0 CA--C 1.514 -0.415 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.009 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 1.021 ' HB3' ' HE3' ' A' ' 24' ' ' TRP . 10.9 Cg_endo -67.54 -37.18 17.6 Favored 'Trans proline' 0 N--CA 1.413 -3.254 0 N-CA-C 117.242 1.978 . . . . 0.0 117.242 -173.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.92 -25.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 112.73 -2.032 . . . . 0.0 109.115 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.02 -32.23 73.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.128 -1.607 . . . . 0.0 113.676 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 -24.82 33.19 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 124.075 0.859 . . . . 0.0 111.5 -168.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 144' ' ' TYR . 2.5 m -86.53 167.08 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 122.008 0.908 . . . . 0.0 111.041 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.18 172.55 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 120.892 -1.13 . . . . 0.0 109.987 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 m -51.03 -50.0 59.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -79.34 -30.88 42.92 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.224 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -70.6 -38.44 74.01 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.004 -1.06 . . . . 0.0 110.374 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.41 -45.18 62.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.105 0.962 . . . . 0.0 111.866 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.35 -47.52 85.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.043 1.464 . . . . 0.0 108.463 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.38 -51.53 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.199 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.408 ' CE2' HG11 ' A' ' 136' ' ' VAL . 6.0 m-30 -63.67 -37.77 88.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.068 0.849 . . . . 0.0 110.834 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -68.02 -38.81 83.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.432 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -58.82 -49.27 78.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.614 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.36 -39.14 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.623 1.169 . . . . 0.0 110.244 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -74.17 -55.47 6.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -36.45 74.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.624 0.647 . . . . 0.0 111.574 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 151' ' ' PHE . 4.6 tp10 -61.51 -30.82 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.791 0.836 . . . . 0.0 110.7 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.814 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 0.8 OUTLIER -113.49 -13.41 12.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 0.0 109.798 -172.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.69 71.92 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.684 1.593 . . . . 0.0 110.848 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 m -66.24 -33.58 76.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.577 0.751 . . . . 0.0 111.029 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.8 t -68.86 -43.02 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.454 HG22 ' SG ' ' A' ' 16' ' ' CYS . 27.4 t -59.37 -42.24 86.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.587 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmt -55.96 -52.92 62.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.079 1.309 . . . . 0.0 109.384 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -68.63 -29.12 67.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.063 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.915 HD12 ' HG2' ' A' ' 163' ' ' PRO . 14.1 tp -69.09 -23.09 63.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.659 1.584 . . . . 0.0 111.596 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.92 -24.85 40.8 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 117.662 -3.149 . . . . 0.0 111.212 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 162' ' ' THR . 29.6 mt-10 -97.97 -31.97 11.9 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 120.234 1.379 . . . . 0.0 114.156 -167.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.476 ' O ' ' HE2' ' A' ' 164' ' ' LYS . 7.8 m-80 -62.89 -18.41 62.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.154 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 160' ' ' GLU . 1.5 p 26.03 62.09 0.51 Allowed Pre-proline 0 CA--C 1.436 -3.42 2 C-N-CA 134.367 5.067 . . . . 0.0 97.748 -142.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.915 ' HG2' HD12 ' A' ' 158' ' ' LEU . 13.8 Cg_endo -57.06 120.12 7.84 Favored 'Trans proline' 1 N--CA 1.385 -4.899 1 N-CA-C 100.11 -4.612 . . . . 0.0 100.11 -178.328 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 161' ' ' ASN 0.345 71.2 mmtt . . . . . 1 N--CA 1.378 -4.034 1 CA-C-N 100.314 -7.676 . . . . 0.0 103.665 -155.155 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt -134.88 143.91 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -72.18 -72.87 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.704 0.684 . . . . 0.0 112.079 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -162.25 -49.96 0.04 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.284 1.034 . . . . 0.0 111.669 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -91.46 15.28 12.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.945 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.8 0.81 77.87 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.726 1.155 . . . . 0.0 113.787 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -95.39 162.62 13.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.349 1.074 . . . . 0.0 108.227 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.4 146.16 24.11 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.049 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 40' ' ' ILE . 44.5 Cg_endo -91.27 131.07 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.603 2.202 . . . . 0.0 111.526 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -128.51 157.97 39.69 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.381 1.472 . . . . 0.0 109.228 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.432 HG13 HD11 ' A' ' 40' ' ' ILE . 16.0 m -134.97 164.17 34.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -153.53 163.53 30.77 Favored Glycine 0 C--N 1.33 0.226 0 O-C-N 121.402 -0.811 . . . . 0.0 112.627 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.07 140.33 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 124.777 1.231 . . . . 0.0 108.582 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.22 137.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.5 mm -111.44 145.22 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.623 1.101 . . . . 0.0 108.054 169.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 p -120.72 150.32 41.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.632 0.773 . . . . 0.0 111.045 169.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -108.29 168.76 9.08 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.747 1.219 . . . . 0.0 108.191 170.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.28 3.82 6.7 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 119.915 -1.741 . . . . 0.0 113.606 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -88.51 -4.78 58.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.353 1.061 . . . . 0.0 110.892 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.26 13.55 83.17 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.896 -0.947 . . . . 0.0 112.296 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -81.9 147.85 29.08 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.175 1.487 . . . . 0.0 107.668 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 m -103.04 149.71 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.777 1.231 . . . . 0.0 108.815 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.67 142.45 30.76 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.147 0.979 . . . . 0.0 109.026 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -146.08 146.77 31.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.319 1.448 . . . . 0.0 108.617 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.43 166.66 29.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.026 1.285 . . . . 0.0 111.82 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -126.8 135.17 50.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.371 1.069 . . . . 0.0 108.828 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -64.96 154.79 36.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 109.7 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.91 128.62 38.0 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.89 0.23 90.1 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.415 -1.214 . . . . 0.0 113.962 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -112.23 150.25 31.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.474 1.637 . . . . 0.0 111.224 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -96.4 -16.2 21.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.154 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 p -83.98 134.68 34.64 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.277 1.431 . . . . 0.0 109.779 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -92.28 153.58 19.15 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.66 0.784 . . . . 0.0 110.729 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -150.39 156.89 42.35 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.967 1.707 . . . . 0.0 109.361 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.89 139.16 69.53 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.65 129.27 13.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.086 2.524 . . . . 0.0 111.455 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 29.6 pt20 -155.43 158.26 38.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 112.598 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.47 -169.74 20.86 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.821 1.677 . . . . 0.0 110.327 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.55 145.99 18.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.43 1.491 . . . . 0.0 110.636 -172.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 11' ' ' VAL . 62.1 mt -79.26 135.51 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 169.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -81.22 156.19 71.72 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.63 121.29 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.07 -2.48 85.47 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.32 -1.267 . . . . 0.0 114.411 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.56 156.05 39.85 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 120.598 2.199 . . . . 0.0 110.286 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -93.08 152.81 19.06 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 168.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.69 80.63 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.302 -0.874 . . . . 0.0 111.837 -172.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.46 -36.43 78.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.61 0.764 . . . . 0.0 110.092 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -68.52 -41.64 79.67 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.04 89.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -60.06 -50.89 71.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.755 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 58.0 m-85 -67.06 -37.35 83.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.39 0.995 . . . . 0.0 112.068 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -63.43 -50.3 70.31 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.579 1.536 . . . . 0.0 109.172 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -71.59 -32.71 68.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -170.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 58' ' ' VAL . 8.3 tp -53.77 -49.64 67.79 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.634 1.174 . . . . 0.0 110.147 169.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.29 -35.76 81.21 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.423 0.556 . . . . 0.0 110.651 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -70.12 -35.2 73.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.919 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.96 -38.38 5.35 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.553 1.07 . . . . 0.0 113.627 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.514 HG21 HD12 ' A' ' 54' ' ' LEU . 13.3 t -92.62 -31.74 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.196 0.999 . . . . 0.0 108.604 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 0.81 88.35 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.928 1.252 . . . . 0.0 112.743 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.8 tp -87.54 153.44 21.4 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.443 1.897 . . . . 0.0 109.615 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -128.74 166.08 19.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.713 1.205 . . . . 0.0 110.529 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 38.8 mtp180 -45.48 -41.43 9.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.228 1.811 . . . . 0.0 113.106 -172.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.94 -24.95 65.23 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.245 0.618 . . . . 0.0 111.902 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -102.74 9.71 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.528 0.731 . . . . 0.0 111.186 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.5 165.84 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.8 1.64 . . . . 0.0 112.08 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 136.3 31.13 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 168.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.5 mt -78.91 115.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 103' ' ' GLN . 78.6 mt -95.87 -31.19 13.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.372 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 154' ' ' VAL . . . -154.21 163.92 39.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.28 1.032 . . . . 0.0 108.454 -178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 p -162.03 154.91 20.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 124.488 1.115 . . . . 0.0 108.835 170.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.427 HG22 ' HG3' ' A' ' 150' ' ' GLU . 6.7 p -69.44 132.18 45.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.92 0.866 . . . . 0.0 110.812 -169.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -79.11 -27.44 42.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.248 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.45 151.4 38.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.201 2.2 . . . . 0.0 108.556 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.7 m95 -79.59 134.81 36.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 mt -94.94 129.14 42.1 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -133.16 148.41 52.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.88 1.218 . . . . 0.0 108.512 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.04 146.18 29.93 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.433 0.458 . . . . 0.0 109.774 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.81 146.23 24.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.99 145.75 91.99 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 111.111 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.92 146.99 60.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 N-CA-C 104.982 -2.738 . . . . 0.0 104.982 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.3 mtpt -68.89 -12.61 61.76 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.075 -1.641 . . . . 0.0 113.994 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.43 -31.73 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.026 0.83 . . . . 0.0 112.81 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.0 mt -91.79 -20.3 21.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.682 0.793 . . . . 0.0 112.03 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 81' ' ' LYS . 90.7 t -65.1 135.81 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -103.16 91.28 4.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.302 1.041 . . . . 0.0 110.071 171.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.65 -23.65 64.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.962 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.73 -33.87 71.29 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.789 0.435 . . . . 0.0 111.801 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -100.01 158.34 15.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.948 0.899 . . . . 0.0 109.576 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -130.63 134.69 26.33 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.434 1.494 . . . . 0.0 109.905 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.45 148.98 91.37 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 O-C-N 122.755 0.871 . . . . 0.0 109.928 -10.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.7 p -78.05 133.81 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.496 0.718 . . . . 0.0 109.37 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.03 128.75 33.65 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.13 -12.09 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 119.03 -0.51 . . . . 0.0 112.022 169.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.25 -178.49 42.49 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -147.3 153.29 39.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.31 1.444 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -108.03 140.2 41.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -127.29 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.362 1.465 . . . . 0.0 108.694 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.7 ttmm -133.5 117.97 17.78 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -103.1 158.25 16.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -134.0 125.59 28.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.329 1.451 . . . . 0.0 107.406 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -89.7 122.08 32.47 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mt -119.42 160.09 22.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.569 ' HB2' HD11 ' A' ' 68' ' ' LEU . 4.1 tt0 -109.42 135.59 50.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 132.91 54.53 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.64 -53.88 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.5 m -78.44 -30.95 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 112.156 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.49 162.26 11.26 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.82 -18.44 43.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.418 1.487 . . . . 0.0 113.668 -173.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.71 48.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.442 0.697 . . . . 0.0 112.484 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 11.82 3.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.6 mt -91.43 134.94 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.43 -43.06 1.62 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.177 0.591 . . . . 0.0 112.354 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 mtp 66.73 13.38 9.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.664 2.386 . . . . 0.0 114.357 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.66 33.02 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 123.413 1.577 . . . . 0.0 112.423 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -51.47 69.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.396 1.478 . . . . 0.0 109.161 169.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 m -73.85 157.23 36.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.721 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -63.53 -36.85 85.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.073 0.463 . . . . 0.0 109.958 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 131.51 45.3 Favored Pre-proline 0 N--CA 1.443 -0.815 0 C-N-CA 125.259 1.424 . . . . 0.0 109.299 169.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.83 147.34 94.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.59 -11.66 39.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -133.33 152.04 51.9 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.519 1.128 . . . . 0.0 109.868 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.11 -2.36 13.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.441 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.86 146.09 12.87 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -150.8 138.96 20.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.269 1.428 . . . . 0.0 107.565 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.99 173.79 13.9 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.342 1.457 . . . . 0.0 109.085 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -119.79 142.21 48.79 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.92 164.05 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.495 . . . . 0.0 110.437 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -69.67 153.05 43.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 169.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -31.65 72.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -169.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -85.99 -27.56 24.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.316 1.416 . . . . 0.0 112.864 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -54.84 -49.88 89.26 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.563 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.27 -29.78 73.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.153 1.805 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.69 -31.9 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.224 -0.923 . . . . 0.0 110.136 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -66.6 -27.16 67.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.209 -0.932 . . . . 0.0 111.569 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -82.11 -23.94 35.41 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.09 159.81 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.313 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.78 179.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.074 1.749 . . . . 0.0 110.769 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.4 m -55.17 -53.44 55.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.405 1.882 . . . . 0.0 113.293 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.62 -41.86 78.92 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.561 . . . . 0.0 110.318 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.63 -43.44 63.23 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.109 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -59.55 -34.36 72.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.486 1.494 . . . . 0.0 111.8 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 -45.53 88.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.309 0.959 . . . . 0.0 111.314 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.27 -47.5 92.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -69.14 -34.95 75.82 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.234 1.014 . . . . 0.0 110.054 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -66.68 -39.24 88.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.655 1.116 . . . . 0.0 109.927 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.34 -46.6 89.36 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.764 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.6 t -56.88 -41.74 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 110.752 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -70.69 -53.83 14.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.02 -33.88 76.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.066 1.303 . . . . 0.0 111.915 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HG3' HG22 ' A' ' 71' ' ' THR . 3.2 mm-40 -53.45 -40.52 65.29 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.854 1.262 . . . . 0.0 111.214 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -110.04 -12.53 14.52 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.006 0.922 . . . . 0.0 112.259 -170.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.44 75.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.811 1.644 . . . . 0.0 110.488 -170.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -69.07 -32.76 72.45 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.444 0.698 . . . . 0.0 109.923 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 69' ' ' ALA . 23.5 t -68.24 -45.24 83.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.99 -34.82 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.544 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 mmt -61.66 -57.57 11.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.833 1.197 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -70.1 -26.05 63.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.782 1.233 . . . . 0.0 111.004 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 68' ' ' LEU . 1.2 tm? -58.33 -35.39 71.82 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 128.714 2.806 . . . . 0.0 111.67 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -71.2 -39.54 71.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.883 0.765 . . . . 0.0 110.67 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.27 -28.77 38.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.482 0.713 . . . . 0.0 112.061 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -114.31 -10.96 12.63 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.274 0.63 . . . . 0.0 112.29 -171.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.1 p 48.63 26.65 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.888 2.075 . . . . 0.0 114.327 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . 0.366 0.1 OUTLIER 12.95 49.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 1 C-N-CA 129.588 6.859 . . . . 0.0 118.815 -167.983 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.427 2.291 . . . . 0.0 111.441 174.688 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptm . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.16 143.19 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.53 -68.85 0.36 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.208 0.603 . . . . 0.0 111.281 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -163.9 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.096 0.958 . . . . 0.0 112.22 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.97 17.15 14.43 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.698 1.199 . . . . 0.0 112.858 -169.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.04 7.42 65.88 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.276 0.941 . . . . 0.0 113.787 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.26 157.95 16.03 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.19 149.3 72.27 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.4 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' A' ' 40' ' ' ILE . 69.3 Cg_endo -84.56 138.92 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.208 1.938 . . . . 0.0 111.242 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -140.8 151.97 44.81 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.367 1.067 . . . . 0.0 110.339 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 40' ' ' ILE . 35.3 m -134.89 153.63 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.717 0.807 . . . . 0.0 109.66 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.88 157.39 24.75 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.85 141.99 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.426 1.09 . . . . 0.0 108.568 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.07 137.73 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -115.95 132.3 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 22' ' ' VAL . 70.7 m -122.93 144.31 49.32 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -96.63 173.57 7.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.848 1.259 . . . . 0.0 108.666 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.76 9.96 5.58 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.833 -1.167 . . . . 0.0 113.59 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -99.09 0.22 43.17 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.693 0.797 . . . . 0.0 111.175 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.44 20.03 78.96 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.169 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -92.56 142.82 26.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.799 1.299 . . . . 0.0 107.786 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -113.39 143.12 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.013 1.725 . . . . 0.0 107.295 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -81.31 147.32 29.94 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.726 0.694 . . . . 0.0 109.465 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.0 t90 -151.86 140.48 20.75 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -171.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.46 149.76 51.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.771 1.169 . . . . 0.0 112.565 -169.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -98.44 120.23 38.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.252 1.821 . . . . 0.0 106.699 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -82.91 143.93 30.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.724 1.602 . . . . 0.0 109.616 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.45 132.79 54.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.426 0.69 . . . . 0.0 109.82 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.85 -9.71 16.41 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.925 1.25 . . . . 0.0 114.507 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -90.88 -39.79 12.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.556 1.678 . . . . 0.0 111.368 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.1 m80 57.5 31.66 20.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.162 0.985 . . . . 0.0 110.974 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -129.17 152.36 48.84 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.729 1.612 . . . . 0.0 108.337 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -104.09 146.62 28.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.267 0.627 . . . . 0.0 110.933 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -156.92 163.2 39.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.801 1.241 . . . . 0.0 110.808 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.16 144.5 44.19 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.014 -0.994 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.4 131.87 45.62 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.423 2.749 . . . . 0.0 112.475 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -158.2 167.81 28.78 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.643 0.656 . . . . 0.0 112.484 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.67 167.2 40.32 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.27 0.462 . . . . 0.0 112.207 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.72 146.47 32.61 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 9' ' ' PRO . 66.2 mt -74.82 127.28 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -78.41 152.57 78.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.12 120.13 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.7 1.6 . . . . 0.0 110.176 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.74 67.99 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.233 -1.315 . . . . 0.0 113.991 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.45 148.58 48.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 120.232 2.016 . . . . 0.0 110.231 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -84.27 153.76 23.37 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -38.67 76.91 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.778 -0.576 . . . . 0.0 111.909 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.91 -34.13 74.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.733 0.813 . . . . 0.0 110.248 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -73.12 -36.12 66.67 Favored 'General case' 0 C--N 1.337 0.045 0 O-C-N 120.89 -1.131 . . . . 0.0 109.908 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.92 90.84 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.8 ttp -58.82 -49.23 78.47 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.999 0.818 . . . . 0.0 109.036 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 49.8 m-85 -66.12 -46.24 78.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.679 1.127 . . . . 0.0 111.584 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -67.6 -45.31 75.84 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.277 0.944 . . . . 0.0 110.17 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -69.49 -34.54 74.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -57.0 -44.86 83.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.848 1.204 . . . . 0.0 110.323 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -61.27 -41.01 96.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.552 0.614 . . . . 0.0 110.212 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.92 -21.53 65.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.312 0.645 . . . . 0.0 112.232 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.39 -60.85 1.63 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.609 1.164 . . . . 0.0 109.629 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 m -112.44 0.69 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.501 1.52 . . . . 0.0 111.972 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.31 48.4 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.376 -1.452 . . . . 0.0 113.897 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -82.41 144.79 30.25 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.416 1.486 . . . . 0.0 110.2 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -123.98 165.5 17.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.34 1.056 . . . . 0.0 109.633 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 50.4 mtt85 -47.73 -35.55 9.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 112.495 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.27 -22.34 66.84 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.403 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.62 22.59 12.62 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.1 164.99 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.758 -1.214 . . . . 0.0 111.869 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 140.72 33.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 116.982 -1.485 . . . . 0.0 107.962 169.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.44 116.28 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 103' ' ' GLN . 97.9 mt -90.5 -36.01 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.229 174.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.98 32.54 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.016 0.926 . . . . 0.0 110.456 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -151.66 149.08 28.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.079 1.752 . . . . 0.0 109.42 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 150' ' ' GLU . 3.3 p -70.81 139.88 51.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.748 1.158 . . . . 0.0 109.786 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -93.2 -29.22 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.332 1.053 . . . . 0.0 109.862 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -110.48 149.61 30.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.471 2.308 . . . . 0.0 107.864 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 65.4 m95 -82.76 143.03 31.14 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -87.78 91.19 8.66 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 139.35 52.31 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -137.25 153.6 50.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.579 0.752 . . . . 0.0 110.209 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -131.34 138.04 49.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.51 1.924 . . . . 0.0 108.151 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.99 146.9 69.01 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.828 0.851 . . . . 0.0 110.694 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.1 145.94 68.78 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 N-CA-C 104.601 -2.884 . . . . 0.0 104.601 166.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.4 mtpt -68.38 -13.27 62.17 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.031 -1.668 . . . . 0.0 113.835 -169.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -58.81 -30.64 67.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.953 0.797 . . . . 0.0 113.071 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.45 -20.29 21.15 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 112.134 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 81' ' ' LYS . 59.6 t -65.24 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -102.83 89.57 3.51 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.959 0.904 . . . . 0.0 109.76 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -67.19 -24.84 65.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.716 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.34 -33.84 71.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.798 0.439 . . . . 0.0 111.747 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -99.36 159.33 15.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.042 0.937 . . . . 0.0 109.398 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -130.79 134.44 26.0 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 125.152 1.381 . . . . 0.0 109.466 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.47 148.23 89.67 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.719 0.852 . . . . 0.0 110.428 -10.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -77.76 139.08 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.675 0.79 . . . . 0.0 109.613 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.1 p -90.43 120.58 31.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.87 0.868 . . . . 0.0 108.89 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -13.09 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 118.848 0.749 . . . . 0.0 112.751 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 -171.47 34.19 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -157.9 167.71 29.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.762 1.225 . . . . 0.0 109.552 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -115.58 127.6 55.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -114.34 129.0 56.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 10.0 ttmm -111.74 139.13 47.47 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -123.19 153.34 40.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.97 128.48 24.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.59 122.5 37.25 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.08 156.83 24.46 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.659 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.1 tt0 -106.73 129.7 54.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 167.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.76 139.69 58.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.1 1.36 . . . . 0.0 108.52 171.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.99 -44.99 14.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.043 0.383 . . . . 0.0 110.698 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.9 m -87.05 -16.06 36.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.571 0.748 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.56 -167.79 24.82 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.451 ' HB2' ' HE1' ' A' ' 126' ' ' TRP . 1.1 p-10 -60.92 -17.66 52.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.485 1.514 . . . . 0.0 114.698 -171.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.24 47.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.116 0.966 . . . . 0.0 111.774 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.49 50.96 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.829 1.252 . . . . 0.0 110.527 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.9 mt -129.93 129.82 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -113.22 161.56 17.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.391 2.276 . . . . 0.0 106.66 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mmt -126.48 -9.2 6.29 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.029 1.332 . . . . 0.0 111.872 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.35 84.13 2.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 123.718 1.723 . . . . 0.0 107.38 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 -61.12 2.11 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.348 2.659 . . . . 0.0 107.59 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 m -73.22 173.98 8.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.726 1.611 . . . . 0.0 109.009 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m -59.94 -36.81 77.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.496 -0.752 . . . . 0.0 109.807 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 137.05 57.33 Favored Pre-proline 0 N--CA 1.444 -0.772 0 C-N-CA 125.928 1.691 . . . . 0.0 109.133 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.02 133.54 47.87 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 107.212 -1.88 . . . . 0.0 107.212 168.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -85.07 -35.73 21.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -110.98 145.86 37.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.79 -29.24 25.58 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.806 0.842 . . . . 0.0 110.41 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.25 169.49 41.03 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.47 159.99 44.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.772 0.786 . . . . 0.0 109.655 169.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -143.95 169.35 17.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.827 1.251 . . . . 0.0 108.888 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.451 ' HE1' ' HB2' ' A' ' 108' ' ' ASP . 75.4 m95 -111.99 139.43 47.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.58 152.85 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.002 1.321 . . . . 0.0 110.648 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -62.94 143.78 57.39 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -32.31 44.73 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -169.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.99 -18.22 31.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.553 1.07 . . . . 0.0 112.947 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.38 -46.22 70.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.422 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.35 -29.39 85.73 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.774 2.026 . . . . 0.0 112.017 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.4 t -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.899 1.279 . . . . 0.0 109.924 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.263 -0.898 . . . . 0.0 111.443 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -94.31 -21.62 18.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.58 154.01 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 119.031 0.832 . . . . 0.0 110.491 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.58 178.42 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.052 1.341 . . . . 0.0 110.478 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.9 m -55.73 -47.15 77.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.868 1.667 . . . . 0.0 113.236 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -71.73 -45.73 60.83 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.987 -0.446 . . . . 0.0 110.451 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.57 -39.95 73.59 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.679 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -59.71 -31.44 69.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.745 1.157 . . . . 0.0 112.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.19 -43.21 95.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.495 1.043 . . . . 0.0 111.05 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.4 t -62.71 -50.3 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.76 -38.41 90.99 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.919 0.782 . . . . 0.0 109.644 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -65.98 -41.15 91.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.696 1.134 . . . . 0.0 110.243 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -59.6 -49.38 78.0 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.037 0.835 . . . . 0.0 109.615 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.29 -37.59 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.736 1.214 . . . . 0.0 110.977 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.3 mmt -74.28 -54.83 6.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -59.85 -34.14 72.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.42 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 71' ' ' THR . 5.5 tp10 -57.71 -42.11 83.12 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 110.763 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.77 -10.24 19.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.668 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.34 67.48 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.354 1.462 . . . . 0.0 110.559 -171.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 m -68.13 -32.72 73.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.386 0.675 . . . . 0.0 110.548 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.64 -42.81 62.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.4 t -57.29 -38.99 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 117.434 -1.27 . . . . 0.0 110.175 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -62.06 -51.68 66.97 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.472 1.487 . . . . 0.0 111.092 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.4 m -77.23 -24.03 51.27 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.812 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 tp -55.8 -48.66 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.138 1.775 . . . . 0.0 109.359 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -60.27 -33.99 73.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.535 0.734 . . . . 0.0 111.601 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -85.42 -17.87 35.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.819 1.248 . . . . 0.0 111.731 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -96.71 -46.0 6.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.283 1.033 . . . . 0.0 109.101 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.448 ' HB ' ' CD ' ' A' ' 163' ' ' PRO 0.256 46.8 p -88.83 -162.08 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.448 ' CD ' ' HB ' ' A' ' 162' ' ' THR . 2.0 Cg_endo -106.52 -179.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.697 2.931 . . . . 0.0 111.65 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.558 179.406 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.315 4.9 ppp? . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.767 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 64.81 129.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.71 2.404 . . . . 0.0 109.833 -169.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.31 -66.7 0.53 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.43 -51.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.05 17.28 14.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.476 1.11 . . . . 0.0 113.385 -169.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.56 62.71 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.12 0.866 . . . . 0.0 113.658 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -103.84 159.44 15.64 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.682 1.241 . . . . 0.0 107.731 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 149.86 64.38 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.25 -1.357 . . . . 0.0 107.834 170.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -91.41 141.52 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.899 1.732 . . . . 0.0 109.425 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -130.1 160.18 34.53 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.253 -0.904 . . . . 0.0 110.455 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.23 167.37 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -159.0 151.9 22.89 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -128.88 142.88 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.444 1.098 . . . . 0.0 108.586 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.77 136.37 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mm -120.37 132.9 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' A' ' 22' ' ' VAL . 43.3 m -124.2 150.84 44.77 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.492 0.587 . . . . 0.0 111.37 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -109.17 173.41 6.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.409 1.484 . . . . 0.0 108.816 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -74.94 0.17 16.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.11 -1.619 . . . . 0.0 113.002 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -88.68 -3.47 58.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 111.419 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.63 18.63 77.36 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 118.835 0.743 . . . . 0.0 111.48 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -86.13 139.73 30.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.511 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.0 m -108.79 143.82 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 125.514 1.526 . . . . 0.0 107.53 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -79.65 143.07 34.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -146.22 144.18 29.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.03 157.17 46.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.044 0.838 . . . . 0.0 111.557 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -111.53 119.07 37.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -72.48 151.31 42.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.297 1.408 . . . . 0.0 110.261 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.35 148.24 47.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.795 0.838 . . . . 0.0 109.633 -175.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 3.36 50.12 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.7 -1.056 . . . . 0.0 113.569 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.81 159.93 40.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.161 1.481 . . . . 0.0 110.577 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -94.11 -22.15 18.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 m -73.52 154.47 39.86 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.145 0.978 . . . . 0.0 111.63 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -106.45 152.57 23.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.222 1.009 . . . . 0.0 109.978 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -148.73 156.8 42.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.943 1.297 . . . . 0.0 110.778 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -80.62 140.64 51.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.35 137.7 82.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.768 1.645 . . . . 0.0 111.118 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -157.18 171.01 21.2 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.214 0.915 . . . . 0.0 112.198 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.05 -168.79 34.01 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -109.17 150.89 17.2 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.411 1.482 . . . . 0.0 109.943 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.29 119.57 34.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -77.1 159.03 79.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.61 127.9 28.12 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.664 1.576 . . . . 0.0 110.246 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.18 -5.47 79.98 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.395 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.55 148.11 37.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.158 1.979 . . . . 0.0 109.471 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.8 m -90.07 157.91 17.57 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.33 77.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.079 0.854 . . . . 0.0 111.583 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.26 -37.68 78.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.734 0.814 . . . . 0.0 110.216 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -66.49 -41.45 88.91 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.1 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.62 85.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -56.32 -50.86 70.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.612 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.451 1.023 . . . . 0.0 110.566 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -64.76 -47.0 79.79 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.453 1.024 . . . . 0.0 109.965 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.81 -31.99 67.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.6 -49.33 73.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.3 -40.92 95.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.008 0.822 . . . . 0.0 110.824 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.6 -26.66 68.5 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.728 -0.607 . . . . 0.0 112.222 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.15 -57.67 2.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.438 1.095 . . . . 0.0 110.451 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.72 0.64 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 112.383 -169.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.48 4.78 32.99 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.758 1.163 . . . . 0.0 113.702 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -84.1 146.58 27.82 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.303 1.841 . . . . 0.0 109.436 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 m -125.03 166.23 16.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.991 0.917 . . . . 0.0 109.76 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -52.93 -32.64 46.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.701 1.6 . . . . 0.0 112.476 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.37 -26.86 68.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.375 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -111.91 22.2 15.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.845 0.831 . . . . 0.0 112.209 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.18 165.06 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.707 -1.245 . . . . 0.0 111.7 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 140.86 40.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 mt -76.4 119.22 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 103' ' ' GLN . 92.7 mt -93.69 -35.34 12.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.81 170.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.578 0.751 . . . . 0.0 110.621 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 p -160.88 153.32 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.744 1.618 . . . . 0.0 109.897 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.08 139.06 54.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.783 0.801 . . . . 0.0 110.742 -170.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -94.62 -33.67 12.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -110.72 144.02 40.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.969 2.107 . . . . 0.0 107.327 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -85.51 141.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.39 72.03 7.04 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -71.6 154.29 41.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.36 151.08 50.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.503 1.121 . . . . 0.0 108.879 -169.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -130.48 132.18 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.696 1.598 . . . . 0.0 107.581 174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -80.9 141.77 51.46 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 124.378 1.071 . . . . 0.0 111.995 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.84 149.95 67.07 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 N-CA-C 104.762 -2.822 . . . . 0.0 104.762 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.9 mtpt -68.99 -13.56 62.52 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.84 -1.788 . . . . 0.0 114.056 -169.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -62.37 -31.02 71.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.113 0.869 . . . . 0.0 112.558 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -93.73 -18.18 22.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.236 1.014 . . . . 0.0 112.009 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 81' ' ' LYS . 95.6 t -64.71 135.02 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -98.1 90.5 4.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.794 0.838 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -71.52 -20.95 61.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.906 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.23 -30.12 57.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.885 0.474 . . . . 0.0 112.196 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.27 160.14 14.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.354 1.061 . . . . 0.0 109.234 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -130.96 133.66 25.03 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 125.783 1.633 . . . . 0.0 108.319 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.32 156.79 94.14 Favored 'Cis proline' 0 CA--C 1.539 0.757 0 O-C-N 122.805 0.897 . . . . 0.0 111.179 -10.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.0 t -74.16 140.33 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.941 0.897 . . . . 0.0 109.741 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 p -93.24 122.61 35.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.119 0.967 . . . . 0.0 108.97 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.15 -12.09 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 119.297 0.953 . . . . 0.0 113.213 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.51 -173.62 43.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -156.31 157.24 35.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.343 1.057 . . . . 0.0 110.173 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -102.72 128.21 49.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -124.58 129.15 50.03 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.531 1.06 . . . . 0.0 111.509 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -88.42 157.37 18.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.626 1.17 . . . . 0.0 108.558 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.494 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 82.5 m95 -133.8 147.26 51.23 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 168.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -131.19 134.69 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.938 1.295 . . . . 0.0 107.924 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.5 tp -96.63 118.45 33.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.79 140.26 49.06 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.6 tt0 -89.11 133.3 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 168.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.26 139.71 58.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.397 1.079 . . . . 0.0 109.069 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.41 -48.74 13.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 118.238 0.472 . . . . 0.0 110.041 -171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.7 m -86.21 -18.44 32.14 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.883 0.473 . . . . 0.0 111.11 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.73 -169.0 22.92 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -55.73 -23.47 29.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.264 1.826 . . . . 0.0 113.345 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.39 51.3 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -89.85 14.52 11.81 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.78 138.51 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -124.07 131.6 53.57 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.57 1.948 . . . . 0.0 107.637 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.3 mmt -98.56 -7.65 27.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 112.497 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.69 75.29 0.98 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.436 1.895 . . . . 0.0 108.027 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -75.56 -65.61 0.88 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.978 2.111 . . . . 0.0 108.963 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.1 m -80.29 177.73 8.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.594 1.557 . . . . 0.0 109.483 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 m -56.57 -35.1 67.79 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.979 0.512 . . . . 0.0 110.361 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 128.94 49.37 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 107.87 169.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.92 122.95 10.37 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 169.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.74 -18.49 62.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -116.76 140.18 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.649 0.78 . . . . 0.0 110.374 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.69 -26.98 40.79 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 110.732 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.44 169.29 41.5 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 123.894 0.759 . . . . 0.0 111.315 -174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 160.63 43.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.768 0.827 . . . . 0.0 109.168 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -152.11 165.73 33.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.976 0.91 . . . . 0.0 108.954 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -110.65 133.86 52.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.24 152.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.838 1.255 . . . . 0.0 111.17 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.4 m -60.47 144.08 52.0 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.94 0.791 . . . . 0.0 109.628 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.15 -34.49 60.54 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -87.0 -7.93 57.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.974 -1.079 . . . . 0.0 113.486 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -75.52 -49.39 3.77 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.918 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.31 -21.6 72.23 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 123.044 2.123 . . . . 0.0 113.282 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.8 -35.92 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -68.97 -25.56 64.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.333 -0.855 . . . . 0.0 111.621 -169.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -83.36 -24.75 31.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.55 165.43 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 118.968 0.803 . . . . 0.0 111.07 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.36 175.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 110.166 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -57.42 -44.15 84.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.503 1.521 . . . . 0.0 113.875 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -70.3 -41.93 72.7 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.474 -0.766 . . . . 0.0 110.827 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -74.93 -35.0 62.18 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.233 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -49.33 -46.02 46.26 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.122 0.969 . . . . 0.0 110.462 170.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.28 -43.04 96.05 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.568 0.622 . . . . 0.0 111.089 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.86 -50.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -66.07 -34.75 78.77 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.055 0.942 . . . . 0.0 110.607 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -67.57 -41.31 84.36 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.808 1.186 . . . . 0.0 109.962 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.93 -43.54 98.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.299 0.954 . . . . 0.0 110.873 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 99' ' ' TRP . 89.8 t -57.74 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.466 1.106 . . . . 0.0 111.542 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.1 mmt -84.33 -59.83 2.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.71 -34.45 67.47 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.362 1.065 . . . . 0.0 112.178 -173.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -57.61 -38.47 75.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.807 0.843 . . . . 0.0 110.727 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -109.78 -10.62 14.77 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 112.817 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.4 -38.99 72.27 Favored 'General case' 0 C--O 1.228 -0.031 0 C-N-CA 125.658 1.583 . . . . 0.0 110.545 -172.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -68.2 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.64 0.776 . . . . 0.0 110.443 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.7 -45.83 72.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.38 -46.32 92.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 117.627 -1.178 . . . . 0.0 110.236 -175.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -43.48 85.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 121.435 1.925 . . . . 0.0 110.317 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.4 t -70.84 -32.13 69.07 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.218 -0.301 . . . . 0.0 111.124 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.0 tp -62.44 -43.28 99.19 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 126.198 1.799 . . . . 0.0 109.568 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -65.38 -43.75 89.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.667 0.387 . . . . 0.0 110.924 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.77 -35.75 70.16 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.508 0.723 . . . . 0.0 111.806 -169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -89.77 -29.87 18.38 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.101 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.321 14.1 t 40.76 60.92 7.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -169.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.48 177.09 5.74 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.377 2.718 . . . . 0.0 112.329 -168.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.138 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ttp . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 67.5 135.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 126.975 2.11 . . . . 0.0 109.697 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.93 -68.49 0.38 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.63 0.772 . . . . 0.0 110.192 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -164.14 -49.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.964 0.906 . . . . 0.0 113.23 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.2 17.13 14.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.688 1.195 . . . . 0.0 113.233 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.11 10.66 60.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.902 0.763 . . . . 0.0 113.38 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -101.09 155.04 18.22 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.53 31.42 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 117.534 -1.222 . . . . 0.0 109.354 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.76 137.68 16.24 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.469 1.446 . . . . 0.0 110.455 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -142.62 157.18 44.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.122 0.969 . . . . 0.0 109.291 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.25 161.2 35.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 121.267 -0.896 . . . . 0.0 109.669 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.9 163.0 28.35 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -121.65 143.31 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 124.522 1.129 . . . . 0.0 108.393 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.82 136.8 59.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -116.95 133.71 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -125.64 154.02 42.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.843 0.747 . . . . 0.0 111.576 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -104.23 175.16 5.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.002 1.321 . . . . 0.0 108.777 172.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 4.83 8.85 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.237 -1.54 . . . . 0.0 113.267 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -90.94 -2.54 57.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.435 1.094 . . . . 0.0 111.416 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.56 0.618 . . . . 0.0 111.848 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -89.0 144.06 26.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.0 m -115.2 150.02 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.498 1.519 . . . . 0.0 109.161 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 42.8 ttm -65.27 139.75 58.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.708 0.803 . . . . 0.0 108.964 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -142.88 136.92 29.15 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.01 154.57 51.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.712 1.142 . . . . 0.0 111.575 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -114.92 123.23 48.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -76.99 147.85 36.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 121.74 2.064 . . . . 0.0 110.681 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.63 129.67 43.07 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.83 0.08 87.56 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.86 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -110.96 164.42 12.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.216 1.508 . . . . 0.0 110.397 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -101.38 -24.57 14.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.228 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -80.36 159.16 25.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.783 1.233 . . . . 0.0 111.796 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -112.3 155.77 23.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.239 1.015 . . . . 0.0 111.674 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -160.58 164.26 32.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.0 1.72 . . . . 0.0 110.936 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -86.48 149.12 48.38 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.72 130.84 38.89 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.758 2.306 . . . . 0.0 111.951 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.67 161.5 34.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 112.218 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.71 171.58 44.52 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.222 0.439 . . . . 0.0 113.534 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.56 152.75 36.0 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.843 1.211 . . . . 0.0 111.755 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.84 130.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -77.22 157.99 80.17 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.29 123.55 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.98 -6.36 83.6 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.709 -1.051 . . . . 0.0 114.593 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.39 156.15 39.82 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 120.115 1.958 . . . . 0.0 109.439 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.0 p -91.94 166.95 12.45 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.0 81.34 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.782 -0.574 . . . . 0.0 110.815 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.22 -36.5 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.247 0.619 . . . . 0.0 110.582 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.01 -37.25 72.64 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.998 -1.064 . . . . 0.0 110.365 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.42 80.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.418 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.3 tmm? -65.62 -51.44 59.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.14 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -66.82 -31.62 72.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.41 1.459 . . . . 0.0 111.839 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -61.07 -52.03 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.411 1.005 . . . . 0.0 108.925 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -71.47 -27.26 63.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.562 0.619 . . . . 0.0 109.962 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.73 -43.88 90.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.928 -1.107 . . . . 0.0 109.388 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.45 -49.07 52.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.977 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.47 -28.94 68.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.656 1.117 . . . . 0.0 112.608 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -96.16 -52.51 3.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.162 0.985 . . . . 0.0 110.657 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.05 -29.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.543 1.137 . . . . 0.0 110.899 -168.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.3 84.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.447 1.023 . . . . 0.0 112.377 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 tp -78.66 154.15 30.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.172 1.789 . . . . 0.0 109.162 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -132.1 163.98 27.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 109.941 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -39.02 -41.78 0.81 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.9 2.48 . . . . 0.0 112.887 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -63.49 -29.23 70.53 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.77 0.828 . . . . 0.0 112.064 -170.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.5 23.36 13.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.575 0.702 . . . . 0.0 112.185 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.57 165.32 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 O-C-N 120.729 -1.232 . . . . 0.0 112.362 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.57 130.34 27.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.854 168.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mt -69.13 117.26 11.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 103' ' ' GLN . 87.1 mt -95.92 -32.84 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.502 173.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -154.81 162.78 40.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.671 0.788 . . . . 0.0 109.267 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -159.19 155.05 26.42 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.888 1.275 . . . . 0.0 109.735 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.637 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -69.27 138.77 54.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.587 0.708 . . . . 0.0 110.525 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -86.9 -28.41 22.82 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.56 1.144 . . . . 0.0 109.801 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -119.97 149.67 41.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.394 2.278 . . . . 0.0 108.069 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -78.3 135.77 37.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.61 0.641 . . . . 0.0 109.489 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.3 mt -90.14 89.32 7.62 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -90.01 146.61 24.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -148.59 145.75 27.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 169.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 139.3 30.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.71 150.46 39.68 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.787 0.835 . . . . 0.0 109.302 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.8 Cg_endo -72.24 158.14 52.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.219 3.28 . . . . 0.0 110.944 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -67.17 -19.37 65.57 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.82 -1.175 . . . . 0.0 112.941 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.84 -30.45 70.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.017 0.826 . . . . 0.0 112.888 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 80' ' ' PRO . 51.2 mt -93.45 -14.19 27.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.182 0.993 . . . . 0.0 112.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.4 t -67.04 133.66 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -94.6 90.75 6.26 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.769 0.795 . . . . 0.0 109.628 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -71.43 -21.9 61.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.497 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.16 -13.26 59.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.743 0.817 . . . . 0.0 112.781 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -121.29 159.86 25.13 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.264 1.025 . . . . 0.0 109.986 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -127.74 131.54 23.87 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 125.522 1.529 . . . . 0.0 109.938 -173.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.19 149.45 93.15 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 O-C-N 122.741 0.864 . . . . 0.0 110.689 -10.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.01 141.46 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.067 0.947 . . . . 0.0 109.969 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.3 p -94.91 137.17 34.32 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.658 0.783 . . . . 0.0 110.762 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.61 -14.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 169.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.39 179.9 35.6 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.54 157.51 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.456 1.502 . . . . 0.0 108.589 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.92 128.66 56.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 170.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -113.3 131.57 55.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.935 0.789 . . . . 0.0 109.652 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -110.74 125.49 53.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -108.23 154.41 21.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 84.5 m-85 -135.53 127.12 28.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 19.7 tp -90.43 120.19 31.34 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.8 131.41 56.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.9 tt0 -86.79 134.55 33.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.49 141.81 58.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 109.014 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.28 -51.8 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.57 0.623 . . . . 0.0 109.826 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 m -83.76 -19.82 34.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.111 0.564 . . . . 0.0 111.742 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.44 -169.12 23.36 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -18.38 47.52 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.584 1.554 . . . . 0.0 114.157 -169.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 -31.73 48.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.041 . . . . 0.0 112.902 172.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.92 17.62 10.35 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.3 mt -94.9 134.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -120.34 -52.73 2.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.327 0.651 . . . . 0.0 112.252 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 70.56 7.77 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.887 2.475 . . . . 0.0 114.884 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -153.79 78.46 1.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 123.988 1.851 . . . . 0.0 109.616 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -59.73 2.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.12 -2.309 . . . . 0.0 107.997 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -67.97 165.11 18.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.19 1.396 . . . . 0.0 109.498 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -62.77 -33.31 74.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.973 0.509 . . . . 0.0 110.12 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.5 129.94 51.2 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 124.91 1.284 . . . . 0.0 110.2 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -65.58 143.84 76.63 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.083 1.855 . . . . 0.0 108.338 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -83.18 -17.53 42.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.021 -0.424 . . . . 0.0 111.308 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.48 140.69 49.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.136 0.88 . . . . 0.0 110.85 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.31 -29.74 57.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.159 1.384 . . . . 0.0 110.303 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.72 164.6 38.2 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.57 158.15 43.91 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.61 167.99 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -107.38 136.97 46.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 154.85 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.813 1.245 . . . . 0.0 110.126 -171.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -61.4 144.44 54.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.215 0.916 . . . . 0.0 109.403 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -27.39 57.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -88.61 -16.45 32.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.047 1.294 . . . . 0.0 112.985 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.85 -50.41 85.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.428 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.2 -25.85 42.77 Favored 'Trans proline' 0 C--N 1.35 0.638 0 CA-C-N 121.985 1.745 . . . . 0.0 112.65 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.24 -42.3 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.586 -0.696 . . . . 0.0 109.237 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -69.86 -7.8 43.19 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.605 -1.309 . . . . 0.0 114.227 -178.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.08 -28.21 39.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.147 0.885 . . . . 0.0 111.721 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.1 160.26 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.14 163.66 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.074 0.95 . . . . 0.0 108.88 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.1 m -54.21 -45.67 72.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -70.24 -34.52 72.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.993 1.27 . . . . 0.0 111.238 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -75.36 -44.6 44.18 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.896 -0.503 . . . . 0.0 109.936 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -48.04 -40.77 23.94 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.982 1.313 . . . . 0.0 112.752 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.47 -37.67 83.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.111 0.869 . . . . 0.0 111.963 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.09 -53.12 47.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -65.11 -32.52 74.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 112.225 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -65.76 -43.9 87.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.449 1.477 . . . . 0.0 110.606 170.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -44.72 93.4 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.541 1.064 . . . . 0.0 110.383 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.5 t -56.97 -31.96 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.593 1.157 . . . . 0.0 111.472 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.6 mmt -82.35 -59.62 2.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -31.96 69.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.463 0.705 . . . . 0.0 112.598 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.637 ' HG3' HG22 ' A' ' 71' ' ' THR . 2.0 mm-40 -57.31 -39.58 76.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 112.18 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.89 -13.75 14.08 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.948 0.899 . . . . 0.0 111.416 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.54 -39.59 64.82 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 126.064 1.746 . . . . 0.0 110.631 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 m -66.52 -31.89 72.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.627 0.771 . . . . 0.0 110.903 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.86 -46.15 74.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.78 -40.46 79.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.434 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -55.31 -51.45 66.67 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 120.576 1.534 . . . . 0.0 109.85 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.0 -27.08 60.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.91 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.415 HD21 ' NE2' ' A' ' 103' ' ' GLN . 27.4 tp -62.5 -40.71 97.6 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.711 1.204 . . . . 0.0 109.937 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -60.41 -44.38 95.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.148 0.579 . . . . 0.0 110.173 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.23 -24.8 61.44 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.516 1.126 . . . . 0.0 113.24 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -85.87 -13.89 46.57 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.229 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.257 30.4 p 42.79 62.52 8.3 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 126.67 1.988 . . . . 0.0 109.536 -175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.41 -178.49 1.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.016 1.811 . . . . 0.0 114.282 -168.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.958 0.903 . . . . 0.0 108.566 174.778 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptm . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.29 145.53 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 169.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -68.28 -66.49 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.337 0.655 . . . . 0.0 110.945 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -164.0 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.952 0.901 . . . . 0.0 112.918 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -95.76 17.2 15.56 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.446 1.098 . . . . 0.0 113.006 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.45 5.66 65.0 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.946 0.784 . . . . 0.0 113.656 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.85 154.81 17.38 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.55 148.46 67.54 Favored Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.935 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.523 ' HB2' HD12 ' A' ' 40' ' ' ILE . 90.3 Cg_endo -79.86 141.06 14.89 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.319 2.012 . . . . 0.0 110.26 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -145.06 158.68 43.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.272 1.029 . . . . 0.0 109.733 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.95 159.64 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 O-C-N 121.201 -0.937 . . . . 0.0 109.718 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -139.85 156.71 25.0 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.53 141.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.999 1.32 . . . . 0.0 108.261 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.24 139.1 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 mm -116.74 142.79 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 117.243 -1.36 . . . . 0.0 107.568 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.8 p -119.82 154.5 34.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 111.493 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -111.57 171.01 7.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 108.972 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.01 0.52 11.13 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.038 -1.664 . . . . 0.0 114.049 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -88.35 -1.07 57.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.906 0.883 . . . . 0.0 111.053 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.55 17.18 76.2 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.583 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -86.26 145.73 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.72 149.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 109.244 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 ttm -63.84 139.85 58.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.718 0.807 . . . . 0.0 109.329 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.415 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 22.0 t-105 -146.23 140.87 26.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.685 1.594 . . . . 0.0 106.804 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' A' ' 121' ' ' PHE . . . -139.15 146.1 40.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.437 1.472 . . . . 0.0 112.478 -171.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -103.04 114.85 29.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.51 1.924 . . . . 0.0 105.845 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -76.1 147.96 38.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 120.448 1.476 . . . . 0.0 110.036 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -57.33 127.45 32.06 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.66 0.784 . . . . 0.0 110.123 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.04 -4.47 31.39 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.14 1.353 . . . . 0.0 114.841 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -87.66 -35.5 17.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.786 1.793 . . . . 0.0 111.851 -173.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.8 m80 54.99 31.04 15.24 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 112.104 -170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.1 m -138.36 154.59 48.94 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.528 1.931 . . . . 0.0 107.859 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 75.4 m95 -105.12 157.3 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -163.62 168.68 19.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.074 1.749 . . . . 0.0 109.706 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -87.49 149.45 46.62 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.15 131.17 35.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.461 2.107 . . . . 0.0 111.033 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -158.02 165.79 34.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.334 0.653 . . . . 0.0 111.47 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.88 168.0 40.42 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.951 -0.468 . . . . 0.0 113.09 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.46 152.62 51.96 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 9' ' ' PRO . 68.2 mt -75.41 125.19 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 169.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.38 147.79 97.09 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.99 126.07 18.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.336 1.357 . . . . 0.0 109.521 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.75 89.15 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.962 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.09 165.05 25.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.032 1.916 . . . . 0.0 110.57 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -103.03 154.09 19.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.073 -1.876 . . . . 0.0 105.995 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.61 87.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.748 1.158 . . . . 0.0 111.589 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.41 -35.51 79.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.75 0.82 . . . . 0.0 109.882 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.47 -38.76 77.86 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.586 -0.696 . . . . 0.0 109.666 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.3 80.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.676 0.671 . . . . 0.0 109.673 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -60.84 -50.41 73.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -66.63 -38.48 87.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.604 1.093 . . . . 0.0 112.097 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -56.18 -50.45 71.15 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.898 0.879 . . . . 0.0 109.479 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.61 -30.6 59.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.215 -0.422 . . . . 0.0 110.239 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 tp -56.71 -45.35 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.518 1.054 . . . . 0.0 109.819 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.2 -31.69 66.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.2 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.96 -29.92 58.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.284 1.402 . . . . 0.0 112.811 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -99.42 -55.08 2.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.527 1.531 . . . . 0.0 110.809 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 -24.07 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 126.431 1.893 . . . . 0.0 111.131 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.73 -1.49 45.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.042 1.306 . . . . 0.0 113.515 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.72 155.34 35.73 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.048 1.739 . . . . 0.0 109.064 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -131.95 165.66 23.43 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.754 0.822 . . . . 0.0 110.092 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -50.91 -35.21 31.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.857 1.663 . . . . 0.0 112.974 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -64.7 -25.18 67.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.818 -173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -114.58 22.6 13.46 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.55 166.07 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.751 1.62 . . . . 0.0 111.972 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 141.72 33.49 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.7 mt -79.51 115.6 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 103' ' ' GLN . 94.8 mt -88.84 -37.49 15.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.381 1.072 . . . . 0.0 110.643 175.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.21 165.25 36.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.999 0.92 . . . . 0.0 109.031 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 p -161.85 154.92 20.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.261 1.024 . . . . 0.0 110.231 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -70.64 136.3 49.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.641 0.734 . . . . 0.0 110.692 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -81.96 -28.37 32.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.304 1.442 . . . . 0.0 109.782 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -119.37 148.98 42.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.595 2.358 . . . . 0.0 108.233 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 69.0 m95 -81.81 137.89 35.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.44 104.81 16.77 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -102.06 147.11 26.99 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.66 147.79 30.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 169.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.29 141.93 28.02 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.45 147.98 85.42 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 123.861 0.864 . . . . 0.0 110.272 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.09 149.73 82.32 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 105.197 -2.655 . . . . 0.0 105.197 167.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.1 mtpt -69.24 -12.29 61.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.834 -1.791 . . . . 0.0 114.24 -169.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -63.41 -32.53 74.0 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.034 0.833 . . . . 0.0 112.299 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.07 -19.99 20.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.071 0.948 . . . . 0.0 111.382 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 81' ' ' LYS . 92.1 t -62.06 135.19 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -103.5 94.54 5.53 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 108.944 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -72.62 -23.0 60.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.763 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.88 -35.48 57.4 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -91.53 157.91 16.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.884 0.874 . . . . 0.0 108.946 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.93 135.54 27.64 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.513 1.525 . . . . 0.0 108.063 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.1 156.22 93.81 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 122.854 0.923 . . . . 0.0 111.002 -10.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.1 t -72.58 137.8 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.993 0.917 . . . . 0.0 109.543 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.7 p -89.95 117.25 28.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.68 -16.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.158 0.89 . . . . 0.0 113.025 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.49 -176.34 37.54 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -156.93 157.13 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.789 1.236 . . . . 0.0 109.016 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -106.93 130.63 54.57 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -113.07 135.48 53.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.783 0.833 . . . . 0.0 109.896 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.6 ttmm -113.04 129.2 56.58 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.9 m95 -110.14 155.11 22.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.211 0.605 . . . . 0.0 109.538 -171.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.57 127.68 25.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -91.54 124.49 35.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 169.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.93 160.33 22.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.767 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.2 tt0 -111.27 131.73 54.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 134.66 57.16 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 108.026 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.5 t -89.18 -53.57 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.467 1.03 . . . . 0.0 110.009 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.7 m -77.05 -21.64 54.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.222 0.609 . . . . 0.0 111.653 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.49 171.83 22.12 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -16.08 19.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.973 1.709 . . . . 0.0 113.983 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.07 19.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.139 0.976 . . . . 0.0 112.53 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -88.48 13.29 12.25 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.87 142.78 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -137.63 106.73 6.01 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 108.581 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.9 mmt -81.58 1.47 33.61 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -120.12 72.72 0.95 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 123.983 1.849 . . . . 0.0 107.459 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 p -65.07 -66.66 0.51 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 111.58 -2.554 . . . . 0.0 106.215 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 m -76.37 169.46 18.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 167.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.9 m -59.61 -40.75 88.56 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.41 132.58 83.74 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 125.304 1.442 . . . . 0.0 108.836 169.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.86 133.63 48.87 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.761 1.641 . . . . 0.0 108.002 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.44 -25.62 50.77 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.08 -0.388 . . . . 0.0 110.286 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 96.9 m-85 -122.55 140.73 52.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.747 0.819 . . . . 0.0 109.769 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.25 -28.38 53.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.86 0.864 . . . . 0.0 110.323 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.63 161.21 32.08 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 155.21 41.01 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.84 168.9 19.68 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.416 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -109.68 134.85 51.5 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.33 153.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.813 1.245 . . . . 0.0 111.259 -169.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.9 m -61.01 143.37 55.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -24.55 62.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -87.05 -20.81 26.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.367 1.44 . . . . 0.0 113.273 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -60.95 -46.7 96.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 117.277 -1.344 . . . . 0.0 113.497 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.48 -30.43 86.64 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 122.524 1.937 . . . . 0.0 111.821 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.04 -29.94 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.141 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -69.59 -23.71 63.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.98 -1.075 . . . . 0.0 111.768 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -85.13 -11.17 55.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.4 HG11 ' HE2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -122.47 167.11 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -74.72 174.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.652 1.181 . . . . 0.0 109.669 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.93 -54.99 38.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.738 . . . . 0.0 113.179 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -69.37 -40.28 77.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.22 0.918 . . . . 0.0 110.902 -171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.4 ' HE2' HG11 ' A' ' 136' ' ' VAL . 53.3 mtpt -65.62 -55.21 18.81 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -60.73 -34.27 74.15 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.771 -174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.77 -40.53 95.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.957 1.253 . . . . 0.0 111.828 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.88 -52.53 59.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.63 -37.53 84.3 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.754 0.706 . . . . 0.0 110.726 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -56.9 -50.06 73.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.857 1.663 . . . . 0.0 109.959 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.8 -47.92 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.427 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -56.93 -42.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.932 1.242 . . . . 0.0 110.847 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.8 mmt -69.0 -51.38 39.88 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -33.55 76.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.408 1.004 . . . . 0.0 111.701 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.85 -43.72 90.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 119.193 0.906 . . . . 0.0 110.411 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.565 ' HB3' HD12 ' A' ' 101' ' ' LEU . 14.5 m-30 -97.69 -12.74 22.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.6 -42.65 67.89 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.769 1.628 . . . . 0.0 110.627 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 m -70.87 -29.63 65.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.744 0.818 . . . . 0.0 111.047 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.92 -43.86 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.93 -44.11 86.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.537 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.25 66.13 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 121.536 1.971 . . . . 0.0 110.649 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -58.33 -30.97 67.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.96 1.704 . . . . 0.0 111.885 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -77.07 -23.9 51.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.505 1.522 . . . . 0.0 112.547 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -84.02 -44.12 14.46 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.866 0.841 . . . . 0.0 108.916 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.52 -45.46 87.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.575 1.95 . . . . 0.0 109.85 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . 0.366 0.5 OUTLIER 51.75 39.68 25.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.739 2.016 . . . . 0.0 112.666 -169.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -143.9 59.31 6.97 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 111.953 -2.385 . . . . 0.0 106.59 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -61.24 164.96 13.61 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 120.819 1.013 . . . . 0.0 110.043 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.543 -169.131 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.97 130.3 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 168.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.89 -67.17 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -164.09 -49.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 11.49 15.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.156 0.982 . . . . 0.0 112.721 -169.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.6 -5.8 83.51 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.464 1.031 . . . . 0.0 113.295 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -93.65 158.2 15.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.376 1.088 . . . . 0.0 108.751 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -139.14 137.03 18.63 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.016 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.02 136.04 4.07 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.403 2.068 . . . . 0.0 110.665 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -140.73 156.89 46.09 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.949 0.899 . . . . 0.0 109.709 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.76 153.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 123.778 0.831 . . . . 0.0 109.349 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -127.7 161.67 21.68 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.86 143.59 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.2 t -129.78 135.67 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.1 mm -115.16 133.74 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.4 m -116.79 144.07 44.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -101.4 173.14 6.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.191 0.997 . . . . 0.0 108.315 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -77.25 3.74 12.21 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.564 -1.335 . . . . 0.0 113.036 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -93.76 -4.42 50.36 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.515 1.126 . . . . 0.0 111.302 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.98 33.7 54.38 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -112.58 154.98 25.15 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.628 1.214 . . . . 0.0 108.51 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -115.63 152.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.883 2.073 . . . . 0.0 107.925 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 ptp -75.42 151.4 38.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.219 0.463 . . . . 0.0 110.49 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -146.45 132.95 19.72 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 149.1 46.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.137 1.335 . . . . 0.0 110.508 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -106.52 130.15 54.35 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.584 0.753 . . . . 0.0 109.934 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -76.33 146.39 38.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.705 1.139 . . . . 0.0 108.583 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -56.95 131.62 50.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.253 1.021 . . . . 0.0 110.111 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.99 -9.12 9.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.696 1.141 . . . . 0.0 114.692 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -93.47 -39.41 10.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.435 1.618 . . . . 0.0 110.843 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.0 m80 65.06 -23.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.266 2.226 . . . . 0.0 114.63 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -70.27 153.59 42.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.262 1.425 . . . . 0.0 109.759 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -102.88 153.22 20.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 111.718 -169.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.62 168.43 27.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.617 1.567 . . . . 0.0 110.49 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -86.64 152.71 54.8 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.55 133.48 37.21 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.092 1.861 . . . . 0.0 110.803 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.41 169.34 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.914 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.95 171.24 44.29 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.844 -0.535 . . . . 0.0 113.069 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.09 150.53 25.0 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.502 1.048 . . . . 0.0 111.496 -173.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.76 125.79 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.78 154.82 91.12 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.52 122.92 12.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 CA-C-N 120.804 1.323 . . . . 0.0 109.585 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.9 -3.96 85.78 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.521 -1.155 . . . . 0.0 114.749 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.78 156.95 38.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 120.135 1.968 . . . . 0.0 110.547 170.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -95.36 158.34 15.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.59 77.81 Favored 'General case' 0 C--O 1.224 -0.243 0 O-C-N 121.721 -0.612 . . . . 0.0 111.434 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.92 -37.59 79.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.55 0.74 . . . . 0.0 109.997 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -73.61 -35.62 65.38 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.46 92.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -60.87 -50.46 73.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.156 -0.926 . . . . 0.0 108.556 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 47.5 m-85 -66.01 -36.98 84.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.649 1.113 . . . . 0.0 112.41 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.1 ttm-85 -68.33 -50.44 53.3 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.826 1.193 . . . . 0.0 109.445 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.92 -27.75 61.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 tp -52.98 -48.02 67.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.456 0.702 . . . . 0.0 109.351 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.38 -42.5 99.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.779 0.718 . . . . 0.0 109.913 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.35 -28.27 69.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.366 0.985 . . . . 0.0 112.231 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.97 -57.91 2.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.579 0.751 . . . . 0.0 109.86 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.06 1.31 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.452 1.501 . . . . 0.0 112.216 -169.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.62 9.59 55.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.661 1.119 . . . . 0.0 113.39 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.74 150.15 20.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.056 2.142 . . . . 0.0 109.031 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 m -129.78 164.73 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.679 0.792 . . . . 0.0 109.903 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 53.0 mtt85 -45.29 -37.41 4.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.535 1.934 . . . . 0.0 113.12 -173.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.45 -30.35 71.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.873 -172.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.59 21.75 15.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.675 1.125 . . . . 0.0 112.505 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -131.38 165.11 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.246 1.418 . . . . 0.0 110.439 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -143.18 139.88 30.52 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 mt -79.59 121.64 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 103' ' ' GLN . 68.2 mt -96.12 -36.66 10.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.218 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.23 166.88 31.28 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.601 0.76 . . . . 0.0 109.295 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 p -162.47 155.47 19.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.394 1.077 . . . . 0.0 110.712 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.457 HG22 ' HG2' ' A' ' 150' ' ' GLU . 5.0 p -71.66 140.35 49.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.947 -170.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.68 -49.64 12.79 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 144.37 26.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.817 1.647 . . . . 0.0 110.457 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -79.36 126.12 30.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.63 126.93 33.78 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -121.88 148.94 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -141.44 145.3 35.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -94.03 143.97 25.89 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.76 142.94 97.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 110.225 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.33 147.18 77.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 104.432 -2.949 . . . . 0.0 104.432 166.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HA ' HG23 ' A' ' 84' ' ' VAL 0.252 86.6 mttt -68.82 -12.81 61.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.03 -1.669 . . . . 0.0 114.546 -168.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -30.27 70.21 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.47 -15.47 25.53 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.815 0.846 . . . . 0.0 112.435 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 81' ' ' LYS . 94.2 t -64.72 133.54 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -100.47 91.79 4.85 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.378 1.071 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -69.92 -22.73 63.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.98 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.7 -25.96 54.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.414 0.686 . . . . 0.0 112.391 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -106.81 155.89 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.944 0.897 . . . . 0.0 109.152 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.46 135.14 27.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.543 1.137 . . . . 0.0 110.246 -169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.76 150.32 94.03 Favored 'Cis proline' 0 N--CA 1.456 -0.691 0 N-CA-C 109.528 -0.989 . . . . 0.0 109.528 -10.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.3 p -71.2 133.89 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.493 0.717 . . . . 0.0 109.48 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 t -74.4 130.18 39.16 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.25 -13.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.203 169.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.84 47.95 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 120.1 1.318 . . . . 0.0 111.226 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.97 157.8 44.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.021 1.728 . . . . 0.0 109.96 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.36 137.22 44.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.73 130.34 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.553 1.141 . . . . 0.0 109.277 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -112.63 134.01 54.38 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.434 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 66.3 m95 -115.0 157.62 23.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.594 0.634 . . . . 0.0 109.839 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.88 125.33 23.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 108.28 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -88.29 121.93 31.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 168.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mt -118.68 152.24 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.632 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.4 tt0 -100.56 135.29 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 131.73 50.5 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.56 -50.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 119.44 1.018 . . . . 0.0 109.724 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.9 m -79.29 -25.12 42.48 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.322 0.649 . . . . 0.0 111.696 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.3 169.89 16.02 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -20.19 15.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.51 1.924 . . . . 0.0 113.073 -170.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.95 -26.24 47.14 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.13 10.43 8.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.31 140.63 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -130.35 118.77 21.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.028 1.731 . . . . 0.0 106.899 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.6 mtp -90.17 -3.06 58.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.549 0.613 . . . . 0.0 112.625 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -119.19 71.84 0.88 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.512 2.101 . . . . 0.0 107.026 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 p -65.22 -63.6 1.06 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.879 -2.873 . . . . 0.0 106.435 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 m -78.23 172.73 13.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.365 1.466 . . . . 0.0 107.343 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.5 m -60.33 -41.38 93.42 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.38 135.19 86.6 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 125.433 1.493 . . . . 0.0 108.777 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.13 140.52 89.79 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.654 1.57 . . . . 0.0 109.444 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.26 -46.55 20.0 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.5 141.76 39.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.882 0.873 . . . . 0.0 109.71 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -87.67 -15.02 38.36 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.253 1.021 . . . . 0.0 111.257 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.93 150.22 17.9 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 121.584 -0.698 . . . . 0.0 111.878 -169.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 51.2 p-90 -127.38 153.99 45.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.402 1.481 . . . . 0.0 108.484 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.36 141.84 24.33 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 168.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -102.55 123.65 46.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.0 161.57 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.062 1.345 . . . . 0.0 112.517 -168.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m -66.72 149.56 50.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.672 -0.642 . . . . 0.0 109.91 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -30.56 59.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.013 1.325 . . . . 0.0 112.584 -173.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -95.81 -2.47 47.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -76.34 -49.5 3.03 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.369 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.74 -32.52 93.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.495 1.927 . . . . 0.0 112.346 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -66.59 -21.87 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.275 -0.89 . . . . 0.0 112.301 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -69.08 -29.62 67.77 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -86.51 -26.83 24.37 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.47 163.12 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -69.72 173.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.971 1.308 . . . . 0.0 109.797 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.8 m -55.9 -54.24 47.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.749 1.62 . . . . 0.0 113.313 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -70.59 -39.94 73.56 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.854 -172.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.53 -49.03 67.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.15 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -63.69 -33.11 74.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.639 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.0 -47.32 77.91 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 119.098 0.863 . . . . 0.0 110.219 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.11 -49.58 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -61.76 -39.86 93.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.029 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.87 -38.74 76.49 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.896 1.68 . . . . 0.0 110.747 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.89 -45.58 94.01 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.852 0.751 . . . . 0.0 110.225 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.81 -40.02 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 110.565 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mmt -67.21 -49.35 64.88 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.279 1.5 tmtt? -59.86 -31.1 69.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.612 1.096 . . . . 0.0 111.879 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.457 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.1 tp10 -60.78 -36.75 79.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.269 0.628 . . . . 0.0 110.697 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.504 ' HB3' HD12 ' A' ' 101' ' ' LEU . 15.7 m-85 -110.83 -15.8 13.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.082 0.953 . . . . 0.0 113.187 -172.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.43 -42.45 70.54 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.428 1.491 . . . . 0.0 110.883 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 m -68.04 -31.78 71.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.855 0.862 . . . . 0.0 110.687 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.28 -44.24 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.9 -40.95 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.831 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.6 mmt -55.77 -47.17 77.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.173 0.897 . . . . 0.0 110.537 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -80.27 -26.68 38.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.921 1.288 . . . . 0.0 111.041 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.4 -41.37 93.73 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.753 1.221 . . . . 0.0 110.142 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -57.29 -36.72 71.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.901 0.481 . . . . 0.0 110.931 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.67 -14.16 49.33 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 112.562 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -100.06 -27.97 13.29 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.456 0.702 . . . . 0.0 112.299 -169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.9 t -142.22 50.1 1.54 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.969 0.508 . . . . 0.0 110.697 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -72.21 -174.03 1.28 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.859 2.373 . . . . 0.0 110.439 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? . . . . . 0 C--O 1.255 1.353 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.398 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.36 144.62 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.76 -68.62 0.36 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.989 0.516 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -164.47 -49.76 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.768 0.827 . . . . 0.0 113.229 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.0 16.35 11.32 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 113.11 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.59 -2.13 82.34 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.391 0.996 . . . . 0.0 113.14 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.54 155.59 17.23 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.083 0.942 . . . . 0.0 108.507 169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -146.31 126.85 7.1 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 117.442 -1.266 . . . . 0.0 107.973 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -76.07 138.36 20.46 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.611 1.541 . . . . 0.0 111.581 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -139.71 154.67 47.52 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.266 1.026 . . . . 0.0 108.849 -171.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.88 162.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.606 -0.683 . . . . 0.0 109.61 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.5 163.37 28.2 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.14 142.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.07 136.49 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -116.42 136.06 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -124.83 145.56 49.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.816 0.735 . . . . 0.0 110.172 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -95.03 174.09 7.25 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -79.32 16.73 0.94 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.037 -1.664 . . . . 0.0 112.282 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -108.37 -1.3 20.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.422 1.489 . . . . 0.0 111.275 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.14 14.99 80.11 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.287 -172.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -86.8 130.42 34.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.07 152.95 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.951 1.3 . . . . 0.0 108.837 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.0 tpp -62.28 137.69 58.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.24 0.616 . . . . 0.0 109.473 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -140.91 129.7 22.99 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.41 44.46 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 122.957 0.503 . . . . 0.0 111.259 -169.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -124.43 125.66 44.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -88.15 165.05 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.862 0.465 . . . . 0.0 110.891 -169.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -49.51 124.43 9.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.227 1.011 . . . . 0.0 111.694 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.59 8.07 62.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.513 1.054 . . . . 0.0 113.412 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -100.05 153.18 19.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.778 1.289 . . . . 0.0 109.417 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -111.5 19.95 17.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 m -128.34 143.23 50.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.857 1.263 . . . . 0.0 108.29 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -98.2 151.45 20.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.379 0.672 . . . . 0.0 110.227 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -155.56 160.61 40.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.434 1.094 . . . . 0.0 111.051 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.75 148.21 75.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.43 127.39 17.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.828 2.352 . . . . 0.0 112.678 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -142.54 161.53 37.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.555 1.07 . . . . 0.0 112.51 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.99 177.11 48.28 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.199 0.428 . . . . 0.0 113.344 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.15 146.02 17.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 125.346 1.45 . . . . 0.0 110.182 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -79.82 124.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -70.33 155.26 93.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -57.7 125.28 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.95 -7.25 81.09 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.331 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.51 158.71 34.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 120.112 1.956 . . . . 0.0 110.396 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 p -102.16 159.57 15.27 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.35 85.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.625 -0.672 . . . . 0.0 111.627 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.16 -34.64 73.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.733 0.813 . . . . 0.0 110.114 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -72.82 -36.78 67.58 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.698 -1.251 . . . . 0.0 110.227 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.98 93.08 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 ttp -59.81 -49.11 79.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.274 -0.869 . . . . 0.0 108.819 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 46.1 m-85 -64.47 -44.35 91.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.664 1.12 . . . . 0.0 111.975 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -65.9 -49.83 66.64 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.849 1.204 . . . . 0.0 109.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.65 -24.49 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.2 -47.49 83.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -57.14 -39.98 76.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.555 0.616 . . . . 0.0 109.458 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -0.96 14.48 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -115.98 -39.4 3.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.273 1.429 . . . . 0.0 111.933 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.46 2.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.735 1.214 . . . . 0.0 112.666 -171.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.87 6.81 19.59 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-N 119.523 1.056 . . . . 0.0 113.269 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.35 148.65 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.356 1.862 . . . . 0.0 109.238 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 p -126.59 170.11 12.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.665 1.186 . . . . 0.0 109.486 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 43.9 mtt85 -50.93 -31.93 19.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.906 1.683 . . . . 0.0 112.166 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -66.69 -24.82 66.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.244 0.618 . . . . 0.0 112.349 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.93 24.28 10.93 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.01 164.06 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 120.778 -1.201 . . . . 0.0 111.464 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -141.9 140.51 32.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 mt -82.61 119.52 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 103' ' ' GLN . 90.0 mt -94.6 -36.64 11.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.429 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.17 164.4 32.91 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.498 0.719 . . . . 0.0 109.773 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 p -160.08 153.85 22.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.904 1.281 . . . . 0.0 110.974 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 p -70.02 140.26 52.84 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.574 0.702 . . . . 0.0 111.199 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -83.29 -28.3 29.21 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.083 1.353 . . . . 0.0 110.053 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -125.5 148.14 48.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.369 2.267 . . . . 0.0 109.094 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -81.83 136.1 35.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.52 62.04 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.823 0.849 . . . . 0.0 109.442 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -71.21 150.33 45.41 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.4 -0.812 . . . . 0.0 109.914 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.17 148.34 31.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.93 136.77 32.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 169.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.283 0.4 OUTLIER -90.83 149.71 40.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.629 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.1 Cg_endo -74.59 157.71 44.28 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 124.093 3.195 . . . . 0.0 111.049 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -65.44 -19.9 66.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -171.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -31.01 69.39 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.414 HD12 ' HD2' ' A' ' 80' ' ' PRO . 35.3 mt -94.22 -22.51 18.37 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.675 1.19 . . . . 0.0 111.489 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 86' ' ' TRP . 62.2 t -65.44 133.44 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -99.99 88.42 3.75 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.782 0.801 . . . . 0.0 109.479 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.41 ' CE2' HG11 ' A' ' 84' ' ' VAL . 85.5 m95 -68.76 -22.04 64.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.768 175.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.54 -8.99 59.16 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.817 0.847 . . . . 0.0 113.046 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -129.77 162.77 27.69 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 110.274 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.18 134.84 26.36 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.404 1.482 . . . . 0.0 109.231 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.61 147.28 88.97 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 O-C-N 122.666 0.824 . . . . 0.0 110.381 -10.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.72 140.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.003 0.921 . . . . 0.0 109.725 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.2 p -94.61 128.33 41.17 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.374 1.07 . . . . 0.0 109.904 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -14.59 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.92 175.5 47.04 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.07 144.74 26.88 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 108.336 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -90.05 135.45 33.64 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -118.42 132.3 56.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.185 0.902 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -115.74 135.26 54.21 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.52 154.3 31.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.1 125.59 22.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.506 1.123 . . . . 0.0 108.146 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 tp -90.4 124.93 35.36 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.35 149.09 41.07 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.9 tt0 -100.67 129.24 46.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.02 134.04 56.11 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.6 t -82.24 -43.27 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.587 -169.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.0 m -97.52 -19.3 18.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.933 0.893 . . . . 0.0 111.704 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.1 -170.11 17.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.416 1.008 . . . . 0.0 111.064 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.68 -22.51 23.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.218 1.807 . . . . 0.0 112.824 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.51 -31.14 63.81 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.957 0.903 . . . . 0.0 113.434 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.96 14.33 14.14 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.98 140.36 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -120.74 115.71 23.83 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.05 6.7 47.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.049 0.539 . . . . 0.0 111.581 -171.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -149.02 66.61 1.04 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.454 1.902 . . . . 0.0 106.663 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -57.03 -60.47 3.55 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 127.218 2.207 . . . . 0.0 111.175 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.4 m -101.19 174.5 5.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.27 1.828 . . . . 0.0 109.93 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -54.67 -37.93 66.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.02 116.16 64.67 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 167.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -61.82 129.99 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 170.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.62 32.5 0.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . 0.26 8.8 t80 -153.18 162.26 41.51 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 120.683 -1.261 . . . . 0.0 112.184 -166.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.75 17.48 0.89 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 171.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.24 149.33 5.13 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 115.443 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.78 153.34 51.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.652 1.181 . . . . 0.0 111.675 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -156.32 152.67 27.93 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.601 1.16 . . . . 0.0 108.742 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -107.72 123.77 49.03 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.64 151.04 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.111 0.964 . . . . 0.0 110.668 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m -55.12 140.03 39.71 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.594 0.758 . . . . 0.0 110.291 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -32.45 18.53 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -85.38 -23.54 27.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.322 1.419 . . . . 0.0 112.971 -176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.72 -46.71 88.5 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.072 -1.442 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.86 -25.79 78.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 123.028 2.117 . . . . 0.0 113.139 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.29 -32.18 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.931 0.893 . . . . 0.0 108.915 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -61.85 -32.58 72.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.368 -0.832 . . . . 0.0 110.949 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -77.99 -27.32 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.33 167.69 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 118.896 0.771 . . . . 0.0 110.879 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.701 1.2 . . . . 0.0 110.226 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.7 m -53.2 -47.0 69.25 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.662 1.585 . . . . 0.0 114.838 -170.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -74.92 -36.7 62.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.051 0.841 . . . . 0.0 111.256 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -74.24 -42.82 59.09 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.503 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -42.88 -44.6 4.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.993 0.917 . . . . 0.0 111.935 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.35 -43.26 98.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.219 0.918 . . . . 0.0 111.097 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.75 -50.63 76.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.23 -32.37 74.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.301 0.64 . . . . 0.0 110.929 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -69.57 -41.78 75.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.836 1.198 . . . . 0.0 110.407 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.06 -41.23 96.22 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.581 1.082 . . . . 0.0 110.576 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.3 t -57.85 -24.97 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 111.591 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.5 mmt -90.51 -58.36 2.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -56.53 -37.12 70.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.637 1.175 . . . . 0.0 112.485 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.1 -36.29 72.68 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 119.062 0.846 . . . . 0.0 111.078 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -106.91 -11.95 15.59 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.183 0.993 . . . . 0.0 112.673 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.68 69.8 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.223 1.409 . . . . 0.0 110.655 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.2 m -67.85 -31.86 71.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.551 0.74 . . . . 0.0 110.654 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.97 -45.23 74.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.43 -41.02 80.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 117.312 -1.327 . . . . 0.0 110.592 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.19 -49.9 72.74 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 120.993 1.724 . . . . 0.0 109.964 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 m -73.55 -26.55 60.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.26 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.5 tp -63.79 -44.07 94.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.296 1.438 . . . . 0.0 109.539 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -61.16 -43.06 99.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.34 -34.84 70.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.937 0.495 . . . . 0.0 112.173 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -92.26 -29.48 16.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.922 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.283 9.8 t 39.6 64.68 4.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.018 1.727 . . . . 0.0 108.069 -169.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.07 164.18 17.68 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.128 1.885 . . . . 0.0 113.682 -168.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp . . . . . 0 C--O 1.251 1.174 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.982 -171.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 92' ' ' CYS . 1.9 mt -127.23 128.27 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 168.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.26 150.12 47.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.472 1.129 . . . . 0.0 108.803 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.98 -24.86 56.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.188 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.15 0.19 19.81 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.87 61.78 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.912 1.244 . . . . 0.0 113.386 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -118.2 161.25 20.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -144.18 132.45 10.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HB2' HD12 ' A' ' 40' ' ' ILE . 93.9 Cg_endo -82.35 136.06 8.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.371 1.381 . . . . 0.0 108.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -139.19 152.56 47.47 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.118 -0.989 . . . . 0.0 108.989 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.454 HG13 HD11 ' A' ' 40' ' ' ILE . 12.5 m -134.26 154.09 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.255 1.022 . . . . 0.0 108.892 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.51 157.5 25.14 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.32 143.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.5 138.69 51.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 170.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 mm -116.89 141.21 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 101' ' ' LEU . 25.6 p -120.74 157.2 30.18 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.321 1.049 . . . . 0.0 111.364 174.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -117.89 168.09 10.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.938 1.295 . . . . 0.0 107.987 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -73.66 -0.71 16.28 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.377 -1.452 . . . . 0.0 113.032 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -85.35 -8.84 58.25 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 111.365 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.95 34.83 41.1 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -106.07 154.34 20.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 169.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.84 150.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.34 1.056 . . . . 0.0 109.736 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.6 ttm -66.67 143.26 57.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.203 1.001 . . . . 0.0 108.397 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -150.5 141.85 23.32 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 147.63 31.37 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.463 1.483 . . . . 0.0 110.379 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.09 136.37 47.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.165 0.986 . . . . 0.0 109.089 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm-85 -73.53 160.68 31.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 111.487 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -49.58 123.94 8.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.174 0.99 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.73 6.79 73.1 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.816 1.198 . . . . 0.0 114.145 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -106.42 160.27 15.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.338 1.569 . . . . 0.0 110.616 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -119.91 17.34 12.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.803 1.241 . . . . 0.0 111.598 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 m -128.1 138.71 52.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.048 1.339 . . . . 0.0 108.149 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -94.46 151.21 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.519 0.727 . . . . 0.0 110.549 -170.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -143.57 155.58 44.34 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.165 1.386 . . . . 0.0 110.139 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -82.54 138.9 44.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 167.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.05 135.58 64.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.708 2.272 . . . . 0.0 112.568 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.87 166.2 32.42 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.962 0.801 . . . . 0.0 112.199 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.0 168.01 40.95 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.507 0.575 . . . . 0.0 111.683 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.88 149.01 40.68 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 9' ' ' PRO . 59.9 mt -73.57 120.49 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -73.59 157.79 87.2 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.59 122.98 12.7 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.331 1.354 . . . . 0.0 111.539 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.23 2.0 88.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.538 -1.146 . . . . 0.0 114.745 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.85 152.74 43.39 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.158 1.979 . . . . 0.0 111.066 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.0 p -84.76 167.49 16.05 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 167.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -36.32 79.2 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.088 -1.008 . . . . 0.0 111.316 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -40.51 61.13 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.484 0.713 . . . . 0.0 109.802 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -65.65 -40.89 92.94 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.26 75.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.856 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -58.15 -48.23 80.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 57.1 m-85 -66.81 -45.64 77.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.1 0.864 . . . . 0.0 111.642 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -53.57 -51.71 62.09 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.919 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -77.72 -32.34 52.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.9 tp -56.48 -45.65 80.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.25 0.932 . . . . 0.0 109.98 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.84 -40.26 92.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.282 0.492 . . . . 0.0 110.082 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.813 0.733 . . . . 0.0 112.366 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.55 -53.55 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.165 0.986 . . . . 0.0 110.414 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -123.27 3.6 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.488 1.515 . . . . 0.0 112.038 -169.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.43 3.27 24.9 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.005 1.275 . . . . 0.0 113.955 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.81 145.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.7 m -124.3 162.21 24.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.062 . . . . 0.0 109.664 -171.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.433 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 46.4 mtp180 -42.73 -40.63 2.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.621 1.968 . . . . 0.0 112.892 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -69.08 -21.15 64.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.376 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.76 19.92 16.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.745 0.784 . . . . 0.0 112.522 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.23 164.19 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.403 1.481 . . . . 0.0 111.337 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 138.93 35.92 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.072 169.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 mt -77.03 116.1 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 103' ' ' GLN . 58.6 mt -93.71 -33.17 13.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.395 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.28 164.45 38.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.866 0.866 . . . . 0.0 109.397 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 p -162.21 154.4 19.17 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 110.787 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.597 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -70.6 136.86 49.53 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.831 -0.543 . . . . 0.0 110.8 -170.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -79.3 -29.79 42.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.633 0.773 . . . . 0.0 110.553 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.344 2.258 . . . . 0.0 108.361 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.3 m95 -77.78 133.64 38.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.998 0.817 . . . . 0.0 109.165 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.03 116.58 27.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -127.05 149.52 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.51 142.55 31.18 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.9 139.77 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.71 139.37 86.05 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.065 0.946 . . . . 0.0 110.418 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.55 148.83 73.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 N-CA-C 104.636 -2.871 . . . . 0.0 104.636 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.7 mtpt -68.84 -13.23 62.28 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 119.847 -1.783 . . . . 0.0 114.236 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -62.54 -30.73 71.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.955 0.798 . . . . 0.0 112.634 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.4 mt -94.07 -18.24 22.02 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.161 0.985 . . . . 0.0 112.212 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 81' ' ' LYS . 59.9 t -64.48 132.65 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.12 88.39 4.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.729 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -69.98 -17.76 63.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.262 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.83 -27.28 55.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -103.18 163.08 12.46 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.973 . . . . 0.0 110.811 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.38 127.67 22.5 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 125.254 1.422 . . . . 0.0 110.72 -171.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.14 145.24 83.44 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 N-CA-C 109.308 -1.074 . . . . 0.0 109.308 -10.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.28 136.35 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.405 ' HB3' HD13 ' A' ' 2' ' ' ILE . 19.5 p -96.92 144.22 27.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.594 0.358 . . . . 0.0 110.585 170.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.84 -7.3 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.45 177.22 41.44 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -150.08 147.25 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.854 1.662 . . . . 0.0 109.016 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -96.23 131.24 42.92 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.17 128.6 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.504 1.047 . . . . 0.0 109.189 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 2.2 ttmm -109.05 121.15 44.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -102.47 151.27 22.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -133.43 131.51 40.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 108.015 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -93.34 124.8 37.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 169.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.51 149.7 42.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.1 tt0 -97.57 133.06 42.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 136.19 57.84 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.235 1.414 . . . . 0.0 107.552 171.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.31 -59.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.563 1.074 . . . . 0.0 110.226 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 m -74.74 -20.03 59.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.423 0.689 . . . . 0.0 111.672 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.21 172.35 25.14 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -58.42 -16.5 15.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.059 1.744 . . . . 0.0 114.112 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.73 -30.89 15.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.194 0.997 . . . . 0.0 113.088 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -85.53 18.98 2.53 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.18 142.05 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.185 1.394 . . . . 0.0 108.614 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -130.94 130.93 44.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.652 1.981 . . . . 0.0 107.895 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mmt -93.95 -14.4 26.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.52 0.728 . . . . 0.0 112.728 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -112.73 74.32 0.86 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 124.38 2.038 . . . . 0.0 107.94 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.0 p -71.49 -63.12 1.18 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 110.891 -2.868 . . . . 0.0 107.117 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.2 m -78.91 175.47 10.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.599 1.56 . . . . 0.0 108.721 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -59.71 -35.24 74.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.541 -0.724 . . . . 0.0 110.486 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.27 137.36 37.04 Favored Pre-proline 0 N--CA 1.446 -0.657 0 C-N-CA 125.945 1.698 . . . . 0.0 108.844 169.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.38 121.32 9.26 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.31 2.007 . . . . 0.0 107.55 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -73.74 -26.05 60.48 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.067 -0.395 . . . . 0.0 111.583 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -107.54 141.29 39.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.22 -27.66 38.74 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.259 0.624 . . . . 0.0 110.313 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.55 150.81 22.88 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.78 140.44 29.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -148.04 168.98 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.586 1.154 . . . . 0.0 109.222 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -117.4 142.56 46.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 149.84 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.702 1.201 . . . . 0.0 109.101 -169.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -51.99 141.81 17.18 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -43.78 -55.51 4.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.78 -7.83 53.53 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.822 1.192 . . . . 0.0 113.596 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.58 -52.44 66.99 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-O 116.825 -1.559 . . . . 0.0 113.68 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.97 -8.73 14.57 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.616 2.877 . . . . 0.0 116.392 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.16 -29.52 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 120.967 -1.083 . . . . 0.0 108.869 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.43 -25.38 63.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.75 -1.219 . . . . 0.0 112.281 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.47 -22.05 21.57 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.92 175.3 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 119.321 0.964 . . . . 0.0 110.612 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 m -83.82 171.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.5 m -56.61 -48.79 76.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.821 2.048 . . . . 0.0 114.327 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -72.07 -35.99 69.42 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.115 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.08 -39.08 72.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.75 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -50.01 -42.81 50.01 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.87 0.868 . . . . 0.0 111.454 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.41 -45.85 91.24 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.465 0.575 . . . . 0.0 110.359 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.1 -50.22 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -62.79 -37.99 88.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.9 0.773 . . . . 0.0 109.974 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -69.24 -36.28 77.02 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.45 -44.66 95.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.077 1.308 . . . . 0.0 110.307 172.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.14 -39.03 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 119.939 1.245 . . . . 0.0 110.451 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.8 mmt -72.45 -59.48 2.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.958 1.303 . . . . 0.0 107.637 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -34.07 72.48 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.588 -1.32 . . . . 0.0 112.313 -172.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 71' ' ' THR . 2.3 mm-40 -57.93 -41.05 81.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.423 ' HB3' HD12 ' A' ' 101' ' ' LEU . 4.5 m-85 -111.52 -11.95 14.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 112.039 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.2 -42.7 63.73 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 126.786 2.034 . . . . 0.0 110.467 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -68.95 -30.66 69.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.994 0.918 . . . . 0.0 110.916 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.83 -46.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.11 -41.25 88.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.293 -171.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.0 mmt -55.51 -44.41 76.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.348 1.431 . . . . 0.0 110.752 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -81.12 -26.04 36.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.324 1.049 . . . . 0.0 111.502 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.59 -43.78 95.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.043 1.337 . . . . 0.0 109.686 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.63 -40.09 93.63 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.752 0.421 . . . . 0.0 110.718 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.62 -32.08 53.27 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.217 0.607 . . . . 0.0 112.238 -169.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -100.45 -20.24 15.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.838 -169.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.1 p 40.8 62.86 6.1 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 126.946 2.098 . . . . 0.0 109.556 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.37 167.1 15.48 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 121.422 1.415 . . . . 0.0 114.113 -167.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt . . . . . 0 C--O 1.255 1.364 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.769 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tmm? . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.43 131.35 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 169.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.44 -63.95 1.12 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.429 0.692 . . . . 0.0 112.627 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.21 -53.84 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.62 17.25 16.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.435 1.094 . . . . 0.0 113.06 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.19 61.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.894 0.759 . . . . 0.0 113.702 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.8 154.4 18.67 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.085 0.943 . . . . 0.0 108.816 171.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -139.01 149.88 63.1 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.361 174.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HB2' HD12 ' A' ' 40' ' ' ILE . 9.4 Cg_exo -90.58 141.78 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.687 1.592 . . . . 0.0 111.757 -174.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -135.8 154.32 51.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.143 0.977 . . . . 0.0 109.711 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 40' ' ' ILE . 6.2 m -133.82 140.53 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -119.81 155.62 16.09 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 124.783 1.182 . . . . 0.0 110.211 176.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.05 142.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.93 135.62 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 104' ' ' LEU . 22.8 mm -108.56 132.76 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.2 m -124.26 145.57 49.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -105.74 173.31 6.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.644 1.177 . . . . 0.0 109.321 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.59 5.75 4.51 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.562 -1.336 . . . . 0.0 113.657 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -96.27 -2.17 46.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 111.482 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.61 22.11 79.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.392 -0.671 . . . . 0.0 111.843 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -93.91 145.39 24.66 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.23 149.85 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.717 1.607 . . . . 0.0 108.934 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.4 ttm -68.37 142.78 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.88 0.872 . . . . 0.0 109.366 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -141.48 123.32 15.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.08 159.35 41.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.134 1.334 . . . . 0.0 112.575 -168.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -157.93 169.52 24.4 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.08 1.309 . . . . 0.0 114.073 177.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.523 ' H ' ' HG3' ' A' ' 26' ' ' ARG . 8.2 tpt180 -59.84 154.39 18.57 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 128.035 2.534 . . . . 0.0 112.855 -169.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -61.15 134.39 56.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.614 1.166 . . . . 0.0 108.242 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.61 1.78 78.26 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.361 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -106.15 160.73 15.1 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.564 1.682 . . . . 0.0 110.654 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -128.91 11.99 6.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.671 1.189 . . . . 0.0 111.453 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -85.68 169.15 13.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.902 0.881 . . . . 0.0 109.082 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -133.2 132.12 41.16 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.03 173.94 13.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.391 1.477 . . . . 0.0 108.037 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -75.46 152.93 85.72 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.098 -0.954 . . . . 0.0 108.601 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 133.36 57.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.865 2.377 . . . . 0.0 111.536 170.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.15 171.2 18.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.66 1.118 . . . . 0.0 112.204 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.48 170.36 41.16 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.992 -0.442 . . . . 0.0 112.755 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 144.01 33.59 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.469 HD11 HG13 ' A' ' 11' ' ' VAL . 31.1 mt -73.99 119.33 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.67 144.1 85.6 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.14 126.17 18.06 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.804 1.67 . . . . 0.0 110.293 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.43 52.79 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.662 1.125 . . . . 0.0 113.283 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 152.1 37.17 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.675 1.737 . . . . 0.0 109.83 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.2 p -80.21 169.4 17.83 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.3 87.75 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 121.68 -0.637 . . . . 0.0 111.379 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.66 -37.77 70.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 110.387 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -68.09 -39.49 82.88 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.603 -1.31 . . . . 0.0 110.08 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.56 -30.66 67.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.676 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.419 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 11.9 tmm? -57.08 -50.73 71.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.425 1.011 . . . . 0.0 108.674 173.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 52.3 m-85 -66.38 -44.96 81.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.322 0.51 . . . . 0.0 111.119 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -57.35 -50.23 73.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.901 0.88 . . . . 0.0 110.023 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -77.12 -31.08 55.51 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -172.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.9 tp -58.11 -43.26 87.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.369 0.986 . . . . 0.0 110.241 172.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -62.38 -41.47 98.66 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.325 0.511 . . . . 0.0 110.087 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.66 -24.84 65.48 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.804 0.729 . . . . 0.0 112.429 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.04 -61.09 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.802 0.841 . . . . 0.0 108.788 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.88 -4.95 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.436 1.094 . . . . 0.0 113.561 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.799 1.181 . . . . 0.0 114.103 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.08 150.28 30.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.83 1.652 . . . . 0.0 109.099 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 m -127.76 164.34 22.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.332 1.053 . . . . 0.0 109.801 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.407 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 60.9 mtt180 -48.28 -36.16 13.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.103 1.761 . . . . 0.0 112.519 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -63.38 -23.45 67.42 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.623 0.769 . . . . 0.0 112.19 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.89 24.58 11.13 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.939 0.4 . . . . 0.0 111.63 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.87 165.09 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.413 1.085 . . . . 0.0 111.957 172.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 134.16 30.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.7 mt -76.65 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -95.88 -32.89 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -154.19 164.43 38.55 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 p -163.18 154.44 17.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.502 1.121 . . . . 0.0 110.798 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -72.81 140.06 47.41 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 109.969 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -92.22 -27.87 17.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -111.29 150.92 28.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.451 2.3 . . . . 0.0 107.482 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 57.1 m95 -82.3 136.94 34.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.438 0.563 . . . . 0.0 109.518 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.4 71.47 6.05 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -71.77 147.36 47.36 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -146.33 144.01 29.5 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.845 0.458 . . . . 0.0 110.0 170.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.84 146.67 24.04 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.074 0.95 . . . . 0.0 108.504 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.05 145.85 91.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 110.682 169.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.79 145.9 64.42 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 N-CA-C 104.499 -2.924 . . . . 0.0 104.499 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.8 mtpt -68.34 -13.13 62.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.909 -1.744 . . . . 0.0 114.151 -169.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -58.7 -31.31 68.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.8 mt -92.55 -19.52 21.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 111.998 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 81' ' ' LYS . 58.2 t -65.31 136.09 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -101.58 90.49 4.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.942 0.897 . . . . 0.0 109.473 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -68.42 -24.17 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.807 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.93 -34.42 73.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.617 0.367 . . . . 0.0 111.831 -171.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.93 159.21 15.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.786 0.834 . . . . 0.0 109.678 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -130.88 134.95 26.59 Favored Pre-proline 0 C--O 1.234 0.268 0 C-N-CA 125.325 1.45 . . . . 0.0 109.615 -171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.46 148.03 90.5 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 O-C-N 122.696 0.84 . . . . 0.0 110.07 -10.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -79.24 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.484 0.713 . . . . 0.0 109.532 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.89 127.69 35.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -14.57 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 118.932 0.787 . . . . 0.0 112.861 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.7 -177.11 38.88 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.77 153.82 30.45 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.794 1.238 . . . . 0.0 108.84 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -98.61 132.55 43.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -123.62 122.81 39.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 119.266 0.939 . . . . 0.0 109.566 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 7.6 ttmm -98.72 153.55 18.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.2 m95 -132.32 151.74 51.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.419 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 75.8 m-85 -137.69 127.88 26.09 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 108.893 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -89.59 122.62 32.91 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.88 136.99 53.75 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.47 132.29 35.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.421 ' HB2' HG21 ' A' ' 15' ' ' ILE . 13.9 tp -73.76 132.64 42.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.064 2.146 . . . . 0.0 107.539 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -77.63 -53.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.538 1.135 . . . . 0.0 111.837 -168.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.7 m -87.24 -15.55 37.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 111.563 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.37 -169.92 21.95 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.707 1.146 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -59.1 -17.39 25.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.627 1.571 . . . . 0.0 114.008 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.81 57.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.268 1.027 . . . . 0.0 112.955 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -95.66 18.29 13.22 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.52 113.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -92.74 -56.12 3.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.799 0.272 . . . . 0.0 110.978 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.2 mtp 69.81 3.16 4.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.704 2.401 . . . . 0.0 115.016 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.05 78.76 1.5 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 123.793 1.759 . . . . 0.0 109.825 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -75.93 -59.92 2.55 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.51 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 m -66.15 167.7 9.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.295 1.838 . . . . 0.0 109.53 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -62.44 -38.0 88.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.88 -0.512 . . . . 0.0 109.739 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.62 139.95 51.22 Favored Pre-proline 0 N--CA 1.442 -0.871 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 169.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.62 135.68 69.04 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.628 1.552 . . . . 0.0 108.112 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -81.62 -29.83 33.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.74 153.67 43.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.122 1.769 . . . . 0.0 107.83 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.67 -25.14 1.91 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.353 1.061 . . . . 0.0 110.58 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.83 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -150.76 133.09 15.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.153 0.981 . . . . 0.0 108.402 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -152.48 164.57 37.3 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.125 1.37 . . . . 0.0 108.471 169.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -114.49 141.27 47.93 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 152.79 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 110.292 -170.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m -60.97 142.54 56.44 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 109.043 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -27.58 48.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 32.5 m95 -88.2 -18.57 28.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.03 1.286 . . . . 0.0 113.19 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.91 -50.41 70.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.132 -1.413 . . . . 0.0 113.294 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.7 -28.95 76.95 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.159 1.906 . . . . 0.0 112.629 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.91 -34.88 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.329 1.052 . . . . 0.0 108.788 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -68.94 -19.7 64.19 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.787 -1.196 . . . . 0.0 112.323 -175.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -79.87 -32.7 40.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.854 1.206 . . . . 0.0 112.614 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.5 156.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 118.995 0.816 . . . . 0.0 111.482 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -68.65 162.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 m -53.22 -46.63 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.862 2.065 . . . . 0.0 115.236 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -69.33 -32.17 71.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.431 1.014 . . . . 0.0 111.153 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -77.54 -39.6 45.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.6 ttp-105 -50.05 -39.0 40.64 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.788 1.235 . . . . 0.0 112.387 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.24 -43.58 94.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.47 0.577 . . . . 0.0 111.378 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.91 -50.94 78.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -66.61 -34.49 77.99 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.701 -0.624 . . . . 0.0 110.897 -168.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -67.45 -40.61 85.42 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.65 1.114 . . . . 0.0 110.248 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.43 -43.74 98.33 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.725 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.91 -43.22 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 120.29 1.404 . . . . 0.0 109.912 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.5 mmt -74.04 -48.86 27.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -33.81 76.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.998 0.817 . . . . 0.0 112.159 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.74 -45.54 89.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.686 1.195 . . . . 0.0 109.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.453 ' HB3' HD12 ' A' ' 101' ' ' LEU . 13.4 m-85 -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.19 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.097 1.359 . . . . 0.0 110.792 -174.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -69.34 -31.57 70.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.786 0.834 . . . . 0.0 110.598 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 69' ' ' ALA . 45.5 t -67.47 -48.5 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.45 -41.77 82.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.172 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.63 -47.48 73.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.365 1.439 . . . . 0.0 110.71 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m -77.28 -26.85 52.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.173 1.389 . . . . 0.0 110.781 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.53 -42.25 96.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.018 1.727 . . . . 0.0 108.778 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -59.07 -24.64 63.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.344 0.657 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.93 -18.54 13.89 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.781 1.232 . . . . 0.0 113.116 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -116.62 -20.83 9.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.795 -169.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 p 41.86 62.76 7.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.201 1.8 . . . . 0.0 110.307 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 157.82 36.79 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.974 1.782 . . . . 0.0 113.798 -168.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt . . . . . 0 C--O 1.253 1.26 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.541 -169.536 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.75 142.12 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 168.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -67.37 -69.42 0.31 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.005 0.522 . . . . 0.0 111.661 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -164.74 -48.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.762 0.825 . . . . 0.0 112.84 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.51 13.29 14.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.293 1.037 . . . . 0.0 113.06 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.22 81.82 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.291 0.948 . . . . 0.0 113.163 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.58 157.24 17.61 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.975 0.91 . . . . 0.0 108.749 169.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 3.2 ptm180 -148.93 139.77 13.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.594 -172.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 16.6 Cg_exo -87.47 139.7 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 CA-C-N 121.63 1.618 . . . . 0.0 111.987 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.27 165.87 24.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.101 1.36 . . . . 0.0 109.127 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.74 172.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -153.08 159.75 28.7 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.39 141.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.25 139.26 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mm -119.47 142.83 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.0 p -121.84 154.28 37.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.186 0.903 . . . . 0.0 111.4 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -112.51 168.47 9.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.865 1.266 . . . . 0.0 108.336 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.39 4.46 5.86 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.133 -1.604 . . . . 0.0 113.196 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -90.78 -4.81 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.185 0.994 . . . . 0.0 111.45 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.3 21.06 70.99 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.841 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -95.67 151.34 19.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.674 1.237 . . . . 0.0 107.963 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.21 153.93 20.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.493 1.517 . . . . 0.0 109.495 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.3 tpp -60.55 137.6 58.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.317 1.047 . . . . 0.0 108.802 169.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -147.73 135.15 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 156.01 47.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.226 1.375 . . . . 0.0 112.554 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -109.44 109.32 20.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.149 1.779 . . . . 0.0 107.166 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -66.74 148.72 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.676 1.126 . . . . 0.0 108.06 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -46.25 118.81 2.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.419 1.087 . . . . 0.0 111.311 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.96 4.25 40.56 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.302 -1.277 . . . . 0.0 115.871 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -82.95 -30.42 28.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.235 2.017 . . . . 0.0 112.579 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 m80 53.78 34.22 18.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.323 1.049 . . . . 0.0 111.957 -172.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.3 p -131.22 170.74 14.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.919 2.088 . . . . 0.0 107.49 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -120.19 145.37 47.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.349 0.522 . . . . 0.0 110.505 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 165.61 36.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.071 1.349 . . . . 0.0 110.17 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -79.93 153.07 75.0 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.859 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.34 139.5 59.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.076 2.517 . . . . 0.0 110.324 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 53.8 mt-30 -138.59 168.38 19.91 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.383 1.073 . . . . 0.0 112.51 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.89 163.05 30.33 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 119.98 -0.344 . . . . 0.0 112.385 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.49 135.15 12.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 174.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.28 122.49 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -69.86 155.85 92.76 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.27 122.93 12.65 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.991 1.127 . . . . 0.0 109.461 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -3.72 86.75 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.338 -1.256 . . . . 0.0 114.594 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.98 158.92 34.53 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.279 2.04 . . . . 0.0 110.753 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m -98.97 155.83 17.22 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.07 86.48 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.132 -0.98 . . . . 0.0 111.389 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.907 0.883 . . . . 0.0 110.287 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -68.76 -39.24 80.37 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.667 -0.646 . . . . 0.0 110.084 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.29 94.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -60.15 -50.88 71.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.903 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -66.29 -37.24 84.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.893 1.224 . . . . 0.0 112.521 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -63.77 -49.8 71.54 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.069 1.304 . . . . 0.0 109.133 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -76.78 -25.67 53.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.04 -40.73 73.92 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.725 -1.235 . . . . 0.0 110.111 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -70.85 -37.82 73.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.52 0.6 . . . . 0.0 110.537 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.39 -34.2 72.29 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.2 -0.937 . . . . 0.0 111.808 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.78 -52.86 4.54 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.415 1.086 . . . . 0.0 110.114 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.27 -30.1 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.359 1.464 . . . . 0.0 110.233 -168.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 0.77 89.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.944 0.783 . . . . 0.0 112.38 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.2 tp -83.78 155.33 23.08 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.694 1.998 . . . . 0.0 109.334 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 p -133.81 169.13 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.296 1.038 . . . . 0.0 109.751 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -52.48 -33.02 42.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.919 1.688 . . . . 0.0 112.306 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -63.26 -28.02 69.74 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.293 0.637 . . . . 0.0 111.897 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.9 23.27 12.72 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 112.159 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 165.86 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 120.782 -1.199 . . . . 0.0 112.016 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 136.67 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.4 mt -76.12 115.71 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 103' ' ' GLN . 72.7 mt -89.18 -36.44 15.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.607 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.79 166.45 33.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.117 0.567 . . . . 0.0 109.778 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 p -161.24 155.6 22.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.981 1.312 . . . . 0.0 110.103 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -68.71 137.28 53.98 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.703 -0.623 . . . . 0.0 111.116 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -81.51 -28.64 33.93 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.214 1.406 . . . . 0.0 109.894 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -120.91 150.38 41.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.613 2.365 . . . . 0.0 108.177 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -81.48 133.38 35.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.4 mt -91.15 136.85 32.8 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -129.63 156.98 43.35 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.933 0.893 . . . . 0.0 111.431 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -143.36 125.92 15.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.17 137.43 36.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.07 142.87 93.6 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.702 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.01 146.49 71.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 104.923 -2.76 . . . . 0.0 104.923 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.61 -11.18 60.63 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.008 -1.682 . . . . 0.0 113.889 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -60.63 -31.42 70.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.973 0.806 . . . . 0.0 112.613 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.3 mt -92.04 -22.23 20.06 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 111.504 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.89 136.88 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -106.52 92.79 4.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.037 0.935 . . . . 0.0 110.063 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -68.4 -24.29 64.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.015 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.3 -25.57 58.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.386 0.674 . . . . 0.0 112.578 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -110.55 156.71 20.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.113 0.965 . . . . 0.0 109.338 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -127.87 137.64 31.21 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 109.975 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.25 149.72 93.66 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.874 0.934 . . . . 0.0 110.177 -10.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.6 p -78.22 134.33 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 110.142 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.4 p -74.25 126.17 30.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.935 0.894 . . . . 0.0 109.4 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.85 -13.67 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 171.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.35 175.65 46.41 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -151.52 145.25 25.04 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.33 1.452 . . . . 0.0 108.961 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.03 133.83 34.2 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -129.48 123.96 32.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.89 0.768 . . . . 0.0 109.987 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -103.68 127.38 51.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.123 0.969 . . . . 0.0 108.407 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -105.75 153.93 21.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -132.97 128.78 37.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.483 1.113 . . . . 0.0 108.264 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -93.01 124.54 37.06 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.473 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 mt -119.2 149.4 41.8 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.62 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.4 tt0 -99.71 126.75 45.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.45 138.65 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.318 1.047 . . . . 0.0 108.794 170.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.8 t -90.72 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.414 0.552 . . . . 0.0 110.556 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.0 m -85.59 -18.71 32.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.218 0.607 . . . . 0.0 111.02 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.52 21.4 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.89 -21.14 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.607 1.963 . . . . 0.0 113.345 -172.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.29 -30.01 59.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.579 0.752 . . . . 0.0 113.028 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -93.58 15.65 15.63 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.9 mt -91.74 135.61 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -122.23 -51.84 1.97 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.331 0.652 . . . . 0.0 112.165 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 mtp 65.64 16.82 10.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.416 2.287 . . . . 0.0 113.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.58 29.84 1.93 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.276 1.512 . . . . 0.0 112.142 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -51.41 70.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.659 1.583 . . . . 0.0 108.345 169.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.5 m -68.96 156.45 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.576 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -65.89 -33.48 75.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.015 0.526 . . . . 0.0 110.456 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.56 134.83 33.36 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 124.997 1.319 . . . . 0.0 107.973 169.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.38 122.28 11.4 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.474 2.116 . . . . 0.0 107.315 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.39 -33.4 72.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -117.77 138.81 51.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.19 -19.6 46.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.6 161.79 32.02 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.65 159.07 43.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -151.88 164.87 36.18 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.147 0.979 . . . . 0.0 109.165 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -114.87 127.38 55.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.03 152.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.481 1.112 . . . . 0.0 110.0 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -59.63 147.63 36.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.476 0.58 . . . . 0.0 109.471 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.95 54.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.465 1.106 . . . . 0.0 113.778 -169.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -88.87 -22.66 23.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.332 -0.855 . . . . 0.0 113.09 -172.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -58.24 -49.06 95.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.248 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.85 -29.3 76.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.169 1.81 . . . . 0.0 111.819 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.86 -30.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.26 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -68.3 -27.73 66.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.166 -0.959 . . . . 0.0 111.31 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -83.6 -24.52 31.44 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -168.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.38 160.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.686 0.755 . . . . 0.0 112.713 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.7 175.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.254 1.421 . . . . 0.0 109.856 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.86 -55.93 26.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.944 1.697 . . . . 0.0 113.002 -173.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -70.17 -32.32 70.21 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 -171.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -74.17 -48.05 31.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.974 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -63.48 -30.93 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.706 1.139 . . . . 0.0 112.204 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.7 -35.31 74.25 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.842 174.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.81 -49.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.494 1.118 . . . . 0.0 109.949 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -62.39 -31.99 72.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.755 1.162 . . . . 0.0 111.106 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.6 -43.44 98.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.487 1.04 . . . . 0.0 111.384 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -61.13 -45.69 93.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.366 0.985 . . . . 0.0 110.239 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.68 -26.11 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.063 0.945 . . . . 0.0 111.58 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.1 mmt -90.81 -56.29 3.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.998 0.919 . . . . 0.0 108.885 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -57.3 -33.65 67.9 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.462 1.028 . . . . 0.0 112.551 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -63.45 -32.81 74.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.947 0.499 . . . . 0.0 110.574 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.516 ' HB3' HD12 ' A' ' 101' ' ' LEU . 8.0 m-85 -111.58 -14.83 13.61 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.284 1.033 . . . . 0.0 112.889 -174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.41 -39.97 67.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.594 1.558 . . . . 0.0 110.794 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 m -67.1 -31.6 72.18 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.971 0.908 . . . . 0.0 110.785 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -46.21 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.13 -39.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 117.851 -1.071 . . . . 0.0 109.714 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.6 mmt -55.34 -48.92 73.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.773 1.17 . . . . 0.0 110.437 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.8 m -79.6 -26.05 41.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.779 1.232 . . . . 0.0 110.957 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.3 tp -63.05 -41.39 99.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.612 1.165 . . . . 0.0 109.936 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -58.46 -44.16 89.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 110.154 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.18 -31.39 64.19 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.713 0.805 . . . . 0.0 111.685 -171.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -89.12 -32.68 17.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.129 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.284 12.4 t 39.35 62.59 5.02 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -75.45 59.7 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.685 2.923 . . . . 0.0 115.568 -166.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.807 2.043 . . . . 0.0 112.118 169.591 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 119.66 -0.209 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 143.71 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -69.33 0.26 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -164.74 -48.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.166 0.986 . . . . 0.0 112.7 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.13 16.67 10.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.594 1.158 . . . . 0.0 113.137 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.7 63.58 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.312 0.958 . . . . 0.0 113.854 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -93.29 153.78 18.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.499 1.15 . . . . 0.0 108.053 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.16 126.58 17.61 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.595 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -72.33 141.13 34.87 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.108 1.872 . . . . 0.0 111.496 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -140.25 156.44 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.802 0.841 . . . . 0.0 109.079 -173.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.74 150.36 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.454 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -128.92 157.53 21.61 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -125.16 142.83 40.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 109.056 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.43 137.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mm -120.01 132.39 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' A' ' 22' ' ' VAL . 78.1 m -119.91 140.6 50.63 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.682 0.674 . . . . 0.0 109.965 173.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -94.8 174.04 7.3 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.02 -2.37 30.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 120.281 -1.512 . . . . 0.0 112.678 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.61 -2.91 58.65 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.971 1.308 . . . . 0.0 111.582 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.87 19.48 76.93 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.819 0.736 . . . . 0.0 111.711 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -88.55 142.51 27.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 171.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.0 m -108.48 142.43 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.37 1.468 . . . . 0.0 108.935 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.0 tpp -60.85 134.65 57.3 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.957 1.303 . . . . 0.0 108.822 170.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -143.3 120.39 11.43 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 151.05 29.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.811 1.187 . . . . 0.0 109.836 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -145.48 162.29 37.71 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.176 1.39 . . . . 0.0 114.102 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.65 149.47 35.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.724 2.009 . . . . 0.0 113.872 -168.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -52.46 124.86 14.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.527 1.931 . . . . 0.0 109.489 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.67 8.31 76.49 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.205 -1.331 . . . . 0.0 114.524 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -109.18 157.41 18.81 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.589 1.695 . . . . 0.0 110.573 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -134.39 15.0 3.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 112.258 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.5 m -107.18 127.78 53.82 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -92.05 139.56 30.52 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -156.62 158.54 37.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.193 2.197 . . . . 0.0 107.731 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -73.35 151.84 89.92 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.445 169.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.42 141.17 97.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.969 2.446 . . . . 0.0 112.259 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.85 176.09 11.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.886 -0.509 . . . . 0.0 112.046 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.86 168.61 40.98 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.333 0.492 . . . . 0.0 112.553 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.51 146.39 27.31 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -77.73 127.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -69.47 152.68 96.29 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.48 124.04 14.93 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 108.958 -1.209 . . . . 0.0 108.958 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.41 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.679 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.96 159.26 34.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.072 1.936 . . . . 0.0 110.229 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 p -102.12 156.57 17.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.33 85.91 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.408 -0.808 . . . . 0.0 111.901 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.19 -35.56 76.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.572 0.749 . . . . 0.0 109.588 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -71.86 -37.04 70.28 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.61 91.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -61.61 -50.88 70.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -66.19 -40.97 90.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.228 0.922 . . . . 0.0 110.825 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.5 ttm-85 -66.37 -48.38 70.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.672 1.124 . . . . 0.0 109.688 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.84 -29.35 63.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.56 -47.64 79.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.864 0.756 . . . . 0.0 109.165 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.97 -39.21 91.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.934 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.42 -40.32 93.21 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.979 . . . . 0.0 112.061 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.13 -51.38 9.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 110.357 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 m -123.8 8.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.188 1.395 . . . . 0.0 113.538 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.27 8.41 62.1 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.791 0.723 . . . . 0.0 113.599 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 tp -98.6 141.14 31.81 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.417 1.887 . . . . 0.0 109.945 -171.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 p -115.43 165.53 12.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 109.926 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -48.69 -34.18 11.46 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.109 1.764 . . . . 0.0 112.053 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -29.61 70.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.759 -171.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.35 25.86 10.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.793 1.179 . . . . 0.0 111.628 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.52 165.0 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 O-C-N 120.818 -1.176 . . . . 0.0 111.501 172.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -139.32 144.29 38.22 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.1 mt -82.52 120.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' A' ' 103' ' ' GLN . 96.1 mt -95.23 -35.98 11.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.615 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -158.02 161.33 38.07 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.348 -171.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -162.35 154.43 18.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.177 1.391 . . . . 0.0 109.669 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.5 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -71.09 139.55 50.38 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.852 -0.53 . . . . 0.0 110.261 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -57.06 4.14 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -89.28 151.62 22.01 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.389 1.476 . . . . 0.0 109.188 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -83.21 135.71 34.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.011 0.369 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.81 96.51 10.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -98.19 150.72 21.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.052 0.941 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -147.27 144.69 29.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 168.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.6 143.89 26.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mt -68.23 138.82 92.09 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 169.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.81 148.13 86.14 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 N-CA-C 105.264 -2.629 . . . . 0.0 105.264 167.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -69.14 -11.9 61.2 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.033 -1.667 . . . . 0.0 113.838 -168.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.9 -32.19 73.63 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.944 0.793 . . . . 0.0 112.522 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -92.8 -22.06 19.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.006 0.922 . . . . 0.0 111.567 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.46 136.2 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -103.14 88.68 3.2 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.005 0.907 . . . . 0.0 110.456 174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -68.52 -22.6 64.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.666 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.06 -9.1 58.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.749 0.819 . . . . 0.0 112.876 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.7 t -128.17 160.86 30.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.095 0.958 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -128.43 135.32 27.38 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 125.346 1.458 . . . . 0.0 109.563 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.54 148.36 91.38 Favored 'Cis proline' 0 CA--C 1.538 0.693 0 O-C-N 122.665 0.824 . . . . 0.0 110.534 -10.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 p -77.62 134.98 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.659 0.784 . . . . 0.0 109.75 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.0 p -80.2 127.32 32.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.91 0.884 . . . . 0.0 109.07 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.03 -17.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.02 0.827 . . . . 0.0 113.174 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.51 168.22 37.35 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 119.772 1.169 . . . . 0.0 110.197 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -152.62 150.9 29.99 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.657 1.183 . . . . 0.0 107.889 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 127.04 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -113.78 135.14 54.28 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.825 0.85 . . . . 0.0 110.209 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -113.27 125.08 53.91 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.454 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 89.1 m95 -104.45 149.92 25.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -173.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -133.37 131.66 40.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.835 0.854 . . . . 0.0 108.832 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 18.8 tp -96.32 119.72 35.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 168.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.09 144.95 40.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.7 tt0 -96.9 129.65 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 135.02 57.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.2 t -85.91 -44.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.049 0.386 . . . . 0.0 110.608 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.1 m -90.19 -19.57 24.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.388 0.675 . . . . 0.0 111.198 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.76 -170.42 19.06 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 124.528 1.061 . . . . 0.0 110.558 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -20.84 38.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.624 1.57 . . . . 0.0 113.568 -172.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.46 47.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -93.24 14.63 17.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -173.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.08 140.98 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -133.86 122.03 22.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.346 1.058 . . . . 0.0 108.445 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mmt -89.28 -3.18 58.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.07 0.948 . . . . 0.0 112.252 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -136.63 83.09 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.321 2.01 . . . . 0.0 108.835 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 p -74.5 -60.67 2.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 128.158 2.583 . . . . 0.0 107.872 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.9 m -72.36 174.05 7.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.097 1.759 . . . . 0.0 109.27 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.1 m -61.46 -37.0 82.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 140.43 45.32 Favored Pre-proline 0 N--CA 1.44 -0.945 0 C-N-CA 125.842 1.657 . . . . 0.0 108.577 169.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.93 140.31 94.71 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.926 1.751 . . . . 0.0 108.558 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -76.36 -38.37 55.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -119.4 152.28 37.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.678 1.591 . . . . 0.0 109.542 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -126.52 -25.4 3.44 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.917 1.287 . . . . 0.0 110.149 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.36 130.96 10.49 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -157.9 130.51 7.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.891 1.345 . . . . 0.0 108.608 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -152.08 161.18 43.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.811 1.244 . . . . 0.0 109.084 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -111.52 134.45 53.1 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.05 153.24 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.485 -169.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 m -59.95 140.34 56.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.013 0.824 . . . . 0.0 109.212 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.93 -36.3 48.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -169.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -80.94 -21.81 40.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.008 1.276 . . . . 0.0 112.912 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -66.92 -45.59 53.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.88 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.7 -14.3 41.42 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.697 1.999 . . . . 0.0 113.759 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.1 t -67.57 -33.71 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -63.17 -34.96 78.76 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.812 -1.18 . . . . 0.0 111.689 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -82.76 -19.86 37.03 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -168.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 m -79.95 165.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 118.972 0.806 . . . . 0.0 110.32 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.73 176.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.911 1.285 . . . . 0.0 109.768 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.1 m -52.93 -50.38 64.13 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.683 1.593 . . . . 0.0 114.179 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -72.49 -26.93 61.97 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.972 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -84.29 -43.01 15.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.203 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -44.86 -45.25 10.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.992 0.917 . . . . 0.0 111.061 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.46 -35.66 76.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.877 0.871 . . . . 0.0 111.592 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 36.4 t -76.72 -49.94 22.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 124.792 1.237 . . . . 0.0 110.408 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.91 -35.35 78.12 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.716 0.807 . . . . 0.0 111.537 -168.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.02 -39.89 95.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.974 172.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -62.25 -47.01 86.27 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.633 1.106 . . . . 0.0 110.633 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 81.3 t -55.19 -33.1 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.425 1.011 . . . . 0.0 110.971 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.5 mmt -80.74 -56.89 3.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.896 0.878 . . . . 0.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -35.73 72.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.483 1.038 . . . . 0.0 111.852 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 71' ' ' THR . 23.5 mm-40 -58.06 -40.68 81.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.528 1.131 . . . . 0.0 111.614 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -111.04 -14.43 13.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.822 0.701 . . . . 0.0 110.961 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.88 62.48 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.701 1.601 . . . . 0.0 111.031 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.5 m -67.28 -31.62 72.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.339 0.656 . . . . 0.0 110.907 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.23 -45.04 72.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.44 -39.82 76.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.21 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.68 -52.51 62.14 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 120.887 1.676 . . . . 0.0 109.717 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.5 m -72.37 -27.13 62.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.223 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.95 -45.61 91.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.212 1.405 . . . . 0.0 109.701 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.35 -43.82 98.22 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.327 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.99 -34.6 71.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.768 0.827 . . . . 0.0 111.868 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -88.51 -27.2 21.61 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.579 -0.725 . . . . 0.0 109.095 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.298 9.7 t 40.1 59.72 7.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.782 . . . . 0.0 107.572 -169.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.25 162.4 41.95 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.797 1.665 . . . . 0.0 111.271 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.928 0.891 . . . . 0.0 108.717 -169.28 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 tmm? . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt -126.46 131.99 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.64 -61.99 2.19 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.497 0.719 . . . . 0.0 111.964 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -162.85 -53.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.01 18.22 16.52 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.651 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.65 9.33 61.44 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.642 0.639 . . . . 0.0 113.513 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -103.85 151.91 22.54 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.507 1.123 . . . . 0.0 108.607 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.57 148.85 63.05 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.369 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HB2' HD12 ' A' ' 40' ' ' ILE . 55.4 Cg_endo -90.36 141.12 3.34 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.746 2.297 . . . . 0.0 111.214 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.36 153.04 46.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.117 -0.989 . . . . 0.0 110.097 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.594 HG13 HD11 ' A' ' 40' ' ' ILE . 2.5 m -135.28 143.01 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.283 1.433 . . . . 0.0 108.798 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.19 162.66 24.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 123.922 0.772 . . . . 0.0 111.982 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 143.44 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.295 1.438 . . . . 0.0 108.155 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.81 134.7 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 168.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.37 136.83 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' SG ' HD11 ' A' ' 101' ' ' LEU . 12.7 p -124.7 162.76 23.49 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.881 0.764 . . . . 0.0 112.457 169.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.5 p30 -110.56 172.93 6.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.557 1.543 . . . . 0.0 108.306 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.34 8.71 3.14 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.451 -1.406 . . . . 0.0 113.233 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -99.54 -1.92 37.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.512 1.525 . . . . 0.0 111.58 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.12 15.97 80.83 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 118.691 0.678 . . . . 0.0 112.022 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -83.96 151.42 25.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.45 150.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.058 1.743 . . . . 0.0 108.501 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -73.23 143.31 47.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -147.4 144.29 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.91 146.8 34.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.389 1.904 . . . . 0.0 112.872 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -88.98 117.88 28.3 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -71.99 151.25 43.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.849 1.204 . . . . 0.0 109.003 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -58.03 129.24 41.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.11 6.24 82.47 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.512 -1.16 . . . . 0.0 114.003 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -113.86 164.25 14.0 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.168 1.484 . . . . 0.0 110.046 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.94 -13.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.829 0.852 . . . . 0.0 111.952 172.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 p -84.38 154.12 23.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.372 1.469 . . . . 0.0 110.281 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -107.45 143.7 35.42 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -142.2 161.21 38.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.169 1.388 . . . . 0.0 110.151 -169.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -90.43 143.11 28.86 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.45 131.93 33.75 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.246 2.63 . . . . 0.0 112.088 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.31 164.8 36.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.05 167.64 40.17 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.324 0.488 . . . . 0.0 113.026 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.14 147.06 43.82 Favored Glycine 0 N--CA 1.444 -0.788 0 O-C-N 121.497 -1.002 . . . . 0.0 110.604 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.603 HD12 ' HB2' ' A' ' 9' ' ' PRO . 70.7 mt -74.61 129.36 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.45 148.31 95.33 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.94 123.88 14.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.96 1.774 . . . . 0.0 110.24 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.45 1.7 90.2 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.425 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.53 159.3 32.39 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.515 2.158 . . . . 0.0 111.016 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 m -85.06 148.65 26.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.29 -40.14 81.17 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.555 -0.716 . . . . 0.0 111.602 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.86 -35.44 76.92 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.812 0.845 . . . . 0.0 110.248 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -73.55 -39.49 64.69 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.253 -0.904 . . . . 0.0 110.145 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.25 70.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.98 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -59.2 -48.47 81.51 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.169 1.349 . . . . 0.0 108.503 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.5 -36.23 83.51 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.35 1.432 . . . . 0.0 111.854 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -59.18 -49.64 77.08 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.328 0.967 . . . . 0.0 110.066 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -77.14 -26.66 53.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 122.125 -0.359 . . . . 0.0 110.362 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.67 -45.26 85.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.139 -0.976 . . . . 0.0 109.093 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.95 -45.6 81.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.689 0.677 . . . . 0.0 110.958 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.53 -37.34 86.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.538 1.063 . . . . 0.0 112.447 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -94.36 -47.98 6.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.517 1.127 . . . . 0.0 110.955 -170.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.61 -33.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.83 1.252 . . . . 0.0 109.883 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.2 89.94 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.562 1.077 . . . . 0.0 112.226 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 64' ' ' ASP . 28.7 tp -87.35 155.08 20.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.619 1.968 . . . . 0.0 109.634 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.8 m -133.52 167.35 20.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.126 0.97 . . . . 0.0 109.533 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -47.78 -33.46 7.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.869 2.067 . . . . 0.0 113.112 -173.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -65.6 -29.89 70.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.284 -171.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' HB3' HD11 ' A' ' 60' ' ' LEU . 4.6 t70 -112.46 24.77 12.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.543 1.065 . . . . 0.0 111.541 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.35 165.54 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.599 -1.313 . . . . 0.0 112.817 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.38 136.53 36.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.418 HG12 HD11 ' A' ' 102' ' ' LEU . 60.8 mt -74.13 122.44 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 103' ' ' GLN . 62.8 mt -93.83 -35.79 12.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.162 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.0 35.91 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.266 1.026 . . . . 0.0 109.904 -173.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.8 p -152.49 153.91 34.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.122 1.769 . . . . 0.0 108.829 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 150' ' ' GLU . 0.7 OUTLIER -65.2 135.48 55.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.799 -169.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -84.17 -32.35 24.65 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.943 1.297 . . . . 0.0 107.868 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.77 148.19 49.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.796 2.038 . . . . 0.0 109.865 172.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -74.69 139.58 43.6 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.68 84.66 5.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -82.01 144.25 31.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -147.6 144.57 28.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.09 145.47 24.37 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.84 145.38 91.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 124.845 1.258 . . . . 0.0 110.925 170.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.16 147.34 72.75 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 104.076 -3.086 . . . . 0.0 104.076 166.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 84' ' ' VAL . 91.4 mttt -68.31 -13.83 62.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 119.927 -1.733 . . . . 0.0 114.509 -168.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -60.2 -29.71 68.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -95.67 -13.28 24.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.11 0.964 . . . . 0.0 112.819 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 81' ' ' LYS . 79.7 t -62.77 133.28 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -96.42 91.52 5.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.285 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.14 -21.6 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.968 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.33 -29.09 57.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 t -99.57 163.88 12.31 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.577 1.151 . . . . 0.0 109.766 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -128.24 130.51 23.56 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.427 1.491 . . . . 0.0 107.022 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.44 159.98 95.31 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 O-C-N 123.043 1.023 . . . . 0.0 110.462 -9.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.14 132.21 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.2 p -87.04 126.78 34.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.14 -13.52 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.382 0.537 . . . . 0.0 112.312 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.48 37.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.24 156.69 32.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.65 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -106.7 126.55 52.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -119.47 128.67 54.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.692 0.678 . . . . 0.0 110.167 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.09 153.21 17.91 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CD1' HG22 ' A' ' 147' ' ' VAL . 85.5 m95 -134.1 154.81 50.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.237 0.615 . . . . 0.0 109.434 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -135.74 129.62 32.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.458 HD11 ' SG ' ' A' ' 16' ' ' CYS . 12.5 tp -91.14 123.32 34.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 67' ' ' ILE . 8.7 mp -115.71 155.16 28.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.635 1.174 . . . . 0.0 107.853 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.775 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.4 tt0 -106.15 131.25 53.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 168.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.63 140.21 56.85 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.027 0.931 . . . . 0.0 108.957 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.6 t -88.15 -44.33 15.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -171.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -90.99 -29.44 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.046 0.538 . . . . 0.0 112.106 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.29 178.82 15.51 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.915 0.769 . . . . 0.0 111.28 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.86 -20.86 54.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.691 1.597 . . . . 0.0 114.035 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.8 66.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.276 0.631 . . . . 0.0 111.554 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.58 48.08 1.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.161 1.785 . . . . 0.0 111.506 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.7 mt -128.5 133.09 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -114.48 -51.54 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.696 0.798 . . . . 0.0 111.972 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.4 mtp 67.98 13.32 9.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.017 2.127 . . . . 0.0 114.735 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -151.87 71.03 0.96 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 124.166 1.936 . . . . 0.0 110.394 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -59.11 2.87 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 111.974 -2.375 . . . . 0.0 107.901 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.6 m -63.47 161.96 13.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.392 1.477 . . . . 0.0 109.756 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -58.56 -38.57 78.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 130.41 52.7 Favored Pre-proline 0 N--CA 1.442 -0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 110.3 170.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.51 143.62 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -83.25 -18.29 39.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.894 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.21 141.19 51.8 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.712 0.805 . . . . 0.0 110.321 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.19 -31.89 33.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.021 1.328 . . . . 0.0 110.669 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.87 29.0 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -125.26 151.28 46.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.161 . . . . 0.0 108.825 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.9 166.08 27.04 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -126.51 133.77 51.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.24 157.79 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.937 1.295 . . . . 0.0 110.956 -168.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 m -65.98 144.38 56.8 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -28.29 63.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -88.01 -20.22 26.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.562 1.528 . . . . 0.0 112.924 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.3 -47.92 92.79 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.699 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.54 -27.06 81.48 Favored 'Trans proline' 0 C--N 1.352 0.76 0 CA-C-N 122.828 2.046 . . . . 0.0 112.957 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.89 -27.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.089 1.356 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -65.99 -27.9 68.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.356 -0.84 . . . . 0.0 111.334 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -86.71 -24.36 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.49 156.56 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.805 0.73 . . . . 0.0 112.528 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.2 179.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 110.184 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.8 m -54.54 -52.12 63.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.662 1.585 . . . . 0.0 114.06 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -74.34 -38.73 63.17 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.81 -44.83 69.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.52 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -62.97 -31.81 73.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.349 0.977 . . . . 0.0 111.74 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.57 -42.9 99.84 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.707 0.685 . . . . 0.0 110.924 172.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.73 -51.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.32 -37.61 86.27 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.26 0.937 . . . . 0.0 110.152 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.643 1.111 . . . . 0.0 110.486 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -60.66 -43.39 97.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.877 1.217 . . . . 0.0 110.49 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 99' ' ' TRP . 96.0 t -57.42 -24.46 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 119.788 1.176 . . . . 0.0 111.831 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.3 -57.3 2.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -56.14 -34.02 65.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.996 1.318 . . . . 0.0 112.606 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.7 tp10 -65.0 -30.04 71.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.04 0.837 . . . . 0.0 111.412 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.39 -11.43 14.13 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.409 1.083 . . . . 0.0 112.684 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.35 69.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.111 1.364 . . . . 0.0 110.905 -171.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -62.49 -37.96 88.02 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.262 1.425 . . . . 0.0 111.635 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.84 -42.87 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.21 -40.54 65.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-O 117.169 -1.396 . . . . 0.0 109.765 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.4 -54.11 49.49 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.764 1.62 . . . . 0.0 110.04 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 m -64.86 -32.21 73.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.531 1.133 . . . . 0.0 110.94 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.592 ' HG ' HD13 ' A' ' 68' ' ' LEU . 1.2 tm? -68.19 -31.01 70.25 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.326 1.85 . . . . 0.0 111.142 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -72.79 -44.58 61.35 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.961 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.28 -24.62 66.53 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.377 0.671 . . . . 0.0 112.461 -170.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -76.51 -36.27 57.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.338 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.6 t -160.34 79.55 2.45 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.856 0.753 . . . . 0.0 109.71 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.48 22.93 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.676 2.917 . . . . 0.0 113.928 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? . . . . . 0 C--O 1.252 1.227 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.162 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 tmm? . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 62.53 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 126.995 2.118 . . . . 0.0 110.757 -170.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -62.68 1.63 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.918 0.887 . . . . 0.0 112.125 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -163.04 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.34 0.186 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -100.84 20.65 14.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.641 1.177 . . . . 0.0 113.302 -169.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.49 18.38 49.04 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.494 0.568 . . . . 0.0 113.419 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -107.48 156.1 19.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.08 25.64 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.566 -1.207 . . . . 0.0 108.677 171.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HB2' HD12 ' A' ' 40' ' ' ILE . 13.2 Cg_exo -82.58 136.49 8.57 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.83 1.687 . . . . 0.0 110.454 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -133.86 160.73 36.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.403 1.481 . . . . 0.0 109.075 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.31 154.79 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 123.518 0.727 . . . . 0.0 109.946 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.24 156.64 23.1 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -116.43 141.98 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 125.499 1.519 . . . . 0.0 107.748 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.1 134.9 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.55 135.11 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 101' ' ' LEU . 13.0 p -128.55 159.33 35.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.22 0.918 . . . . 0.0 112.289 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -110.17 177.3 4.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 108.78 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -75.87 0.36 18.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.405 -1.434 . . . . 0.0 112.995 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -88.21 -3.6 58.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.386 1.074 . . . . 0.0 111.013 172.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.67 76.59 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -90.31 143.27 26.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 m -108.45 145.89 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.513 1.525 . . . . 0.0 107.805 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -87.29 139.43 30.56 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -148.02 146.37 28.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.699 1.599 . . . . 0.0 107.051 -170.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.66 154.79 44.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.226 1.375 . . . . 0.0 113.577 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -98.54 118.23 34.77 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.193 1.797 . . . . 0.0 106.857 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -77.57 141.83 39.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 121.886 2.13 . . . . 0.0 108.471 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -55.13 127.1 27.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.368 1.067 . . . . 0.0 109.477 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -6.39 20.28 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.612 -1.104 . . . . 0.0 115.089 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -91.29 -32.13 15.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.787 1.794 . . . . 0.0 111.656 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.1 m80 64.55 -21.84 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.347 2.259 . . . . 0.0 114.611 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -75.9 160.76 29.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.298 1.439 . . . . 0.0 110.643 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.03 149.96 28.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.743 0.817 . . . . 0.0 110.939 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.89 155.38 42.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.362 1.865 . . . . 0.0 111.122 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -84.12 131.84 49.79 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -51.63 128.08 24.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.328 2.685 . . . . 0.0 112.3 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.36 164.54 36.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.751 1.16 . . . . 0.0 112.906 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.16 -178.97 42.75 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 123.458 0.551 . . . . 0.0 112.793 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.89 151.25 23.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.252 0.929 . . . . 0.0 111.913 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 9' ' ' PRO . 78.5 mt -77.91 126.9 38.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -74.08 156.39 87.78 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.69 122.19 10.66 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 109.038 -1.178 . . . . 0.0 109.038 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 0.0 87.98 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.643 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.14 154.35 41.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.361 2.081 . . . . 0.0 109.837 169.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.07 153.61 17.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.07 84.02 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.324 -0.86 . . . . 0.0 111.719 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.81 -31.95 70.13 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.288 0.635 . . . . 0.0 110.367 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -70.93 -39.6 72.57 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.271 -0.893 . . . . 0.0 109.792 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.31 83.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -63.3 -50.72 68.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.792 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 55.8 m-85 -66.72 -33.06 74.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.926 1.239 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -60.86 -50.28 74.05 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.07 1.305 . . . . 0.0 109.187 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.27 -27.58 62.58 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.384 0.538 . . . . 0.0 110.33 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.69 -43.43 90.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 109.454 170.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -69.55 -48.76 59.26 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.474 0.579 . . . . 0.0 110.834 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.85 -30.7 69.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.988 1.267 . . . . 0.0 112.609 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -93.29 -51.48 4.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.153 0.981 . . . . 0.0 110.532 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.61 -31.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.267 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.17 -1.85 78.73 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.464 1.03 . . . . 0.0 112.275 -171.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.76 155.74 32.93 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.645 1.978 . . . . 0.0 108.854 174.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.5 p -133.09 170.3 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.988 0.915 . . . . 0.0 110.466 -172.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 37.3 mtp180 -46.13 -37.15 6.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.819 2.047 . . . . 0.0 112.52 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -68.77 -26.04 65.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.385 0.674 . . . . 0.0 112.525 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.36 23.59 12.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.522 0.677 . . . . 0.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.5 165.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 O-C-N 120.734 -1.229 . . . . 0.0 112.729 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.83 132.94 29.61 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -73.69 116.21 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 103' ' ' GLN . 95.6 mt -89.63 -36.88 15.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.426 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.41 164.7 36.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.864 0.865 . . . . 0.0 109.749 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 p -162.63 153.41 17.11 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.795 1.238 . . . . 0.0 110.265 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.633 HG22 ' HG2' ' A' ' 150' ' ' GLU . 2.6 p -71.89 138.76 48.41 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.635 -0.666 . . . . 0.0 109.579 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -77.86 -51.41 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -70.26 171.12 10.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 110.962 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 84.2 m95 -112.38 123.72 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 168.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -79.2 142.32 36.38 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.62 152.35 43.9 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.289 1.036 . . . . 0.0 108.955 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -140.3 139.78 35.55 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.974 1.31 . . . . 0.0 108.115 169.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -77.27 139.04 39.74 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.68 139.17 95.76 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.766 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -68.2 145.36 66.19 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 104.431 -2.95 . . . . 0.0 104.431 167.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.3 mtpt -67.96 -12.94 61.72 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.05 -1.657 . . . . 0.0 114.16 -168.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.11 -31.01 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.809 0.732 . . . . 0.0 112.806 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.5 -20.01 21.4 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.776 0.83 . . . . 0.0 112.085 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 81' ' ' LYS . 61.5 t -65.16 135.28 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -101.37 89.89 3.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 109.807 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.8 -22.31 63.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.918 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -74.86 -19.22 60.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.573 0.749 . . . . 0.0 112.728 -171.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -117.37 161.0 20.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.487 1.115 . . . . 0.0 109.957 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -128.24 135.45 27.55 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 125.178 1.391 . . . . 0.0 109.59 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.48 148.56 92.16 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 O-C-N 122.731 0.858 . . . . 0.0 110.384 -10.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.76 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 109.532 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.5 p -89.91 138.58 31.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.0 109.566 170.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.44 -13.07 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 170.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.29 -174.05 31.72 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.09 -178.23 6.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.593 1.157 . . . . 0.0 109.02 -172.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -127.33 137.26 52.76 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 104.322 -2.474 . . . . 0.0 104.322 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -122.59 122.7 39.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 120.82 1.646 . . . . 0.0 107.951 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 ttmm -111.78 129.1 56.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -114.27 152.21 31.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -134.78 121.73 21.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 16' ' ' CYS . 14.9 tp -88.67 119.64 29.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.56 144.46 43.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.667 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.1 tt0 -97.47 132.7 42.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 168.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 141.93 58.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 108.923 171.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.91 -48.79 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.568 0.622 . . . . 0.0 109.827 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.5 m -89.33 -19.58 25.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.408 0.683 . . . . 0.0 111.786 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.59 20.67 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.42 -22.35 31.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.093 1.757 . . . . 0.0 113.105 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.08 59.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 113.438 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -92.62 16.55 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.73 139.73 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.694 1.198 . . . . 0.0 108.088 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -120.6 -50.98 2.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.593 0.757 . . . . 0.0 112.304 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.2 mtp 70.44 9.25 6.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.84 2.456 . . . . 0.0 115.122 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.71 76.96 1.03 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 124.016 1.865 . . . . 0.0 110.184 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.85 -59.58 2.67 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.05 -2.341 . . . . 0.0 107.695 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -66.37 162.73 19.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.157 1.383 . . . . 0.0 109.452 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 m -63.01 -33.73 76.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.087 0.555 . . . . 0.0 110.367 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 128.95 52.89 Favored Pre-proline 0 N--CA 1.447 -0.587 0 C-N-CA 124.911 1.284 . . . . 0.0 110.193 170.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.88 137.23 48.3 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.357 2.038 . . . . 0.0 108.097 168.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.83 -16.0 59.56 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.876 -0.515 . . . . 0.0 111.566 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -119.91 138.43 53.43 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.63 -26.73 45.3 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.924 1.29 . . . . 0.0 111.255 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.84 162.37 34.55 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 153.74 45.93 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.306 1.043 . . . . 0.0 108.193 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -152.42 159.63 43.37 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -109.38 131.99 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.72 170.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.062 1.745 . . . . 0.0 109.739 -169.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.8 p -65.41 166.82 9.57 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -18.65 64.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.858 172.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -98.81 -31.62 11.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 113.225 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.21 -43.98 96.21 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.84 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.36 -24.84 76.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 122.508 1.931 . . . . 0.0 113.264 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.7 t -67.55 -41.4 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -57.68 -35.53 70.72 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.528 -0.732 . . . . 0.0 111.963 -171.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -79.13 -26.4 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.46 171.66 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 118.499 0.591 . . . . 0.0 112.127 -172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 175.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.9 m -54.7 -49.99 69.39 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.031 1.733 . . . . 0.0 114.208 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -72.35 -32.34 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.178 -0.952 . . . . 0.0 111.459 -174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.1 -39.96 32.38 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.221 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -47.25 -46.2 24.32 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.899 0.88 . . . . 0.0 110.733 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.12 -45.76 92.02 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.245 0.341 . . . . 0.0 110.287 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.5 -46.86 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.772 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -62.01 -47.68 83.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.45 -42.18 96.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.349 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.64 -49.69 76.5 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.436 1.017 . . . . 0.0 110.5 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.9 t -56.68 -42.58 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.217 1.007 . . . . 0.0 109.39 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.7 mmt -67.43 -51.81 47.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.268 1.027 . . . . 0.0 108.273 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -37.03 69.91 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.804 0.842 . . . . 0.0 110.729 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.633 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.1 tp10 -59.18 -35.33 73.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 118.797 0.726 . . . . 0.0 111.526 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.62 -13.49 15.29 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.641 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.21 -39.13 63.49 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.401 1.48 . . . . 0.0 110.949 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -66.86 -32.07 73.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.289 0.636 . . . . 0.0 110.722 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.2 -44.95 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.4 -40.54 78.64 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 CA-C-O 117.365 -1.303 . . . . 0.0 110.097 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -56.07 -51.93 66.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 120.82 1.645 . . . . 0.0 109.969 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -71.25 -28.7 64.36 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.93 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.401 HD21 ' NE2' ' A' ' 103' ' ' GLN . 19.1 tp -63.37 -41.11 98.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.084 1.354 . . . . 0.0 110.184 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.8 -43.98 97.38 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.66 -30.02 66.51 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -86.69 -15.69 38.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.595 -170.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.255 33.7 p 41.83 63.81 6.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 126.802 2.041 . . . . 0.0 109.441 -174.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.98 -178.93 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 121.507 1.472 . . . . 0.0 114.171 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt . . . . . 0 C--O 1.252 1.197 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.978 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.276 13.7 ptm . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.264 0.9 OUTLIER 66.76 134.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.886 2.075 . . . . 0.0 109.41 -168.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.85 -68.19 0.45 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.456 0.702 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -163.06 -51.68 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.969 0.908 . . . . 0.0 112.421 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.04 17.04 14.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 112.82 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.54 7.09 65.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.36 0.981 . . . . 0.0 113.741 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -96.19 155.66 16.67 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.49 152.65 71.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.649 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -88.11 134.87 3.14 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.276 1.984 . . . . 0.0 111.135 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -131.79 163.92 27.17 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.022 1.329 . . . . 0.0 109.484 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 98' ' ' LYS . 3.2 m -133.04 167.77 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.263 175.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 163.08 33.3 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.82 144.94 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.1 137.91 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.81 133.19 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 22' ' ' VAL . 61.7 m -124.45 145.59 49.42 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.814 0.696 . . . . 0.0 110.571 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -97.74 170.58 8.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.849 1.259 . . . . 0.0 108.626 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.61 8.56 3.46 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.039 -1.663 . . . . 0.0 113.151 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.63 -3.68 54.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.386 1.075 . . . . 0.0 111.164 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.35 18.69 79.89 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 118.861 0.755 . . . . 0.0 112.071 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -90.23 141.42 28.72 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.3 m -108.31 147.74 12.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.081 1.753 . . . . 0.0 108.452 178.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.6 ttm -65.86 138.58 57.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.583 0.753 . . . . 0.0 109.337 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -142.82 140.36 31.28 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.78 1.632 . . . . 0.0 106.833 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -139.17 161.68 36.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.66 1.118 . . . . 0.0 112.187 -171.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -118.97 118.88 32.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.555 1.942 . . . . 0.0 106.978 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -67.21 150.68 48.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.605 1.093 . . . . 0.0 108.873 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.41 142.35 58.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.35 6.57 75.88 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.318 -1.268 . . . . 0.0 114.038 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -134.03 157.21 46.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.543 1.671 . . . . 0.0 109.612 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -98.42 -14.12 20.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.864 0.466 . . . . 0.0 112.227 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -78.57 152.24 31.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.397 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -110.6 158.17 18.87 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.461 1.104 . . . . 0.0 111.155 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -159.74 159.31 32.67 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.728 1.211 . . . . 0.0 110.396 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.73 157.49 71.92 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.84 134.65 60.02 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -131.26 169.59 15.76 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.059 1.344 . . . . 0.0 112.282 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.08 169.61 38.29 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.571 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.7 137.24 13.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.3 mt -75.14 126.24 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -84.65 150.41 56.43 Favored Pre-proline 0 C--O 1.235 0.324 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.26 122.18 10.28 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.775 1.65 . . . . 0.0 109.832 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.79 -20.64 43.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.845 1.212 . . . . 0.0 113.469 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.08 152.92 42.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.722 1.761 . . . . 0.0 109.941 170.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.2 p -83.43 169.8 15.16 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.1 80.55 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 122.001 -0.437 . . . . 0.0 110.461 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.74 -38.79 64.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.592 0.757 . . . . 0.0 110.586 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -67.82 -41.32 83.24 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.251 -0.906 . . . . 0.0 110.03 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -36.41 81.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.956 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.57 -53.72 52.93 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.147 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -67.68 -42.19 82.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.302 0.955 . . . . 0.0 111.706 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -45.44 94.79 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.971 0.509 . . . . 0.0 109.942 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.76 -31.13 35.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.094 -0.479 . . . . 0.0 110.227 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 58' ' ' VAL . 32.9 tp -53.27 -43.27 67.29 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.709 0.686 . . . . 0.0 110.091 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -57.14 -38.21 73.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.464 0.574 . . . . 0.0 111.231 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -70.29 -20.89 63.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.097 0.862 . . . . 0.0 111.734 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -94.73 -48.88 5.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.357 1.063 . . . . 0.0 110.936 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 60' ' ' LEU . 3.5 p -120.17 -3.3 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.759 1.224 . . . . 0.0 112.413 -169.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.83 1.02 9.85 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 121.24 -0.913 . . . . 0.0 112.957 -170.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 58' ' ' VAL . 14.6 tp -79.08 144.07 34.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.277 1.031 . . . . 0.0 110.002 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 p -122.5 164.43 18.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.647 1.179 . . . . 0.0 109.498 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -40.71 -38.87 0.97 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.168 1.787 . . . . 0.0 112.616 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -67.34 -20.33 65.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.269 -169.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.72 21.03 10.91 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.527 0.603 . . . . 0.0 112.528 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.61 160.36 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.925 -1.109 . . . . 0.0 110.73 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -138.12 137.37 37.64 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.13 120.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.624 HD11 ' HB2' ' A' ' 103' ' ' GLN . 96.4 mt -94.76 -36.77 11.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.721 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.56 164.3 34.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.127 0.971 . . . . 0.0 109.523 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.0 p -160.42 151.47 19.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.267 1.427 . . . . 0.0 109.897 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -69.09 131.47 45.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.729 0.776 . . . . 0.0 109.645 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -79.81 -48.16 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -75.53 179.94 4.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.44 2.296 . . . . 0.0 108.247 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.555 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 73.2 m95 -114.49 142.91 45.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 168.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.37 85.43 6.57 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -81.44 144.01 31.69 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.43 147.93 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.41 144.67 25.36 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.8 mt -73.05 144.88 85.52 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 124.998 1.319 . . . . 0.0 111.302 171.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.32 149.26 69.46 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 105.174 -2.664 . . . . 0.0 105.174 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.1 mtpt -68.73 -13.46 62.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.944 -1.723 . . . . 0.0 113.956 -169.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -61.76 -30.78 71.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.094 0.861 . . . . 0.0 112.789 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.64 -18.16 21.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.906 0.883 . . . . 0.0 112.123 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 81' ' ' LYS . 80.1 t -63.61 134.9 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -98.9 89.83 4.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.71 0.804 . . . . 0.0 109.687 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.5 -21.2 62.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.082 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.81 -30.55 56.46 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 t -97.64 162.15 13.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.576 1.15 . . . . 0.0 109.523 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -130.67 132.43 23.94 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.529 1.532 . . . . 0.0 108.319 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.25 157.33 93.54 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 O-C-N 122.72 0.853 . . . . 0.0 111.307 -10.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.4 t -74.45 138.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.889 0.876 . . . . 0.0 109.455 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 p -89.13 122.64 32.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.899 0.88 . . . . 0.0 108.726 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -14.56 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.184 0.902 . . . . 0.0 113.296 172.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.57 38.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -158.19 158.92 35.48 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.052 0.941 . . . . 0.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -101.5 124.82 47.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 169.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.22 123.9 50.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.903 1.229 . . . . 0.0 109.548 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.555 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -86.73 149.33 24.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -127.99 153.89 46.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.057 0.844 . . . . 0.0 109.467 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -134.36 134.29 41.58 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.833 1.253 . . . . 0.0 108.451 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.9 tp -98.08 120.86 39.22 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mt -116.97 146.83 42.77 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.624 ' HB2' HD11 ' A' ' 68' ' ' LEU . 4.3 tt0 -97.42 135.69 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 168.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.55 132.38 49.72 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.0 t -81.29 -46.0 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 122.74 0.416 . . . . 0.0 110.256 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 t -83.12 -37.31 23.94 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.0 -169.04 12.82 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -170.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 -15.88 38.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.61 1.564 . . . . 0.0 114.307 -172.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.03 63.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 0.0 113.031 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -95.12 26.18 3.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.19 0.996 . . . . 0.0 113.357 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 89.7 mt -99.58 139.98 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.808 1.243 . . . . 0.0 108.765 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -138.98 117.2 11.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.779 1.232 . . . . 0.0 109.757 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 mmt -89.78 -4.29 57.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.424 0.69 . . . . 0.0 112.58 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -119.8 75.5 1.08 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 124.207 1.956 . . . . 0.0 107.145 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 p -65.48 -65.07 0.72 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 111.204 -2.725 . . . . 0.0 106.777 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -78.48 173.63 12.17 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -58.1 -42.15 85.05 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.166 -0.959 . . . . 0.0 109.168 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 134.91 82.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 108.512 169.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -62.16 135.36 54.15 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 107.537 -1.755 . . . . 0.0 107.537 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -85.17 -34.21 22.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -109.88 135.82 50.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -75.03 -35.08 61.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.671 0.788 . . . . 0.0 110.475 173.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.48 29.84 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -148.84 158.77 44.41 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.566 0.746 . . . . 0.0 109.057 169.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -145.9 167.57 22.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.916 1.286 . . . . 0.0 108.828 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -109.9 129.7 55.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.46 153.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.815 1.246 . . . . 0.0 110.714 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 m -57.85 143.04 43.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.036 0.835 . . . . 0.0 109.835 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -32.87 61.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -83.84 -21.23 32.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.158 1.344 . . . . 0.0 112.692 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -60.11 -50.79 84.5 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.118 -1.42 . . . . 0.0 113.407 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.84 -27.7 85.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 122.681 1.993 . . . . 0.0 113.291 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.69 -31.59 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.848 0.859 . . . . 0.0 109.013 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -66.22 -24.42 66.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.163 -0.961 . . . . 0.0 111.679 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.94 -27.91 28.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.14 168.58 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 118.744 0.702 . . . . 0.0 112.397 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -83.16 175.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.379 1.471 . . . . 0.0 110.487 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 m -52.44 -51.4 59.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.825 1.65 . . . . 0.0 114.586 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -74.05 -36.77 64.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.458 1.026 . . . . 0.0 110.716 -175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.05 -36.61 66.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.51 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -51.28 -45.14 62.03 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.106 0.866 . . . . 0.0 110.493 171.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.63 -42.98 95.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.503 0.592 . . . . 0.0 110.926 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.15 -52.62 56.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.55 -32.56 74.21 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.211 -0.93 . . . . 0.0 111.24 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -67.27 -42.83 83.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.237 1.38 . . . . 0.0 110.327 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.41 -42.65 96.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.76 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.2 -25.95 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.49 1.041 . . . . 0.0 111.427 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -88.42 -58.66 2.48 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -33.41 70.47 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.716 1.207 . . . . 0.0 112.501 -172.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.72 -40.12 78.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.391 0.996 . . . . 0.0 110.565 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -106.42 -9.86 16.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.272 1.029 . . . . 0.0 112.952 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.33 73.12 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 125.187 1.395 . . . . 0.0 110.594 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -67.13 -31.98 72.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.677 0.791 . . . . 0.0 110.653 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.75 -43.63 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.31 -41.36 81.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.083 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -46.53 87.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 120.478 1.49 . . . . 0.0 110.53 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 t -66.46 -28.45 68.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 110.689 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.7 tp -69.59 -31.34 69.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.299 -1.501 . . . . 0.0 109.875 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -75.76 -25.74 56.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.67 -9.3 56.78 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.026 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.62 20.98 4.24 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.977 0.894 . . . . 0.0 108.915 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.385 24.6 p 73.71 140.61 0.08 OUTLIER Pre-proline 0 N--CA 1.436 -1.149 1 C-N-CA 133.386 4.674 . . . . 0.0 114.434 170.521 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.34 33.46 0.51 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.444 2.096 . . . . 0.0 113.061 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.254 1.329 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.154 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tmm? . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt -132.16 130.88 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.53 -68.37 0.34 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.0 -49.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -87.02 11.32 13.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.104 0.962 . . . . 0.0 112.735 -169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.63 -8.4 79.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.698 1.142 . . . . 0.0 113.069 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -90.4 159.13 16.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.263 1.032 . . . . 0.0 108.498 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -137.65 142.33 36.42 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.248 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HB2' HD12 ' A' ' 40' ' ' ILE . 69.5 Cg_endo -89.34 135.91 2.71 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.879 1.719 . . . . 0.0 111.035 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.3 159.75 41.25 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.158 -0.964 . . . . 0.0 110.387 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.56 159.8 34.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 119.538 1.063 . . . . 0.0 110.418 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.88 160.21 24.21 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.05 143.66 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.182 1.393 . . . . 0.0 107.762 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.01 136.93 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm -121.09 133.03 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 101' ' ' LEU . 13.0 p -124.97 156.65 37.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.506 0.594 . . . . 0.0 111.623 170.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -104.51 172.73 6.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.438 1.495 . . . . 0.0 108.18 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -73.79 2.6 8.01 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.269 -1.519 . . . . 0.0 113.119 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -88.01 -4.84 58.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.069 0.947 . . . . 0.0 111.277 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.57 19.87 79.75 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.943 0.792 . . . . 0.0 111.601 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.87 147.01 25.3 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.09 148.72 17.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.171 1.789 . . . . 0.0 107.058 174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.6 ptm -76.12 148.5 37.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.392 0.542 . . . . 0.0 109.863 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -148.22 140.1 23.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -174.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB1' ' CD2' ' A' ' 121' ' ' PHE . . . -144.32 148.17 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.426 1.466 . . . . 0.0 113.087 -169.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -101.06 115.29 30.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.661 1.984 . . . . 0.0 106.559 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -68.75 151.6 46.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.663 1.119 . . . . 0.0 109.226 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.32 132.52 54.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.46 85.03 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.746 1.165 . . . . 0.0 113.726 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -115.3 162.32 17.27 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.33 1.565 . . . . 0.0 110.296 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.62 -13.68 16.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.479 0.711 . . . . 0.0 111.662 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -86.34 150.35 24.39 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.726 1.61 . . . . 0.0 110.968 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -103.61 151.64 22.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.141 0.977 . . . . 0.0 110.061 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -155.18 166.87 32.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.139 1.376 . . . . 0.0 110.211 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -85.38 155.15 59.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.95 127.2 19.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.321 2.014 . . . . 0.0 110.473 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -157.55 163.55 38.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.69 44.26 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.792 -0.567 . . . . 0.0 113.454 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.75 152.6 41.06 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 124.733 1.159 . . . . 0.0 112.075 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 9' ' ' PRO . 62.2 mt -84.03 122.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 169.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.22 159.38 85.58 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.0 123.87 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 121.199 1.266 . . . . 0.0 109.414 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.17 -6.07 80.79 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 118.772 -1.015 . . . . 0.0 114.646 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.37 156.55 39.36 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.043 1.922 . . . . 0.0 109.227 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -93.26 167.29 11.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.67 83.37 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.62 -0.675 . . . . 0.0 110.987 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -36.46 69.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.299 0.64 . . . . 0.0 110.503 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.76 -36.21 70.33 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.893 -1.129 . . . . 0.0 110.629 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.21 86.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -63.4 -51.74 64.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.104 -0.951 . . . . 0.0 108.672 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -66.76 -31.74 72.59 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 112.133 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -63.69 -52.95 58.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.528 1.058 . . . . 0.0 109.071 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -71.23 -25.07 62.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -172.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.73 -42.51 88.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 171.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -71.91 -50.14 31.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.121 0.873 . . . . 0.0 110.753 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.28 -21.92 66.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.905 1.229 . . . . 0.0 112.806 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.39 -53.5 2.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.791 1.236 . . . . 0.0 111.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.2 -21.92 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 112.396 -168.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 -3.19 33.66 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.204 1.383 . . . . 0.0 112.887 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.77 157.95 34.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.712 2.005 . . . . 0.0 109.768 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 p -137.11 168.15 20.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 110.185 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -53.14 -34.09 55.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.099 1.76 . . . . 0.0 112.292 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.781 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.95 24.39 12.72 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.844 1.202 . . . . 0.0 111.419 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.74 166.06 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.912 -1.118 . . . . 0.0 112.266 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 133.73 27.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.599 169.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.57 113.01 10.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 103' ' ' GLN . 70.8 mt -88.16 -34.0 18.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.489 173.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.44 39.12 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 109.759 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 p -158.66 154.33 26.26 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.112 1.365 . . . . 0.0 110.04 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.416 HG22 ' HG2' ' A' ' 150' ' ' GLU . 2.1 p -69.04 139.72 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.508 0.671 . . . . 0.0 111.472 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -86.11 -28.48 23.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.804 1.642 . . . . 0.0 109.838 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -121.77 148.64 44.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.022 2.129 . . . . 0.0 108.536 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -80.68 133.39 35.7 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.24 64.79 7.06 Favored 'General case' 0 N--CA 1.46 0.072 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -71.52 146.17 48.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -142.94 145.53 33.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.285 0.634 . . . . 0.0 110.256 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.26 147.04 23.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.87 148.06 98.92 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.823 0.849 . . . . 0.0 109.782 169.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -66.92 143.86 68.11 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 N-CA-C 104.311 -2.996 . . . . 0.0 104.311 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.1 mtpt -67.99 -13.07 61.89 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.051 -1.656 . . . . 0.0 114.135 -168.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -57.15 -30.56 64.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 170.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.8 mt -91.79 -20.49 21.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.382 0.673 . . . . 0.0 112.034 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.509 HG23 ' HA ' ' A' ' 81' ' ' LYS . 48.0 t -67.17 135.23 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -103.34 89.97 3.56 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.188 0.995 . . . . 0.0 108.486 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.423 ' CE2' HG11 ' A' ' 84' ' ' VAL . 84.7 m95 -65.28 -9.31 23.1 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.17 27.93 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.443 1.097 . . . . 0.0 110.472 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.6 p -77.16 157.72 30.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.113 0.959 . . . . 0.0 112.873 -169.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -130.56 110.16 16.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.697 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.37 142.26 64.97 Favored 'Cis proline' 0 CA--C 1.537 0.66 0 N-CA-C 108.09 -1.542 . . . . 0.0 108.09 -11.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.4 p -64.47 133.96 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 O-C-N 121.659 -0.65 . . . . 0.0 110.79 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.3 t -72.57 124.73 25.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.97 -14.9 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.24 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.42 -179.56 48.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 119.689 1.131 . . . . 0.0 110.342 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.77 152.98 45.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.308 . . . . 0.0 110.037 173.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.55 135.51 34.75 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -128.42 129.34 46.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.09 0.859 . . . . 0.0 110.485 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -111.92 142.02 44.84 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -124.2 155.28 38.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.417 0.553 . . . . 0.0 109.703 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -137.73 125.64 22.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.42 HD11 ' SG ' ' A' ' 16' ' ' CYS . 10.9 tp -92.33 122.77 35.11 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 168.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mt -117.87 148.28 42.27 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.459 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.0 tt0 -97.34 132.37 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.76 138.31 58.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.881 1.272 . . . . 0.0 108.922 171.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -88.38 -49.45 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.241 0.616 . . . . 0.0 110.09 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.2 m -87.08 -19.38 28.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.77 -169.39 20.13 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -20.42 44.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.649 1.58 . . . . 0.0 113.792 -171.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -30.58 43.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.508 1.123 . . . . 0.0 112.839 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.87 13.0 23.97 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 66.9 mt -85.17 137.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -136.7 105.2 5.77 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.1 mmt -82.67 1.7 37.17 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.67 73.97 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 123.942 1.83 . . . . 0.0 107.961 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -70.05 -64.13 0.95 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.589 -2.096 . . . . 0.0 105.558 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.0 m -72.44 167.24 20.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.459 1.503 . . . . 0.0 107.647 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 m -61.46 -41.16 96.79 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.286 -0.884 . . . . 0.0 109.171 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.49 132.76 89.27 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.67 1.588 . . . . 0.0 109.387 170.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.94 143.3 99.32 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.763 1.642 . . . . 0.0 109.537 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -86.74 -21.1 26.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.76 0.424 . . . . 0.0 110.673 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.436 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 85.2 m-85 -128.37 144.07 51.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.067 0.947 . . . . 0.0 109.136 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.74 -30.52 59.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.152 0.981 . . . . 0.0 110.522 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.86 155.54 26.44 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 150.39 37.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -146.58 170.28 17.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 109.13 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -116.2 137.23 52.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.05 154.17 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 109.954 -169.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.8 m -60.32 144.06 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.947 0.794 . . . . 0.0 109.504 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -25.42 63.83 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -88.66 -10.9 46.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.403 1.456 . . . . 0.0 113.38 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -72.79 -47.35 8.9 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.608 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.84 -24.53 68.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.903 2.073 . . . . 0.0 112.921 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.2 -30.77 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.268 1.027 . . . . 0.0 109.273 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.06 -24.4 63.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.042 -1.036 . . . . 0.0 111.514 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -81.18 -30.12 34.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.068 0.849 . . . . 0.0 112.87 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.12 168.43 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.554 0.615 . . . . 0.0 112.638 -169.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -85.13 175.33 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.206 1.402 . . . . 0.0 110.417 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -52.65 -50.68 62.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.617 1.567 . . . . 0.0 114.64 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -74.16 -34.74 63.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.142 0.883 . . . . 0.0 110.984 -175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.4 -37.92 60.2 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.705 -0.622 . . . . 0.0 110.353 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -50.18 -44.11 52.73 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.538 171.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -65.45 -41.52 93.34 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.626 0.648 . . . . 0.0 111.064 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.9 -53.0 46.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -65.11 -31.93 73.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.385 0.993 . . . . 0.0 112.229 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -66.21 -44.6 83.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.255 1.389 . . . . 0.0 110.276 171.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -59.54 -43.76 93.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.378 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.8 t -56.95 -27.95 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.571 1.148 . . . . 0.0 111.779 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -87.75 -58.18 2.67 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -58.18 -36.07 72.52 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.082 0.953 . . . . 0.0 112.276 -173.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.7 tp10 -58.81 -36.82 75.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 119.086 0.857 . . . . 0.0 110.723 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -105.27 -12.76 15.93 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.055 0.942 . . . . 0.0 112.337 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.96 68.7 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.416 1.487 . . . . 0.0 110.78 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 m -68.19 -30.65 69.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.759 0.823 . . . . 0.0 111.058 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.9 t -69.68 -43.03 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.72 -43.88 88.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.545 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -45.19 84.37 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 121.991 2.178 . . . . 0.0 111.666 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -81.2 -8.71 59.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 125.146 1.378 . . . . 0.0 111.924 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.84 -42.5 19.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 120.417 -1.427 . . . . 0.0 108.851 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.45 -41.8 90.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 162' ' ' THR . 38.4 mt-10 -89.56 40.99 1.02 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.195 1.398 . . . . 0.0 114.226 170.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 39.21 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 136.257 5.823 . . . . 0.0 120.679 165.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 160' ' ' GLU . 6.3 t -136.04 77.28 49.93 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.85 158.44 51.06 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.167 1.911 . . . . 0.0 110.296 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.253 1.248 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.531 -169.682 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 119.007 -0.52 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.03 143.95 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.48 -77.46 0.07 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.682 0.793 . . . . 0.0 110.903 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -164.47 -44.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -91.79 16.89 9.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.712 1.205 . . . . 0.0 113.072 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 17.29 60.28 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.11 0.862 . . . . 0.0 112.929 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -111.93 155.31 23.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.8 128.08 22.92 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.44 141.27 46.07 Favored 'Trans proline' 0 C--N 1.345 0.391 0 CA-C-N 121.328 1.51 . . . . 0.0 110.053 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -138.43 148.24 44.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.78 0.832 . . . . 0.0 109.214 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 40' ' ' ILE . 4.6 m -134.52 149.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.206 1.402 . . . . 0.0 108.081 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -144.85 161.6 28.08 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 122.043 -0.411 . . . . 0.0 112.246 174.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.21 143.2 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 122.991 0.517 . . . . 0.0 109.933 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -122.44 131.59 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 mm -108.39 130.96 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.597 ' SG ' HG12 ' A' ' 22' ' ' VAL . 64.2 m -111.98 146.82 37.18 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 124.362 1.039 . . . . 0.0 109.289 169.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -98.78 176.65 5.54 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 14.38 3.71 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.905 -1.122 . . . . 0.0 113.028 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -106.35 -3.85 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.587 1.555 . . . . 0.0 111.307 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.47 83.22 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.756 -170.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -80.56 149.8 29.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.075 1.438 . . . . 0.0 107.477 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.597 HG12 ' SG ' ' A' ' 16' ' ' CYS . 6.4 m -128.03 153.49 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.969 2.107 . . . . 0.0 108.424 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.7 ptm -68.18 153.7 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.845 0.458 . . . . 0.0 110.713 171.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -154.74 132.34 11.33 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.03 150.54 41.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.39 1.45 . . . . 0.0 111.468 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -102.4 115.57 30.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -70.1 149.07 47.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.844 1.656 . . . . 0.0 109.644 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.67 140.91 57.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.16 85.96 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.219 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -123.34 169.08 11.69 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.025 1.413 . . . . 0.0 109.812 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -125.69 27.61 6.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.11 1.364 . . . . 0.0 108.93 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -125.35 143.3 51.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.042 1.337 . . . . 0.0 108.458 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -99.48 149.48 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.812 0.845 . . . . 0.0 110.491 -174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -159.77 168.65 25.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.918 1.287 . . . . 0.0 110.214 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.83 152.54 66.24 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -46.99 129.57 15.07 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.582 2.855 . . . . 0.0 111.443 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 7.2 pt20 -161.35 155.88 23.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.163 0.985 . . . . 0.0 110.176 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.55 168.21 40.84 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.265 0.935 . . . . 0.0 111.664 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.03 147.4 39.57 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 11' ' ' VAL . 68.6 mt -74.78 113.36 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 169.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.68 144.59 96.27 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.39 127.18 24.49 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.681 1.587 . . . . 0.0 110.883 -169.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.34 -8.83 77.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 114.15 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.64 152.84 39.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.829 1.814 . . . . 0.0 111.273 171.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.0 p -86.62 166.81 15.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 167.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.78 77.07 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 120.723 -1.236 . . . . 0.0 111.588 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.92 -38.3 61.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.362 0.665 . . . . 0.0 110.534 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -66.55 -40.27 88.97 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.55 -33.26 72.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.904 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.404 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 12.0 tmm? -56.75 -50.42 72.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 60.7 m-85 -66.67 -44.67 81.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.915 0.78 . . . . 0.0 111.84 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -54.92 -52.02 64.25 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.474 1.034 . . . . 0.0 111.04 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.96 -36.14 64.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.5 tp -53.42 -51.14 63.57 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.409 0.684 . . . . 0.0 110.129 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.78 -43.23 99.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -63.42 -23.51 67.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.728 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.81 -35.9 4.03 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 120.495 1.498 . . . . 0.0 113.385 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.561 ' HB ' HG23 ' A' ' 111' ' ' ILE . 27.5 m -117.02 5.04 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 119.373 0.988 . . . . 0.0 111.959 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.55 -4.3 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.781 -1.2 . . . . 0.0 114.869 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.1 144.26 34.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.887 1.675 . . . . 0.0 109.987 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -122.58 163.0 20.79 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.296 1.038 . . . . 0.0 109.813 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 47.3 mtp180 -42.02 -40.59 2.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.876 2.07 . . . . 0.0 112.527 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -67.84 -20.86 65.2 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.37 -0.824 . . . . 0.0 113.131 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.56 20.69 15.78 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.366 0.53 . . . . 0.0 111.516 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -137.68 161.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 O-C-N 120.533 -1.354 . . . . 0.0 112.896 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.55 138.81 46.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.09 121.09 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 103' ' ' GLN . 52.3 mt -94.77 -36.1 11.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.563 0.745 . . . . 0.0 109.77 174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.06 164.8 27.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.64 1.176 . . . . 0.0 109.546 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 p -155.54 154.93 32.51 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.593 1.557 . . . . 0.0 108.896 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 150' ' ' GLU . 0.7 OUTLIER -63.25 136.73 57.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.02 0.914 . . . . 0.0 111.106 -169.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtt-85 -80.16 -30.49 38.87 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.061 1.745 . . . . 0.0 108.419 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 146.6 52.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.202 2.201 . . . . 0.0 109.565 176.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -73.89 143.43 45.79 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.94 86.37 6.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -68.85 142.59 54.79 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -137.13 142.31 42.26 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.089 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -131.99 141.48 49.29 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.538 2.335 . . . . 0.0 106.451 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER -104.87 148.42 36.08 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.139 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.464 ' HD2' HD12 ' A' ' 83' ' ' LEU . 74.4 Cg_endo -71.1 153.87 62.53 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.447 2.765 . . . . 0.0 109.148 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.559 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.8 mtmt -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -59.55 -31.09 69.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 170.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' ' 80' ' ' PRO . 53.4 mt -90.77 -15.35 30.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.694 0.798 . . . . 0.0 112.042 -178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 81' ' ' LYS . 95.8 t -67.57 133.37 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -94.51 93.66 7.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.544 0.738 . . . . 0.0 109.195 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -71.09 -23.73 62.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.126 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.81 -26.45 57.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.227 0.611 . . . . 0.0 112.485 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -104.6 156.16 18.21 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.726 0.81 . . . . 0.0 109.249 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.23 137.54 31.09 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 124.94 1.296 . . . . 0.0 109.974 -169.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.23 144.13 80.03 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.807 0.898 . . . . 0.0 110.309 -10.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 141.76 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.014 0.926 . . . . 0.0 110.351 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 p -100.25 140.93 33.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.397 1.079 . . . . 0.0 110.794 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.05 -14.34 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.341 0.656 . . . . 0.0 112.505 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.01 -175.18 36.19 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -164.39 164.93 21.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.317 1.447 . . . . 0.0 110.124 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.41 117.63 34.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 120.341 1.428 . . . . 0.0 108.528 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -94.53 152.86 18.22 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -136.59 150.54 48.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.299 0.5 . . . . 0.0 109.806 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.404 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 48.8 m-85 -136.57 127.53 27.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.65 117.85 30.11 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.29 157.68 19.87 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.743 ' HB2' HD11 ' A' ' 68' ' ' LEU . 8.4 tt0 -110.61 142.43 42.47 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 144.54 38.06 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.669 1.188 . . . . 0.0 109.682 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.35 -44.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.2 m -91.03 -30.12 16.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.385 0.674 . . . . 0.0 111.464 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.58 -178.41 16.41 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.778 1.18 . . . . 0.0 110.478 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -52.46 -25.45 10.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.389 1.876 . . . . 0.0 113.143 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.7 -31.08 62.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 113.916 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.84 16.03 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -170.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.561 HG23 ' HB ' ' A' ' 58' ' ' VAL . 77.9 mt -100.71 134.94 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 107.371 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -123.6 122.58 38.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 125.98 1.712 . . . . 0.0 107.311 174.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.7 mmt -84.32 -17.96 37.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.045 0.538 . . . . 0.0 112.201 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.55 71.81 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.144 1.778 . . . . 0.0 107.293 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.7 p -75.52 -64.86 0.98 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.487 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -85.62 -178.18 6.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 108.648 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 m -56.7 -35.77 68.89 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.733 -0.604 . . . . 0.0 109.925 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.96 130.46 46.42 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.936 1.694 . . . . 0.0 107.722 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.39 135.56 37.02 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 N-CA-C 107.499 -1.77 . . . . 0.0 107.499 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.73 -21.64 63.45 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -121.98 142.23 50.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.942 0.897 . . . . 0.0 109.634 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.24 -23.24 38.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 111.072 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.51 156.95 27.54 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.41 151.44 41.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 109.159 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -153.93 169.91 22.31 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.616 1.166 . . . . 0.0 109.015 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.47 137.29 54.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.57 158.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.406 1.482 . . . . 0.0 111.057 -168.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -64.32 145.27 56.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.277 169.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -30.87 49.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -86.72 -21.23 26.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.354 1.433 . . . . 0.0 112.568 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -63.48 -43.46 78.78 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 116.594 -1.669 . . . . 0.0 114.149 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.22 -30.54 91.46 Favored 'Trans proline' 0 C--N 1.353 0.784 0 CA-C-N 123.364 2.237 . . . . 0.0 112.833 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.17 -27.37 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.097 0.959 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -71.39 -24.35 62.05 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.117 -0.99 . . . . 0.0 111.595 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.66 -33.06 41.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.314 0.961 . . . . 0.0 112.533 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 m -83.76 166.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -85.1 174.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.569 1.548 . . . . 0.0 109.126 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.3 m -54.04 -44.79 71.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.442 1.497 . . . . 0.0 114.418 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -64.1 -41.95 97.08 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.111 0.868 . . . . 0.0 111.463 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.78 -35.65 38.26 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.282 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -52.0 -45.92 64.7 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.232 0.924 . . . . 0.0 110.527 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.96 -44.31 89.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.323 0.511 . . . . 0.0 110.864 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.15 -52.29 49.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -69.25 -30.57 68.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.157 -169.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -66.49 -42.35 87.55 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.507 1.503 . . . . 0.0 110.213 169.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -58.78 -46.24 87.97 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 119.231 0.923 . . . . 0.0 110.606 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.17 -24.61 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.657 1.183 . . . . 0.0 112.041 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.8 mmt -86.54 -58.11 2.74 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -60.0 -32.97 71.36 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.305 1.042 . . . . 0.0 112.082 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.409 ' HG2' HG22 ' A' ' 71' ' ' THR . 2.0 tp10 -59.08 -34.82 72.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.228 0.922 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -112.15 -9.05 13.97 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.466 1.106 . . . . 0.0 113.343 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.47 72.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.977 1.262 . . . . 0.0 110.958 -169.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.0 m -67.8 -32.35 72.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.281 0.632 . . . . 0.0 110.763 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.8 t -69.26 -44.43 80.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.33 -42.34 73.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.432 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.2 mmt -56.95 -54.44 46.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.235 1.38 . . . . 0.0 110.065 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.6 m -70.32 -26.59 63.83 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.835 1.254 . . . . 0.0 110.787 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.62 ' HG ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -65.79 -36.7 84.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.598 1.959 . . . . 0.0 109.541 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -70.54 -20.73 62.78 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.837 1.199 . . . . 0.0 112.668 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.87 0.93 52.69 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.85 1.66 . . . . 0.0 111.306 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -122.6 -47.43 2.09 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.387 1.075 . . . . 0.0 109.253 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.448 ' HB ' ' CD ' ' A' ' 163' ' ' PRO 0.316 30.2 p -85.5 -176.25 0.74 Allowed Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.448 ' CD ' ' HB ' ' A' ' 162' ' ' THR . 8.1 Cg_endo -85.29 -164.59 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.906 3.07 . . . . 0.0 110.759 -169.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 164' ' ' LYS . 9.1 mmpt? . . . . . 0 C--O 1.25 1.083 0 O-C-N 121.101 -1.0 . . . . 0.0 109.606 170.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.12 140.74 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 168.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.55 -45.98 81.29 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 112.978 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -147.71 -118.81 0.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.175 0.99 . . . . 0.0 108.784 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.14 -15.63 56.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.675 1.59 . . . . 0.0 111.396 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.16 178.82 47.51 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 126.133 1.825 . . . . 0.0 109.567 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.4 153.15 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.617 2.767 . . . . 0.0 113.743 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.69 137.56 15.34 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 120.506 -1.371 . . . . 0.0 107.974 174.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -74.09 140.88 28.77 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.323 2.015 . . . . 0.0 109.42 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -141.27 154.09 45.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.765 0.826 . . . . 0.0 109.143 -170.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 98' ' ' LYS . 3.3 m -129.29 136.32 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.524 1.53 . . . . 0.0 107.475 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -122.03 158.09 16.75 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 172.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -124.12 144.33 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 125.619 1.568 . . . . 0.0 107.556 -171.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.65 137.12 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm -120.94 134.17 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 101' ' ' LEU . 19.2 p -124.83 158.24 33.91 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.1 0.864 . . . . 0.0 112.267 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -108.24 170.6 7.91 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.462 1.505 . . . . 0.0 108.658 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -0.56 15.88 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.095 -1.628 . . . . 0.0 113.648 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -81.61 -6.51 59.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.679 0.672 . . . . 0.0 110.544 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.68 78.66 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.028 -0.874 . . . . 0.0 111.489 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -89.15 150.36 22.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.73 148.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.487 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.9 tpp -63.53 128.4 35.66 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.706 1.202 . . . . 0.0 108.175 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 33' ' ' TRP . 10.0 t90 -146.73 140.45 25.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.45 146.55 33.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.669 1.122 . . . . 0.0 113.653 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -85.53 121.32 28.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.329 1.852 . . . . 0.0 106.704 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -79.66 149.62 31.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.63 1.559 . . . . 0.0 109.349 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.42 117.09 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.061 1.745 . . . . 0.0 110.925 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.62 -1.07 31.39 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.738 1.161 . . . . 0.0 115.499 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -83.39 -31.25 26.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.747 1.774 . . . . 0.0 111.987 -172.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.8 m80 54.66 31.2 14.75 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.518 1.127 . . . . 0.0 112.008 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.2 m -138.43 154.03 48.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.548 1.939 . . . . 0.0 107.518 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 24' ' ' TRP . 77.4 m95 -108.55 151.76 25.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.109 0.564 . . . . 0.0 111.176 -169.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -148.17 159.71 43.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.921 1.688 . . . . 0.0 110.833 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.3 141.39 29.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.77 130.19 32.13 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 0.0 111.586 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -159.5 162.26 35.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.243 0.929 . . . . 0.0 112.764 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.19 176.98 47.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.421 1.01 . . . . 0.0 111.926 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.85 150.16 32.25 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 121.166 -1.196 . . . . 0.0 111.859 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 11' ' ' VAL . 46.1 mt -79.94 129.37 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 168.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -71.95 152.86 93.0 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -57.53 123.58 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 120.962 1.108 . . . . 0.0 109.334 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.91 -5.58 84.43 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.384 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.05 155.47 37.19 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.237 2.018 . . . . 0.0 109.681 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -97.19 154.93 17.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.43 88.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.464 -0.773 . . . . 0.0 112.32 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.96 -34.35 75.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.951 0.501 . . . . 0.0 109.96 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -68.03 -42.96 79.79 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.08 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.15 81.5 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 119.272 -0.395 . . . . 0.0 110.15 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -57.41 -49.02 77.56 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.49 -35.18 79.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -62.95 -46.21 88.84 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.817 1.644 . . . . 0.0 109.686 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -69.15 -25.55 64.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.708 -0.62 . . . . 0.0 110.728 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.22 -43.12 95.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.746 -1.221 . . . . 0.0 109.774 172.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.19 -37.11 86.3 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.754 -0.591 . . . . 0.0 110.389 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.33 -35.56 66.05 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.425 -0.797 . . . . 0.0 112.629 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.3 -57.14 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.335 0.654 . . . . 0.0 110.294 -169.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.01 -15.78 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.713 0.805 . . . . 0.0 110.15 -172.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.71 19.29 79.17 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.716 -0.615 . . . . 0.0 111.737 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.7 tp -108.48 150.86 26.85 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.683 1.993 . . . . 0.0 108.266 -172.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m -127.58 168.22 15.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.607 0.763 . . . . 0.0 109.819 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -49.51 -33.95 15.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.664 1.585 . . . . 0.0 112.606 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -65.33 -23.36 66.98 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.037 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.98 24.66 10.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.488 0.661 . . . . 0.0 112.708 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -134.15 165.24 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.336 1.054 . . . . 0.0 111.34 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -141.06 141.37 34.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -80.51 120.59 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 103' ' ' GLN . 79.9 mt -96.49 -35.52 11.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.816 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -157.01 161.97 39.56 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.338 0.59 . . . . 0.0 110.16 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 p -158.16 155.2 28.66 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.651 1.58 . . . . 0.0 109.526 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 150' ' ' GLU . 0.6 OUTLIER -66.7 143.64 56.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.69 0.757 . . . . 0.0 111.595 -170.648 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -80.47 -29.34 37.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.199 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -136.74 152.23 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.594 2.358 . . . . 0.0 109.065 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -76.06 136.93 39.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.75 102.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -106.94 146.19 31.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -147.67 146.36 29.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -91.26 144.68 25.36 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -71.46 149.22 93.63 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 123.943 0.897 . . . . 0.0 110.55 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.52 144.91 74.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 N-CA-C 105.082 -2.699 . . . . 0.0 105.082 167.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.4 mtpt -68.52 -12.1 60.78 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.242 -1.536 . . . . 0.0 113.831 -169.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -58.14 -31.62 67.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -90.0 -23.08 21.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 111.817 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 81' ' ' LYS . 53.1 t -66.05 137.96 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 109.45 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -107.82 90.99 3.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.14 0.976 . . . . 0.0 109.934 169.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -68.55 -24.6 64.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.825 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.58 -24.74 60.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.69 0.796 . . . . 0.0 112.433 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -111.3 156.79 20.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.228 1.011 . . . . 0.0 109.293 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -129.9 140.16 37.82 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.101 1.36 . . . . 0.0 109.239 -169.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.74 150.8 96.06 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 O-C-N 122.826 0.908 . . . . 0.0 110.865 -10.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.7 136.8 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.922 0.889 . . . . 0.0 111.656 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.2 t -81.85 108.37 15.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.6 -14.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.727 0.811 . . . . 0.0 112.584 170.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.37 -174.52 47.03 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.99 157.9 36.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 109.11 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.3 125.61 54.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 169.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -117.26 129.54 55.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.013 0.824 . . . . 0.0 111.405 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HB2' HG12 ' A' ' 11' ' ' VAL . 32.5 mmtt -88.04 154.04 20.79 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 84.5 m95 -132.54 143.6 49.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -130.41 132.5 45.77 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.572 1.149 . . . . 0.0 107.926 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 22.1 tp -97.06 126.03 41.93 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.85 146.64 43.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.6 tt0 -95.72 133.34 39.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 167.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.97 130.78 47.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.225 1.41 . . . . 0.0 108.542 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.9 t -86.31 -38.6 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.587 0.631 . . . . 0.0 110.803 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.5 m -95.41 -21.15 18.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.865 0.757 . . . . 0.0 112.302 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.65 -176.43 24.07 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -19.24 28.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.686 1.594 . . . . 0.0 114.506 -169.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.33 -31.46 33.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.378 1.071 . . . . 0.0 112.912 171.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -92.85 16.07 13.32 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.86 141.17 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -126.23 -49.38 1.56 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.529 0.732 . . . . 0.0 111.676 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 68.64 9.87 7.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.3 2.24 . . . . 0.0 115.2 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.26 69.66 0.83 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 124.325 2.012 . . . . 0.0 111.227 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -56.37 5.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.347 169.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 m -63.99 160.92 16.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.044 1.337 . . . . 0.0 109.063 168.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -63.57 -33.17 75.01 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.99 -0.444 . . . . 0.0 110.721 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.53 131.38 38.28 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.356 1.463 . . . . 0.0 110.27 170.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.67 132.67 31.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.212 1.941 . . . . 0.0 107.883 168.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -73.4 -23.65 60.19 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.862 -0.524 . . . . 0.0 111.074 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -116.12 139.29 50.46 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.543 0.737 . . . . 0.0 110.085 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.74 -21.09 34.85 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.072 0.949 . . . . 0.0 110.709 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -165.93 158.57 31.53 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.39 155.53 47.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.167 0.983 . . . . 0.0 108.497 169.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -144.79 149.03 34.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -96.9 98.11 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.52 168.92 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 110.296 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -64.31 168.13 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 109.507 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -30.68 70.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.196 -0.94 . . . . 0.0 111.563 175.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -92.01 -32.7 15.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.127 1.331 . . . . 0.0 113.607 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -54.39 -45.25 99.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 116.825 -1.559 . . . . 0.0 114.326 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.74 -19.96 68.01 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 123.273 2.205 . . . . 0.0 113.646 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.83 -33.68 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.11 -37.11 85.92 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.268 -0.895 . . . . 0.0 111.11 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -78.75 -27.0 44.65 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.78 166.23 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 118.804 0.729 . . . . 0.0 111.229 -173.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.65 174.23 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.855 1.262 . . . . 0.0 109.857 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.2 m -54.59 -49.42 70.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.493 1.517 . . . . 0.0 113.429 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -60.1 -39.09 84.96 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.317 0.647 . . . . 0.0 111.146 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -85.6 -40.14 16.57 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.974 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -46.85 -46.33 20.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.861 0.864 . . . . 0.0 111.097 170.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.83 -35.49 78.4 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.484 0.713 . . . . 0.0 111.367 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.14 -50.8 17.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.015 . . . . 0.0 110.169 171.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -61.78 -32.69 72.99 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.302 0.955 . . . . 0.0 111.586 -169.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -63.71 -42.99 97.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.259 0.936 . . . . 0.0 111.27 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -61.88 -44.7 96.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.83 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -55.73 -30.84 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.484 1.038 . . . . 0.0 111.222 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.4 mmt -86.25 -54.81 4.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.362 1.065 . . . . 0.0 108.717 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -36.49 73.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.076 0.853 . . . . 0.0 111.635 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 71' ' ' THR . 4.4 mm-40 -57.73 -40.13 78.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.143 0.977 . . . . 0.0 111.077 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.24 -14.15 13.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 111.025 -172.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.31 57.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 111.139 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 m -66.34 -31.48 72.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.312 0.645 . . . . 0.0 111.067 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.32 -45.91 67.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -58.47 -41.12 80.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 116.949 -1.5 . . . . 0.0 110.217 -173.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.3 mmt -54.48 -49.42 70.15 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 121.137 1.79 . . . . 0.0 110.318 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 m -76.64 -26.48 54.94 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.355 1.062 . . . . 0.0 111.144 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 18.6 tp -62.68 -44.22 96.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.111 1.365 . . . . 0.0 109.411 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -60.12 -39.9 87.83 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.845 0.458 . . . . 0.0 110.827 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.41 -32.67 54.91 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -95.26 -22.86 17.52 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.198 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.259 14.6 p 44.36 60.18 12.48 Favored Pre-proline 0 N--CA 1.445 -0.678 0 C-N-CA 126.431 1.892 . . . . 0.0 110.071 -172.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -62.44 158.38 41.12 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.687 0.924 . . . . 0.0 113.524 -168.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -169.294 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 61.43 122.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.628 2.371 . . . . 0.0 110.611 -169.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -63.76 -67.08 0.46 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -169.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -162.68 -52.64 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.82 14.83 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 112.776 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.85 1.08 77.31 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.788 1.185 . . . . 0.0 114.001 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.51 165.28 11.18 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.917 0.865 . . . . 0.0 109.223 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -148.47 145.74 20.98 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.163 1.385 . . . . 0.0 107.456 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HB2' HD12 ' A' ' 40' ' ' ILE . 93.1 Cg_endo -85.71 133.39 4.37 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.476 1.451 . . . . 0.0 109.935 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.7 150.01 52.29 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 109.253 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.461 HG13 HD11 ' A' ' 40' ' ' ILE . 18.3 m -129.13 154.97 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.071 0.948 . . . . 0.0 108.83 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.13 158.29 25.23 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.49 143.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.565 1.146 . . . . 0.0 108.06 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.14 136.73 58.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mm -117.45 135.96 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' HD11 ' A' ' 101' ' ' LEU . 15.6 p -123.56 153.76 40.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.987 0.812 . . . . 0.0 112.117 171.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -103.72 175.12 5.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.425 1.49 . . . . 0.0 109.156 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -78.27 8.07 5.51 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.466 -1.396 . . . . 0.0 113.241 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -96.52 -5.76 38.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.439 1.096 . . . . 0.0 111.447 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.79 66.9 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.867 0.758 . . . . 0.0 111.885 -172.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -98.11 150.35 21.53 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -114.39 146.47 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 106.938 174.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 ptm -78.95 147.69 32.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.851 0.75 . . . . 0.0 109.672 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 20.3 t90 -148.55 146.59 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.63 148.2 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.977 1.262 . . . . 0.0 111.701 -170.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -99.5 127.79 45.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.81 0.732 . . . . 0.0 109.203 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -78.18 145.69 35.45 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.699 0.681 . . . . 0.0 109.867 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.13 136.1 57.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.066 0.946 . . . . 0.0 109.508 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.86 10.26 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.885 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -100.88 -45.21 5.51 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.328 1.564 . . . . 0.0 110.083 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 53.92 29.56 10.15 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.844 1.258 . . . . 0.0 111.826 -174.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -120.28 148.48 43.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.895 2.078 . . . . 0.0 106.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 70.3 m95 -92.82 148.61 21.89 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -152.24 162.89 40.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.538 1.935 . . . . 0.0 110.141 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.54 141.23 23.17 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.39 135.92 44.79 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.036 2.491 . . . . 0.0 111.671 -174.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -158.22 166.96 31.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.445 -171.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.29 172.57 42.31 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.165 0.412 . . . . 0.0 112.127 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.77 143.62 16.83 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.461 HD11 HG13 ' A' ' 11' ' ' VAL . 57.4 mt -76.81 122.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 168.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.99 148.29 78.46 Favored Pre-proline 0 N--CA 1.464 0.253 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.21 124.12 14.55 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.162 1.241 . . . . 0.0 109.055 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.38 -15.79 58.53 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.636 1.112 . . . . 0.0 113.803 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -73.67 148.16 43.02 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.644 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 p -85.96 168.95 13.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 168.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.59 87.88 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.262 -0.899 . . . . 0.0 110.943 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.97 -39.01 63.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.239 0.616 . . . . 0.0 110.611 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.81 -41.82 86.92 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.638 -0.664 . . . . 0.0 109.59 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.85 79.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.411 0.55 . . . . 0.0 109.629 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -62.02 -51.72 66.89 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.06 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.75 -35.35 79.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.916 1.235 . . . . 0.0 111.571 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.35 94.86 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.851 0.86 . . . . 0.0 110.388 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.89 -24.56 26.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.276 0.489 . . . . 0.0 110.933 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.44 HD12 HG21 ' A' ' 58' ' ' VAL . 11.1 tp -55.23 -39.59 69.88 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.152 -0.967 . . . . 0.0 109.471 169.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -63.12 -49.15 75.56 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.004 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.63 -32.74 73.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 0.0 112.715 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.8 -46.29 10.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.763 0.711 . . . . 0.0 111.135 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 54' ' ' LEU . 4.6 t -106.75 -31.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.562 1.145 . . . . 0.0 110.975 -168.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.67 87.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.817 1.199 . . . . 0.0 111.778 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 64' ' ' ASP . 22.9 tp -87.79 155.47 19.88 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.456 1.902 . . . . 0.0 110.039 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 p -131.76 164.48 25.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.765 1.226 . . . . 0.0 109.724 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -41.39 -40.56 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.315 2.246 . . . . 0.0 112.698 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.91 -28.18 69.36 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.42 0.688 . . . . 0.0 112.659 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' HD11 ' A' ' 60' ' ' LEU . 3.8 t70 -111.67 22.6 14.82 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.458 0.647 . . . . 0.0 112.08 -176.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.22 165.38 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 O-C-N 120.769 -1.207 . . . . 0.0 112.544 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 137.48 39.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 168.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.7 mt -74.53 119.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 171.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 103' ' ' GLN . 88.1 mt -95.76 -33.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.889 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -157.05 163.15 39.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.404 1.082 . . . . 0.0 108.745 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -162.24 153.24 17.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.587 1.155 . . . . 0.0 109.573 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 150' ' ' GLU . 3.7 p -70.7 136.09 48.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.346 -170.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -52.51 21.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -72.33 170.4 14.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.582 1.553 . . . . 0.0 111.652 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.477 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 87.0 m95 -108.44 125.58 51.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 167.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.97 106.04 8.4 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -73.62 140.3 46.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.74 143.32 50.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -131.66 141.7 49.66 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 126.283 1.833 . . . . 0.0 106.081 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pp -110.29 150.2 41.22 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.527 1.131 . . . . 0.0 109.613 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 83' ' ' LEU . 82.8 Cg_endo -73.12 158.18 49.57 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.427 3.418 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.6 mtmt -68.41 -18.41 64.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.41 -29.07 68.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD12 ' HD2' ' A' ' 80' ' ' PRO . 52.0 mt -94.55 -7.89 39.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.123 0.969 . . . . 0.0 112.416 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 81' ' ' LYS . 74.2 t -70.03 132.02 33.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.74 97.01 10.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -75.6 -19.52 59.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.861 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.29 -27.94 56.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -101.12 158.17 16.22 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.125 0.97 . . . . 0.0 109.836 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -132.66 132.02 22.43 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 125.967 1.707 . . . . 0.0 109.724 -170.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.5 150.72 89.94 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 O-C-N 122.879 0.936 . . . . 0.0 110.858 -10.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.24 141.55 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.899 1.28 . . . . 0.0 111.269 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.0 p -81.24 123.18 28.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.62 -16.11 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.843 0.747 . . . . 0.0 111.449 169.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.2 -174.16 40.07 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -160.96 162.84 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.223 1.809 . . . . 0.0 110.536 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -98.6 129.58 45.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -111.72 143.32 42.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.045 1.293 . . . . 0.0 110.237 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 6.2 ttmm -131.88 118.92 20.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -104.43 153.89 20.55 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.65 125.31 30.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.58 HD11 ' SG ' ' A' ' 16' ' ' CYS . 13.1 tp -91.16 121.41 32.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 168.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.67 157.09 23.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.682 ' HB2' HD11 ' A' ' 68' ' ' LEU . 5.1 tt0 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 167.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 141.23 56.62 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.956 1.303 . . . . 0.0 109.43 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.94 -47.51 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.114 0.566 . . . . 0.0 110.094 -171.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.8 m -86.1 -16.0 39.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.138 0.575 . . . . 0.0 111.55 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.25 -169.61 22.84 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -17.01 53.55 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 125.264 1.426 . . . . 0.0 114.311 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.68 57.05 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.917 0.887 . . . . 0.0 111.76 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -91.71 51.76 1.91 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 110.958 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.16 129.61 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.76 -53.72 2.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.375 0.67 . . . . 0.0 111.406 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 67.57 12.01 8.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.948 2.099 . . . . 0.0 114.628 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -150.31 73.89 1.17 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 124.016 1.865 . . . . 0.0 109.713 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -71.93 -60.08 2.41 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.269 -2.241 . . . . 0.0 107.843 171.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -66.71 166.44 13.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 109.917 169.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -57.43 -38.01 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.895 . . . . 0.0 110.829 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 130.52 54.77 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.865 1.266 . . . . 0.0 110.454 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.99 142.0 73.02 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.926 1.751 . . . . 0.0 108.453 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -81.34 -24.94 36.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.552 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.08 140.04 53.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.303 0.956 . . . . 0.0 109.998 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.0 -17.97 24.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.691 1.196 . . . . 0.0 111.371 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.85 151.82 23.19 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.57 148.85 31.57 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.816 0.847 . . . . 0.0 108.778 171.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -148.52 172.65 14.16 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.905 1.282 . . . . 0.0 109.204 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -112.97 139.77 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.59 152.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 109.853 -169.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m -59.94 147.9 37.09 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.819 0.736 . . . . 0.0 109.419 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -38.16 37.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -88.53 -25.1 22.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -170.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -57.87 -47.82 98.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.055 -1.45 . . . . 0.0 113.693 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -63.84 -21.3 69.24 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.865 2.059 . . . . 0.0 113.171 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.62 -36.38 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -62.85 -35.57 80.38 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.285 -0.885 . . . . 0.0 111.099 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.89 -21.4 34.27 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -81.73 167.87 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.389 0.995 . . . . 0.0 110.251 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.2 176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.719 1.208 . . . . 0.0 110.638 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 m -53.12 -48.5 67.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.021 1.729 . . . . 0.0 114.494 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -74.5 -31.34 62.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.257 -0.902 . . . . 0.0 111.394 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -80.77 -40.16 25.61 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.253 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -44.33 -46.2 9.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 0.0 111.633 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.96 -42.45 94.6 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.302 0.501 . . . . 0.0 111.352 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -67.5 -44.84 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 121.638 -0.664 . . . . 0.0 109.361 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.45 -41.76 98.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -66.34 -43.9 84.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.159 0.891 . . . . 0.0 110.333 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.31 -47.73 84.6 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.071 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.1 -39.45 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.733 1.213 . . . . 0.0 110.431 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.2 mmt -69.49 -54.45 14.19 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -57.24 -34.66 68.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.878 0.871 . . . . 0.0 111.774 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.627 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -56.07 -45.55 79.29 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.281 1.033 . . . . 0.0 110.185 -178.717 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.445 ' CZ ' HG23 ' A' ' 71' ' ' THR . 3.1 m-85 -104.63 -9.52 18.19 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.485 0.714 . . . . 0.0 112.381 -173.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.13 -43.81 70.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.133 1.773 . . . . 0.0 110.548 -173.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.7 m -66.7 -31.99 73.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.463 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.63 -47.14 81.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 118.055 -0.974 . . . . 0.0 108.384 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.6 t -58.42 -45.35 89.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 109.48 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.9 mtt -61.62 -33.82 74.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.624 0.647 . . . . 0.0 111.216 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -82.79 -31.36 28.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.575 1.15 . . . . 0.0 110.824 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.413 HD21 ' NE2' ' A' ' 103' ' ' GLN . 28.1 tp -58.33 -40.25 81.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.154 1.782 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.93 -29.75 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.194 0.598 . . . . 0.0 111.985 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -93.74 -8.47 40.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.825 1.65 . . . . 0.0 111.74 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -110.63 -22.87 11.4 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.919 1.287 . . . . 0.0 111.397 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.7 p -124.08 38.31 0.38 Allowed Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.3 -178.88 2.36 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.454 2.769 . . . . 0.0 111.25 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.279 1.832 . . . . 0.0 110.026 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tmm? . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.37 128.84 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 169.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.23 -64.83 0.81 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.4 -50.69 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.31 16.79 14.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 113.084 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 10.47 67.94 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.888 0.756 . . . . 0.0 113.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -105.0 155.6 18.81 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 108.714 170.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.96 147.76 67.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.446 169.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HB2' HD12 ' A' ' 40' ' ' ILE . 92.5 Cg_endo -85.55 142.23 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 110.528 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -143.57 155.44 44.3 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.252 1.421 . . . . 0.0 109.498 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.17 153.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.072 0.549 . . . . 0.0 110.372 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.74 160.37 19.36 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.84 146.55 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.76 135.9 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.9 mm -112.03 134.75 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.0 m -124.12 145.38 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.842 0.714 . . . . 0.0 110.008 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -104.22 173.53 6.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.116 1.366 . . . . 0.0 108.51 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.31 9.86 5.27 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.5 -1.375 . . . . 0.0 112.632 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -98.41 -3.51 36.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.099 1.36 . . . . 0.0 111.444 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.2 21.54 70.19 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 118.777 0.717 . . . . 0.0 111.916 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.98 150.7 21.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.647 1.223 . . . . 0.0 107.842 172.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.87 151.04 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 108.296 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.3 mtp -70.56 147.57 49.14 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.277 0.49 . . . . 0.0 110.026 169.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 14.4 t90 -151.2 141.16 22.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.62 145.74 47.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.28 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -97.13 107.95 20.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.961 2.105 . . . . 0.0 107.143 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -74.7 139.32 43.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.556 1.525 . . . . 0.0 109.939 -169.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.68 135.99 57.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.36 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.55 -24.56 3.64 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.546 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -82.49 -44.68 15.68 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.56 1.68 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m80 59.47 28.45 17.83 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.23 0.956 . . . . 0.0 109.734 -168.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -122.93 155.27 37.08 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 108.025 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 73.5 m95 -101.88 146.53 27.7 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -169.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -149.43 164.06 36.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.512 1.525 . . . . 0.0 110.334 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -87.52 143.95 34.82 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 130.49 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 110.59 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -159.07 168.17 27.37 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.113 0.87 . . . . 0.0 112.244 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.44 163.52 37.24 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.653 0.644 . . . . 0.0 111.661 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.6 150.85 45.52 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 9' ' ' PRO . 67.7 mt -77.55 113.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -70.93 156.03 92.58 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.58 123.9 12.83 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 CA-C-N 120.719 1.293 . . . . 0.0 109.674 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.09 -5.35 78.56 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.212 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -74.34 154.19 38.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.075 1.937 . . . . 0.0 110.524 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.4 p -94.56 168.37 10.9 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.46 90.02 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.024 -1.048 . . . . 0.0 111.342 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.06 -38.62 72.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.146 0.578 . . . . 0.0 110.26 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -67.69 -39.18 84.45 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.8 92.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 102' ' ' LEU . 12.6 tmm? -60.52 -52.52 64.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.6 m-85 -66.46 -44.44 82.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.973 0.806 . . . . 0.0 111.465 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -44.78 80.04 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 121.816 -0.552 . . . . 0.0 110.337 -173.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -71.54 -37.14 71.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 tp -53.76 -43.83 69.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.094 0.861 . . . . 0.0 110.588 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.27 -39.14 81.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.232 0.469 . . . . 0.0 110.834 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.11 -18.71 60.19 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.3 -0.875 . . . . 0.0 112.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -90.03 -50.38 6.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.666 0.787 . . . . 0.0 110.563 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.86 3.33 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 0.0 111.837 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.58 -1.52 14.26 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.469 -1.395 . . . . 0.0 113.529 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -80.72 144.42 32.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.186 1.794 . . . . 0.0 109.741 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -125.04 166.3 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 109.445 -174.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 56.7 mtt180 -48.96 -35.28 14.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.361 1.464 . . . . 0.0 112.43 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.35 -24.28 67.21 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.82 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.29 22.84 12.57 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.491 0.662 . . . . 0.0 112.113 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.19 164.24 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.675 1.19 . . . . 0.0 112.212 170.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.35 134.52 29.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.576 -1.202 . . . . 0.0 108.114 168.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mt -71.27 113.64 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 103' ' ' GLN . 68.7 mt -91.54 -33.99 14.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.848 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -153.93 165.42 36.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.406 0.682 . . . . 0.0 109.344 -174.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 p -159.09 157.53 31.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.61 1.164 . . . . 0.0 110.422 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -75.04 134.72 41.34 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.562 -0.711 . . . . 0.0 109.169 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.11 -48.17 25.09 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -79.41 165.17 23.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.022 1.329 . . . . 0.0 110.461 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 68.5 m95 -102.79 128.65 49.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -80.3 92.34 5.75 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -81.41 145.31 30.86 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.74 151.16 49.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -128.43 133.13 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.758 1.623 . . . . 0.0 106.898 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -90.64 147.9 37.35 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.36 0.664 . . . . 0.0 112.715 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.2 150.53 71.72 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 105.046 -2.713 . . . . 0.0 105.046 166.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.8 mtpt -69.35 -13.45 62.38 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 119.805 -1.809 . . . . 0.0 114.147 -169.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.16 -31.38 71.86 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.821 0.737 . . . . 0.0 112.76 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.08 -18.69 21.55 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.107 0.963 . . . . 0.0 112.009 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 81' ' ' LYS . 86.5 t -62.91 134.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.53 83.96 3.89 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.151 0.976 . . . . 0.0 110.223 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -67.29 -19.92 65.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.066 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.49 -20.99 53.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -107.07 160.88 15.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.948 0.899 . . . . 0.0 109.965 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -130.43 127.07 22.35 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 125.442 1.497 . . . . 0.0 109.19 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.39 159.53 91.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 O-C-N 122.717 0.851 . . . . 0.0 111.246 -10.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 80.5 t -75.01 140.04 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 123.906 0.882 . . . . 0.0 110.045 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 p -91.89 121.45 33.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.697 1.199 . . . . 0.0 108.925 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.29 -13.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.803 0.728 . . . . 0.0 112.716 171.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.91 46.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -157.01 161.48 39.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.675 1.19 . . . . 0.0 109.566 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -112.43 132.69 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -123.29 122.15 37.62 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.429 0.692 . . . . 0.0 109.524 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.2 ttmm -105.97 140.35 39.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.67 156.16 38.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.676 0.671 . . . . 0.0 109.364 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -139.8 127.01 21.17 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.161 0.984 . . . . 0.0 108.516 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -88.82 116.3 26.99 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.603 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 50' ' ' MET . 9.6 mp -112.11 137.46 50.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.866 0.867 . . . . 0.0 108.917 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.3 tt0 -89.99 134.88 33.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.477 1.49 . . . . 0.0 107.213 168.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.97 133.43 51.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.64 1.576 . . . . 0.0 107.269 170.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.34 -55.24 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.834 1.197 . . . . 0.0 110.634 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.1 m -75.78 -19.46 58.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.59 0.756 . . . . 0.0 111.227 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.44 27.26 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -57.75 -18.18 19.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 0.0 114.367 -169.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.03 10.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.268 1.027 . . . . 0.0 112.619 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -87.15 14.97 6.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.1 mt -91.33 137.9 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -129.27 128.46 43.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.337 1.855 . . . . 0.0 106.874 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.1 mmt -97.91 -11.04 23.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.579 0.627 . . . . 0.0 111.526 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.91 63.32 0.71 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.979 2.112 . . . . 0.0 106.587 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -68.65 -60.05 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 127.185 2.194 . . . . 0.0 109.361 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -90.67 174.87 7.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.457 1.903 . . . . 0.0 110.021 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 m -60.17 -25.72 65.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.192 0.997 . . . . 0.0 112.004 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.94 136.82 23.37 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 168.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 155.2 68.4 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.575 2.183 . . . . 0.0 111.8 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.39 -35.25 27.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.745 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.67 137.8 54.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.574 0.75 . . . . 0.0 109.437 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.3 -26.71 56.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.837 0.855 . . . . 0.0 110.787 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.89 166.84 38.33 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.39 160.01 44.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 169.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -145.65 167.05 24.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.79 133.93 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 151.29 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.853 1.261 . . . . 0.0 110.083 -169.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -60.73 146.6 45.28 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -33.53 30.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.022 1.329 . . . . 0.0 113.698 -169.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -91.72 -14.75 29.46 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -65.17 -47.81 71.05 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.335 -1.317 . . . . 0.0 112.858 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.55 -28.88 83.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 CA-C-N 122.547 1.945 . . . . 0.0 112.35 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.15 -25.82 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.191 1.396 . . . . 0.0 109.819 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -65.87 -31.42 72.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.424 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -100.01 -22.16 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.75 151.89 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 118.793 0.724 . . . . 0.0 110.065 171.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.36 176.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.688 1.195 . . . . 0.0 109.706 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -55.38 -44.3 75.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.393 1.477 . . . . 0.0 112.911 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -70.65 -41.75 71.73 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 111.088 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.42 -41.06 28.49 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.83 -0.544 . . . . 0.0 110.731 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -61.63 -29.41 70.04 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.853 0.751 . . . . 0.0 112.383 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.17 -45.75 87.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.497 0.589 . . . . 0.0 110.688 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.25 -47.14 91.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.525 -0.734 . . . . 0.0 109.099 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -61.62 -45.52 93.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -66.08 -40.65 90.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.971 -1.081 . . . . 0.0 110.933 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.63 -48.02 83.65 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.474 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.01 -39.9 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.279 1.032 . . . . 0.0 110.039 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.6 mmt -67.12 -52.83 36.98 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.996 0.919 . . . . 0.0 108.647 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.462 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -29.54 69.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.37 0.987 . . . . 0.0 112.006 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.422 ' HB3' HD12 ' A' ' 101' ' ' LEU . 14.9 m-85 -111.37 -14.47 13.76 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.09 0.956 . . . . 0.0 113.468 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.28 69.33 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.371 1.468 . . . . 0.0 110.641 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 m -68.53 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.864 0.866 . . . . 0.0 110.687 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 69' ' ' ALA . 41.5 t -68.62 -43.67 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.68 -39.91 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.458 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.0 mmt -57.44 -50.38 73.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.643 1.11 . . . . 0.0 109.852 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 m -73.31 -28.04 61.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.173 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.408 HD21 ' NE2' ' A' ' 103' ' ' GLN . 65.6 tp -62.01 -42.58 99.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.666 1.186 . . . . 0.0 110.152 172.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.44 -42.52 98.88 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.08 -28.07 64.07 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -170.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.89 -21.13 23.8 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.336 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.5 p 38.89 56.44 5.5 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.726 2.011 . . . . 0.0 109.306 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.59 167.13 21.73 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.081 1.188 . . . . 0.0 111.971 -167.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.4 mttt . . . . . 0 C--O 1.25 1.096 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -169.92 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mt -138.56 141.72 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.61 -69.09 0.31 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.246 0.618 . . . . 0.0 112.623 -169.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.34 -52.4 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.663 0.785 . . . . 0.0 112.953 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.62 17.0 10.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.699 1.199 . . . . 0.0 112.459 -169.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.54 85.72 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.744 1.164 . . . . 0.0 113.24 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -88.21 157.88 18.67 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.263 1.025 . . . . 0.0 109.367 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -150.31 127.29 5.4 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 116.996 -1.478 . . . . 0.0 107.292 -169.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -80.32 132.58 9.25 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.505 1.47 . . . . 0.0 109.424 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.36 155.61 49.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.909 0.884 . . . . 0.0 108.656 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.42 137.77 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.16 154.41 16.82 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.45 141.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 125.397 1.479 . . . . 0.0 107.962 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.88 142.7 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mm -117.09 142.25 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 117.293 -1.337 . . . . 0.0 107.663 169.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' SG ' HD21 ' A' ' 101' ' ' LEU . 27.6 p -125.78 160.11 30.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.651 1.114 . . . . 0.0 112.708 170.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -121.61 172.18 8.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.613 1.565 . . . . 0.0 109.145 176.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.99 7.7 4.6 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.439 -1.413 . . . . 0.0 112.977 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -94.08 -5.13 48.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.434 1.093 . . . . 0.0 111.715 174.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 31.72 60.75 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -108.57 154.6 21.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.22 150.3 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 174.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -84.52 143.59 29.25 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -144.65 140.47 28.68 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -175.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.78 158.46 42.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.581 1.537 . . . . 0.0 111.531 -170.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.68 145.83 51.05 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.875 1.67 . . . . 0.0 108.45 -171.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -112.11 163.39 14.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.341 0.973 . . . . 0.0 109.664 174.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -72.88 153.67 40.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.328 1.051 . . . . 0.0 109.013 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.96 -52.63 3.3 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.138 1.351 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.17 -45.73 66.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.43 0.615 . . . . 0.0 110.079 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.1 m170 56.18 -0.37 0.05 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.292 2.237 . . . . 0.0 115.377 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -77.82 163.23 26.27 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.565 1.946 . . . . 0.0 108.348 169.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -112.68 146.7 38.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -174.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.34 158.51 44.14 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.958 1.303 . . . . 0.0 110.686 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.62 134.22 65.87 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 169.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -54.34 139.76 73.42 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.214 2.609 . . . . 0.0 112.578 -178.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -161.95 169.17 21.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.161 0.891 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.86 169.48 42.54 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.156 0.407 . . . . 0.0 112.368 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.79 147.51 36.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -73.89 114.94 14.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 169.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -68.22 145.72 97.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.19 125.14 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.518 1.479 . . . . 0.0 112.076 -169.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.2 85.93 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.55 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.15 147.55 48.27 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.133 1.967 . . . . 0.0 110.595 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -85.24 156.48 20.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 167.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.64 75.63 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.014 -1.054 . . . . 0.0 112.119 -169.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.71 -36.67 70.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 110.094 -178.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -70.28 -37.65 74.88 Favored 'General case' 0 C--O 1.23 0.061 0 O-C-N 121.172 -0.955 . . . . 0.0 109.995 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.57 77.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.566 175.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -58.09 -48.65 79.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.4 m-85 -66.32 -46.91 75.24 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.913 0.779 . . . . 0.0 111.766 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -52.52 -52.51 54.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.133 0.973 . . . . 0.0 110.901 177.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.87 -37.35 59.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -170.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -54.61 -45.41 73.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 110.595 173.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.76 -39.62 89.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.159 0.436 . . . . 0.0 110.28 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.36 -24.64 60.37 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.08 -46.01 12.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.313 0.96 . . . . 0.0 111.459 -175.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.52 4.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 112.32 -169.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.93 -2.97 14.5 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 120.431 -1.418 . . . . 0.0 113.513 -178.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.0 tp -78.89 140.88 38.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.677 1.591 . . . . 0.0 109.771 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 p -120.96 163.67 17.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.877 1.271 . . . . 0.0 109.902 -171.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 67.0 mtt85 -46.58 -37.58 8.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.054 1.742 . . . . 0.0 112.23 -177.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -30.19 71.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.885 -173.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.33 21.42 16.71 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.679 1.127 . . . . 0.0 112.011 -173.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.01 165.6 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.53 1.532 . . . . 0.0 111.829 171.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.65 140.31 33.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.279 169.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.52 116.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 177.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 103' ' ' GLN . 78.0 mt -94.58 -33.57 12.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.405 174.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.82 164.04 39.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.799 0.84 . . . . 0.0 108.919 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -163.68 154.4 15.92 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.1 0.96 . . . . 0.0 109.879 170.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 150' ' ' GLU . 2.1 p -70.07 139.28 52.57 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -175.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -56.98 4.87 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -72.84 -178.16 2.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.514 1.925 . . . . 0.0 111.062 174.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 55.8 m95 -118.75 146.85 44.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.12 102.16 13.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 137.37 40.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -135.82 143.26 45.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -87.74 139.13 30.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 83' ' ' LEU . 1.1 pp -91.02 148.82 38.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 169.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.8 Cg_endo -71.92 155.14 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.45 2.767 . . . . 0.0 110.497 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -65.75 -20.24 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.046 -1.034 . . . . 0.0 112.8 -170.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.62 -32.81 67.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.688 0.676 . . . . 0.0 112.739 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.465 HD12 ' HD2' ' A' ' 80' ' ' PRO . 67.4 mt -91.05 -20.08 22.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.042 0.937 . . . . 0.0 111.436 -177.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.17 134.79 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -109.26 96.21 6.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.126 0.97 . . . . 0.0 109.398 171.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -70.99 -27.15 63.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.237 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.16 -10.32 59.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.309 1.043 . . . . 0.0 112.534 -170.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -129.73 158.9 38.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.928 0.891 . . . . 0.0 108.974 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -127.29 141.5 41.0 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.177 1.391 . . . . 0.0 108.993 -171.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.76 147.55 89.84 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 O-C-N 122.875 0.934 . . . . 0.0 111.35 -10.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -83.72 141.27 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.405 1.082 . . . . 0.0 108.908 175.245 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -103.96 139.6 38.88 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.461 0.704 . . . . 0.0 109.533 169.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 -17.42 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 122.937 0.495 . . . . 0.0 111.347 169.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.91 161.97 28.12 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.98 143.41 33.19 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.586 1.154 . . . . 0.0 108.599 -177.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HE2' ' CD2' ' A' ' 74' ' ' TRP . 85.2 tttt -94.72 120.77 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -119.15 131.0 55.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.065 1.302 . . . . 0.0 112.893 -172.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 3.7 ttmm -99.4 152.79 19.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -128.54 148.6 50.77 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -133.58 129.73 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.871 1.269 . . . . 0.0 108.491 -177.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -95.07 125.64 39.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.444 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.13 157.02 31.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.655 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.0 tt0 -105.84 132.99 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 137.83 58.32 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -89.5 -55.33 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.611 1.096 . . . . 0.0 109.97 -172.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -76.87 -21.62 54.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.458 0.703 . . . . 0.0 111.432 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.18 169.32 20.56 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -13.91 26.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.573 1.549 . . . . 0.0 114.433 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.63 39.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.286 1.034 . . . . 0.0 112.712 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.59 22.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.39 137.21 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.193 1.397 . . . . 0.0 108.155 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -124.03 129.01 50.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.332 1.853 . . . . 0.0 107.888 170.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.8 mmt -93.68 -8.04 42.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.369 0.668 . . . . 0.0 112.697 -176.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -127.22 81.08 1.99 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 124.084 1.897 . . . . 0.0 108.83 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 p -79.57 -64.14 1.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.209 2.603 . . . . 0.0 107.58 178.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -72.85 174.22 8.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.578 1.551 . . . . 0.0 109.711 169.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -60.53 -36.82 79.32 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.85 -0.531 . . . . 0.0 109.974 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.12 136.28 57.54 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.48 1.512 . . . . 0.0 107.991 169.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 117.55 4.34 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 122.44 2.093 . . . . 0.0 107.622 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -72.99 -18.87 61.31 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.763 -0.586 . . . . 0.0 110.297 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.03 155.88 49.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.919 1.288 . . . . 0.0 107.974 168.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.3 -14.77 14.1 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.975 2.11 . . . . 0.0 110.808 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.02 154.55 25.56 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.68 149.88 51.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.43 164.96 33.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -121.88 132.44 54.57 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.28 162.48 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.166 1.386 . . . . 0.0 111.984 -168.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.7 m -69.07 157.56 36.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 109.567 169.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.95 78.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 112.651 -171.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -91.31 -27.9 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.241 -0.912 . . . . 0.0 112.969 -169.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -51.34 -46.92 89.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.99 -25.4 59.29 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.14 1.8 . . . . 0.0 113.152 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.62 -41.3 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.318 0.0 OUTLIER -74.16 -5.53 42.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.273 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -95.01 -15.93 23.13 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.338 -0.839 . . . . 0.0 113.129 -174.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 m -104.16 172.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.624 1.102 . . . . 0.0 111.771 -175.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.5 m -73.27 166.61 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.905 0.882 . . . . 0.0 109.584 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -52.67 -50.54 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.048 1.739 . . . . 0.0 114.188 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -69.69 -33.12 72.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.656 -0.652 . . . . 0.0 110.888 -175.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -76.81 -37.26 56.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.375 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -51.4 -47.03 63.07 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.008 0.822 . . . . 0.0 109.915 173.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.55 -42.97 99.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.868 0.304 . . . . 0.0 110.791 -176.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.69 -50.79 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -58.61 -41.98 87.1 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.607 0.763 . . . . 0.0 109.027 -176.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.98 -52.93 63.66 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.679 0.792 . . . . 0.0 110.345 176.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -54.9 -49.55 70.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.68 -43.77 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.087 0.858 . . . . 0.0 110.491 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.8 mmt -69.8 -52.44 25.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -173.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -30.59 71.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.218 0.917 . . . . 0.0 112.234 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.547 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -57.52 -45.31 85.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.793 0.724 . . . . 0.0 110.616 177.577 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.49 ' HB3' HD12 ' A' ' 101' ' ' LEU . 7.3 m-85 -106.11 -11.41 16.11 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.01 66.83 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.169 1.788 . . . . 0.0 110.652 -174.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -67.11 -31.64 72.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.591 0.756 . . . . 0.0 110.465 -174.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.91 -45.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.3 -44.38 92.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.054 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -47.49 82.91 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 120.453 1.479 . . . . 0.0 110.056 -177.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.7 t -68.61 -31.23 70.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.712 0.405 . . . . 0.0 111.077 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.435 HD21 ' NE2' ' A' ' 103' ' ' GLN . 21.2 tp -64.29 -38.63 91.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.124 1.369 . . . . 0.0 110.464 176.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -67.19 -44.15 80.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.803 0.274 . . . . 0.0 110.332 173.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.29 -28.92 64.47 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -81.02 -18.36 47.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.392 -175.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.258 24.1 p 42.48 55.4 10.12 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 126.192 1.797 . . . . 0.0 108.631 -169.28 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.36 179.42 5.07 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.689 1.593 . . . . 0.0 112.25 -167.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.745 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 mt . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.43 -66.16 0.59 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.096 0.872 . . . . 0.0 110.188 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -164.16 -53.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.918 0.487 . . . . 0.0 110.093 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.04 16.66 17.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 123.625 1.678 . . . . 0.0 110.746 -164.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.71 2.16 65.29 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 120.206 -1.558 . . . . 0.0 112.704 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -97.12 159.24 15.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.272 1.536 . . . . 0.0 109.035 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -140.16 142.03 28.66 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.518 ' HB2' HD12 ' A' ' 40' ' ' ILE . 10.9 Cg_endo -80.93 144.59 15.21 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.934 1.756 . . . . 0.0 110.648 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.25 154.98 41.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.55 158.26 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.961 0.904 . . . . 0.0 109.126 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -141.16 162.1 26.81 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG21 HD13 ' A' ' 54' ' ' LEU . 2.9 mp -126.27 144.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -172.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -128.17 136.46 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 ' HG ' ' A' ' 104' ' ' LEU . 17.5 mm -116.19 137.46 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 167.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.905 ' SG ' HD11 ' A' ' 101' ' ' LEU . 2.1 p -124.12 162.31 23.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.543 1.639 . . . . 0.0 112.69 161.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -106.14 172.65 6.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.047 -2.342 . . . . 0.0 108.834 172.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.0 5.48 6.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -94.1 0.29 55.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.716 0.806 . . . . 0.0 110.975 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.45 21.81 76.73 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.551 0.614 . . . . 0.0 112.196 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -95.15 147.25 23.65 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.8 145.98 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ttm -67.02 145.48 55.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.592 -1.185 . . . . 0.0 107.897 169.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 1.059 ' NE1' ' HB3' ' A' ' 33' ' ' TRP . 1.8 t90 -144.23 141.14 29.68 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.553 ' N ' ' HD1' ' A' ' 24' ' ' TRP . . . -133.28 167.28 20.68 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 123.52 1.629 . . . . 0.0 115.331 173.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.413 ' HB2' ' CE3' ' A' ' 33' ' ' TRP . 37.3 ttp180 -125.27 124.24 41.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 120.97 -1.081 . . . . 0.0 108.669 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -75.01 148.76 39.6 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.167 -169.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -54.77 132.89 46.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.292 1.62 . . . . 0.0 109.953 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -7.57 5.15 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.446 -1.196 . . . . 0.0 114.395 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -88.17 177.7 6.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -132.95 13.76 4.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.472 0.654 . . . . 0.0 109.853 165.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.89 154.49 21.51 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 1.059 ' HB3' ' NE1' ' A' ' 24' ' ' TRP 0.286 91.7 m95 -120.72 154.29 35.81 Favored 'General case' 0 N--CA 1.399 -2.977 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.715 -165.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.11 167.76 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.139 1.775 . . . . 0.0 110.952 -170.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -81.48 146.08 56.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.02 160.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -56.23 135.19 68.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.227 2.618 . . . . 0.0 110.666 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.433 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 14.2 pt20 -159.53 171.09 20.3 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.236 0.926 . . . . 0.0 111.356 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.04 171.36 44.39 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.972 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.12 147.28 24.55 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.656 -0.908 . . . . 0.0 111.179 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 9' ' ' PRO . 84.1 mt -74.25 123.12 28.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 165.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.32 155.71 91.16 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.9 124.74 15.54 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 N-CA-C 109.451 -1.019 . . . . 0.0 109.451 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.01 -9.81 76.77 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.803 -0.998 . . . . 0.0 114.322 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.35 151.71 44.93 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 119.683 1.742 . . . . 0.0 111.045 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.11 161.28 18.96 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 161.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.86 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 122.062 -0.398 . . . . 0.0 111.213 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.98 -35.06 74.14 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.971 -0.456 . . . . 0.0 111.016 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -70.08 -43.77 70.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.863 -1.148 . . . . 0.0 109.687 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.99 78.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 123.975 0.797 . . . . 0.0 109.557 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.479 ' SD ' HD11 ' A' ' 102' ' ' LEU . 13.3 tmm? -62.54 -48.86 77.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 35.0 m-85 -68.08 -38.3 82.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.87 0.759 . . . . 0.0 111.338 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.4 ttm-85 -60.07 -55.59 32.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.23 -28.52 64.24 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 13' ' ' ILE . 16.1 tp -54.66 -48.33 72.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 120.442 -1.411 . . . . 0.0 109.699 169.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.412 ' O ' HG21 ' A' ' 115' ' ' THR . 34.6 t80 -60.28 -45.17 94.26 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 117.318 -1.325 . . . . 0.0 109.213 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.97 -31.9 73.36 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.586 1.539 . . . . 0.0 111.652 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -91.67 -49.23 6.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.282 0.947 . . . . 0.0 110.06 -171.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.555 HG12 HG23 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -110.92 -10.83 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 124.498 1.119 . . . . 0.0 112.27 -168.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.92 1.09 37.71 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 123.824 0.726 . . . . 0.0 113.918 -173.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -83.23 150.33 26.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.075 1.35 . . . . 0.0 108.682 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.48 168.45 15.63 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.095 0.95 . . . . 0.0 108.731 -175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.49 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 28.4 mtt180 -48.7 -31.87 7.53 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 63' ' ' LYS . 28.9 mmmt -61.78 -31.14 71.32 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.703 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -114.53 23.52 12.67 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 126.728 2.517 . . . . 0.0 108.23 -168.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.26 162.69 33.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 O-C-N 120.439 -1.413 . . . . 0.0 111.127 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.04 138.09 38.47 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 117.845 -1.074 . . . . 0.0 108.206 165.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.31 119.66 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' A' ' 101' ' ' LEU . 84.0 mt -98.67 -32.47 11.39 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.649 0.593 . . . . 0.0 110.872 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.5 165.56 35.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.5 p -157.3 157.52 34.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.726 1.21 . . . . 0.0 108.738 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.532 HG22 ' HG2' ' A' ' 150' ' ' GLU . 1.7 p -70.64 136.33 49.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.267 1.032 . . . . 0.0 110.633 -174.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -81.98 -37.99 25.81 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.468 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -104.34 153.45 21.03 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.004 1.322 . . . . 0.0 108.139 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -84.24 134.91 34.52 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.026 -1.047 . . . . 0.0 108.425 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -89.31 98.71 11.92 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -97.92 147.64 24.26 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.88 153.63 39.36 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.717 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.13 143.49 27.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.488 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.13 150.94 83.56 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 123.863 0.727 . . . . 0.0 109.267 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.05 149.19 71.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.692 2.261 . . . . 0.0 109.225 160.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.8 mtpt -67.9 -18.29 64.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -167.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -59.17 -30.56 68.28 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.953 -0.546 . . . . 0.0 112.003 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.38 -19.11 21.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.222 0.609 . . . . 0.0 111.09 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 81' ' ' LYS . 93.3 t -63.5 136.55 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.15 75.44 1.37 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.079 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -56.3 -23.11 34.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -73.61 -28.18 61.68 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.078 0.551 . . . . 0.0 111.911 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.3 t -104.82 164.65 11.63 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.441 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -133.05 136.93 28.41 Favored Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.87 149.79 83.89 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 -16.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.97 136.53 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.104 0.961 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.4 p -88.05 132.29 34.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -12.54 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.118 0.567 . . . . 0.0 112.004 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.15 -177.69 41.15 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -153.58 158.1 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -105.48 134.91 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -117.58 130.92 56.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.898 1.279 . . . . 0.0 110.129 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -110.65 136.87 49.08 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -117.83 156.96 27.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -142.25 128.1 19.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.193 1.397 . . . . 0.0 107.748 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.905 HD11 ' SG ' ' A' ' 16' ' ' CYS . 1.2 tp -95.6 127.34 41.55 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.479 HD11 ' SD ' ' A' ' 50' ' ' MET . 5.9 mt -115.84 152.57 33.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.6 tt0 -100.69 134.85 43.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 159.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.526 ' HG ' HG21 ' A' ' 15' ' ' ILE . 1.6 mt -62.64 135.16 57.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 125.51 1.756 . . . . 0.0 109.298 169.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.5 t -88.72 -51.49 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -171.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -82.81 -17.3 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.8 0.727 . . . . 0.0 111.739 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.33 175.22 35.91 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -21.27 2.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.707 2.403 . . . . 0.0 114.301 -165.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.02 -31.24 40.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.334 1.454 . . . . 0.0 112.456 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.54 19.42 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.847 0.832 . . . . 0.0 112.503 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.555 HG23 HG12 ' A' ' 58' ' ' VAL . 79.0 mt -94.17 135.74 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.51 -1.369 . . . . 0.0 108.385 171.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -134.35 109.11 8.58 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 125.724 1.609 . . . . 0.0 107.855 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.02 9.3 20.04 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.99 -1.069 . . . . 0.0 112.651 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 77.04 1.69 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 124.061 1.886 . . . . 0.0 107.777 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 55' ' ' PHE . 2.0 p -73.75 -60.72 2.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.072 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -72.6 168.58 18.34 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.017 168.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.0 m -58.5 -39.2 79.4 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.954 -0.466 . . . . 0.0 110.446 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 132.6 62.67 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.38 133.59 50.14 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.587 1.524 . . . . 0.0 109.626 164.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -75.25 -26.76 59.11 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.903 0.858 . . . . 0.0 110.792 173.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -118.86 144.97 46.05 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 120.805 -1.185 . . . . 0.0 108.424 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.16 -31.05 22.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.007 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.76 158.95 27.93 Favored Glycine 0 C--N 1.335 0.524 0 O-C-N 120.689 -1.257 . . . . 0.0 111.012 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.73 155.15 42.18 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -150.89 165.59 33.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 108.304 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -112.78 137.93 50.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.45 152.97 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.94 1.296 . . . . 0.0 109.201 -168.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -59.97 147.47 38.79 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 117.178 -1.391 . . . . 0.0 109.536 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.12 66.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -93.06 -22.93 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.023 -1.048 . . . . 0.0 112.404 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.441 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 87.5 t80 -53.6 -37.79 55.01 Favored Pre-proline 0 CA--C 1.514 -0.415 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.009 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 1.021 ' HB3' ' HE3' ' A' ' 24' ' ' TRP . 10.9 Cg_endo -67.54 -37.18 17.6 Favored 'Trans proline' 0 N--CA 1.413 -3.254 0 N-CA-C 117.242 1.978 . . . . 0.0 117.242 -173.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.92 -25.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 112.73 -2.032 . . . . 0.0 109.115 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.02 -32.23 73.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.128 -1.607 . . . . 0.0 113.676 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 -24.82 33.19 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 124.075 0.859 . . . . 0.0 111.5 -168.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 144' ' ' TYR . 2.5 m -86.53 167.08 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 122.008 0.908 . . . . 0.0 111.041 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.18 172.55 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 120.892 -1.13 . . . . 0.0 109.987 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 m -51.03 -50.0 59.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -79.34 -30.88 42.92 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.224 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -70.6 -38.44 74.01 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.004 -1.06 . . . . 0.0 110.374 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.41 -45.18 62.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.105 0.962 . . . . 0.0 111.866 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.35 -47.52 85.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.043 1.464 . . . . 0.0 108.463 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.38 -51.53 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.199 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.408 ' CE2' HG11 ' A' ' 136' ' ' VAL . 6.0 m-30 -63.67 -37.77 88.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.068 0.849 . . . . 0.0 110.834 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -68.02 -38.81 83.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.432 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -58.82 -49.27 78.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.614 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.36 -39.14 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.623 1.169 . . . . 0.0 110.244 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -74.17 -55.47 6.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -36.45 74.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.624 0.647 . . . . 0.0 111.574 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 151' ' ' PHE . 4.6 tp10 -61.51 -30.82 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.791 0.836 . . . . 0.0 110.7 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.814 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 0.8 OUTLIER -113.49 -13.41 12.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 0.0 109.798 -172.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.69 71.92 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.684 1.593 . . . . 0.0 110.848 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 m -66.24 -33.58 76.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.577 0.751 . . . . 0.0 111.029 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.8 t -68.86 -43.02 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.454 HG22 ' SG ' ' A' ' 16' ' ' CYS . 27.4 t -59.37 -42.24 86.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.587 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmt -55.96 -52.92 62.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.079 1.309 . . . . 0.0 109.384 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -68.63 -29.12 67.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.063 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.504 HD13 HD13 ' A' ' 68' ' ' LEU . 14.1 tp -69.09 -23.09 63.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.659 1.584 . . . . 0.0 111.596 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.92 -24.85 40.8 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 117.662 -3.149 . . . . 0.0 111.212 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 CA--C 1.498 -1.038 0 CA-C-N 120.234 1.379 . . . . 0.0 114.156 -167.434 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -72.18 -72.87 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.704 0.684 . . . . 0.0 112.079 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -162.25 -49.96 0.04 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.284 1.034 . . . . 0.0 111.669 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -91.46 15.28 12.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.945 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.8 0.81 77.87 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.726 1.155 . . . . 0.0 113.787 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -95.39 162.62 13.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.349 1.074 . . . . 0.0 108.227 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.4 146.16 24.11 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.049 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 40' ' ' ILE . 44.5 Cg_endo -91.27 131.07 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.603 2.202 . . . . 0.0 111.526 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -128.51 157.97 39.69 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.381 1.472 . . . . 0.0 109.228 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.432 HG13 HD11 ' A' ' 40' ' ' ILE . 16.0 m -134.97 164.17 34.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -153.53 163.53 30.77 Favored Glycine 0 C--N 1.33 0.226 0 O-C-N 121.402 -0.811 . . . . 0.0 112.627 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.07 140.33 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 124.777 1.231 . . . . 0.0 108.582 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.22 137.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.5 mm -111.44 145.22 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.623 1.101 . . . . 0.0 108.054 169.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 p -120.72 150.32 41.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.632 0.773 . . . . 0.0 111.045 169.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -108.29 168.76 9.08 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.747 1.219 . . . . 0.0 108.191 170.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.28 3.82 6.7 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 119.915 -1.741 . . . . 0.0 113.606 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -88.51 -4.78 58.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.353 1.061 . . . . 0.0 110.892 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.26 13.55 83.17 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.896 -0.947 . . . . 0.0 112.296 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -81.9 147.85 29.08 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.175 1.487 . . . . 0.0 107.668 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 m -103.04 149.71 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.777 1.231 . . . . 0.0 108.815 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.67 142.45 30.76 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.147 0.979 . . . . 0.0 109.026 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -146.08 146.77 31.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.319 1.448 . . . . 0.0 108.617 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.43 166.66 29.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.026 1.285 . . . . 0.0 111.82 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -126.8 135.17 50.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.371 1.069 . . . . 0.0 108.828 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -64.96 154.79 36.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 109.7 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.91 128.62 38.0 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.89 0.23 90.1 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.415 -1.214 . . . . 0.0 113.962 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -112.23 150.25 31.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.474 1.637 . . . . 0.0 111.224 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -96.4 -16.2 21.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.154 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 p -83.98 134.68 34.64 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.277 1.431 . . . . 0.0 109.779 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -92.28 153.58 19.15 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.66 0.784 . . . . 0.0 110.729 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -150.39 156.89 42.35 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.967 1.707 . . . . 0.0 109.361 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.89 139.16 69.53 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.65 129.27 13.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.086 2.524 . . . . 0.0 111.455 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 29.6 pt20 -155.43 158.26 38.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 112.598 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.47 -169.74 20.86 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.821 1.677 . . . . 0.0 110.327 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.55 145.99 18.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.43 1.491 . . . . 0.0 110.636 -172.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 11' ' ' VAL . 62.1 mt -79.26 135.51 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 169.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -81.22 156.19 71.72 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.63 121.29 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.07 -2.48 85.47 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.32 -1.267 . . . . 0.0 114.411 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.56 156.05 39.85 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 120.598 2.199 . . . . 0.0 110.286 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -93.08 152.81 19.06 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 168.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.69 80.63 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.302 -0.874 . . . . 0.0 111.837 -172.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.46 -36.43 78.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.61 0.764 . . . . 0.0 110.092 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -68.52 -41.64 79.67 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.04 89.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -60.06 -50.89 71.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.755 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 58.0 m-85 -67.06 -37.35 83.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.39 0.995 . . . . 0.0 112.068 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -63.43 -50.3 70.31 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.579 1.536 . . . . 0.0 109.172 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -71.59 -32.71 68.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -170.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 58' ' ' VAL . 8.3 tp -53.77 -49.64 67.79 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.634 1.174 . . . . 0.0 110.147 169.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.29 -35.76 81.21 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.423 0.556 . . . . 0.0 110.651 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -70.12 -35.2 73.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.919 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.96 -38.38 5.35 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.553 1.07 . . . . 0.0 113.627 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.514 HG21 HD12 ' A' ' 54' ' ' LEU . 13.3 t -92.62 -31.74 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.196 0.999 . . . . 0.0 108.604 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 0.81 88.35 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.928 1.252 . . . . 0.0 112.743 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.8 tp -87.54 153.44 21.4 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.443 1.897 . . . . 0.0 109.615 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -128.74 166.08 19.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.713 1.205 . . . . 0.0 110.529 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 38.8 mtp180 -45.48 -41.43 9.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.228 1.811 . . . . 0.0 113.106 -172.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.94 -24.95 65.23 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.245 0.618 . . . . 0.0 111.902 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -102.74 9.71 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.528 0.731 . . . . 0.0 111.186 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.5 165.84 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.8 1.64 . . . . 0.0 112.08 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 136.3 31.13 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 168.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.5 mt -78.91 115.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 103' ' ' GLN . 78.6 mt -95.87 -31.19 13.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.372 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 154' ' ' VAL . . . -154.21 163.92 39.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.28 1.032 . . . . 0.0 108.454 -178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 p -162.03 154.91 20.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 124.488 1.115 . . . . 0.0 108.835 170.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.427 HG22 ' HG3' ' A' ' 150' ' ' GLU . 6.7 p -69.44 132.18 45.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.92 0.866 . . . . 0.0 110.812 -169.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -79.11 -27.44 42.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.248 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.45 151.4 38.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.201 2.2 . . . . 0.0 108.556 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.7 m95 -79.59 134.81 36.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 mt -94.94 129.14 42.1 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -133.16 148.41 52.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.88 1.218 . . . . 0.0 108.512 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.04 146.18 29.93 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.433 0.458 . . . . 0.0 109.774 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.81 146.23 24.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.99 145.75 91.99 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 111.111 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.92 146.99 60.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 N-CA-C 104.982 -2.738 . . . . 0.0 104.982 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.3 mtpt -68.89 -12.61 61.76 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.075 -1.641 . . . . 0.0 113.994 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.43 -31.73 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.026 0.83 . . . . 0.0 112.81 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.0 mt -91.79 -20.3 21.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.682 0.793 . . . . 0.0 112.03 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 81' ' ' LYS . 90.7 t -65.1 135.81 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -103.16 91.28 4.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.302 1.041 . . . . 0.0 110.071 171.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.65 -23.65 64.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.962 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.73 -33.87 71.29 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.789 0.435 . . . . 0.0 111.801 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -100.01 158.34 15.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.948 0.899 . . . . 0.0 109.576 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -130.63 134.69 26.33 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.434 1.494 . . . . 0.0 109.905 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.45 148.98 91.37 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 O-C-N 122.755 0.871 . . . . 0.0 109.928 -10.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.7 p -78.05 133.81 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.496 0.718 . . . . 0.0 109.37 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.03 128.75 33.65 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.13 -12.09 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 119.03 -0.51 . . . . 0.0 112.022 169.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.25 -178.49 42.49 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -147.3 153.29 39.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.31 1.444 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -108.03 140.2 41.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -127.29 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.362 1.465 . . . . 0.0 108.694 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.7 ttmm -133.5 117.97 17.78 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -103.1 158.25 16.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -134.0 125.59 28.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.329 1.451 . . . . 0.0 107.406 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -89.7 122.08 32.47 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mt -119.42 160.09 22.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.569 ' HB2' HD11 ' A' ' 68' ' ' LEU . 4.1 tt0 -109.42 135.59 50.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 132.91 54.53 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.64 -53.88 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.5 m -78.44 -30.95 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 112.156 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.49 162.26 11.26 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.82 -18.44 43.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.418 1.487 . . . . 0.0 113.668 -173.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.71 48.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.442 0.697 . . . . 0.0 112.484 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 11.82 3.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.6 mt -91.43 134.94 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.43 -43.06 1.62 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.177 0.591 . . . . 0.0 112.354 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 mtp 66.73 13.38 9.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.664 2.386 . . . . 0.0 114.357 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.66 33.02 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 123.413 1.577 . . . . 0.0 112.423 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -51.47 69.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.396 1.478 . . . . 0.0 109.161 169.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 m -73.85 157.23 36.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.721 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -63.53 -36.85 85.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.073 0.463 . . . . 0.0 109.958 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 131.51 45.3 Favored Pre-proline 0 N--CA 1.443 -0.815 0 C-N-CA 125.259 1.424 . . . . 0.0 109.299 169.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.83 147.34 94.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.59 -11.66 39.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -133.33 152.04 51.9 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.519 1.128 . . . . 0.0 109.868 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.11 -2.36 13.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.441 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.86 146.09 12.87 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -150.8 138.96 20.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.269 1.428 . . . . 0.0 107.565 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.99 173.79 13.9 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.342 1.457 . . . . 0.0 109.085 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -119.79 142.21 48.79 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.92 164.05 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.495 . . . . 0.0 110.437 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -69.67 153.05 43.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 169.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -31.65 72.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -169.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -85.99 -27.56 24.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.316 1.416 . . . . 0.0 112.864 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -54.84 -49.88 89.26 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.563 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.27 -29.78 73.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.153 1.805 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.69 -31.9 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.224 -0.923 . . . . 0.0 110.136 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -66.6 -27.16 67.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.209 -0.932 . . . . 0.0 111.569 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -82.11 -23.94 35.41 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.09 159.81 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.313 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.78 179.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.074 1.749 . . . . 0.0 110.769 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.4 m -55.17 -53.44 55.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.405 1.882 . . . . 0.0 113.293 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.62 -41.86 78.92 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.561 . . . . 0.0 110.318 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.63 -43.44 63.23 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.109 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -59.55 -34.36 72.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.486 1.494 . . . . 0.0 111.8 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 -45.53 88.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.309 0.959 . . . . 0.0 111.314 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.27 -47.5 92.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -69.14 -34.95 75.82 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.234 1.014 . . . . 0.0 110.054 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -66.68 -39.24 88.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.655 1.116 . . . . 0.0 109.927 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.34 -46.6 89.36 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.764 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.6 t -56.88 -41.74 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 110.752 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -70.69 -53.83 14.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.02 -33.88 76.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.066 1.303 . . . . 0.0 111.915 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HG3' HG22 ' A' ' 71' ' ' THR . 3.2 mm-40 -53.45 -40.52 65.29 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.854 1.262 . . . . 0.0 111.214 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -110.04 -12.53 14.52 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.006 0.922 . . . . 0.0 112.259 -170.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.44 75.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.811 1.644 . . . . 0.0 110.488 -170.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -69.07 -32.76 72.45 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.444 0.698 . . . . 0.0 109.923 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 69' ' ' ALA . 23.5 t -68.24 -45.24 83.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.99 -34.82 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.544 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 mmt -61.66 -57.57 11.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.833 1.197 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -70.1 -26.05 63.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.782 1.233 . . . . 0.0 111.004 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 68' ' ' LEU . 1.2 tm? -58.33 -35.39 71.82 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 128.714 2.806 . . . . 0.0 111.67 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -71.2 -39.54 71.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.883 0.765 . . . . 0.0 110.67 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.533 0.295 0 C-N-CA 123.482 0.713 . . . . 0.0 112.061 -169.635 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.53 -68.85 0.36 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.208 0.603 . . . . 0.0 111.281 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -163.9 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.096 0.958 . . . . 0.0 112.22 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.97 17.15 14.43 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.698 1.199 . . . . 0.0 112.858 -169.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.04 7.42 65.88 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.276 0.941 . . . . 0.0 113.787 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.26 157.95 16.03 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.19 149.3 72.27 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.4 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' A' ' 40' ' ' ILE . 69.3 Cg_endo -84.56 138.92 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.208 1.938 . . . . 0.0 111.242 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -140.8 151.97 44.81 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.367 1.067 . . . . 0.0 110.339 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 40' ' ' ILE . 35.3 m -134.89 153.63 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.717 0.807 . . . . 0.0 109.66 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.88 157.39 24.75 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.85 141.99 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.426 1.09 . . . . 0.0 108.568 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.07 137.73 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -115.95 132.3 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 22' ' ' VAL . 70.7 m -122.93 144.31 49.32 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -96.63 173.57 7.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.848 1.259 . . . . 0.0 108.666 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.76 9.96 5.58 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.833 -1.167 . . . . 0.0 113.59 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -99.09 0.22 43.17 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.693 0.797 . . . . 0.0 111.175 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.44 20.03 78.96 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.169 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -92.56 142.82 26.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.799 1.299 . . . . 0.0 107.786 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -113.39 143.12 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.013 1.725 . . . . 0.0 107.295 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -81.31 147.32 29.94 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.726 0.694 . . . . 0.0 109.465 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.0 t90 -151.86 140.48 20.75 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -171.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.46 149.76 51.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.771 1.169 . . . . 0.0 112.565 -169.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -98.44 120.23 38.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.252 1.821 . . . . 0.0 106.699 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -82.91 143.93 30.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.724 1.602 . . . . 0.0 109.616 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.45 132.79 54.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.426 0.69 . . . . 0.0 109.82 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.85 -9.71 16.41 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.925 1.25 . . . . 0.0 114.507 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -90.88 -39.79 12.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.556 1.678 . . . . 0.0 111.368 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.1 m80 57.5 31.66 20.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.162 0.985 . . . . 0.0 110.974 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -129.17 152.36 48.84 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.729 1.612 . . . . 0.0 108.337 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -104.09 146.62 28.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.267 0.627 . . . . 0.0 110.933 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -156.92 163.2 39.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.801 1.241 . . . . 0.0 110.808 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.16 144.5 44.19 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.014 -0.994 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.4 131.87 45.62 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.423 2.749 . . . . 0.0 112.475 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -158.2 167.81 28.78 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.643 0.656 . . . . 0.0 112.484 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.67 167.2 40.32 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.27 0.462 . . . . 0.0 112.207 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.72 146.47 32.61 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 9' ' ' PRO . 66.2 mt -74.82 127.28 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -78.41 152.57 78.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.12 120.13 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.7 1.6 . . . . 0.0 110.176 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.74 67.99 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.233 -1.315 . . . . 0.0 113.991 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.45 148.58 48.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 120.232 2.016 . . . . 0.0 110.231 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -84.27 153.76 23.37 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -38.67 76.91 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.778 -0.576 . . . . 0.0 111.909 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.91 -34.13 74.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.733 0.813 . . . . 0.0 110.248 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -73.12 -36.12 66.67 Favored 'General case' 0 C--N 1.337 0.045 0 O-C-N 120.89 -1.131 . . . . 0.0 109.908 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.92 90.84 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.8 ttp -58.82 -49.23 78.47 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.999 0.818 . . . . 0.0 109.036 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 49.8 m-85 -66.12 -46.24 78.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.679 1.127 . . . . 0.0 111.584 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -67.6 -45.31 75.84 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.277 0.944 . . . . 0.0 110.17 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -69.49 -34.54 74.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -57.0 -44.86 83.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.848 1.204 . . . . 0.0 110.323 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -61.27 -41.01 96.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.552 0.614 . . . . 0.0 110.212 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.92 -21.53 65.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.312 0.645 . . . . 0.0 112.232 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.39 -60.85 1.63 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.609 1.164 . . . . 0.0 109.629 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 m -112.44 0.69 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.501 1.52 . . . . 0.0 111.972 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.31 48.4 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.376 -1.452 . . . . 0.0 113.897 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -82.41 144.79 30.25 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.416 1.486 . . . . 0.0 110.2 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -123.98 165.5 17.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.34 1.056 . . . . 0.0 109.633 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 50.4 mtt85 -47.73 -35.55 9.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 112.495 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.27 -22.34 66.84 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.403 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.62 22.59 12.62 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.1 164.99 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.758 -1.214 . . . . 0.0 111.869 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 140.72 33.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 116.982 -1.485 . . . . 0.0 107.962 169.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.44 116.28 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 103' ' ' GLN . 97.9 mt -90.5 -36.01 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.229 174.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.98 32.54 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.016 0.926 . . . . 0.0 110.456 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -151.66 149.08 28.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.079 1.752 . . . . 0.0 109.42 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 150' ' ' GLU . 3.3 p -70.81 139.88 51.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.748 1.158 . . . . 0.0 109.786 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -93.2 -29.22 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.332 1.053 . . . . 0.0 109.862 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -110.48 149.61 30.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.471 2.308 . . . . 0.0 107.864 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 65.4 m95 -82.76 143.03 31.14 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -87.78 91.19 8.66 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 139.35 52.31 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -137.25 153.6 50.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.579 0.752 . . . . 0.0 110.209 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -131.34 138.04 49.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.51 1.924 . . . . 0.0 108.151 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.99 146.9 69.01 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.828 0.851 . . . . 0.0 110.694 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.1 145.94 68.78 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 N-CA-C 104.601 -2.884 . . . . 0.0 104.601 166.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.4 mtpt -68.38 -13.27 62.17 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.031 -1.668 . . . . 0.0 113.835 -169.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -58.81 -30.64 67.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.953 0.797 . . . . 0.0 113.071 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.45 -20.29 21.15 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 112.134 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 81' ' ' LYS . 59.6 t -65.24 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -102.83 89.57 3.51 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.959 0.904 . . . . 0.0 109.76 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -67.19 -24.84 65.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.716 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.34 -33.84 71.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.798 0.439 . . . . 0.0 111.747 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -99.36 159.33 15.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.042 0.937 . . . . 0.0 109.398 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -130.79 134.44 26.0 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 125.152 1.381 . . . . 0.0 109.466 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.47 148.23 89.67 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.719 0.852 . . . . 0.0 110.428 -10.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -77.76 139.08 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.675 0.79 . . . . 0.0 109.613 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.1 p -90.43 120.58 31.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.87 0.868 . . . . 0.0 108.89 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -13.09 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 118.848 0.749 . . . . 0.0 112.751 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 -171.47 34.19 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -157.9 167.71 29.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.762 1.225 . . . . 0.0 109.552 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -115.58 127.6 55.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -114.34 129.0 56.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 10.0 ttmm -111.74 139.13 47.47 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -123.19 153.34 40.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.97 128.48 24.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.59 122.5 37.25 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.08 156.83 24.46 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.659 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.1 tt0 -106.73 129.7 54.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 167.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.76 139.69 58.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.1 1.36 . . . . 0.0 108.52 171.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.99 -44.99 14.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.043 0.383 . . . . 0.0 110.698 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.9 m -87.05 -16.06 36.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.571 0.748 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.56 -167.79 24.82 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.451 ' HB2' ' HE1' ' A' ' 126' ' ' TRP . 1.1 p-10 -60.92 -17.66 52.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.485 1.514 . . . . 0.0 114.698 -171.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.24 47.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.116 0.966 . . . . 0.0 111.774 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.49 50.96 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.829 1.252 . . . . 0.0 110.527 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.9 mt -129.93 129.82 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -113.22 161.56 17.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.391 2.276 . . . . 0.0 106.66 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mmt -126.48 -9.2 6.29 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.029 1.332 . . . . 0.0 111.872 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.35 84.13 2.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 123.718 1.723 . . . . 0.0 107.38 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 -61.12 2.11 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.348 2.659 . . . . 0.0 107.59 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 m -73.22 173.98 8.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.726 1.611 . . . . 0.0 109.009 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m -59.94 -36.81 77.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.496 -0.752 . . . . 0.0 109.807 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 137.05 57.33 Favored Pre-proline 0 N--CA 1.444 -0.772 0 C-N-CA 125.928 1.691 . . . . 0.0 109.133 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.02 133.54 47.87 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 107.212 -1.88 . . . . 0.0 107.212 168.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -85.07 -35.73 21.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -110.98 145.86 37.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.79 -29.24 25.58 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.806 0.842 . . . . 0.0 110.41 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.25 169.49 41.03 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.47 159.99 44.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.772 0.786 . . . . 0.0 109.655 169.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -143.95 169.35 17.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.827 1.251 . . . . 0.0 108.888 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.451 ' HE1' ' HB2' ' A' ' 108' ' ' ASP . 75.4 m95 -111.99 139.43 47.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.58 152.85 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.002 1.321 . . . . 0.0 110.648 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -62.94 143.78 57.39 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -32.31 44.73 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -169.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.99 -18.22 31.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.553 1.07 . . . . 0.0 112.947 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.38 -46.22 70.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.422 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.35 -29.39 85.73 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.774 2.026 . . . . 0.0 112.017 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.4 t -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.899 1.279 . . . . 0.0 109.924 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.263 -0.898 . . . . 0.0 111.443 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -94.31 -21.62 18.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.58 154.01 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 119.031 0.832 . . . . 0.0 110.491 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.58 178.42 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.052 1.341 . . . . 0.0 110.478 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.9 m -55.73 -47.15 77.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.868 1.667 . . . . 0.0 113.236 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -71.73 -45.73 60.83 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.987 -0.446 . . . . 0.0 110.451 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.57 -39.95 73.59 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.679 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -59.71 -31.44 69.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.745 1.157 . . . . 0.0 112.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.19 -43.21 95.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.495 1.043 . . . . 0.0 111.05 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.4 t -62.71 -50.3 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.76 -38.41 90.99 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.919 0.782 . . . . 0.0 109.644 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -65.98 -41.15 91.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.696 1.134 . . . . 0.0 110.243 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -59.6 -49.38 78.0 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.037 0.835 . . . . 0.0 109.615 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.29 -37.59 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.736 1.214 . . . . 0.0 110.977 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.3 mmt -74.28 -54.83 6.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -59.85 -34.14 72.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.42 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 71' ' ' THR . 5.5 tp10 -57.71 -42.11 83.12 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 110.763 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.77 -10.24 19.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.668 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.34 67.48 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.354 1.462 . . . . 0.0 110.559 -171.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 m -68.13 -32.72 73.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.386 0.675 . . . . 0.0 110.548 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.64 -42.81 62.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.4 t -57.29 -38.99 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 117.434 -1.27 . . . . 0.0 110.175 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -62.06 -51.68 66.97 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.472 1.487 . . . . 0.0 111.092 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.4 m -77.23 -24.03 51.27 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.812 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 tp -55.8 -48.66 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.138 1.775 . . . . 0.0 109.359 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -60.27 -33.99 73.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.535 0.734 . . . . 0.0 111.601 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 CA--C 1.531 0.249 0 C-N-CA 124.819 1.248 . . . . 0.0 111.731 -174.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.679 0.752 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.31 -66.7 0.53 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.43 -51.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.05 17.28 14.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.476 1.11 . . . . 0.0 113.385 -169.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.56 62.71 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.12 0.866 . . . . 0.0 113.658 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -103.84 159.44 15.64 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.682 1.241 . . . . 0.0 107.731 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 149.86 64.38 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.25 -1.357 . . . . 0.0 107.834 170.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -91.41 141.52 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.899 1.732 . . . . 0.0 109.425 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -130.1 160.18 34.53 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.253 -0.904 . . . . 0.0 110.455 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.23 167.37 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -159.0 151.9 22.89 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -128.88 142.88 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.444 1.098 . . . . 0.0 108.586 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.77 136.37 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mm -120.37 132.9 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' A' ' 22' ' ' VAL . 43.3 m -124.2 150.84 44.77 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.492 0.587 . . . . 0.0 111.37 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -109.17 173.41 6.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.409 1.484 . . . . 0.0 108.816 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -74.94 0.17 16.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.11 -1.619 . . . . 0.0 113.002 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -88.68 -3.47 58.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 111.419 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.63 18.63 77.36 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 118.835 0.743 . . . . 0.0 111.48 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -86.13 139.73 30.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.511 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.0 m -108.79 143.82 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 125.514 1.526 . . . . 0.0 107.53 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -79.65 143.07 34.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -146.22 144.18 29.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.03 157.17 46.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.044 0.838 . . . . 0.0 111.557 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -111.53 119.07 37.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -72.48 151.31 42.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.297 1.408 . . . . 0.0 110.261 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.35 148.24 47.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.795 0.838 . . . . 0.0 109.633 -175.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 3.36 50.12 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.7 -1.056 . . . . 0.0 113.569 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.81 159.93 40.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.161 1.481 . . . . 0.0 110.577 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -94.11 -22.15 18.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 m -73.52 154.47 39.86 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.145 0.978 . . . . 0.0 111.63 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -106.45 152.57 23.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.222 1.009 . . . . 0.0 109.978 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -148.73 156.8 42.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.943 1.297 . . . . 0.0 110.778 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -80.62 140.64 51.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.35 137.7 82.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.768 1.645 . . . . 0.0 111.118 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -157.18 171.01 21.2 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.214 0.915 . . . . 0.0 112.198 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.05 -168.79 34.01 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -109.17 150.89 17.2 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.411 1.482 . . . . 0.0 109.943 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.29 119.57 34.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -77.1 159.03 79.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.61 127.9 28.12 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.664 1.576 . . . . 0.0 110.246 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.18 -5.47 79.98 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.395 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.55 148.11 37.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.158 1.979 . . . . 0.0 109.471 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.8 m -90.07 157.91 17.57 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.33 77.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.079 0.854 . . . . 0.0 111.583 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.26 -37.68 78.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.734 0.814 . . . . 0.0 110.216 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -66.49 -41.45 88.91 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.1 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.62 85.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -56.32 -50.86 70.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.612 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.451 1.023 . . . . 0.0 110.566 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -64.76 -47.0 79.79 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.453 1.024 . . . . 0.0 109.965 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.81 -31.99 67.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.6 -49.33 73.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.3 -40.92 95.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.008 0.822 . . . . 0.0 110.824 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.6 -26.66 68.5 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.728 -0.607 . . . . 0.0 112.222 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.15 -57.67 2.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.438 1.095 . . . . 0.0 110.451 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.72 0.64 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 112.383 -169.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.48 4.78 32.99 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.758 1.163 . . . . 0.0 113.702 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -84.1 146.58 27.82 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.303 1.841 . . . . 0.0 109.436 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 m -125.03 166.23 16.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.991 0.917 . . . . 0.0 109.76 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -52.93 -32.64 46.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.701 1.6 . . . . 0.0 112.476 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.37 -26.86 68.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.375 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -111.91 22.2 15.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.845 0.831 . . . . 0.0 112.209 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.18 165.06 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.707 -1.245 . . . . 0.0 111.7 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 140.86 40.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 mt -76.4 119.22 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 103' ' ' GLN . 92.7 mt -93.69 -35.34 12.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.81 170.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.578 0.751 . . . . 0.0 110.621 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 p -160.88 153.32 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.744 1.618 . . . . 0.0 109.897 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.08 139.06 54.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.783 0.801 . . . . 0.0 110.742 -170.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -94.62 -33.67 12.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -110.72 144.02 40.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.969 2.107 . . . . 0.0 107.327 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -85.51 141.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.39 72.03 7.04 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -71.6 154.29 41.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.36 151.08 50.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.503 1.121 . . . . 0.0 108.879 -169.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -130.48 132.18 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.696 1.598 . . . . 0.0 107.581 174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -80.9 141.77 51.46 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 124.378 1.071 . . . . 0.0 111.995 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.84 149.95 67.07 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 N-CA-C 104.762 -2.822 . . . . 0.0 104.762 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.9 mtpt -68.99 -13.56 62.52 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.84 -1.788 . . . . 0.0 114.056 -169.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -62.37 -31.02 71.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.113 0.869 . . . . 0.0 112.558 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -93.73 -18.18 22.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.236 1.014 . . . . 0.0 112.009 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 81' ' ' LYS . 95.6 t -64.71 135.02 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -98.1 90.5 4.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.794 0.838 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -71.52 -20.95 61.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.906 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.23 -30.12 57.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.885 0.474 . . . . 0.0 112.196 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.27 160.14 14.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.354 1.061 . . . . 0.0 109.234 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -130.96 133.66 25.03 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 125.783 1.633 . . . . 0.0 108.319 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.32 156.79 94.14 Favored 'Cis proline' 0 CA--C 1.539 0.757 0 O-C-N 122.805 0.897 . . . . 0.0 111.179 -10.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.0 t -74.16 140.33 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.941 0.897 . . . . 0.0 109.741 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 p -93.24 122.61 35.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.119 0.967 . . . . 0.0 108.97 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.15 -12.09 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 119.297 0.953 . . . . 0.0 113.213 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.51 -173.62 43.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -156.31 157.24 35.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.343 1.057 . . . . 0.0 110.173 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -102.72 128.21 49.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -124.58 129.15 50.03 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.531 1.06 . . . . 0.0 111.509 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -88.42 157.37 18.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.626 1.17 . . . . 0.0 108.558 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.494 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 82.5 m95 -133.8 147.26 51.23 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 168.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -131.19 134.69 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.938 1.295 . . . . 0.0 107.924 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.5 tp -96.63 118.45 33.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.79 140.26 49.06 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.6 tt0 -89.11 133.3 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 168.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.26 139.71 58.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.397 1.079 . . . . 0.0 109.069 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.41 -48.74 13.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 118.238 0.472 . . . . 0.0 110.041 -171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.7 m -86.21 -18.44 32.14 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.883 0.473 . . . . 0.0 111.11 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.73 -169.0 22.92 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -55.73 -23.47 29.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.264 1.826 . . . . 0.0 113.345 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.39 51.3 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -89.85 14.52 11.81 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.78 138.51 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -124.07 131.6 53.57 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.57 1.948 . . . . 0.0 107.637 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.3 mmt -98.56 -7.65 27.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 112.497 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.69 75.29 0.98 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.436 1.895 . . . . 0.0 108.027 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -75.56 -65.61 0.88 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.978 2.111 . . . . 0.0 108.963 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.1 m -80.29 177.73 8.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.594 1.557 . . . . 0.0 109.483 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 m -56.57 -35.1 67.79 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.979 0.512 . . . . 0.0 110.361 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 128.94 49.37 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 107.87 169.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.92 122.95 10.37 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 169.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.74 -18.49 62.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -116.76 140.18 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.649 0.78 . . . . 0.0 110.374 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.69 -26.98 40.79 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 110.732 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.44 169.29 41.5 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 123.894 0.759 . . . . 0.0 111.315 -174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 160.63 43.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.768 0.827 . . . . 0.0 109.168 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -152.11 165.73 33.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.976 0.91 . . . . 0.0 108.954 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -110.65 133.86 52.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.24 152.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.838 1.255 . . . . 0.0 111.17 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.4 m -60.47 144.08 52.0 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.94 0.791 . . . . 0.0 109.628 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.15 -34.49 60.54 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -87.0 -7.93 57.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.974 -1.079 . . . . 0.0 113.486 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -75.52 -49.39 3.77 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.918 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.31 -21.6 72.23 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 123.044 2.123 . . . . 0.0 113.282 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.8 -35.92 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -68.97 -25.56 64.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.333 -0.855 . . . . 0.0 111.621 -169.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -83.36 -24.75 31.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.55 165.43 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 118.968 0.803 . . . . 0.0 111.07 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.36 175.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 110.166 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -57.42 -44.15 84.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.503 1.521 . . . . 0.0 113.875 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -70.3 -41.93 72.7 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.474 -0.766 . . . . 0.0 110.827 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -74.93 -35.0 62.18 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.233 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -49.33 -46.02 46.26 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.122 0.969 . . . . 0.0 110.462 170.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.28 -43.04 96.05 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.568 0.622 . . . . 0.0 111.089 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.86 -50.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -66.07 -34.75 78.77 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.055 0.942 . . . . 0.0 110.607 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -67.57 -41.31 84.36 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.808 1.186 . . . . 0.0 109.962 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.93 -43.54 98.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.299 0.954 . . . . 0.0 110.873 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 99' ' ' TRP . 89.8 t -57.74 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.466 1.106 . . . . 0.0 111.542 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.1 mmt -84.33 -59.83 2.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.71 -34.45 67.47 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.362 1.065 . . . . 0.0 112.178 -173.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -57.61 -38.47 75.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.807 0.843 . . . . 0.0 110.727 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -109.78 -10.62 14.77 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 112.817 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.4 -38.99 72.27 Favored 'General case' 0 C--O 1.228 -0.031 0 C-N-CA 125.658 1.583 . . . . 0.0 110.545 -172.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -68.2 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.64 0.776 . . . . 0.0 110.443 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.7 -45.83 72.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.38 -46.32 92.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 117.627 -1.178 . . . . 0.0 110.236 -175.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -43.48 85.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 121.435 1.925 . . . . 0.0 110.317 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.4 t -70.84 -32.13 69.07 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.218 -0.301 . . . . 0.0 111.124 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.0 tp -62.44 -43.28 99.19 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 126.198 1.799 . . . . 0.0 109.568 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -65.38 -43.75 89.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.667 0.387 . . . . 0.0 110.924 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 123.508 0.723 . . . . 0.0 111.806 -169.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 121.414 0.626 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.93 -68.49 0.38 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.63 0.772 . . . . 0.0 110.192 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -164.14 -49.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.964 0.906 . . . . 0.0 113.23 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.2 17.13 14.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.688 1.195 . . . . 0.0 113.233 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.11 10.66 60.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.902 0.763 . . . . 0.0 113.38 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -101.09 155.04 18.22 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.53 31.42 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 117.534 -1.222 . . . . 0.0 109.354 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.76 137.68 16.24 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.469 1.446 . . . . 0.0 110.455 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -142.62 157.18 44.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.122 0.969 . . . . 0.0 109.291 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.25 161.2 35.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 121.267 -0.896 . . . . 0.0 109.669 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.9 163.0 28.35 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -121.65 143.31 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 124.522 1.129 . . . . 0.0 108.393 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.82 136.8 59.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -116.95 133.71 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -125.64 154.02 42.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.843 0.747 . . . . 0.0 111.576 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -104.23 175.16 5.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.002 1.321 . . . . 0.0 108.777 172.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 4.83 8.85 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.237 -1.54 . . . . 0.0 113.267 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -90.94 -2.54 57.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.435 1.094 . . . . 0.0 111.416 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.56 0.618 . . . . 0.0 111.848 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -89.0 144.06 26.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.0 m -115.2 150.02 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.498 1.519 . . . . 0.0 109.161 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 42.8 ttm -65.27 139.75 58.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.708 0.803 . . . . 0.0 108.964 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -142.88 136.92 29.15 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.01 154.57 51.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.712 1.142 . . . . 0.0 111.575 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -114.92 123.23 48.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -76.99 147.85 36.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 121.74 2.064 . . . . 0.0 110.681 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.63 129.67 43.07 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.83 0.08 87.56 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.86 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -110.96 164.42 12.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.216 1.508 . . . . 0.0 110.397 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -101.38 -24.57 14.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.228 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -80.36 159.16 25.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.783 1.233 . . . . 0.0 111.796 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -112.3 155.77 23.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.239 1.015 . . . . 0.0 111.674 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -160.58 164.26 32.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.0 1.72 . . . . 0.0 110.936 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -86.48 149.12 48.38 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.72 130.84 38.89 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.758 2.306 . . . . 0.0 111.951 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.67 161.5 34.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 112.218 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.71 171.58 44.52 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.222 0.439 . . . . 0.0 113.534 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.56 152.75 36.0 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.843 1.211 . . . . 0.0 111.755 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.84 130.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -77.22 157.99 80.17 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.29 123.55 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.98 -6.36 83.6 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.709 -1.051 . . . . 0.0 114.593 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.39 156.15 39.82 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 120.115 1.958 . . . . 0.0 109.439 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.0 p -91.94 166.95 12.45 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.0 81.34 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.782 -0.574 . . . . 0.0 110.815 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.22 -36.5 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.247 0.619 . . . . 0.0 110.582 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.01 -37.25 72.64 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.998 -1.064 . . . . 0.0 110.365 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.42 80.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.418 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.3 tmm? -65.62 -51.44 59.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.14 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -66.82 -31.62 72.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.41 1.459 . . . . 0.0 111.839 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -61.07 -52.03 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.411 1.005 . . . . 0.0 108.925 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -71.47 -27.26 63.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.562 0.619 . . . . 0.0 109.962 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.73 -43.88 90.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.928 -1.107 . . . . 0.0 109.388 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.45 -49.07 52.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.977 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.47 -28.94 68.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.656 1.117 . . . . 0.0 112.608 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -96.16 -52.51 3.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.162 0.985 . . . . 0.0 110.657 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.05 -29.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.543 1.137 . . . . 0.0 110.899 -168.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.3 84.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.447 1.023 . . . . 0.0 112.377 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 tp -78.66 154.15 30.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.172 1.789 . . . . 0.0 109.162 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -132.1 163.98 27.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 109.941 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -39.02 -41.78 0.81 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.9 2.48 . . . . 0.0 112.887 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -63.49 -29.23 70.53 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.77 0.828 . . . . 0.0 112.064 -170.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.5 23.36 13.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.575 0.702 . . . . 0.0 112.185 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.57 165.32 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 O-C-N 120.729 -1.232 . . . . 0.0 112.362 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.57 130.34 27.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.854 168.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mt -69.13 117.26 11.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 103' ' ' GLN . 87.1 mt -95.92 -32.84 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.502 173.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -154.81 162.78 40.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.671 0.788 . . . . 0.0 109.267 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -159.19 155.05 26.42 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.888 1.275 . . . . 0.0 109.735 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.637 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -69.27 138.77 54.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.587 0.708 . . . . 0.0 110.525 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -86.9 -28.41 22.82 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.56 1.144 . . . . 0.0 109.801 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -119.97 149.67 41.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.394 2.278 . . . . 0.0 108.069 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -78.3 135.77 37.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.61 0.641 . . . . 0.0 109.489 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.3 mt -90.14 89.32 7.62 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -90.01 146.61 24.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -148.59 145.75 27.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 169.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 139.3 30.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.71 150.46 39.68 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.787 0.835 . . . . 0.0 109.302 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.8 Cg_endo -72.24 158.14 52.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.219 3.28 . . . . 0.0 110.944 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -67.17 -19.37 65.57 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.82 -1.175 . . . . 0.0 112.941 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.84 -30.45 70.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.017 0.826 . . . . 0.0 112.888 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 80' ' ' PRO . 51.2 mt -93.45 -14.19 27.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.182 0.993 . . . . 0.0 112.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.4 t -67.04 133.66 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -94.6 90.75 6.26 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.769 0.795 . . . . 0.0 109.628 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -71.43 -21.9 61.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.497 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.16 -13.26 59.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.743 0.817 . . . . 0.0 112.781 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -121.29 159.86 25.13 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.264 1.025 . . . . 0.0 109.986 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -127.74 131.54 23.87 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 125.522 1.529 . . . . 0.0 109.938 -173.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.19 149.45 93.15 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 O-C-N 122.741 0.864 . . . . 0.0 110.689 -10.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.01 141.46 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.067 0.947 . . . . 0.0 109.969 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.3 p -94.91 137.17 34.32 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.658 0.783 . . . . 0.0 110.762 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.61 -14.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 169.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.39 179.9 35.6 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.54 157.51 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.456 1.502 . . . . 0.0 108.589 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.92 128.66 56.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 170.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -113.3 131.57 55.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.935 0.789 . . . . 0.0 109.652 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -110.74 125.49 53.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -108.23 154.41 21.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 84.5 m-85 -135.53 127.12 28.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 19.7 tp -90.43 120.19 31.34 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.8 131.41 56.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.9 tt0 -86.79 134.55 33.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.49 141.81 58.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 109.014 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.28 -51.8 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.57 0.623 . . . . 0.0 109.826 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 m -83.76 -19.82 34.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.111 0.564 . . . . 0.0 111.742 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.44 -169.12 23.36 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -18.38 47.52 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.584 1.554 . . . . 0.0 114.157 -169.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 -31.73 48.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.041 . . . . 0.0 112.902 172.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.92 17.62 10.35 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.3 mt -94.9 134.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -120.34 -52.73 2.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.327 0.651 . . . . 0.0 112.252 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 70.56 7.77 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.887 2.475 . . . . 0.0 114.884 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -153.79 78.46 1.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 123.988 1.851 . . . . 0.0 109.616 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -59.73 2.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.12 -2.309 . . . . 0.0 107.997 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -67.97 165.11 18.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.19 1.396 . . . . 0.0 109.498 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -62.77 -33.31 74.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.973 0.509 . . . . 0.0 110.12 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.5 129.94 51.2 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 124.91 1.284 . . . . 0.0 110.2 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -65.58 143.84 76.63 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.083 1.855 . . . . 0.0 108.338 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -83.18 -17.53 42.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.021 -0.424 . . . . 0.0 111.308 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.48 140.69 49.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.136 0.88 . . . . 0.0 110.85 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.31 -29.74 57.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.159 1.384 . . . . 0.0 110.303 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.72 164.6 38.2 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.57 158.15 43.91 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.61 167.99 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -107.38 136.97 46.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 154.85 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.813 1.245 . . . . 0.0 110.126 -171.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -61.4 144.44 54.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.215 0.916 . . . . 0.0 109.403 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -27.39 57.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -88.61 -16.45 32.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.047 1.294 . . . . 0.0 112.985 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.85 -50.41 85.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.428 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.2 -25.85 42.77 Favored 'Trans proline' 0 C--N 1.35 0.638 0 CA-C-N 121.985 1.745 . . . . 0.0 112.65 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.24 -42.3 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.586 -0.696 . . . . 0.0 109.237 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -69.86 -7.8 43.19 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.605 -1.309 . . . . 0.0 114.227 -178.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.08 -28.21 39.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.147 0.885 . . . . 0.0 111.721 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.1 160.26 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.14 163.66 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.074 0.95 . . . . 0.0 108.88 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.1 m -54.21 -45.67 72.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -70.24 -34.52 72.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.993 1.27 . . . . 0.0 111.238 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -75.36 -44.6 44.18 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.896 -0.503 . . . . 0.0 109.936 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -48.04 -40.77 23.94 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.982 1.313 . . . . 0.0 112.752 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.47 -37.67 83.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.111 0.869 . . . . 0.0 111.963 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.09 -53.12 47.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -65.11 -32.52 74.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 112.225 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -65.76 -43.9 87.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.449 1.477 . . . . 0.0 110.606 170.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -44.72 93.4 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.541 1.064 . . . . 0.0 110.383 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.5 t -56.97 -31.96 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.593 1.157 . . . . 0.0 111.472 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.6 mmt -82.35 -59.62 2.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -31.96 69.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.463 0.705 . . . . 0.0 112.598 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.637 ' HG3' HG22 ' A' ' 71' ' ' THR . 2.0 mm-40 -57.31 -39.58 76.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 112.18 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.89 -13.75 14.08 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.948 0.899 . . . . 0.0 111.416 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.54 -39.59 64.82 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 126.064 1.746 . . . . 0.0 110.631 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 m -66.52 -31.89 72.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.627 0.771 . . . . 0.0 110.903 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.86 -46.15 74.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.78 -40.46 79.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.434 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -55.31 -51.45 66.67 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 120.576 1.534 . . . . 0.0 109.85 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.0 -27.08 60.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.91 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.415 HD21 ' NE2' ' A' ' 103' ' ' GLN . 27.4 tp -62.5 -40.71 97.6 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.711 1.204 . . . . 0.0 109.937 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -60.41 -44.38 95.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.148 0.579 . . . . 0.0 110.173 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 124.516 1.126 . . . . 0.0 113.24 -170.185 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -68.28 -66.49 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.337 0.655 . . . . 0.0 110.945 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -164.0 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.952 0.901 . . . . 0.0 112.918 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -95.76 17.2 15.56 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.446 1.098 . . . . 0.0 113.006 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.45 5.66 65.0 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.946 0.784 . . . . 0.0 113.656 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.85 154.81 17.38 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.55 148.46 67.54 Favored Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.935 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.523 ' HB2' HD12 ' A' ' 40' ' ' ILE . 90.3 Cg_endo -79.86 141.06 14.89 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.319 2.012 . . . . 0.0 110.26 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -145.06 158.68 43.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.272 1.029 . . . . 0.0 109.733 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.95 159.64 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 O-C-N 121.201 -0.937 . . . . 0.0 109.718 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -139.85 156.71 25.0 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.53 141.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.999 1.32 . . . . 0.0 108.261 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.24 139.1 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 mm -116.74 142.79 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 117.243 -1.36 . . . . 0.0 107.568 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.8 p -119.82 154.5 34.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 111.493 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -111.57 171.01 7.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 108.972 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.01 0.52 11.13 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.038 -1.664 . . . . 0.0 114.049 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -88.35 -1.07 57.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.906 0.883 . . . . 0.0 111.053 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.55 17.18 76.2 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.583 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -86.26 145.73 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.72 149.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 109.244 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 ttm -63.84 139.85 58.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.718 0.807 . . . . 0.0 109.329 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.415 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 22.0 t-105 -146.23 140.87 26.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.685 1.594 . . . . 0.0 106.804 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' A' ' 121' ' ' PHE . . . -139.15 146.1 40.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.437 1.472 . . . . 0.0 112.478 -171.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -103.04 114.85 29.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.51 1.924 . . . . 0.0 105.845 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -76.1 147.96 38.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 120.448 1.476 . . . . 0.0 110.036 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -57.33 127.45 32.06 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.66 0.784 . . . . 0.0 110.123 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.04 -4.47 31.39 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.14 1.353 . . . . 0.0 114.841 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -87.66 -35.5 17.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.786 1.793 . . . . 0.0 111.851 -173.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.8 m80 54.99 31.04 15.24 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 112.104 -170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.1 m -138.36 154.59 48.94 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.528 1.931 . . . . 0.0 107.859 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 75.4 m95 -105.12 157.3 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -163.62 168.68 19.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.074 1.749 . . . . 0.0 109.706 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -87.49 149.45 46.62 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.15 131.17 35.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.461 2.107 . . . . 0.0 111.033 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -158.02 165.79 34.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.334 0.653 . . . . 0.0 111.47 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.88 168.0 40.42 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.951 -0.468 . . . . 0.0 113.09 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.46 152.62 51.96 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 9' ' ' PRO . 68.2 mt -75.41 125.19 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 169.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.38 147.79 97.09 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.99 126.07 18.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.336 1.357 . . . . 0.0 109.521 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.75 89.15 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.962 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.09 165.05 25.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.032 1.916 . . . . 0.0 110.57 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -103.03 154.09 19.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.073 -1.876 . . . . 0.0 105.995 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.61 87.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.748 1.158 . . . . 0.0 111.589 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.41 -35.51 79.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.75 0.82 . . . . 0.0 109.882 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.47 -38.76 77.86 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.586 -0.696 . . . . 0.0 109.666 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.3 80.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.676 0.671 . . . . 0.0 109.673 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -60.84 -50.41 73.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -66.63 -38.48 87.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.604 1.093 . . . . 0.0 112.097 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -56.18 -50.45 71.15 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.898 0.879 . . . . 0.0 109.479 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.61 -30.6 59.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.215 -0.422 . . . . 0.0 110.239 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 tp -56.71 -45.35 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.518 1.054 . . . . 0.0 109.819 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.2 -31.69 66.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.2 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.96 -29.92 58.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.284 1.402 . . . . 0.0 112.811 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -99.42 -55.08 2.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.527 1.531 . . . . 0.0 110.809 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 -24.07 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 126.431 1.893 . . . . 0.0 111.131 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.73 -1.49 45.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.042 1.306 . . . . 0.0 113.515 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.72 155.34 35.73 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.048 1.739 . . . . 0.0 109.064 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -131.95 165.66 23.43 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.754 0.822 . . . . 0.0 110.092 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -50.91 -35.21 31.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.857 1.663 . . . . 0.0 112.974 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -64.7 -25.18 67.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.818 -173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -114.58 22.6 13.46 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.55 166.07 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.751 1.62 . . . . 0.0 111.972 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 141.72 33.49 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.7 mt -79.51 115.6 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 103' ' ' GLN . 94.8 mt -88.84 -37.49 15.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.381 1.072 . . . . 0.0 110.643 175.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.21 165.25 36.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.999 0.92 . . . . 0.0 109.031 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 p -161.85 154.92 20.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.261 1.024 . . . . 0.0 110.231 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -70.64 136.3 49.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.641 0.734 . . . . 0.0 110.692 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -81.96 -28.37 32.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.304 1.442 . . . . 0.0 109.782 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -119.37 148.98 42.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.595 2.358 . . . . 0.0 108.233 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 69.0 m95 -81.81 137.89 35.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.44 104.81 16.77 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -102.06 147.11 26.99 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.66 147.79 30.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 169.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.29 141.93 28.02 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.45 147.98 85.42 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 123.861 0.864 . . . . 0.0 110.272 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.09 149.73 82.32 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 105.197 -2.655 . . . . 0.0 105.197 167.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.1 mtpt -69.24 -12.29 61.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.834 -1.791 . . . . 0.0 114.24 -169.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -63.41 -32.53 74.0 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.034 0.833 . . . . 0.0 112.299 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.07 -19.99 20.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.071 0.948 . . . . 0.0 111.382 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 81' ' ' LYS . 92.1 t -62.06 135.19 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -103.5 94.54 5.53 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 108.944 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -72.62 -23.0 60.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.763 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.88 -35.48 57.4 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -91.53 157.91 16.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.884 0.874 . . . . 0.0 108.946 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.93 135.54 27.64 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.513 1.525 . . . . 0.0 108.063 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.1 156.22 93.81 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 122.854 0.923 . . . . 0.0 111.002 -10.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.1 t -72.58 137.8 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.993 0.917 . . . . 0.0 109.543 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.7 p -89.95 117.25 28.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.68 -16.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.158 0.89 . . . . 0.0 113.025 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.49 -176.34 37.54 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -156.93 157.13 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.789 1.236 . . . . 0.0 109.016 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -106.93 130.63 54.57 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -113.07 135.48 53.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.783 0.833 . . . . 0.0 109.896 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.6 ttmm -113.04 129.2 56.58 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.9 m95 -110.14 155.11 22.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.211 0.605 . . . . 0.0 109.538 -171.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.57 127.68 25.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -91.54 124.49 35.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 169.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.93 160.33 22.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.767 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.2 tt0 -111.27 131.73 54.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 134.66 57.16 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 108.026 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.5 t -89.18 -53.57 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.467 1.03 . . . . 0.0 110.009 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.7 m -77.05 -21.64 54.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.222 0.609 . . . . 0.0 111.653 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.49 171.83 22.12 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -16.08 19.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.973 1.709 . . . . 0.0 113.983 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.07 19.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.139 0.976 . . . . 0.0 112.53 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -88.48 13.29 12.25 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.87 142.78 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -137.63 106.73 6.01 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 108.581 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.9 mmt -81.58 1.47 33.61 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -120.12 72.72 0.95 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 123.983 1.849 . . . . 0.0 107.459 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 p -65.07 -66.66 0.51 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 111.58 -2.554 . . . . 0.0 106.215 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 m -76.37 169.46 18.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 167.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.9 m -59.61 -40.75 88.56 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.41 132.58 83.74 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 125.304 1.442 . . . . 0.0 108.836 169.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.86 133.63 48.87 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.761 1.641 . . . . 0.0 108.002 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.44 -25.62 50.77 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.08 -0.388 . . . . 0.0 110.286 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 96.9 m-85 -122.55 140.73 52.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.747 0.819 . . . . 0.0 109.769 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.25 -28.38 53.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.86 0.864 . . . . 0.0 110.323 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.63 161.21 32.08 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 155.21 41.01 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.84 168.9 19.68 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.416 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -109.68 134.85 51.5 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.33 153.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.813 1.245 . . . . 0.0 111.259 -169.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.9 m -61.01 143.37 55.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -24.55 62.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -87.05 -20.81 26.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.367 1.44 . . . . 0.0 113.273 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -60.95 -46.7 96.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 117.277 -1.344 . . . . 0.0 113.497 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.48 -30.43 86.64 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 122.524 1.937 . . . . 0.0 111.821 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.04 -29.94 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.141 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -69.59 -23.71 63.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.98 -1.075 . . . . 0.0 111.768 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -85.13 -11.17 55.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.4 HG11 ' HE2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -122.47 167.11 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -74.72 174.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.652 1.181 . . . . 0.0 109.669 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.93 -54.99 38.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.738 . . . . 0.0 113.179 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -69.37 -40.28 77.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.22 0.918 . . . . 0.0 110.902 -171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.4 ' HE2' HG11 ' A' ' 136' ' ' VAL . 53.3 mtpt -65.62 -55.21 18.81 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -60.73 -34.27 74.15 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.771 -174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.77 -40.53 95.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.957 1.253 . . . . 0.0 111.828 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.88 -52.53 59.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.63 -37.53 84.3 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.754 0.706 . . . . 0.0 110.726 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -56.9 -50.06 73.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.857 1.663 . . . . 0.0 109.959 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.8 -47.92 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.427 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -56.93 -42.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.932 1.242 . . . . 0.0 110.847 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.8 mmt -69.0 -51.38 39.88 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -33.55 76.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.408 1.004 . . . . 0.0 111.701 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.85 -43.72 90.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 119.193 0.906 . . . . 0.0 110.411 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.565 ' HB3' HD12 ' A' ' 101' ' ' LEU . 14.5 m-30 -97.69 -12.74 22.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.6 -42.65 67.89 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.769 1.628 . . . . 0.0 110.627 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 m -70.87 -29.63 65.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.744 0.818 . . . . 0.0 111.047 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.92 -43.86 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.93 -44.11 86.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.537 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.25 66.13 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 121.536 1.971 . . . . 0.0 110.649 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -58.33 -30.97 67.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.96 1.704 . . . . 0.0 111.885 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -77.07 -23.9 51.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.505 1.522 . . . . 0.0 112.547 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -84.02 -44.12 14.46 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.866 0.841 . . . . 0.0 108.916 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 N--CA 1.452 -0.368 0 C-N-CA 126.575 1.95 . . . . 0.0 109.85 -175.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.89 -67.17 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -164.09 -49.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 11.49 15.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.156 0.982 . . . . 0.0 112.721 -169.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.6 -5.8 83.51 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.464 1.031 . . . . 0.0 113.295 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -93.65 158.2 15.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.376 1.088 . . . . 0.0 108.751 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -139.14 137.03 18.63 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.016 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.02 136.04 4.07 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.403 2.068 . . . . 0.0 110.665 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -140.73 156.89 46.09 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.949 0.899 . . . . 0.0 109.709 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.76 153.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 123.778 0.831 . . . . 0.0 109.349 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -127.7 161.67 21.68 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.86 143.59 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.2 t -129.78 135.67 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.1 mm -115.16 133.74 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.4 m -116.79 144.07 44.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -101.4 173.14 6.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.191 0.997 . . . . 0.0 108.315 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -77.25 3.74 12.21 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.564 -1.335 . . . . 0.0 113.036 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -93.76 -4.42 50.36 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.515 1.126 . . . . 0.0 111.302 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.98 33.7 54.38 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -112.58 154.98 25.15 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.628 1.214 . . . . 0.0 108.51 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -115.63 152.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.883 2.073 . . . . 0.0 107.925 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 ptp -75.42 151.4 38.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.219 0.463 . . . . 0.0 110.49 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -146.45 132.95 19.72 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 149.1 46.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.137 1.335 . . . . 0.0 110.508 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -106.52 130.15 54.35 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.584 0.753 . . . . 0.0 109.934 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -76.33 146.39 38.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.705 1.139 . . . . 0.0 108.583 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -56.95 131.62 50.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.253 1.021 . . . . 0.0 110.111 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.99 -9.12 9.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.696 1.141 . . . . 0.0 114.692 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -93.47 -39.41 10.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.435 1.618 . . . . 0.0 110.843 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.0 m80 65.06 -23.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.266 2.226 . . . . 0.0 114.63 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -70.27 153.59 42.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.262 1.425 . . . . 0.0 109.759 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -102.88 153.22 20.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 111.718 -169.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.62 168.43 27.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.617 1.567 . . . . 0.0 110.49 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -86.64 152.71 54.8 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.55 133.48 37.21 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.092 1.861 . . . . 0.0 110.803 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.41 169.34 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.914 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.95 171.24 44.29 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.844 -0.535 . . . . 0.0 113.069 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.09 150.53 25.0 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.502 1.048 . . . . 0.0 111.496 -173.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.76 125.79 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.78 154.82 91.12 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.52 122.92 12.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 CA-C-N 120.804 1.323 . . . . 0.0 109.585 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.9 -3.96 85.78 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.521 -1.155 . . . . 0.0 114.749 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.78 156.95 38.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 120.135 1.968 . . . . 0.0 110.547 170.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -95.36 158.34 15.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.59 77.81 Favored 'General case' 0 C--O 1.224 -0.243 0 O-C-N 121.721 -0.612 . . . . 0.0 111.434 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.92 -37.59 79.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.55 0.74 . . . . 0.0 109.997 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -73.61 -35.62 65.38 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.46 92.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -60.87 -50.46 73.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.156 -0.926 . . . . 0.0 108.556 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 47.5 m-85 -66.01 -36.98 84.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.649 1.113 . . . . 0.0 112.41 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.1 ttm-85 -68.33 -50.44 53.3 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.826 1.193 . . . . 0.0 109.445 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.92 -27.75 61.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 tp -52.98 -48.02 67.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.456 0.702 . . . . 0.0 109.351 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.38 -42.5 99.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.779 0.718 . . . . 0.0 109.913 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.35 -28.27 69.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.366 0.985 . . . . 0.0 112.231 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.97 -57.91 2.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.579 0.751 . . . . 0.0 109.86 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.06 1.31 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.452 1.501 . . . . 0.0 112.216 -169.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.62 9.59 55.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.661 1.119 . . . . 0.0 113.39 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.74 150.15 20.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.056 2.142 . . . . 0.0 109.031 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 m -129.78 164.73 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.679 0.792 . . . . 0.0 109.903 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 53.0 mtt85 -45.29 -37.41 4.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.535 1.934 . . . . 0.0 113.12 -173.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.45 -30.35 71.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.873 -172.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.59 21.75 15.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.675 1.125 . . . . 0.0 112.505 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -131.38 165.11 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.246 1.418 . . . . 0.0 110.439 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -143.18 139.88 30.52 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 mt -79.59 121.64 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 103' ' ' GLN . 68.2 mt -96.12 -36.66 10.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.218 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.23 166.88 31.28 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.601 0.76 . . . . 0.0 109.295 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 p -162.47 155.47 19.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.394 1.077 . . . . 0.0 110.712 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.457 HG22 ' HG2' ' A' ' 150' ' ' GLU . 5.0 p -71.66 140.35 49.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.947 -170.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.68 -49.64 12.79 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 144.37 26.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.817 1.647 . . . . 0.0 110.457 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -79.36 126.12 30.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.63 126.93 33.78 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -121.88 148.94 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -141.44 145.3 35.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -94.03 143.97 25.89 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.76 142.94 97.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 110.225 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.33 147.18 77.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 104.432 -2.949 . . . . 0.0 104.432 166.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HA ' HG23 ' A' ' 84' ' ' VAL 0.252 86.6 mttt -68.82 -12.81 61.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.03 -1.669 . . . . 0.0 114.546 -168.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -30.27 70.21 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.47 -15.47 25.53 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.815 0.846 . . . . 0.0 112.435 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 81' ' ' LYS . 94.2 t -64.72 133.54 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -100.47 91.79 4.85 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.378 1.071 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -69.92 -22.73 63.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.98 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.7 -25.96 54.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.414 0.686 . . . . 0.0 112.391 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -106.81 155.89 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.944 0.897 . . . . 0.0 109.152 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.46 135.14 27.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.543 1.137 . . . . 0.0 110.246 -169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.76 150.32 94.03 Favored 'Cis proline' 0 N--CA 1.456 -0.691 0 N-CA-C 109.528 -0.989 . . . . 0.0 109.528 -10.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.3 p -71.2 133.89 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.493 0.717 . . . . 0.0 109.48 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 t -74.4 130.18 39.16 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.25 -13.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.203 169.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.84 47.95 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 120.1 1.318 . . . . 0.0 111.226 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.97 157.8 44.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.021 1.728 . . . . 0.0 109.96 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.36 137.22 44.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.73 130.34 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.553 1.141 . . . . 0.0 109.277 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -112.63 134.01 54.38 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.434 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 66.3 m95 -115.0 157.62 23.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.594 0.634 . . . . 0.0 109.839 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.88 125.33 23.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 108.28 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -88.29 121.93 31.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 168.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mt -118.68 152.24 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.632 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.4 tt0 -100.56 135.29 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 131.73 50.5 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.56 -50.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 119.44 1.018 . . . . 0.0 109.724 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.9 m -79.29 -25.12 42.48 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.322 0.649 . . . . 0.0 111.696 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.3 169.89 16.02 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -20.19 15.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.51 1.924 . . . . 0.0 113.073 -170.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.95 -26.24 47.14 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.13 10.43 8.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.31 140.63 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -130.35 118.77 21.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.028 1.731 . . . . 0.0 106.899 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.6 mtp -90.17 -3.06 58.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.549 0.613 . . . . 0.0 112.625 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -119.19 71.84 0.88 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.512 2.101 . . . . 0.0 107.026 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 p -65.22 -63.6 1.06 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.879 -2.873 . . . . 0.0 106.435 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 m -78.23 172.73 13.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.365 1.466 . . . . 0.0 107.343 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.5 m -60.33 -41.38 93.42 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.38 135.19 86.6 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 125.433 1.493 . . . . 0.0 108.777 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.13 140.52 89.79 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.654 1.57 . . . . 0.0 109.444 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.26 -46.55 20.0 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.5 141.76 39.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.882 0.873 . . . . 0.0 109.71 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -87.67 -15.02 38.36 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.253 1.021 . . . . 0.0 111.257 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.93 150.22 17.9 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 121.584 -0.698 . . . . 0.0 111.878 -169.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 51.2 p-90 -127.38 153.99 45.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.402 1.481 . . . . 0.0 108.484 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.36 141.84 24.33 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 168.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -102.55 123.65 46.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.0 161.57 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.062 1.345 . . . . 0.0 112.517 -168.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m -66.72 149.56 50.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.672 -0.642 . . . . 0.0 109.91 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -30.56 59.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.013 1.325 . . . . 0.0 112.584 -173.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -95.81 -2.47 47.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -76.34 -49.5 3.03 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.369 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.74 -32.52 93.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.495 1.927 . . . . 0.0 112.346 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -66.59 -21.87 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.275 -0.89 . . . . 0.0 112.301 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -69.08 -29.62 67.77 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -86.51 -26.83 24.37 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.47 163.12 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -69.72 173.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.971 1.308 . . . . 0.0 109.797 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.8 m -55.9 -54.24 47.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.749 1.62 . . . . 0.0 113.313 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -70.59 -39.94 73.56 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.854 -172.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.53 -49.03 67.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.15 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -63.69 -33.11 74.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.639 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.0 -47.32 77.91 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 119.098 0.863 . . . . 0.0 110.219 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.11 -49.58 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -61.76 -39.86 93.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.029 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.87 -38.74 76.49 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.896 1.68 . . . . 0.0 110.747 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.89 -45.58 94.01 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.852 0.751 . . . . 0.0 110.225 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.81 -40.02 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 110.565 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mmt -67.21 -49.35 64.88 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.279 1.5 tmtt? -59.86 -31.1 69.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.612 1.096 . . . . 0.0 111.879 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.457 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.1 tp10 -60.78 -36.75 79.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.269 0.628 . . . . 0.0 110.697 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.504 ' HB3' HD12 ' A' ' 101' ' ' LEU . 15.7 m-85 -110.83 -15.8 13.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.082 0.953 . . . . 0.0 113.187 -172.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.43 -42.45 70.54 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.428 1.491 . . . . 0.0 110.883 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 m -68.04 -31.78 71.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.855 0.862 . . . . 0.0 110.687 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.28 -44.24 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.9 -40.95 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.831 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.6 mmt -55.77 -47.17 77.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.173 0.897 . . . . 0.0 110.537 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -80.27 -26.68 38.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.921 1.288 . . . . 0.0 111.041 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.4 -41.37 93.73 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.753 1.221 . . . . 0.0 110.142 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -57.29 -36.72 71.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.901 0.481 . . . . 0.0 110.931 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 112.562 -176.092 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.76 -68.62 0.36 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.989 0.516 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -164.47 -49.76 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.768 0.827 . . . . 0.0 113.229 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.0 16.35 11.32 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 113.11 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.59 -2.13 82.34 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.391 0.996 . . . . 0.0 113.14 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.54 155.59 17.23 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.083 0.942 . . . . 0.0 108.507 169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -146.31 126.85 7.1 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 117.442 -1.266 . . . . 0.0 107.973 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -76.07 138.36 20.46 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.611 1.541 . . . . 0.0 111.581 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -139.71 154.67 47.52 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.266 1.026 . . . . 0.0 108.849 -171.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.88 162.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.606 -0.683 . . . . 0.0 109.61 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.5 163.37 28.2 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.14 142.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.07 136.49 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -116.42 136.06 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -124.83 145.56 49.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.816 0.735 . . . . 0.0 110.172 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -95.03 174.09 7.25 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -79.32 16.73 0.94 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.037 -1.664 . . . . 0.0 112.282 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -108.37 -1.3 20.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.422 1.489 . . . . 0.0 111.275 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.14 14.99 80.11 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.287 -172.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -86.8 130.42 34.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.07 152.95 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.951 1.3 . . . . 0.0 108.837 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.0 tpp -62.28 137.69 58.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.24 0.616 . . . . 0.0 109.473 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -140.91 129.7 22.99 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.41 44.46 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 122.957 0.503 . . . . 0.0 111.259 -169.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -124.43 125.66 44.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -88.15 165.05 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.862 0.465 . . . . 0.0 110.891 -169.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -49.51 124.43 9.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.227 1.011 . . . . 0.0 111.694 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.59 8.07 62.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.513 1.054 . . . . 0.0 113.412 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -100.05 153.18 19.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.778 1.289 . . . . 0.0 109.417 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -111.5 19.95 17.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 m -128.34 143.23 50.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.857 1.263 . . . . 0.0 108.29 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -98.2 151.45 20.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.379 0.672 . . . . 0.0 110.227 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -155.56 160.61 40.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.434 1.094 . . . . 0.0 111.051 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.75 148.21 75.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.43 127.39 17.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.828 2.352 . . . . 0.0 112.678 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -142.54 161.53 37.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.555 1.07 . . . . 0.0 112.51 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.99 177.11 48.28 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.199 0.428 . . . . 0.0 113.344 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.15 146.02 17.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 125.346 1.45 . . . . 0.0 110.182 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -79.82 124.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -70.33 155.26 93.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -57.7 125.28 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.95 -7.25 81.09 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.331 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.51 158.71 34.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 120.112 1.956 . . . . 0.0 110.396 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 p -102.16 159.57 15.27 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.35 85.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.625 -0.672 . . . . 0.0 111.627 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.16 -34.64 73.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.733 0.813 . . . . 0.0 110.114 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -72.82 -36.78 67.58 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.698 -1.251 . . . . 0.0 110.227 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.98 93.08 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 ttp -59.81 -49.11 79.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.274 -0.869 . . . . 0.0 108.819 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 46.1 m-85 -64.47 -44.35 91.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.664 1.12 . . . . 0.0 111.975 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -65.9 -49.83 66.64 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.849 1.204 . . . . 0.0 109.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.65 -24.49 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.2 -47.49 83.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -57.14 -39.98 76.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.555 0.616 . . . . 0.0 109.458 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -0.96 14.48 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -115.98 -39.4 3.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.273 1.429 . . . . 0.0 111.933 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.46 2.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.735 1.214 . . . . 0.0 112.666 -171.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.87 6.81 19.59 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-N 119.523 1.056 . . . . 0.0 113.269 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.35 148.65 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.356 1.862 . . . . 0.0 109.238 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 p -126.59 170.11 12.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.665 1.186 . . . . 0.0 109.486 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 43.9 mtt85 -50.93 -31.93 19.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.906 1.683 . . . . 0.0 112.166 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -66.69 -24.82 66.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.244 0.618 . . . . 0.0 112.349 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.93 24.28 10.93 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.01 164.06 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 120.778 -1.201 . . . . 0.0 111.464 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -141.9 140.51 32.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 mt -82.61 119.52 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 103' ' ' GLN . 90.0 mt -94.6 -36.64 11.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.429 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.17 164.4 32.91 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.498 0.719 . . . . 0.0 109.773 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 p -160.08 153.85 22.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.904 1.281 . . . . 0.0 110.974 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 p -70.02 140.26 52.84 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.574 0.702 . . . . 0.0 111.199 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -83.29 -28.3 29.21 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.083 1.353 . . . . 0.0 110.053 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -125.5 148.14 48.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.369 2.267 . . . . 0.0 109.094 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -81.83 136.1 35.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.52 62.04 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.823 0.849 . . . . 0.0 109.442 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -71.21 150.33 45.41 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.4 -0.812 . . . . 0.0 109.914 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.17 148.34 31.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.93 136.77 32.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 169.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.283 0.4 OUTLIER -90.83 149.71 40.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.629 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.1 Cg_endo -74.59 157.71 44.28 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 124.093 3.195 . . . . 0.0 111.049 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -65.44 -19.9 66.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -171.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -31.01 69.39 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.414 HD12 ' HD2' ' A' ' 80' ' ' PRO . 35.3 mt -94.22 -22.51 18.37 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.675 1.19 . . . . 0.0 111.489 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 86' ' ' TRP . 62.2 t -65.44 133.44 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -99.99 88.42 3.75 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.782 0.801 . . . . 0.0 109.479 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.41 ' CE2' HG11 ' A' ' 84' ' ' VAL . 85.5 m95 -68.76 -22.04 64.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.768 175.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.54 -8.99 59.16 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.817 0.847 . . . . 0.0 113.046 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -129.77 162.77 27.69 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 110.274 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.18 134.84 26.36 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.404 1.482 . . . . 0.0 109.231 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.61 147.28 88.97 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 O-C-N 122.666 0.824 . . . . 0.0 110.381 -10.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.72 140.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.003 0.921 . . . . 0.0 109.725 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.2 p -94.61 128.33 41.17 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.374 1.07 . . . . 0.0 109.904 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -14.59 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.92 175.5 47.04 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.07 144.74 26.88 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 108.336 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -90.05 135.45 33.64 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -118.42 132.3 56.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.185 0.902 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -115.74 135.26 54.21 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.52 154.3 31.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.1 125.59 22.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.506 1.123 . . . . 0.0 108.146 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 tp -90.4 124.93 35.36 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.35 149.09 41.07 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.9 tt0 -100.67 129.24 46.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.02 134.04 56.11 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.6 t -82.24 -43.27 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.587 -169.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.0 m -97.52 -19.3 18.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.933 0.893 . . . . 0.0 111.704 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.1 -170.11 17.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.416 1.008 . . . . 0.0 111.064 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.68 -22.51 23.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.218 1.807 . . . . 0.0 112.824 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.51 -31.14 63.81 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.957 0.903 . . . . 0.0 113.434 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.96 14.33 14.14 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.98 140.36 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -120.74 115.71 23.83 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.05 6.7 47.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.049 0.539 . . . . 0.0 111.581 -171.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -149.02 66.61 1.04 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.454 1.902 . . . . 0.0 106.663 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -57.03 -60.47 3.55 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 127.218 2.207 . . . . 0.0 111.175 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.4 m -101.19 174.5 5.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.27 1.828 . . . . 0.0 109.93 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -54.67 -37.93 66.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.02 116.16 64.67 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 167.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -61.82 129.99 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 170.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.62 32.5 0.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . 0.26 8.8 t80 -153.18 162.26 41.51 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 120.683 -1.261 . . . . 0.0 112.184 -166.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.75 17.48 0.89 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 171.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.24 149.33 5.13 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 115.443 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.78 153.34 51.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.652 1.181 . . . . 0.0 111.675 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -156.32 152.67 27.93 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.601 1.16 . . . . 0.0 108.742 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -107.72 123.77 49.03 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.64 151.04 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.111 0.964 . . . . 0.0 110.668 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m -55.12 140.03 39.71 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.594 0.758 . . . . 0.0 110.291 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -32.45 18.53 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -85.38 -23.54 27.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.322 1.419 . . . . 0.0 112.971 -176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.72 -46.71 88.5 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.072 -1.442 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.86 -25.79 78.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 123.028 2.117 . . . . 0.0 113.139 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.29 -32.18 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.931 0.893 . . . . 0.0 108.915 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -61.85 -32.58 72.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.368 -0.832 . . . . 0.0 110.949 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -77.99 -27.32 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.33 167.69 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 118.896 0.771 . . . . 0.0 110.879 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.701 1.2 . . . . 0.0 110.226 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.7 m -53.2 -47.0 69.25 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.662 1.585 . . . . 0.0 114.838 -170.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -74.92 -36.7 62.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.051 0.841 . . . . 0.0 111.256 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -74.24 -42.82 59.09 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.503 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -42.88 -44.6 4.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.993 0.917 . . . . 0.0 111.935 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.35 -43.26 98.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.219 0.918 . . . . 0.0 111.097 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.75 -50.63 76.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.23 -32.37 74.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.301 0.64 . . . . 0.0 110.929 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -69.57 -41.78 75.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.836 1.198 . . . . 0.0 110.407 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.06 -41.23 96.22 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.581 1.082 . . . . 0.0 110.576 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.3 t -57.85 -24.97 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 111.591 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.5 mmt -90.51 -58.36 2.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -56.53 -37.12 70.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.637 1.175 . . . . 0.0 112.485 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.1 -36.29 72.68 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 119.062 0.846 . . . . 0.0 111.078 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -106.91 -11.95 15.59 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.183 0.993 . . . . 0.0 112.673 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.68 69.8 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.223 1.409 . . . . 0.0 110.655 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.2 m -67.85 -31.86 71.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.551 0.74 . . . . 0.0 110.654 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.97 -45.23 74.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.43 -41.02 80.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 117.312 -1.327 . . . . 0.0 110.592 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.19 -49.9 72.74 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 120.993 1.724 . . . . 0.0 109.964 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 m -73.55 -26.55 60.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.26 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.5 tp -63.79 -44.07 94.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.296 1.438 . . . . 0.0 109.539 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -61.16 -43.06 99.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.233 0.232 0 C-N-CA 122.937 0.495 . . . . 0.0 112.173 -171.637 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 92' ' ' CYS . 1.9 mt . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.26 150.12 47.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.472 1.129 . . . . 0.0 108.803 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.98 -24.86 56.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.188 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.15 0.19 19.81 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.87 61.78 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.912 1.244 . . . . 0.0 113.386 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -118.2 161.25 20.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -144.18 132.45 10.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HB2' HD12 ' A' ' 40' ' ' ILE . 93.9 Cg_endo -82.35 136.06 8.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.371 1.381 . . . . 0.0 108.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -139.19 152.56 47.47 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.118 -0.989 . . . . 0.0 108.989 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.454 HG13 HD11 ' A' ' 40' ' ' ILE . 12.5 m -134.26 154.09 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.255 1.022 . . . . 0.0 108.892 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.51 157.5 25.14 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.32 143.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.5 138.69 51.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 170.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 mm -116.89 141.21 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 101' ' ' LEU . 25.6 p -120.74 157.2 30.18 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.321 1.049 . . . . 0.0 111.364 174.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -117.89 168.09 10.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.938 1.295 . . . . 0.0 107.987 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -73.66 -0.71 16.28 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.377 -1.452 . . . . 0.0 113.032 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -85.35 -8.84 58.25 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 111.365 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.95 34.83 41.1 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -106.07 154.34 20.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 169.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.84 150.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.34 1.056 . . . . 0.0 109.736 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.6 ttm -66.67 143.26 57.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.203 1.001 . . . . 0.0 108.397 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -150.5 141.85 23.32 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 147.63 31.37 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.463 1.483 . . . . 0.0 110.379 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.09 136.37 47.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.165 0.986 . . . . 0.0 109.089 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm-85 -73.53 160.68 31.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 111.487 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -49.58 123.94 8.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.174 0.99 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.73 6.79 73.1 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.816 1.198 . . . . 0.0 114.145 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -106.42 160.27 15.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.338 1.569 . . . . 0.0 110.616 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -119.91 17.34 12.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.803 1.241 . . . . 0.0 111.598 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 m -128.1 138.71 52.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.048 1.339 . . . . 0.0 108.149 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -94.46 151.21 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.519 0.727 . . . . 0.0 110.549 -170.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -143.57 155.58 44.34 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.165 1.386 . . . . 0.0 110.139 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -82.54 138.9 44.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 167.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.05 135.58 64.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.708 2.272 . . . . 0.0 112.568 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.87 166.2 32.42 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.962 0.801 . . . . 0.0 112.199 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.0 168.01 40.95 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.507 0.575 . . . . 0.0 111.683 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.88 149.01 40.68 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 9' ' ' PRO . 59.9 mt -73.57 120.49 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -73.59 157.79 87.2 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.59 122.98 12.7 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.331 1.354 . . . . 0.0 111.539 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.23 2.0 88.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.538 -1.146 . . . . 0.0 114.745 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.85 152.74 43.39 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.158 1.979 . . . . 0.0 111.066 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.0 p -84.76 167.49 16.05 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 167.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -36.32 79.2 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.088 -1.008 . . . . 0.0 111.316 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -40.51 61.13 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.484 0.713 . . . . 0.0 109.802 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -65.65 -40.89 92.94 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.26 75.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.856 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -58.15 -48.23 80.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 57.1 m-85 -66.81 -45.64 77.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.1 0.864 . . . . 0.0 111.642 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -53.57 -51.71 62.09 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.919 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -77.72 -32.34 52.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.9 tp -56.48 -45.65 80.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.25 0.932 . . . . 0.0 109.98 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.84 -40.26 92.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.282 0.492 . . . . 0.0 110.082 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.813 0.733 . . . . 0.0 112.366 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.55 -53.55 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.165 0.986 . . . . 0.0 110.414 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -123.27 3.6 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.488 1.515 . . . . 0.0 112.038 -169.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.43 3.27 24.9 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.005 1.275 . . . . 0.0 113.955 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.81 145.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.7 m -124.3 162.21 24.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.062 . . . . 0.0 109.664 -171.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.433 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 46.4 mtp180 -42.73 -40.63 2.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.621 1.968 . . . . 0.0 112.892 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -69.08 -21.15 64.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.376 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.76 19.92 16.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.745 0.784 . . . . 0.0 112.522 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.23 164.19 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.403 1.481 . . . . 0.0 111.337 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 138.93 35.92 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.072 169.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 mt -77.03 116.1 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 103' ' ' GLN . 58.6 mt -93.71 -33.17 13.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.395 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.28 164.45 38.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.866 0.866 . . . . 0.0 109.397 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 p -162.21 154.4 19.17 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 110.787 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.597 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -70.6 136.86 49.53 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.831 -0.543 . . . . 0.0 110.8 -170.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -79.3 -29.79 42.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.633 0.773 . . . . 0.0 110.553 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.344 2.258 . . . . 0.0 108.361 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.3 m95 -77.78 133.64 38.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.998 0.817 . . . . 0.0 109.165 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.03 116.58 27.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -127.05 149.52 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.51 142.55 31.18 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.9 139.77 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.71 139.37 86.05 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.065 0.946 . . . . 0.0 110.418 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.55 148.83 73.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 N-CA-C 104.636 -2.871 . . . . 0.0 104.636 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.7 mtpt -68.84 -13.23 62.28 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 119.847 -1.783 . . . . 0.0 114.236 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -62.54 -30.73 71.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.955 0.798 . . . . 0.0 112.634 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.4 mt -94.07 -18.24 22.02 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.161 0.985 . . . . 0.0 112.212 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 81' ' ' LYS . 59.9 t -64.48 132.65 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.12 88.39 4.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.729 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -69.98 -17.76 63.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.262 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.83 -27.28 55.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -103.18 163.08 12.46 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.973 . . . . 0.0 110.811 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.38 127.67 22.5 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 125.254 1.422 . . . . 0.0 110.72 -171.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.14 145.24 83.44 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 N-CA-C 109.308 -1.074 . . . . 0.0 109.308 -10.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.28 136.35 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.405 ' HB3' HD13 ' A' ' 2' ' ' ILE . 19.5 p -96.92 144.22 27.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.594 0.358 . . . . 0.0 110.585 170.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.84 -7.3 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.45 177.22 41.44 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -150.08 147.25 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.854 1.662 . . . . 0.0 109.016 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -96.23 131.24 42.92 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.17 128.6 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.504 1.047 . . . . 0.0 109.189 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 2.2 ttmm -109.05 121.15 44.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -102.47 151.27 22.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -133.43 131.51 40.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 108.015 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -93.34 124.8 37.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 169.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.51 149.7 42.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.1 tt0 -97.57 133.06 42.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 136.19 57.84 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.235 1.414 . . . . 0.0 107.552 171.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.31 -59.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.563 1.074 . . . . 0.0 110.226 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 m -74.74 -20.03 59.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.423 0.689 . . . . 0.0 111.672 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.21 172.35 25.14 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -58.42 -16.5 15.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.059 1.744 . . . . 0.0 114.112 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.73 -30.89 15.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.194 0.997 . . . . 0.0 113.088 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -85.53 18.98 2.53 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.18 142.05 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.185 1.394 . . . . 0.0 108.614 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -130.94 130.93 44.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.652 1.981 . . . . 0.0 107.895 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mmt -93.95 -14.4 26.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.52 0.728 . . . . 0.0 112.728 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -112.73 74.32 0.86 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 124.38 2.038 . . . . 0.0 107.94 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.0 p -71.49 -63.12 1.18 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 110.891 -2.868 . . . . 0.0 107.117 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.2 m -78.91 175.47 10.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.599 1.56 . . . . 0.0 108.721 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -59.71 -35.24 74.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.541 -0.724 . . . . 0.0 110.486 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.27 137.36 37.04 Favored Pre-proline 0 N--CA 1.446 -0.657 0 C-N-CA 125.945 1.698 . . . . 0.0 108.844 169.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.38 121.32 9.26 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.31 2.007 . . . . 0.0 107.55 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -73.74 -26.05 60.48 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.067 -0.395 . . . . 0.0 111.583 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -107.54 141.29 39.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.22 -27.66 38.74 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.259 0.624 . . . . 0.0 110.313 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.55 150.81 22.88 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.78 140.44 29.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -148.04 168.98 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.586 1.154 . . . . 0.0 109.222 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -117.4 142.56 46.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 149.84 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.702 1.201 . . . . 0.0 109.101 -169.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -51.99 141.81 17.18 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -43.78 -55.51 4.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.78 -7.83 53.53 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.822 1.192 . . . . 0.0 113.596 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.58 -52.44 66.99 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-O 116.825 -1.559 . . . . 0.0 113.68 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.97 -8.73 14.57 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.616 2.877 . . . . 0.0 116.392 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.16 -29.52 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 120.967 -1.083 . . . . 0.0 108.869 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.43 -25.38 63.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.75 -1.219 . . . . 0.0 112.281 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.47 -22.05 21.57 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.92 175.3 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 119.321 0.964 . . . . 0.0 110.612 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 m -83.82 171.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.5 m -56.61 -48.79 76.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.821 2.048 . . . . 0.0 114.327 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -72.07 -35.99 69.42 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.115 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.08 -39.08 72.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.75 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -50.01 -42.81 50.01 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.87 0.868 . . . . 0.0 111.454 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.41 -45.85 91.24 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.465 0.575 . . . . 0.0 110.359 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.1 -50.22 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -62.79 -37.99 88.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.9 0.773 . . . . 0.0 109.974 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -69.24 -36.28 77.02 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.45 -44.66 95.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.077 1.308 . . . . 0.0 110.307 172.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.14 -39.03 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 119.939 1.245 . . . . 0.0 110.451 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.8 mmt -72.45 -59.48 2.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.958 1.303 . . . . 0.0 107.637 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -34.07 72.48 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.588 -1.32 . . . . 0.0 112.313 -172.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 71' ' ' THR . 2.3 mm-40 -57.93 -41.05 81.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.423 ' HB3' HD12 ' A' ' 101' ' ' LEU . 4.5 m-85 -111.52 -11.95 14.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 112.039 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.2 -42.7 63.73 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 126.786 2.034 . . . . 0.0 110.467 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -68.95 -30.66 69.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.994 0.918 . . . . 0.0 110.916 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.83 -46.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.11 -41.25 88.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.293 -171.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.0 mmt -55.51 -44.41 76.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.348 1.431 . . . . 0.0 110.752 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -81.12 -26.04 36.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.324 1.049 . . . . 0.0 111.502 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.59 -43.78 95.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.043 1.337 . . . . 0.0 109.686 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.63 -40.09 93.63 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.752 0.421 . . . . 0.0 110.718 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 C--O 1.234 0.243 0 C-N-CA 123.217 0.607 . . . . 0.0 112.238 -169.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.44 -63.95 1.12 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.429 0.692 . . . . 0.0 112.627 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.21 -53.84 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.62 17.25 16.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.435 1.094 . . . . 0.0 113.06 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.19 61.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.894 0.759 . . . . 0.0 113.702 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.8 154.4 18.67 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.085 0.943 . . . . 0.0 108.816 171.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -139.01 149.88 63.1 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.361 174.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HB2' HD12 ' A' ' 40' ' ' ILE . 9.4 Cg_exo -90.58 141.78 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.687 1.592 . . . . 0.0 111.757 -174.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -135.8 154.32 51.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.143 0.977 . . . . 0.0 109.711 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 40' ' ' ILE . 6.2 m -133.82 140.53 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -119.81 155.62 16.09 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 124.783 1.182 . . . . 0.0 110.211 176.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.05 142.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.93 135.62 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 104' ' ' LEU . 22.8 mm -108.56 132.76 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.2 m -124.26 145.57 49.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -105.74 173.31 6.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.644 1.177 . . . . 0.0 109.321 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.59 5.75 4.51 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.562 -1.336 . . . . 0.0 113.657 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -96.27 -2.17 46.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 111.482 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.61 22.11 79.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.392 -0.671 . . . . 0.0 111.843 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -93.91 145.39 24.66 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.23 149.85 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.717 1.607 . . . . 0.0 108.934 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.4 ttm -68.37 142.78 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.88 0.872 . . . . 0.0 109.366 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -141.48 123.32 15.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.08 159.35 41.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.134 1.334 . . . . 0.0 112.575 -168.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -157.93 169.52 24.4 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.08 1.309 . . . . 0.0 114.073 177.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.523 ' H ' ' HG3' ' A' ' 26' ' ' ARG . 8.2 tpt180 -59.84 154.39 18.57 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 128.035 2.534 . . . . 0.0 112.855 -169.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -61.15 134.39 56.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.614 1.166 . . . . 0.0 108.242 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.61 1.78 78.26 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.361 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -106.15 160.73 15.1 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.564 1.682 . . . . 0.0 110.654 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -128.91 11.99 6.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.671 1.189 . . . . 0.0 111.453 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -85.68 169.15 13.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.902 0.881 . . . . 0.0 109.082 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -133.2 132.12 41.16 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.03 173.94 13.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.391 1.477 . . . . 0.0 108.037 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -75.46 152.93 85.72 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.098 -0.954 . . . . 0.0 108.601 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 133.36 57.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.865 2.377 . . . . 0.0 111.536 170.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.15 171.2 18.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.66 1.118 . . . . 0.0 112.204 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.48 170.36 41.16 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.992 -0.442 . . . . 0.0 112.755 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 144.01 33.59 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.469 HD11 HG13 ' A' ' 11' ' ' VAL . 31.1 mt -73.99 119.33 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.67 144.1 85.6 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.14 126.17 18.06 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.804 1.67 . . . . 0.0 110.293 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.43 52.79 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.662 1.125 . . . . 0.0 113.283 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 152.1 37.17 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.675 1.737 . . . . 0.0 109.83 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.2 p -80.21 169.4 17.83 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.3 87.75 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 121.68 -0.637 . . . . 0.0 111.379 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.66 -37.77 70.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 110.387 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -68.09 -39.49 82.88 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.603 -1.31 . . . . 0.0 110.08 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.56 -30.66 67.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.676 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.419 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 11.9 tmm? -57.08 -50.73 71.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.425 1.011 . . . . 0.0 108.674 173.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 52.3 m-85 -66.38 -44.96 81.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.322 0.51 . . . . 0.0 111.119 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -57.35 -50.23 73.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.901 0.88 . . . . 0.0 110.023 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -77.12 -31.08 55.51 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -172.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.9 tp -58.11 -43.26 87.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.369 0.986 . . . . 0.0 110.241 172.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -62.38 -41.47 98.66 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.325 0.511 . . . . 0.0 110.087 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.66 -24.84 65.48 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.804 0.729 . . . . 0.0 112.429 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.04 -61.09 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.802 0.841 . . . . 0.0 108.788 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.88 -4.95 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.436 1.094 . . . . 0.0 113.561 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.799 1.181 . . . . 0.0 114.103 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.08 150.28 30.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.83 1.652 . . . . 0.0 109.099 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 m -127.76 164.34 22.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.332 1.053 . . . . 0.0 109.801 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.407 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 60.9 mtt180 -48.28 -36.16 13.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.103 1.761 . . . . 0.0 112.519 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -63.38 -23.45 67.42 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.623 0.769 . . . . 0.0 112.19 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.89 24.58 11.13 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.939 0.4 . . . . 0.0 111.63 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.87 165.09 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.413 1.085 . . . . 0.0 111.957 172.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 134.16 30.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.7 mt -76.65 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -95.88 -32.89 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -154.19 164.43 38.55 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 p -163.18 154.44 17.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.502 1.121 . . . . 0.0 110.798 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -72.81 140.06 47.41 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 109.969 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -92.22 -27.87 17.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -111.29 150.92 28.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.451 2.3 . . . . 0.0 107.482 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 57.1 m95 -82.3 136.94 34.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.438 0.563 . . . . 0.0 109.518 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.4 71.47 6.05 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -71.77 147.36 47.36 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -146.33 144.01 29.5 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.845 0.458 . . . . 0.0 110.0 170.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.84 146.67 24.04 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.074 0.95 . . . . 0.0 108.504 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.05 145.85 91.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 110.682 169.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.79 145.9 64.42 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 N-CA-C 104.499 -2.924 . . . . 0.0 104.499 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.8 mtpt -68.34 -13.13 62.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.909 -1.744 . . . . 0.0 114.151 -169.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -58.7 -31.31 68.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.8 mt -92.55 -19.52 21.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 111.998 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 81' ' ' LYS . 58.2 t -65.31 136.09 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -101.58 90.49 4.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.942 0.897 . . . . 0.0 109.473 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -68.42 -24.17 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.807 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.93 -34.42 73.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.617 0.367 . . . . 0.0 111.831 -171.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.93 159.21 15.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.786 0.834 . . . . 0.0 109.678 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -130.88 134.95 26.59 Favored Pre-proline 0 C--O 1.234 0.268 0 C-N-CA 125.325 1.45 . . . . 0.0 109.615 -171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.46 148.03 90.5 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 O-C-N 122.696 0.84 . . . . 0.0 110.07 -10.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -79.24 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.484 0.713 . . . . 0.0 109.532 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.89 127.69 35.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -14.57 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 118.932 0.787 . . . . 0.0 112.861 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.7 -177.11 38.88 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.77 153.82 30.45 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.794 1.238 . . . . 0.0 108.84 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -98.61 132.55 43.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -123.62 122.81 39.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 119.266 0.939 . . . . 0.0 109.566 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 7.6 ttmm -98.72 153.55 18.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.2 m95 -132.32 151.74 51.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.419 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 75.8 m-85 -137.69 127.88 26.09 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 108.893 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -89.59 122.62 32.91 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.88 136.99 53.75 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.47 132.29 35.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.421 ' HB2' HG21 ' A' ' 15' ' ' ILE . 13.9 tp -73.76 132.64 42.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.064 2.146 . . . . 0.0 107.539 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -77.63 -53.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.538 1.135 . . . . 0.0 111.837 -168.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.7 m -87.24 -15.55 37.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 111.563 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.37 -169.92 21.95 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.707 1.146 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -59.1 -17.39 25.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.627 1.571 . . . . 0.0 114.008 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.81 57.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.268 1.027 . . . . 0.0 112.955 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -95.66 18.29 13.22 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.52 113.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -92.74 -56.12 3.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.799 0.272 . . . . 0.0 110.978 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.2 mtp 69.81 3.16 4.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.704 2.401 . . . . 0.0 115.016 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.05 78.76 1.5 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 123.793 1.759 . . . . 0.0 109.825 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -75.93 -59.92 2.55 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.51 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 m -66.15 167.7 9.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.295 1.838 . . . . 0.0 109.53 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -62.44 -38.0 88.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.88 -0.512 . . . . 0.0 109.739 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.62 139.95 51.22 Favored Pre-proline 0 N--CA 1.442 -0.871 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 169.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.62 135.68 69.04 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.628 1.552 . . . . 0.0 108.112 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -81.62 -29.83 33.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.74 153.67 43.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.122 1.769 . . . . 0.0 107.83 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.67 -25.14 1.91 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.353 1.061 . . . . 0.0 110.58 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.83 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -150.76 133.09 15.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.153 0.981 . . . . 0.0 108.402 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -152.48 164.57 37.3 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.125 1.37 . . . . 0.0 108.471 169.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -114.49 141.27 47.93 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 152.79 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 110.292 -170.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m -60.97 142.54 56.44 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 109.043 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -27.58 48.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 32.5 m95 -88.2 -18.57 28.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.03 1.286 . . . . 0.0 113.19 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.91 -50.41 70.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.132 -1.413 . . . . 0.0 113.294 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.7 -28.95 76.95 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.159 1.906 . . . . 0.0 112.629 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.91 -34.88 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.329 1.052 . . . . 0.0 108.788 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -68.94 -19.7 64.19 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.787 -1.196 . . . . 0.0 112.323 -175.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -79.87 -32.7 40.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.854 1.206 . . . . 0.0 112.614 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.5 156.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 118.995 0.816 . . . . 0.0 111.482 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -68.65 162.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 m -53.22 -46.63 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.862 2.065 . . . . 0.0 115.236 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -69.33 -32.17 71.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.431 1.014 . . . . 0.0 111.153 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -77.54 -39.6 45.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.6 ttp-105 -50.05 -39.0 40.64 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.788 1.235 . . . . 0.0 112.387 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.24 -43.58 94.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.47 0.577 . . . . 0.0 111.378 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.91 -50.94 78.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -66.61 -34.49 77.99 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.701 -0.624 . . . . 0.0 110.897 -168.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -67.45 -40.61 85.42 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.65 1.114 . . . . 0.0 110.248 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.43 -43.74 98.33 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.725 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.91 -43.22 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 120.29 1.404 . . . . 0.0 109.912 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.5 mmt -74.04 -48.86 27.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -33.81 76.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.998 0.817 . . . . 0.0 112.159 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.74 -45.54 89.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.686 1.195 . . . . 0.0 109.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.453 ' HB3' HD12 ' A' ' 101' ' ' LEU . 13.4 m-85 -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.19 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.097 1.359 . . . . 0.0 110.792 -174.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -69.34 -31.57 70.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.786 0.834 . . . . 0.0 110.598 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 69' ' ' ALA . 45.5 t -67.47 -48.5 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.45 -41.77 82.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.172 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.63 -47.48 73.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.365 1.439 . . . . 0.0 110.71 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m -77.28 -26.85 52.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.173 1.389 . . . . 0.0 110.781 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.53 -42.25 96.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.018 1.727 . . . . 0.0 108.778 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -59.07 -24.64 63.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.344 0.657 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 124.781 1.232 . . . . 0.0 113.116 -171.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -67.37 -69.42 0.31 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.005 0.522 . . . . 0.0 111.661 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -164.74 -48.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.762 0.825 . . . . 0.0 112.84 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.51 13.29 14.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.293 1.037 . . . . 0.0 113.06 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.22 81.82 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.291 0.948 . . . . 0.0 113.163 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.58 157.24 17.61 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.975 0.91 . . . . 0.0 108.749 169.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 3.2 ptm180 -148.93 139.77 13.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.594 -172.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 16.6 Cg_exo -87.47 139.7 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 CA-C-N 121.63 1.618 . . . . 0.0 111.987 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.27 165.87 24.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.101 1.36 . . . . 0.0 109.127 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.74 172.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -153.08 159.75 28.7 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.39 141.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.25 139.26 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mm -119.47 142.83 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.0 p -121.84 154.28 37.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.186 0.903 . . . . 0.0 111.4 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -112.51 168.47 9.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.865 1.266 . . . . 0.0 108.336 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.39 4.46 5.86 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.133 -1.604 . . . . 0.0 113.196 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -90.78 -4.81 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.185 0.994 . . . . 0.0 111.45 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.3 21.06 70.99 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.841 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -95.67 151.34 19.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.674 1.237 . . . . 0.0 107.963 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.21 153.93 20.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.493 1.517 . . . . 0.0 109.495 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.3 tpp -60.55 137.6 58.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.317 1.047 . . . . 0.0 108.802 169.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -147.73 135.15 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 156.01 47.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.226 1.375 . . . . 0.0 112.554 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -109.44 109.32 20.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.149 1.779 . . . . 0.0 107.166 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -66.74 148.72 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.676 1.126 . . . . 0.0 108.06 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -46.25 118.81 2.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.419 1.087 . . . . 0.0 111.311 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.96 4.25 40.56 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.302 -1.277 . . . . 0.0 115.871 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -82.95 -30.42 28.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.235 2.017 . . . . 0.0 112.579 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 m80 53.78 34.22 18.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.323 1.049 . . . . 0.0 111.957 -172.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.3 p -131.22 170.74 14.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.919 2.088 . . . . 0.0 107.49 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -120.19 145.37 47.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.349 0.522 . . . . 0.0 110.505 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 165.61 36.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.071 1.349 . . . . 0.0 110.17 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -79.93 153.07 75.0 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.859 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.34 139.5 59.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.076 2.517 . . . . 0.0 110.324 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 53.8 mt-30 -138.59 168.38 19.91 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.383 1.073 . . . . 0.0 112.51 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.89 163.05 30.33 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 119.98 -0.344 . . . . 0.0 112.385 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.49 135.15 12.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 174.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.28 122.49 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -69.86 155.85 92.76 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.27 122.93 12.65 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.991 1.127 . . . . 0.0 109.461 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -3.72 86.75 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.338 -1.256 . . . . 0.0 114.594 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.98 158.92 34.53 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.279 2.04 . . . . 0.0 110.753 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m -98.97 155.83 17.22 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.07 86.48 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.132 -0.98 . . . . 0.0 111.389 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.907 0.883 . . . . 0.0 110.287 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -68.76 -39.24 80.37 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.667 -0.646 . . . . 0.0 110.084 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.29 94.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -60.15 -50.88 71.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.903 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -66.29 -37.24 84.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.893 1.224 . . . . 0.0 112.521 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -63.77 -49.8 71.54 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.069 1.304 . . . . 0.0 109.133 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -76.78 -25.67 53.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.04 -40.73 73.92 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.725 -1.235 . . . . 0.0 110.111 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -70.85 -37.82 73.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.52 0.6 . . . . 0.0 110.537 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.39 -34.2 72.29 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.2 -0.937 . . . . 0.0 111.808 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.78 -52.86 4.54 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.415 1.086 . . . . 0.0 110.114 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.27 -30.1 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.359 1.464 . . . . 0.0 110.233 -168.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 0.77 89.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.944 0.783 . . . . 0.0 112.38 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.2 tp -83.78 155.33 23.08 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.694 1.998 . . . . 0.0 109.334 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 p -133.81 169.13 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.296 1.038 . . . . 0.0 109.751 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -52.48 -33.02 42.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.919 1.688 . . . . 0.0 112.306 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -63.26 -28.02 69.74 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.293 0.637 . . . . 0.0 111.897 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.9 23.27 12.72 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 112.159 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 165.86 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 120.782 -1.199 . . . . 0.0 112.016 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 136.67 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.4 mt -76.12 115.71 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 103' ' ' GLN . 72.7 mt -89.18 -36.44 15.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.607 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.79 166.45 33.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.117 0.567 . . . . 0.0 109.778 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 p -161.24 155.6 22.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.981 1.312 . . . . 0.0 110.103 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -68.71 137.28 53.98 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.703 -0.623 . . . . 0.0 111.116 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -81.51 -28.64 33.93 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.214 1.406 . . . . 0.0 109.894 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -120.91 150.38 41.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.613 2.365 . . . . 0.0 108.177 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -81.48 133.38 35.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.4 mt -91.15 136.85 32.8 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -129.63 156.98 43.35 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.933 0.893 . . . . 0.0 111.431 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -143.36 125.92 15.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.17 137.43 36.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.07 142.87 93.6 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.702 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.01 146.49 71.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 104.923 -2.76 . . . . 0.0 104.923 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.61 -11.18 60.63 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.008 -1.682 . . . . 0.0 113.889 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -60.63 -31.42 70.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.973 0.806 . . . . 0.0 112.613 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.3 mt -92.04 -22.23 20.06 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 111.504 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.89 136.88 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -106.52 92.79 4.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.037 0.935 . . . . 0.0 110.063 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -68.4 -24.29 64.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.015 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.3 -25.57 58.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.386 0.674 . . . . 0.0 112.578 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -110.55 156.71 20.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.113 0.965 . . . . 0.0 109.338 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -127.87 137.64 31.21 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 109.975 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.25 149.72 93.66 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.874 0.934 . . . . 0.0 110.177 -10.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.6 p -78.22 134.33 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 110.142 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.4 p -74.25 126.17 30.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.935 0.894 . . . . 0.0 109.4 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.85 -13.67 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 171.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.35 175.65 46.41 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -151.52 145.25 25.04 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.33 1.452 . . . . 0.0 108.961 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.03 133.83 34.2 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -129.48 123.96 32.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.89 0.768 . . . . 0.0 109.987 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -103.68 127.38 51.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.123 0.969 . . . . 0.0 108.407 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -105.75 153.93 21.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -132.97 128.78 37.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.483 1.113 . . . . 0.0 108.264 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -93.01 124.54 37.06 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 mt -119.2 149.4 41.8 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.62 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.4 tt0 -99.71 126.75 45.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.45 138.65 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.318 1.047 . . . . 0.0 108.794 170.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.8 t -90.72 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.414 0.552 . . . . 0.0 110.556 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.0 m -85.59 -18.71 32.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.218 0.607 . . . . 0.0 111.02 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.52 21.4 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.89 -21.14 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.607 1.963 . . . . 0.0 113.345 -172.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.29 -30.01 59.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.579 0.752 . . . . 0.0 113.028 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -93.58 15.65 15.63 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.9 mt -91.74 135.61 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -122.23 -51.84 1.97 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.331 0.652 . . . . 0.0 112.165 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 mtp 65.64 16.82 10.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.416 2.287 . . . . 0.0 113.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.58 29.84 1.93 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.276 1.512 . . . . 0.0 112.142 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -51.41 70.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.659 1.583 . . . . 0.0 108.345 169.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.5 m -68.96 156.45 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.576 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -65.89 -33.48 75.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.015 0.526 . . . . 0.0 110.456 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.56 134.83 33.36 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 124.997 1.319 . . . . 0.0 107.973 169.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.38 122.28 11.4 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.474 2.116 . . . . 0.0 107.315 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.39 -33.4 72.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -117.77 138.81 51.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.19 -19.6 46.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.6 161.79 32.02 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.65 159.07 43.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -151.88 164.87 36.18 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.147 0.979 . . . . 0.0 109.165 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -114.87 127.38 55.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.03 152.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.481 1.112 . . . . 0.0 110.0 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -59.63 147.63 36.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.476 0.58 . . . . 0.0 109.471 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.95 54.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.465 1.106 . . . . 0.0 113.778 -169.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -88.87 -22.66 23.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.332 -0.855 . . . . 0.0 113.09 -172.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -58.24 -49.06 95.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.248 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.85 -29.3 76.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.169 1.81 . . . . 0.0 111.819 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.86 -30.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.26 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -68.3 -27.73 66.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.166 -0.959 . . . . 0.0 111.31 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -83.6 -24.52 31.44 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -168.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.38 160.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.686 0.755 . . . . 0.0 112.713 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.7 175.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.254 1.421 . . . . 0.0 109.856 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.86 -55.93 26.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.944 1.697 . . . . 0.0 113.002 -173.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -70.17 -32.32 70.21 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 -171.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -74.17 -48.05 31.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.974 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -63.48 -30.93 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.706 1.139 . . . . 0.0 112.204 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.7 -35.31 74.25 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.842 174.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.81 -49.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.494 1.118 . . . . 0.0 109.949 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -62.39 -31.99 72.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.755 1.162 . . . . 0.0 111.106 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.6 -43.44 98.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.487 1.04 . . . . 0.0 111.384 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -61.13 -45.69 93.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.366 0.985 . . . . 0.0 110.239 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.68 -26.11 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.063 0.945 . . . . 0.0 111.58 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.1 mmt -90.81 -56.29 3.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.998 0.919 . . . . 0.0 108.885 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -57.3 -33.65 67.9 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.462 1.028 . . . . 0.0 112.551 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -63.45 -32.81 74.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.947 0.499 . . . . 0.0 110.574 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.516 ' HB3' HD12 ' A' ' 101' ' ' LEU . 8.0 m-85 -111.58 -14.83 13.61 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.284 1.033 . . . . 0.0 112.889 -174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.41 -39.97 67.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.594 1.558 . . . . 0.0 110.794 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 m -67.1 -31.6 72.18 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.971 0.908 . . . . 0.0 110.785 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -46.21 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.13 -39.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 117.851 -1.071 . . . . 0.0 109.714 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.6 mmt -55.34 -48.92 73.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.773 1.17 . . . . 0.0 110.437 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.8 m -79.6 -26.05 41.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.779 1.232 . . . . 0.0 110.957 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.3 tp -63.05 -41.39 99.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.612 1.165 . . . . 0.0 109.936 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -58.46 -44.16 89.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 110.154 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.235 0.293 0 C-N-CA 123.713 0.805 . . . . 0.0 111.685 -171.087 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -69.33 0.26 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -164.74 -48.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.166 0.986 . . . . 0.0 112.7 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.13 16.67 10.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.594 1.158 . . . . 0.0 113.137 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.7 63.58 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.312 0.958 . . . . 0.0 113.854 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -93.29 153.78 18.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.499 1.15 . . . . 0.0 108.053 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.16 126.58 17.61 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.595 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -72.33 141.13 34.87 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.108 1.872 . . . . 0.0 111.496 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -140.25 156.44 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.802 0.841 . . . . 0.0 109.079 -173.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.74 150.36 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.454 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -128.92 157.53 21.61 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -125.16 142.83 40.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 109.056 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.43 137.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mm -120.01 132.39 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' A' ' 22' ' ' VAL . 78.1 m -119.91 140.6 50.63 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.682 0.674 . . . . 0.0 109.965 173.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -94.8 174.04 7.3 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.02 -2.37 30.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 120.281 -1.512 . . . . 0.0 112.678 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.61 -2.91 58.65 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.971 1.308 . . . . 0.0 111.582 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.87 19.48 76.93 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.819 0.736 . . . . 0.0 111.711 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -88.55 142.51 27.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 171.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.0 m -108.48 142.43 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.37 1.468 . . . . 0.0 108.935 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.0 tpp -60.85 134.65 57.3 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.957 1.303 . . . . 0.0 108.822 170.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -143.3 120.39 11.43 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 151.05 29.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.811 1.187 . . . . 0.0 109.836 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -145.48 162.29 37.71 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.176 1.39 . . . . 0.0 114.102 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.65 149.47 35.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.724 2.009 . . . . 0.0 113.872 -168.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -52.46 124.86 14.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.527 1.931 . . . . 0.0 109.489 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.67 8.31 76.49 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.205 -1.331 . . . . 0.0 114.524 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -109.18 157.41 18.81 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.589 1.695 . . . . 0.0 110.573 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -134.39 15.0 3.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 112.258 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.5 m -107.18 127.78 53.82 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -92.05 139.56 30.52 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -156.62 158.54 37.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.193 2.197 . . . . 0.0 107.731 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -73.35 151.84 89.92 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.445 169.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.42 141.17 97.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.969 2.446 . . . . 0.0 112.259 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.85 176.09 11.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.886 -0.509 . . . . 0.0 112.046 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.86 168.61 40.98 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.333 0.492 . . . . 0.0 112.553 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.51 146.39 27.31 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -77.73 127.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -69.47 152.68 96.29 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.48 124.04 14.93 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 108.958 -1.209 . . . . 0.0 108.958 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.41 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.679 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.96 159.26 34.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.072 1.936 . . . . 0.0 110.229 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 p -102.12 156.57 17.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.33 85.91 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.408 -0.808 . . . . 0.0 111.901 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.19 -35.56 76.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.572 0.749 . . . . 0.0 109.588 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -71.86 -37.04 70.28 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.61 91.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -61.61 -50.88 70.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -66.19 -40.97 90.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.228 0.922 . . . . 0.0 110.825 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.5 ttm-85 -66.37 -48.38 70.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.672 1.124 . . . . 0.0 109.688 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.84 -29.35 63.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.56 -47.64 79.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.864 0.756 . . . . 0.0 109.165 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.97 -39.21 91.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.934 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.42 -40.32 93.21 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.979 . . . . 0.0 112.061 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.13 -51.38 9.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 110.357 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 m -123.8 8.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.188 1.395 . . . . 0.0 113.538 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.27 8.41 62.1 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.791 0.723 . . . . 0.0 113.599 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 tp -98.6 141.14 31.81 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.417 1.887 . . . . 0.0 109.945 -171.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 p -115.43 165.53 12.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 109.926 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -48.69 -34.18 11.46 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.109 1.764 . . . . 0.0 112.053 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -29.61 70.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.759 -171.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.35 25.86 10.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.793 1.179 . . . . 0.0 111.628 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.52 165.0 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 O-C-N 120.818 -1.176 . . . . 0.0 111.501 172.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -139.32 144.29 38.22 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.1 mt -82.52 120.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' A' ' 103' ' ' GLN . 96.1 mt -95.23 -35.98 11.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.615 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -158.02 161.33 38.07 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.348 -171.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -162.35 154.43 18.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.177 1.391 . . . . 0.0 109.669 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.5 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -71.09 139.55 50.38 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.852 -0.53 . . . . 0.0 110.261 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -57.06 4.14 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -89.28 151.62 22.01 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.389 1.476 . . . . 0.0 109.188 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -83.21 135.71 34.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.011 0.369 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.81 96.51 10.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -98.19 150.72 21.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.052 0.941 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -147.27 144.69 29.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 168.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.6 143.89 26.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mt -68.23 138.82 92.09 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 169.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.81 148.13 86.14 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 N-CA-C 105.264 -2.629 . . . . 0.0 105.264 167.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -69.14 -11.9 61.2 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.033 -1.667 . . . . 0.0 113.838 -168.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.9 -32.19 73.63 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.944 0.793 . . . . 0.0 112.522 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -92.8 -22.06 19.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.006 0.922 . . . . 0.0 111.567 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.46 136.2 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -103.14 88.68 3.2 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.005 0.907 . . . . 0.0 110.456 174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -68.52 -22.6 64.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.666 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.06 -9.1 58.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.749 0.819 . . . . 0.0 112.876 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.7 t -128.17 160.86 30.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.095 0.958 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -128.43 135.32 27.38 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 125.346 1.458 . . . . 0.0 109.563 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.54 148.36 91.38 Favored 'Cis proline' 0 CA--C 1.538 0.693 0 O-C-N 122.665 0.824 . . . . 0.0 110.534 -10.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 p -77.62 134.98 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.659 0.784 . . . . 0.0 109.75 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.0 p -80.2 127.32 32.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.91 0.884 . . . . 0.0 109.07 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.03 -17.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.02 0.827 . . . . 0.0 113.174 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.51 168.22 37.35 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 119.772 1.169 . . . . 0.0 110.197 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -152.62 150.9 29.99 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.657 1.183 . . . . 0.0 107.889 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 127.04 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -113.78 135.14 54.28 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.825 0.85 . . . . 0.0 110.209 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -113.27 125.08 53.91 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.454 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 89.1 m95 -104.45 149.92 25.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -173.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -133.37 131.66 40.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.835 0.854 . . . . 0.0 108.832 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 18.8 tp -96.32 119.72 35.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 168.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.09 144.95 40.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.625 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.7 tt0 -96.9 129.65 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 135.02 57.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.2 t -85.91 -44.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.049 0.386 . . . . 0.0 110.608 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.1 m -90.19 -19.57 24.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.388 0.675 . . . . 0.0 111.198 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.76 -170.42 19.06 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 124.528 1.061 . . . . 0.0 110.558 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -20.84 38.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.624 1.57 . . . . 0.0 113.568 -172.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.46 47.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -93.24 14.63 17.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -173.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.08 140.98 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -133.86 122.03 22.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.346 1.058 . . . . 0.0 108.445 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mmt -89.28 -3.18 58.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.07 0.948 . . . . 0.0 112.252 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -136.63 83.09 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.321 2.01 . . . . 0.0 108.835 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 p -74.5 -60.67 2.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 128.158 2.583 . . . . 0.0 107.872 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.9 m -72.36 174.05 7.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.097 1.759 . . . . 0.0 109.27 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.1 m -61.46 -37.0 82.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 140.43 45.32 Favored Pre-proline 0 N--CA 1.44 -0.945 0 C-N-CA 125.842 1.657 . . . . 0.0 108.577 169.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.93 140.31 94.71 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.926 1.751 . . . . 0.0 108.558 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -76.36 -38.37 55.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -119.4 152.28 37.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.678 1.591 . . . . 0.0 109.542 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -126.52 -25.4 3.44 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.917 1.287 . . . . 0.0 110.149 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.36 130.96 10.49 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -157.9 130.51 7.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.891 1.345 . . . . 0.0 108.608 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -152.08 161.18 43.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.811 1.244 . . . . 0.0 109.084 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -111.52 134.45 53.1 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.05 153.24 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.485 -169.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 m -59.95 140.34 56.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.013 0.824 . . . . 0.0 109.212 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.93 -36.3 48.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -169.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -80.94 -21.81 40.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.008 1.276 . . . . 0.0 112.912 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -66.92 -45.59 53.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.88 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.7 -14.3 41.42 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.697 1.999 . . . . 0.0 113.759 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.1 t -67.57 -33.71 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -63.17 -34.96 78.76 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.812 -1.18 . . . . 0.0 111.689 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -82.76 -19.86 37.03 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -168.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 m -79.95 165.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 118.972 0.806 . . . . 0.0 110.32 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.73 176.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.911 1.285 . . . . 0.0 109.768 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.1 m -52.93 -50.38 64.13 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.683 1.593 . . . . 0.0 114.179 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -72.49 -26.93 61.97 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.972 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -84.29 -43.01 15.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.203 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -44.86 -45.25 10.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.992 0.917 . . . . 0.0 111.061 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.46 -35.66 76.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.877 0.871 . . . . 0.0 111.592 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 36.4 t -76.72 -49.94 22.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 124.792 1.237 . . . . 0.0 110.408 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.91 -35.35 78.12 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.716 0.807 . . . . 0.0 111.537 -168.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.02 -39.89 95.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.974 172.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -62.25 -47.01 86.27 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.633 1.106 . . . . 0.0 110.633 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 81.3 t -55.19 -33.1 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.425 1.011 . . . . 0.0 110.971 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.5 mmt -80.74 -56.89 3.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.896 0.878 . . . . 0.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -35.73 72.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.483 1.038 . . . . 0.0 111.852 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 71' ' ' THR . 23.5 mm-40 -58.06 -40.68 81.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.528 1.131 . . . . 0.0 111.614 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -111.04 -14.43 13.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.822 0.701 . . . . 0.0 110.961 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.88 62.48 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.701 1.601 . . . . 0.0 111.031 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.5 m -67.28 -31.62 72.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.339 0.656 . . . . 0.0 110.907 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.23 -45.04 72.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.44 -39.82 76.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.21 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.68 -52.51 62.14 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 120.887 1.676 . . . . 0.0 109.717 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.5 m -72.37 -27.13 62.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.223 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.95 -45.61 91.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.212 1.405 . . . . 0.0 109.701 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.35 -43.82 98.22 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.327 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.233 0.205 0 C-N-CA 123.768 0.827 . . . . 0.0 111.868 -169.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.64 -61.99 2.19 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.497 0.719 . . . . 0.0 111.964 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -162.85 -53.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.01 18.22 16.52 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.651 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.65 9.33 61.44 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.642 0.639 . . . . 0.0 113.513 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -103.85 151.91 22.54 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.507 1.123 . . . . 0.0 108.607 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.57 148.85 63.05 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.369 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HB2' HD12 ' A' ' 40' ' ' ILE . 55.4 Cg_endo -90.36 141.12 3.34 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.746 2.297 . . . . 0.0 111.214 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.36 153.04 46.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.117 -0.989 . . . . 0.0 110.097 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.594 HG13 HD11 ' A' ' 40' ' ' ILE . 2.5 m -135.28 143.01 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.283 1.433 . . . . 0.0 108.798 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.19 162.66 24.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 123.922 0.772 . . . . 0.0 111.982 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 143.44 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.295 1.438 . . . . 0.0 108.155 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.81 134.7 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 168.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.37 136.83 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' SG ' HD11 ' A' ' 101' ' ' LEU . 12.7 p -124.7 162.76 23.49 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.881 0.764 . . . . 0.0 112.457 169.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.5 p30 -110.56 172.93 6.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.557 1.543 . . . . 0.0 108.306 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.34 8.71 3.14 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.451 -1.406 . . . . 0.0 113.233 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -99.54 -1.92 37.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.512 1.525 . . . . 0.0 111.58 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.12 15.97 80.83 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 118.691 0.678 . . . . 0.0 112.022 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -83.96 151.42 25.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.45 150.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.058 1.743 . . . . 0.0 108.501 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -73.23 143.31 47.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -147.4 144.29 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.91 146.8 34.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.389 1.904 . . . . 0.0 112.872 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -88.98 117.88 28.3 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -71.99 151.25 43.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.849 1.204 . . . . 0.0 109.003 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -58.03 129.24 41.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.11 6.24 82.47 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.512 -1.16 . . . . 0.0 114.003 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -113.86 164.25 14.0 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.168 1.484 . . . . 0.0 110.046 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.94 -13.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.829 0.852 . . . . 0.0 111.952 172.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 p -84.38 154.12 23.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.372 1.469 . . . . 0.0 110.281 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -107.45 143.7 35.42 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -142.2 161.21 38.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.169 1.388 . . . . 0.0 110.151 -169.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -90.43 143.11 28.86 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.45 131.93 33.75 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.246 2.63 . . . . 0.0 112.088 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.31 164.8 36.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.05 167.64 40.17 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.324 0.488 . . . . 0.0 113.026 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.14 147.06 43.82 Favored Glycine 0 N--CA 1.444 -0.788 0 O-C-N 121.497 -1.002 . . . . 0.0 110.604 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.603 HD12 ' HB2' ' A' ' 9' ' ' PRO . 70.7 mt -74.61 129.36 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.45 148.31 95.33 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.94 123.88 14.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.96 1.774 . . . . 0.0 110.24 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.45 1.7 90.2 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.425 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.53 159.3 32.39 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.515 2.158 . . . . 0.0 111.016 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 m -85.06 148.65 26.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.29 -40.14 81.17 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.555 -0.716 . . . . 0.0 111.602 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.86 -35.44 76.92 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.812 0.845 . . . . 0.0 110.248 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -73.55 -39.49 64.69 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.253 -0.904 . . . . 0.0 110.145 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.25 70.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.98 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -59.2 -48.47 81.51 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.169 1.349 . . . . 0.0 108.503 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.5 -36.23 83.51 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.35 1.432 . . . . 0.0 111.854 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -59.18 -49.64 77.08 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.328 0.967 . . . . 0.0 110.066 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -77.14 -26.66 53.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 122.125 -0.359 . . . . 0.0 110.362 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.67 -45.26 85.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.139 -0.976 . . . . 0.0 109.093 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.95 -45.6 81.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.689 0.677 . . . . 0.0 110.958 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.53 -37.34 86.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.538 1.063 . . . . 0.0 112.447 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -94.36 -47.98 6.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.517 1.127 . . . . 0.0 110.955 -170.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.61 -33.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.83 1.252 . . . . 0.0 109.883 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.2 89.94 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.562 1.077 . . . . 0.0 112.226 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 64' ' ' ASP . 28.7 tp -87.35 155.08 20.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.619 1.968 . . . . 0.0 109.634 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.8 m -133.52 167.35 20.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.126 0.97 . . . . 0.0 109.533 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -47.78 -33.46 7.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.869 2.067 . . . . 0.0 113.112 -173.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -65.6 -29.89 70.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.284 -171.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' HB3' HD11 ' A' ' 60' ' ' LEU . 4.6 t70 -112.46 24.77 12.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.543 1.065 . . . . 0.0 111.541 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.35 165.54 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.599 -1.313 . . . . 0.0 112.817 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.38 136.53 36.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.418 HG12 HD11 ' A' ' 102' ' ' LEU . 60.8 mt -74.13 122.44 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 103' ' ' GLN . 62.8 mt -93.83 -35.79 12.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.162 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.0 35.91 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.266 1.026 . . . . 0.0 109.904 -173.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.8 p -152.49 153.91 34.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.122 1.769 . . . . 0.0 108.829 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 150' ' ' GLU . 0.7 OUTLIER -65.2 135.48 55.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.799 -169.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -84.17 -32.35 24.65 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.943 1.297 . . . . 0.0 107.868 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.77 148.19 49.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.796 2.038 . . . . 0.0 109.865 172.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -74.69 139.58 43.6 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.68 84.66 5.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -82.01 144.25 31.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -147.6 144.57 28.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.09 145.47 24.37 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.84 145.38 91.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 124.845 1.258 . . . . 0.0 110.925 170.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.16 147.34 72.75 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 104.076 -3.086 . . . . 0.0 104.076 166.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 84' ' ' VAL . 91.4 mttt -68.31 -13.83 62.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 119.927 -1.733 . . . . 0.0 114.509 -168.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -60.2 -29.71 68.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -95.67 -13.28 24.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.11 0.964 . . . . 0.0 112.819 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 81' ' ' LYS . 79.7 t -62.77 133.28 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -96.42 91.52 5.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.285 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.14 -21.6 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.968 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.33 -29.09 57.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 t -99.57 163.88 12.31 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.577 1.151 . . . . 0.0 109.766 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -128.24 130.51 23.56 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.427 1.491 . . . . 0.0 107.022 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.44 159.98 95.31 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 O-C-N 123.043 1.023 . . . . 0.0 110.462 -9.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.14 132.21 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.2 p -87.04 126.78 34.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.14 -13.52 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.382 0.537 . . . . 0.0 112.312 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.48 37.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.24 156.69 32.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.65 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -106.7 126.55 52.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -119.47 128.67 54.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.692 0.678 . . . . 0.0 110.167 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.09 153.21 17.91 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CD1' HG22 ' A' ' 147' ' ' VAL . 85.5 m95 -134.1 154.81 50.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.237 0.615 . . . . 0.0 109.434 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -135.74 129.62 32.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.458 HD11 ' SG ' ' A' ' 16' ' ' CYS . 12.5 tp -91.14 123.32 34.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 67' ' ' ILE . 8.7 mp -115.71 155.16 28.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.635 1.174 . . . . 0.0 107.853 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.775 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.4 tt0 -106.15 131.25 53.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 168.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.63 140.21 56.85 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.027 0.931 . . . . 0.0 108.957 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.6 t -88.15 -44.33 15.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -171.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -90.99 -29.44 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.046 0.538 . . . . 0.0 112.106 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.29 178.82 15.51 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.915 0.769 . . . . 0.0 111.28 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.86 -20.86 54.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.691 1.597 . . . . 0.0 114.035 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.8 66.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.276 0.631 . . . . 0.0 111.554 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.58 48.08 1.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.161 1.785 . . . . 0.0 111.506 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.7 mt -128.5 133.09 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -114.48 -51.54 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.696 0.798 . . . . 0.0 111.972 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.4 mtp 67.98 13.32 9.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.017 2.127 . . . . 0.0 114.735 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -151.87 71.03 0.96 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 124.166 1.936 . . . . 0.0 110.394 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -59.11 2.87 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 111.974 -2.375 . . . . 0.0 107.901 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.6 m -63.47 161.96 13.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.392 1.477 . . . . 0.0 109.756 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -58.56 -38.57 78.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 130.41 52.7 Favored Pre-proline 0 N--CA 1.442 -0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 110.3 170.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.51 143.62 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -83.25 -18.29 39.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.894 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.21 141.19 51.8 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.712 0.805 . . . . 0.0 110.321 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.19 -31.89 33.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.021 1.328 . . . . 0.0 110.669 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.87 29.0 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -125.26 151.28 46.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.161 . . . . 0.0 108.825 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.9 166.08 27.04 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -126.51 133.77 51.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.24 157.79 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.937 1.295 . . . . 0.0 110.956 -168.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 m -65.98 144.38 56.8 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -28.29 63.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -88.01 -20.22 26.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.562 1.528 . . . . 0.0 112.924 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.3 -47.92 92.79 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.699 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.54 -27.06 81.48 Favored 'Trans proline' 0 C--N 1.352 0.76 0 CA-C-N 122.828 2.046 . . . . 0.0 112.957 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.89 -27.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.089 1.356 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -65.99 -27.9 68.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.356 -0.84 . . . . 0.0 111.334 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -86.71 -24.36 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.49 156.56 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.805 0.73 . . . . 0.0 112.528 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.2 179.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 110.184 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.8 m -54.54 -52.12 63.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.662 1.585 . . . . 0.0 114.06 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -74.34 -38.73 63.17 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.81 -44.83 69.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.52 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -62.97 -31.81 73.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.349 0.977 . . . . 0.0 111.74 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.57 -42.9 99.84 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.707 0.685 . . . . 0.0 110.924 172.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.73 -51.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.32 -37.61 86.27 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.26 0.937 . . . . 0.0 110.152 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.643 1.111 . . . . 0.0 110.486 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -60.66 -43.39 97.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.877 1.217 . . . . 0.0 110.49 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 99' ' ' TRP . 96.0 t -57.42 -24.46 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 119.788 1.176 . . . . 0.0 111.831 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.3 -57.3 2.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -56.14 -34.02 65.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.996 1.318 . . . . 0.0 112.606 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.7 tp10 -65.0 -30.04 71.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.04 0.837 . . . . 0.0 111.412 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.39 -11.43 14.13 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.409 1.083 . . . . 0.0 112.684 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.35 69.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.111 1.364 . . . . 0.0 110.905 -171.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -62.49 -37.96 88.02 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.262 1.425 . . . . 0.0 111.635 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.84 -42.87 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.21 -40.54 65.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-O 117.169 -1.396 . . . . 0.0 109.765 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.4 -54.11 49.49 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.764 1.62 . . . . 0.0 110.04 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 m -64.86 -32.21 73.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.531 1.133 . . . . 0.0 110.94 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.592 ' HG ' HD13 ' A' ' 68' ' ' LEU . 1.2 tm? -68.19 -31.01 70.25 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.326 1.85 . . . . 0.0 111.142 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -72.79 -44.58 61.35 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.961 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 123.377 0.671 . . . . 0.0 112.461 -170.177 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 121.79 0.805 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -62.68 1.63 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.918 0.887 . . . . 0.0 112.125 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -163.04 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.34 0.186 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -100.84 20.65 14.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.641 1.177 . . . . 0.0 113.302 -169.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.49 18.38 49.04 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.494 0.568 . . . . 0.0 113.419 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -107.48 156.1 19.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.08 25.64 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.566 -1.207 . . . . 0.0 108.677 171.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HB2' HD12 ' A' ' 40' ' ' ILE . 13.2 Cg_exo -82.58 136.49 8.57 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.83 1.687 . . . . 0.0 110.454 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -133.86 160.73 36.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.403 1.481 . . . . 0.0 109.075 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.31 154.79 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 123.518 0.727 . . . . 0.0 109.946 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.24 156.64 23.1 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -116.43 141.98 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 125.499 1.519 . . . . 0.0 107.748 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.1 134.9 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.55 135.11 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 101' ' ' LEU . 13.0 p -128.55 159.33 35.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.22 0.918 . . . . 0.0 112.289 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -110.17 177.3 4.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 108.78 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -75.87 0.36 18.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.405 -1.434 . . . . 0.0 112.995 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -88.21 -3.6 58.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.386 1.074 . . . . 0.0 111.013 172.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.67 76.59 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -90.31 143.27 26.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 m -108.45 145.89 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.513 1.525 . . . . 0.0 107.805 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -87.29 139.43 30.56 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -148.02 146.37 28.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.699 1.599 . . . . 0.0 107.051 -170.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.66 154.79 44.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.226 1.375 . . . . 0.0 113.577 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -98.54 118.23 34.77 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.193 1.797 . . . . 0.0 106.857 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -77.57 141.83 39.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 121.886 2.13 . . . . 0.0 108.471 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -55.13 127.1 27.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.368 1.067 . . . . 0.0 109.477 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -6.39 20.28 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.612 -1.104 . . . . 0.0 115.089 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -91.29 -32.13 15.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.787 1.794 . . . . 0.0 111.656 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.1 m80 64.55 -21.84 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.347 2.259 . . . . 0.0 114.611 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -75.9 160.76 29.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.298 1.439 . . . . 0.0 110.643 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.03 149.96 28.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.743 0.817 . . . . 0.0 110.939 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.89 155.38 42.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.362 1.865 . . . . 0.0 111.122 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -84.12 131.84 49.79 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -51.63 128.08 24.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.328 2.685 . . . . 0.0 112.3 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.36 164.54 36.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.751 1.16 . . . . 0.0 112.906 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.16 -178.97 42.75 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 123.458 0.551 . . . . 0.0 112.793 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.89 151.25 23.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.252 0.929 . . . . 0.0 111.913 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 9' ' ' PRO . 78.5 mt -77.91 126.9 38.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -74.08 156.39 87.78 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.69 122.19 10.66 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 109.038 -1.178 . . . . 0.0 109.038 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 0.0 87.98 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.643 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.14 154.35 41.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.361 2.081 . . . . 0.0 109.837 169.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.07 153.61 17.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.07 84.02 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.324 -0.86 . . . . 0.0 111.719 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.81 -31.95 70.13 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.288 0.635 . . . . 0.0 110.367 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -70.93 -39.6 72.57 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.271 -0.893 . . . . 0.0 109.792 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.31 83.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -63.3 -50.72 68.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.792 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 55.8 m-85 -66.72 -33.06 74.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.926 1.239 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -60.86 -50.28 74.05 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.07 1.305 . . . . 0.0 109.187 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.27 -27.58 62.58 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.384 0.538 . . . . 0.0 110.33 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.69 -43.43 90.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 109.454 170.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -69.55 -48.76 59.26 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.474 0.579 . . . . 0.0 110.834 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.85 -30.7 69.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.988 1.267 . . . . 0.0 112.609 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -93.29 -51.48 4.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.153 0.981 . . . . 0.0 110.532 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.61 -31.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.267 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.17 -1.85 78.73 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.464 1.03 . . . . 0.0 112.275 -171.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.76 155.74 32.93 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.645 1.978 . . . . 0.0 108.854 174.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.5 p -133.09 170.3 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.988 0.915 . . . . 0.0 110.466 -172.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 37.3 mtp180 -46.13 -37.15 6.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.819 2.047 . . . . 0.0 112.52 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -68.77 -26.04 65.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.385 0.674 . . . . 0.0 112.525 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.36 23.59 12.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.522 0.677 . . . . 0.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.5 165.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 O-C-N 120.734 -1.229 . . . . 0.0 112.729 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.83 132.94 29.61 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -73.69 116.21 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 103' ' ' GLN . 95.6 mt -89.63 -36.88 15.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.426 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.41 164.7 36.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.864 0.865 . . . . 0.0 109.749 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 p -162.63 153.41 17.11 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.795 1.238 . . . . 0.0 110.265 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.633 HG22 ' HG2' ' A' ' 150' ' ' GLU . 2.6 p -71.89 138.76 48.41 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.635 -0.666 . . . . 0.0 109.579 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -77.86 -51.41 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -70.26 171.12 10.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 110.962 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 84.2 m95 -112.38 123.72 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 168.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -79.2 142.32 36.38 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.62 152.35 43.9 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.289 1.036 . . . . 0.0 108.955 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -140.3 139.78 35.55 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.974 1.31 . . . . 0.0 108.115 169.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -77.27 139.04 39.74 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.68 139.17 95.76 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.766 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -68.2 145.36 66.19 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 104.431 -2.95 . . . . 0.0 104.431 167.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.506 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.3 mtpt -67.96 -12.94 61.72 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.05 -1.657 . . . . 0.0 114.16 -168.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.11 -31.01 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.809 0.732 . . . . 0.0 112.806 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.5 -20.01 21.4 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.776 0.83 . . . . 0.0 112.085 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 81' ' ' LYS . 61.5 t -65.16 135.28 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -101.37 89.89 3.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 109.807 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.8 -22.31 63.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.918 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -74.86 -19.22 60.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.573 0.749 . . . . 0.0 112.728 -171.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -117.37 161.0 20.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.487 1.115 . . . . 0.0 109.957 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -128.24 135.45 27.55 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 125.178 1.391 . . . . 0.0 109.59 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.48 148.56 92.16 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 O-C-N 122.731 0.858 . . . . 0.0 110.384 -10.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.76 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 109.532 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.5 p -89.91 138.58 31.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.0 109.566 170.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.44 -13.07 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 170.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.29 -174.05 31.72 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.09 -178.23 6.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.593 1.157 . . . . 0.0 109.02 -172.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -127.33 137.26 52.76 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 104.322 -2.474 . . . . 0.0 104.322 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -122.59 122.7 39.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 120.82 1.646 . . . . 0.0 107.951 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 ttmm -111.78 129.1 56.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -114.27 152.21 31.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -134.78 121.73 21.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 16' ' ' CYS . 14.9 tp -88.67 119.64 29.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.56 144.46 43.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.667 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.1 tt0 -97.47 132.7 42.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 168.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 141.93 58.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 108.923 171.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.91 -48.79 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.568 0.622 . . . . 0.0 109.827 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.5 m -89.33 -19.58 25.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.408 0.683 . . . . 0.0 111.786 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.59 20.67 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.42 -22.35 31.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.093 1.757 . . . . 0.0 113.105 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.08 59.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 113.438 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -92.62 16.55 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.73 139.73 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.694 1.198 . . . . 0.0 108.088 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -120.6 -50.98 2.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.593 0.757 . . . . 0.0 112.304 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.2 mtp 70.44 9.25 6.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.84 2.456 . . . . 0.0 115.122 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.71 76.96 1.03 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 124.016 1.865 . . . . 0.0 110.184 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.85 -59.58 2.67 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.05 -2.341 . . . . 0.0 107.695 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -66.37 162.73 19.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.157 1.383 . . . . 0.0 109.452 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 m -63.01 -33.73 76.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.087 0.555 . . . . 0.0 110.367 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 128.95 52.89 Favored Pre-proline 0 N--CA 1.447 -0.587 0 C-N-CA 124.911 1.284 . . . . 0.0 110.193 170.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.88 137.23 48.3 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.357 2.038 . . . . 0.0 108.097 168.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.83 -16.0 59.56 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.876 -0.515 . . . . 0.0 111.566 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -119.91 138.43 53.43 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.63 -26.73 45.3 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.924 1.29 . . . . 0.0 111.255 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.84 162.37 34.55 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 153.74 45.93 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.306 1.043 . . . . 0.0 108.193 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -152.42 159.63 43.37 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -109.38 131.99 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.72 170.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.062 1.745 . . . . 0.0 109.739 -169.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.8 p -65.41 166.82 9.57 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -18.65 64.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.858 172.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -98.81 -31.62 11.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 113.225 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.21 -43.98 96.21 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.84 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.36 -24.84 76.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 122.508 1.931 . . . . 0.0 113.264 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.7 t -67.55 -41.4 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -57.68 -35.53 70.72 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.528 -0.732 . . . . 0.0 111.963 -171.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -79.13 -26.4 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.46 171.66 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 118.499 0.591 . . . . 0.0 112.127 -172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 175.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.9 m -54.7 -49.99 69.39 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.031 1.733 . . . . 0.0 114.208 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -72.35 -32.34 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.178 -0.952 . . . . 0.0 111.459 -174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.1 -39.96 32.38 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.221 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -47.25 -46.2 24.32 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.899 0.88 . . . . 0.0 110.733 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.12 -45.76 92.02 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.245 0.341 . . . . 0.0 110.287 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.5 -46.86 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.772 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -62.01 -47.68 83.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.45 -42.18 96.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.349 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.64 -49.69 76.5 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.436 1.017 . . . . 0.0 110.5 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.9 t -56.68 -42.58 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.217 1.007 . . . . 0.0 109.39 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.7 mmt -67.43 -51.81 47.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.268 1.027 . . . . 0.0 108.273 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -37.03 69.91 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.804 0.842 . . . . 0.0 110.729 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.633 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.1 tp10 -59.18 -35.33 73.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 118.797 0.726 . . . . 0.0 111.526 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.62 -13.49 15.29 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.641 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.21 -39.13 63.49 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.401 1.48 . . . . 0.0 110.949 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -66.86 -32.07 73.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.289 0.636 . . . . 0.0 110.722 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.2 -44.95 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.4 -40.54 78.64 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 CA-C-O 117.365 -1.303 . . . . 0.0 110.097 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -56.07 -51.93 66.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 120.82 1.645 . . . . 0.0 109.969 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -71.25 -28.7 64.36 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.93 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.401 HD21 ' NE2' ' A' ' 103' ' ' GLN . 19.1 tp -63.37 -41.11 98.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.084 1.354 . . . . 0.0 110.184 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.8 -43.98 97.38 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--O 1.233 0.216 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.702 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.264 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.519 0.676 . . . . 0.0 109.41 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.85 -68.19 0.45 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.456 0.702 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -163.06 -51.68 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.969 0.908 . . . . 0.0 112.421 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.04 17.04 14.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 112.82 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.54 7.09 65.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.36 0.981 . . . . 0.0 113.741 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -96.19 155.66 16.67 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.49 152.65 71.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.649 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -88.11 134.87 3.14 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.276 1.984 . . . . 0.0 111.135 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -131.79 163.92 27.17 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.022 1.329 . . . . 0.0 109.484 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 98' ' ' LYS . 3.2 m -133.04 167.77 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.263 175.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 163.08 33.3 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.82 144.94 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.1 137.91 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.81 133.19 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 22' ' ' VAL . 61.7 m -124.45 145.59 49.42 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.814 0.696 . . . . 0.0 110.571 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -97.74 170.58 8.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.849 1.259 . . . . 0.0 108.626 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.61 8.56 3.46 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.039 -1.663 . . . . 0.0 113.151 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.63 -3.68 54.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.386 1.075 . . . . 0.0 111.164 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.35 18.69 79.89 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 118.861 0.755 . . . . 0.0 112.071 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -90.23 141.42 28.72 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.552 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.3 m -108.31 147.74 12.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.081 1.753 . . . . 0.0 108.452 178.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.6 ttm -65.86 138.58 57.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.583 0.753 . . . . 0.0 109.337 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -142.82 140.36 31.28 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.78 1.632 . . . . 0.0 106.833 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -139.17 161.68 36.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.66 1.118 . . . . 0.0 112.187 -171.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -118.97 118.88 32.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.555 1.942 . . . . 0.0 106.978 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -67.21 150.68 48.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.605 1.093 . . . . 0.0 108.873 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.41 142.35 58.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.35 6.57 75.88 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.318 -1.268 . . . . 0.0 114.038 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -134.03 157.21 46.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.543 1.671 . . . . 0.0 109.612 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -98.42 -14.12 20.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.864 0.466 . . . . 0.0 112.227 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -78.57 152.24 31.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.397 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -110.6 158.17 18.87 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.461 1.104 . . . . 0.0 111.155 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -159.74 159.31 32.67 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.728 1.211 . . . . 0.0 110.396 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.73 157.49 71.92 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.84 134.65 60.02 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -131.26 169.59 15.76 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.059 1.344 . . . . 0.0 112.282 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.08 169.61 38.29 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.571 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.7 137.24 13.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.3 mt -75.14 126.24 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -84.65 150.41 56.43 Favored Pre-proline 0 C--O 1.235 0.324 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.26 122.18 10.28 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.775 1.65 . . . . 0.0 109.832 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.79 -20.64 43.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.845 1.212 . . . . 0.0 113.469 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.08 152.92 42.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.722 1.761 . . . . 0.0 109.941 170.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.2 p -83.43 169.8 15.16 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.1 80.55 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 122.001 -0.437 . . . . 0.0 110.461 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.74 -38.79 64.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.592 0.757 . . . . 0.0 110.586 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -67.82 -41.32 83.24 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.251 -0.906 . . . . 0.0 110.03 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -36.41 81.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.956 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.57 -53.72 52.93 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.147 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -67.68 -42.19 82.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.302 0.955 . . . . 0.0 111.706 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -45.44 94.79 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.971 0.509 . . . . 0.0 109.942 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.76 -31.13 35.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.094 -0.479 . . . . 0.0 110.227 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 58' ' ' VAL . 32.9 tp -53.27 -43.27 67.29 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.709 0.686 . . . . 0.0 110.091 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -57.14 -38.21 73.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.464 0.574 . . . . 0.0 111.231 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -70.29 -20.89 63.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.097 0.862 . . . . 0.0 111.734 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -94.73 -48.88 5.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.357 1.063 . . . . 0.0 110.936 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 60' ' ' LEU . 3.5 p -120.17 -3.3 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.759 1.224 . . . . 0.0 112.413 -169.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.83 1.02 9.85 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 121.24 -0.913 . . . . 0.0 112.957 -170.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 58' ' ' VAL . 14.6 tp -79.08 144.07 34.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.277 1.031 . . . . 0.0 110.002 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 p -122.5 164.43 18.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.647 1.179 . . . . 0.0 109.498 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -40.71 -38.87 0.97 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.168 1.787 . . . . 0.0 112.616 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -67.34 -20.33 65.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.269 -169.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.72 21.03 10.91 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.527 0.603 . . . . 0.0 112.528 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.61 160.36 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.925 -1.109 . . . . 0.0 110.73 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -138.12 137.37 37.64 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.13 120.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.624 HD11 ' HB2' ' A' ' 103' ' ' GLN . 96.4 mt -94.76 -36.77 11.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.721 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.56 164.3 34.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.127 0.971 . . . . 0.0 109.523 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.0 p -160.42 151.47 19.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.267 1.427 . . . . 0.0 109.897 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -69.09 131.47 45.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.729 0.776 . . . . 0.0 109.645 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -79.81 -48.16 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -75.53 179.94 4.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.44 2.296 . . . . 0.0 108.247 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.555 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 73.2 m95 -114.49 142.91 45.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 168.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.37 85.43 6.57 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -81.44 144.01 31.69 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.43 147.93 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.41 144.67 25.36 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.8 mt -73.05 144.88 85.52 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 124.998 1.319 . . . . 0.0 111.302 171.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.32 149.26 69.46 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 105.174 -2.664 . . . . 0.0 105.174 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.1 mtpt -68.73 -13.46 62.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.944 -1.723 . . . . 0.0 113.956 -169.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -61.76 -30.78 71.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.094 0.861 . . . . 0.0 112.789 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.64 -18.16 21.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.906 0.883 . . . . 0.0 112.123 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 81' ' ' LYS . 80.1 t -63.61 134.9 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -98.9 89.83 4.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.71 0.804 . . . . 0.0 109.687 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.5 -21.2 62.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.082 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.81 -30.55 56.46 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 t -97.64 162.15 13.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.576 1.15 . . . . 0.0 109.523 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -130.67 132.43 23.94 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.529 1.532 . . . . 0.0 108.319 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.25 157.33 93.54 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 O-C-N 122.72 0.853 . . . . 0.0 111.307 -10.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.4 t -74.45 138.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.889 0.876 . . . . 0.0 109.455 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 p -89.13 122.64 32.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.899 0.88 . . . . 0.0 108.726 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -14.56 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.184 0.902 . . . . 0.0 113.296 172.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.57 38.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -158.19 158.92 35.48 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.052 0.941 . . . . 0.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -101.5 124.82 47.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 169.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.22 123.9 50.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.903 1.229 . . . . 0.0 109.548 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.555 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -86.73 149.33 24.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -127.99 153.89 46.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.057 0.844 . . . . 0.0 109.467 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -134.36 134.29 41.58 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.833 1.253 . . . . 0.0 108.451 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.9 tp -98.08 120.86 39.22 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mt -116.97 146.83 42.77 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.624 ' HB2' HD11 ' A' ' 68' ' ' LEU . 4.3 tt0 -97.42 135.69 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 168.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.55 132.38 49.72 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.0 t -81.29 -46.0 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 122.74 0.416 . . . . 0.0 110.256 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 t -83.12 -37.31 23.94 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.0 -169.04 12.82 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -170.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 -15.88 38.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.61 1.564 . . . . 0.0 114.307 -172.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.03 63.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 0.0 113.031 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -95.12 26.18 3.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.19 0.996 . . . . 0.0 113.357 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 89.7 mt -99.58 139.98 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.808 1.243 . . . . 0.0 108.765 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -138.98 117.2 11.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.779 1.232 . . . . 0.0 109.757 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 mmt -89.78 -4.29 57.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.424 0.69 . . . . 0.0 112.58 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -119.8 75.5 1.08 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 124.207 1.956 . . . . 0.0 107.145 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 p -65.48 -65.07 0.72 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 111.204 -2.725 . . . . 0.0 106.777 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -78.48 173.63 12.17 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -58.1 -42.15 85.05 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.166 -0.959 . . . . 0.0 109.168 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 134.91 82.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 108.512 169.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -62.16 135.36 54.15 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 107.537 -1.755 . . . . 0.0 107.537 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -85.17 -34.21 22.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -109.88 135.82 50.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -75.03 -35.08 61.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.671 0.788 . . . . 0.0 110.475 173.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.48 29.84 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -148.84 158.77 44.41 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.566 0.746 . . . . 0.0 109.057 169.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -145.9 167.57 22.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.916 1.286 . . . . 0.0 108.828 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -109.9 129.7 55.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.46 153.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.815 1.246 . . . . 0.0 110.714 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 m -57.85 143.04 43.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.036 0.835 . . . . 0.0 109.835 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -32.87 61.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -83.84 -21.23 32.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.158 1.344 . . . . 0.0 112.692 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -60.11 -50.79 84.5 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.118 -1.42 . . . . 0.0 113.407 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.84 -27.7 85.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 122.681 1.993 . . . . 0.0 113.291 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.69 -31.59 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.848 0.859 . . . . 0.0 109.013 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -66.22 -24.42 66.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.163 -0.961 . . . . 0.0 111.679 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.94 -27.91 28.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.14 168.58 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 118.744 0.702 . . . . 0.0 112.397 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -83.16 175.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.379 1.471 . . . . 0.0 110.487 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 m -52.44 -51.4 59.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.825 1.65 . . . . 0.0 114.586 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -74.05 -36.77 64.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.458 1.026 . . . . 0.0 110.716 -175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.05 -36.61 66.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.51 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -51.28 -45.14 62.03 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.106 0.866 . . . . 0.0 110.493 171.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.63 -42.98 95.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.503 0.592 . . . . 0.0 110.926 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.15 -52.62 56.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.55 -32.56 74.21 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.211 -0.93 . . . . 0.0 111.24 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -67.27 -42.83 83.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.237 1.38 . . . . 0.0 110.327 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.41 -42.65 96.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.76 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.2 -25.95 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.49 1.041 . . . . 0.0 111.427 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -88.42 -58.66 2.48 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -33.41 70.47 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.716 1.207 . . . . 0.0 112.501 -172.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.72 -40.12 78.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.391 0.996 . . . . 0.0 110.565 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -106.42 -9.86 16.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.272 1.029 . . . . 0.0 112.952 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.33 73.12 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 125.187 1.395 . . . . 0.0 110.594 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -67.13 -31.98 72.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.677 0.791 . . . . 0.0 110.653 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.75 -43.63 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.31 -41.36 81.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.083 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -46.53 87.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 120.478 1.49 . . . . 0.0 110.53 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 t -66.46 -28.45 68.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 110.689 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.7 tp -69.59 -31.34 69.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.299 -1.501 . . . . 0.0 109.875 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -75.76 -25.74 56.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.026 169.895 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.53 -68.37 0.34 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.0 -49.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -87.02 11.32 13.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.104 0.962 . . . . 0.0 112.735 -169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.63 -8.4 79.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.698 1.142 . . . . 0.0 113.069 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -90.4 159.13 16.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.263 1.032 . . . . 0.0 108.498 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -137.65 142.33 36.42 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.248 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HB2' HD12 ' A' ' 40' ' ' ILE . 69.5 Cg_endo -89.34 135.91 2.71 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.879 1.719 . . . . 0.0 111.035 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.3 159.75 41.25 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.158 -0.964 . . . . 0.0 110.387 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.56 159.8 34.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 119.538 1.063 . . . . 0.0 110.418 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.88 160.21 24.21 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.05 143.66 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.182 1.393 . . . . 0.0 107.762 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.01 136.93 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm -121.09 133.03 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 101' ' ' LEU . 13.0 p -124.97 156.65 37.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.506 0.594 . . . . 0.0 111.623 170.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -104.51 172.73 6.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.438 1.495 . . . . 0.0 108.18 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -73.79 2.6 8.01 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.269 -1.519 . . . . 0.0 113.119 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -88.01 -4.84 58.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.069 0.947 . . . . 0.0 111.277 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.57 19.87 79.75 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.943 0.792 . . . . 0.0 111.601 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.87 147.01 25.3 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.09 148.72 17.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.171 1.789 . . . . 0.0 107.058 174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.6 ptm -76.12 148.5 37.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.392 0.542 . . . . 0.0 109.863 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -148.22 140.1 23.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -174.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB1' ' CD2' ' A' ' 121' ' ' PHE . . . -144.32 148.17 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.426 1.466 . . . . 0.0 113.087 -169.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -101.06 115.29 30.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.661 1.984 . . . . 0.0 106.559 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -68.75 151.6 46.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.663 1.119 . . . . 0.0 109.226 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.32 132.52 54.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.46 85.03 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.746 1.165 . . . . 0.0 113.726 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -115.3 162.32 17.27 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.33 1.565 . . . . 0.0 110.296 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.62 -13.68 16.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.479 0.711 . . . . 0.0 111.662 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -86.34 150.35 24.39 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.726 1.61 . . . . 0.0 110.968 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -103.61 151.64 22.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.141 0.977 . . . . 0.0 110.061 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -155.18 166.87 32.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.139 1.376 . . . . 0.0 110.211 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -85.38 155.15 59.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.95 127.2 19.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.321 2.014 . . . . 0.0 110.473 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -157.55 163.55 38.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.69 44.26 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.792 -0.567 . . . . 0.0 113.454 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.75 152.6 41.06 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 124.733 1.159 . . . . 0.0 112.075 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 9' ' ' PRO . 62.2 mt -84.03 122.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 169.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.22 159.38 85.58 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.0 123.87 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 121.199 1.266 . . . . 0.0 109.414 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.17 -6.07 80.79 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 118.772 -1.015 . . . . 0.0 114.646 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.37 156.55 39.36 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.043 1.922 . . . . 0.0 109.227 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -93.26 167.29 11.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.67 83.37 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.62 -0.675 . . . . 0.0 110.987 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -36.46 69.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.299 0.64 . . . . 0.0 110.503 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.76 -36.21 70.33 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.893 -1.129 . . . . 0.0 110.629 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.21 86.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -63.4 -51.74 64.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.104 -0.951 . . . . 0.0 108.672 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -66.76 -31.74 72.59 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 112.133 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -63.69 -52.95 58.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.528 1.058 . . . . 0.0 109.071 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -71.23 -25.07 62.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -172.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.73 -42.51 88.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 171.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -71.91 -50.14 31.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.121 0.873 . . . . 0.0 110.753 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.28 -21.92 66.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.905 1.229 . . . . 0.0 112.806 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.39 -53.5 2.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.791 1.236 . . . . 0.0 111.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.2 -21.92 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 112.396 -168.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 -3.19 33.66 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.204 1.383 . . . . 0.0 112.887 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.77 157.95 34.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.712 2.005 . . . . 0.0 109.768 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 p -137.11 168.15 20.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 110.185 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -53.14 -34.09 55.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.099 1.76 . . . . 0.0 112.292 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.781 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.95 24.39 12.72 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.844 1.202 . . . . 0.0 111.419 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.74 166.06 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.912 -1.118 . . . . 0.0 112.266 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 133.73 27.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.599 169.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.57 113.01 10.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 103' ' ' GLN . 70.8 mt -88.16 -34.0 18.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.489 173.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.44 39.12 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 109.759 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 p -158.66 154.33 26.26 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.112 1.365 . . . . 0.0 110.04 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.416 HG22 ' HG2' ' A' ' 150' ' ' GLU . 2.1 p -69.04 139.72 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.508 0.671 . . . . 0.0 111.472 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -86.11 -28.48 23.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.804 1.642 . . . . 0.0 109.838 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -121.77 148.64 44.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.022 2.129 . . . . 0.0 108.536 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -80.68 133.39 35.7 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.24 64.79 7.06 Favored 'General case' 0 N--CA 1.46 0.072 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -71.52 146.17 48.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -142.94 145.53 33.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.285 0.634 . . . . 0.0 110.256 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.26 147.04 23.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.87 148.06 98.92 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.823 0.849 . . . . 0.0 109.782 169.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -66.92 143.86 68.11 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 N-CA-C 104.311 -2.996 . . . . 0.0 104.311 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.1 mtpt -67.99 -13.07 61.89 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.051 -1.656 . . . . 0.0 114.135 -168.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -57.15 -30.56 64.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 170.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.8 mt -91.79 -20.49 21.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.382 0.673 . . . . 0.0 112.034 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.509 HG23 ' HA ' ' A' ' 81' ' ' LYS . 48.0 t -67.17 135.23 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -103.34 89.97 3.56 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.188 0.995 . . . . 0.0 108.486 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.423 ' CE2' HG11 ' A' ' 84' ' ' VAL . 84.7 m95 -65.28 -9.31 23.1 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.17 27.93 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.443 1.097 . . . . 0.0 110.472 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.6 p -77.16 157.72 30.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.113 0.959 . . . . 0.0 112.873 -169.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -130.56 110.16 16.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.697 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.37 142.26 64.97 Favored 'Cis proline' 0 CA--C 1.537 0.66 0 N-CA-C 108.09 -1.542 . . . . 0.0 108.09 -11.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.4 p -64.47 133.96 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 O-C-N 121.659 -0.65 . . . . 0.0 110.79 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.3 t -72.57 124.73 25.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.97 -14.9 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.24 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.42 -179.56 48.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 119.689 1.131 . . . . 0.0 110.342 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.77 152.98 45.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.308 . . . . 0.0 110.037 173.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.55 135.51 34.75 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -128.42 129.34 46.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.09 0.859 . . . . 0.0 110.485 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -111.92 142.02 44.84 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -124.2 155.28 38.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.417 0.553 . . . . 0.0 109.703 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -137.73 125.64 22.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.42 HD11 ' SG ' ' A' ' 16' ' ' CYS . 10.9 tp -92.33 122.77 35.11 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 168.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mt -117.87 148.28 42.27 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.459 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.0 tt0 -97.34 132.37 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.76 138.31 58.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.881 1.272 . . . . 0.0 108.922 171.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -88.38 -49.45 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.241 0.616 . . . . 0.0 110.09 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.2 m -87.08 -19.38 28.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.77 -169.39 20.13 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -20.42 44.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.649 1.58 . . . . 0.0 113.792 -171.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -30.58 43.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.508 1.123 . . . . 0.0 112.839 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.87 13.0 23.97 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 66.9 mt -85.17 137.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -136.7 105.2 5.77 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.1 mmt -82.67 1.7 37.17 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.67 73.97 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 123.942 1.83 . . . . 0.0 107.961 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -70.05 -64.13 0.95 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.589 -2.096 . . . . 0.0 105.558 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.0 m -72.44 167.24 20.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.459 1.503 . . . . 0.0 107.647 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 m -61.46 -41.16 96.79 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.286 -0.884 . . . . 0.0 109.171 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.49 132.76 89.27 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.67 1.588 . . . . 0.0 109.387 170.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.94 143.3 99.32 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.763 1.642 . . . . 0.0 109.537 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -86.74 -21.1 26.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.76 0.424 . . . . 0.0 110.673 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.436 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 85.2 m-85 -128.37 144.07 51.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.067 0.947 . . . . 0.0 109.136 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.74 -30.52 59.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.152 0.981 . . . . 0.0 110.522 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.86 155.54 26.44 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 150.39 37.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -146.58 170.28 17.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 109.13 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -116.2 137.23 52.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.05 154.17 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 109.954 -169.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.8 m -60.32 144.06 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.947 0.794 . . . . 0.0 109.504 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -25.42 63.83 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -88.66 -10.9 46.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.403 1.456 . . . . 0.0 113.38 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -72.79 -47.35 8.9 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.608 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.84 -24.53 68.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.903 2.073 . . . . 0.0 112.921 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.2 -30.77 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.268 1.027 . . . . 0.0 109.273 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.06 -24.4 63.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.042 -1.036 . . . . 0.0 111.514 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -81.18 -30.12 34.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.068 0.849 . . . . 0.0 112.87 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.12 168.43 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.554 0.615 . . . . 0.0 112.638 -169.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -85.13 175.33 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.206 1.402 . . . . 0.0 110.417 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -52.65 -50.68 62.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.617 1.567 . . . . 0.0 114.64 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -74.16 -34.74 63.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.142 0.883 . . . . 0.0 110.984 -175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.4 -37.92 60.2 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.705 -0.622 . . . . 0.0 110.353 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -50.18 -44.11 52.73 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.538 171.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -65.45 -41.52 93.34 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.626 0.648 . . . . 0.0 111.064 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.9 -53.0 46.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -65.11 -31.93 73.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.385 0.993 . . . . 0.0 112.229 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -66.21 -44.6 83.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.255 1.389 . . . . 0.0 110.276 171.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -59.54 -43.76 93.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.378 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.8 t -56.95 -27.95 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.571 1.148 . . . . 0.0 111.779 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -87.75 -58.18 2.67 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -58.18 -36.07 72.52 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.082 0.953 . . . . 0.0 112.276 -173.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.7 tp10 -58.81 -36.82 75.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 119.086 0.857 . . . . 0.0 110.723 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -105.27 -12.76 15.93 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.055 0.942 . . . . 0.0 112.337 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.96 68.7 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.416 1.487 . . . . 0.0 110.78 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 m -68.19 -30.65 69.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.759 0.823 . . . . 0.0 111.058 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.9 t -69.68 -43.03 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.72 -43.88 88.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.545 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -45.19 84.37 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 121.991 2.178 . . . . 0.0 111.666 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -81.2 -8.71 59.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 125.146 1.378 . . . . 0.0 111.924 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.84 -42.5 19.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 120.417 -1.427 . . . . 0.0 108.851 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.45 -41.8 90.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 125.195 1.398 . . . . 0.0 114.226 170.048 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.48 -77.46 0.07 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.682 0.793 . . . . 0.0 110.903 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -164.47 -44.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -91.79 16.89 9.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.712 1.205 . . . . 0.0 113.072 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 17.29 60.28 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.11 0.862 . . . . 0.0 112.929 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -111.93 155.31 23.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.8 128.08 22.92 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.44 141.27 46.07 Favored 'Trans proline' 0 C--N 1.345 0.391 0 CA-C-N 121.328 1.51 . . . . 0.0 110.053 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -138.43 148.24 44.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.78 0.832 . . . . 0.0 109.214 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 40' ' ' ILE . 4.6 m -134.52 149.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.206 1.402 . . . . 0.0 108.081 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -144.85 161.6 28.08 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 122.043 -0.411 . . . . 0.0 112.246 174.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.21 143.2 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 122.991 0.517 . . . . 0.0 109.933 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -122.44 131.59 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 mm -108.39 130.96 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.597 ' SG ' HG12 ' A' ' 22' ' ' VAL . 64.2 m -111.98 146.82 37.18 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 124.362 1.039 . . . . 0.0 109.289 169.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -98.78 176.65 5.54 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 14.38 3.71 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.905 -1.122 . . . . 0.0 113.028 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -106.35 -3.85 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.587 1.555 . . . . 0.0 111.307 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.47 83.22 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.756 -170.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -80.56 149.8 29.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.075 1.438 . . . . 0.0 107.477 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.597 HG12 ' SG ' ' A' ' 16' ' ' CYS . 6.4 m -128.03 153.49 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.969 2.107 . . . . 0.0 108.424 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.7 ptm -68.18 153.7 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.845 0.458 . . . . 0.0 110.713 171.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -154.74 132.34 11.33 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.03 150.54 41.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.39 1.45 . . . . 0.0 111.468 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -102.4 115.57 30.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -70.1 149.07 47.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.844 1.656 . . . . 0.0 109.644 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.67 140.91 57.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.16 85.96 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.219 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -123.34 169.08 11.69 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.025 1.413 . . . . 0.0 109.812 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -125.69 27.61 6.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.11 1.364 . . . . 0.0 108.93 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -125.35 143.3 51.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.042 1.337 . . . . 0.0 108.458 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -99.48 149.48 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.812 0.845 . . . . 0.0 110.491 -174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -159.77 168.65 25.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.918 1.287 . . . . 0.0 110.214 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.83 152.54 66.24 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -46.99 129.57 15.07 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.582 2.855 . . . . 0.0 111.443 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 7.2 pt20 -161.35 155.88 23.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.163 0.985 . . . . 0.0 110.176 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.55 168.21 40.84 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.265 0.935 . . . . 0.0 111.664 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.03 147.4 39.57 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 11' ' ' VAL . 68.6 mt -74.78 113.36 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 169.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.68 144.59 96.27 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.39 127.18 24.49 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.681 1.587 . . . . 0.0 110.883 -169.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.34 -8.83 77.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 114.15 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.64 152.84 39.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.829 1.814 . . . . 0.0 111.273 171.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.0 p -86.62 166.81 15.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 167.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.78 77.07 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 120.723 -1.236 . . . . 0.0 111.588 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.92 -38.3 61.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.362 0.665 . . . . 0.0 110.534 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -66.55 -40.27 88.97 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.55 -33.26 72.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.904 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.404 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 12.0 tmm? -56.75 -50.42 72.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 60.7 m-85 -66.67 -44.67 81.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.915 0.78 . . . . 0.0 111.84 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -54.92 -52.02 64.25 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.474 1.034 . . . . 0.0 111.04 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.96 -36.14 64.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.5 tp -53.42 -51.14 63.57 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.409 0.684 . . . . 0.0 110.129 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.78 -43.23 99.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -63.42 -23.51 67.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.728 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.81 -35.9 4.03 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 120.495 1.498 . . . . 0.0 113.385 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.561 ' HB ' HG23 ' A' ' 111' ' ' ILE . 27.5 m -117.02 5.04 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 119.373 0.988 . . . . 0.0 111.959 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.55 -4.3 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.781 -1.2 . . . . 0.0 114.869 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.1 144.26 34.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.887 1.675 . . . . 0.0 109.987 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -122.58 163.0 20.79 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.296 1.038 . . . . 0.0 109.813 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 47.3 mtp180 -42.02 -40.59 2.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.876 2.07 . . . . 0.0 112.527 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -67.84 -20.86 65.2 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.37 -0.824 . . . . 0.0 113.131 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.56 20.69 15.78 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.366 0.53 . . . . 0.0 111.516 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -137.68 161.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 O-C-N 120.533 -1.354 . . . . 0.0 112.896 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.55 138.81 46.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.09 121.09 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 103' ' ' GLN . 52.3 mt -94.77 -36.1 11.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.563 0.745 . . . . 0.0 109.77 174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.06 164.8 27.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.64 1.176 . . . . 0.0 109.546 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 p -155.54 154.93 32.51 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.593 1.557 . . . . 0.0 108.896 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 150' ' ' GLU . 0.7 OUTLIER -63.25 136.73 57.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.02 0.914 . . . . 0.0 111.106 -169.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtt-85 -80.16 -30.49 38.87 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.061 1.745 . . . . 0.0 108.419 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 146.6 52.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.202 2.201 . . . . 0.0 109.565 176.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -73.89 143.43 45.79 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.94 86.37 6.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -68.85 142.59 54.79 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -137.13 142.31 42.26 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.089 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -131.99 141.48 49.29 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.538 2.335 . . . . 0.0 106.451 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER -104.87 148.42 36.08 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.464 ' HD2' HD12 ' A' ' 83' ' ' LEU . 74.4 Cg_endo -71.1 153.87 62.53 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.447 2.765 . . . . 0.0 109.148 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.559 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.8 mtmt -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -59.55 -31.09 69.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 170.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' ' 80' ' ' PRO . 53.4 mt -90.77 -15.35 30.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.694 0.798 . . . . 0.0 112.042 -178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 81' ' ' LYS . 95.8 t -67.57 133.37 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -94.51 93.66 7.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.544 0.738 . . . . 0.0 109.195 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -71.09 -23.73 62.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.126 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.81 -26.45 57.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.227 0.611 . . . . 0.0 112.485 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -104.6 156.16 18.21 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.726 0.81 . . . . 0.0 109.249 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.23 137.54 31.09 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 124.94 1.296 . . . . 0.0 109.974 -169.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.23 144.13 80.03 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.807 0.898 . . . . 0.0 110.309 -10.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 141.76 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.014 0.926 . . . . 0.0 110.351 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 p -100.25 140.93 33.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.397 1.079 . . . . 0.0 110.794 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.05 -14.34 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.341 0.656 . . . . 0.0 112.505 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.01 -175.18 36.19 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -164.39 164.93 21.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.317 1.447 . . . . 0.0 110.124 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.41 117.63 34.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 120.341 1.428 . . . . 0.0 108.528 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -94.53 152.86 18.22 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -136.59 150.54 48.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.299 0.5 . . . . 0.0 109.806 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.404 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 48.8 m-85 -136.57 127.53 27.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.65 117.85 30.11 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.29 157.68 19.87 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.743 ' HB2' HD11 ' A' ' 68' ' ' LEU . 8.4 tt0 -110.61 142.43 42.47 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 144.54 38.06 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.669 1.188 . . . . 0.0 109.682 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.35 -44.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.2 m -91.03 -30.12 16.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.385 0.674 . . . . 0.0 111.464 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.58 -178.41 16.41 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.778 1.18 . . . . 0.0 110.478 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -52.46 -25.45 10.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.389 1.876 . . . . 0.0 113.143 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.7 -31.08 62.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 113.916 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.84 16.03 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -170.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.561 HG23 ' HB ' ' A' ' 58' ' ' VAL . 77.9 mt -100.71 134.94 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 107.371 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -123.6 122.58 38.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 125.98 1.712 . . . . 0.0 107.311 174.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.7 mmt -84.32 -17.96 37.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.045 0.538 . . . . 0.0 112.201 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.55 71.81 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.144 1.778 . . . . 0.0 107.293 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.7 p -75.52 -64.86 0.98 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.487 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -85.62 -178.18 6.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 108.648 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 m -56.7 -35.77 68.89 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.733 -0.604 . . . . 0.0 109.925 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.96 130.46 46.42 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.936 1.694 . . . . 0.0 107.722 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.39 135.56 37.02 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 N-CA-C 107.499 -1.77 . . . . 0.0 107.499 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.73 -21.64 63.45 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -121.98 142.23 50.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.942 0.897 . . . . 0.0 109.634 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.24 -23.24 38.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 111.072 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.51 156.95 27.54 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.41 151.44 41.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 109.159 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -153.93 169.91 22.31 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.616 1.166 . . . . 0.0 109.015 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.47 137.29 54.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.57 158.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.406 1.482 . . . . 0.0 111.057 -168.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -64.32 145.27 56.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.277 169.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -30.87 49.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -86.72 -21.23 26.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.354 1.433 . . . . 0.0 112.568 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -63.48 -43.46 78.78 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 116.594 -1.669 . . . . 0.0 114.149 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.22 -30.54 91.46 Favored 'Trans proline' 0 C--N 1.353 0.784 0 CA-C-N 123.364 2.237 . . . . 0.0 112.833 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.17 -27.37 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.097 0.959 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -71.39 -24.35 62.05 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.117 -0.99 . . . . 0.0 111.595 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.66 -33.06 41.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.314 0.961 . . . . 0.0 112.533 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 m -83.76 166.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -85.1 174.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.569 1.548 . . . . 0.0 109.126 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.3 m -54.04 -44.79 71.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.442 1.497 . . . . 0.0 114.418 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -64.1 -41.95 97.08 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.111 0.868 . . . . 0.0 111.463 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.78 -35.65 38.26 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.282 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -52.0 -45.92 64.7 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.232 0.924 . . . . 0.0 110.527 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.96 -44.31 89.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.323 0.511 . . . . 0.0 110.864 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.15 -52.29 49.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -69.25 -30.57 68.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.157 -169.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -66.49 -42.35 87.55 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.507 1.503 . . . . 0.0 110.213 169.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -58.78 -46.24 87.97 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 119.231 0.923 . . . . 0.0 110.606 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.17 -24.61 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.657 1.183 . . . . 0.0 112.041 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.8 mmt -86.54 -58.11 2.74 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -60.0 -32.97 71.36 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.305 1.042 . . . . 0.0 112.082 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.409 ' HG2' HG22 ' A' ' 71' ' ' THR . 2.0 tp10 -59.08 -34.82 72.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.228 0.922 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -112.15 -9.05 13.97 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.466 1.106 . . . . 0.0 113.343 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.47 72.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.977 1.262 . . . . 0.0 110.958 -169.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.0 m -67.8 -32.35 72.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.281 0.632 . . . . 0.0 110.763 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.8 t -69.26 -44.43 80.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.33 -42.34 73.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.432 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.2 mmt -56.95 -54.44 46.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.235 1.38 . . . . 0.0 110.065 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.6 m -70.32 -26.59 63.83 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.835 1.254 . . . . 0.0 110.787 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.62 ' HG ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -65.79 -36.7 84.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.598 1.959 . . . . 0.0 109.541 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -70.54 -20.73 62.78 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.837 1.199 . . . . 0.0 112.668 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 N--CA 1.466 0.354 0 C-N-CA 125.85 1.66 . . . . 0.0 111.306 -177.172 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.55 -45.98 81.29 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 112.978 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -147.71 -118.81 0.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.175 0.99 . . . . 0.0 108.784 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.14 -15.63 56.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.675 1.59 . . . . 0.0 111.396 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.16 178.82 47.51 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 126.133 1.825 . . . . 0.0 109.567 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.4 153.15 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.617 2.767 . . . . 0.0 113.743 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.69 137.56 15.34 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 120.506 -1.371 . . . . 0.0 107.974 174.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -74.09 140.88 28.77 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.323 2.015 . . . . 0.0 109.42 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -141.27 154.09 45.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.765 0.826 . . . . 0.0 109.143 -170.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 98' ' ' LYS . 3.3 m -129.29 136.32 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.524 1.53 . . . . 0.0 107.475 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -122.03 158.09 16.75 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 172.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -124.12 144.33 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 125.619 1.568 . . . . 0.0 107.556 -171.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.65 137.12 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm -120.94 134.17 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 101' ' ' LEU . 19.2 p -124.83 158.24 33.91 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.1 0.864 . . . . 0.0 112.267 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -108.24 170.6 7.91 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.462 1.505 . . . . 0.0 108.658 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -0.56 15.88 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.095 -1.628 . . . . 0.0 113.648 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -81.61 -6.51 59.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.679 0.672 . . . . 0.0 110.544 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.68 78.66 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.028 -0.874 . . . . 0.0 111.489 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -89.15 150.36 22.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.73 148.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.487 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.9 tpp -63.53 128.4 35.66 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.706 1.202 . . . . 0.0 108.175 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 33' ' ' TRP . 10.0 t90 -146.73 140.45 25.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.45 146.55 33.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.669 1.122 . . . . 0.0 113.653 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -85.53 121.32 28.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.329 1.852 . . . . 0.0 106.704 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -79.66 149.62 31.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.63 1.559 . . . . 0.0 109.349 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.42 117.09 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.061 1.745 . . . . 0.0 110.925 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.62 -1.07 31.39 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.738 1.161 . . . . 0.0 115.499 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -83.39 -31.25 26.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.747 1.774 . . . . 0.0 111.987 -172.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.8 m80 54.66 31.2 14.75 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.518 1.127 . . . . 0.0 112.008 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.2 m -138.43 154.03 48.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.548 1.939 . . . . 0.0 107.518 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 24' ' ' TRP . 77.4 m95 -108.55 151.76 25.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.109 0.564 . . . . 0.0 111.176 -169.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -148.17 159.71 43.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.921 1.688 . . . . 0.0 110.833 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.3 141.39 29.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.77 130.19 32.13 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 0.0 111.586 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -159.5 162.26 35.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.243 0.929 . . . . 0.0 112.764 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.19 176.98 47.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.421 1.01 . . . . 0.0 111.926 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.85 150.16 32.25 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 121.166 -1.196 . . . . 0.0 111.859 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 11' ' ' VAL . 46.1 mt -79.94 129.37 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 168.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -71.95 152.86 93.0 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -57.53 123.58 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 120.962 1.108 . . . . 0.0 109.334 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.91 -5.58 84.43 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.384 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.05 155.47 37.19 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.237 2.018 . . . . 0.0 109.681 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -97.19 154.93 17.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.43 88.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.464 -0.773 . . . . 0.0 112.32 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.96 -34.35 75.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.951 0.501 . . . . 0.0 109.96 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -68.03 -42.96 79.79 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.08 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.15 81.5 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 119.272 -0.395 . . . . 0.0 110.15 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -57.41 -49.02 77.56 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.49 -35.18 79.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -62.95 -46.21 88.84 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.817 1.644 . . . . 0.0 109.686 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -69.15 -25.55 64.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.708 -0.62 . . . . 0.0 110.728 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.22 -43.12 95.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.746 -1.221 . . . . 0.0 109.774 172.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.19 -37.11 86.3 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.754 -0.591 . . . . 0.0 110.389 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.33 -35.56 66.05 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.425 -0.797 . . . . 0.0 112.629 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.3 -57.14 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.335 0.654 . . . . 0.0 110.294 -169.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.01 -15.78 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.713 0.805 . . . . 0.0 110.15 -172.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.71 19.29 79.17 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.716 -0.615 . . . . 0.0 111.737 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.7 tp -108.48 150.86 26.85 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.683 1.993 . . . . 0.0 108.266 -172.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m -127.58 168.22 15.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.607 0.763 . . . . 0.0 109.819 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -49.51 -33.95 15.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.664 1.585 . . . . 0.0 112.606 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -65.33 -23.36 66.98 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.037 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.98 24.66 10.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.488 0.661 . . . . 0.0 112.708 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -134.15 165.24 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.336 1.054 . . . . 0.0 111.34 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -141.06 141.37 34.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -80.51 120.59 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 103' ' ' GLN . 79.9 mt -96.49 -35.52 11.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.816 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -157.01 161.97 39.56 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.338 0.59 . . . . 0.0 110.16 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 p -158.16 155.2 28.66 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.651 1.58 . . . . 0.0 109.526 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 150' ' ' GLU . 0.6 OUTLIER -66.7 143.64 56.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.69 0.757 . . . . 0.0 111.595 -170.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -80.47 -29.34 37.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.199 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -136.74 152.23 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.594 2.358 . . . . 0.0 109.065 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -76.06 136.93 39.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.75 102.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -106.94 146.19 31.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -147.67 146.36 29.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -91.26 144.68 25.36 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -71.46 149.22 93.63 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 123.943 0.897 . . . . 0.0 110.55 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.52 144.91 74.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 N-CA-C 105.082 -2.699 . . . . 0.0 105.082 167.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.4 mtpt -68.52 -12.1 60.78 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.242 -1.536 . . . . 0.0 113.831 -169.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -58.14 -31.62 67.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -90.0 -23.08 21.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 111.817 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 81' ' ' LYS . 53.1 t -66.05 137.96 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 109.45 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -107.82 90.99 3.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.14 0.976 . . . . 0.0 109.934 169.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -68.55 -24.6 64.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.825 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.58 -24.74 60.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.69 0.796 . . . . 0.0 112.433 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -111.3 156.79 20.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.228 1.011 . . . . 0.0 109.293 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -129.9 140.16 37.82 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.101 1.36 . . . . 0.0 109.239 -169.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.74 150.8 96.06 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 O-C-N 122.826 0.908 . . . . 0.0 110.865 -10.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.7 136.8 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.922 0.889 . . . . 0.0 111.656 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.2 t -81.85 108.37 15.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.6 -14.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.727 0.811 . . . . 0.0 112.584 170.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.37 -174.52 47.03 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.99 157.9 36.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 109.11 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.3 125.61 54.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 169.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -117.26 129.54 55.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.013 0.824 . . . . 0.0 111.405 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HB2' HG12 ' A' ' 11' ' ' VAL . 32.5 mmtt -88.04 154.04 20.79 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 84.5 m95 -132.54 143.6 49.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -130.41 132.5 45.77 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.572 1.149 . . . . 0.0 107.926 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 22.1 tp -97.06 126.03 41.93 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.85 146.64 43.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.6 tt0 -95.72 133.34 39.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 167.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.97 130.78 47.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.225 1.41 . . . . 0.0 108.542 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.9 t -86.31 -38.6 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.587 0.631 . . . . 0.0 110.803 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.5 m -95.41 -21.15 18.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.865 0.757 . . . . 0.0 112.302 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.65 -176.43 24.07 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -19.24 28.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.686 1.594 . . . . 0.0 114.506 -169.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.33 -31.46 33.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.378 1.071 . . . . 0.0 112.912 171.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -92.85 16.07 13.32 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.86 141.17 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -126.23 -49.38 1.56 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.529 0.732 . . . . 0.0 111.676 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 68.64 9.87 7.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.3 2.24 . . . . 0.0 115.2 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.26 69.66 0.83 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 124.325 2.012 . . . . 0.0 111.227 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -56.37 5.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.347 169.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 m -63.99 160.92 16.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.044 1.337 . . . . 0.0 109.063 168.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -63.57 -33.17 75.01 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.99 -0.444 . . . . 0.0 110.721 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.53 131.38 38.28 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.356 1.463 . . . . 0.0 110.27 170.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.67 132.67 31.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.212 1.941 . . . . 0.0 107.883 168.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -73.4 -23.65 60.19 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.862 -0.524 . . . . 0.0 111.074 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -116.12 139.29 50.46 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.543 0.737 . . . . 0.0 110.085 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.74 -21.09 34.85 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.072 0.949 . . . . 0.0 110.709 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -165.93 158.57 31.53 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.39 155.53 47.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.167 0.983 . . . . 0.0 108.497 169.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -144.79 149.03 34.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -96.9 98.11 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.52 168.92 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 110.296 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -64.31 168.13 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 109.507 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -30.68 70.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.196 -0.94 . . . . 0.0 111.563 175.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -92.01 -32.7 15.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.127 1.331 . . . . 0.0 113.607 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -54.39 -45.25 99.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 116.825 -1.559 . . . . 0.0 114.326 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.74 -19.96 68.01 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 123.273 2.205 . . . . 0.0 113.646 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.83 -33.68 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.11 -37.11 85.92 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.268 -0.895 . . . . 0.0 111.11 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -78.75 -27.0 44.65 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.78 166.23 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 118.804 0.729 . . . . 0.0 111.229 -173.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.65 174.23 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.855 1.262 . . . . 0.0 109.857 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.2 m -54.59 -49.42 70.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.493 1.517 . . . . 0.0 113.429 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -60.1 -39.09 84.96 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.317 0.647 . . . . 0.0 111.146 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -85.6 -40.14 16.57 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.974 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -46.85 -46.33 20.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.861 0.864 . . . . 0.0 111.097 170.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.83 -35.49 78.4 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.484 0.713 . . . . 0.0 111.367 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.14 -50.8 17.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.015 . . . . 0.0 110.169 171.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -61.78 -32.69 72.99 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.302 0.955 . . . . 0.0 111.586 -169.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -63.71 -42.99 97.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.259 0.936 . . . . 0.0 111.27 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -61.88 -44.7 96.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.83 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -55.73 -30.84 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.484 1.038 . . . . 0.0 111.222 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.4 mmt -86.25 -54.81 4.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.362 1.065 . . . . 0.0 108.717 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -36.49 73.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.076 0.853 . . . . 0.0 111.635 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 71' ' ' THR . 4.4 mm-40 -57.73 -40.13 78.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.143 0.977 . . . . 0.0 111.077 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.24 -14.15 13.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 111.025 -172.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.31 57.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 111.139 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 m -66.34 -31.48 72.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.312 0.645 . . . . 0.0 111.067 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.32 -45.91 67.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -58.47 -41.12 80.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 116.949 -1.5 . . . . 0.0 110.217 -173.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.3 mmt -54.48 -49.42 70.15 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 121.137 1.79 . . . . 0.0 110.318 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 m -76.64 -26.48 54.94 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.355 1.062 . . . . 0.0 111.144 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 18.6 tp -62.68 -44.22 96.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.111 1.365 . . . . 0.0 109.411 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -60.12 -39.9 87.83 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.845 0.458 . . . . 0.0 110.827 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.233 0.195 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.109 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.406 0.622 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -63.76 -67.08 0.46 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -169.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -162.68 -52.64 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.82 14.83 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 112.776 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.85 1.08 77.31 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.788 1.185 . . . . 0.0 114.001 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.51 165.28 11.18 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.917 0.865 . . . . 0.0 109.223 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -148.47 145.74 20.98 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.163 1.385 . . . . 0.0 107.456 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HB2' HD12 ' A' ' 40' ' ' ILE . 93.1 Cg_endo -85.71 133.39 4.37 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.476 1.451 . . . . 0.0 109.935 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.7 150.01 52.29 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 109.253 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.461 HG13 HD11 ' A' ' 40' ' ' ILE . 18.3 m -129.13 154.97 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.071 0.948 . . . . 0.0 108.83 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.13 158.29 25.23 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.49 143.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.565 1.146 . . . . 0.0 108.06 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.14 136.73 58.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mm -117.45 135.96 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' HD11 ' A' ' 101' ' ' LEU . 15.6 p -123.56 153.76 40.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.987 0.812 . . . . 0.0 112.117 171.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -103.72 175.12 5.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.425 1.49 . . . . 0.0 109.156 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -78.27 8.07 5.51 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.466 -1.396 . . . . 0.0 113.241 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -96.52 -5.76 38.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.439 1.096 . . . . 0.0 111.447 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.79 66.9 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.867 0.758 . . . . 0.0 111.885 -172.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -98.11 150.35 21.53 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -114.39 146.47 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 106.938 174.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 ptm -78.95 147.69 32.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.851 0.75 . . . . 0.0 109.672 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 20.3 t90 -148.55 146.59 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.63 148.2 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.977 1.262 . . . . 0.0 111.701 -170.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -99.5 127.79 45.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.81 0.732 . . . . 0.0 109.203 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -78.18 145.69 35.45 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.699 0.681 . . . . 0.0 109.867 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.13 136.1 57.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.066 0.946 . . . . 0.0 109.508 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.86 10.26 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.885 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -100.88 -45.21 5.51 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.328 1.564 . . . . 0.0 110.083 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 53.92 29.56 10.15 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.844 1.258 . . . . 0.0 111.826 -174.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -120.28 148.48 43.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.895 2.078 . . . . 0.0 106.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 70.3 m95 -92.82 148.61 21.89 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -152.24 162.89 40.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.538 1.935 . . . . 0.0 110.141 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.54 141.23 23.17 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.39 135.92 44.79 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.036 2.491 . . . . 0.0 111.671 -174.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -158.22 166.96 31.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.445 -171.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.29 172.57 42.31 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.165 0.412 . . . . 0.0 112.127 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.77 143.62 16.83 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.461 HD11 HG13 ' A' ' 11' ' ' VAL . 57.4 mt -76.81 122.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 168.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.99 148.29 78.46 Favored Pre-proline 0 N--CA 1.464 0.253 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.21 124.12 14.55 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.162 1.241 . . . . 0.0 109.055 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.38 -15.79 58.53 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.636 1.112 . . . . 0.0 113.803 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -73.67 148.16 43.02 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.644 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 p -85.96 168.95 13.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 168.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.59 87.88 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.262 -0.899 . . . . 0.0 110.943 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.97 -39.01 63.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.239 0.616 . . . . 0.0 110.611 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.81 -41.82 86.92 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.638 -0.664 . . . . 0.0 109.59 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.85 79.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.411 0.55 . . . . 0.0 109.629 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -62.02 -51.72 66.89 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.06 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.75 -35.35 79.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.916 1.235 . . . . 0.0 111.571 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.35 94.86 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.851 0.86 . . . . 0.0 110.388 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.89 -24.56 26.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.276 0.489 . . . . 0.0 110.933 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.44 HD12 HG21 ' A' ' 58' ' ' VAL . 11.1 tp -55.23 -39.59 69.88 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.152 -0.967 . . . . 0.0 109.471 169.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -63.12 -49.15 75.56 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.004 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.63 -32.74 73.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 0.0 112.715 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.8 -46.29 10.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.763 0.711 . . . . 0.0 111.135 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 54' ' ' LEU . 4.6 t -106.75 -31.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.562 1.145 . . . . 0.0 110.975 -168.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.67 87.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.817 1.199 . . . . 0.0 111.778 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 64' ' ' ASP . 22.9 tp -87.79 155.47 19.88 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.456 1.902 . . . . 0.0 110.039 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 p -131.76 164.48 25.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.765 1.226 . . . . 0.0 109.724 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -41.39 -40.56 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.315 2.246 . . . . 0.0 112.698 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.91 -28.18 69.36 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.42 0.688 . . . . 0.0 112.659 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' HD11 ' A' ' 60' ' ' LEU . 3.8 t70 -111.67 22.6 14.82 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.458 0.647 . . . . 0.0 112.08 -176.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.22 165.38 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 O-C-N 120.769 -1.207 . . . . 0.0 112.544 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 137.48 39.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 168.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.7 mt -74.53 119.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 171.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 103' ' ' GLN . 88.1 mt -95.76 -33.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.889 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -157.05 163.15 39.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.404 1.082 . . . . 0.0 108.745 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -162.24 153.24 17.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.587 1.155 . . . . 0.0 109.573 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 150' ' ' GLU . 3.7 p -70.7 136.09 48.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.346 -170.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -52.51 21.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -72.33 170.4 14.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.582 1.553 . . . . 0.0 111.652 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.477 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 87.0 m95 -108.44 125.58 51.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 167.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.97 106.04 8.4 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -73.62 140.3 46.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.74 143.32 50.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -131.66 141.7 49.66 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 126.283 1.833 . . . . 0.0 106.081 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pp -110.29 150.2 41.22 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.527 1.131 . . . . 0.0 109.613 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 83' ' ' LEU . 82.8 Cg_endo -73.12 158.18 49.57 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.427 3.418 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.6 mtmt -68.41 -18.41 64.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.41 -29.07 68.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD12 ' HD2' ' A' ' 80' ' ' PRO . 52.0 mt -94.55 -7.89 39.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.123 0.969 . . . . 0.0 112.416 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 81' ' ' LYS . 74.2 t -70.03 132.02 33.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.74 97.01 10.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -75.6 -19.52 59.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.861 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.29 -27.94 56.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -101.12 158.17 16.22 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.125 0.97 . . . . 0.0 109.836 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -132.66 132.02 22.43 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 125.967 1.707 . . . . 0.0 109.724 -170.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.5 150.72 89.94 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 O-C-N 122.879 0.936 . . . . 0.0 110.858 -10.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.24 141.55 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.899 1.28 . . . . 0.0 111.269 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.0 p -81.24 123.18 28.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.62 -16.11 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.843 0.747 . . . . 0.0 111.449 169.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.2 -174.16 40.07 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -160.96 162.84 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.223 1.809 . . . . 0.0 110.536 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -98.6 129.58 45.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -111.72 143.32 42.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.045 1.293 . . . . 0.0 110.237 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 6.2 ttmm -131.88 118.92 20.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -104.43 153.89 20.55 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.65 125.31 30.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.58 HD11 ' SG ' ' A' ' 16' ' ' CYS . 13.1 tp -91.16 121.41 32.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 168.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.67 157.09 23.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.682 ' HB2' HD11 ' A' ' 68' ' ' LEU . 5.1 tt0 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 167.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 141.23 56.62 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.956 1.303 . . . . 0.0 109.43 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.94 -47.51 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.114 0.566 . . . . 0.0 110.094 -171.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.8 m -86.1 -16.0 39.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.138 0.575 . . . . 0.0 111.55 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.25 -169.61 22.84 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -17.01 53.55 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 125.264 1.426 . . . . 0.0 114.311 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.68 57.05 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.917 0.887 . . . . 0.0 111.76 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -91.71 51.76 1.91 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 110.958 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.16 129.61 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.76 -53.72 2.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.375 0.67 . . . . 0.0 111.406 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 67.57 12.01 8.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.948 2.099 . . . . 0.0 114.628 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -150.31 73.89 1.17 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 124.016 1.865 . . . . 0.0 109.713 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -71.93 -60.08 2.41 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.269 -2.241 . . . . 0.0 107.843 171.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -66.71 166.44 13.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 109.917 169.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -57.43 -38.01 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.895 . . . . 0.0 110.829 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 130.52 54.77 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.865 1.266 . . . . 0.0 110.454 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.99 142.0 73.02 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.926 1.751 . . . . 0.0 108.453 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -81.34 -24.94 36.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.552 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.08 140.04 53.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.303 0.956 . . . . 0.0 109.998 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.0 -17.97 24.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.691 1.196 . . . . 0.0 111.371 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.85 151.82 23.19 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.57 148.85 31.57 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.816 0.847 . . . . 0.0 108.778 171.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -148.52 172.65 14.16 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.905 1.282 . . . . 0.0 109.204 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -112.97 139.77 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.59 152.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 109.853 -169.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m -59.94 147.9 37.09 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.819 0.736 . . . . 0.0 109.419 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -38.16 37.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -88.53 -25.1 22.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -170.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -57.87 -47.82 98.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.055 -1.45 . . . . 0.0 113.693 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -63.84 -21.3 69.24 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.865 2.059 . . . . 0.0 113.171 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.62 -36.38 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -62.85 -35.57 80.38 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.285 -0.885 . . . . 0.0 111.099 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.89 -21.4 34.27 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -81.73 167.87 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.389 0.995 . . . . 0.0 110.251 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.2 176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.719 1.208 . . . . 0.0 110.638 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 m -53.12 -48.5 67.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.021 1.729 . . . . 0.0 114.494 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -74.5 -31.34 62.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.257 -0.902 . . . . 0.0 111.394 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -80.77 -40.16 25.61 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.253 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -44.33 -46.2 9.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 0.0 111.633 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.96 -42.45 94.6 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.302 0.501 . . . . 0.0 111.352 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -67.5 -44.84 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 121.638 -0.664 . . . . 0.0 109.361 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.45 -41.76 98.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -66.34 -43.9 84.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.159 0.891 . . . . 0.0 110.333 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.31 -47.73 84.6 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.071 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.1 -39.45 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.733 1.213 . . . . 0.0 110.431 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.2 mmt -69.49 -54.45 14.19 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -57.24 -34.66 68.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.878 0.871 . . . . 0.0 111.774 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.627 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -56.07 -45.55 79.29 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.281 1.033 . . . . 0.0 110.185 -178.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.445 ' CZ ' HG23 ' A' ' 71' ' ' THR . 3.1 m-85 -104.63 -9.52 18.19 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.485 0.714 . . . . 0.0 112.381 -173.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.13 -43.81 70.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.133 1.773 . . . . 0.0 110.548 -173.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.7 m -66.7 -31.99 73.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.463 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.63 -47.14 81.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 118.055 -0.974 . . . . 0.0 108.384 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.6 t -58.42 -45.35 89.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 109.48 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.9 mtt -61.62 -33.82 74.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.624 0.647 . . . . 0.0 111.216 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -82.79 -31.36 28.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.575 1.15 . . . . 0.0 110.824 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.413 HD21 ' NE2' ' A' ' 103' ' ' GLN . 28.1 tp -58.33 -40.25 81.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.154 1.782 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.93 -29.75 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.194 0.598 . . . . 0.0 111.985 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 125.825 1.65 . . . . 0.0 111.74 -177.826 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.23 -64.83 0.81 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.4 -50.69 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.31 16.79 14.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 113.084 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 10.47 67.94 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.888 0.756 . . . . 0.0 113.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -105.0 155.6 18.81 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 108.714 170.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.96 147.76 67.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.446 169.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HB2' HD12 ' A' ' 40' ' ' ILE . 92.5 Cg_endo -85.55 142.23 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 110.528 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -143.57 155.44 44.3 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.252 1.421 . . . . 0.0 109.498 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.17 153.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.072 0.549 . . . . 0.0 110.372 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.74 160.37 19.36 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.84 146.55 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.76 135.9 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.9 mm -112.03 134.75 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.0 m -124.12 145.38 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.842 0.714 . . . . 0.0 110.008 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -104.22 173.53 6.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.116 1.366 . . . . 0.0 108.51 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.31 9.86 5.27 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.5 -1.375 . . . . 0.0 112.632 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -98.41 -3.51 36.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.099 1.36 . . . . 0.0 111.444 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.2 21.54 70.19 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 118.777 0.717 . . . . 0.0 111.916 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.98 150.7 21.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.647 1.223 . . . . 0.0 107.842 172.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.87 151.04 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 108.296 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.3 mtp -70.56 147.57 49.14 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.277 0.49 . . . . 0.0 110.026 169.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 14.4 t90 -151.2 141.16 22.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.62 145.74 47.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.28 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -97.13 107.95 20.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.961 2.105 . . . . 0.0 107.143 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -74.7 139.32 43.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.556 1.525 . . . . 0.0 109.939 -169.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.68 135.99 57.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.36 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.55 -24.56 3.64 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.546 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -82.49 -44.68 15.68 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.56 1.68 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m80 59.47 28.45 17.83 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.23 0.956 . . . . 0.0 109.734 -168.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -122.93 155.27 37.08 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 108.025 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 73.5 m95 -101.88 146.53 27.7 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -169.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -149.43 164.06 36.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.512 1.525 . . . . 0.0 110.334 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -87.52 143.95 34.82 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 130.49 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 110.59 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -159.07 168.17 27.37 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.113 0.87 . . . . 0.0 112.244 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.44 163.52 37.24 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.653 0.644 . . . . 0.0 111.661 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.6 150.85 45.52 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 9' ' ' PRO . 67.7 mt -77.55 113.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -70.93 156.03 92.58 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.58 123.9 12.83 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 CA-C-N 120.719 1.293 . . . . 0.0 109.674 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.09 -5.35 78.56 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.212 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -74.34 154.19 38.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.075 1.937 . . . . 0.0 110.524 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.4 p -94.56 168.37 10.9 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.46 90.02 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.024 -1.048 . . . . 0.0 111.342 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.06 -38.62 72.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.146 0.578 . . . . 0.0 110.26 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -67.69 -39.18 84.45 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.8 92.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 102' ' ' LEU . 12.6 tmm? -60.52 -52.52 64.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.6 m-85 -66.46 -44.44 82.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.973 0.806 . . . . 0.0 111.465 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -44.78 80.04 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 121.816 -0.552 . . . . 0.0 110.337 -173.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -71.54 -37.14 71.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 tp -53.76 -43.83 69.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.094 0.861 . . . . 0.0 110.588 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.27 -39.14 81.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.232 0.469 . . . . 0.0 110.834 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.11 -18.71 60.19 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.3 -0.875 . . . . 0.0 112.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -90.03 -50.38 6.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.666 0.787 . . . . 0.0 110.563 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.86 3.33 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 0.0 111.837 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.58 -1.52 14.26 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.469 -1.395 . . . . 0.0 113.529 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -80.72 144.42 32.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.186 1.794 . . . . 0.0 109.741 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -125.04 166.3 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 109.445 -174.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 56.7 mtt180 -48.96 -35.28 14.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.361 1.464 . . . . 0.0 112.43 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.35 -24.28 67.21 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.82 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.29 22.84 12.57 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.491 0.662 . . . . 0.0 112.113 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.19 164.24 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.675 1.19 . . . . 0.0 112.212 170.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.35 134.52 29.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.576 -1.202 . . . . 0.0 108.114 168.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mt -71.27 113.64 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 103' ' ' GLN . 68.7 mt -91.54 -33.99 14.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.848 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -153.93 165.42 36.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.406 0.682 . . . . 0.0 109.344 -174.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 p -159.09 157.53 31.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.61 1.164 . . . . 0.0 110.422 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -75.04 134.72 41.34 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.562 -0.711 . . . . 0.0 109.169 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.11 -48.17 25.09 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -79.41 165.17 23.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.022 1.329 . . . . 0.0 110.461 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 68.5 m95 -102.79 128.65 49.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -80.3 92.34 5.75 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -81.41 145.31 30.86 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.74 151.16 49.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -128.43 133.13 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.758 1.623 . . . . 0.0 106.898 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -90.64 147.9 37.35 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.36 0.664 . . . . 0.0 112.715 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.2 150.53 71.72 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 105.046 -2.713 . . . . 0.0 105.046 166.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.8 mtpt -69.35 -13.45 62.38 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 119.805 -1.809 . . . . 0.0 114.147 -169.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.16 -31.38 71.86 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.821 0.737 . . . . 0.0 112.76 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.08 -18.69 21.55 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.107 0.963 . . . . 0.0 112.009 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 81' ' ' LYS . 86.5 t -62.91 134.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.53 83.96 3.89 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.151 0.976 . . . . 0.0 110.223 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -67.29 -19.92 65.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.066 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.49 -20.99 53.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -107.07 160.88 15.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.948 0.899 . . . . 0.0 109.965 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -130.43 127.07 22.35 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 125.442 1.497 . . . . 0.0 109.19 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.39 159.53 91.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 O-C-N 122.717 0.851 . . . . 0.0 111.246 -10.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 80.5 t -75.01 140.04 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 123.906 0.882 . . . . 0.0 110.045 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 p -91.89 121.45 33.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.697 1.199 . . . . 0.0 108.925 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.29 -13.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.803 0.728 . . . . 0.0 112.716 171.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.91 46.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -157.01 161.48 39.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.675 1.19 . . . . 0.0 109.566 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -112.43 132.69 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -123.29 122.15 37.62 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.429 0.692 . . . . 0.0 109.524 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.2 ttmm -105.97 140.35 39.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.67 156.16 38.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.676 0.671 . . . . 0.0 109.364 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -139.8 127.01 21.17 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.161 0.984 . . . . 0.0 108.516 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -88.82 116.3 26.99 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 50' ' ' MET . 9.6 mp -112.11 137.46 50.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.866 0.867 . . . . 0.0 108.917 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.3 tt0 -89.99 134.88 33.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.477 1.49 . . . . 0.0 107.213 168.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.97 133.43 51.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.64 1.576 . . . . 0.0 107.269 170.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.34 -55.24 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.834 1.197 . . . . 0.0 110.634 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.1 m -75.78 -19.46 58.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.59 0.756 . . . . 0.0 111.227 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.44 27.26 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -57.75 -18.18 19.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 0.0 114.367 -169.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.03 10.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.268 1.027 . . . . 0.0 112.619 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -87.15 14.97 6.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.1 mt -91.33 137.9 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -129.27 128.46 43.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.337 1.855 . . . . 0.0 106.874 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.1 mmt -97.91 -11.04 23.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.579 0.627 . . . . 0.0 111.526 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.91 63.32 0.71 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.979 2.112 . . . . 0.0 106.587 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -68.65 -60.05 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 127.185 2.194 . . . . 0.0 109.361 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -90.67 174.87 7.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.457 1.903 . . . . 0.0 110.021 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 m -60.17 -25.72 65.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.192 0.997 . . . . 0.0 112.004 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.94 136.82 23.37 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 168.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 155.2 68.4 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.575 2.183 . . . . 0.0 111.8 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.39 -35.25 27.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.745 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.67 137.8 54.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.574 0.75 . . . . 0.0 109.437 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.3 -26.71 56.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.837 0.855 . . . . 0.0 110.787 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.89 166.84 38.33 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.39 160.01 44.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 169.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -145.65 167.05 24.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.79 133.93 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 151.29 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.853 1.261 . . . . 0.0 110.083 -169.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -60.73 146.6 45.28 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -33.53 30.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.022 1.329 . . . . 0.0 113.698 -169.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -91.72 -14.75 29.46 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -65.17 -47.81 71.05 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.335 -1.317 . . . . 0.0 112.858 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.55 -28.88 83.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 CA-C-N 122.547 1.945 . . . . 0.0 112.35 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.15 -25.82 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.191 1.396 . . . . 0.0 109.819 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -65.87 -31.42 72.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.424 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -100.01 -22.16 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.75 151.89 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 118.793 0.724 . . . . 0.0 110.065 171.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.36 176.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.688 1.195 . . . . 0.0 109.706 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -55.38 -44.3 75.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.393 1.477 . . . . 0.0 112.911 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -70.65 -41.75 71.73 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 111.088 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.42 -41.06 28.49 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.83 -0.544 . . . . 0.0 110.731 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -61.63 -29.41 70.04 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.853 0.751 . . . . 0.0 112.383 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.17 -45.75 87.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.497 0.589 . . . . 0.0 110.688 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.25 -47.14 91.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.525 -0.734 . . . . 0.0 109.099 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -61.62 -45.52 93.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -66.08 -40.65 90.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.971 -1.081 . . . . 0.0 110.933 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.63 -48.02 83.65 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.474 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.01 -39.9 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.279 1.032 . . . . 0.0 110.039 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.6 mmt -67.12 -52.83 36.98 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.996 0.919 . . . . 0.0 108.647 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.462 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -29.54 69.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.37 0.987 . . . . 0.0 112.006 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.422 ' HB3' HD12 ' A' ' 101' ' ' LEU . 14.9 m-85 -111.37 -14.47 13.76 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.09 0.956 . . . . 0.0 113.468 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.28 69.33 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.371 1.468 . . . . 0.0 110.641 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 m -68.53 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.864 0.866 . . . . 0.0 110.687 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 69' ' ' ALA . 41.5 t -68.62 -43.67 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.68 -39.91 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.458 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.0 mmt -57.44 -50.38 73.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.643 1.11 . . . . 0.0 109.852 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 m -73.31 -28.04 61.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.173 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.408 HD21 ' NE2' ' A' ' 103' ' ' GLN . 65.6 tp -62.01 -42.58 99.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.666 1.186 . . . . 0.0 110.152 172.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.44 -42.52 98.88 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -170.143 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.61 -69.09 0.31 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.246 0.618 . . . . 0.0 112.623 -169.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.34 -52.4 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.663 0.785 . . . . 0.0 112.953 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.62 17.0 10.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.699 1.199 . . . . 0.0 112.459 -169.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.54 85.72 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.744 1.164 . . . . 0.0 113.24 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -88.21 157.88 18.67 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.263 1.025 . . . . 0.0 109.367 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -150.31 127.29 5.4 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 116.996 -1.478 . . . . 0.0 107.292 -169.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -80.32 132.58 9.25 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.505 1.47 . . . . 0.0 109.424 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.36 155.61 49.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.909 0.884 . . . . 0.0 108.656 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.42 137.77 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.16 154.41 16.82 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.45 141.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 125.397 1.479 . . . . 0.0 107.962 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.88 142.7 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mm -117.09 142.25 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 117.293 -1.337 . . . . 0.0 107.663 169.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' SG ' HD21 ' A' ' 101' ' ' LEU . 27.6 p -125.78 160.11 30.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.651 1.114 . . . . 0.0 112.708 170.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -121.61 172.18 8.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.613 1.565 . . . . 0.0 109.145 176.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.99 7.7 4.6 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.439 -1.413 . . . . 0.0 112.977 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -94.08 -5.13 48.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.434 1.093 . . . . 0.0 111.715 174.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 31.72 60.75 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -108.57 154.6 21.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.22 150.3 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 174.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -84.52 143.59 29.25 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -144.65 140.47 28.68 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -175.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.78 158.46 42.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.581 1.537 . . . . 0.0 111.531 -170.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.68 145.83 51.05 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.875 1.67 . . . . 0.0 108.45 -171.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -112.11 163.39 14.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.341 0.973 . . . . 0.0 109.664 174.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -72.88 153.67 40.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.328 1.051 . . . . 0.0 109.013 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.96 -52.63 3.3 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.138 1.351 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.17 -45.73 66.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.43 0.615 . . . . 0.0 110.079 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.1 m170 56.18 -0.37 0.05 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.292 2.237 . . . . 0.0 115.377 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -77.82 163.23 26.27 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.565 1.946 . . . . 0.0 108.348 169.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -112.68 146.7 38.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -174.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.34 158.51 44.14 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.958 1.303 . . . . 0.0 110.686 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.62 134.22 65.87 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 169.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -54.34 139.76 73.42 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.214 2.609 . . . . 0.0 112.578 -178.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -161.95 169.17 21.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.161 0.891 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.86 169.48 42.54 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.156 0.407 . . . . 0.0 112.368 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.79 147.51 36.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -73.89 114.94 14.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 169.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -68.22 145.72 97.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.19 125.14 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.518 1.479 . . . . 0.0 112.076 -169.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.2 85.93 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.55 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.15 147.55 48.27 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.133 1.967 . . . . 0.0 110.595 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -85.24 156.48 20.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 167.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.64 75.63 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.014 -1.054 . . . . 0.0 112.119 -169.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.71 -36.67 70.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 110.094 -178.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -70.28 -37.65 74.88 Favored 'General case' 0 C--O 1.23 0.061 0 O-C-N 121.172 -0.955 . . . . 0.0 109.995 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.57 77.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.566 175.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -58.09 -48.65 79.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.4 m-85 -66.32 -46.91 75.24 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.913 0.779 . . . . 0.0 111.766 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -52.52 -52.51 54.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.133 0.973 . . . . 0.0 110.901 177.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.87 -37.35 59.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -170.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -54.61 -45.41 73.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 110.595 173.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.76 -39.62 89.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.159 0.436 . . . . 0.0 110.28 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.36 -24.64 60.37 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.08 -46.01 12.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.313 0.96 . . . . 0.0 111.459 -175.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.52 4.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 112.32 -169.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.93 -2.97 14.5 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 120.431 -1.418 . . . . 0.0 113.513 -178.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.0 tp -78.89 140.88 38.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.677 1.591 . . . . 0.0 109.771 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 p -120.96 163.67 17.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.877 1.271 . . . . 0.0 109.902 -171.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 67.0 mtt85 -46.58 -37.58 8.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.054 1.742 . . . . 0.0 112.23 -177.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -30.19 71.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.885 -173.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.33 21.42 16.71 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.679 1.127 . . . . 0.0 112.011 -173.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.01 165.6 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.53 1.532 . . . . 0.0 111.829 171.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.65 140.31 33.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.279 169.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.52 116.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 177.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 103' ' ' GLN . 78.0 mt -94.58 -33.57 12.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.405 174.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.82 164.04 39.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.799 0.84 . . . . 0.0 108.919 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -163.68 154.4 15.92 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.1 0.96 . . . . 0.0 109.879 170.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 150' ' ' GLU . 2.1 p -70.07 139.28 52.57 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -175.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -56.98 4.87 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -72.84 -178.16 2.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.514 1.925 . . . . 0.0 111.062 174.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 55.8 m95 -118.75 146.85 44.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.12 102.16 13.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 137.37 40.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -135.82 143.26 45.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -87.74 139.13 30.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 83' ' ' LEU . 1.1 pp -91.02 148.82 38.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 169.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.8 Cg_endo -71.92 155.14 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.45 2.767 . . . . 0.0 110.497 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -65.75 -20.24 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.046 -1.034 . . . . 0.0 112.8 -170.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.62 -32.81 67.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.688 0.676 . . . . 0.0 112.739 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.465 HD12 ' HD2' ' A' ' 80' ' ' PRO . 67.4 mt -91.05 -20.08 22.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.042 0.937 . . . . 0.0 111.436 -177.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.17 134.79 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -109.26 96.21 6.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.126 0.97 . . . . 0.0 109.398 171.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -70.99 -27.15 63.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.237 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.16 -10.32 59.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.309 1.043 . . . . 0.0 112.534 -170.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -129.73 158.9 38.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.928 0.891 . . . . 0.0 108.974 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -127.29 141.5 41.0 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.177 1.391 . . . . 0.0 108.993 -171.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.76 147.55 89.84 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 O-C-N 122.875 0.934 . . . . 0.0 111.35 -10.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -83.72 141.27 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.405 1.082 . . . . 0.0 108.908 175.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -103.96 139.6 38.88 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.461 0.704 . . . . 0.0 109.533 169.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 -17.42 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 122.937 0.495 . . . . 0.0 111.347 169.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.91 161.97 28.12 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.98 143.41 33.19 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.586 1.154 . . . . 0.0 108.599 -177.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HE2' ' CD2' ' A' ' 74' ' ' TRP . 85.2 tttt -94.72 120.77 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -119.15 131.0 55.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.065 1.302 . . . . 0.0 112.893 -172.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 3.7 ttmm -99.4 152.79 19.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -128.54 148.6 50.77 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -133.58 129.73 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.871 1.269 . . . . 0.0 108.491 -177.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -95.07 125.64 39.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.444 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.13 157.02 31.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.655 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.0 tt0 -105.84 132.99 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 137.83 58.32 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -89.5 -55.33 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.611 1.096 . . . . 0.0 109.97 -172.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -76.87 -21.62 54.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.458 0.703 . . . . 0.0 111.432 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.18 169.32 20.56 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -13.91 26.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.573 1.549 . . . . 0.0 114.433 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.63 39.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.286 1.034 . . . . 0.0 112.712 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.59 22.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.39 137.21 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.193 1.397 . . . . 0.0 108.155 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -124.03 129.01 50.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.332 1.853 . . . . 0.0 107.888 170.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.8 mmt -93.68 -8.04 42.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.369 0.668 . . . . 0.0 112.697 -176.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -127.22 81.08 1.99 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 124.084 1.897 . . . . 0.0 108.83 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 p -79.57 -64.14 1.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.209 2.603 . . . . 0.0 107.58 178.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -72.85 174.22 8.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.578 1.551 . . . . 0.0 109.711 169.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -60.53 -36.82 79.32 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.85 -0.531 . . . . 0.0 109.974 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.12 136.28 57.54 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.48 1.512 . . . . 0.0 107.991 169.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 117.55 4.34 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 122.44 2.093 . . . . 0.0 107.622 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -72.99 -18.87 61.31 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.763 -0.586 . . . . 0.0 110.297 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.03 155.88 49.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.919 1.288 . . . . 0.0 107.974 168.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.3 -14.77 14.1 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.975 2.11 . . . . 0.0 110.808 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.02 154.55 25.56 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.68 149.88 51.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.43 164.96 33.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -121.88 132.44 54.57 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.28 162.48 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.166 1.386 . . . . 0.0 111.984 -168.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.7 m -69.07 157.56 36.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 109.567 169.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.95 78.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 112.651 -171.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -91.31 -27.9 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.241 -0.912 . . . . 0.0 112.969 -169.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -51.34 -46.92 89.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.99 -25.4 59.29 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.14 1.8 . . . . 0.0 113.152 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.62 -41.3 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.318 0.0 OUTLIER -74.16 -5.53 42.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.273 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -95.01 -15.93 23.13 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.338 -0.839 . . . . 0.0 113.129 -174.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 m -104.16 172.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.624 1.102 . . . . 0.0 111.771 -175.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.5 m -73.27 166.61 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.905 0.882 . . . . 0.0 109.584 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -52.67 -50.54 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.048 1.739 . . . . 0.0 114.188 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -69.69 -33.12 72.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.656 -0.652 . . . . 0.0 110.888 -175.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -76.81 -37.26 56.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.375 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -51.4 -47.03 63.07 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.008 0.822 . . . . 0.0 109.915 173.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.55 -42.97 99.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.868 0.304 . . . . 0.0 110.791 -176.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.69 -50.79 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -58.61 -41.98 87.1 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.607 0.763 . . . . 0.0 109.027 -176.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.98 -52.93 63.66 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.679 0.792 . . . . 0.0 110.345 176.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -54.9 -49.55 70.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.68 -43.77 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.087 0.858 . . . . 0.0 110.491 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.8 mmt -69.8 -52.44 25.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -173.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -30.59 71.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.218 0.917 . . . . 0.0 112.234 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.547 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -57.52 -45.31 85.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.793 0.724 . . . . 0.0 110.616 177.577 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.49 ' HB3' HD12 ' A' ' 101' ' ' LEU . 7.3 m-85 -106.11 -11.41 16.11 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.01 66.83 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.169 1.788 . . . . 0.0 110.652 -174.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -67.11 -31.64 72.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.591 0.756 . . . . 0.0 110.465 -174.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.91 -45.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.3 -44.38 92.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.054 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -47.49 82.91 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 120.453 1.479 . . . . 0.0 110.056 -177.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.7 t -68.61 -31.23 70.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.712 0.405 . . . . 0.0 111.077 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.435 HD21 ' NE2' ' A' ' 103' ' ' GLN . 21.2 tp -64.29 -38.63 91.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.124 1.369 . . . . 0.0 110.464 176.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -67.19 -44.15 80.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.803 0.274 . . . . 0.0 110.332 173.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.237 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.89 144.52 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 164.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.43 -66.16 0.59 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.096 0.872 . . . . 0.0 110.188 -171.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -164.16 -53.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.918 0.487 . . . . 0.0 110.093 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -96.04 16.66 17.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 123.625 1.678 . . . . 0.0 110.746 -164.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.71 2.16 65.29 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 120.206 -1.558 . . . . 0.0 112.704 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -97.12 159.24 15.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.272 1.536 . . . . 0.0 109.035 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -140.16 142.03 28.66 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.518 ' HB2' HD12 ' A' ' 40' ' ' ILE . 10.9 Cg_endo -80.93 144.59 15.21 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.934 1.756 . . . . 0.0 110.648 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.25 154.98 41.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.55 158.26 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.961 0.904 . . . . 0.0 109.126 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -141.16 162.1 26.81 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG21 HD13 ' A' ' 54' ' ' LEU . 2.9 mp -126.27 144.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -172.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.3 t -128.17 136.46 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 169.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.526 HG21 ' HG ' ' A' ' 104' ' ' LEU . 17.5 mm -116.19 137.46 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 167.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.905 ' SG ' HD11 ' A' ' 101' ' ' LEU . 2.1 p -124.12 162.31 23.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.543 1.639 . . . . 0.0 112.69 161.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -106.14 172.65 6.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 112.047 -2.342 . . . . 0.0 108.834 172.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.0 5.48 6.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -94.1 0.29 55.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.716 0.806 . . . . 0.0 110.975 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.45 21.81 76.73 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.551 0.614 . . . . 0.0 112.196 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -95.15 147.25 23.65 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.8 145.98 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ttm -67.02 145.48 55.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.592 -1.185 . . . . 0.0 107.897 169.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 1.059 ' NE1' ' HB3' ' A' ' 33' ' ' TRP . 1.8 t90 -144.23 141.14 29.68 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' N ' ' HD1' ' A' ' 24' ' ' TRP . . . -133.28 167.28 20.68 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 123.52 1.629 . . . . 0.0 115.331 173.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.413 ' HB2' ' CE3' ' A' ' 33' ' ' TRP . 37.3 ttp180 -125.27 124.24 41.21 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 120.97 -1.081 . . . . 0.0 108.669 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 -75.01 148.76 39.6 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.167 -169.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -54.77 132.89 46.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.292 1.62 . . . . 0.0 109.953 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -7.57 5.15 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.446 -1.196 . . . . 0.0 114.395 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -88.17 177.7 6.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -132.95 13.76 4.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.472 0.654 . . . . 0.0 109.853 165.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.89 154.49 21.51 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 1.059 ' HB3' ' NE1' ' A' ' 24' ' ' TRP 0.286 91.7 m95 -120.72 154.29 35.81 Favored 'General case' 0 N--CA 1.399 -2.977 0 C-N-CA 117.766 -1.574 . . . . 0.0 109.715 -165.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.11 167.76 28.17 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.139 1.775 . . . . 0.0 110.952 -170.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -81.48 146.08 56.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.02 160.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -56.23 135.19 68.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 123.227 2.618 . . . . 0.0 110.666 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.433 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 14.2 pt20 -159.53 171.09 20.3 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.236 0.926 . . . . 0.0 111.356 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.04 171.36 44.39 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-O 121.232 0.351 . . . . 0.0 112.972 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.12 147.28 24.55 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.656 -0.908 . . . . 0.0 111.179 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 9' ' ' PRO . 84.1 mt -74.25 123.12 28.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 165.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.32 155.71 91.16 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.9 124.74 15.54 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 N-CA-C 109.451 -1.019 . . . . 0.0 109.451 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.01 -9.81 76.77 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.803 -0.998 . . . . 0.0 114.322 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -70.35 151.71 44.93 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 119.683 1.742 . . . . 0.0 111.045 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.11 161.28 18.96 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 161.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.86 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 122.062 -0.398 . . . . 0.0 111.213 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.98 -35.06 74.14 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.971 -0.456 . . . . 0.0 111.016 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -70.08 -43.77 70.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 120.863 -1.148 . . . . 0.0 109.687 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.99 78.67 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 123.975 0.797 . . . . 0.0 109.557 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.479 ' SD ' HD11 ' A' ' 102' ' ' LEU . 13.3 tmm? -62.54 -48.86 77.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 35.0 m-85 -68.08 -38.3 82.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.87 0.759 . . . . 0.0 111.338 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.4 ttm-85 -60.07 -55.59 32.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.23 -28.52 64.24 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -170.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 13' ' ' ILE . 16.1 tp -54.66 -48.33 72.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 120.442 -1.411 . . . . 0.0 109.699 169.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.412 ' O ' HG21 ' A' ' 115' ' ' THR . 34.6 t80 -60.28 -45.17 94.26 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 117.318 -1.325 . . . . 0.0 109.213 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.97 -31.9 73.36 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.586 1.539 . . . . 0.0 111.652 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -91.67 -49.23 6.39 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.282 0.947 . . . . 0.0 110.06 -171.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.555 HG12 HG23 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -110.92 -10.83 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 124.498 1.119 . . . . 0.0 112.27 -168.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.92 1.09 37.71 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 123.824 0.726 . . . . 0.0 113.918 -173.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -83.23 150.33 26.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.075 1.35 . . . . 0.0 108.682 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.48 168.45 15.63 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.095 0.95 . . . . 0.0 108.731 -175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.49 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 28.4 mtt180 -48.7 -31.87 7.53 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 63' ' ' LYS . 28.9 mmmt -61.78 -31.14 71.32 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.703 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -114.53 23.52 12.67 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 126.728 2.517 . . . . 0.0 108.23 -168.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.26 162.69 33.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 O-C-N 120.439 -1.413 . . . . 0.0 111.127 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.04 138.09 38.47 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 117.845 -1.074 . . . . 0.0 108.206 165.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -74.31 119.66 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' A' ' 101' ' ' LEU . 84.0 mt -98.67 -32.47 11.39 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.649 0.593 . . . . 0.0 110.872 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.5 165.56 35.96 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.5 p -157.3 157.52 34.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.726 1.21 . . . . 0.0 108.738 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.532 HG22 ' HG2' ' A' ' 150' ' ' GLU . 1.7 p -70.64 136.33 49.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.267 1.032 . . . . 0.0 110.633 -174.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -81.98 -37.99 25.81 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.468 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -104.34 153.45 21.03 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.004 1.322 . . . . 0.0 108.139 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -84.24 134.91 34.52 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.026 -1.047 . . . . 0.0 108.425 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -89.31 98.71 11.92 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -97.92 147.64 24.26 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.88 153.63 39.36 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.717 166.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -97.13 143.49 27.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.488 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.13 150.94 83.56 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 123.863 0.727 . . . . 0.0 109.267 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.05 149.19 71.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.692 2.261 . . . . 0.0 109.225 160.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.8 mtpt -67.9 -18.29 64.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -167.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -59.17 -30.56 68.28 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 118.953 -0.546 . . . . 0.0 112.003 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.38 -19.11 21.64 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.222 0.609 . . . . 0.0 111.09 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 81' ' ' LYS . 93.3 t -63.5 136.55 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.15 75.44 1.37 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.079 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -56.3 -23.11 34.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -73.61 -28.18 61.68 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 123.078 0.551 . . . . 0.0 111.911 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.3 t -104.82 164.65 11.63 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.441 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -133.05 136.93 28.41 Favored Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.87 149.79 83.89 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 -16.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.97 136.53 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.104 0.961 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.4 p -88.05 132.29 34.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 -12.54 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.118 0.567 . . . . 0.0 112.004 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.15 -177.69 41.15 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -153.58 158.1 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -105.48 134.91 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 166.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -117.58 130.92 56.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.898 1.279 . . . . 0.0 110.129 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -110.65 136.87 49.08 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -117.83 156.96 27.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -142.25 128.1 19.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.193 1.397 . . . . 0.0 107.748 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.905 HD11 ' SG ' ' A' ' 16' ' ' CYS . 1.2 tp -95.6 127.34 41.55 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.479 HD11 ' SD ' ' A' ' 50' ' ' MET . 5.9 mt -115.84 152.57 33.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.6 tt0 -100.69 134.85 43.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 159.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.526 ' HG ' HG21 ' A' ' 15' ' ' ILE . 1.6 mt -62.64 135.16 57.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 125.51 1.756 . . . . 0.0 109.298 169.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.5 t -88.72 -51.49 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -171.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.1 m -82.81 -17.3 44.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.8 0.727 . . . . 0.0 111.739 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.33 175.22 35.91 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -21.27 2.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.707 2.403 . . . . 0.0 114.301 -165.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.02 -31.24 40.09 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.334 1.454 . . . . 0.0 112.456 174.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.54 19.42 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.847 0.832 . . . . 0.0 112.503 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.555 HG23 HG12 ' A' ' 58' ' ' VAL . 79.0 mt -94.17 135.74 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.51 -1.369 . . . . 0.0 108.385 171.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -134.35 109.11 8.58 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 125.724 1.609 . . . . 0.0 107.855 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.02 9.3 20.04 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 120.99 -1.069 . . . . 0.0 112.651 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 77.04 1.69 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 124.061 1.886 . . . . 0.0 107.777 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 55' ' ' PHE . 2.0 p -73.75 -60.72 2.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.072 170.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.7 m -72.6 168.58 18.34 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.017 168.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.0 m -58.5 -39.2 79.4 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.954 -0.466 . . . . 0.0 110.446 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.17 132.6 62.67 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.38 133.59 50.14 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.587 1.524 . . . . 0.0 109.626 164.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -75.25 -26.76 59.11 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.903 0.858 . . . . 0.0 110.792 173.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -118.86 144.97 46.05 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 120.805 -1.185 . . . . 0.0 108.424 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -86.16 -31.05 22.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.007 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.76 158.95 27.93 Favored Glycine 0 C--N 1.335 0.524 0 O-C-N 120.689 -1.257 . . . . 0.0 111.012 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.73 155.15 42.18 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -150.89 165.59 33.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.337 1.055 . . . . 0.0 108.304 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -112.78 137.93 50.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.45 152.97 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.94 1.296 . . . . 0.0 109.201 -168.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.9 m -59.97 147.47 38.79 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 117.178 -1.391 . . . . 0.0 109.536 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -26.12 66.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -169.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -93.06 -22.93 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.023 -1.048 . . . . 0.0 112.404 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.441 ' N ' ' HD2' ' A' ' 132' ' ' PRO . 87.5 t80 -53.6 -37.79 55.01 Favored Pre-proline 0 CA--C 1.514 -0.415 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.009 173.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 1.021 ' HB3' ' HE3' ' A' ' 24' ' ' TRP . 10.9 Cg_endo -67.54 -37.18 17.6 Favored 'Trans proline' 0 N--CA 1.413 -3.254 0 N-CA-C 117.242 1.978 . . . . 0.0 117.242 -173.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.92 -25.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 112.73 -2.032 . . . . 0.0 109.115 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.02 -32.23 73.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.128 -1.607 . . . . 0.0 113.676 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 -24.82 33.19 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 124.075 0.859 . . . . 0.0 111.5 -168.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 144' ' ' TYR . 2.5 m -86.53 167.08 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 122.008 0.908 . . . . 0.0 111.041 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.18 172.55 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 O-C-N 120.892 -1.13 . . . . 0.0 109.987 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.7 m -51.03 -50.0 59.42 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -169.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -79.34 -30.88 42.92 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.224 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -70.6 -38.44 74.01 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.004 -1.06 . . . . 0.0 110.374 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -51.41 -45.18 62.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.105 0.962 . . . . 0.0 111.866 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -61.35 -47.52 85.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.043 1.464 . . . . 0.0 108.463 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.38 -51.53 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.199 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.408 ' CE2' HG11 ' A' ' 136' ' ' VAL . 6.0 m-30 -63.67 -37.77 88.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.068 0.849 . . . . 0.0 110.834 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -68.02 -38.81 83.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.432 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -58.82 -49.27 78.35 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.614 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.36 -39.14 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.623 1.169 . . . . 0.0 110.244 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -74.17 -55.47 6.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.76 -36.45 74.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.624 0.647 . . . . 0.0 111.574 -174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 151' ' ' PHE . 4.6 tp10 -61.51 -30.82 70.87 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.791 0.836 . . . . 0.0 110.7 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.814 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 0.8 OUTLIER -113.49 -13.41 12.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 0.0 109.798 -172.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.69 71.92 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.684 1.593 . . . . 0.0 110.848 -173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 m -66.24 -33.58 76.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.577 0.751 . . . . 0.0 111.029 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.8 t -68.86 -43.02 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.454 HG22 ' SG ' ' A' ' 16' ' ' CYS . 27.4 t -59.37 -42.24 86.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.587 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmt -55.96 -52.92 62.46 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.079 1.309 . . . . 0.0 109.384 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -68.63 -29.12 67.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.063 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.915 HD12 ' HG2' ' A' ' 163' ' ' PRO . 14.1 tp -69.09 -23.09 63.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.659 1.584 . . . . 0.0 111.596 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.92 -24.85 40.8 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 117.662 -3.149 . . . . 0.0 111.212 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 162' ' ' THR . 29.6 mt-10 -97.97 -31.97 11.9 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 120.234 1.379 . . . . 0.0 114.156 -167.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.476 ' O ' ' HE2' ' A' ' 164' ' ' LYS . 7.8 m-80 -62.89 -18.41 62.94 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.154 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 160' ' ' GLU . 1.5 p 26.03 62.09 0.51 Allowed Pre-proline 0 CA--C 1.436 -3.42 2 C-N-CA 134.367 5.067 . . . . 0.0 97.748 -142.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.915 ' HG2' HD12 ' A' ' 158' ' ' LEU . 13.8 Cg_endo -57.06 120.12 7.84 Favored 'Trans proline' 1 N--CA 1.385 -4.899 1 N-CA-C 100.11 -4.612 . . . . 0.0 100.11 -178.328 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 161' ' ' ASN 0.345 71.2 mmtt . . . . . 1 N--CA 1.378 -4.034 1 CA-C-N 100.314 -7.676 . . . . 0.0 103.665 -155.155 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt -134.88 143.91 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 168.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -72.18 -72.87 0.21 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.704 0.684 . . . . 0.0 112.079 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -162.25 -49.96 0.04 OUTLIER 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.284 1.034 . . . . 0.0 111.669 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -91.46 15.28 12.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.276 1.03 . . . . 0.0 111.945 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.8 0.81 77.87 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.726 1.155 . . . . 0.0 113.787 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -95.39 162.62 13.59 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.349 1.074 . . . . 0.0 108.227 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.4 146.16 24.11 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.049 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 40' ' ' ILE . 44.5 Cg_endo -91.27 131.07 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.603 2.202 . . . . 0.0 111.526 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -128.51 157.97 39.69 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.381 1.472 . . . . 0.0 109.228 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.432 HG13 HD11 ' A' ' 40' ' ' ILE . 16.0 m -134.97 164.17 34.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -153.53 163.53 30.77 Favored Glycine 0 C--N 1.33 0.226 0 O-C-N 121.402 -0.811 . . . . 0.0 112.627 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.07 140.33 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 124.777 1.231 . . . . 0.0 108.582 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.22 137.26 58.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.5 mm -111.44 145.22 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.623 1.101 . . . . 0.0 108.054 169.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 p -120.72 150.32 41.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.632 0.773 . . . . 0.0 111.045 169.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -108.29 168.76 9.08 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.747 1.219 . . . . 0.0 108.191 170.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.28 3.82 6.7 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 119.915 -1.741 . . . . 0.0 113.606 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -88.51 -4.78 58.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.353 1.061 . . . . 0.0 110.892 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.26 13.55 83.17 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.896 -0.947 . . . . 0.0 112.296 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -81.9 147.85 29.08 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.175 1.487 . . . . 0.0 107.668 174.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 m -103.04 149.71 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.777 1.231 . . . . 0.0 108.815 170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.67 142.45 30.76 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.147 0.979 . . . . 0.0 109.026 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -146.08 146.77 31.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.319 1.448 . . . . 0.0 108.617 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.43 166.66 29.42 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.026 1.285 . . . . 0.0 111.82 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -126.8 135.17 50.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.371 1.069 . . . . 0.0 108.828 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -64.96 154.79 36.53 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 109.7 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.91 128.62 38.0 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.89 0.23 90.1 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.415 -1.214 . . . . 0.0 113.962 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -112.23 150.25 31.17 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.474 1.637 . . . . 0.0 111.224 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -96.4 -16.2 21.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.154 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 p -83.98 134.68 34.64 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.277 1.431 . . . . 0.0 109.779 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -92.28 153.58 19.15 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.66 0.784 . . . . 0.0 110.729 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -150.39 156.89 42.35 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.967 1.707 . . . . 0.0 109.361 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.89 139.16 69.53 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.65 129.27 13.91 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.086 2.524 . . . . 0.0 111.455 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 29.6 pt20 -155.43 158.26 38.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.642 0.734 . . . . 0.0 112.598 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.47 -169.74 20.86 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.821 1.677 . . . . 0.0 110.327 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.55 145.99 18.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.43 1.491 . . . . 0.0 110.636 -172.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 11' ' ' VAL . 62.1 mt -79.26 135.51 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 169.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -81.22 156.19 71.72 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.63 121.29 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.07 -2.48 85.47 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.32 -1.267 . . . . 0.0 114.411 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.56 156.05 39.85 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 120.598 2.199 . . . . 0.0 110.286 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -93.08 152.81 19.06 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 168.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.69 80.63 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.302 -0.874 . . . . 0.0 111.837 -172.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.46 -36.43 78.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.61 0.764 . . . . 0.0 110.092 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -68.52 -41.64 79.67 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.04 89.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -60.06 -50.89 71.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.755 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 58.0 m-85 -67.06 -37.35 83.88 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.39 0.995 . . . . 0.0 112.068 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -63.43 -50.3 70.31 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.579 1.536 . . . . 0.0 109.172 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -71.59 -32.71 68.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -170.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 HG21 ' A' ' 58' ' ' VAL . 8.3 tp -53.77 -49.64 67.79 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.634 1.174 . . . . 0.0 110.147 169.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.29 -35.76 81.21 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.423 0.556 . . . . 0.0 110.651 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -70.12 -35.2 73.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.402 -0.809 . . . . 0.0 111.919 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.96 -38.38 5.35 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.553 1.07 . . . . 0.0 113.627 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.514 HG21 HD12 ' A' ' 54' ' ' LEU . 13.3 t -92.62 -31.74 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.196 0.999 . . . . 0.0 108.604 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.34 0.81 88.35 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.928 1.252 . . . . 0.0 112.743 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.8 tp -87.54 153.44 21.4 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.443 1.897 . . . . 0.0 109.615 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -128.74 166.08 19.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.713 1.205 . . . . 0.0 110.529 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 38.8 mtp180 -45.48 -41.43 9.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.228 1.811 . . . . 0.0 113.106 -172.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -67.94 -24.95 65.23 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.245 0.618 . . . . 0.0 111.902 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -102.74 9.71 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.528 0.731 . . . . 0.0 111.186 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -135.5 165.84 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.8 1.64 . . . . 0.0 112.08 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.47 136.3 31.13 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 168.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.5 mt -78.91 115.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 103' ' ' GLN . 78.6 mt -95.87 -31.19 13.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.372 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 154' ' ' VAL . . . -154.21 163.92 39.36 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.28 1.032 . . . . 0.0 108.454 -178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 p -162.03 154.91 20.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 124.488 1.115 . . . . 0.0 108.835 170.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.427 HG22 ' HG3' ' A' ' 150' ' ' GLU . 6.7 p -69.44 132.18 45.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.92 0.866 . . . . 0.0 110.812 -169.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -79.11 -27.44 42.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.248 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.45 151.4 38.61 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.201 2.2 . . . . 0.0 108.556 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.7 m95 -79.59 134.81 36.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 mt -94.94 129.14 42.1 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -133.16 148.41 52.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.88 1.218 . . . . 0.0 108.512 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.04 146.18 29.93 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.433 0.458 . . . . 0.0 109.774 169.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.81 146.23 24.61 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.99 145.75 91.99 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 111.111 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.92 146.99 60.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 N-CA-C 104.982 -2.738 . . . . 0.0 104.982 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.3 mtpt -68.89 -12.61 61.76 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.075 -1.641 . . . . 0.0 113.994 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.43 -31.73 70.68 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.026 0.83 . . . . 0.0 112.81 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.0 mt -91.79 -20.3 21.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.682 0.793 . . . . 0.0 112.03 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 81' ' ' LYS . 90.7 t -65.1 135.81 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -103.16 91.28 4.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.302 1.041 . . . . 0.0 110.071 171.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -68.65 -23.65 64.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.962 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -70.73 -33.87 71.29 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.789 0.435 . . . . 0.0 111.801 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -100.01 158.34 15.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.948 0.899 . . . . 0.0 109.576 -175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -130.63 134.69 26.33 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.434 1.494 . . . . 0.0 109.905 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.45 148.98 91.37 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 O-C-N 122.755 0.871 . . . . 0.0 109.928 -10.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.7 p -78.05 133.81 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.496 0.718 . . . . 0.0 109.37 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.03 128.75 33.65 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.13 -12.09 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 119.03 -0.51 . . . . 0.0 112.022 169.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.25 -178.49 42.49 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -147.3 153.29 39.55 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.31 1.444 . . . . 0.0 109.765 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -108.03 140.2 41.54 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -127.29 143.07 51.3 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.362 1.465 . . . . 0.0 108.694 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.7 ttmm -133.5 117.97 17.78 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -103.1 158.25 16.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -134.0 125.59 28.48 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.329 1.451 . . . . 0.0 107.406 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -89.7 122.08 32.47 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mt -119.42 160.09 22.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.569 ' HB2' HD11 ' A' ' 68' ' ' LEU . 4.1 tt0 -109.42 135.59 50.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 167.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 132.91 54.53 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.64 -53.88 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.5 m -78.44 -30.95 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.126 0.971 . . . . 0.0 112.156 -174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.49 162.26 11.26 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -59.82 -18.44 43.88 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.418 1.487 . . . . 0.0 113.668 -173.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.71 48.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.442 0.697 . . . . 0.0 112.484 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 11.82 3.15 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 72.6 mt -91.43 134.94 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -127.43 -43.06 1.62 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.177 0.591 . . . . 0.0 112.354 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 mtp 66.73 13.38 9.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.664 2.386 . . . . 0.0 114.357 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.66 33.02 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 123.413 1.577 . . . . 0.0 112.423 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -51.47 69.19 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.396 1.478 . . . . 0.0 109.161 169.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 m -73.85 157.23 36.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.721 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -63.53 -36.85 85.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.073 0.463 . . . . 0.0 109.958 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 131.51 45.3 Favored Pre-proline 0 N--CA 1.443 -0.815 0 C-N-CA 125.259 1.424 . . . . 0.0 109.299 169.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.83 147.34 94.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -90.59 -11.66 39.34 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -133.33 152.04 51.9 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.519 1.128 . . . . 0.0 109.868 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -114.11 -2.36 13.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.995 0.918 . . . . 0.0 111.441 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.86 146.09 12.87 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -150.8 138.96 20.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.269 1.428 . . . . 0.0 107.565 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.99 173.79 13.9 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.342 1.457 . . . . 0.0 109.085 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -119.79 142.21 48.79 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 m -146.92 164.05 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.495 . . . . 0.0 110.437 -169.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.3 m -69.67 153.05 43.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 169.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -31.65 72.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -169.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -85.99 -27.56 24.77 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.316 1.416 . . . . 0.0 112.864 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -54.84 -49.88 89.26 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.563 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.27 -29.78 73.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.153 1.805 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.69 -31.9 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.224 -0.923 . . . . 0.0 110.136 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -66.6 -27.16 67.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.209 -0.932 . . . . 0.0 111.569 176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -82.11 -23.94 35.41 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.09 159.81 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 112.313 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.78 179.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.074 1.749 . . . . 0.0 110.769 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.4 m -55.17 -53.44 55.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.405 1.882 . . . . 0.0 113.293 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.62 -41.86 78.92 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.803 -0.561 . . . . 0.0 110.318 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -72.63 -43.44 63.23 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 117.784 -1.103 . . . . 0.0 110.109 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -59.55 -34.36 72.57 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.486 1.494 . . . . 0.0 111.8 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.92 -45.53 88.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.309 0.959 . . . . 0.0 111.314 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.27 -47.5 92.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -69.14 -34.95 75.82 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.234 1.014 . . . . 0.0 110.054 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -66.68 -39.24 88.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.655 1.116 . . . . 0.0 109.927 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.34 -46.6 89.36 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.764 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.6 t -56.88 -41.74 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 120.0 1.273 . . . . 0.0 110.752 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.9 mmt -70.69 -53.83 14.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.02 -33.88 76.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.066 1.303 . . . . 0.0 111.915 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HG3' HG22 ' A' ' 71' ' ' THR . 3.2 mm-40 -53.45 -40.52 65.29 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.854 1.262 . . . . 0.0 111.214 175.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -110.04 -12.53 14.52 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.006 0.922 . . . . 0.0 112.259 -170.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.44 75.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.811 1.644 . . . . 0.0 110.488 -170.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.3 m -69.07 -32.76 72.45 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.444 0.698 . . . . 0.0 109.923 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 69' ' ' ALA . 23.5 t -68.24 -45.24 83.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.99 -34.82 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.544 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.4 mmt -61.66 -57.57 11.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.833 1.197 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -70.1 -26.05 63.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.782 1.233 . . . . 0.0 111.004 -173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 68' ' ' LEU . 1.2 tm? -58.33 -35.39 71.82 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 128.714 2.806 . . . . 0.0 111.67 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -71.2 -39.54 71.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.883 0.765 . . . . 0.0 110.67 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -80.27 -28.77 38.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.482 0.713 . . . . 0.0 112.061 -169.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -114.31 -10.96 12.63 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.274 0.63 . . . . 0.0 112.29 -171.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.1 p 48.63 26.65 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.888 2.075 . . . . 0.0 114.327 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . 0.366 0.1 OUTLIER 12.95 49.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 1 C-N-CA 129.588 6.859 . . . . 0.0 118.815 -167.983 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.427 2.291 . . . . 0.0 111.441 174.688 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptm . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.16 143.19 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.53 -68.85 0.36 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.208 0.603 . . . . 0.0 111.281 -171.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -163.9 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.096 0.958 . . . . 0.0 112.22 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -94.97 17.15 14.43 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.698 1.199 . . . . 0.0 112.858 -169.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.04 7.42 65.88 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.276 0.941 . . . . 0.0 113.787 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.26 157.95 16.03 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.19 149.3 72.27 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.4 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' A' ' 40' ' ' ILE . 69.3 Cg_endo -84.56 138.92 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.208 1.938 . . . . 0.0 111.242 -173.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -140.8 151.97 44.81 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.367 1.067 . . . . 0.0 110.339 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 40' ' ' ILE . 35.3 m -134.89 153.63 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.717 0.807 . . . . 0.0 109.66 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.88 157.39 24.75 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -123.85 141.99 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.426 1.09 . . . . 0.0 108.568 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.07 137.73 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -115.95 132.3 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 22' ' ' VAL . 70.7 m -122.93 144.31 49.32 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -96.63 173.57 7.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.848 1.259 . . . . 0.0 108.666 173.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.76 9.96 5.58 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.833 -1.167 . . . . 0.0 113.59 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -99.09 0.22 43.17 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.693 0.797 . . . . 0.0 111.175 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.44 20.03 78.96 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.314 -0.714 . . . . 0.0 112.169 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -92.56 142.82 26.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.799 1.299 . . . . 0.0 107.786 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -113.39 143.12 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.013 1.725 . . . . 0.0 107.295 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -81.31 147.32 29.94 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.726 0.694 . . . . 0.0 109.465 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.0 t90 -151.86 140.48 20.75 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -171.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.46 149.76 51.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.771 1.169 . . . . 0.0 112.565 -169.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -98.44 120.23 38.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.252 1.821 . . . . 0.0 106.699 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -82.91 143.93 30.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.724 1.602 . . . . 0.0 109.616 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -58.45 132.79 54.76 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.426 0.69 . . . . 0.0 109.82 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.85 -9.71 16.41 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.925 1.25 . . . . 0.0 114.507 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -90.88 -39.79 12.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.556 1.678 . . . . 0.0 111.368 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.1 m80 57.5 31.66 20.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.162 0.985 . . . . 0.0 110.974 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -129.17 152.36 48.84 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.729 1.612 . . . . 0.0 108.337 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -104.09 146.62 28.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.267 0.627 . . . . 0.0 110.933 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -156.92 163.2 39.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.801 1.241 . . . . 0.0 110.808 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.16 144.5 44.19 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 118.014 -0.994 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.4 131.87 45.62 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.423 2.749 . . . . 0.0 112.475 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -158.2 167.81 28.78 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.643 0.656 . . . . 0.0 112.484 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.67 167.2 40.32 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.27 0.462 . . . . 0.0 112.207 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.72 146.47 32.61 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 9' ' ' PRO . 66.2 mt -74.82 127.28 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -78.41 152.57 78.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.12 120.13 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.7 1.6 . . . . 0.0 110.176 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.74 67.99 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.233 -1.315 . . . . 0.0 113.991 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.45 148.58 48.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 120.232 2.016 . . . . 0.0 110.231 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.3 m -84.27 153.76 23.37 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.11 -38.67 76.91 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.778 -0.576 . . . . 0.0 111.909 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.91 -34.13 74.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.733 0.813 . . . . 0.0 110.248 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -73.12 -36.12 66.67 Favored 'General case' 0 C--N 1.337 0.045 0 O-C-N 120.89 -1.131 . . . . 0.0 109.908 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.92 90.84 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.8 ttp -58.82 -49.23 78.47 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.999 0.818 . . . . 0.0 109.036 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 49.8 m-85 -66.12 -46.24 78.26 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.679 1.127 . . . . 0.0 111.584 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -67.6 -45.31 75.84 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.277 0.944 . . . . 0.0 110.17 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -69.49 -34.54 74.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.7 tp -57.0 -44.86 83.17 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.848 1.204 . . . . 0.0 110.323 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -61.27 -41.01 96.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.552 0.614 . . . . 0.0 110.212 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.92 -21.53 65.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.312 0.645 . . . . 0.0 112.232 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.39 -60.85 1.63 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.609 1.164 . . . . 0.0 109.629 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 m -112.44 0.69 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.501 1.52 . . . . 0.0 111.972 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.31 48.4 Favored Glycine 0 CA--C 1.536 1.405 0 O-C-N 120.376 -1.452 . . . . 0.0 113.897 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -82.41 144.79 30.25 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.416 1.486 . . . . 0.0 110.2 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -123.98 165.5 17.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.34 1.056 . . . . 0.0 109.633 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 50.4 mtt85 -47.73 -35.55 9.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.242 1.817 . . . . 0.0 112.495 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.27 -22.34 66.84 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.403 -171.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -116.62 22.59 12.62 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.1 164.99 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.758 -1.214 . . . . 0.0 111.869 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 140.72 33.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 116.982 -1.485 . . . . 0.0 107.962 169.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.44 116.28 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 103' ' ' GLN . 97.9 mt -90.5 -36.01 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.229 174.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.98 32.54 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.016 0.926 . . . . 0.0 110.456 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -151.66 149.08 28.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.079 1.752 . . . . 0.0 109.42 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 150' ' ' GLU . 3.3 p -70.81 139.88 51.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.748 1.158 . . . . 0.0 109.786 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -93.2 -29.22 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.332 1.053 . . . . 0.0 109.862 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -110.48 149.61 30.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.471 2.308 . . . . 0.0 107.864 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 65.4 m95 -82.76 143.03 31.14 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -87.78 91.19 8.66 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 139.35 52.31 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -137.25 153.6 50.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.579 0.752 . . . . 0.0 110.209 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -131.34 138.04 49.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.51 1.924 . . . . 0.0 108.151 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.8 mt -78.99 146.9 69.01 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.828 0.851 . . . . 0.0 110.694 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.1 145.94 68.78 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 N-CA-C 104.601 -2.884 . . . . 0.0 104.601 166.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.4 mtpt -68.38 -13.27 62.17 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.031 -1.668 . . . . 0.0 113.835 -169.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -58.81 -30.64 67.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.953 0.797 . . . . 0.0 113.071 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.45 -20.29 21.15 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 112.134 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 81' ' ' LYS . 59.6 t -65.24 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -102.83 89.57 3.51 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.959 0.904 . . . . 0.0 109.76 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -67.19 -24.84 65.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.716 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.34 -33.84 71.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.798 0.439 . . . . 0.0 111.747 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -99.36 159.33 15.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.042 0.937 . . . . 0.0 109.398 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -130.79 134.44 26.0 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 125.152 1.381 . . . . 0.0 109.466 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.47 148.23 89.67 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.719 0.852 . . . . 0.0 110.428 -10.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -77.76 139.08 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.675 0.79 . . . . 0.0 109.613 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.1 p -90.43 120.58 31.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.87 0.868 . . . . 0.0 108.89 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -13.09 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 118.848 0.749 . . . . 0.0 112.751 173.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 -171.47 34.19 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -157.9 167.71 29.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.762 1.225 . . . . 0.0 109.552 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -115.58 127.6 55.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -114.34 129.0 56.63 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 10.0 ttmm -111.74 139.13 47.47 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -123.19 153.34 40.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.97 128.48 24.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 tp -94.59 122.5 37.25 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.08 156.83 24.46 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.659 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.1 tt0 -106.73 129.7 54.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 167.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.76 139.69 58.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.1 1.36 . . . . 0.0 108.52 171.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.99 -44.99 14.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.043 0.383 . . . . 0.0 110.698 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.9 m -87.05 -16.06 36.75 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.571 0.748 . . . . 0.0 111.152 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.56 -167.79 24.82 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.451 ' HB2' ' HE1' ' A' ' 126' ' ' TRP . 1.1 p-10 -60.92 -17.66 52.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.485 1.514 . . . . 0.0 114.698 -171.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.24 47.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.116 0.966 . . . . 0.0 111.774 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.49 50.96 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.829 1.252 . . . . 0.0 110.527 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.9 mt -129.93 129.82 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -113.22 161.56 17.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.391 2.276 . . . . 0.0 106.66 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mmt -126.48 -9.2 6.29 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.029 1.332 . . . . 0.0 111.872 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.35 84.13 2.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 123.718 1.723 . . . . 0.0 107.38 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 -61.12 2.11 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.348 2.659 . . . . 0.0 107.59 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 m -73.22 173.98 8.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.726 1.611 . . . . 0.0 109.009 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m -59.94 -36.81 77.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.496 -0.752 . . . . 0.0 109.807 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.01 137.05 57.33 Favored Pre-proline 0 N--CA 1.444 -0.772 0 C-N-CA 125.928 1.691 . . . . 0.0 109.133 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.02 133.54 47.87 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 N-CA-C 107.212 -1.88 . . . . 0.0 107.212 168.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -85.07 -35.73 21.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -110.98 145.86 37.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.79 -29.24 25.58 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.806 0.842 . . . . 0.0 110.41 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.25 169.49 41.03 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.47 159.99 44.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.772 0.786 . . . . 0.0 109.655 169.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -143.95 169.35 17.97 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.827 1.251 . . . . 0.0 108.888 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.451 ' HE1' ' HB2' ' A' ' 108' ' ' ASP . 75.4 m95 -111.99 139.43 47.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.58 152.85 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.002 1.321 . . . . 0.0 110.648 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -62.94 143.78 57.39 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 -32.31 44.73 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -169.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.99 -18.22 31.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.553 1.07 . . . . 0.0 112.947 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.38 -46.22 70.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.422 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.35 -29.39 85.73 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 122.774 2.026 . . . . 0.0 112.017 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.4 t -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.899 1.279 . . . . 0.0 109.924 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.263 -0.898 . . . . 0.0 111.443 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -94.31 -21.62 18.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -168.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.58 154.01 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 119.031 0.832 . . . . 0.0 110.491 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -68.58 178.42 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.052 1.341 . . . . 0.0 110.478 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.9 m -55.73 -47.15 77.42 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.868 1.667 . . . . 0.0 113.236 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -71.73 -45.73 60.83 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.987 -0.446 . . . . 0.0 110.451 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -70.57 -39.95 73.59 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 110.679 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -59.71 -31.44 69.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.745 1.157 . . . . 0.0 112.173 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.19 -43.21 95.8 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.495 1.043 . . . . 0.0 111.05 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.4 t -62.71 -50.3 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -63.76 -38.41 90.99 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.919 0.782 . . . . 0.0 109.644 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -65.98 -41.15 91.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.696 1.134 . . . . 0.0 110.243 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -59.6 -49.38 78.0 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 119.037 0.835 . . . . 0.0 109.615 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.29 -37.59 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.736 1.214 . . . . 0.0 110.977 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.3 mmt -74.28 -54.83 6.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -59.85 -34.14 72.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.42 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 71' ' ' THR . 5.5 tp10 -57.71 -42.11 83.12 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 118.883 0.765 . . . . 0.0 110.763 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.77 -10.24 19.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.668 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.34 67.48 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.354 1.462 . . . . 0.0 110.559 -171.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 m -68.13 -32.72 73.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.386 0.675 . . . . 0.0 110.548 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.64 -42.81 62.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.4 t -57.29 -38.99 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 117.434 -1.27 . . . . 0.0 110.175 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -62.06 -51.68 66.97 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.472 1.487 . . . . 0.0 111.092 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.4 m -77.23 -24.03 51.27 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.812 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 tp -55.8 -48.66 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.138 1.775 . . . . 0.0 109.359 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -60.27 -33.99 73.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.535 0.734 . . . . 0.0 111.601 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -85.42 -17.87 35.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.819 1.248 . . . . 0.0 111.731 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -96.71 -46.0 6.46 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.283 1.033 . . . . 0.0 109.101 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.448 ' HB ' ' CD ' ' A' ' 163' ' ' PRO 0.256 46.8 p -88.83 -162.08 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.448 ' CD ' ' HB ' ' A' ' 162' ' ' THR . 2.0 Cg_endo -106.52 -179.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.697 2.931 . . . . 0.0 111.65 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.558 179.406 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.315 4.9 ppp? . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.767 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 64.81 129.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.71 2.404 . . . . 0.0 109.833 -169.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.31 -66.7 0.53 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.43 -51.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.05 17.28 14.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.476 1.11 . . . . 0.0 113.385 -169.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.35 6.56 62.71 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.12 0.866 . . . . 0.0 113.658 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -103.84 159.44 15.64 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 118.682 1.241 . . . . 0.0 107.731 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 149.86 64.38 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.25 -1.357 . . . . 0.0 107.834 170.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -91.41 141.52 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.899 1.732 . . . . 0.0 109.425 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -130.1 160.18 34.53 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 121.253 -0.904 . . . . 0.0 110.455 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.23 167.37 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -159.0 151.9 22.89 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -128.88 142.88 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.444 1.098 . . . . 0.0 108.586 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.77 136.37 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.3 mm -120.37 132.9 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 169.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' A' ' 22' ' ' VAL . 43.3 m -124.2 150.84 44.77 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.492 0.587 . . . . 0.0 111.37 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -109.17 173.41 6.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.409 1.484 . . . . 0.0 108.816 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -74.94 0.17 16.65 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.11 -1.619 . . . . 0.0 113.002 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -88.68 -3.47 58.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 111.419 170.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.63 18.63 77.36 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 118.835 0.743 . . . . 0.0 111.48 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -86.13 139.73 30.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.511 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.0 m -108.79 143.82 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 125.514 1.526 . . . . 0.0 107.53 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -79.65 143.07 34.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -146.22 144.18 29.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.03 157.17 46.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.044 0.838 . . . . 0.0 111.557 -169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -111.53 119.07 37.5 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -72.48 151.31 42.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 120.297 1.408 . . . . 0.0 110.261 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.35 148.24 47.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.795 0.838 . . . . 0.0 109.633 -175.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.82 3.36 50.12 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.7 -1.056 . . . . 0.0 113.569 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.81 159.93 40.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.161 1.481 . . . . 0.0 110.577 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -94.11 -22.15 18.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 m -73.52 154.47 39.86 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.145 0.978 . . . . 0.0 111.63 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -106.45 152.57 23.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.222 1.009 . . . . 0.0 109.978 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -148.73 156.8 42.86 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.943 1.297 . . . . 0.0 110.778 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -80.62 140.64 51.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.35 137.7 82.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.768 1.645 . . . . 0.0 111.118 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -157.18 171.01 21.2 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.214 0.915 . . . . 0.0 112.198 -170.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.05 -168.79 34.01 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -109.17 150.89 17.2 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.411 1.482 . . . . 0.0 109.943 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.29 119.57 34.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -77.1 159.03 79.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.61 127.9 28.12 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.664 1.576 . . . . 0.0 110.246 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.18 -5.47 79.98 Favored Glycine 0 CA--C 1.536 1.36 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.395 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -76.55 148.11 37.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.158 1.979 . . . . 0.0 109.471 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.8 m -90.07 157.91 17.57 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.33 77.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.079 0.854 . . . . 0.0 111.583 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.26 -37.68 78.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.734 0.814 . . . . 0.0 110.216 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -66.49 -41.45 88.91 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.1 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -39.62 85.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -56.32 -50.86 70.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.612 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -66.6 -39.14 88.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.451 1.023 . . . . 0.0 110.566 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -64.76 -47.0 79.79 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.453 1.024 . . . . 0.0 109.965 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -71.81 -31.99 67.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.6 -49.33 73.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.3 -40.92 95.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.008 0.822 . . . . 0.0 110.824 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.6 -26.66 68.5 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.728 -0.607 . . . . 0.0 112.222 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -94.15 -57.67 2.45 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.438 1.095 . . . . 0.0 110.451 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.72 0.64 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.569 1.547 . . . . 0.0 112.383 -169.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.48 4.78 32.99 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.758 1.163 . . . . 0.0 113.702 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -84.1 146.58 27.82 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.303 1.841 . . . . 0.0 109.436 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 m -125.03 166.23 16.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.991 0.917 . . . . 0.0 109.76 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -52.93 -32.64 46.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.701 1.6 . . . . 0.0 112.476 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.37 -26.86 68.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 118.891 -0.576 . . . . 0.0 112.375 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -111.91 22.2 15.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.845 0.831 . . . . 0.0 112.209 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.18 165.06 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.707 -1.245 . . . . 0.0 111.7 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 140.86 40.32 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.6 mt -76.4 119.22 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 103' ' ' GLN . 92.7 mt -93.69 -35.34 12.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.81 170.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.578 0.751 . . . . 0.0 110.621 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 p -160.88 153.32 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.744 1.618 . . . . 0.0 109.897 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.08 139.06 54.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.783 0.801 . . . . 0.0 110.742 -170.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -94.62 -33.67 12.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.164 1.386 . . . . 0.0 109.046 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -110.72 144.02 40.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.969 2.107 . . . . 0.0 107.327 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -85.51 141.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.39 72.03 7.04 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -71.6 154.29 41.52 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.36 151.08 50.15 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.503 1.121 . . . . 0.0 108.879 -169.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -130.48 132.18 45.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.696 1.598 . . . . 0.0 107.581 174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.8 mt -80.9 141.77 51.46 Favored Pre-proline 0 N--CA 1.451 -0.392 0 C-N-CA 124.378 1.071 . . . . 0.0 111.995 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.84 149.95 67.07 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 N-CA-C 104.762 -2.822 . . . . 0.0 104.762 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.9 mtpt -68.99 -13.56 62.52 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 119.84 -1.788 . . . . 0.0 114.056 -169.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -62.37 -31.02 71.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.113 0.869 . . . . 0.0 112.558 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -93.73 -18.18 22.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.236 1.014 . . . . 0.0 112.009 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 81' ' ' LYS . 95.6 t -64.71 135.02 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -98.1 90.5 4.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.794 0.838 . . . . 0.0 109.503 173.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -71.52 -20.95 61.97 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.906 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.23 -30.12 57.8 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.885 0.474 . . . . 0.0 112.196 -171.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.27 160.14 14.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.354 1.061 . . . . 0.0 109.234 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -130.96 133.66 25.03 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 125.783 1.633 . . . . 0.0 108.319 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.32 156.79 94.14 Favored 'Cis proline' 0 CA--C 1.539 0.757 0 O-C-N 122.805 0.897 . . . . 0.0 111.179 -10.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.0 t -74.16 140.33 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.941 0.897 . . . . 0.0 109.741 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 p -93.24 122.61 35.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.119 0.967 . . . . 0.0 108.97 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.15 -12.09 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 119.297 0.953 . . . . 0.0 113.213 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.51 -173.62 43.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -156.31 157.24 35.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.343 1.057 . . . . 0.0 110.173 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -102.72 128.21 49.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -124.58 129.15 50.03 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.531 1.06 . . . . 0.0 111.509 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -88.42 157.37 18.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.626 1.17 . . . . 0.0 108.558 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.494 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 82.5 m95 -133.8 147.26 51.23 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 168.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -131.19 134.69 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.938 1.295 . . . . 0.0 107.924 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.5 tp -96.63 118.45 33.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.79 140.26 49.06 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 169.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.6 tt0 -89.11 133.3 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 168.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.26 139.71 58.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.397 1.079 . . . . 0.0 109.069 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.41 -48.74 13.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 118.238 0.472 . . . . 0.0 110.041 -171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.7 m -86.21 -18.44 32.14 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.883 0.473 . . . . 0.0 111.11 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.73 -169.0 22.92 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -55.73 -23.47 29.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.264 1.826 . . . . 0.0 113.345 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.39 51.3 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -89.85 14.52 11.81 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -172.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.78 138.51 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -124.07 131.6 53.57 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.57 1.948 . . . . 0.0 107.637 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.3 mmt -98.56 -7.65 27.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.303 1.041 . . . . 0.0 112.497 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.69 75.29 0.98 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.436 1.895 . . . . 0.0 108.027 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -75.56 -65.61 0.88 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.978 2.111 . . . . 0.0 108.963 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.1 m -80.29 177.73 8.77 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.594 1.557 . . . . 0.0 109.483 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.4 m -56.57 -35.1 67.79 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.979 0.512 . . . . 0.0 110.361 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 128.94 49.37 Favored Pre-proline 0 N--CA 1.444 -0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 107.87 169.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.92 122.95 10.37 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 169.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.74 -18.49 62.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -116.76 140.18 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.649 0.78 . . . . 0.0 110.374 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.69 -26.98 40.79 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 110.732 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.44 169.29 41.5 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 123.894 0.759 . . . . 0.0 111.315 -174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 160.63 43.24 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.768 0.827 . . . . 0.0 109.168 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -152.11 165.73 33.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.976 0.91 . . . . 0.0 108.954 173.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -110.65 133.86 52.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.24 152.85 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.838 1.255 . . . . 0.0 111.17 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.4 m -60.47 144.08 52.0 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.94 0.791 . . . . 0.0 109.628 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.15 -34.49 60.54 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -87.0 -7.93 57.67 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.974 -1.079 . . . . 0.0 113.486 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -75.52 -49.39 3.77 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.918 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.31 -21.6 72.23 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 123.044 2.123 . . . . 0.0 113.282 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.8 -35.92 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.714 1.206 . . . . 0.0 109.167 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -68.97 -25.56 64.6 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.333 -0.855 . . . . 0.0 111.621 -169.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -83.36 -24.75 31.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.55 165.43 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 118.968 0.803 . . . . 0.0 111.07 -175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.36 175.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 110.166 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -57.42 -44.15 84.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.503 1.521 . . . . 0.0 113.875 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -70.3 -41.93 72.7 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.474 -0.766 . . . . 0.0 110.827 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -74.93 -35.0 62.18 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.233 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -49.33 -46.02 46.26 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.122 0.969 . . . . 0.0 110.462 170.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.28 -43.04 96.05 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.568 0.622 . . . . 0.0 111.089 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.86 -50.2 80.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -66.07 -34.75 78.77 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.055 0.942 . . . . 0.0 110.607 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -67.57 -41.31 84.36 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.808 1.186 . . . . 0.0 109.962 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.93 -43.54 98.47 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.299 0.954 . . . . 0.0 110.873 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 99' ' ' TRP . 89.8 t -57.74 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.466 1.106 . . . . 0.0 111.542 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.1 mmt -84.33 -59.83 2.27 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -56.71 -34.45 67.47 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.362 1.065 . . . . 0.0 112.178 -173.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -57.61 -38.47 75.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.807 0.843 . . . . 0.0 110.727 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -109.78 -10.62 14.77 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 112.817 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.4 -38.99 72.27 Favored 'General case' 0 C--O 1.228 -0.031 0 C-N-CA 125.658 1.583 . . . . 0.0 110.545 -172.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.1 m -68.2 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.64 0.776 . . . . 0.0 110.443 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.7 -45.83 72.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.38 -46.32 92.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 117.627 -1.178 . . . . 0.0 110.236 -175.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -43.48 85.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 121.435 1.925 . . . . 0.0 110.317 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.4 t -70.84 -32.13 69.07 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.218 -0.301 . . . . 0.0 111.124 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.0 tp -62.44 -43.28 99.19 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 126.198 1.799 . . . . 0.0 109.568 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -65.38 -43.75 89.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.667 0.387 . . . . 0.0 110.924 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.77 -35.75 70.16 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.508 0.723 . . . . 0.0 111.806 -169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -89.77 -29.87 18.38 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.101 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.321 14.1 t 40.76 60.92 7.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 -169.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.48 177.09 5.74 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.377 2.718 . . . . 0.0 112.329 -168.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.138 179.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ttp . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 67.5 135.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 126.975 2.11 . . . . 0.0 109.697 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.93 -68.49 0.38 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.63 0.772 . . . . 0.0 110.192 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -164.14 -49.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.964 0.906 . . . . 0.0 113.23 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.2 17.13 14.81 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.688 1.195 . . . . 0.0 113.233 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.11 10.66 60.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.902 0.763 . . . . 0.0 113.38 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -101.09 155.04 18.22 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.53 31.42 Favored Pre-proline 0 N--CA 1.468 0.461 0 CA-C-O 117.534 -1.222 . . . . 0.0 109.354 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.76 137.68 16.24 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.469 1.446 . . . . 0.0 110.455 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -142.62 157.18 44.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.122 0.969 . . . . 0.0 109.291 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.25 161.2 35.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 121.267 -0.896 . . . . 0.0 109.669 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.9 163.0 28.35 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.694 -0.563 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -121.65 143.31 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 124.522 1.129 . . . . 0.0 108.393 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.82 136.8 59.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -116.95 133.71 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 168.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.7 p -125.64 154.02 42.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.843 0.747 . . . . 0.0 111.576 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -104.23 175.16 5.58 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.002 1.321 . . . . 0.0 108.777 172.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 4.83 8.85 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.237 -1.54 . . . . 0.0 113.267 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -90.94 -2.54 57.7 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.435 1.094 . . . . 0.0 111.416 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.49 19.98 78.07 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.56 0.618 . . . . 0.0 111.848 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -89.0 144.06 26.42 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.0 m -115.2 150.02 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.498 1.519 . . . . 0.0 109.161 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 42.8 ttm -65.27 139.75 58.64 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.708 0.803 . . . . 0.0 108.964 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -142.88 136.92 29.15 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.01 154.57 51.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.712 1.142 . . . . 0.0 111.575 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -114.92 123.23 48.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -76.99 147.85 36.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 121.74 2.064 . . . . 0.0 110.681 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.63 129.67 43.07 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.83 0.08 87.56 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.583 -1.12 . . . . 0.0 113.86 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -110.96 164.42 12.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.216 1.508 . . . . 0.0 110.397 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -101.38 -24.57 14.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.228 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -80.36 159.16 25.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.783 1.233 . . . . 0.0 111.796 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -112.3 155.77 23.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.239 1.015 . . . . 0.0 111.674 -176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -160.58 164.26 32.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.0 1.72 . . . . 0.0 110.936 -173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -86.48 149.12 48.38 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.72 130.84 38.89 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.758 2.306 . . . . 0.0 111.951 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.67 161.5 34.94 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.955 0.798 . . . . 0.0 112.218 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.71 171.58 44.52 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.222 0.439 . . . . 0.0 113.534 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.56 152.75 36.0 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.843 1.211 . . . . 0.0 111.755 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.84 130.38 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -77.22 157.99 80.17 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.29 123.55 12.68 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.98 -6.36 83.6 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.709 -1.051 . . . . 0.0 114.593 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -71.39 156.15 39.82 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 120.115 1.958 . . . . 0.0 109.439 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 89.0 p -91.94 166.95 12.45 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.0 81.34 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 121.782 -0.574 . . . . 0.0 110.815 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.22 -36.5 66.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.247 0.619 . . . . 0.0 110.582 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.01 -37.25 72.64 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.998 -1.064 . . . . 0.0 110.365 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.42 80.47 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.418 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.3 tmm? -65.62 -51.44 59.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.155 -0.926 . . . . 0.0 109.14 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -66.82 -31.62 72.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.41 1.459 . . . . 0.0 111.839 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -61.07 -52.03 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.411 1.005 . . . . 0.0 108.925 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -71.47 -27.26 63.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.562 0.619 . . . . 0.0 109.962 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.73 -43.88 90.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.928 -1.107 . . . . 0.0 109.388 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -70.45 -49.07 52.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.977 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -67.47 -28.94 68.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.656 1.117 . . . . 0.0 112.608 -172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -96.16 -52.51 3.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.162 0.985 . . . . 0.0 110.657 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.05 -29.93 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.543 1.137 . . . . 0.0 110.899 -168.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.79 0.3 84.44 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.447 1.023 . . . . 0.0 112.377 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.9 tp -78.66 154.15 30.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.172 1.789 . . . . 0.0 109.162 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -132.1 163.98 27.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 109.941 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -39.02 -41.78 0.81 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.9 2.48 . . . . 0.0 112.887 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -63.49 -29.23 70.53 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.77 0.828 . . . . 0.0 112.064 -170.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.5 23.36 13.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.575 0.702 . . . . 0.0 112.185 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.57 165.32 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 O-C-N 120.729 -1.232 . . . . 0.0 112.362 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.57 130.34 27.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.854 168.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mt -69.13 117.26 11.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 103' ' ' GLN . 87.1 mt -95.92 -32.84 12.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.502 173.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -154.81 162.78 40.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.671 0.788 . . . . 0.0 109.267 -174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -159.19 155.05 26.42 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.888 1.275 . . . . 0.0 109.735 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.637 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -69.27 138.77 54.17 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.587 0.708 . . . . 0.0 110.525 -169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mtt-85 -86.9 -28.41 22.82 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.56 1.144 . . . . 0.0 109.801 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -119.97 149.67 41.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.394 2.278 . . . . 0.0 108.069 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -78.3 135.77 37.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.61 0.641 . . . . 0.0 109.489 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.3 mt -90.14 89.32 7.62 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -90.01 146.61 24.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -148.59 145.75 27.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 169.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 139.3 30.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.71 150.46 39.68 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.787 0.835 . . . . 0.0 109.302 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.8 Cg_endo -72.24 158.14 52.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.219 3.28 . . . . 0.0 110.944 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -67.17 -19.37 65.57 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.82 -1.175 . . . . 0.0 112.941 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.84 -30.45 70.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.017 0.826 . . . . 0.0 112.888 170.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 80' ' ' PRO . 51.2 mt -93.45 -14.19 27.02 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.182 0.993 . . . . 0.0 112.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.4 t -67.04 133.66 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 mmt-85 -94.6 90.75 6.26 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.769 0.795 . . . . 0.0 109.628 174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -71.43 -21.9 61.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.497 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.16 -13.26 59.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.743 0.817 . . . . 0.0 112.781 -170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -121.29 159.86 25.13 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.264 1.025 . . . . 0.0 109.986 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -127.74 131.54 23.87 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 125.522 1.529 . . . . 0.0 109.938 -173.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.19 149.45 93.15 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 O-C-N 122.741 0.864 . . . . 0.0 110.689 -10.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -72.01 141.46 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.067 0.947 . . . . 0.0 109.969 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.3 p -94.91 137.17 34.32 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.658 0.783 . . . . 0.0 110.762 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.61 -14.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 169.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.39 179.9 35.6 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.54 157.51 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.456 1.502 . . . . 0.0 108.589 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.92 128.66 56.53 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 170.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -113.3 131.57 55.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.935 0.789 . . . . 0.0 109.652 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -110.74 125.49 53.58 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -108.23 154.41 21.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 84.5 m-85 -135.53 127.12 28.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 19.7 tp -90.43 120.19 31.34 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 169.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.8 131.41 56.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.9 tt0 -86.79 134.55 33.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.49 141.81 58.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.98 1.312 . . . . 0.0 109.014 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.28 -51.8 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.57 0.623 . . . . 0.0 109.826 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 m -83.76 -19.82 34.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.111 0.564 . . . . 0.0 111.742 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.44 -169.12 23.36 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -18.38 47.52 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.584 1.554 . . . . 0.0 114.157 -169.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.69 -31.73 48.99 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.041 . . . . 0.0 112.902 172.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.92 17.62 10.35 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 63.3 mt -94.9 134.53 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -120.34 -52.73 2.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.327 0.651 . . . . 0.0 112.252 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 70.56 7.77 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.887 2.475 . . . . 0.0 114.884 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -153.79 78.46 1.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 123.988 1.851 . . . . 0.0 109.616 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -59.73 2.59 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.12 -2.309 . . . . 0.0 107.997 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -67.97 165.11 18.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.19 1.396 . . . . 0.0 109.498 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -62.77 -33.31 74.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.973 0.509 . . . . 0.0 110.12 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.5 129.94 51.2 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 124.91 1.284 . . . . 0.0 110.2 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -65.58 143.84 76.63 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.083 1.855 . . . . 0.0 108.338 168.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -83.18 -17.53 42.54 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.021 -0.424 . . . . 0.0 111.308 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -118.48 140.69 49.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.136 0.88 . . . . 0.0 110.85 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.31 -29.74 57.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.159 1.384 . . . . 0.0 110.303 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.72 164.6 38.2 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.57 158.15 43.91 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 169.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.61 167.99 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -107.38 136.97 46.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 154.85 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.813 1.245 . . . . 0.0 110.126 -171.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -61.4 144.44 54.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.215 0.916 . . . . 0.0 109.403 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -27.39 57.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -88.61 -16.45 32.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.047 1.294 . . . . 0.0 112.985 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -60.85 -50.41 85.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.428 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.2 -25.85 42.77 Favored 'Trans proline' 0 C--N 1.35 0.638 0 CA-C-N 121.985 1.745 . . . . 0.0 112.65 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.24 -42.3 95.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.586 -0.696 . . . . 0.0 109.237 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -69.86 -7.8 43.19 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.605 -1.309 . . . . 0.0 114.227 -178.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.08 -28.21 39.16 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.147 0.885 . . . . 0.0 111.721 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 m -98.1 160.26 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.14 163.66 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.074 0.95 . . . . 0.0 108.88 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.1 m -54.21 -45.67 72.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -70.24 -34.52 72.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.993 1.27 . . . . 0.0 111.238 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -75.36 -44.6 44.18 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.896 -0.503 . . . . 0.0 109.936 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -48.04 -40.77 23.94 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.982 1.313 . . . . 0.0 112.752 173.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.47 -37.67 83.26 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.111 0.869 . . . . 0.0 111.963 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.09 -53.12 47.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -65.11 -32.52 74.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.842 1.201 . . . . 0.0 112.225 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -65.76 -43.9 87.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.449 1.477 . . . . 0.0 110.606 170.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -59.64 -44.72 93.4 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.541 1.064 . . . . 0.0 110.383 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.5 t -56.97 -31.96 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.593 1.157 . . . . 0.0 111.472 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.6 mmt -82.35 -59.62 2.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -31.96 69.44 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.463 0.705 . . . . 0.0 112.598 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.637 ' HG3' HG22 ' A' ' 71' ' ' THR . 2.0 mm-40 -57.31 -39.58 76.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 112.18 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.89 -13.75 14.08 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.948 0.899 . . . . 0.0 111.416 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.54 -39.59 64.82 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 126.064 1.746 . . . . 0.0 110.631 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 m -66.52 -31.89 72.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.627 0.771 . . . . 0.0 110.903 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.86 -46.15 74.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.1 t -58.78 -40.46 79.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.434 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.5 mmt -55.31 -51.45 66.67 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 120.576 1.534 . . . . 0.0 109.85 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.9 m -74.0 -27.08 60.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.91 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.415 HD21 ' NE2' ' A' ' 103' ' ' GLN . 27.4 tp -62.5 -40.71 97.6 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.711 1.204 . . . . 0.0 109.937 175.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -60.41 -44.38 95.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.148 0.579 . . . . 0.0 110.173 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.23 -24.8 61.44 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.516 1.126 . . . . 0.0 113.24 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -85.87 -13.89 46.57 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.229 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.257 30.4 p 42.79 62.52 8.3 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 126.67 1.988 . . . . 0.0 109.536 -175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -67.41 -178.49 1.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.016 1.811 . . . . 0.0 114.282 -168.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.958 0.903 . . . . 0.0 108.566 174.778 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptm . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 119.52 -0.276 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.29 145.53 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 169.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -68.28 -66.49 0.56 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.337 0.655 . . . . 0.0 110.945 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -164.0 -50.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.952 0.901 . . . . 0.0 112.918 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -95.76 17.2 15.56 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.446 1.098 . . . . 0.0 113.006 -169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.45 5.66 65.0 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 123.946 0.784 . . . . 0.0 113.656 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.85 154.81 17.38 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.55 148.46 67.54 Favored Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 121.244 -0.91 . . . . 0.0 109.935 174.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.523 ' HB2' HD12 ' A' ' 40' ' ' ILE . 90.3 Cg_endo -79.86 141.06 14.89 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.319 2.012 . . . . 0.0 110.26 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -145.06 158.68 43.74 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.272 1.029 . . . . 0.0 109.733 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.95 159.64 36.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 O-C-N 121.201 -0.937 . . . . 0.0 109.718 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -139.85 156.71 25.0 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.53 141.88 35.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.999 1.32 . . . . 0.0 108.261 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.24 139.1 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 mm -116.74 142.79 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 117.243 -1.36 . . . . 0.0 107.568 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.8 p -119.82 154.5 34.18 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.327 0.967 . . . . 0.0 111.493 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -111.57 171.01 7.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 108.972 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.01 0.52 11.13 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.038 -1.664 . . . . 0.0 114.049 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -88.35 -1.07 57.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.906 0.883 . . . . 0.0 111.053 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.55 17.18 76.2 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.237 -0.757 . . . . 0.0 111.583 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -86.26 145.73 26.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.72 149.78 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.333 1.453 . . . . 0.0 109.244 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.7 ttm -63.84 139.85 58.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.718 0.807 . . . . 0.0 109.329 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.415 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 22.0 t-105 -146.23 140.87 26.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.685 1.594 . . . . 0.0 106.804 176.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' A' ' 121' ' ' PHE . . . -139.15 146.1 40.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.437 1.472 . . . . 0.0 112.478 -171.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -103.04 114.85 29.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.51 1.924 . . . . 0.0 105.845 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -76.1 147.96 38.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 120.448 1.476 . . . . 0.0 110.036 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -57.33 127.45 32.06 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.66 0.784 . . . . 0.0 110.123 -171.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.04 -4.47 31.39 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.14 1.353 . . . . 0.0 114.841 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -87.66 -35.5 17.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.786 1.793 . . . . 0.0 111.851 -173.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.8 m80 54.99 31.04 15.24 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.638 1.175 . . . . 0.0 112.104 -170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.1 m -138.36 154.59 48.94 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.528 1.931 . . . . 0.0 107.859 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 75.4 m95 -105.12 157.3 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -163.62 168.68 19.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.074 1.749 . . . . 0.0 109.706 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -87.49 149.45 46.62 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.15 131.17 35.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.461 2.107 . . . . 0.0 111.033 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -158.02 165.79 34.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.334 0.653 . . . . 0.0 111.47 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.88 168.0 40.42 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.951 -0.468 . . . . 0.0 113.09 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.46 152.62 51.96 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 9' ' ' PRO . 68.2 mt -75.41 125.19 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 169.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.38 147.79 97.09 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.99 126.07 18.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.336 1.357 . . . . 0.0 109.521 -174.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.75 89.15 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.962 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.09 165.05 25.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 120.032 1.916 . . . . 0.0 110.57 169.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -103.03 154.09 19.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.073 -1.876 . . . . 0.0 105.995 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.61 87.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.748 1.158 . . . . 0.0 111.589 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.41 -35.51 79.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.75 0.82 . . . . 0.0 109.882 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.47 -38.76 77.86 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.586 -0.696 . . . . 0.0 109.666 175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.19 -35.3 80.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.676 0.671 . . . . 0.0 109.673 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -60.84 -50.41 73.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -66.63 -38.48 87.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.604 1.093 . . . . 0.0 112.097 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -56.18 -50.45 71.15 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.898 0.879 . . . . 0.0 109.479 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.61 -30.6 59.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 119.215 -0.422 . . . . 0.0 110.239 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 tp -56.71 -45.35 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.518 1.054 . . . . 0.0 109.819 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -72.2 -31.69 66.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.2 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.96 -29.92 58.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.284 1.402 . . . . 0.0 112.811 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -99.42 -55.08 2.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.527 1.531 . . . . 0.0 110.809 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 -24.07 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 126.431 1.893 . . . . 0.0 111.131 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.73 -1.49 45.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.042 1.306 . . . . 0.0 113.515 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.72 155.34 35.73 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.048 1.739 . . . . 0.0 109.064 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 m -131.95 165.66 23.43 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.754 0.822 . . . . 0.0 110.092 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -50.91 -35.21 31.88 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.857 1.663 . . . . 0.0 112.974 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -64.7 -25.18 67.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.818 -173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -114.58 22.6 13.46 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.55 166.07 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.751 1.62 . . . . 0.0 111.972 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.58 141.72 33.49 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 169.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.7 mt -79.51 115.6 22.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 103' ' ' GLN . 94.8 mt -88.84 -37.49 15.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.381 1.072 . . . . 0.0 110.643 175.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.21 165.25 36.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.999 0.92 . . . . 0.0 109.031 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 p -161.85 154.92 20.61 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.261 1.024 . . . . 0.0 110.231 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -70.64 136.3 49.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.641 0.734 . . . . 0.0 110.692 -169.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -81.96 -28.37 32.75 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.304 1.442 . . . . 0.0 109.782 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -119.37 148.98 42.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.595 2.358 . . . . 0.0 108.233 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 69.0 m95 -81.81 137.89 35.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.8 mt -94.44 104.81 16.77 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -102.06 147.11 26.99 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.66 147.79 30.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 169.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.29 141.93 28.02 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.45 147.98 85.42 Favored Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 123.861 0.864 . . . . 0.0 110.272 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.09 149.73 82.32 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 105.197 -2.655 . . . . 0.0 105.197 167.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.1 mtpt -69.24 -12.29 61.54 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 119.834 -1.791 . . . . 0.0 114.24 -169.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.7 ptt-85 -63.41 -32.53 74.0 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.034 0.833 . . . . 0.0 112.299 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.07 -19.99 20.99 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.071 0.948 . . . . 0.0 111.382 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 81' ' ' LYS . 92.1 t -62.06 135.19 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -103.5 94.54 5.53 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 108.944 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -72.62 -23.0 60.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.763 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.88 -35.48 57.4 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -91.53 157.91 16.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.884 0.874 . . . . 0.0 108.946 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.93 135.54 27.64 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 125.513 1.525 . . . . 0.0 108.063 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.1 156.22 93.81 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 122.854 0.923 . . . . 0.0 111.002 -10.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.1 t -72.58 137.8 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 123.993 0.917 . . . . 0.0 109.543 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.7 p -89.95 117.25 28.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.68 -16.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.158 0.89 . . . . 0.0 113.025 173.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.49 -176.34 37.54 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -156.93 157.13 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.789 1.236 . . . . 0.0 109.016 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -106.93 130.63 54.57 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -113.07 135.48 53.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.783 0.833 . . . . 0.0 109.896 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.6 ttmm -113.04 129.2 56.58 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.9 m95 -110.14 155.11 22.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 123.211 0.605 . . . . 0.0 109.538 -171.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.57 127.68 25.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -91.54 124.49 35.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 169.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.93 160.33 22.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.767 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.2 tt0 -111.27 131.73 54.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 134.66 57.16 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.311 1.445 . . . . 0.0 108.026 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.5 t -89.18 -53.57 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.467 1.03 . . . . 0.0 110.009 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.7 m -77.05 -21.64 54.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.222 0.609 . . . . 0.0 111.653 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.49 171.83 22.12 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -16.08 19.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.973 1.709 . . . . 0.0 113.983 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.07 19.17 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.139 0.976 . . . . 0.0 112.53 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -88.48 13.29 12.25 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.87 142.78 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -137.63 106.73 6.01 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 108.581 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.9 mmt -81.58 1.47 33.61 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -120.12 72.72 0.95 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 123.983 1.849 . . . . 0.0 107.459 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.8 p -65.07 -66.66 0.51 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 111.58 -2.554 . . . . 0.0 106.215 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.8 m -76.37 169.46 18.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 167.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.9 m -59.61 -40.75 88.56 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.41 132.58 83.74 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 125.304 1.442 . . . . 0.0 108.836 169.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -60.86 133.63 48.87 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 121.761 1.641 . . . . 0.0 108.002 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.44 -25.62 50.77 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.08 -0.388 . . . . 0.0 110.286 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 96.9 m-85 -122.55 140.73 52.45 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.747 0.819 . . . . 0.0 109.769 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.25 -28.38 53.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.86 0.864 . . . . 0.0 110.323 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -159.63 161.21 32.08 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.31 155.21 41.01 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.84 168.9 19.68 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.952 0.901 . . . . 0.0 109.416 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -109.68 134.85 51.5 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.33 153.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.813 1.245 . . . . 0.0 111.259 -169.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.9 m -61.01 143.37 55.46 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -24.55 62.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -87.05 -20.81 26.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.367 1.44 . . . . 0.0 113.273 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -60.95 -46.7 96.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 117.277 -1.344 . . . . 0.0 113.497 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.48 -30.43 86.64 Favored 'Trans proline' 0 C--N 1.354 0.844 0 CA-C-N 122.524 1.937 . . . . 0.0 111.821 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.04 -29.94 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.141 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -69.59 -23.71 63.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.98 -1.075 . . . . 0.0 111.768 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -85.13 -11.17 55.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -168.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.4 HG11 ' HE2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -122.47 167.11 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -74.72 174.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.652 1.181 . . . . 0.0 109.669 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.93 -54.99 38.01 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.738 . . . . 0.0 113.179 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -69.37 -40.28 77.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.22 0.918 . . . . 0.0 110.902 -171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.4 ' HE2' HG11 ' A' ' 136' ' ' VAL . 53.3 mtpt -65.62 -55.21 18.81 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -60.73 -34.27 74.15 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.771 -174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.77 -40.53 95.42 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.957 1.253 . . . . 0.0 111.828 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.88 -52.53 59.47 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -61.63 -37.53 84.3 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 118.754 0.706 . . . . 0.0 110.726 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -56.9 -50.06 73.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.857 1.663 . . . . 0.0 109.959 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.8 -47.92 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.427 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.8 t -56.93 -42.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.932 1.242 . . . . 0.0 110.847 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.8 mmt -69.0 -51.38 39.88 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -33.55 76.04 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.408 1.004 . . . . 0.0 111.701 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.85 -43.72 90.82 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 119.193 0.906 . . . . 0.0 110.411 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.565 ' HB3' HD12 ' A' ' 101' ' ' LEU . 14.5 m-30 -97.69 -12.74 22.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.6 -42.65 67.89 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.769 1.628 . . . . 0.0 110.627 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 m -70.87 -29.63 65.79 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.744 0.818 . . . . 0.0 111.047 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.5 t -67.92 -43.86 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.93 -44.11 86.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-O 117.227 -1.368 . . . . 0.0 110.537 -172.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.25 66.13 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 121.536 1.971 . . . . 0.0 110.649 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m -58.33 -30.97 67.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.96 1.704 . . . . 0.0 111.885 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -77.07 -23.9 51.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.505 1.522 . . . . 0.0 112.547 178.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -84.02 -44.12 14.46 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.866 0.841 . . . . 0.0 108.916 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.52 -45.46 87.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.575 1.95 . . . . 0.0 109.85 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . 0.366 0.5 OUTLIER 51.75 39.68 25.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.739 2.016 . . . . 0.0 112.666 -169.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -143.9 59.31 6.97 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 111.953 -2.385 . . . . 0.0 106.59 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -61.24 164.96 13.61 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 120.819 1.013 . . . . 0.0 110.043 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.543 -169.131 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.97 130.3 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 168.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.89 -67.17 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -164.09 -49.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 11.49 15.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.156 0.982 . . . . 0.0 112.721 -169.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.6 -5.8 83.51 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.464 1.031 . . . . 0.0 113.295 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -93.65 158.2 15.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.376 1.088 . . . . 0.0 108.751 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -139.14 137.03 18.63 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.016 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.02 136.04 4.07 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.403 2.068 . . . . 0.0 110.665 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -140.73 156.89 46.09 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.949 0.899 . . . . 0.0 109.709 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.76 153.43 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 123.778 0.831 . . . . 0.0 109.349 172.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -127.7 161.67 21.68 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.86 143.59 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.2 t -129.78 135.67 60.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 169.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.1 mm -115.16 133.74 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.4 m -116.79 144.07 44.91 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -101.4 173.14 6.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.191 0.997 . . . . 0.0 108.315 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -77.25 3.74 12.21 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.564 -1.335 . . . . 0.0 113.036 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -93.76 -4.42 50.36 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.515 1.126 . . . . 0.0 111.302 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.98 33.7 54.38 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -112.58 154.98 25.15 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.628 1.214 . . . . 0.0 108.51 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -115.63 152.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.883 2.073 . . . . 0.0 107.925 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.1 ptp -75.42 151.4 38.13 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.219 0.463 . . . . 0.0 110.49 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -146.45 132.95 19.72 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 149.1 46.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.137 1.335 . . . . 0.0 110.508 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -106.52 130.15 54.35 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.584 0.753 . . . . 0.0 109.934 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -76.33 146.39 38.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.705 1.139 . . . . 0.0 108.583 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -56.95 131.62 50.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.253 1.021 . . . . 0.0 110.111 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.99 -9.12 9.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.696 1.141 . . . . 0.0 114.692 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -93.47 -39.41 10.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.435 1.618 . . . . 0.0 110.843 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.0 m80 65.06 -23.38 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.266 2.226 . . . . 0.0 114.63 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -70.27 153.59 42.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.262 1.425 . . . . 0.0 109.759 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -102.88 153.22 20.42 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.189 0.996 . . . . 0.0 111.718 -169.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.62 168.43 27.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.617 1.567 . . . . 0.0 110.49 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -86.64 152.71 54.8 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.55 133.48 37.21 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.092 1.861 . . . . 0.0 110.803 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.41 169.34 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.914 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.95 171.24 44.29 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.844 -0.535 . . . . 0.0 113.069 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.09 150.53 25.0 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.502 1.048 . . . . 0.0 111.496 -173.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.76 125.79 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.78 154.82 91.12 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.52 122.92 12.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 CA-C-N 120.804 1.323 . . . . 0.0 109.585 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.9 -3.96 85.78 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.521 -1.155 . . . . 0.0 114.749 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.78 156.95 38.75 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 120.135 1.968 . . . . 0.0 110.547 170.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 p -95.36 158.34 15.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.59 77.81 Favored 'General case' 0 C--O 1.224 -0.243 0 O-C-N 121.721 -0.612 . . . . 0.0 111.434 -174.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.92 -37.59 79.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.55 0.74 . . . . 0.0 109.997 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -73.61 -35.62 65.38 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.46 92.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -60.87 -50.46 73.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.156 -0.926 . . . . 0.0 108.556 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 47.5 m-85 -66.01 -36.98 84.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.649 1.113 . . . . 0.0 112.41 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.1 ttm-85 -68.33 -50.44 53.3 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.826 1.193 . . . . 0.0 109.445 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.92 -27.75 61.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -170.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.1 tp -52.98 -48.02 67.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.456 0.702 . . . . 0.0 109.351 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.38 -42.5 99.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.779 0.718 . . . . 0.0 109.913 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.35 -28.27 69.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.366 0.985 . . . . 0.0 112.231 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.97 -57.91 2.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.579 0.751 . . . . 0.0 109.86 -172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.06 1.31 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.452 1.501 . . . . 0.0 112.216 -169.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.62 9.59 55.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.661 1.119 . . . . 0.0 113.39 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.74 150.15 20.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.056 2.142 . . . . 0.0 109.031 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 m -129.78 164.73 23.41 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.679 0.792 . . . . 0.0 109.903 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 53.0 mtt85 -45.29 -37.41 4.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.535 1.934 . . . . 0.0 113.12 -173.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -65.45 -30.35 71.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.873 -172.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.59 21.75 15.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.675 1.125 . . . . 0.0 112.505 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -131.38 165.11 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.246 1.418 . . . . 0.0 110.439 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -143.18 139.88 30.52 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.9 mt -79.59 121.64 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 103' ' ' GLN . 68.2 mt -96.12 -36.66 10.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.218 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.23 166.88 31.28 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.601 0.76 . . . . 0.0 109.295 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 p -162.47 155.47 19.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.394 1.077 . . . . 0.0 110.712 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.457 HG22 ' HG2' ' A' ' 150' ' ' GLU . 5.0 p -71.66 140.35 49.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 110.947 -170.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.68 -49.64 12.79 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 144.37 26.47 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.817 1.647 . . . . 0.0 110.457 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -79.36 126.12 30.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.63 126.93 33.78 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -121.88 148.94 44.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -141.44 145.3 35.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -94.03 143.97 25.89 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 169.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt -66.76 142.94 97.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 110.225 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.33 147.18 77.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 104.432 -2.949 . . . . 0.0 104.432 166.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HA ' HG23 ' A' ' 84' ' ' VAL 0.252 86.6 mttt -68.82 -12.81 61.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.03 -1.669 . . . . 0.0 114.546 -168.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -30.27 70.21 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.47 -15.47 25.53 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.815 0.846 . . . . 0.0 112.435 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 81' ' ' LYS . 94.2 t -64.72 133.54 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -100.47 91.79 4.85 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.378 1.071 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -69.92 -22.73 63.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.98 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -76.7 -25.96 54.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.414 0.686 . . . . 0.0 112.391 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -106.81 155.89 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.944 0.897 . . . . 0.0 109.152 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.46 135.14 27.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.543 1.137 . . . . 0.0 110.246 -169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.76 150.32 94.03 Favored 'Cis proline' 0 N--CA 1.456 -0.691 0 N-CA-C 109.528 -0.989 . . . . 0.0 109.528 -10.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.3 p -71.2 133.89 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.493 0.717 . . . . 0.0 109.48 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.5 t -74.4 130.18 39.16 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.25 -13.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.203 169.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.84 47.95 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 120.1 1.318 . . . . 0.0 111.226 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -140.97 157.8 44.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.021 1.728 . . . . 0.0 109.96 173.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -106.36 137.22 44.71 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -123.73 130.34 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.553 1.141 . . . . 0.0 109.277 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -112.63 134.01 54.38 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.434 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 66.3 m95 -115.0 157.62 23.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.594 0.634 . . . . 0.0 109.839 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.88 125.33 23.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 108.28 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -88.29 121.93 31.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 168.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mt -118.68 152.24 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.632 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.4 tt0 -100.56 135.29 42.23 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 167.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.13 131.73 50.5 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.56 -50.42 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 119.44 1.018 . . . . 0.0 109.724 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.9 m -79.29 -25.12 42.48 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.322 0.649 . . . . 0.0 111.696 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.3 169.89 16.02 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -20.19 15.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.51 1.924 . . . . 0.0 113.073 -170.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.95 -26.24 47.14 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -83.13 10.43 8.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.31 140.63 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -130.35 118.77 21.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.028 1.731 . . . . 0.0 106.899 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.6 mtp -90.17 -3.06 58.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.549 0.613 . . . . 0.0 112.625 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -119.19 71.84 0.88 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.512 2.101 . . . . 0.0 107.026 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.1 p -65.22 -63.6 1.06 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.879 -2.873 . . . . 0.0 106.435 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.3 m -78.23 172.73 13.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.365 1.466 . . . . 0.0 107.343 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.5 m -60.33 -41.38 93.42 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.38 135.19 86.6 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 125.433 1.493 . . . . 0.0 108.777 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.13 140.52 89.79 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 121.654 1.57 . . . . 0.0 109.444 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.26 -46.55 20.0 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.5 141.76 39.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.882 0.873 . . . . 0.0 109.71 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -87.67 -15.02 38.36 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.253 1.021 . . . . 0.0 111.257 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.93 150.22 17.9 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 121.584 -0.698 . . . . 0.0 111.878 -169.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 51.2 p-90 -127.38 153.99 45.54 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.402 1.481 . . . . 0.0 108.484 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.36 141.84 24.33 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 168.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -102.55 123.65 46.67 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -137.0 161.57 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.062 1.345 . . . . 0.0 112.517 -168.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m -66.72 149.56 50.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.672 -0.642 . . . . 0.0 109.91 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -30.56 59.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.013 1.325 . . . . 0.0 112.584 -173.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -95.81 -2.47 47.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -76.34 -49.5 3.03 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 117.452 -1.261 . . . . 0.0 113.369 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.74 -32.52 93.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.495 1.927 . . . . 0.0 112.346 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -66.59 -21.87 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 121.275 -0.89 . . . . 0.0 112.301 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -69.08 -29.62 67.77 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.132 -0.98 . . . . 0.0 110.527 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -86.51 -26.83 24.37 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.47 163.12 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -69.72 173.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.971 1.308 . . . . 0.0 109.797 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.8 m -55.9 -54.24 47.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.749 1.62 . . . . 0.0 113.313 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -70.59 -39.94 73.56 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.437 -0.789 . . . . 0.0 110.854 -172.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.53 -49.03 67.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.15 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -63.69 -33.11 74.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.639 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.0 -47.32 77.91 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 119.098 0.863 . . . . 0.0 110.219 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.11 -49.58 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -61.76 -39.86 93.11 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.029 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -69.87 -38.74 76.49 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.896 1.68 . . . . 0.0 110.747 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.89 -45.58 94.01 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.852 0.751 . . . . 0.0 110.225 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.81 -40.02 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 110.565 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mmt -67.21 -49.35 64.88 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.279 1.5 tmtt? -59.86 -31.1 69.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.612 1.096 . . . . 0.0 111.879 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.457 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.1 tp10 -60.78 -36.75 79.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.269 0.628 . . . . 0.0 110.697 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.504 ' HB3' HD12 ' A' ' 101' ' ' LEU . 15.7 m-85 -110.83 -15.8 13.71 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.082 0.953 . . . . 0.0 113.187 -172.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.43 -42.45 70.54 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 125.428 1.491 . . . . 0.0 110.883 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 m -68.04 -31.78 71.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.855 0.862 . . . . 0.0 110.687 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.7 t -66.28 -44.24 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.9 -40.95 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.831 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.6 mmt -55.77 -47.17 77.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.173 0.897 . . . . 0.0 110.537 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.6 m -80.27 -26.68 38.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.921 1.288 . . . . 0.0 111.041 -177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.8 tp -60.4 -41.37 93.73 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.753 1.221 . . . . 0.0 110.142 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -57.29 -36.72 71.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.901 0.481 . . . . 0.0 110.931 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.67 -14.16 49.33 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 112.562 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -100.06 -27.97 13.29 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.456 0.702 . . . . 0.0 112.299 -169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.9 t -142.22 50.1 1.54 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.969 0.508 . . . . 0.0 110.697 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -72.21 -174.03 1.28 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.859 2.373 . . . . 0.0 110.439 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? . . . . . 0 C--O 1.255 1.353 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.398 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.36 144.62 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.76 -68.62 0.36 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 122.989 0.516 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -164.47 -49.76 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.768 0.827 . . . . 0.0 113.229 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.0 16.35 11.32 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.689 1.195 . . . . 0.0 113.11 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.59 -2.13 82.34 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.391 0.996 . . . . 0.0 113.14 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.54 155.59 17.23 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.083 0.942 . . . . 0.0 108.507 169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -146.31 126.85 7.1 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 117.442 -1.266 . . . . 0.0 107.973 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -76.07 138.36 20.46 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.611 1.541 . . . . 0.0 111.581 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -139.71 154.67 47.52 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.266 1.026 . . . . 0.0 108.849 -171.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -136.88 162.73 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.606 -0.683 . . . . 0.0 109.61 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -145.5 163.37 28.2 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.14 142.4 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.07 136.49 55.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -116.42 136.06 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -124.83 145.56 49.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.816 0.735 . . . . 0.0 110.172 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -95.03 174.09 7.25 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -79.32 16.73 0.94 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.037 -1.664 . . . . 0.0 112.282 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -108.37 -1.3 20.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.422 1.489 . . . . 0.0 111.275 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.14 14.99 80.11 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.181 -0.788 . . . . 0.0 112.287 -172.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -86.8 130.42 34.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.4 m -103.07 152.95 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.951 1.3 . . . . 0.0 108.837 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.0 tpp -62.28 137.69 58.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.24 0.616 . . . . 0.0 109.473 170.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -140.91 129.7 22.99 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.41 44.46 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 122.957 0.503 . . . . 0.0 111.259 -169.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -124.43 125.66 44.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 -88.15 165.05 15.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.862 0.465 . . . . 0.0 110.891 -169.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -49.51 124.43 9.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.227 1.011 . . . . 0.0 111.694 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.59 8.07 62.42 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.513 1.054 . . . . 0.0 113.412 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -100.05 153.18 19.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.778 1.289 . . . . 0.0 109.417 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -111.5 19.95 17.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.7 m -128.34 143.23 50.98 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.857 1.263 . . . . 0.0 108.29 -172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -98.2 151.45 20.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.379 0.672 . . . . 0.0 110.227 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -155.56 160.61 40.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.434 1.094 . . . . 0.0 111.051 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -77.75 148.21 75.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.43 127.39 17.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.828 2.352 . . . . 0.0 112.678 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -142.54 161.53 37.83 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.555 1.07 . . . . 0.0 112.51 -171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.99 177.11 48.28 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.199 0.428 . . . . 0.0 113.344 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.15 146.02 17.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 125.346 1.45 . . . . 0.0 110.182 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mt -79.82 124.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -70.33 155.26 93.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -57.7 125.28 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.95 -7.25 81.09 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.331 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.51 158.71 34.38 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 120.112 1.956 . . . . 0.0 110.396 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 p -102.16 159.57 15.27 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.35 85.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.625 -0.672 . . . . 0.0 111.627 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.16 -34.64 73.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.733 0.813 . . . . 0.0 110.114 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -72.82 -36.78 67.58 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.698 -1.251 . . . . 0.0 110.227 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.98 93.08 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.3 ttp -59.81 -49.11 79.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.274 -0.869 . . . . 0.0 108.819 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 46.1 m-85 -64.47 -44.35 91.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.664 1.12 . . . . 0.0 111.975 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -65.9 -49.83 66.64 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.849 1.204 . . . . 0.0 109.595 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.65 -24.49 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.2 -47.49 83.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.762 0.71 . . . . 0.0 110.445 169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -57.14 -39.98 76.27 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.555 0.616 . . . . 0.0 109.458 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -0.96 14.48 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -115.98 -39.4 3.46 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.273 1.429 . . . . 0.0 111.933 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.46 2.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.735 1.214 . . . . 0.0 112.666 -171.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.87 6.81 19.59 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-N 119.523 1.056 . . . . 0.0 113.269 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.35 148.65 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.356 1.862 . . . . 0.0 109.238 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.9 p -126.59 170.11 12.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.665 1.186 . . . . 0.0 109.486 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 43.9 mtt85 -50.93 -31.93 19.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.906 1.683 . . . . 0.0 112.166 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -66.69 -24.82 66.31 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.244 0.618 . . . . 0.0 112.349 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.93 24.28 10.93 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.274 0.559 . . . . 0.0 111.723 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.01 164.06 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 120.778 -1.201 . . . . 0.0 111.464 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -141.9 140.51 32.86 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 mt -82.61 119.52 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 103' ' ' GLN . 90.0 mt -94.6 -36.64 11.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.429 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.17 164.4 32.91 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.498 0.719 . . . . 0.0 109.773 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.4 p -160.08 153.85 22.78 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.904 1.281 . . . . 0.0 110.974 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 p -70.02 140.26 52.84 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.574 0.702 . . . . 0.0 111.199 -169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -83.29 -28.3 29.21 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.083 1.353 . . . . 0.0 110.053 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -125.5 148.14 48.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.369 2.267 . . . . 0.0 109.094 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -81.83 136.1 35.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.52 62.04 2.36 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.823 0.849 . . . . 0.0 109.442 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -71.21 150.33 45.41 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 121.4 -0.812 . . . . 0.0 109.914 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -147.17 148.34 31.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.93 136.77 32.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 169.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.283 0.4 OUTLIER -90.83 149.71 40.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.629 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.1 Cg_endo -74.59 157.71 44.28 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 124.093 3.195 . . . . 0.0 111.049 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -65.44 -19.9 66.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -171.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -31.01 69.39 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.414 HD12 ' HD2' ' A' ' 80' ' ' PRO . 35.3 mt -94.22 -22.51 18.37 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.675 1.19 . . . . 0.0 111.489 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 86' ' ' TRP . 62.2 t -65.44 133.44 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -99.99 88.42 3.75 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.782 0.801 . . . . 0.0 109.479 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.41 ' CE2' HG11 ' A' ' 84' ' ' VAL . 85.5 m95 -68.76 -22.04 64.32 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.768 175.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.54 -8.99 59.16 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.817 0.847 . . . . 0.0 113.046 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -129.77 162.77 27.69 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.256 1.022 . . . . 0.0 110.274 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.18 134.84 26.36 Favored Pre-proline 0 C--O 1.234 0.27 0 C-N-CA 125.404 1.482 . . . . 0.0 109.231 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.61 147.28 88.97 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 O-C-N 122.666 0.824 . . . . 0.0 110.381 -10.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.72 140.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.003 0.921 . . . . 0.0 109.725 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.2 p -94.61 128.33 41.17 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.374 1.07 . . . . 0.0 109.904 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -14.59 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.92 175.5 47.04 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.07 144.74 26.88 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.834 1.654 . . . . 0.0 108.336 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -90.05 135.45 33.64 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -118.42 132.3 56.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.185 0.902 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -115.74 135.26 54.21 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -117.52 154.3 31.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.1 125.59 22.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.506 1.123 . . . . 0.0 108.146 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 tp -90.4 124.93 35.36 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.35 149.09 41.07 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.9 tt0 -100.67 129.24 46.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.02 134.04 56.11 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.6 t -82.24 -43.27 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.587 -169.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.0 m -97.52 -19.3 18.46 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.933 0.893 . . . . 0.0 111.704 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.1 -170.11 17.36 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.416 1.008 . . . . 0.0 111.064 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.68 -22.51 23.53 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.218 1.807 . . . . 0.0 112.824 -174.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.51 -31.14 63.81 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.957 0.903 . . . . 0.0 113.434 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -90.96 14.33 14.14 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.98 140.36 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -120.74 115.71 23.83 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.05 6.7 47.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.049 0.539 . . . . 0.0 111.581 -171.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -149.02 66.61 1.04 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.454 1.902 . . . . 0.0 106.663 -169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -57.03 -60.47 3.55 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 127.218 2.207 . . . . 0.0 111.175 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 73.4 m -101.19 174.5 5.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.27 1.828 . . . . 0.0 109.93 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -54.67 -37.93 66.34 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.02 116.16 64.67 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 167.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -61.82 129.99 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 N-CA-C 107.449 -1.789 . . . . 0.0 107.449 170.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -76.62 32.5 0.13 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . 0.26 8.8 t80 -153.18 162.26 41.51 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 120.683 -1.261 . . . . 0.0 112.184 -166.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.75 17.48 0.89 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 171.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 153.24 149.33 5.13 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 115.443 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.78 153.34 51.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.652 1.181 . . . . 0.0 111.675 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -156.32 152.67 27.93 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.601 1.16 . . . . 0.0 108.742 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -107.72 123.77 49.03 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.64 151.04 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.111 0.964 . . . . 0.0 110.668 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m -55.12 140.03 39.71 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.594 0.758 . . . . 0.0 110.291 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.55 -32.45 18.53 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -169.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -85.38 -23.54 27.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.322 1.419 . . . . 0.0 112.971 -176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.72 -46.71 88.5 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.072 -1.442 . . . . 0.0 113.797 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.86 -25.79 78.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 123.028 2.117 . . . . 0.0 113.139 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.4 t -64.29 -32.18 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.931 0.893 . . . . 0.0 108.915 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -61.85 -32.58 72.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.368 -0.832 . . . . 0.0 110.949 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -77.99 -27.32 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.33 167.69 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 118.896 0.771 . . . . 0.0 110.879 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.08 175.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.701 1.2 . . . . 0.0 110.226 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.7 m -53.2 -47.0 69.25 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.662 1.585 . . . . 0.0 114.838 -170.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -74.92 -36.7 62.17 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.051 0.841 . . . . 0.0 111.256 -174.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -74.24 -42.82 59.09 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.503 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -42.88 -44.6 4.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.993 0.917 . . . . 0.0 111.935 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.35 -43.26 98.2 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.219 0.918 . . . . 0.0 111.097 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.75 -50.63 76.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.23 -32.37 74.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.301 0.64 . . . . 0.0 110.929 -169.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -69.57 -41.78 75.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.836 1.198 . . . . 0.0 110.407 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -61.06 -41.23 96.22 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.581 1.082 . . . . 0.0 110.576 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.3 t -57.85 -24.97 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 111.591 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.5 mmt -90.51 -58.36 2.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -56.53 -37.12 70.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.637 1.175 . . . . 0.0 112.485 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.1 -36.29 72.68 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 119.062 0.846 . . . . 0.0 111.078 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -106.91 -11.95 15.59 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.183 0.993 . . . . 0.0 112.673 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.68 69.8 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.223 1.409 . . . . 0.0 110.655 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.2 m -67.85 -31.86 71.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.551 0.74 . . . . 0.0 110.654 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.97 -45.23 74.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.43 -41.02 80.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 117.312 -1.327 . . . . 0.0 110.592 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.19 -49.9 72.74 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 120.993 1.724 . . . . 0.0 109.964 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.9 m -73.55 -26.55 60.9 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.26 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.5 tp -63.79 -44.07 94.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.296 1.438 . . . . 0.0 109.539 172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -61.16 -43.06 99.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.34 -34.84 70.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.937 0.495 . . . . 0.0 112.173 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -92.26 -29.48 16.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.922 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.283 9.8 t 39.6 64.68 4.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.018 1.727 . . . . 0.0 108.069 -169.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.07 164.18 17.68 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.128 1.885 . . . . 0.0 113.682 -168.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp . . . . . 0 C--O 1.251 1.174 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.982 -171.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 92' ' ' CYS . 1.9 mt -127.23 128.27 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 103.887 -2.635 . . . . 0.0 103.887 168.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.26 150.12 47.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.472 1.129 . . . . 0.0 108.803 171.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -56.98 -24.86 56.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.222 -1.354 . . . . 0.0 114.188 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.15 0.19 19.81 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.87 61.78 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.912 1.244 . . . . 0.0 113.386 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -118.2 161.25 20.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 169.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -144.18 132.45 10.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HB2' HD12 ' A' ' 40' ' ' ILE . 93.9 Cg_endo -82.35 136.06 8.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.371 1.381 . . . . 0.0 108.821 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -139.19 152.56 47.47 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.118 -0.989 . . . . 0.0 108.989 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.454 HG13 HD11 ' A' ' 40' ' ' ILE . 12.5 m -134.26 154.09 36.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.255 1.022 . . . . 0.0 108.892 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.51 157.5 25.14 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.32 143.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.5 138.69 51.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 170.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.5 mm -116.89 141.21 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' SG ' HD21 ' A' ' 101' ' ' LEU . 25.6 p -120.74 157.2 30.18 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.321 1.049 . . . . 0.0 111.364 174.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -117.89 168.09 10.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.938 1.295 . . . . 0.0 107.987 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -73.66 -0.71 16.28 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.377 -1.452 . . . . 0.0 113.032 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -85.35 -8.84 58.25 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.945 0.898 . . . . 0.0 111.365 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.95 34.83 41.1 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -106.07 154.34 20.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 169.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.84 150.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.34 1.056 . . . . 0.0 109.736 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.6 ttm -66.67 143.26 57.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.203 1.001 . . . . 0.0 108.397 169.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -150.5 141.85 23.32 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 147.63 31.37 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.463 1.483 . . . . 0.0 110.379 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -107.09 136.37 47.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.165 0.986 . . . . 0.0 109.089 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 ttm-85 -73.53 160.68 31.33 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 111.487 -169.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -49.58 123.94 8.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.174 0.99 . . . . 0.0 110.884 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.73 6.79 73.1 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.816 1.198 . . . . 0.0 114.145 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -106.42 160.27 15.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.338 1.569 . . . . 0.0 110.616 -177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -119.91 17.34 12.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.803 1.241 . . . . 0.0 111.598 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 m -128.1 138.71 52.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.048 1.339 . . . . 0.0 108.149 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -94.46 151.21 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.519 0.727 . . . . 0.0 110.549 -170.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -143.57 155.58 44.34 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.165 1.386 . . . . 0.0 110.139 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -82.54 138.9 44.2 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 167.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -54.05 135.58 64.42 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.708 2.272 . . . . 0.0 112.568 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -158.87 166.2 32.42 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.962 0.801 . . . . 0.0 112.199 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.0 168.01 40.95 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.507 0.575 . . . . 0.0 111.683 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.88 149.01 40.68 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 9' ' ' PRO . 59.9 mt -73.57 120.49 22.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -73.59 157.79 87.2 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.59 122.98 12.7 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.331 1.354 . . . . 0.0 111.539 -169.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.23 2.0 88.67 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.538 -1.146 . . . . 0.0 114.745 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.85 152.74 43.39 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.158 1.979 . . . . 0.0 111.066 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.0 p -84.76 167.49 16.05 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 167.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -36.32 79.2 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.088 -1.008 . . . . 0.0 111.316 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -40.51 61.13 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.484 0.713 . . . . 0.0 109.802 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -65.65 -40.89 92.94 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.26 75.26 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.856 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -58.15 -48.23 80.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 57.1 m-85 -66.81 -45.64 77.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.1 0.864 . . . . 0.0 111.642 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -53.57 -51.71 62.09 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.919 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -77.72 -32.34 52.78 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.9 tp -56.48 -45.65 80.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.25 0.932 . . . . 0.0 109.98 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.84 -40.26 92.16 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.282 0.492 . . . . 0.0 110.082 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -66.22 -25.99 67.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.813 0.733 . . . . 0.0 112.366 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.55 -53.55 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.165 0.986 . . . . 0.0 110.414 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -123.27 3.6 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.488 1.515 . . . . 0.0 112.038 -169.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.43 3.27 24.9 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 120.005 1.275 . . . . 0.0 113.955 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -79.81 145.09 32.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.7 m -124.3 162.21 24.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.062 . . . . 0.0 109.664 -171.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.433 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 46.4 mtp180 -42.73 -40.63 2.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.621 1.968 . . . . 0.0 112.892 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -69.08 -21.15 64.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.376 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.76 19.92 16.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.745 0.784 . . . . 0.0 112.522 -176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.23 164.19 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.403 1.481 . . . . 0.0 111.337 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 138.93 35.92 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 117.384 -1.293 . . . . 0.0 108.072 169.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 mt -77.03 116.1 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 103' ' ' GLN . 58.6 mt -93.71 -33.17 13.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.395 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.28 164.45 38.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.866 0.866 . . . . 0.0 109.397 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 p -162.21 154.4 19.17 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 110.787 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.597 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -70.6 136.86 49.53 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.831 -0.543 . . . . 0.0 110.8 -170.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -79.3 -29.79 42.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.633 0.773 . . . . 0.0 110.553 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -119.9 153.64 35.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.344 2.258 . . . . 0.0 108.361 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.495 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 78.3 m95 -77.78 133.64 38.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.998 0.817 . . . . 0.0 109.165 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.03 116.58 27.42 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -127.05 149.52 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.51 142.55 31.18 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.9 139.77 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.0 mt -70.71 139.37 86.05 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.065 0.946 . . . . 0.0 110.418 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.55 148.83 73.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 N-CA-C 104.636 -2.871 . . . . 0.0 104.636 167.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.7 mtpt -68.84 -13.23 62.28 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 119.847 -1.783 . . . . 0.0 114.236 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -62.54 -30.73 71.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.955 0.798 . . . . 0.0 112.634 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.4 mt -94.07 -18.24 22.02 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.161 0.985 . . . . 0.0 112.212 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 81' ' ' LYS . 59.9 t -64.48 132.65 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 174.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.12 88.39 4.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.729 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -69.98 -17.76 63.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.262 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.83 -27.28 55.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -103.18 163.08 12.46 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.131 0.973 . . . . 0.0 110.811 -173.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -130.38 127.67 22.5 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 125.254 1.422 . . . . 0.0 110.72 -171.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.14 145.24 83.44 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 N-CA-C 109.308 -1.074 . . . . 0.0 109.308 -10.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.28 136.35 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.405 ' HB3' HD13 ' A' ' 2' ' ' ILE . 19.5 p -96.92 144.22 27.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.594 0.358 . . . . 0.0 110.585 170.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.84 -7.3 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.45 177.22 41.44 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -150.08 147.25 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.854 1.662 . . . . 0.0 109.016 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -96.23 131.24 42.92 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.17 128.6 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 119.504 1.047 . . . . 0.0 109.189 176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 2.2 ttmm -109.05 121.15 44.54 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -102.47 151.27 22.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -133.43 131.51 40.03 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 108.015 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -93.34 124.8 37.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 169.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.51 149.7 42.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.634 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.1 tt0 -97.57 133.06 42.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 136.19 57.84 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.235 1.414 . . . . 0.0 107.552 171.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.31 -59.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.563 1.074 . . . . 0.0 110.226 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.4 m -74.74 -20.03 59.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.423 0.689 . . . . 0.0 111.672 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.21 172.35 25.14 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -58.42 -16.5 15.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.059 1.744 . . . . 0.0 114.112 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.73 -30.89 15.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.194 0.997 . . . . 0.0 113.088 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -85.53 18.98 2.53 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.18 142.05 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.185 1.394 . . . . 0.0 108.614 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -130.94 130.93 44.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.652 1.981 . . . . 0.0 107.895 171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mmt -93.95 -14.4 26.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.52 0.728 . . . . 0.0 112.728 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -112.73 74.32 0.86 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 124.38 2.038 . . . . 0.0 107.94 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.0 p -71.49 -63.12 1.18 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 110.891 -2.868 . . . . 0.0 107.117 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.2 m -78.91 175.47 10.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.599 1.56 . . . . 0.0 108.721 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -59.71 -35.24 74.11 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.541 -0.724 . . . . 0.0 110.486 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.27 137.36 37.04 Favored Pre-proline 0 N--CA 1.446 -0.657 0 C-N-CA 125.945 1.698 . . . . 0.0 108.844 169.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.38 121.32 9.26 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.31 2.007 . . . . 0.0 107.55 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -73.74 -26.05 60.48 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.067 -0.395 . . . . 0.0 111.583 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -107.54 141.29 39.21 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.22 -27.66 38.74 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.259 0.624 . . . . 0.0 110.313 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.55 150.81 22.88 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.78 140.44 29.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -148.04 168.98 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.586 1.154 . . . . 0.0 109.222 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -117.4 142.56 46.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 149.84 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.702 1.201 . . . . 0.0 109.101 -169.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -51.99 141.81 17.18 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -43.78 -55.51 4.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -168.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.78 -7.83 53.53 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.822 1.192 . . . . 0.0 113.596 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.58 -52.44 66.99 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-O 116.825 -1.559 . . . . 0.0 113.68 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.97 -8.73 14.57 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.616 2.877 . . . . 0.0 116.392 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.16 -29.52 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 120.967 -1.083 . . . . 0.0 108.869 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.43 -25.38 63.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.75 -1.219 . . . . 0.0 112.281 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.47 -22.05 21.57 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -169.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.92 175.3 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 119.321 0.964 . . . . 0.0 110.612 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 m -83.82 171.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.26 -0.9 . . . . 0.0 109.378 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.5 m -56.61 -48.79 76.69 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.821 2.048 . . . . 0.0 114.327 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -72.07 -35.99 69.42 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.115 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.08 -39.08 72.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.968 -0.539 . . . . 0.0 109.75 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -50.01 -42.81 50.01 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.87 0.868 . . . . 0.0 111.454 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.41 -45.85 91.24 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.465 0.575 . . . . 0.0 110.359 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.1 -50.22 80.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -62.79 -37.99 88.9 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.9 0.773 . . . . 0.0 109.974 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -69.24 -36.28 77.02 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -62.45 -44.66 95.89 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.077 1.308 . . . . 0.0 110.307 172.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.14 -39.03 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 119.939 1.245 . . . . 0.0 110.451 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.8 mmt -72.45 -59.48 2.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.958 1.303 . . . . 0.0 107.637 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -34.07 72.48 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.588 -1.32 . . . . 0.0 112.313 -172.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 71' ' ' THR . 2.3 mm-40 -57.93 -41.05 81.94 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.423 ' HB3' HD12 ' A' ' 101' ' ' LEU . 4.5 m-85 -111.52 -11.95 14.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.591 0.756 . . . . 0.0 112.039 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.2 -42.7 63.73 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 126.786 2.034 . . . . 0.0 110.467 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -68.95 -30.66 69.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.994 0.918 . . . . 0.0 110.916 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.83 -46.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.11 -41.25 88.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.293 -171.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.0 mmt -55.51 -44.41 76.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.348 1.431 . . . . 0.0 110.752 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -81.12 -26.04 36.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.324 1.049 . . . . 0.0 111.502 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.59 -43.78 95.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.043 1.337 . . . . 0.0 109.686 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.63 -40.09 93.63 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.752 0.421 . . . . 0.0 110.718 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.62 -32.08 53.27 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.217 0.607 . . . . 0.0 112.238 -169.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -100.45 -20.24 15.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.838 -169.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.1 p 40.8 62.86 6.1 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 126.946 2.098 . . . . 0.0 109.556 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.37 167.1 15.48 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 121.422 1.415 . . . . 0.0 114.113 -167.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt . . . . . 0 C--O 1.255 1.364 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.769 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tmm? . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.43 131.35 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 169.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.44 -63.95 1.12 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.429 0.692 . . . . 0.0 112.627 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -162.21 -53.84 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.62 17.25 16.77 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.435 1.094 . . . . 0.0 113.06 -169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.19 61.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.894 0.759 . . . . 0.0 113.702 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.8 154.4 18.67 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.085 0.943 . . . . 0.0 108.816 171.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -139.01 149.88 63.1 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.361 174.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HB2' HD12 ' A' ' 40' ' ' ILE . 9.4 Cg_exo -90.58 141.78 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.687 1.592 . . . . 0.0 111.757 -174.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -135.8 154.32 51.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.143 0.977 . . . . 0.0 109.711 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 40' ' ' ILE . 6.2 m -133.82 140.53 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -119.81 155.62 16.09 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 124.783 1.182 . . . . 0.0 110.211 176.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -127.05 142.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.93 135.62 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 104' ' ' LEU . 22.8 mm -108.56 132.76 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.2 m -124.26 145.57 49.29 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -105.74 173.31 6.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.644 1.177 . . . . 0.0 109.321 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.59 5.75 4.51 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.562 -1.336 . . . . 0.0 113.657 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -96.27 -2.17 46.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.087 0.955 . . . . 0.0 111.482 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.61 22.11 79.18 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.392 -0.671 . . . . 0.0 111.843 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -93.91 145.39 24.66 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.23 149.85 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.717 1.607 . . . . 0.0 108.934 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 37.4 ttm -68.37 142.78 55.35 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.88 0.872 . . . . 0.0 109.366 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -141.48 123.32 15.3 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.08 159.35 41.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.134 1.334 . . . . 0.0 112.575 -168.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -157.93 169.52 24.4 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 120.08 1.309 . . . . 0.0 114.073 177.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.523 ' H ' ' HG3' ' A' ' 26' ' ' ARG . 8.2 tpt180 -59.84 154.39 18.57 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 128.035 2.534 . . . . 0.0 112.855 -169.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -61.15 134.39 56.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.614 1.166 . . . . 0.0 108.242 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.61 1.78 78.26 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.361 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -106.15 160.73 15.1 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.564 1.682 . . . . 0.0 110.654 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -128.91 11.99 6.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.671 1.189 . . . . 0.0 111.453 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 p -85.68 169.15 13.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.902 0.881 . . . . 0.0 109.082 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -133.2 132.12 41.16 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.03 173.94 13.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.391 1.477 . . . . 0.0 108.037 174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -75.46 152.93 85.72 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.098 -0.954 . . . . 0.0 108.601 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 133.36 57.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.865 2.377 . . . . 0.0 111.536 170.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -161.15 171.2 18.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.66 1.118 . . . . 0.0 112.204 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.48 170.36 41.16 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.992 -0.442 . . . . 0.0 112.755 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 144.01 33.59 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.469 HD11 HG13 ' A' ' 11' ' ' VAL . 31.1 mt -73.99 119.33 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -72.67 144.1 85.6 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.14 126.17 18.06 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.804 1.67 . . . . 0.0 110.293 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.43 52.79 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.662 1.125 . . . . 0.0 113.283 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 152.1 37.17 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.675 1.737 . . . . 0.0 109.83 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.2 p -80.21 169.4 17.83 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.3 87.75 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 121.68 -0.637 . . . . 0.0 111.379 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -71.66 -37.77 70.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.922 0.889 . . . . 0.0 110.387 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -68.09 -39.49 82.88 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.603 -1.31 . . . . 0.0 110.08 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.56 -30.66 67.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.676 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.419 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 11.9 tmm? -57.08 -50.73 71.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.425 1.011 . . . . 0.0 108.674 173.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 52.3 m-85 -66.38 -44.96 81.65 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.322 0.51 . . . . 0.0 111.119 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.5 ttt-85 -57.35 -50.23 73.63 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.901 0.88 . . . . 0.0 110.023 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -77.12 -31.08 55.51 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -172.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.9 tp -58.11 -43.26 87.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.369 0.986 . . . . 0.0 110.241 172.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -62.38 -41.47 98.66 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.325 0.511 . . . . 0.0 110.087 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.66 -24.84 65.48 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.804 0.729 . . . . 0.0 112.429 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.04 -61.09 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.802 0.841 . . . . 0.0 108.788 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.88 -4.95 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.436 1.094 . . . . 0.0 113.561 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.76 9.16 69.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.799 1.181 . . . . 0.0 114.103 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.08 150.28 30.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.83 1.652 . . . . 0.0 109.099 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.4 m -127.76 164.34 22.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.332 1.053 . . . . 0.0 109.801 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.407 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 60.9 mtt180 -48.28 -36.16 13.57 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.103 1.761 . . . . 0.0 112.519 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -63.38 -23.45 67.42 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.623 0.769 . . . . 0.0 112.19 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.89 24.58 11.13 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.939 0.4 . . . . 0.0 111.63 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.87 165.09 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.413 1.085 . . . . 0.0 111.957 172.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 134.16 30.76 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.7 mt -76.65 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -95.88 -32.89 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.684 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -154.19 164.43 38.55 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 p -163.18 154.44 17.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.502 1.121 . . . . 0.0 110.798 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -72.81 140.06 47.41 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.668 0.747 . . . . 0.0 109.969 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -92.22 -27.87 17.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -111.29 150.92 28.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.451 2.3 . . . . 0.0 107.482 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 57.1 m95 -82.3 136.94 34.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.438 0.563 . . . . 0.0 109.518 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 mt -91.4 71.47 6.05 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -71.77 147.36 47.36 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -146.33 144.01 29.5 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.845 0.458 . . . . 0.0 110.0 170.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.84 146.67 24.04 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.074 0.95 . . . . 0.0 108.504 169.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.7 mt -71.05 145.85 91.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.324 1.05 . . . . 0.0 110.682 169.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.79 145.9 64.42 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 N-CA-C 104.499 -2.924 . . . . 0.0 104.499 166.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.8 mtpt -68.34 -13.13 62.06 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.909 -1.744 . . . . 0.0 114.151 -169.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -58.7 -31.31 68.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.8 mt -92.55 -19.52 21.86 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 111.998 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 81' ' ' LYS . 58.2 t -65.31 136.09 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -101.58 90.49 4.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.942 0.897 . . . . 0.0 109.473 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -68.42 -24.17 64.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.807 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.93 -34.42 73.43 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.617 0.367 . . . . 0.0 111.831 -171.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -98.93 159.21 15.12 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.786 0.834 . . . . 0.0 109.678 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -130.88 134.95 26.59 Favored Pre-proline 0 C--O 1.234 0.268 0 C-N-CA 125.325 1.45 . . . . 0.0 109.615 -171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.46 148.03 90.5 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 O-C-N 122.696 0.84 . . . . 0.0 110.07 -10.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.1 p -79.24 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.484 0.713 . . . . 0.0 109.532 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.89 127.69 35.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -14.57 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 118.932 0.787 . . . . 0.0 112.861 170.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.7 -177.11 38.88 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -155.77 153.82 30.45 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.794 1.238 . . . . 0.0 108.84 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -98.61 132.55 43.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -123.62 122.81 39.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 119.266 0.939 . . . . 0.0 109.566 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 7.6 ttmm -98.72 153.55 18.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 89.2 m95 -132.32 151.74 51.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.419 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 75.8 m-85 -137.69 127.88 26.09 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 108.893 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -89.59 122.62 32.91 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.88 136.99 53.75 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.47 132.29 35.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 167.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.421 ' HB2' HG21 ' A' ' 15' ' ' ILE . 13.9 tp -73.76 132.64 42.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.064 2.146 . . . . 0.0 107.539 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -77.63 -53.57 14.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.538 1.135 . . . . 0.0 111.837 -168.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 62.7 m -87.24 -15.55 37.85 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.114 0.566 . . . . 0.0 111.563 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.37 -169.92 21.95 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.707 1.146 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -59.1 -17.39 25.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.627 1.571 . . . . 0.0 114.008 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.81 57.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.268 1.027 . . . . 0.0 112.955 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -95.66 18.29 13.22 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.52 113.74 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 171.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -92.74 -56.12 3.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.799 0.272 . . . . 0.0 110.978 -170.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.2 mtp 69.81 3.16 4.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.704 2.401 . . . . 0.0 115.016 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.05 78.76 1.5 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 123.793 1.759 . . . . 0.0 109.825 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -75.93 -59.92 2.55 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.51 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 m -66.15 167.7 9.67 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.295 1.838 . . . . 0.0 109.53 169.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -62.44 -38.0 88.05 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.88 -0.512 . . . . 0.0 109.739 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.62 139.95 51.22 Favored Pre-proline 0 N--CA 1.442 -0.871 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 169.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.62 135.68 69.04 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.628 1.552 . . . . 0.0 108.112 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -81.62 -29.83 33.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -125.74 153.67 43.6 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.122 1.769 . . . . 0.0 107.83 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -132.67 -25.14 1.91 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.353 1.061 . . . . 0.0 110.58 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.48 122.83 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -150.76 133.09 15.48 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.153 0.981 . . . . 0.0 108.402 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -152.48 164.57 37.3 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.125 1.37 . . . . 0.0 108.471 169.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -114.49 141.27 47.93 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 152.79 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 110.292 -170.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m -60.97 142.54 56.44 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 109.043 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -27.58 48.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 32.5 m95 -88.2 -18.57 28.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.03 1.286 . . . . 0.0 113.19 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.91 -50.41 70.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.132 -1.413 . . . . 0.0 113.294 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.7 -28.95 76.95 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.159 1.906 . . . . 0.0 112.629 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.91 -34.88 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.329 1.052 . . . . 0.0 108.788 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -68.94 -19.7 64.19 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.787 -1.196 . . . . 0.0 112.323 -175.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -79.87 -32.7 40.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.854 1.206 . . . . 0.0 112.614 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.5 156.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 118.995 0.816 . . . . 0.0 111.482 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.1 m -68.65 162.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.7 m -53.22 -46.63 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.862 2.065 . . . . 0.0 115.236 -169.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -69.33 -32.17 71.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.431 1.014 . . . . 0.0 111.153 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -77.54 -39.6 45.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.6 ttp-105 -50.05 -39.0 40.64 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.788 1.235 . . . . 0.0 112.387 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.24 -43.58 94.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.47 0.577 . . . . 0.0 111.378 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.91 -50.94 78.11 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -66.61 -34.49 77.99 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.701 -0.624 . . . . 0.0 110.897 -168.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -67.45 -40.61 85.42 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.65 1.114 . . . . 0.0 110.248 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.43 -43.74 98.33 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 117.401 -1.285 . . . . 0.0 110.725 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.91 -43.22 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 120.29 1.404 . . . . 0.0 109.912 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.5 mmt -74.04 -48.86 27.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -33.81 76.53 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.998 0.817 . . . . 0.0 112.159 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -58.74 -45.54 89.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.686 1.195 . . . . 0.0 109.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.453 ' HB3' HD12 ' A' ' 101' ' ' LEU . 13.4 m-85 -96.65 -16.41 20.99 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.72 -39.19 65.04 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.097 1.359 . . . . 0.0 110.792 -174.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 m -69.34 -31.57 70.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.786 0.834 . . . . 0.0 110.598 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 69' ' ' ALA . 45.5 t -67.47 -48.5 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.45 -41.77 82.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.172 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.63 -47.48 73.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.365 1.439 . . . . 0.0 110.71 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m -77.28 -26.85 52.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.173 1.389 . . . . 0.0 110.781 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.53 -42.25 96.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.018 1.727 . . . . 0.0 108.778 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -59.07 -24.64 63.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.344 0.657 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -106.93 -18.54 13.89 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.781 1.232 . . . . 0.0 113.116 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -116.62 -20.83 9.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.795 -169.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 p 41.86 62.76 7.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.201 1.8 . . . . 0.0 110.307 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.94 157.82 36.79 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.974 1.782 . . . . 0.0 113.798 -168.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt . . . . . 0 C--O 1.253 1.26 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.541 -169.536 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mt -136.75 142.12 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 103.938 -2.615 . . . . 0.0 103.938 168.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -67.37 -69.42 0.31 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.005 0.522 . . . . 0.0 111.661 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -164.74 -48.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.762 0.825 . . . . 0.0 112.84 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.51 13.29 14.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.293 1.037 . . . . 0.0 113.06 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.22 81.82 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.291 0.948 . . . . 0.0 113.163 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.58 157.24 17.61 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.975 0.91 . . . . 0.0 108.749 169.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 3.2 ptm180 -148.93 139.77 13.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 116.99 -1.481 . . . . 0.0 107.594 -172.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 16.6 Cg_exo -87.47 139.7 5.07 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 CA-C-N 121.63 1.618 . . . . 0.0 111.987 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.27 165.87 24.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.101 1.36 . . . . 0.0 109.127 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.74 172.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -153.08 159.75 28.7 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 173.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -121.39 141.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.25 139.26 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.4 mm -119.47 142.83 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.0 p -121.84 154.28 37.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.186 0.903 . . . . 0.0 111.4 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -112.51 168.47 9.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.865 1.266 . . . . 0.0 108.336 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -74.39 4.46 5.86 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.133 -1.604 . . . . 0.0 113.196 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -90.78 -4.81 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.185 0.994 . . . . 0.0 111.45 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.3 21.06 70.99 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.841 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -95.67 151.34 19.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.674 1.237 . . . . 0.0 107.963 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.21 153.93 20.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.493 1.517 . . . . 0.0 109.495 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.3 tpp -60.55 137.6 58.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.317 1.047 . . . . 0.0 108.802 169.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -147.73 135.15 20.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 156.01 47.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.226 1.375 . . . . 0.0 112.554 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -109.44 109.32 20.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.149 1.779 . . . . 0.0 107.166 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -66.74 148.72 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.676 1.126 . . . . 0.0 108.06 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -46.25 118.81 2.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.419 1.087 . . . . 0.0 111.311 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.96 4.25 40.56 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 118.302 -1.277 . . . . 0.0 115.871 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -82.95 -30.42 28.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.235 2.017 . . . . 0.0 112.579 -172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 m80 53.78 34.22 18.63 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.323 1.049 . . . . 0.0 111.957 -172.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.3 p -131.22 170.74 14.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.919 2.088 . . . . 0.0 107.49 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -120.19 145.37 47.05 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.349 0.522 . . . . 0.0 110.505 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 165.61 36.03 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.071 1.349 . . . . 0.0 110.17 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -79.93 153.07 75.0 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.859 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.34 139.5 59.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.076 2.517 . . . . 0.0 110.324 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 53.8 mt-30 -138.59 168.38 19.91 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.383 1.073 . . . . 0.0 112.51 -168.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.89 163.05 30.33 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 119.98 -0.344 . . . . 0.0 112.385 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -114.49 135.15 12.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 174.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.5 mt -78.28 122.49 33.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -69.86 155.85 92.76 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -57.27 122.93 12.65 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.991 1.127 . . . . 0.0 109.461 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -3.72 86.75 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.338 -1.256 . . . . 0.0 114.594 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.98 158.92 34.53 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 120.279 2.04 . . . . 0.0 110.753 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 m -98.97 155.83 17.22 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.07 86.48 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.132 -0.98 . . . . 0.0 111.389 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -37.08 84.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.907 0.883 . . . . 0.0 110.287 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -68.76 -39.24 80.37 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.667 -0.646 . . . . 0.0 110.084 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.29 94.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -60.15 -50.88 71.94 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.146 -0.93 . . . . 0.0 108.903 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -66.29 -37.24 84.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.893 1.224 . . . . 0.0 112.521 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -63.77 -49.8 71.54 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.069 1.304 . . . . 0.0 109.133 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -76.78 -25.67 53.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -169.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.04 -40.73 73.92 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.725 -1.235 . . . . 0.0 110.111 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -70.85 -37.82 73.15 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.52 0.6 . . . . 0.0 110.537 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.39 -34.2 72.29 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.2 -0.937 . . . . 0.0 111.808 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.78 -52.86 4.54 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.415 1.086 . . . . 0.0 110.114 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.27 -30.1 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.359 1.464 . . . . 0.0 110.233 -168.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 0.77 89.96 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.944 0.783 . . . . 0.0 112.38 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.2 tp -83.78 155.33 23.08 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.694 1.998 . . . . 0.0 109.334 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 p -133.81 169.13 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.296 1.038 . . . . 0.0 109.751 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -52.48 -33.02 42.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.919 1.688 . . . . 0.0 112.306 -170.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -63.26 -28.02 69.74 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.293 0.637 . . . . 0.0 111.897 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.9 23.27 12.72 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 112.159 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 165.86 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 120.782 -1.199 . . . . 0.0 112.016 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 136.67 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.4 mt -76.12 115.71 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 103' ' ' GLN . 72.7 mt -89.18 -36.44 15.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.607 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.79 166.45 33.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.117 0.567 . . . . 0.0 109.778 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 p -161.24 155.6 22.93 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.981 1.312 . . . . 0.0 110.103 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -68.71 137.28 53.98 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.703 -0.623 . . . . 0.0 111.116 -169.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -81.51 -28.64 33.93 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.214 1.406 . . . . 0.0 109.894 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -120.91 150.38 41.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.613 2.365 . . . . 0.0 108.177 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -81.48 133.38 35.39 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.4 mt -91.15 136.85 32.8 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -129.63 156.98 43.35 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.933 0.893 . . . . 0.0 111.431 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -143.36 125.92 15.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -80.17 137.43 36.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.07 142.87 93.6 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.702 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.01 146.49 71.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 104.923 -2.76 . . . . 0.0 104.923 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.61 -11.18 60.63 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.008 -1.682 . . . . 0.0 113.889 -168.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -60.63 -31.42 70.62 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.973 0.806 . . . . 0.0 112.613 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.3 mt -92.04 -22.23 20.06 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 111.504 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.89 136.88 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -106.52 92.79 4.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.037 0.935 . . . . 0.0 110.063 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -68.4 -24.29 64.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.015 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -75.3 -25.57 58.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.386 0.674 . . . . 0.0 112.578 -170.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -110.55 156.71 20.53 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.113 0.965 . . . . 0.0 109.338 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -127.87 137.64 31.21 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 109.975 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.25 149.72 93.66 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.874 0.934 . . . . 0.0 110.177 -10.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.6 p -78.22 134.33 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 110.142 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.4 p -74.25 126.17 30.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.935 0.894 . . . . 0.0 109.4 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.85 -13.67 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 171.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.35 175.65 46.41 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -151.52 145.25 25.04 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.33 1.452 . . . . 0.0 108.961 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.03 133.83 34.2 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 169.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -129.48 123.96 32.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.89 0.768 . . . . 0.0 109.987 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -103.68 127.38 51.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.123 0.969 . . . . 0.0 108.407 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -105.75 153.93 21.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -132.97 128.78 37.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.483 1.113 . . . . 0.0 108.264 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -93.01 124.54 37.06 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.4 mt -119.2 149.4 41.8 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.62 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.4 tt0 -99.71 126.75 45.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 167.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.45 138.65 58.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.318 1.047 . . . . 0.0 108.794 170.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.8 t -90.72 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.414 0.552 . . . . 0.0 110.556 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.0 m -85.59 -18.71 32.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.218 0.607 . . . . 0.0 111.02 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.52 21.4 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.89 -21.14 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.607 1.963 . . . . 0.0 113.345 -172.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.29 -30.01 59.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.579 0.752 . . . . 0.0 113.028 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -93.58 15.65 15.63 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.9 mt -91.74 135.61 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -122.23 -51.84 1.97 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.331 0.652 . . . . 0.0 112.165 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 mtp 65.64 16.82 10.68 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.416 2.287 . . . . 0.0 113.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -140.58 29.84 1.93 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.276 1.512 . . . . 0.0 112.142 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -51.41 70.02 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.659 1.583 . . . . 0.0 108.345 169.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.5 m -68.96 156.45 38.55 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.576 169.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -65.89 -33.48 75.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.015 0.526 . . . . 0.0 110.456 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.56 134.83 33.36 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 124.997 1.319 . . . . 0.0 107.973 169.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.38 122.28 11.4 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.474 2.116 . . . . 0.0 107.315 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.39 -33.4 72.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.933 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -117.77 138.81 51.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 170.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.19 -19.6 46.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.6 161.79 32.02 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.65 159.07 43.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -151.88 164.87 36.18 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.147 0.979 . . . . 0.0 109.165 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -114.87 127.38 55.67 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.6 m -139.03 152.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.481 1.112 . . . . 0.0 110.0 -170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -59.63 147.63 36.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.476 0.58 . . . . 0.0 109.471 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.95 54.17 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.465 1.106 . . . . 0.0 113.778 -169.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -88.87 -22.66 23.05 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.332 -0.855 . . . . 0.0 113.09 -172.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -58.24 -49.06 95.69 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.248 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.85 -29.3 76.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.169 1.81 . . . . 0.0 111.819 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.86 -30.97 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.426 -0.796 . . . . 0.0 110.26 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -68.3 -27.73 66.56 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.166 -0.959 . . . . 0.0 111.31 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -83.6 -24.52 31.44 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -168.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.38 160.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.686 0.755 . . . . 0.0 112.713 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.7 175.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.254 1.421 . . . . 0.0 109.856 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.7 m -55.86 -55.93 26.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.944 1.697 . . . . 0.0 113.002 -173.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -70.17 -32.32 70.21 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.584 -0.697 . . . . 0.0 111.346 -171.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -74.17 -48.05 31.73 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.702 -0.666 . . . . 0.0 109.974 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -63.48 -30.93 71.97 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.706 1.139 . . . . 0.0 112.204 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.7 -35.31 74.25 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.579 0.752 . . . . 0.0 111.842 174.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.81 -49.53 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 124.494 1.118 . . . . 0.0 109.949 170.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -62.39 -31.99 72.74 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.755 1.162 . . . . 0.0 111.106 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -61.6 -43.44 98.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.487 1.04 . . . . 0.0 111.384 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -61.13 -45.69 93.62 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.366 0.985 . . . . 0.0 110.239 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.68 -26.11 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.063 0.945 . . . . 0.0 111.58 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.1 mmt -90.81 -56.29 3.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.998 0.919 . . . . 0.0 108.885 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -57.3 -33.65 67.9 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.462 1.028 . . . . 0.0 112.551 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -63.45 -32.81 74.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 122.947 0.499 . . . . 0.0 110.574 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.516 ' HB3' HD12 ' A' ' 101' ' ' LEU . 8.0 m-85 -111.58 -14.83 13.61 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.284 1.033 . . . . 0.0 112.889 -174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.41 -39.97 67.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.594 1.558 . . . . 0.0 110.794 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.8 m -67.1 -31.6 72.18 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.971 0.908 . . . . 0.0 110.785 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -46.21 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.13 -39.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 117.851 -1.071 . . . . 0.0 109.714 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.6 mmt -55.34 -48.92 73.49 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 119.773 1.17 . . . . 0.0 110.437 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.8 m -79.6 -26.05 41.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.779 1.232 . . . . 0.0 110.957 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.3 tp -63.05 -41.39 99.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.612 1.165 . . . . 0.0 109.936 174.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -58.46 -44.16 89.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 110.154 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.18 -31.39 64.19 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.713 0.805 . . . . 0.0 111.685 -171.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -89.12 -32.68 17.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.129 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.284 12.4 t 39.35 62.59 5.02 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -75.45 59.7 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.685 2.923 . . . . 0.0 115.568 -166.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.807 2.043 . . . . 0.0 112.118 169.591 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 119.66 -0.209 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 143.71 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -69.33 0.26 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -164.74 -48.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.166 0.986 . . . . 0.0 112.7 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -92.13 16.67 10.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.594 1.158 . . . . 0.0 113.137 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.7 63.58 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.312 0.958 . . . . 0.0 113.854 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -93.29 153.78 18.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.499 1.15 . . . . 0.0 108.053 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.16 126.58 17.61 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.595 174.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -72.33 141.13 34.87 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.108 1.872 . . . . 0.0 111.496 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -140.25 156.44 46.48 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.802 0.841 . . . . 0.0 109.079 -173.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.74 150.36 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.454 ' HA3' ' CE3' ' A' ' 99' ' ' TRP . . . -128.92 157.53 21.61 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -125.16 142.83 40.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 109.056 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -130.43 137.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 mm -120.01 132.39 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' A' ' 22' ' ' VAL . 78.1 m -119.91 140.6 50.63 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.682 0.674 . . . . 0.0 109.965 173.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -94.8 174.04 7.3 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.02 -2.37 30.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 120.281 -1.512 . . . . 0.0 112.678 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -85.61 -2.91 58.65 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.971 1.308 . . . . 0.0 111.582 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.87 19.48 76.93 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.819 0.736 . . . . 0.0 111.711 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -88.55 142.51 27.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 171.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.0 m -108.48 142.43 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.37 1.468 . . . . 0.0 108.935 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.0 tpp -60.85 134.65 57.3 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.957 1.303 . . . . 0.0 108.822 170.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -143.3 120.39 11.43 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.6 151.05 29.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.811 1.187 . . . . 0.0 109.836 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -145.48 162.29 37.71 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.176 1.39 . . . . 0.0 114.102 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.65 149.47 35.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 126.724 2.009 . . . . 0.0 113.872 -168.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -52.46 124.86 14.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.527 1.931 . . . . 0.0 109.489 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.67 8.31 76.49 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.205 -1.331 . . . . 0.0 114.524 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -109.18 157.41 18.81 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.589 1.695 . . . . 0.0 110.573 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -134.39 15.0 3.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 112.258 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.5 m -107.18 127.78 53.82 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -92.05 139.56 30.52 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -156.62 158.54 37.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.193 2.197 . . . . 0.0 107.731 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -73.35 151.84 89.92 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.445 169.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.42 141.17 97.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.969 2.446 . . . . 0.0 112.259 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -161.85 176.09 11.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.886 -0.509 . . . . 0.0 112.046 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.86 168.61 40.98 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.333 0.492 . . . . 0.0 112.553 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.51 146.39 27.31 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -77.73 127.07 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -69.47 152.68 96.29 Favored Pre-proline 0 N--CA 1.464 0.272 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.48 124.04 14.93 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 108.958 -1.209 . . . . 0.0 108.958 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.41 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.679 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -71.96 159.26 34.53 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.072 1.936 . . . . 0.0 110.229 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 p -102.12 156.57 17.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.33 85.91 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.408 -0.808 . . . . 0.0 111.901 -169.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.19 -35.56 76.38 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.572 0.749 . . . . 0.0 109.588 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -71.86 -37.04 70.28 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.61 91.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -61.61 -50.88 70.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -66.19 -40.97 90.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.228 0.922 . . . . 0.0 110.825 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.5 ttm-85 -66.37 -48.38 70.38 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.672 1.124 . . . . 0.0 109.688 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -72.84 -29.35 63.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.56 -47.64 79.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.864 0.756 . . . . 0.0 109.165 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.97 -39.21 91.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.934 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.42 -40.32 93.21 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.355 0.979 . . . . 0.0 112.061 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.13 -51.38 9.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.885 1.274 . . . . 0.0 110.357 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 m -123.8 8.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.188 1.395 . . . . 0.0 113.538 -168.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.27 8.41 62.1 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.791 0.723 . . . . 0.0 113.599 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 tp -98.6 141.14 31.81 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.417 1.887 . . . . 0.0 109.945 -171.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 p -115.43 165.53 12.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.003 1.321 . . . . 0.0 109.926 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -48.69 -34.18 11.46 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.109 1.764 . . . . 0.0 112.053 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -29.61 70.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.759 -171.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -113.35 25.86 10.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.793 1.179 . . . . 0.0 111.628 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.52 165.0 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 O-C-N 120.818 -1.176 . . . . 0.0 111.501 172.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -139.32 144.29 38.22 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.1 mt -82.52 120.2 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' A' ' 103' ' ' GLN . 96.1 mt -95.23 -35.98 11.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.615 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -158.02 161.33 38.07 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.698 0.799 . . . . 0.0 109.348 -171.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -162.35 154.43 18.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.177 1.391 . . . . 0.0 109.669 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.5 HG22 ' HG3' ' A' ' 150' ' ' GLU . 1.2 p -71.09 139.55 50.38 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.852 -0.53 . . . . 0.0 110.261 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -57.06 4.14 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -89.28 151.62 22.01 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.389 1.476 . . . . 0.0 109.188 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -83.21 135.71 34.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.011 0.369 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.81 96.51 10.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -98.19 150.72 21.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.052 0.941 . . . . 0.0 110.437 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -147.27 144.69 29.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 168.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.6 143.89 26.45 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mt -68.23 138.82 92.09 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 169.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.81 148.13 86.14 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 N-CA-C 105.264 -2.629 . . . . 0.0 105.264 167.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -69.14 -11.9 61.2 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.033 -1.667 . . . . 0.0 113.838 -168.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.9 -32.19 73.63 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.944 0.793 . . . . 0.0 112.522 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -92.8 -22.06 19.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.006 0.922 . . . . 0.0 111.567 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.46 136.2 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -103.14 88.68 3.2 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 122.005 0.907 . . . . 0.0 110.456 174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -68.52 -22.6 64.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.666 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.06 -9.1 58.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.749 0.819 . . . . 0.0 112.876 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.7 t -128.17 160.86 30.74 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.095 0.958 . . . . 0.0 109.917 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -128.43 135.32 27.38 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 125.346 1.458 . . . . 0.0 109.563 -173.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.54 148.36 91.38 Favored 'Cis proline' 0 CA--C 1.538 0.693 0 O-C-N 122.665 0.824 . . . . 0.0 110.534 -10.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 p -77.62 134.98 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.659 0.784 . . . . 0.0 109.75 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.0 p -80.2 127.32 32.21 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.91 0.884 . . . . 0.0 109.07 172.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.03 -17.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.02 0.827 . . . . 0.0 113.174 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.51 168.22 37.35 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 119.772 1.169 . . . . 0.0 110.197 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -152.62 150.9 29.99 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.657 1.183 . . . . 0.0 107.889 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 127.04 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -113.78 135.14 54.28 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.825 0.85 . . . . 0.0 110.209 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -113.27 125.08 53.91 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.454 ' CE3' ' HA3' ' A' ' 12' ' ' GLY . 89.1 m95 -104.45 149.92 25.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -173.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -133.37 131.66 40.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.835 0.854 . . . . 0.0 108.832 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 18.8 tp -96.32 119.72 35.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 168.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.09 144.95 40.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.7 tt0 -96.9 129.65 44.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.66 135.02 57.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.2 t -85.91 -44.13 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.049 0.386 . . . . 0.0 110.608 -169.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.1 m -90.19 -19.57 24.06 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.388 0.675 . . . . 0.0 111.198 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.76 -170.42 19.06 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 124.528 1.061 . . . . 0.0 110.558 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.81 -20.84 38.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.624 1.57 . . . . 0.0 113.568 -172.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.46 47.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -93.24 14.63 17.61 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -173.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 54.2 mt -86.08 140.98 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -133.86 122.03 22.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.346 1.058 . . . . 0.0 108.445 171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mmt -89.28 -3.18 58.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.07 0.948 . . . . 0.0 112.252 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -136.63 83.09 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.321 2.01 . . . . 0.0 108.835 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.7 p -74.5 -60.67 2.17 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 128.158 2.583 . . . . 0.0 107.872 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.9 m -72.36 174.05 7.88 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.097 1.759 . . . . 0.0 109.27 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.1 m -61.46 -37.0 82.02 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.554 -0.716 . . . . 0.0 109.601 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.33 140.43 45.32 Favored Pre-proline 0 N--CA 1.44 -0.945 0 C-N-CA 125.842 1.657 . . . . 0.0 108.577 169.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.93 140.31 94.71 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.926 1.751 . . . . 0.0 108.558 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -76.36 -38.37 55.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -119.4 152.28 37.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.678 1.591 . . . . 0.0 109.542 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -126.52 -25.4 3.44 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.917 1.287 . . . . 0.0 110.149 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.36 130.96 10.49 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -157.9 130.51 7.28 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.891 1.345 . . . . 0.0 108.608 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -152.08 161.18 43.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.811 1.244 . . . . 0.0 109.084 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -111.52 134.45 53.1 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.05 153.24 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.154 0.981 . . . . 0.0 111.485 -169.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.6 m -59.95 140.34 56.79 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.013 0.824 . . . . 0.0 109.212 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.93 -36.3 48.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -169.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -80.94 -21.81 40.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.008 1.276 . . . . 0.0 112.912 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -66.92 -45.59 53.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.88 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.7 -14.3 41.42 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.697 1.999 . . . . 0.0 113.759 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.1 t -67.57 -33.71 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -63.17 -34.96 78.76 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.812 -1.18 . . . . 0.0 111.689 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -82.76 -19.86 37.03 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -168.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 m -79.95 165.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 118.972 0.806 . . . . 0.0 110.32 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.73 176.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.911 1.285 . . . . 0.0 109.768 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.1 m -52.93 -50.38 64.13 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.683 1.593 . . . . 0.0 114.179 -171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -72.49 -26.93 61.97 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.972 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -84.29 -43.01 15.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.203 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -44.86 -45.25 10.14 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.992 0.917 . . . . 0.0 111.061 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.46 -35.66 76.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.877 0.871 . . . . 0.0 111.592 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 36.4 t -76.72 -49.94 22.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 C-N-CA 124.792 1.237 . . . . 0.0 110.408 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -61.91 -35.35 78.12 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.716 0.807 . . . . 0.0 111.537 -168.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.02 -39.89 95.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.974 172.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -62.25 -47.01 86.27 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.633 1.106 . . . . 0.0 110.633 172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 81.3 t -55.19 -33.1 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.425 1.011 . . . . 0.0 110.971 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.5 mmt -80.74 -56.89 3.83 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.896 0.878 . . . . 0.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -35.73 72.39 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.483 1.038 . . . . 0.0 111.852 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 71' ' ' THR . 23.5 mm-40 -58.06 -40.68 81.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.528 1.131 . . . . 0.0 111.614 -175.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -111.04 -14.43 13.92 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.822 0.701 . . . . 0.0 110.961 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.88 62.48 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.701 1.601 . . . . 0.0 111.031 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.5 m -67.28 -31.62 72.07 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.339 0.656 . . . . 0.0 110.907 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.23 -45.04 72.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 170.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.44 -39.82 76.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.21 -173.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -54.68 -52.51 62.14 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 120.887 1.676 . . . . 0.0 109.717 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.5 m -72.37 -27.13 62.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.223 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.95 -45.61 91.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.212 1.405 . . . . 0.0 109.701 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.35 -43.82 98.22 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.327 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.99 -34.6 71.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.768 0.827 . . . . 0.0 111.868 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -88.51 -27.2 21.61 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.579 -0.725 . . . . 0.0 109.095 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.298 9.7 t 40.1 59.72 7.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.156 1.782 . . . . 0.0 107.572 -169.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.25 162.4 41.95 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 C-N-CA 121.797 1.665 . . . . 0.0 111.271 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.928 0.891 . . . . 0.0 108.717 -169.28 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 tmm? . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 mt -126.46 131.99 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.64 -61.99 2.19 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.497 0.719 . . . . 0.0 111.964 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -162.85 -53.42 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -98.01 18.22 16.52 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.651 -168.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.65 9.33 61.44 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.642 0.639 . . . . 0.0 113.513 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -103.85 151.91 22.54 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.507 1.123 . . . . 0.0 108.607 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.57 148.85 63.05 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.369 176.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HB2' HD12 ' A' ' 40' ' ' ILE . 55.4 Cg_endo -90.36 141.12 3.34 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.746 2.297 . . . . 0.0 111.214 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.36 153.04 46.25 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.117 -0.989 . . . . 0.0 110.097 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.594 HG13 HD11 ' A' ' 40' ' ' ILE . 2.5 m -135.28 143.01 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.283 1.433 . . . . 0.0 108.798 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.19 162.66 24.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 123.922 0.772 . . . . 0.0 111.982 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 143.44 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.295 1.438 . . . . 0.0 108.155 -174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.81 134.7 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 168.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.37 136.83 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' SG ' HD11 ' A' ' 101' ' ' LEU . 12.7 p -124.7 162.76 23.49 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.881 0.764 . . . . 0.0 112.457 169.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.5 p30 -110.56 172.93 6.58 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.557 1.543 . . . . 0.0 108.306 171.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.34 8.71 3.14 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.451 -1.406 . . . . 0.0 113.233 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -99.54 -1.92 37.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.512 1.525 . . . . 0.0 111.58 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.12 15.97 80.83 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 118.691 0.678 . . . . 0.0 112.022 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -83.96 151.42 25.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.45 150.58 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.058 1.743 . . . . 0.0 108.501 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -73.23 143.31 47.16 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -147.4 144.29 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.91 146.8 34.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.389 1.904 . . . . 0.0 112.872 -170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -88.98 117.88 28.3 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -71.99 151.25 43.34 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.849 1.204 . . . . 0.0 109.003 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -58.03 129.24 41.05 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.11 6.24 82.47 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.512 -1.16 . . . . 0.0 114.003 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -113.86 164.25 14.0 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.168 1.484 . . . . 0.0 110.046 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -107.94 -13.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.829 0.852 . . . . 0.0 111.952 172.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 p -84.38 154.12 23.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.372 1.469 . . . . 0.0 110.281 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -107.45 143.7 35.42 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -142.2 161.21 38.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.169 1.388 . . . . 0.0 110.151 -169.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -90.43 143.11 28.86 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 169.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.45 131.93 33.75 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.246 2.63 . . . . 0.0 112.088 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -158.31 164.8 36.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.05 167.64 40.17 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.324 0.488 . . . . 0.0 113.026 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.14 147.06 43.82 Favored Glycine 0 N--CA 1.444 -0.788 0 O-C-N 121.497 -1.002 . . . . 0.0 110.604 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.603 HD12 ' HB2' ' A' ' 9' ' ' PRO . 70.7 mt -74.61 129.36 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 169.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.45 148.31 95.33 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.94 123.88 14.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.96 1.774 . . . . 0.0 110.24 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.45 1.7 90.2 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.425 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.53 159.3 32.39 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.515 2.158 . . . . 0.0 111.016 170.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 m -85.06 148.65 26.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.29 -40.14 81.17 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.555 -0.716 . . . . 0.0 111.602 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.86 -35.44 76.92 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.812 0.845 . . . . 0.0 110.248 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -73.55 -39.49 64.69 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.253 -0.904 . . . . 0.0 110.145 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.25 70.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.98 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -59.2 -48.47 81.51 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.169 1.349 . . . . 0.0 108.503 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -64.5 -36.23 83.51 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.35 1.432 . . . . 0.0 111.854 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -59.18 -49.64 77.08 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.328 0.967 . . . . 0.0 110.066 174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -77.14 -26.66 53.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 122.125 -0.359 . . . . 0.0 110.362 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.67 -45.26 85.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.139 -0.976 . . . . 0.0 109.093 169.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -65.95 -45.6 81.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.689 0.677 . . . . 0.0 110.958 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.53 -37.34 86.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.538 1.063 . . . . 0.0 112.447 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -94.36 -47.98 6.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.517 1.127 . . . . 0.0 110.955 -170.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.61 -33.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.83 1.252 . . . . 0.0 109.883 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.2 89.94 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.562 1.077 . . . . 0.0 112.226 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 64' ' ' ASP . 28.7 tp -87.35 155.08 20.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.619 1.968 . . . . 0.0 109.634 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.8 m -133.52 167.35 20.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.126 0.97 . . . . 0.0 109.533 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -47.78 -33.46 7.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.869 2.067 . . . . 0.0 113.112 -173.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.267 0.0 OUTLIER -65.6 -29.89 70.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.284 -171.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' HB3' HD11 ' A' ' 60' ' ' LEU . 4.6 t70 -112.46 24.77 12.16 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.543 1.065 . . . . 0.0 111.541 -177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.35 165.54 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.599 -1.313 . . . . 0.0 112.817 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.38 136.53 36.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.418 HG12 HD11 ' A' ' 102' ' ' LEU . 60.8 mt -74.13 122.44 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 103' ' ' GLN . 62.8 mt -93.83 -35.79 12.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.162 173.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.01 164.0 35.91 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.266 1.026 . . . . 0.0 109.904 -173.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.8 p -152.49 153.91 34.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.122 1.769 . . . . 0.0 108.829 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 150' ' ' GLU . 0.7 OUTLIER -65.2 135.48 55.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.799 -169.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mtt-85 -84.17 -32.35 24.65 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.943 1.297 . . . . 0.0 107.868 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.77 148.19 49.94 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.796 2.038 . . . . 0.0 109.865 172.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -74.69 139.58 43.6 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.68 84.66 5.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -82.01 144.25 31.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -147.6 144.57 28.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 169.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.09 145.47 24.37 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -70.84 145.38 91.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 124.845 1.258 . . . . 0.0 110.925 170.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -68.16 147.34 72.75 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 104.076 -3.086 . . . . 0.0 104.076 166.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 84' ' ' VAL . 91.4 mttt -68.31 -13.83 62.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 119.927 -1.733 . . . . 0.0 114.509 -168.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -60.2 -29.71 68.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 169.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.3 mt -95.67 -13.28 24.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.11 0.964 . . . . 0.0 112.819 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 81' ' ' LYS . 79.7 t -62.77 133.28 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -96.42 91.52 5.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.285 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.14 -21.6 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.968 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.33 -29.09 57.15 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.8 t -99.57 163.88 12.31 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.577 1.151 . . . . 0.0 109.766 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -128.24 130.51 23.56 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.427 1.491 . . . . 0.0 107.022 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.44 159.98 95.31 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 O-C-N 123.043 1.023 . . . . 0.0 110.462 -9.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.14 132.21 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.2 p -87.04 126.78 34.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 170.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.14 -13.52 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.382 0.537 . . . . 0.0 112.312 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.36 -177.48 37.78 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -157.24 156.69 32.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.903 1.281 . . . . 0.0 108.65 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -106.7 126.55 52.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -119.47 128.67 54.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.692 0.678 . . . . 0.0 110.167 -174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.09 153.21 17.91 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CD1' HG22 ' A' ' 147' ' ' VAL . 85.5 m95 -134.1 154.81 50.95 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.237 0.615 . . . . 0.0 109.434 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -135.74 129.62 32.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.458 HD11 ' SG ' ' A' ' 16' ' ' CYS . 12.5 tp -91.14 123.32 34.51 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 67' ' ' ILE . 8.7 mp -115.71 155.16 28.25 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.635 1.174 . . . . 0.0 107.853 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.775 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.4 tt0 -106.15 131.25 53.64 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 168.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.63 140.21 56.85 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.027 0.931 . . . . 0.0 108.957 171.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.6 t -88.15 -44.33 15.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -171.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -90.99 -29.44 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.046 0.538 . . . . 0.0 112.106 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.29 178.82 15.51 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.915 0.769 . . . . 0.0 111.28 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -58.86 -20.86 54.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.691 1.597 . . . . 0.0 114.035 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.8 66.57 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.276 0.631 . . . . 0.0 111.554 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.58 48.08 1.26 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.161 1.785 . . . . 0.0 111.506 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.7 mt -128.5 133.09 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -114.48 -51.54 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.696 0.798 . . . . 0.0 111.972 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.4 mtp 67.98 13.32 9.12 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.017 2.127 . . . . 0.0 114.735 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -151.87 71.03 0.96 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 124.166 1.936 . . . . 0.0 110.394 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -59.11 2.87 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 111.974 -2.375 . . . . 0.0 107.901 169.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.6 m -63.47 161.96 13.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.392 1.477 . . . . 0.0 109.756 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -58.56 -38.57 78.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 130.41 52.7 Favored Pre-proline 0 N--CA 1.442 -0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 110.3 170.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.51 143.62 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 N-CA-C 107.972 -1.588 . . . . 0.0 107.972 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -83.25 -18.29 39.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.894 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.21 141.19 51.8 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.712 0.805 . . . . 0.0 110.321 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.19 -31.89 33.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.021 1.328 . . . . 0.0 110.669 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.32 158.87 29.0 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -125.26 151.28 46.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.161 . . . . 0.0 108.825 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -145.9 166.08 27.04 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -126.51 133.77 51.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.24 157.79 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.937 1.295 . . . . 0.0 110.956 -168.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.2 m -65.98 144.38 56.8 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 169.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 -28.29 63.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -88.01 -20.22 26.11 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.562 1.528 . . . . 0.0 112.924 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.3 -47.92 92.79 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.699 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.54 -27.06 81.48 Favored 'Trans proline' 0 C--N 1.352 0.76 0 CA-C-N 122.828 2.046 . . . . 0.0 112.957 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.89 -27.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.089 1.356 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -65.99 -27.9 68.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.356 -0.84 . . . . 0.0 111.334 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -86.71 -24.36 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.49 156.56 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.805 0.73 . . . . 0.0 112.528 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -76.2 179.02 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 110.184 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.8 m -54.54 -52.12 63.05 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.662 1.585 . . . . 0.0 114.06 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -74.34 -38.73 63.17 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.356 -0.84 . . . . 0.0 110.878 -174.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.81 -44.83 69.2 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.52 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -62.97 -31.81 73.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.349 0.977 . . . . 0.0 111.74 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.57 -42.9 99.84 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.707 0.685 . . . . 0.0 110.924 172.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.73 -51.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.32 -37.61 86.27 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.26 0.937 . . . . 0.0 110.152 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.643 1.111 . . . . 0.0 110.486 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -60.66 -43.39 97.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.877 1.217 . . . . 0.0 110.49 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 99' ' ' TRP . 96.0 t -57.42 -24.46 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 119.788 1.176 . . . . 0.0 111.831 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.6 mmt -90.3 -57.3 2.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -56.14 -34.02 65.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.996 1.318 . . . . 0.0 112.606 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.7 tp10 -65.0 -30.04 71.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.04 0.837 . . . . 0.0 111.412 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.39 -11.43 14.13 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.409 1.083 . . . . 0.0 112.684 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.35 69.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.111 1.364 . . . . 0.0 110.905 -171.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -62.49 -37.96 88.02 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.262 1.425 . . . . 0.0 111.635 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.84 -42.87 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.21 -40.54 65.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 CA-C-O 117.169 -1.396 . . . . 0.0 109.765 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.2 mmt -56.4 -54.11 49.49 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.764 1.62 . . . . 0.0 110.04 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.0 m -64.86 -32.21 73.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.531 1.133 . . . . 0.0 110.94 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.592 ' HG ' HD13 ' A' ' 68' ' ' LEU . 1.2 tm? -68.19 -31.01 70.25 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.326 1.85 . . . . 0.0 111.142 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -72.79 -44.58 61.35 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.961 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.28 -24.62 66.53 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.377 0.671 . . . . 0.0 112.461 -170.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -76.51 -36.27 57.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.338 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.6 t -160.34 79.55 2.45 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 118.856 0.753 . . . . 0.0 109.71 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.48 22.93 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.676 2.917 . . . . 0.0 113.928 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? . . . . . 0 C--O 1.252 1.227 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.162 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 tmm? . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 62.53 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 126.995 2.118 . . . . 0.0 110.757 -170.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -62.68 1.63 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.918 0.887 . . . . 0.0 112.125 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -163.04 -53.31 0.04 OUTLIER 'General case' 0 C--N 1.34 0.186 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -100.84 20.65 14.95 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.641 1.177 . . . . 0.0 113.302 -169.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.49 18.38 49.04 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.494 0.568 . . . . 0.0 113.419 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -107.48 156.1 19.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.08 25.64 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.566 -1.207 . . . . 0.0 108.677 171.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HB2' HD12 ' A' ' 40' ' ' ILE . 13.2 Cg_exo -82.58 136.49 8.57 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.83 1.687 . . . . 0.0 110.454 176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -133.86 160.73 36.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.403 1.481 . . . . 0.0 109.075 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.31 154.79 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 123.518 0.727 . . . . 0.0 109.946 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.24 156.64 23.1 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -116.43 141.98 31.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 125.499 1.519 . . . . 0.0 107.748 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.1 134.9 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.4 mm -115.55 135.11 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 169.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 101' ' ' LEU . 13.0 p -128.55 159.33 35.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.22 0.918 . . . . 0.0 112.289 169.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -110.17 177.3 4.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.744 1.618 . . . . 0.0 108.78 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -75.87 0.36 18.47 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.405 -1.434 . . . . 0.0 112.995 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -88.21 -3.6 58.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.386 1.074 . . . . 0.0 111.013 172.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.49 22.67 76.59 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -90.31 143.27 26.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 m -108.45 145.89 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.513 1.525 . . . . 0.0 107.805 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -87.29 139.43 30.56 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -148.02 146.37 28.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.699 1.599 . . . . 0.0 107.051 -170.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.66 154.79 44.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.226 1.375 . . . . 0.0 113.577 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -98.54 118.23 34.77 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.193 1.797 . . . . 0.0 106.857 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -77.57 141.83 39.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 121.886 2.13 . . . . 0.0 108.471 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -55.13 127.1 27.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.368 1.067 . . . . 0.0 109.477 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -6.39 20.28 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.612 -1.104 . . . . 0.0 115.089 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -91.29 -32.13 15.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.787 1.794 . . . . 0.0 111.656 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.1 m80 64.55 -21.84 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.347 2.259 . . . . 0.0 114.611 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -75.9 160.76 29.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.298 1.439 . . . . 0.0 110.643 169.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -109.03 149.96 28.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.743 0.817 . . . . 0.0 110.939 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -146.89 155.38 42.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.362 1.865 . . . . 0.0 111.122 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -84.12 131.84 49.79 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -51.63 128.08 24.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.328 2.685 . . . . 0.0 112.3 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.36 164.54 36.24 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.751 1.16 . . . . 0.0 112.906 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.16 -178.97 42.75 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 123.458 0.551 . . . . 0.0 112.793 174.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.89 151.25 23.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 124.252 0.929 . . . . 0.0 111.913 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 9' ' ' PRO . 78.5 mt -77.91 126.9 38.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -74.08 156.39 87.78 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.69 122.19 10.66 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 109.038 -1.178 . . . . 0.0 109.038 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 0.0 87.98 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.643 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.14 154.35 41.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.361 2.081 . . . . 0.0 109.837 169.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.07 153.61 17.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.07 84.02 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.324 -0.86 . . . . 0.0 111.719 -172.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.81 -31.95 70.13 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.288 0.635 . . . . 0.0 110.367 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -70.93 -39.6 72.57 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.271 -0.893 . . . . 0.0 109.792 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.31 83.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -63.3 -50.72 68.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.792 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 55.8 m-85 -66.72 -33.06 74.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.926 1.239 . . . . 0.0 111.994 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -60.86 -50.28 74.05 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.07 1.305 . . . . 0.0 109.187 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.27 -27.58 62.58 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.384 0.538 . . . . 0.0 110.33 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.69 -43.43 90.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.138 -0.976 . . . . 0.0 109.454 170.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -69.55 -48.76 59.26 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.474 0.579 . . . . 0.0 110.834 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.85 -30.7 69.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.988 1.267 . . . . 0.0 112.609 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -93.29 -51.48 4.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.153 0.981 . . . . 0.0 110.532 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.61 -31.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.267 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.17 -1.85 78.73 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.464 1.03 . . . . 0.0 112.275 -171.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.76 155.74 32.93 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.645 1.978 . . . . 0.0 108.854 174.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.5 p -133.09 170.3 15.59 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.988 0.915 . . . . 0.0 110.466 -172.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 37.3 mtp180 -46.13 -37.15 6.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.819 2.047 . . . . 0.0 112.52 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -68.77 -26.04 65.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.385 0.674 . . . . 0.0 112.525 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -115.36 23.59 12.3 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.522 0.677 . . . . 0.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.5 165.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 O-C-N 120.734 -1.229 . . . . 0.0 112.729 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.83 132.94 29.61 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 168.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -73.69 116.21 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 103' ' ' GLN . 95.6 mt -89.63 -36.88 15.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.426 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.41 164.7 36.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.864 0.865 . . . . 0.0 109.749 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 p -162.63 153.41 17.11 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.795 1.238 . . . . 0.0 110.265 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.633 HG22 ' HG2' ' A' ' 150' ' ' GLU . 2.6 p -71.89 138.76 48.41 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.635 -0.666 . . . . 0.0 109.579 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -77.86 -51.41 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -70.26 171.12 10.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.478 1.511 . . . . 0.0 110.962 171.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 84.2 m95 -112.38 123.72 50.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 168.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -79.2 142.32 36.38 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.62 152.35 43.9 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.289 1.036 . . . . 0.0 108.955 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -140.3 139.78 35.55 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.974 1.31 . . . . 0.0 108.115 169.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -77.27 139.04 39.74 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.68 139.17 95.76 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.766 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -68.2 145.36 66.19 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 104.431 -2.95 . . . . 0.0 104.431 167.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' HA ' HG23 ' A' ' 84' ' ' VAL . 49.3 mtpt -67.96 -12.94 61.72 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.05 -1.657 . . . . 0.0 114.16 -168.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -60.11 -31.01 69.64 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.809 0.732 . . . . 0.0 112.806 169.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -92.5 -20.01 21.4 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.776 0.83 . . . . 0.0 112.085 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 81' ' ' LYS . 61.5 t -65.16 135.28 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -101.37 89.89 3.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 109.807 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.8 -22.31 63.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.918 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -74.86 -19.22 60.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.573 0.749 . . . . 0.0 112.728 -171.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -117.37 161.0 20.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.487 1.115 . . . . 0.0 109.957 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -128.24 135.45 27.55 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 125.178 1.391 . . . . 0.0 109.59 -172.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.48 148.56 92.16 Favored 'Cis proline' 0 CA--C 1.536 0.614 0 O-C-N 122.731 0.858 . . . . 0.0 110.384 -10.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.76 138.6 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 109.532 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.5 p -89.91 138.58 31.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.0 109.566 170.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.44 -13.07 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 170.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.29 -174.05 31.72 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.09 -178.23 6.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.593 1.157 . . . . 0.0 109.02 -172.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -127.33 137.26 52.76 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 104.322 -2.474 . . . . 0.0 104.322 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -122.59 122.7 39.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 120.82 1.646 . . . . 0.0 107.951 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 ttmm -111.78 129.1 56.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -114.27 152.21 31.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -134.78 121.73 21.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 16' ' ' CYS . 14.9 tp -88.67 119.64 29.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 169.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.56 144.46 43.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.667 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.1 tt0 -97.47 132.7 42.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 168.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 141.93 58.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.532 1.133 . . . . 0.0 108.923 171.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.91 -48.79 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.568 0.622 . . . . 0.0 109.827 -172.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 70.5 m -89.33 -19.58 25.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.408 0.683 . . . . 0.0 111.786 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.38 -169.59 20.67 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.42 -22.35 31.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.093 1.757 . . . . 0.0 113.105 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.44 -30.08 59.84 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.092 0.957 . . . . 0.0 113.438 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -92.62 16.55 11.86 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -172.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.73 139.73 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.694 1.198 . . . . 0.0 108.088 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -120.6 -50.98 2.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.593 0.757 . . . . 0.0 112.304 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.2 mtp 70.44 9.25 6.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.84 2.456 . . . . 0.0 115.122 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.71 76.96 1.03 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 124.016 1.865 . . . . 0.0 110.184 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -74.85 -59.58 2.67 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 112.05 -2.341 . . . . 0.0 107.695 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -66.37 162.73 19.72 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.157 1.383 . . . . 0.0 109.452 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.9 m -63.01 -33.73 76.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.087 0.555 . . . . 0.0 110.367 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.53 128.95 52.89 Favored Pre-proline 0 N--CA 1.447 -0.587 0 C-N-CA 124.911 1.284 . . . . 0.0 110.193 170.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.88 137.23 48.3 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.357 2.038 . . . . 0.0 108.097 168.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.83 -16.0 59.56 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.876 -0.515 . . . . 0.0 111.566 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -119.91 138.43 53.43 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.63 -26.73 45.3 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.924 1.29 . . . . 0.0 111.255 171.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.84 162.37 34.55 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 153.74 45.93 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.306 1.043 . . . . 0.0 108.193 176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -152.42 159.63 43.37 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -109.38 131.99 54.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.72 170.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.062 1.745 . . . . 0.0 109.739 -169.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.8 p -65.41 166.82 9.57 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -18.65 64.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.269 -0.895 . . . . 0.0 111.858 172.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -98.81 -31.62 11.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 113.225 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.21 -43.98 96.21 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.84 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.36 -24.84 76.01 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 122.508 1.931 . . . . 0.0 113.264 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.7 t -67.55 -41.4 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -57.68 -35.53 70.72 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.528 -0.732 . . . . 0.0 111.963 -171.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -79.13 -26.4 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.46 171.66 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 118.499 0.591 . . . . 0.0 112.127 -172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 175.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.9 m -54.7 -49.99 69.39 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.031 1.733 . . . . 0.0 114.208 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -72.35 -32.34 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.178 -0.952 . . . . 0.0 111.459 -174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.1 -39.96 32.38 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.221 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -47.25 -46.2 24.32 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.899 0.88 . . . . 0.0 110.733 170.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.12 -45.76 92.02 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.245 0.341 . . . . 0.0 110.287 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.5 -46.86 88.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.772 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -62.01 -47.68 83.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -64.45 -42.18 96.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.349 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.64 -49.69 76.5 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.436 1.017 . . . . 0.0 110.5 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.9 t -56.68 -42.58 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 124.217 1.007 . . . . 0.0 109.39 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.7 mmt -67.43 -51.81 47.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.268 1.027 . . . . 0.0 108.273 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -37.03 69.91 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.804 0.842 . . . . 0.0 110.729 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.633 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.1 tp10 -59.18 -35.33 73.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 118.797 0.726 . . . . 0.0 111.526 -174.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -106.62 -13.49 15.29 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.641 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.21 -39.13 63.49 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.401 1.48 . . . . 0.0 110.949 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.9 m -66.86 -32.07 73.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.289 0.636 . . . . 0.0 110.722 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.2 -44.95 73.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.4 -40.54 78.64 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 CA-C-O 117.365 -1.303 . . . . 0.0 110.097 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 13.9 mmt -56.07 -51.93 66.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 120.82 1.645 . . . . 0.0 109.969 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -71.25 -28.7 64.36 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.93 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.401 HD21 ' NE2' ' A' ' 103' ' ' GLN . 19.1 tp -63.37 -41.11 98.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.084 1.354 . . . . 0.0 110.184 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -62.8 -43.98 97.38 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.66 -30.02 66.51 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -86.69 -15.69 38.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.595 -170.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.255 33.7 p 41.83 63.81 6.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 126.802 2.041 . . . . 0.0 109.441 -174.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -66.98 -178.93 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 121.507 1.472 . . . . 0.0 114.171 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt . . . . . 0 C--O 1.252 1.197 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.276 13.7 ptm . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.264 0.9 OUTLIER 66.76 134.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.886 2.075 . . . . 0.0 109.41 -168.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -70.85 -68.19 0.45 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.456 0.702 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -163.06 -51.68 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.969 0.908 . . . . 0.0 112.421 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.04 17.04 14.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.811 1.244 . . . . 0.0 112.82 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.54 7.09 65.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.36 0.981 . . . . 0.0 113.741 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -96.19 155.66 16.67 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.49 152.65 71.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.649 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -88.11 134.87 3.14 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.276 1.984 . . . . 0.0 111.135 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -131.79 163.92 27.17 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.022 1.329 . . . . 0.0 109.484 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 98' ' ' LYS . 3.2 m -133.04 167.77 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.263 175.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.45 163.08 33.3 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.82 144.94 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.1 137.91 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.81 133.19 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 22' ' ' VAL . 61.7 m -124.45 145.59 49.42 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.814 0.696 . . . . 0.0 110.571 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -97.74 170.58 8.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.849 1.259 . . . . 0.0 108.626 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -76.61 8.56 3.46 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.039 -1.663 . . . . 0.0 113.151 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.63 -3.68 54.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.386 1.075 . . . . 0.0 111.164 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.35 18.69 79.89 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 118.861 0.755 . . . . 0.0 112.071 -175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -90.23 141.42 28.72 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG12 ' SG ' ' A' ' 16' ' ' CYS . 4.3 m -108.31 147.74 12.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.081 1.753 . . . . 0.0 108.452 178.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 38.6 ttm -65.86 138.58 57.98 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.583 0.753 . . . . 0.0 109.337 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -142.82 140.36 31.28 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.78 1.632 . . . . 0.0 106.833 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -139.17 161.68 36.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.66 1.118 . . . . 0.0 112.187 -171.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -118.97 118.88 32.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.555 1.942 . . . . 0.0 106.978 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -67.21 150.68 48.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.605 1.093 . . . . 0.0 108.873 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.41 142.35 58.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.35 6.57 75.88 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.318 -1.268 . . . . 0.0 114.038 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -134.03 157.21 46.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.543 1.671 . . . . 0.0 109.612 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -98.42 -14.12 20.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.864 0.466 . . . . 0.0 112.227 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -78.57 152.24 31.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.397 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -110.6 158.17 18.87 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.461 1.104 . . . . 0.0 111.155 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -159.74 159.31 32.67 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.728 1.211 . . . . 0.0 110.396 -169.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -80.73 157.49 71.92 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.84 134.65 60.02 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.776 2.317 . . . . 0.0 112.432 169.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -131.26 169.59 15.76 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.059 1.344 . . . . 0.0 112.282 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.08 169.61 38.29 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.571 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.7 137.24 13.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.3 mt -75.14 126.24 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -84.65 150.41 56.43 Favored Pre-proline 0 C--O 1.235 0.324 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.26 122.18 10.28 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.775 1.65 . . . . 0.0 109.832 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.79 -20.64 43.15 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.845 1.212 . . . . 0.0 113.469 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.08 152.92 42.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.722 1.761 . . . . 0.0 109.941 170.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.2 p -83.43 169.8 15.16 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.1 80.55 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 122.001 -0.437 . . . . 0.0 110.461 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.74 -38.79 64.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.592 0.757 . . . . 0.0 110.586 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -67.82 -41.32 83.24 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.251 -0.906 . . . . 0.0 110.03 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -36.41 81.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.956 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.57 -53.72 52.93 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.147 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -67.68 -42.19 82.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.302 0.955 . . . . 0.0 111.706 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -45.44 94.79 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.971 0.509 . . . . 0.0 109.942 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.76 -31.13 35.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.094 -0.479 . . . . 0.0 110.227 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 58' ' ' VAL . 32.9 tp -53.27 -43.27 67.29 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.709 0.686 . . . . 0.0 110.091 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -57.14 -38.21 73.16 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.464 0.574 . . . . 0.0 111.231 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -70.29 -20.89 63.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.097 0.862 . . . . 0.0 111.734 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -94.73 -48.88 5.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.357 1.063 . . . . 0.0 110.936 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 60' ' ' LEU . 3.5 p -120.17 -3.3 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.759 1.224 . . . . 0.0 112.413 -169.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.83 1.02 9.85 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 121.24 -0.913 . . . . 0.0 112.957 -170.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 58' ' ' VAL . 14.6 tp -79.08 144.07 34.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.277 1.031 . . . . 0.0 110.002 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 p -122.5 164.43 18.1 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.647 1.179 . . . . 0.0 109.498 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -40.71 -38.87 0.97 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.168 1.787 . . . . 0.0 112.616 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -67.34 -20.33 65.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.269 -169.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.72 21.03 10.91 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.527 0.603 . . . . 0.0 112.528 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.61 160.36 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.925 -1.109 . . . . 0.0 110.73 170.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -138.12 137.37 37.64 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.13 120.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.624 HD11 ' HB2' ' A' ' 103' ' ' GLN . 96.4 mt -94.76 -36.77 11.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.721 172.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.56 164.3 34.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.127 0.971 . . . . 0.0 109.523 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.0 p -160.42 151.47 19.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.267 1.427 . . . . 0.0 109.897 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -69.09 131.47 45.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.729 0.776 . . . . 0.0 109.645 -172.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -79.81 -48.16 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.563 -1.644 . . . . 0.0 106.563 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -75.53 179.94 4.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.44 2.296 . . . . 0.0 108.247 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.555 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 73.2 m95 -114.49 142.91 45.78 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 168.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.37 85.43 6.57 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -81.44 144.01 31.69 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.43 147.93 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.41 144.67 25.36 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.8 mt -73.05 144.88 85.52 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 124.998 1.319 . . . . 0.0 111.302 171.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.32 149.26 69.46 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 N-CA-C 105.174 -2.664 . . . . 0.0 105.174 166.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.1 mtpt -68.73 -13.46 62.4 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 119.944 -1.723 . . . . 0.0 113.956 -169.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -61.76 -30.78 71.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.094 0.861 . . . . 0.0 112.789 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.64 -18.16 21.61 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.906 0.883 . . . . 0.0 112.123 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 81' ' ' LYS . 80.1 t -63.61 134.9 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -98.9 89.83 4.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.71 0.804 . . . . 0.0 109.687 173.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.5 -21.2 62.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.082 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.81 -30.55 56.46 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -170.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 t -97.64 162.15 13.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.576 1.15 . . . . 0.0 109.523 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -130.67 132.43 23.94 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 125.529 1.532 . . . . 0.0 108.319 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.25 157.33 93.54 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 O-C-N 122.72 0.853 . . . . 0.0 111.307 -10.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.4 t -74.45 138.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.889 0.876 . . . . 0.0 109.455 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 p -89.13 122.64 32.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.899 0.88 . . . . 0.0 108.726 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.8 -14.56 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.184 0.902 . . . . 0.0 113.296 172.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 -175.57 38.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -158.19 158.92 35.48 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.052 0.941 . . . . 0.0 109.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -101.5 124.82 47.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 169.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.22 123.9 50.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.903 1.229 . . . . 0.0 109.548 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.555 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -86.73 149.33 24.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -127.99 153.89 46.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.057 0.844 . . . . 0.0 109.467 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -134.36 134.29 41.58 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.833 1.253 . . . . 0.0 108.451 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.9 tp -98.08 120.86 39.22 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.0 mt -116.97 146.83 42.77 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.624 ' HB2' HD11 ' A' ' 68' ' ' LEU . 4.3 tt0 -97.42 135.69 38.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 168.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.55 132.38 49.72 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.0 t -81.29 -46.0 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 122.74 0.416 . . . . 0.0 110.256 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 t -83.12 -37.31 23.94 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.0 -169.04 12.82 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -170.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 -15.88 38.28 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.61 1.564 . . . . 0.0 114.307 -172.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.03 63.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 0.0 113.031 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -95.12 26.18 3.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.19 0.996 . . . . 0.0 113.357 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 89.7 mt -99.58 139.98 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.808 1.243 . . . . 0.0 108.765 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -138.98 117.2 11.84 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.779 1.232 . . . . 0.0 109.757 173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 mmt -89.78 -4.29 57.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.424 0.69 . . . . 0.0 112.58 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -119.8 75.5 1.08 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 124.207 1.956 . . . . 0.0 107.145 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 p -65.48 -65.07 0.72 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 111.204 -2.725 . . . . 0.0 106.777 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.2 m -78.48 173.63 12.17 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m -58.1 -42.15 85.05 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.166 -0.959 . . . . 0.0 109.168 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.21 134.91 82.48 Favored Pre-proline 0 N--CA 1.443 -0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 108.512 169.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -62.16 135.36 54.15 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 107.537 -1.755 . . . . 0.0 107.537 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -85.17 -34.21 22.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -109.88 135.82 50.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -75.03 -35.08 61.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.671 0.788 . . . . 0.0 110.475 173.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.51 159.48 29.84 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -148.84 158.77 44.41 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.566 0.746 . . . . 0.0 109.057 169.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -145.9 167.57 22.95 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.916 1.286 . . . . 0.0 108.828 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -109.9 129.7 55.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.46 153.98 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.815 1.246 . . . . 0.0 110.714 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 m -57.85 143.04 43.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.036 0.835 . . . . 0.0 109.835 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.83 -32.87 61.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -83.84 -21.23 32.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.158 1.344 . . . . 0.0 112.692 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -60.11 -50.79 84.5 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.118 -1.42 . . . . 0.0 113.407 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.84 -27.7 85.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 122.681 1.993 . . . . 0.0 113.291 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.69 -31.59 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.848 0.859 . . . . 0.0 109.013 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -66.22 -24.42 66.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.163 -0.961 . . . . 0.0 111.679 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.94 -27.91 28.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.14 168.58 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 118.744 0.702 . . . . 0.0 112.397 -169.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -83.16 175.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.379 1.471 . . . . 0.0 110.487 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.4 m -52.44 -51.4 59.39 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.825 1.65 . . . . 0.0 114.586 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -74.05 -36.77 64.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.458 1.026 . . . . 0.0 110.716 -175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -73.05 -36.61 66.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.51 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -51.28 -45.14 62.03 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.106 0.866 . . . . 0.0 110.493 171.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.63 -42.98 95.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.503 0.592 . . . . 0.0 110.926 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.15 -52.62 56.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.55 -32.56 74.21 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.211 -0.93 . . . . 0.0 111.24 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -67.27 -42.83 83.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.237 1.38 . . . . 0.0 110.327 172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -60.41 -42.65 96.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.76 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.2 -25.95 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.49 1.041 . . . . 0.0 111.427 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -88.42 -58.66 2.48 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -33.41 70.47 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.716 1.207 . . . . 0.0 112.501 -172.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.72 -40.12 78.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.391 0.996 . . . . 0.0 110.565 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -106.42 -9.86 16.54 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.272 1.029 . . . . 0.0 112.952 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -39.33 73.12 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 125.187 1.395 . . . . 0.0 110.594 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -67.13 -31.98 72.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.677 0.791 . . . . 0.0 110.653 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.75 -43.63 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.31 -41.36 81.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.083 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -46.53 87.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 120.478 1.49 . . . . 0.0 110.53 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 t -66.46 -28.45 68.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.268 1.027 . . . . 0.0 110.689 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.7 tp -69.59 -31.34 69.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.299 -1.501 . . . . 0.0 109.875 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -75.76 -25.74 56.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.366 -0.834 . . . . 0.0 112.13 170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.67 -9.3 56.78 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.026 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.62 20.98 4.24 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.977 0.894 . . . . 0.0 108.915 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.385 24.6 p 73.71 140.61 0.08 OUTLIER Pre-proline 0 N--CA 1.436 -1.149 1 C-N-CA 133.386 4.674 . . . . 0.0 114.434 170.521 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.34 33.46 0.51 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.444 2.096 . . . . 0.0 113.061 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.254 1.329 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.154 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tmm? . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mt -132.16 130.88 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -62.53 -68.37 0.34 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -164.0 -49.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -87.02 11.32 13.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.104 0.962 . . . . 0.0 112.735 -169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.63 -8.4 79.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.698 1.142 . . . . 0.0 113.069 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -90.4 159.13 16.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.263 1.032 . . . . 0.0 108.498 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -137.65 142.33 36.42 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.248 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HB2' HD12 ' A' ' 40' ' ' ILE . 69.5 Cg_endo -89.34 135.91 2.71 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.879 1.719 . . . . 0.0 111.035 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -138.3 159.75 41.25 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.158 -0.964 . . . . 0.0 110.387 -173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.56 159.8 34.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 119.538 1.063 . . . . 0.0 110.418 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.88 160.21 24.21 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 173.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.05 143.66 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.182 1.393 . . . . 0.0 107.762 -176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.01 136.93 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mm -121.09 133.03 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 101' ' ' LEU . 13.0 p -124.97 156.65 37.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.506 0.594 . . . . 0.0 111.623 170.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -104.51 172.73 6.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.438 1.495 . . . . 0.0 108.18 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -73.79 2.6 8.01 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.269 -1.519 . . . . 0.0 113.119 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -88.01 -4.84 58.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.069 0.947 . . . . 0.0 111.277 170.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.57 19.87 79.75 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 118.943 0.792 . . . . 0.0 111.601 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.87 147.01 25.3 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.09 148.72 17.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.171 1.789 . . . . 0.0 107.058 174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.6 ptm -76.12 148.5 37.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.392 0.542 . . . . 0.0 109.863 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -148.22 140.1 23.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -174.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB1' ' CD2' ' A' ' 121' ' ' PHE . . . -144.32 148.17 34.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.426 1.466 . . . . 0.0 113.087 -169.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -101.06 115.29 30.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.661 1.984 . . . . 0.0 106.559 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -68.75 151.6 46.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.663 1.119 . . . . 0.0 109.226 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -60.32 132.52 54.17 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.07 5.46 85.03 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.746 1.165 . . . . 0.0 113.726 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -115.3 162.32 17.27 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.33 1.565 . . . . 0.0 110.296 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.62 -13.68 16.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.479 0.711 . . . . 0.0 111.662 170.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -86.34 150.35 24.39 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.726 1.61 . . . . 0.0 110.968 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -103.61 151.64 22.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.141 0.977 . . . . 0.0 110.061 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -155.18 166.87 32.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.139 1.376 . . . . 0.0 110.211 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -85.38 155.15 59.97 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.95 127.2 19.77 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.321 2.014 . . . . 0.0 110.473 172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -157.55 163.55 38.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.745 0.818 . . . . 0.0 111.773 -173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.69 44.26 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 121.792 -0.567 . . . . 0.0 113.454 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.75 152.6 41.06 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 124.733 1.159 . . . . 0.0 112.075 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 9' ' ' PRO . 62.2 mt -84.03 122.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 169.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.22 159.38 85.58 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.0 123.87 14.44 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 121.199 1.266 . . . . 0.0 109.414 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.17 -6.07 80.79 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-O 118.772 -1.015 . . . . 0.0 114.646 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -71.37 156.55 39.36 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.043 1.922 . . . . 0.0 109.227 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -93.26 167.29 11.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.67 83.37 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.62 -0.675 . . . . 0.0 110.987 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -36.46 69.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.299 0.64 . . . . 0.0 110.503 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -71.76 -36.21 70.33 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.893 -1.129 . . . . 0.0 110.629 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.21 86.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -63.4 -51.74 64.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.104 -0.951 . . . . 0.0 108.672 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -66.76 -31.74 72.59 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 112.133 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.1 ttm-85 -63.69 -52.95 58.34 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.528 1.058 . . . . 0.0 109.071 172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -71.23 -25.07 62.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -172.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.73 -42.51 88.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.589 171.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -71.91 -50.14 31.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.121 0.873 . . . . 0.0 110.753 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.28 -21.92 66.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.905 1.229 . . . . 0.0 112.806 -170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.39 -53.5 2.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.791 1.236 . . . . 0.0 111.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.2 -21.92 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 112.396 -168.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.4 -3.19 33.66 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.204 1.383 . . . . 0.0 112.887 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.77 157.95 34.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.712 2.005 . . . . 0.0 109.768 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 p -137.11 168.15 20.16 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 110.185 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -53.14 -34.09 55.29 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.099 1.76 . . . . 0.0 112.292 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.781 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.95 24.39 12.72 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.844 1.202 . . . . 0.0 111.419 -174.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -138.74 166.06 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.912 -1.118 . . . . 0.0 112.266 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 133.73 27.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.599 169.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.57 113.01 10.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 103' ' ' GLN . 70.8 mt -88.16 -34.0 18.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.489 173.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.98 163.44 39.12 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 109.759 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 p -158.66 154.33 26.26 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 125.112 1.365 . . . . 0.0 110.04 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.416 HG22 ' HG2' ' A' ' 150' ' ' GLU . 2.1 p -69.04 139.72 54.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.508 0.671 . . . . 0.0 111.472 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -86.11 -28.48 23.99 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.804 1.642 . . . . 0.0 109.838 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -121.77 148.64 44.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.022 2.129 . . . . 0.0 108.536 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -80.68 133.39 35.7 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.24 64.79 7.06 Favored 'General case' 0 N--CA 1.46 0.072 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -71.52 146.17 48.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -142.94 145.53 33.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.285 0.634 . . . . 0.0 110.256 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -90.26 147.04 23.77 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 169.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.5 mt -66.87 148.06 98.92 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.823 0.849 . . . . 0.0 109.782 169.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -66.92 143.86 68.11 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 N-CA-C 104.311 -2.996 . . . . 0.0 104.311 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HA ' HG23 ' A' ' 84' ' ' VAL . 50.1 mtpt -67.99 -13.07 61.89 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.051 -1.656 . . . . 0.0 114.135 -168.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -57.15 -30.56 64.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 170.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.8 mt -91.79 -20.49 21.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.382 0.673 . . . . 0.0 112.034 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.509 HG23 ' HA ' ' A' ' 81' ' ' LYS . 48.0 t -67.17 135.23 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -103.34 89.97 3.56 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.188 0.995 . . . . 0.0 108.486 169.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.423 ' CE2' HG11 ' A' ' 84' ' ' VAL . 84.7 m95 -65.28 -9.31 23.1 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.17 27.93 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.443 1.097 . . . . 0.0 110.472 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.6 p -77.16 157.72 30.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.113 0.959 . . . . 0.0 112.873 -169.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -130.56 110.16 16.13 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.697 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.37 142.26 64.97 Favored 'Cis proline' 0 CA--C 1.537 0.66 0 N-CA-C 108.09 -1.542 . . . . 0.0 108.09 -11.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 91' ' ' VAL . 1.4 p -64.47 133.96 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 O-C-N 121.659 -0.65 . . . . 0.0 110.79 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.3 t -72.57 124.73 25.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.97 -14.9 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.24 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.42 -179.56 48.85 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 119.689 1.131 . . . . 0.0 110.342 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.77 152.98 45.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.969 1.308 . . . . 0.0 110.037 173.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -93.55 135.51 34.75 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -128.42 129.34 46.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.09 0.859 . . . . 0.0 110.485 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -111.92 142.02 44.84 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -124.2 155.28 38.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.417 0.553 . . . . 0.0 109.703 -172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -137.73 125.64 22.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.42 HD11 ' SG ' ' A' ' 16' ' ' CYS . 10.9 tp -92.33 122.77 35.11 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 168.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mt -117.87 148.28 42.27 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.459 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.0 tt0 -97.34 132.37 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.76 138.31 58.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.881 1.272 . . . . 0.0 108.922 171.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -88.38 -49.45 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.241 0.616 . . . . 0.0 110.09 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.2 m -87.08 -19.38 28.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 111.377 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.77 -169.39 20.13 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.4 -20.42 44.14 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.649 1.58 . . . . 0.0 113.792 -171.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.65 -30.58 43.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.508 1.123 . . . . 0.0 112.839 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -93.87 13.0 23.97 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 66.9 mt -85.17 137.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -136.7 105.2 5.77 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.1 mmt -82.67 1.7 37.17 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -129.67 73.97 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 123.942 1.83 . . . . 0.0 107.961 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.6 p -70.05 -64.13 0.95 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.589 -2.096 . . . . 0.0 105.558 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.0 m -72.44 167.24 20.99 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.459 1.503 . . . . 0.0 107.647 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.2 m -61.46 -41.16 96.79 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.286 -0.884 . . . . 0.0 109.171 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.49 132.76 89.27 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.67 1.588 . . . . 0.0 109.387 170.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.94 143.3 99.32 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.763 1.642 . . . . 0.0 109.537 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -86.74 -21.1 26.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.76 0.424 . . . . 0.0 110.673 172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.436 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 85.2 m-85 -128.37 144.07 51.09 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.067 0.947 . . . . 0.0 109.136 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.74 -30.52 59.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.152 0.981 . . . . 0.0 110.522 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.86 155.54 26.44 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.65 150.39 37.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -146.58 170.28 17.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.236 1.415 . . . . 0.0 109.13 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -116.2 137.23 52.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.05 154.17 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 109.954 -169.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.8 m -60.32 144.06 51.45 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.947 0.794 . . . . 0.0 109.504 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -25.42 63.83 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -88.66 -10.9 46.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 120.403 1.456 . . . . 0.0 113.38 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -72.79 -47.35 8.9 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.608 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.84 -24.53 68.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.903 2.073 . . . . 0.0 112.921 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.2 -30.77 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.268 1.027 . . . . 0.0 109.273 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.06 -24.4 63.24 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.042 -1.036 . . . . 0.0 111.514 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -81.18 -30.12 34.44 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.068 0.849 . . . . 0.0 112.87 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.12 168.43 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 118.554 0.615 . . . . 0.0 112.638 -169.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -85.13 175.33 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.206 1.402 . . . . 0.0 110.417 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -52.65 -50.68 62.7 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.617 1.567 . . . . 0.0 114.64 -169.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -74.16 -34.74 63.91 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.142 0.883 . . . . 0.0 110.984 -175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -75.4 -37.92 60.2 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.705 -0.622 . . . . 0.0 110.353 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -50.18 -44.11 52.73 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.538 171.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -65.45 -41.52 93.34 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.626 0.648 . . . . 0.0 111.064 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.9 -53.0 46.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -65.11 -31.93 73.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.385 0.993 . . . . 0.0 112.229 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -66.21 -44.6 83.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.255 1.389 . . . . 0.0 110.276 171.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -59.54 -43.76 93.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.378 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 86.8 t -56.95 -27.95 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.571 1.148 . . . . 0.0 111.779 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 33.3 mmt -87.75 -58.18 2.67 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -58.18 -36.07 72.52 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.082 0.953 . . . . 0.0 112.276 -173.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' A' ' 71' ' ' THR . 1.7 tp10 -58.81 -36.82 75.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 119.086 0.857 . . . . 0.0 110.723 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -105.27 -12.76 15.93 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.055 0.942 . . . . 0.0 112.337 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.96 68.7 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.416 1.487 . . . . 0.0 110.78 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.4 m -68.19 -30.65 69.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.759 0.823 . . . . 0.0 111.058 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.9 t -69.68 -43.03 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -58.72 -43.88 88.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.545 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -45.19 84.37 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 121.991 2.178 . . . . 0.0 111.666 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -81.2 -8.71 59.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 125.146 1.378 . . . . 0.0 111.924 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.84 -42.5 19.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 120.417 -1.427 . . . . 0.0 108.851 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -59.45 -41.8 90.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.636 ' C ' HD22 ' A' ' 161' ' ' ASN . 38.4 mt-10 -89.56 40.99 1.02 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.195 1.398 . . . . 0.0 114.226 170.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.636 HD22 ' C ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER 39.21 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 136.257 5.823 . . . . 0.0 120.679 165.458 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 160' ' ' GLU . 6.3 t -136.04 77.28 49.93 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.85 158.44 51.06 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.167 1.911 . . . . 0.0 110.296 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.253 1.248 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.531 -169.682 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 119.007 -0.52 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.03 143.95 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.48 -77.46 0.07 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.682 0.793 . . . . 0.0 110.903 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -164.47 -44.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -91.79 16.89 9.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.712 1.205 . . . . 0.0 113.072 -169.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 17.29 60.28 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.11 0.862 . . . . 0.0 112.929 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -111.93 155.31 23.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.8 128.08 22.92 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.44 141.27 46.07 Favored 'Trans proline' 0 C--N 1.345 0.391 0 CA-C-N 121.328 1.51 . . . . 0.0 110.053 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -138.43 148.24 44.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.78 0.832 . . . . 0.0 109.214 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 40' ' ' ILE . 4.6 m -134.52 149.99 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 125.206 1.402 . . . . 0.0 108.081 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 37' ' ' GLN . . . -144.85 161.6 28.08 Favored Glycine 0 N--CA 1.448 -0.51 0 O-C-N 122.043 -0.411 . . . . 0.0 112.246 174.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.21 143.2 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 122.991 0.517 . . . . 0.0 109.933 -169.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 t -122.44 131.59 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 mm -108.39 130.96 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.597 ' SG ' HG12 ' A' ' 22' ' ' VAL . 64.2 m -111.98 146.82 37.18 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 124.362 1.039 . . . . 0.0 109.289 169.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -98.78 176.65 5.54 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 14.38 3.71 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.905 -1.122 . . . . 0.0 113.028 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -106.35 -3.85 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.587 1.555 . . . . 0.0 111.307 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.47 83.22 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.756 -170.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -80.56 149.8 29.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.075 1.438 . . . . 0.0 107.477 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.597 HG12 ' SG ' ' A' ' 16' ' ' CYS . 6.4 m -128.03 153.49 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.969 2.107 . . . . 0.0 108.424 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.7 ptm -68.18 153.7 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.845 0.458 . . . . 0.0 110.713 171.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -154.74 132.34 11.33 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.03 150.54 41.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.39 1.45 . . . . 0.0 111.468 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -102.4 115.57 30.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -70.1 149.07 47.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.844 1.656 . . . . 0.0 109.644 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.67 140.91 57.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.76 7.16 85.96 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.219 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -123.34 169.08 11.69 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 119.025 1.413 . . . . 0.0 109.812 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -125.69 27.61 6.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.11 1.364 . . . . 0.0 108.93 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.7 m -125.35 143.3 51.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.042 1.337 . . . . 0.0 108.458 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -99.48 149.48 23.17 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.812 0.845 . . . . 0.0 110.491 -174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -159.77 168.65 25.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.918 1.287 . . . . 0.0 110.214 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.83 152.54 66.24 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -46.99 129.57 15.07 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.582 2.855 . . . . 0.0 111.443 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 7.2 pt20 -161.35 155.88 23.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.163 0.985 . . . . 0.0 110.176 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.55 168.21 40.84 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.265 0.935 . . . . 0.0 111.664 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.03 147.4 39.57 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 11' ' ' VAL . 68.6 mt -74.78 113.36 13.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 169.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.68 144.59 96.27 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.39 127.18 24.49 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.681 1.587 . . . . 0.0 110.883 -169.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.34 -8.83 77.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.75 1.167 . . . . 0.0 114.15 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -74.64 152.84 39.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.829 1.814 . . . . 0.0 111.273 171.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.0 p -86.62 166.81 15.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 167.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.65 -35.78 77.07 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 120.723 -1.236 . . . . 0.0 111.588 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.92 -38.3 61.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.362 0.665 . . . . 0.0 110.534 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -66.55 -40.27 88.97 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.55 -33.26 72.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 119.513 -0.28 . . . . 0.0 110.904 177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.404 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 12.0 tmm? -56.75 -50.42 72.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 60.7 m-85 -66.67 -44.67 81.22 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.915 0.78 . . . . 0.0 111.84 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -54.92 -52.02 64.25 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.474 1.034 . . . . 0.0 111.04 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.96 -36.14 64.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -171.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.5 tp -53.42 -51.14 63.57 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.409 0.684 . . . . 0.0 110.129 171.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.78 -43.23 99.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -63.42 -23.51 67.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.728 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.81 -35.9 4.03 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 120.495 1.498 . . . . 0.0 113.385 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.561 ' HB ' HG23 ' A' ' 111' ' ' ILE . 27.5 m -117.02 5.04 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 119.373 0.988 . . . . 0.0 111.959 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.55 -4.3 9.6 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 120.781 -1.2 . . . . 0.0 114.869 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.1 144.26 34.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.887 1.675 . . . . 0.0 109.987 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -122.58 163.0 20.79 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.296 1.038 . . . . 0.0 109.813 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 47.3 mtp180 -42.02 -40.59 2.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.876 2.07 . . . . 0.0 112.527 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -67.84 -20.86 65.2 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.37 -0.824 . . . . 0.0 113.131 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.56 20.69 15.78 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.366 0.53 . . . . 0.0 111.516 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -137.68 161.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 O-C-N 120.533 -1.354 . . . . 0.0 112.896 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.55 138.81 46.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.09 121.09 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.743 HD11 ' HB2' ' A' ' 103' ' ' GLN . 52.3 mt -94.77 -36.1 11.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.563 0.745 . . . . 0.0 109.77 174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.06 164.8 27.95 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.64 1.176 . . . . 0.0 109.546 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 p -155.54 154.93 32.51 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.593 1.557 . . . . 0.0 108.896 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 ' HG2' ' A' ' 150' ' ' GLU . 0.7 OUTLIER -63.25 136.73 57.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.02 0.914 . . . . 0.0 111.106 -169.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtt-85 -80.16 -30.49 38.87 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.061 1.745 . . . . 0.0 108.419 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 146.6 52.08 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.202 2.201 . . . . 0.0 109.565 176.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -73.89 143.43 45.79 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.94 86.37 6.59 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -68.85 142.59 54.79 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -137.13 142.31 42.26 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.089 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -131.99 141.48 49.29 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.538 2.335 . . . . 0.0 106.451 170.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER -104.87 148.42 36.08 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.464 ' HD2' HD12 ' A' ' 83' ' ' LEU . 74.4 Cg_endo -71.1 153.87 62.53 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.447 2.765 . . . . 0.0 109.148 -177.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.559 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.8 mtmt -68.32 -15.61 63.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -59.55 -31.09 69.1 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 170.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' ' 80' ' ' PRO . 53.4 mt -90.77 -15.35 30.31 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.694 0.798 . . . . 0.0 112.042 -178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 81' ' ' LYS . 95.8 t -67.57 133.37 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -94.51 93.66 7.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.544 0.738 . . . . 0.0 109.195 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -71.09 -23.73 62.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.126 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.81 -26.45 57.25 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.227 0.611 . . . . 0.0 112.485 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -104.6 156.16 18.21 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.726 0.81 . . . . 0.0 109.249 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -130.23 137.54 31.09 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 124.94 1.296 . . . . 0.0 109.974 -169.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.23 144.13 80.03 Favored 'Cis proline' 0 N--CA 1.456 -0.695 0 O-C-N 122.807 0.898 . . . . 0.0 110.309 -10.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 141.76 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.014 0.926 . . . . 0.0 110.351 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 p -100.25 140.93 33.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.397 1.079 . . . . 0.0 110.794 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.05 -14.34 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.341 0.656 . . . . 0.0 112.505 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.01 -175.18 36.19 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -164.39 164.93 21.98 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.317 1.447 . . . . 0.0 110.124 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -106.07 126.13 51.83 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 168.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.41 117.63 34.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 120.341 1.428 . . . . 0.0 108.528 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -94.53 152.86 18.22 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 169.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -136.59 150.54 48.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.299 0.5 . . . . 0.0 109.806 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.404 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 48.8 m-85 -136.57 127.53 27.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.65 117.85 30.11 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -111.29 157.68 19.87 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.743 ' HB2' HD11 ' A' ' 68' ' ' LEU . 8.4 tt0 -110.61 142.43 42.47 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 144.54 38.06 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.669 1.188 . . . . 0.0 109.682 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.35 -44.3 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.2 m -91.03 -30.12 16.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.385 0.674 . . . . 0.0 111.464 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.58 -178.41 16.41 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.778 1.18 . . . . 0.0 110.478 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -52.46 -25.45 10.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.389 1.876 . . . . 0.0 113.143 -176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.7 -31.08 62.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.051 1.34 . . . . 0.0 113.916 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.84 16.03 2.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -170.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.561 HG23 ' HB ' ' A' ' 58' ' ' VAL . 77.9 mt -100.71 134.94 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 107.371 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -123.6 122.58 38.53 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 125.98 1.712 . . . . 0.0 107.311 174.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.7 mmt -84.32 -17.96 37.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.045 0.538 . . . . 0.0 112.201 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.55 71.81 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.144 1.778 . . . . 0.0 107.293 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.7 p -75.52 -64.86 0.98 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.131 -1.85 . . . . 0.0 108.487 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.5 m -85.62 -178.18 6.59 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.082 1.753 . . . . 0.0 108.648 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 m -56.7 -35.77 68.89 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.733 -0.604 . . . . 0.0 109.925 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.96 130.46 46.42 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.936 1.694 . . . . 0.0 107.722 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.39 135.56 37.02 Favored 'Trans proline' 0 N--CA 1.442 -1.517 0 N-CA-C 107.499 -1.77 . . . . 0.0 107.499 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.73 -21.64 63.45 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -121.98 142.23 50.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.942 0.897 . . . . 0.0 109.634 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.24 -23.24 38.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 111.072 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.51 156.95 27.54 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.41 151.44 41.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 109.159 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -153.93 169.91 22.31 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 124.616 1.166 . . . . 0.0 109.015 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -124.47 137.29 54.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.57 158.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.406 1.482 . . . . 0.0 111.057 -168.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -64.32 145.27 56.3 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.127 -0.983 . . . . 0.0 109.277 169.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -30.87 49.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -86.72 -21.23 26.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.354 1.433 . . . . 0.0 112.568 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -63.48 -43.46 78.78 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 116.594 -1.669 . . . . 0.0 114.149 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.22 -30.54 91.46 Favored 'Trans proline' 0 C--N 1.353 0.784 0 CA-C-N 123.364 2.237 . . . . 0.0 112.833 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.17 -27.37 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.097 0.959 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -71.39 -24.35 62.05 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.117 -0.99 . . . . 0.0 111.595 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.66 -33.06 41.56 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.314 0.961 . . . . 0.0 112.533 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 m -83.76 166.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -85.1 174.38 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.569 1.548 . . . . 0.0 109.126 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.3 m -54.04 -44.79 71.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.442 1.497 . . . . 0.0 114.418 -173.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -64.1 -41.95 97.08 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.111 0.868 . . . . 0.0 111.463 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -79.78 -35.65 38.26 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.282 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -52.0 -45.92 64.7 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.232 0.924 . . . . 0.0 110.527 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.96 -44.31 89.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.323 0.511 . . . . 0.0 110.864 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.15 -52.29 49.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -69.25 -30.57 68.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.157 -169.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -66.49 -42.35 87.55 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.507 1.503 . . . . 0.0 110.213 169.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -58.78 -46.24 87.97 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 119.231 0.923 . . . . 0.0 110.606 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.17 -24.61 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.657 1.183 . . . . 0.0 112.041 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 31.8 mmt -86.54 -58.11 2.74 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -60.0 -32.97 71.36 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.305 1.042 . . . . 0.0 112.082 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.409 ' HG2' HG22 ' A' ' 71' ' ' THR . 2.0 tp10 -59.08 -34.82 72.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.228 0.922 . . . . 0.0 111.366 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -112.15 -9.05 13.97 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 124.466 1.106 . . . . 0.0 113.343 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.22 -41.47 72.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.977 1.262 . . . . 0.0 110.958 -169.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.0 m -67.8 -32.35 72.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.281 0.632 . . . . 0.0 110.763 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.8 t -69.26 -44.43 80.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.33 -42.34 73.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.432 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.2 mmt -56.95 -54.44 46.58 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 120.235 1.38 . . . . 0.0 110.065 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.6 m -70.32 -26.59 63.83 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.835 1.254 . . . . 0.0 110.787 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.62 ' HG ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -65.79 -36.7 84.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.598 1.959 . . . . 0.0 109.541 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -70.54 -20.73 62.78 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.837 1.199 . . . . 0.0 112.668 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.87 0.93 52.69 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.85 1.66 . . . . 0.0 111.306 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -122.6 -47.43 2.09 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.387 1.075 . . . . 0.0 109.253 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.448 ' HB ' ' CD ' ' A' ' 163' ' ' PRO 0.316 30.2 p -85.5 -176.25 0.74 Allowed Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.448 ' CD ' ' HB ' ' A' ' 162' ' ' THR . 8.1 Cg_endo -85.29 -164.59 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.906 3.07 . . . . 0.0 110.759 -169.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 164' ' ' LYS . 9.1 mmpt? . . . . . 0 C--O 1.25 1.083 0 O-C-N 121.101 -1.0 . . . . 0.0 109.606 170.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.12 140.74 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 168.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.55 -45.98 81.29 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 112.978 -169.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -147.71 -118.81 0.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.175 0.99 . . . . 0.0 108.784 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.14 -15.63 56.67 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.675 1.59 . . . . 0.0 111.396 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.16 178.82 47.51 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 126.133 1.825 . . . . 0.0 109.567 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.4 153.15 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.617 2.767 . . . . 0.0 113.743 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.69 137.56 15.34 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 120.506 -1.371 . . . . 0.0 107.974 174.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -74.09 140.88 28.77 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.323 2.015 . . . . 0.0 109.42 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -141.27 154.09 45.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.765 0.826 . . . . 0.0 109.143 -170.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 98' ' ' LYS . 3.3 m -129.29 136.32 59.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 125.524 1.53 . . . . 0.0 107.475 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' ' CZ3' ' A' ' 99' ' ' TRP . . . -122.03 158.09 16.75 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 172.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -124.12 144.33 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 125.619 1.568 . . . . 0.0 107.556 -171.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 t -128.65 137.12 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm -120.94 134.17 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 101' ' ' LEU . 19.2 p -124.83 158.24 33.91 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.1 0.864 . . . . 0.0 112.267 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.0 p30 -108.24 170.6 7.91 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.462 1.505 . . . . 0.0 108.658 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -0.56 15.88 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.095 -1.628 . . . . 0.0 113.648 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -81.61 -6.51 59.07 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.679 0.672 . . . . 0.0 110.544 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.78 18.68 78.66 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.028 -0.874 . . . . 0.0 111.489 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -89.15 150.36 22.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.73 148.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.967 1.707 . . . . 0.0 109.487 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 32.9 tpp -63.53 128.4 35.66 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.706 1.202 . . . . 0.0 108.175 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 33' ' ' TRP . 10.0 t90 -146.73 140.45 25.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.45 146.55 33.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.669 1.122 . . . . 0.0 113.653 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -85.53 121.32 28.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.329 1.852 . . . . 0.0 106.704 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -79.66 149.62 31.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.63 1.559 . . . . 0.0 109.349 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -44.42 117.09 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.061 1.745 . . . . 0.0 110.925 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.62 -1.07 31.39 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.738 1.161 . . . . 0.0 115.499 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -83.39 -31.25 26.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.747 1.774 . . . . 0.0 111.987 -172.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.8 m80 54.66 31.2 14.75 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.518 1.127 . . . . 0.0 112.008 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.2 m -138.43 154.03 48.87 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.548 1.939 . . . . 0.0 107.518 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 24' ' ' TRP . 77.4 m95 -108.55 151.76 25.67 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.109 0.564 . . . . 0.0 111.176 -169.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -148.17 159.71 43.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.921 1.688 . . . . 0.0 110.833 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.3 141.39 29.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 166.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.77 130.19 32.13 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 0.0 111.586 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -159.5 162.26 35.49 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.243 0.929 . . . . 0.0 112.764 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.19 176.98 47.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.421 1.01 . . . . 0.0 111.926 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.85 150.16 32.25 Favored Glycine 0 N--CA 1.446 -0.648 0 O-C-N 121.166 -1.196 . . . . 0.0 111.859 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 11' ' ' VAL . 46.1 mt -79.94 129.37 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 168.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -71.95 152.86 93.0 Favored Pre-proline 0 N--CA 1.466 0.353 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -57.53 123.58 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 120.962 1.108 . . . . 0.0 109.334 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.91 -5.58 84.43 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.384 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.05 155.47 37.19 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 120.237 2.018 . . . . 0.0 109.681 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.7 m -97.19 154.93 17.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.43 88.53 Favored 'General case' 0 C--O 1.224 -0.276 0 O-C-N 121.464 -0.773 . . . . 0.0 112.32 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.96 -34.35 75.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.951 0.501 . . . . 0.0 109.96 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -68.03 -42.96 79.79 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.08 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.15 81.5 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 119.272 -0.395 . . . . 0.0 110.15 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.0 tmm? -57.41 -49.02 77.56 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.49 -35.18 79.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.035 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -62.95 -46.21 88.84 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.817 1.644 . . . . 0.0 109.686 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -69.15 -25.55 64.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.708 -0.62 . . . . 0.0 110.728 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.22 -43.12 95.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.746 -1.221 . . . . 0.0 109.774 172.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -65.19 -37.11 86.3 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.754 -0.591 . . . . 0.0 110.389 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.33 -35.56 66.05 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.425 -0.797 . . . . 0.0 112.629 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.3 -57.14 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.335 0.654 . . . . 0.0 110.294 -169.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.01 -15.78 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.713 0.805 . . . . 0.0 110.15 -172.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.71 19.29 79.17 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.716 -0.615 . . . . 0.0 111.737 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.7 tp -108.48 150.86 26.85 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.683 1.993 . . . . 0.0 108.266 -172.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.7 m -127.58 168.22 15.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.607 0.763 . . . . 0.0 109.819 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -49.51 -33.95 15.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.664 1.585 . . . . 0.0 112.606 -173.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -65.33 -23.36 66.98 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.31 -0.853 . . . . 0.0 112.037 -172.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.98 24.66 10.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.488 0.661 . . . . 0.0 112.708 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -134.15 165.24 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.336 1.054 . . . . 0.0 111.34 171.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -141.06 141.37 34.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mt -80.51 120.59 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 103' ' ' GLN . 79.9 mt -96.49 -35.52 11.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.816 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -157.01 161.97 39.56 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.338 0.59 . . . . 0.0 110.16 -172.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 p -158.16 155.2 28.66 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.651 1.58 . . . . 0.0 109.526 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.525 HG22 ' HG3' ' A' ' 150' ' ' GLU . 0.6 OUTLIER -66.7 143.64 56.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.69 0.757 . . . . 0.0 111.595 -170.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -80.47 -29.34 37.44 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.199 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -136.74 152.23 50.11 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.594 2.358 . . . . 0.0 109.065 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -76.06 136.93 39.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.75 102.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -106.94 146.19 31.34 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -147.67 146.36 29.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 169.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -91.26 144.68 25.36 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -71.46 149.22 93.63 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 123.943 0.897 . . . . 0.0 110.55 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.52 144.91 74.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 N-CA-C 105.082 -2.699 . . . . 0.0 105.082 167.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.4 mtpt -68.52 -12.1 60.78 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.242 -1.536 . . . . 0.0 113.831 -169.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -58.14 -31.62 67.37 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 70.9 mt -90.0 -23.08 21.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 111.817 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 81' ' ' LYS . 53.1 t -66.05 137.96 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 109.45 -177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -107.82 90.99 3.47 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.14 0.976 . . . . 0.0 109.934 169.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -68.55 -24.6 64.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.825 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.58 -24.74 60.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.69 0.796 . . . . 0.0 112.433 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 t -111.3 156.79 20.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.228 1.011 . . . . 0.0 109.293 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -129.9 140.16 37.82 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.101 1.36 . . . . 0.0 109.239 -169.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.74 150.8 96.06 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 O-C-N 122.826 0.908 . . . . 0.0 110.865 -10.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.7 136.8 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.922 0.889 . . . . 0.0 111.656 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.2 t -81.85 108.37 15.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.6 -14.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.727 0.811 . . . . 0.0 112.584 170.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.37 -174.52 47.03 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.99 157.9 36.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.544 1.538 . . . . 0.0 109.11 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -112.3 125.61 54.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 169.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -117.26 129.54 55.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.013 0.824 . . . . 0.0 111.405 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HB2' HG12 ' A' ' 11' ' ' VAL . 32.5 mmtt -88.04 154.04 20.79 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.44 ' CZ3' ' HA3' ' A' ' 12' ' ' GLY . 84.5 m95 -132.54 143.6 49.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -130.41 132.5 45.77 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.572 1.149 . . . . 0.0 107.926 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 22.1 tp -97.06 126.03 41.93 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.85 146.64 43.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' LEU . 1.6 tt0 -95.72 133.34 39.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 167.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.97 130.78 47.21 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.225 1.41 . . . . 0.0 108.542 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.9 t -86.31 -38.6 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.587 0.631 . . . . 0.0 110.803 -169.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.5 m -95.41 -21.15 18.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.865 0.757 . . . . 0.0 112.302 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.65 -176.43 24.07 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.95 -19.24 28.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.686 1.594 . . . . 0.0 114.506 -169.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.33 -31.46 33.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.378 1.071 . . . . 0.0 112.912 171.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -92.85 16.07 13.32 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.86 141.17 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -126.23 -49.38 1.56 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.529 0.732 . . . . 0.0 111.676 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 68.64 9.87 7.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.3 2.24 . . . . 0.0 115.2 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.26 69.66 0.83 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 124.325 2.012 . . . . 0.0 111.227 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -56.37 5.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.347 169.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.6 m -63.99 160.92 16.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.044 1.337 . . . . 0.0 109.063 168.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 m -63.57 -33.17 75.01 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.99 -0.444 . . . . 0.0 110.721 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.53 131.38 38.28 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.356 1.463 . . . . 0.0 110.27 170.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.67 132.67 31.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.212 1.941 . . . . 0.0 107.883 168.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -73.4 -23.65 60.19 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.862 -0.524 . . . . 0.0 111.074 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -116.12 139.29 50.46 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.543 0.737 . . . . 0.0 110.085 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.74 -21.09 34.85 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.072 0.949 . . . . 0.0 110.709 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -165.93 158.57 31.53 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.39 155.53 47.59 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.167 0.983 . . . . 0.0 108.497 169.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -144.79 149.03 34.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -96.9 98.11 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.52 168.92 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.449 1.5 . . . . 0.0 110.296 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 86.4 p -64.31 168.13 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 109.507 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -30.68 70.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.196 -0.94 . . . . 0.0 111.563 175.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -92.01 -32.7 15.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.127 1.331 . . . . 0.0 113.607 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -54.39 -45.25 99.37 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 116.825 -1.559 . . . . 0.0 114.326 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.74 -19.96 68.01 Favored 'Trans proline' 0 C--N 1.35 0.654 0 CA-C-N 123.273 2.205 . . . . 0.0 113.646 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 t -70.83 -33.68 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.11 -37.11 85.92 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.268 -0.895 . . . . 0.0 111.11 -172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -78.75 -27.0 44.65 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -170.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.78 166.23 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 118.804 0.729 . . . . 0.0 111.229 -173.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.65 174.23 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.855 1.262 . . . . 0.0 109.857 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.2 m -54.59 -49.42 70.45 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.493 1.517 . . . . 0.0 113.429 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -60.1 -39.09 84.96 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.317 0.647 . . . . 0.0 111.146 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -85.6 -40.14 16.57 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.974 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -46.85 -46.33 20.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.861 0.864 . . . . 0.0 111.097 170.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.83 -35.49 78.4 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.484 0.713 . . . . 0.0 111.367 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.14 -50.8 17.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 C-N-CA 124.236 1.015 . . . . 0.0 110.169 171.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -61.78 -32.69 72.99 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.302 0.955 . . . . 0.0 111.586 -169.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -63.71 -42.99 97.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.259 0.936 . . . . 0.0 111.27 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -61.88 -44.7 96.27 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.83 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 76.7 t -55.73 -30.84 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.484 1.038 . . . . 0.0 111.222 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.4 mmt -86.25 -54.81 4.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.362 1.065 . . . . 0.0 108.717 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.26 -36.49 73.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.076 0.853 . . . . 0.0 111.635 -175.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 71' ' ' THR . 4.4 mm-40 -57.73 -40.13 78.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.143 0.977 . . . . 0.0 111.077 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.24 -14.15 13.86 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.713 0.805 . . . . 0.0 111.025 -172.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.31 57.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 111.139 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 m -66.34 -31.48 72.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.312 0.645 . . . . 0.0 111.067 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.32 -45.91 67.63 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -58.47 -41.12 80.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 CA-C-O 116.949 -1.5 . . . . 0.0 110.217 -173.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.3 mmt -54.48 -49.42 70.15 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 121.137 1.79 . . . . 0.0 110.318 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.6 m -76.64 -26.48 54.94 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.355 1.062 . . . . 0.0 111.144 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 18.6 tp -62.68 -44.22 96.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.111 1.365 . . . . 0.0 109.411 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -60.12 -39.9 87.83 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.845 0.458 . . . . 0.0 110.827 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.41 -32.67 54.91 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -95.26 -22.86 17.52 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.198 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.259 14.6 p 44.36 60.18 12.48 Favored Pre-proline 0 N--CA 1.445 -0.678 0 C-N-CA 126.431 1.892 . . . . 0.0 110.071 -172.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -62.44 158.38 41.12 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 120.687 0.924 . . . . 0.0 113.524 -168.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 C--O 1.252 1.207 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -169.294 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 61.43 122.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 127.628 2.371 . . . . 0.0 110.611 -169.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -63.76 -67.08 0.46 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -169.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -162.68 -52.64 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.82 14.83 12.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 112.776 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.85 1.08 77.31 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.788 1.185 . . . . 0.0 114.001 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.51 165.28 11.18 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.917 0.865 . . . . 0.0 109.223 169.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -148.47 145.74 20.98 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.163 1.385 . . . . 0.0 107.456 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HB2' HD12 ' A' ' 40' ' ' ILE . 93.1 Cg_endo -85.71 133.39 4.37 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.476 1.451 . . . . 0.0 109.935 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.7 150.01 52.29 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 109.253 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.461 HG13 HD11 ' A' ' 40' ' ' ILE . 18.3 m -129.13 154.97 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.071 0.948 . . . . 0.0 108.83 170.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.13 158.29 25.23 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.49 143.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.565 1.146 . . . . 0.0 108.06 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.14 136.73 58.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 mm -117.45 135.96 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' HD11 ' A' ' 101' ' ' LEU . 15.6 p -123.56 153.76 40.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.987 0.812 . . . . 0.0 112.117 171.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -103.72 175.12 5.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.425 1.49 . . . . 0.0 109.156 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -78.27 8.07 5.51 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.466 -1.396 . . . . 0.0 113.241 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -96.52 -5.76 38.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.439 1.096 . . . . 0.0 111.447 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.5 23.79 66.9 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.867 0.758 . . . . 0.0 111.885 -172.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -98.11 150.35 21.53 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -114.39 146.47 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.352 1.861 . . . . 0.0 106.938 174.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 ptm -78.95 147.69 32.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.851 0.75 . . . . 0.0 109.672 172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 20.3 t90 -148.55 146.59 28.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.63 148.2 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.977 1.262 . . . . 0.0 111.701 -170.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -99.5 127.79 45.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.81 0.732 . . . . 0.0 109.203 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -78.18 145.69 35.45 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.699 0.681 . . . . 0.0 109.867 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.13 136.1 57.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.066 0.946 . . . . 0.0 109.508 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.96 -8.86 10.26 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.885 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -100.88 -45.21 5.51 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.328 1.564 . . . . 0.0 110.083 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 53.92 29.56 10.15 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.844 1.258 . . . . 0.0 111.826 -174.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -120.28 148.48 43.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.895 2.078 . . . . 0.0 106.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 70.3 m95 -92.82 148.61 21.89 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -152.24 162.89 40.47 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.538 1.935 . . . . 0.0 110.141 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.54 141.23 23.17 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 167.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.39 135.92 44.79 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.036 2.491 . . . . 0.0 111.671 -174.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -158.22 166.96 31.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.445 -171.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.29 172.57 42.31 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.165 0.412 . . . . 0.0 112.127 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.77 143.62 16.83 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.461 HD11 HG13 ' A' ' 11' ' ' VAL . 57.4 mt -76.81 122.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 168.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.99 148.29 78.46 Favored Pre-proline 0 N--CA 1.464 0.253 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.21 124.12 14.55 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.162 1.241 . . . . 0.0 109.055 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.38 -15.79 58.53 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.636 1.112 . . . . 0.0 113.803 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -73.67 148.16 43.02 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 119.856 1.828 . . . . 0.0 108.644 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 p -85.96 168.95 13.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 168.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.59 87.88 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.262 -0.899 . . . . 0.0 110.943 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.97 -39.01 63.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.239 0.616 . . . . 0.0 110.611 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.81 -41.82 86.92 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.638 -0.664 . . . . 0.0 109.59 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.85 79.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.411 0.55 . . . . 0.0 109.629 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -62.02 -51.72 66.89 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.06 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.75 -35.35 79.9 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.916 1.235 . . . . 0.0 111.571 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.35 94.86 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.851 0.86 . . . . 0.0 110.388 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.89 -24.56 26.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.276 0.489 . . . . 0.0 110.933 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.44 HD12 HG21 ' A' ' 58' ' ' VAL . 11.1 tp -55.23 -39.59 69.88 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.152 -0.967 . . . . 0.0 109.471 169.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -63.12 -49.15 75.56 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.004 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -67.63 -32.74 73.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 0.0 112.715 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.8 -46.29 10.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.763 0.711 . . . . 0.0 111.135 -173.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 54' ' ' LEU . 4.6 t -106.75 -31.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.562 1.145 . . . . 0.0 110.975 -168.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.67 87.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.817 1.199 . . . . 0.0 111.778 -169.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 64' ' ' ASP . 22.9 tp -87.79 155.47 19.88 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.456 1.902 . . . . 0.0 110.039 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 p -131.76 164.48 25.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.765 1.226 . . . . 0.0 109.724 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -41.39 -40.56 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 127.315 2.246 . . . . 0.0 112.698 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -64.91 -28.18 69.36 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.42 0.688 . . . . 0.0 112.659 -169.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HB3' HD11 ' A' ' 60' ' ' LEU . 3.8 t70 -111.67 22.6 14.82 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.458 0.647 . . . . 0.0 112.08 -176.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.22 165.38 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 O-C-N 120.769 -1.207 . . . . 0.0 112.544 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.11 137.48 39.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 168.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.7 mt -74.53 119.94 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 171.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 103' ' ' GLN . 88.1 mt -95.76 -33.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.889 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -157.05 163.15 39.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.404 1.082 . . . . 0.0 108.745 -175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 p -162.24 153.24 17.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 124.587 1.155 . . . . 0.0 109.573 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.627 HG22 ' HG3' ' A' ' 150' ' ' GLU . 3.7 p -70.7 136.09 48.76 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.346 -170.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -52.51 21.1 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -72.33 170.4 14.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.582 1.553 . . . . 0.0 111.652 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.477 ' CE2' ' HE3' ' A' ' 98' ' ' LYS . 87.0 m95 -108.44 125.58 51.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 167.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -76.97 106.04 8.4 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -73.62 140.3 46.08 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -124.74 143.32 50.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -131.66 141.7 49.66 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 126.283 1.833 . . . . 0.0 106.081 172.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pp -110.29 150.2 41.22 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.527 1.131 . . . . 0.0 109.613 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 83' ' ' LEU . 82.8 Cg_endo -73.12 158.18 49.57 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.427 3.418 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.6 mtmt -68.41 -18.41 64.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -60.41 -29.07 68.74 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 171.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD12 ' HD2' ' A' ' 80' ' ' PRO . 52.0 mt -94.55 -7.89 39.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.123 0.969 . . . . 0.0 112.416 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 81' ' ' LYS . 74.2 t -70.03 132.02 33.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.74 97.01 10.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -75.6 -19.52 59.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.861 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.29 -27.94 56.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.8 t -101.12 158.17 16.22 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.125 0.97 . . . . 0.0 109.836 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -132.66 132.02 22.43 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 125.967 1.707 . . . . 0.0 109.724 -170.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.5 150.72 89.94 Favored 'Cis proline' 0 CA--C 1.541 0.854 0 O-C-N 122.879 0.936 . . . . 0.0 110.858 -10.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.24 141.55 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.899 1.28 . . . . 0.0 111.269 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.0 p -81.24 123.18 28.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.62 -16.11 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.843 0.747 . . . . 0.0 111.449 169.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.2 -174.16 40.07 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -160.96 162.84 32.05 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.223 1.809 . . . . 0.0 110.536 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -98.6 129.58 45.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -111.72 143.32 42.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 120.045 1.293 . . . . 0.0 110.237 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 74' ' ' TRP . 6.2 ttmm -131.88 118.92 20.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -104.43 153.89 20.55 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.65 125.31 30.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.58 HD11 ' SG ' ' A' ' 16' ' ' CYS . 13.1 tp -91.16 121.41 32.92 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 168.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.67 157.09 23.59 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.682 ' HB2' HD11 ' A' ' 68' ' ' LEU . 5.1 tt0 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 167.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 141.23 56.62 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.956 1.303 . . . . 0.0 109.43 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.94 -47.51 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.114 0.566 . . . . 0.0 110.094 -171.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 71.8 m -86.1 -16.0 39.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.138 0.575 . . . . 0.0 111.55 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.25 -169.61 22.84 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -17.01 53.55 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 125.264 1.426 . . . . 0.0 114.311 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.68 57.05 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.917 0.887 . . . . 0.0 111.76 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -91.71 51.76 1.91 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 110.958 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.16 129.61 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.76 -53.72 2.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.375 0.67 . . . . 0.0 111.406 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mtp 67.57 12.01 8.66 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.948 2.099 . . . . 0.0 114.628 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -150.31 73.89 1.17 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 124.016 1.865 . . . . 0.0 109.713 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -71.93 -60.08 2.41 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 112.269 -2.241 . . . . 0.0 107.843 171.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -66.71 166.44 13.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.332 1.453 . . . . 0.0 109.917 169.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.6 p -57.43 -38.01 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.895 . . . . 0.0 110.829 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 130.52 54.77 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.865 1.266 . . . . 0.0 110.454 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.99 142.0 73.02 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.926 1.751 . . . . 0.0 108.453 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -81.34 -24.94 36.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.552 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.08 140.04 53.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.303 0.956 . . . . 0.0 109.998 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.0 -17.97 24.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.691 1.196 . . . . 0.0 111.371 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.85 151.82 23.19 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.57 148.85 31.57 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.816 0.847 . . . . 0.0 108.778 171.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -148.52 172.65 14.16 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.905 1.282 . . . . 0.0 109.204 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -112.97 139.77 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.59 152.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 109.853 -169.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m -59.94 147.9 37.09 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.819 0.736 . . . . 0.0 109.419 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -38.16 37.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -88.53 -25.1 22.71 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -170.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -57.87 -47.82 98.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.055 -1.45 . . . . 0.0 113.693 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -63.84 -21.3 69.24 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.865 2.059 . . . . 0.0 113.171 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.62 -36.38 75.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -62.85 -35.57 80.38 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.285 -0.885 . . . . 0.0 111.099 -172.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.89 -21.4 34.27 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -81.73 167.87 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 119.389 0.995 . . . . 0.0 110.251 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.0 m -87.2 176.03 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.719 1.208 . . . . 0.0 110.638 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 m -53.12 -48.5 67.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.021 1.729 . . . . 0.0 114.494 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -74.5 -31.34 62.15 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.257 -0.902 . . . . 0.0 111.394 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -80.77 -40.16 25.61 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.253 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -44.33 -46.2 9.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 0.0 111.633 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -64.96 -42.45 94.6 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.302 0.501 . . . . 0.0 111.352 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -67.5 -44.84 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 121.638 -0.664 . . . . 0.0 109.361 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.45 -41.76 98.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ptt85 -66.34 -43.9 84.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.159 0.891 . . . . 0.0 110.333 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -61.31 -47.73 84.6 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.276 0.944 . . . . 0.0 110.071 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.1 -39.45 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.733 1.213 . . . . 0.0 110.431 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 36.2 mmt -69.49 -54.45 14.19 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -57.24 -34.66 68.82 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.878 0.871 . . . . 0.0 111.774 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.627 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -56.07 -45.55 79.29 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.281 1.033 . . . . 0.0 110.185 -178.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.445 ' CZ ' HG23 ' A' ' 71' ' ' THR . 3.1 m-85 -104.63 -9.52 18.19 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.485 0.714 . . . . 0.0 112.381 -173.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.13 -43.81 70.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.133 1.773 . . . . 0.0 110.548 -173.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.7 m -66.7 -31.99 73.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.514 0.726 . . . . 0.0 110.463 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.63 -47.14 81.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 CA-C-O 118.055 -0.974 . . . . 0.0 108.384 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.6 t -58.42 -45.35 89.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 109.48 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.9 mtt -61.62 -33.82 74.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 118.624 0.647 . . . . 0.0 111.216 -173.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -82.79 -31.36 28.27 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.575 1.15 . . . . 0.0 110.824 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.413 HD21 ' NE2' ' A' ' 103' ' ' GLN . 28.1 tp -58.33 -40.25 81.61 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.154 1.782 . . . . 0.0 110.155 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.93 -29.75 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.194 0.598 . . . . 0.0 111.985 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -93.74 -8.47 40.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.825 1.65 . . . . 0.0 111.74 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -110.63 -22.87 11.4 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.919 1.287 . . . . 0.0 111.397 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.7 p -124.08 38.31 0.38 Allowed Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.3 -178.88 2.36 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.454 2.769 . . . . 0.0 111.25 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.159 0 C-N-CA 126.279 1.832 . . . . 0.0 110.026 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tmm? . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.37 128.84 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 169.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.23 -64.83 0.81 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.4 -50.69 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.31 16.79 14.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.609 1.164 . . . . 0.0 113.084 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.44 10.47 67.94 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.888 0.756 . . . . 0.0 113.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -105.0 155.6 18.81 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.39 1.076 . . . . 0.0 108.714 170.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.96 147.76 67.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.446 169.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HB2' HD12 ' A' ' 40' ' ' ILE . 92.5 Cg_endo -85.55 142.23 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.664 2.243 . . . . 0.0 110.528 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -143.57 155.44 44.3 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.252 1.421 . . . . 0.0 109.498 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.17 153.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.072 0.549 . . . . 0.0 110.372 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.74 160.37 19.36 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.84 146.55 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.0 t -124.76 135.9 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.9 mm -112.03 134.75 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 169.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.0 m -124.12 145.38 49.32 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.842 0.714 . . . . 0.0 110.008 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -104.22 173.53 6.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.116 1.366 . . . . 0.0 108.51 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.31 9.86 5.27 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.5 -1.375 . . . . 0.0 112.632 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -98.41 -3.51 36.69 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.099 1.36 . . . . 0.0 111.444 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.2 21.54 70.19 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 118.777 0.717 . . . . 0.0 111.916 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.98 150.7 21.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.647 1.223 . . . . 0.0 107.842 172.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.87 151.04 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 108.296 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.3 mtp -70.56 147.57 49.14 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.277 0.49 . . . . 0.0 110.026 169.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 33' ' ' TRP . 14.4 t90 -151.2 141.16 22.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.62 145.74 47.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.886 1.221 . . . . 0.0 112.28 -169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -97.13 107.95 20.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.961 2.105 . . . . 0.0 107.143 -175.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -74.7 139.32 43.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.556 1.525 . . . . 0.0 109.939 -169.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.68 135.99 57.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.36 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.55 -24.56 3.64 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.546 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -82.49 -44.68 15.68 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.56 1.68 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m80 59.47 28.45 17.83 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.23 0.956 . . . . 0.0 109.734 -168.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -122.93 155.27 37.08 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 108.025 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 24' ' ' TRP . 73.5 m95 -101.88 146.53 27.7 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -169.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -149.43 164.06 36.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.512 1.525 . . . . 0.0 110.334 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -87.52 143.95 34.82 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 130.49 33.95 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.431 2.087 . . . . 0.0 110.59 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -159.07 168.17 27.37 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.113 0.87 . . . . 0.0 112.244 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.44 163.52 37.24 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.653 0.644 . . . . 0.0 111.661 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.6 150.85 45.52 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 9' ' ' PRO . 67.7 mt -77.55 113.39 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -70.93 156.03 92.58 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.58 123.9 12.83 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 CA-C-N 120.719 1.293 . . . . 0.0 109.674 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.09 -5.35 78.56 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-O 118.558 -1.134 . . . . 0.0 114.212 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -74.34 154.19 38.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.075 1.937 . . . . 0.0 110.524 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.4 p -94.56 168.37 10.9 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.46 90.02 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 121.024 -1.048 . . . . 0.0 111.342 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.06 -38.62 72.5 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.146 0.578 . . . . 0.0 110.26 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -67.69 -39.18 84.45 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.8 92.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 102' ' ' LEU . 12.6 tmm? -60.52 -52.52 64.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.6 m-85 -66.46 -44.44 82.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.973 0.806 . . . . 0.0 111.465 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -44.78 80.04 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 121.816 -0.552 . . . . 0.0 110.337 -173.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -71.54 -37.14 71.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 tp -53.76 -43.83 69.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.094 0.861 . . . . 0.0 110.588 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -59.27 -39.14 81.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.232 0.469 . . . . 0.0 110.834 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.11 -18.71 60.19 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.3 -0.875 . . . . 0.0 112.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -90.03 -50.38 6.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.666 0.787 . . . . 0.0 110.563 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.86 3.33 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.685 1.194 . . . . 0.0 111.837 -169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.58 -1.52 14.26 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 120.469 -1.395 . . . . 0.0 113.529 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -80.72 144.42 32.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.186 1.794 . . . . 0.0 109.741 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 p -125.04 166.3 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 109.445 -174.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 56.7 mtt180 -48.96 -35.28 14.73 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.361 1.464 . . . . 0.0 112.43 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -65.35 -24.28 67.21 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.82 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -116.29 22.84 12.57 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.491 0.662 . . . . 0.0 112.113 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.19 164.24 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.675 1.19 . . . . 0.0 112.212 170.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.35 134.52 29.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 117.576 -1.202 . . . . 0.0 108.114 168.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mt -71.27 113.64 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 174.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 103' ' ' GLN . 68.7 mt -91.54 -33.99 14.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.848 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . . . -153.93 165.42 36.15 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.406 0.682 . . . . 0.0 109.344 -174.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.0 p -159.09 157.53 31.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.61 1.164 . . . . 0.0 110.422 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -75.04 134.72 41.34 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.562 -0.711 . . . . 0.0 109.169 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.11 -48.17 25.09 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -79.41 165.17 23.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.022 1.329 . . . . 0.0 110.461 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 68.5 m95 -102.79 128.65 49.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 167.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -80.3 92.34 5.75 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -81.41 145.31 30.86 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.74 151.16 49.87 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -128.43 133.13 48.49 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.758 1.623 . . . . 0.0 106.898 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 mt -90.64 147.9 37.35 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.36 0.664 . . . . 0.0 112.715 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.2 150.53 71.72 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 105.046 -2.713 . . . . 0.0 105.046 166.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' HG23 ' A' ' 84' ' ' VAL . 48.8 mtpt -69.35 -13.45 62.38 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 119.805 -1.809 . . . . 0.0 114.147 -169.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -62.16 -31.38 71.86 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.821 0.737 . . . . 0.0 112.76 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.08 -18.69 21.55 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.107 0.963 . . . . 0.0 112.009 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 81' ' ' LYS . 86.5 t -62.91 134.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.53 83.96 3.89 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.151 0.976 . . . . 0.0 110.223 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -67.29 -19.92 65.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.066 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.49 -20.99 53.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 t -107.07 160.88 15.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.948 0.899 . . . . 0.0 109.965 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -130.43 127.07 22.35 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 125.442 1.497 . . . . 0.0 109.19 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.39 159.53 91.49 Favored 'Cis proline' 0 CA--C 1.537 0.67 0 O-C-N 122.717 0.851 . . . . 0.0 111.246 -10.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 80.5 t -75.01 140.04 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 123.906 0.882 . . . . 0.0 110.045 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.6 p -91.89 121.45 33.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.697 1.199 . . . . 0.0 108.925 169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.29 -13.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.803 0.728 . . . . 0.0 112.716 171.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.91 46.49 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -157.01 161.48 39.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.675 1.19 . . . . 0.0 109.566 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -112.43 132.69 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -123.29 122.15 37.62 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.429 0.692 . . . . 0.0 109.524 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 8.2 ttmm -105.97 140.35 39.1 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -124.67 156.16 38.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.676 0.671 . . . . 0.0 109.364 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -139.8 127.01 21.17 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.161 0.984 . . . . 0.0 108.516 -173.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -88.82 116.3 26.99 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 50' ' ' MET . 9.6 mp -112.11 137.46 50.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.866 0.867 . . . . 0.0 108.917 172.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 68' ' ' LEU . 2.3 tt0 -89.99 134.88 33.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.477 1.49 . . . . 0.0 107.213 168.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.97 133.43 51.72 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.64 1.576 . . . . 0.0 107.269 170.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.34 -55.24 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.834 1.197 . . . . 0.0 110.634 -170.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.1 m -75.78 -19.46 58.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.59 0.756 . . . . 0.0 111.227 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.44 27.26 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -57.75 -18.18 19.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.084 1.754 . . . . 0.0 114.367 -169.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.03 10.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.268 1.027 . . . . 0.0 112.619 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -87.15 14.97 6.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.1 mt -91.33 137.9 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -129.27 128.46 43.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.337 1.855 . . . . 0.0 106.874 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.1 mmt -97.91 -11.04 23.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.579 0.627 . . . . 0.0 111.526 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.91 63.32 0.71 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.979 2.112 . . . . 0.0 106.587 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -68.65 -60.05 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 127.185 2.194 . . . . 0.0 109.361 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -90.67 174.87 7.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.457 1.903 . . . . 0.0 110.021 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 m -60.17 -25.72 65.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.192 0.997 . . . . 0.0 112.004 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.94 136.82 23.37 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 168.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.69 155.2 68.4 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.575 2.183 . . . . 0.0 111.8 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -82.39 -35.25 27.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.745 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.67 137.8 54.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.574 0.75 . . . . 0.0 109.437 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.3 -26.71 56.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.837 0.855 . . . . 0.0 110.787 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.89 166.84 38.33 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.39 160.01 44.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 169.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -145.65 167.05 24.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.79 133.93 50.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 151.29 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.853 1.261 . . . . 0.0 110.083 -169.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -60.73 146.6 45.28 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -33.53 30.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.022 1.329 . . . . 0.0 113.698 -169.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -91.72 -14.75 29.46 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -65.17 -47.81 71.05 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.335 -1.317 . . . . 0.0 112.858 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.55 -28.88 83.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 CA-C-N 122.547 1.945 . . . . 0.0 112.35 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.15 -25.82 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.191 1.396 . . . . 0.0 109.819 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -65.87 -31.42 72.36 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.424 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -100.01 -22.16 15.35 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.75 151.89 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 118.793 0.724 . . . . 0.0 110.065 171.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.36 176.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.688 1.195 . . . . 0.0 109.706 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -55.38 -44.3 75.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.393 1.477 . . . . 0.0 112.911 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -70.65 -41.75 71.73 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 111.088 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -79.42 -41.06 28.49 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.83 -0.544 . . . . 0.0 110.731 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -61.63 -29.41 70.04 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.853 0.751 . . . . 0.0 112.383 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.17 -45.75 87.01 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.497 0.589 . . . . 0.0 110.688 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.25 -47.14 91.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.525 -0.734 . . . . 0.0 109.099 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -61.62 -45.52 93.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -66.08 -40.65 90.99 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.971 -1.081 . . . . 0.0 110.933 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -60.63 -48.02 83.65 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.474 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.01 -39.9 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.279 1.032 . . . . 0.0 110.039 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 34.6 mmt -67.12 -52.83 36.98 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.996 0.919 . . . . 0.0 108.647 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -32.77 70.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.462 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -29.54 69.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 119.37 0.987 . . . . 0.0 112.006 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.422 ' HB3' HD12 ' A' ' 101' ' ' LEU . 14.9 m-85 -111.37 -14.47 13.76 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.09 0.956 . . . . 0.0 113.468 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.28 69.33 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.371 1.468 . . . . 0.0 110.641 -169.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 m -68.53 -31.97 71.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.864 0.866 . . . . 0.0 110.687 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 69' ' ' ALA . 41.5 t -68.62 -43.67 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.68 -39.91 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.458 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 16.0 mmt -57.44 -50.38 73.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.643 1.11 . . . . 0.0 109.852 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 m -73.31 -28.04 61.87 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.173 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.408 HD21 ' NE2' ' A' ' 103' ' ' GLN . 65.6 tp -62.01 -42.58 99.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.666 1.186 . . . . 0.0 110.152 172.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.44 -42.52 98.88 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.08 -28.07 64.07 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -170.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.89 -21.13 23.8 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 118.561 -0.733 . . . . 0.0 111.336 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.5 p 38.89 56.44 5.5 Favored Pre-proline 0 N--CA 1.446 -0.67 0 C-N-CA 126.726 2.011 . . . . 0.0 109.306 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.59 167.13 21.73 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 121.081 1.188 . . . . 0.0 111.971 -167.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.4 mttt . . . . . 0 C--O 1.25 1.096 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -169.92 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 119.274 -0.393 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mt -138.56 141.72 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.61 -69.09 0.31 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.246 0.618 . . . . 0.0 112.623 -169.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -163.34 -52.4 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.663 0.785 . . . . 0.0 112.953 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -92.62 17.0 10.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.699 1.199 . . . . 0.0 112.459 -169.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.59 -1.54 85.72 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.744 1.164 . . . . 0.0 113.24 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -88.21 157.88 18.67 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.263 1.025 . . . . 0.0 109.367 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -150.31 127.29 5.4 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 116.996 -1.478 . . . . 0.0 107.292 -169.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -80.32 132.58 9.25 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 121.505 1.47 . . . . 0.0 109.424 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.36 155.61 49.15 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.909 0.884 . . . . 0.0 108.656 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.42 137.77 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.16 154.41 16.82 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.45 141.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 125.397 1.479 . . . . 0.0 107.962 -175.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.1 t -121.88 142.7 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 170.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mm -117.09 142.25 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 117.293 -1.337 . . . . 0.0 107.663 169.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' SG ' HD21 ' A' ' 101' ' ' LEU . 27.6 p -125.78 160.11 30.67 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.651 1.114 . . . . 0.0 112.708 170.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -121.61 172.18 8.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.613 1.565 . . . . 0.0 109.145 176.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -76.99 7.7 4.6 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.439 -1.413 . . . . 0.0 112.977 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -94.08 -5.13 48.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.434 1.093 . . . . 0.0 111.715 174.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.4 31.72 60.75 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -173.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -108.57 154.6 21.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.22 150.3 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 174.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -84.52 143.59 29.25 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -144.65 140.47 28.68 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -175.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.78 158.46 42.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.581 1.537 . . . . 0.0 111.531 -170.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -128.68 145.83 51.05 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.875 1.67 . . . . 0.0 108.45 -171.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -112.11 163.39 14.37 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.341 0.973 . . . . 0.0 109.664 174.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -72.88 153.67 40.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.328 1.051 . . . . 0.0 109.013 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.96 -52.63 3.3 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.138 1.351 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.17 -45.73 66.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.43 0.615 . . . . 0.0 110.079 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.1 m170 56.18 -0.37 0.05 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.292 2.237 . . . . 0.0 115.377 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -77.82 163.23 26.27 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 126.565 1.946 . . . . 0.0 108.348 169.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -112.68 146.7 38.23 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -174.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.34 158.51 44.14 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.958 1.303 . . . . 0.0 110.686 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.62 134.22 65.87 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 169.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -54.34 139.76 73.42 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.214 2.609 . . . . 0.0 112.578 -178.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -161.95 169.17 21.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.161 0.891 . . . . 0.0 112.566 -174.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.86 169.48 42.54 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.156 0.407 . . . . 0.0 112.368 177.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.79 147.51 36.86 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -73.89 114.94 14.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 169.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -68.22 145.72 97.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.19 125.14 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.518 1.479 . . . . 0.0 112.076 -169.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.2 85.93 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.55 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.15 147.55 48.27 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.133 1.967 . . . . 0.0 110.595 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -85.24 156.48 20.95 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 167.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.16 -36.64 75.63 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.014 -1.054 . . . . 0.0 112.119 -169.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.71 -36.67 70.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 110.094 -178.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -70.28 -37.65 74.88 Favored 'General case' 0 C--O 1.23 0.061 0 O-C-N 121.172 -0.955 . . . . 0.0 109.995 177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.14 -34.57 77.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.566 175.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -58.09 -48.65 79.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 62' ' ' ARG . 50.4 m-85 -66.32 -46.91 75.24 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.913 0.779 . . . . 0.0 111.766 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -52.52 -52.51 54.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.133 0.973 . . . . 0.0 110.901 177.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -75.87 -37.35 59.0 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -170.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.1 tp -54.61 -45.41 73.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.814 0.734 . . . . 0.0 110.595 173.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.76 -39.62 89.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.159 0.436 . . . . 0.0 110.28 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.36 -24.64 60.37 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.805 0.729 . . . . 0.0 112.281 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.08 -46.01 12.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.313 0.96 . . . . 0.0 111.459 -175.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.7 m -131.52 4.4 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.845 1.258 . . . . 0.0 112.32 -169.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.93 -2.97 14.5 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 120.431 -1.418 . . . . 0.0 113.513 -178.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.0 tp -78.89 140.88 38.03 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.677 1.591 . . . . 0.0 109.771 -173.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 p -120.96 163.67 17.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.877 1.271 . . . . 0.0 109.902 -171.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 51' ' ' TYR . 67.0 mtt85 -46.58 -37.58 8.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.054 1.742 . . . . 0.0 112.23 -177.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -30.19 71.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.885 -173.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -110.33 21.42 16.71 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.679 1.127 . . . . 0.0 112.011 -173.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.01 165.6 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.53 1.532 . . . . 0.0 111.829 171.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.65 140.31 33.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.11 -1.424 . . . . 0.0 107.279 169.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.52 116.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 177.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 103' ' ' GLN . 78.0 mt -94.58 -33.57 12.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.405 174.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.82 164.04 39.41 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.799 0.84 . . . . 0.0 108.919 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -163.68 154.4 15.92 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.1 0.96 . . . . 0.0 109.879 170.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 150' ' ' GLU . 2.1 p -70.07 139.28 52.57 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -175.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -56.98 4.87 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -72.84 -178.16 2.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.514 1.925 . . . . 0.0 111.062 174.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 98' ' ' LYS . 55.8 m95 -118.75 146.85 44.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -101.12 102.16 13.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.74 137.37 40.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -135.82 143.26 45.05 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 172.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -87.74 139.13 30.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 83' ' ' LEU . 1.1 pp -91.02 148.82 38.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 169.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HD2' HD12 ' A' ' 83' ' ' LEU . 72.8 Cg_endo -71.92 155.14 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.45 2.767 . . . . 0.0 110.497 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -65.75 -20.24 66.19 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.046 -1.034 . . . . 0.0 112.8 -170.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -57.62 -32.81 67.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.688 0.676 . . . . 0.0 112.739 171.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.465 HD12 ' HD2' ' A' ' 80' ' ' PRO . 67.4 mt -91.05 -20.08 22.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.042 0.937 . . . . 0.0 111.436 -177.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.17 134.79 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.5 mmt-85 -109.26 96.21 6.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.126 0.97 . . . . 0.0 109.398 171.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -70.99 -27.15 63.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.237 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.16 -10.32 59.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.309 1.043 . . . . 0.0 112.534 -170.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -129.73 158.9 38.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.928 0.891 . . . . 0.0 108.974 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -127.29 141.5 41.0 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.177 1.391 . . . . 0.0 108.993 -171.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.76 147.55 89.84 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 O-C-N 122.875 0.934 . . . . 0.0 111.35 -10.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -83.72 141.27 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.405 1.082 . . . . 0.0 108.908 175.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.4 t -103.96 139.6 38.88 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.461 0.704 . . . . 0.0 109.533 169.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 -17.42 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 122.937 0.495 . . . . 0.0 111.347 169.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.91 161.97 28.12 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.98 143.41 33.19 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.586 1.154 . . . . 0.0 108.599 -177.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HE2' ' CD2' ' A' ' 74' ' ' TRP . 85.2 tttt -94.72 120.77 35.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -119.15 131.0 55.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.065 1.302 . . . . 0.0 112.893 -172.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 3.7 ttmm -99.4 152.79 19.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -128.54 148.6 50.77 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -175.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -133.58 129.73 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.871 1.269 . . . . 0.0 108.491 -177.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -95.07 125.64 39.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.444 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.13 157.02 31.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.655 ' HB2' HD11 ' A' ' 68' ' ' LEU . 3.0 tt0 -105.84 132.99 51.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 137.83 58.32 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 73.9 t -89.5 -55.33 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 119.611 1.096 . . . . 0.0 109.97 -172.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -76.87 -21.62 54.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.458 0.703 . . . . 0.0 111.432 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.18 169.32 20.56 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -172.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -13.91 26.0 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.573 1.549 . . . . 0.0 114.433 -169.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.63 39.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.286 1.034 . . . . 0.0 112.712 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -83.59 22.17 1.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.39 137.21 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.193 1.397 . . . . 0.0 108.155 174.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -124.03 129.01 50.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.332 1.853 . . . . 0.0 107.888 170.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.8 mmt -93.68 -8.04 42.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.369 0.668 . . . . 0.0 112.697 -176.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -127.22 81.08 1.99 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 124.084 1.897 . . . . 0.0 108.83 -177.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 p -79.57 -64.14 1.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.209 2.603 . . . . 0.0 107.58 178.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.6 m -72.85 174.22 8.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.578 1.551 . . . . 0.0 109.711 169.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -60.53 -36.82 79.32 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.85 -0.531 . . . . 0.0 109.974 173.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.12 136.28 57.54 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.48 1.512 . . . . 0.0 107.991 169.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.23 117.55 4.34 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 122.44 2.093 . . . . 0.0 107.622 169.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -72.99 -18.87 61.31 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.763 -0.586 . . . . 0.0 110.297 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.03 155.88 49.12 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.919 1.288 . . . . 0.0 107.974 168.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.3 -14.77 14.1 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.975 2.11 . . . . 0.0 110.808 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.02 154.55 25.56 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.68 149.88 51.25 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.43 164.96 33.51 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -121.88 132.44 54.57 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.28 162.48 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.166 1.386 . . . . 0.0 111.984 -168.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 34.7 m -69.07 157.56 36.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 109.567 169.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -35.95 78.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 112.651 -171.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -91.31 -27.9 18.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.241 -0.912 . . . . 0.0 112.969 -169.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -51.34 -46.92 89.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 177.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.99 -25.4 59.29 Favored 'Trans proline' 0 C--N 1.352 0.738 0 CA-C-N 122.14 1.8 . . . . 0.0 113.152 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.62 -41.3 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . 0.318 0.0 OUTLIER -74.16 -5.53 42.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.273 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -95.01 -15.93 23.13 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.338 -0.839 . . . . 0.0 113.129 -174.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 m -104.16 172.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.624 1.102 . . . . 0.0 111.771 -175.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.5 m -73.27 166.61 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.905 0.882 . . . . 0.0 109.584 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -52.67 -50.54 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.048 1.739 . . . . 0.0 114.188 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -69.69 -33.12 72.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.656 -0.652 . . . . 0.0 110.888 -175.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -76.81 -37.26 56.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.375 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -51.4 -47.03 63.07 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.008 0.822 . . . . 0.0 109.915 173.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.55 -42.97 99.61 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.868 0.304 . . . . 0.0 110.791 -176.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.69 -50.79 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -58.61 -41.98 87.1 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.607 0.763 . . . . 0.0 109.027 -176.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.98 -52.93 63.66 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.679 0.792 . . . . 0.0 110.345 176.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -54.9 -49.55 70.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.68 -43.77 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.087 0.858 . . . . 0.0 110.491 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 35.8 mmt -69.8 -52.44 25.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -173.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -30.59 71.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.218 0.917 . . . . 0.0 112.234 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.547 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -57.52 -45.31 85.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.793 0.724 . . . . 0.0 110.616 177.577 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.49 ' HB3' HD12 ' A' ' 101' ' ' LEU . 7.3 m-85 -106.11 -11.41 16.11 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.01 66.83 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.169 1.788 . . . . 0.0 110.652 -174.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 m -67.11 -31.64 72.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.591 0.756 . . . . 0.0 110.465 -174.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.91 -45.21 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.3 -44.38 92.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.054 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.02 -47.49 82.91 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 120.453 1.479 . . . . 0.0 110.056 -177.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.7 t -68.61 -31.23 70.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.712 0.405 . . . . 0.0 111.077 -179.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.435 HD21 ' NE2' ' A' ' 103' ' ' GLN . 21.2 tp -64.29 -38.63 91.71 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.124 1.369 . . . . 0.0 110.464 176.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -67.19 -44.15 80.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.803 0.274 . . . . 0.0 110.332 173.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.29 -28.92 64.47 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -81.02 -18.36 47.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.392 -175.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.258 24.1 p 42.48 55.4 10.12 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 126.192 1.797 . . . . 0.0 108.631 -169.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.36 179.42 5.07 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.689 1.593 . . . . 0.0 112.25 -167.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.253 1.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.745 . . . . . . . . 0 0 . 1 stop_ save_